Conventional	O	O
cultivation	O	O
methods	O	O
were	O	O
used	O	O
to	O	O
evaluate	O	O
total	O	O
bacterial	O	O
growth	O	O
.	O	O

Total	O	O
genomic	O	O
DNA	O	O
was	O	O
isolated	O	O
and	O	O
a	O	O
specific	O	O
16S	O	O
rRNA	O	O
gene-targeted	O	O
region	O	O
was	O	O
PCR-amplified	O	O
and	O	O
separated	O	O
by	O	O
denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
.	O	O

A	O	O
combination	O	O
of	O	O
1D	O	O
sodium	O	O
dodecyl	O	O
sulfate	O	O
polyacrylamide	O	O
gel	O	O
electrophoresis	O	O
and	O	O
LC-MS/MS	O	O
methods	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
effect	O	O
of	O	O
the	O	O
protease	O	O
inhibitors	O	O
on	O	O
the	O	O
integrity	O	O
of	O	O
salivary	O	O
proteins	O	O
and	O	O
peptides	O	O
.	O	O

Interestingly	O	O
,	O	O
no	O	O
significant	O	O
differences	O	O
were	O	O
observed	O	O
in	O	O
either	O	O
the	O	O
bacterial	O	O
growth	O	O
and	O	O
composition	O	O
or	O	O
the	O	O
integrity	O	O
of	O	O
salivary	O	O
proteins	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

Correlation	O	O
coefficients	O	O
between	O	O
the	O	O
paired	O	O
samples	O	O
for	O	O
total	O	O
cultivable	O	O
microbiota	O	O
(	O	O
r	O	O
(	O	O
2	O	O
)	O	O
=0.847	O	O
)	O	O
,	O	O
total	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
r	O	O
(	O	O
2	O	O
)	O	O
=0.898	O	O
)	O	O
,	O	O
total	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
r	O	O
(	O	O
2	O	O
)	O	O
=0.933	O	O
)	O	O
,	O	O
and	O	O
total	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
r	O	O
(	O	O
2	O	O
)	O	O
=0.870	O	O
)	O	O
also	O	O
exceeded	O	O
expected	O	O
values	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
addition	O	O
of	O	O
a	O	O
protease	O	O
inhibitor	O	O
cocktail	O	O
in	O	O
saliva	O	O
samples	O	O
does	O	O
not	O	O
impact	O	O
the	O	O
growth	O	O
of	O	O
oral	O	O
microbiota	O	O
or	O	O
compromise	O	O
the	O	O
ability	O	O
to	O	O
characterize	O	O
its	O	O
composition	O	O
.	O	O

Using	O	O
food	O	O
and	O	O
commensal	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
LAB	B-bacteria	B-bacteria
)	O	O
as	O	O
vehicles	O	O
for	O	O
DNA	O	O
delivery	O	O
into	O	O
epithelial	O	O
cells	O	O
is	O	O
a	O	O
new	O	O
strategy	O	O
for	O	O
vaccine	O	O
delivery	O	O
or	O	O
gene	O	O
therapy	O	O
.	O	O

However	O	O
,	O	O
present	O	O
methods	O	O
for	O	O
DNA	O	O
delivery	O	O
with	O	O
LAB	B-bacteria	B-bacteria
have	O	O
suffered	O	O
low	O	O
efficiency	O	O
.	O	O

Our	O	O
goal	O	O
was	O	O
to	O	O
develop	O	O
a	O	O
new	O	O
system	O	O
to	O	O
deliver	O	O
DNA	O	O
into	O	O
epithelial	O	O
cells	O	O
with	O	O
high	O	O
efficiency	O	O
using	O	O
food	O	O
and	O	O
commensal	O	O
LAB	B-bacteria	B-bacteria
.	O	O

An	O	O
Escherichia	O	O
coli-LAB	O	O
shuttle	O	O
plasmid	O	O
,	O	O
pLKV1	O	O
,	O	O
for	O	O
DNA	O	O
delivery	O	O
into	O	O
eukaryotic	O	O
cells	O	O
was	O	O
constructed	O	O
.	O	O

Two	O	O
reporter	O	O
plasmids	O	O
with	O	O
green	O	O
and	O	O
red	O	O
fluorescent	O	O
protein	O	O
genes	O	O
were	O	O
also	O	O
constructed	O	O
to	O	O
monitor	O	O
the	O	O
uptake	O	O
of	O	O
protein	O	O
and	O	O
DNA	O	O
,	O	O
respectively	O	O
.	O	O

Bacteria	O	O
delivering	O	O
these	O	O
reporter	O	O
plasmids	O	O
into	O	O
Caco-2	O	O
cells	O	O
were	O	O
monitored	O	O
by	O	O
fluorescence	O	O
microscopy	O	O
.	O	O

Several	O	O
methods	O	O
that	O	O
weaken	O	O
the	O	O
bacterial	O	O
cell	O	O
wall	O	O
prior	O	O
to	O	O
co-culture	O	O
with	O	O
Caco-2	O	O
cells	O	O
were	O	O
evaluated	O	O
for	O	O
their	O	O
role	O	O
in	O	O
the	O	O
improvement	O	O
of	O	O
gene	O	O
transfer	O	O
efficiency	O	O
.	O	O

Treating	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
with	O	O
penicillin	O	O
and	O	O
lysozyme	O	O
greatly	O	O
increased	O	O
its	O	O
rate	O	O
of	O	O
gene	O	O
delivery	O	O
to	O	O
mammalian	O	O
cells	O	O
compared	O	O
to	O	O
untreated	O	O
control	O	O
bacteria	O	O
,	O	O
while	O	O
glycine	O	O
pretreatment	O	O
promoted	O	O
the	O	O
highest	O	O
gene	O	O
transfer	O	O
rate	O	O
for	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
.	O	O

Uptake	O	O
of	O	O
green	O	O
fluorescent	O	O
bacteria	O	O
by	O	O
Caco-2	O	O
cells	O	O
showed	O	O
that	O	O
the	O	O
cell	O	O
wall-weakening	O	O
treatment	O	O
promoted	O	O
the	O	O
internalization	O	O
of	O	O
the	O	O
noninvasive	O	O
bacteria	O	O
into	O	O
Caco-2	O	O
cells	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
we	O	O
have	O	O
developed	O	O
a	O	O
noninvasive	O	O
system	O	O
using	O	O
LAB	B-bacteria	B-bacteria
as	O	O
a	O	O
vehicle	O	O
for	O	O
vaccine	O	O
delivery	O	O
or	O	O
gene	O	O
therapy	O	O
,	O	O
and	O	O
tested	O	O
this	O	O
system	O	O
in	O	O
vitro	O	O
with	O	O
Caco-2	O	O
cells	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
is	O	O
associated	O	O
with	O	O
peptic	O	O
ulcer	O	O
and	O	O
gastric	O	O
carcinoma	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
may	O	O
be	O	O
a	O	O
reservoir	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
;	O	O
however	O	O
,	O	O
the	O	O
results	O	O
of	O	O
studies	O	O
on	O	O
this	O	O
subject	O	O
are	O	O
controversial	O	O
.	O	O

We	O	O
employed	O	O
single-step	O	O
and	O	O
nested	O	O
polymerase	O	O
chain	O	O
reactions	O	O
(	O	O
PCR	O	O
)	O	O
to	O	O
detect	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
vacA	O	O
,	O	O
ureA	O	O
and	O	O
16S	O	O
rDNA	O	O
genes	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
stomach	O	O
,	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
of	O	O
30	O	O
subjects	O	O
.	O	O

The	O	O
results	O	O
were	O	O
confirmed	O	O
by	O	O
sequencing	O	O
.	O	O

Nested	O	O
16S	O	O
rDNA	O	O
and	O	O
ureA	O	O
amplification	O	O
was	O	O
achieved	O	O
in	O	O
80	O	O
%	O	O
of	O	O
gastric	O	O
,	O	O
30	O	O
%	O	O
of	O	O
saliva	O	O
and	O	O
20	O	O
%	O	O
of	O	O
dental	O	O
plaque	O	O
specimens	O	O
.	O	O

Sequencing	O	O
of	O	O
10	O	O
,	O	O
seven	O	O
and	O	O
four	O	O
16S	O	O
rDNA	O	O
products	O	O
from	O	O
stomach	O	O
,	O	O
saliva	O	O
and	O	O
dental	O	O
plaque	O	O
,	O	O
respectively	O	O
,	O	O
showed	O	O
>	O	O
99	O	O
%	O	O
identity	O	O
with	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
.	O	O

Sequencing	O	O
of	O	O
the	O	O
other	O	O
four	O	O
oral	O	O
cavity	O	O
PCR	O	O
products	O	O
showed	O	O
similarity	O	O
with	O	O
Campylobacter	B-bacteria	B-bacteria
and	O	O
Wolinella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Additionally	O	O
,	O	O
the	O	O
vacA	O	O
genotype	O	O
identified	O	O
in	O	O
the	O	O
samples	O	O
of	O	O
different	O	O
sites	O	O
was	O	O
the	O	O
same	O	O
within	O	O
a	O	O
given	O	O
subject	O	O
.	O	O

H	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
pylori	E-bacteria	I-bacteria
may	O	O
be	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
gastric	O	O
infection	O	O
,	O	O
thus	O	O
it	O	O
could	O	O
be	O	O
a	O	O
source	O	O
of	O	O
transmission	O	O
.	O	O

However	O	O
,	O	O
results	O	O
obtained	O	O
with	O	O
detection	O	O
methods	O	O
based	O	O
only	O	O
on	O	O
PCR	O	O
should	O	O
be	O	O
interpreted	O	O
with	O	O
caution	O	O
because	O	O
other	O	O
microorganisms	O	O
that	O	O
are	O	O
phylogenetically	O	O
very	O	O
close	O	O
to	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
are	O	O
also	O	O
present	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

Periodontitis	O	O
is	O	O
a	O	O
chronic	O	O
inflammatory	O	O
disease	O	O
that	O	O
results	O	O
in	O	O
the	O	O
destruction	O	O
of	O	O
the	O	O
supporting	O	O
tissues	O	O
of	O	O
the	O	O
teeth	O	O
.	O	O

Gingival	O	O
epithelial	O	O
cells	O	O
are	O	O
an	O	O
important	O	O
mechanical	O	O
barrier	O	O
and	O	O
participate	O	O
in	O	O
the	O	O
host	O	O
inflammatory	O	O
response	O	O
to	O	O
periodontopathogens	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
study	O	O
is	O	O
to	O	O
investigate	O	O
the	O	O
capacity	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
bind	O	O
to	O	O
the	O	O
complement	O	O
regulatory	O	O
protein	O	O
CD46	O	O
expressed	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
impact	O	O
of	O	O
the	O	O
binding	O	O
on	O	O
the	O	O
gene	O	O
expression	O	O
and	O	O
protein	O	O
secretion	O	O
of	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-6	O	O
,	O	O
IL-8	O	O
,	O	O
and	O	O
matrix	O	O
metalloproteinase	O	O
(	O	O
MMP	O	O
)	O	O
-9	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Binding	O	O
of	O	O
recombinant	O	O
human	O	O
CD46	O	O
to	O	O
the	O	O
surface	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
demonstrated	O	O
by	O	O
immunologic	O	O
assays	O	O
.	O	O

After	O	O
stimulation	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
gene	O	O
expression	O	O
was	O	O
determined	O	O
by	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
analysis	O	O
while	O	O
protein	O	O
secretion	O	O
was	O	O
monitored	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assays	O	O
.	O	O

Heat	O	O
and	O	O
protease	O	O
treatments	O	O
of	O	O
bacterial	O	O
cells	O	O
reduced	O	O
CD46	O	O
binding	O	O
.	O	O

F.	O	O
nucleatum-bound	O	O
CD46	O	O
mediated	O	O
the	O	O
cleavage	O	O
of	O	O
C3b	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
factor	O	O
I	O	O
.	O	O

Stimulating	O	O
oral	O	O
epithelial	O	O
cells	O	O
with	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
at	O	O
a	O	O
multiplicity	O	O
of	O	O
infection	O	O
of	O	O
50	O	O
resulted	O	O
in	O	O
a	O	O
significant	O	O
upregulation	O	O
of	O	O
the	O	O
gene	O	O
expression	O	O
and	O	O
protein	O	O
secretion	O	O
of	O	O
IL-6	O	O
,	O	O
IL-8	O	O
,	O	O
and	O	O
MMP-9	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

However	O	O
,	O	O
pretreating	O	O
the	O	O
epithelial	O	O
cells	O	O
with	O	O
an	O	O
anti-CD46	O	O
polyclonal	O	O
antibody	O	O
attenuated	O	O
the	O	O
production	O	O
of	O	O
IL-6	O	O
,	O	O
IL-8	O	O
,	O	O
and	O	O
MMP-9	O	O
in	O	O
response	O	O
to	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Such	O	O
an	O	O
inhibitory	O	O
effect	O	O
was	O	O
not	O	O
observed	O	O
with	O	O
non-specific	O	O
antibodies	O	O
.	O	O

The	O	O
present	O	O
study	O	O
demonstrates	O	O
that	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
can	O	O
bind	O	O
the	O	O
complement	O	O
regulatory	O	O
protein	O	O
CD46	O	O
.	O	O

The	O	O
interaction	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
with	O	O
epithelial	O	O
cell	O	O
surface	O	O
CD46	O	O
may	O	O
contribute	O	O
to	O	O
increasing	O	O
the	O	O
levels	O	O
of	O	O
proinflammatory	O	O
mediators	O	O
and	O	O
MMPs	O	O
in	O	O
periodontal	O	O
sites	O	O
and	O	O
consequently	O	O
modulate	O	O
tissue	O	O
destruction	O	O
.	O	O

The	O	O
oral	O	O
microbiota	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
buccal	O	O
health	O	O
and	O	O
in	O	O
diseases	O	O
such	O	O
as	O	O
periodontitis	O	O
and	O	O
meningitis	O	O
.	O	O

The	O	O
study	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
bacteria	O	O
has	O	O
so	O	O
far	O	O
focused	O	O
on	O	O
subjects	O	O
from	O	O
Western	O	O
societies	O	O
,	O	O
while	O	O
little	O	O
is	O	O
known	O	O
about	O	O
subjects	O	O
from	O	O
isolated	O	O
communities	O	O
.	O	O

This	O	O
work	O	O
determined	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
microbiota	O	O
from	O	O
six	O	O
Amazon	O	O
Amerindians	O	O
,	O	O
and	O	O
tested	O	O
a	O	O
sample	O	O
preservation	O	O
alternative	O	O
to	O	O
freezing	O	O
.	O	O

Paired	O	O
oral	O	O
swabs	O	O
were	O	O
taken	O	O
from	O	O
six	O	O
adults	O	O
of	O	O
Guahibo	O	O
ethnicity	O	O
living	O	O
in	O	O
the	O	O
community	O	O
of	O	O
Platanillal	O	O
,	O	O
Amazonas	O	O
State	O	O
,	O	O
Venezuela	O	O
.	O	O

Replicate	O	O
swabs	O	O
were	O	O
preserved	O	O
in	O	O
liquid	O	O
nitrogen	O	O
and	O	O
in	O	O
Aware	O	O
Messenger	O	O
fluid	O	O
(	O	O
Calypte	O	O
)	O	O
.	O	O

Buccal	O	O
DNA	O	O
was	O	O
extracted	O	O
,	O	O
and	O	O
the	O	O
V2	O	O
region	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
was	O	O
amplified	O	O
and	O	O
pyrosequenced	O	O
.	O	O

A	O	O
total	O	O
of	O	O
17	O	O
214	O	O
oral	O	O
bacterial	O	O
sequences	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
six	O	O
subjects	O	O
;	O	O
these	O	O
were	O	O
binned	O	O
into	O	O
1034	O	O
OTUs	O	O
from	O	O
10	O	O
phyla	O	O
,	O	O
30	O	O
families	O	O
and	O	O
51	O	O
genera	O	O
.	O	O

The	O	O
oral	O	O
mucosa	O	O
was	O	O
highly	O	O
dominated	O	O
by	O	O
four	O	O
phyla	O	O
:	O	O
Firmicutes	B-bacteria	B-bacteria
(	O	O
mostly	O	O
the	O	O
genera	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
)	O	O
,	O	O
Proteobacteria	B-bacteria	B-bacteria
(	O	O
mostly	O	O
Neisseria	B-bacteria	B-bacteria
)	O	O
,	O	O
Bacterioidetes	B-bacteria	B-bacteria
(	O	O
Prevotella	B-bacteria	B-bacteria
)	O	O
and	O	O
Actinobacteria	B-bacteria	B-bacteria
(	O	O
Micrococcineae	B-bacteria	B-bacteria
)	O	O
.	O	O

Although	O	O
the	O	O
microbiota	O	O
were	O	O
similar	O	O
at	O	O
the	O	O
phylum	O	O
level	O	O
,	O	O
the	O	O
Amerindians	O	O
shared	O	O
only	O	O
62	O	O
%	O	O
of	O	O
the	O	O
families	O	O
and	O	O
23	O	O
%	O	O
of	O	O
the	O	O
genera	O	O
with	O	O
non-Amerindians	O	O
from	O	O
previous	O	O
studies	O	O
,	O	O
and	O	O
had	O	O
a	O	O
lower	O	O
richness	O	O
of	O	O
genera	O	O
(	O	O
51	O	O
vs	O	O
177	O	O
reported	O	O
in	O	O
non-Amerindians	O	O
)	O	O
.	O	O

The	O	O
Amerindians	O	O
carried	O	O
unidentified	O	O
members	O	O
of	O	O
the	O	O
phyla	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
Firmicutes	B-bacteria	B-bacteria
and	O	O
Proteobacteria	B-bacteria	B-bacteria
and	O	O
their	O	O
microbiota	O	O
included	O	O
soil	O	O
bacteria	O	O
Gp1	B-bacteria	B-bacteria
(	O	O
Acidobacteriaceae	B-bacteria	B-bacteria
)	O	O
and	O	O
Xylanibacter	B-bacteria	B-bacteria
(	O	O
Prevotellaceae	B-bacteria	B-bacteria
)	O	O
,	O	O
and	O	O
the	O	O
rare	O	O
genus	O	O
Phocoenobacter	B-bacteria	B-bacteria
(	O	O
Pasteurellaceae	B-bacteria	B-bacteria
)	O	O
.	O	O

Preserving	O	O
buccal	O	O
swabs	O	O
in	O	O
the	O	O
Aware	O	O
Messenger	O	O
oral	O	O
fluid	O	O
collection	O	O
device	O	O
substantially	O	O
altered	O	O
the	O	O
bacterial	O	O
composition	O	O
in	O	O
comparison	O	O
to	O	O
freezing	O	O
,	O	O
and	O	O
therefore	O	O
this	O	O
method	O	O
can	O	O
not	O	O
be	O	O
used	O	O
to	O	O
preserve	O	O
samples	O	O
for	O	O
the	O	O
study	O	O
of	O	O
microbial	O	O
communities	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
assess	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
sodium	O	O
citrate	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
and	O	O
several	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
was	O	O
determined	O	O
by	O	O
broth	O	O
microdilution	O	O
method	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
although	O	O
Enterocuccus	B-bacteria	B-bacteria
faecium	I-bacteria	I-bacteria
OB7084	E-bacteria	I-bacteria
and	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	I-bacteria	I-bacteria
OB7088	E-bacteria	I-bacteria
had	O	O
high	O	O
tolerance	O	O
to	O	O
sodium	O	O
citrate	O	O
,	O	O
several	O	O
oral	O	O
bacteria	O	O
including	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
JCM8532	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
JCM5705	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
and	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
pneumoniae	I-bacteria	I-bacteria
NBRC102642	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
were	O	O
susceptible	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
bactericidal	O	O
activity	O	O
of	O	O
sodium	O	O
citrate	O	O
against	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
pneumoniae	I-bacteria	I-bacteria
NBRC102642	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
not	O	O
influenced	O	O
by	O	O
pH	O	O
in	O	O
the	O	O
range	O	O
of	O	O
5.0-8.0	O	O
,	O	O
whereas	O	O
that	O	O
of	O	O
sodium	O	O
lactate	O	O
was	O	O
weakened	O	O
at	O	O
neutral	O	O
or	O	O
weak	O	O
alkaline	O	O
pH	O	O
.	O	O

When	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
pneumoniae	I-bacteria	I-bacteria
NBRC102642	E-bacteria	I-bacteria
(	O	O
T	O	O
)	O	O
was	O	O
treated	O	O
with	O	O
sodium	O	O
citrate	O	O
for	O	O
2	O	O
h	O	O
,	O	O
many	O	O
burst	O	O
cells	O	O
were	O	O
observed	O	O
.	O	O

However	O	O
,	O	O
addition	O	O
of	O	O
MgCl	O	O
(	O	O
2	O	O
)	O	O
or	O	O
CaCl	O	O
(	O	O
2	O	O
)	O	O
to	O	O
an	O	O
assay	O	O
medium	O	O
weakened	O	O
the	O	O
antimicrobial	O	O
activity	O	O
although	O	O
ZnCl	O	O
(	O	O
2	O	O
)	O	O
or	O	O
MnCl	O	O
(	O	O
2	O	O
)	O	O
did	O	O
not	O	O
influence	O	O
.	O	O

Independent	O	O
of	O	O
pH	O	O
,	O	O
sodium	O	O
citrate	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
which	O	O
suggests	O	O
that	O	O
the	O	O
mechanism	O	O
is	O	O
different	O	O
from	O	O
that	O	O
of	O	O
sodium	O	O
lactate	O	O
.	O	O

The	O	O
results	O	O
presented	O	O
in	O	O
this	O	O
study	O	O
would	O	O
be	O	O
available	O	O
for	O	O
understanding	O	O
the	O	O
antimicrobial	O	O
property	O	O
of	O	O
sodium	O	O
citrate	O	O
.	O	O

Acid	O	O
etching	O	O
procedures	O	O
may	O	O
disrupt	O	O
residual	O	O
bacteria	O	O
and	O	O
contribute	O	O
to	O	O
the	O	O
success	O	O
of	O	O
incomplete	O	O
caries	O	O
removal	O	O
followed	O	O
by	O	O
adhesive	O	O
restoration	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
in	O	O
vivo	O	O
effect	O	O
of	O	O
acid	O	O
etching	O	O
on	O	O
cariogenic	O	O
bacterial	O	O
activity	O	O
within	O	O
affected	O	O
dentin	O	O
after	O	O
minimally	O	O
invasive	O	O
treatment	O	O
of	O	O
caries	O	O
lesions	O	O
.	O	O

Twenty-eight	O	O
carious	O	O
permanent	O	O
teeth	O	O
received	O	O
standardized	O	O
selective	O	O
caries	O	O
removal	O	O
and	O	O
random	O	O
acid	O	O
etch	O	O
treatment	O	O
(	O	O
E	O	O
)	O	O
or	O	O
not	O	O
(	O	O
NE	O	O
)	O	O
prior	O	O
to	O	O
adhesive	O	O
restoration	O	O
.	O	O

Baseline	O	O
and	O	O
3-month	O	O
dentin	O	O
biopsies	O	O
were	O	O
collected	O	O
.	O	O

The	O	O
number	O	O
of	O	O
bacteria	O	O
and	O	O
activity	O	O
of	O	O
total	O	O
bacterial	O	O
cells	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
determined	O	O
by	O	O
quantitative	O	O
PCR	O	O
and	O	O
RT-PCR	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
were	O	O
observed	O	O
in	O	O
total	O	O
bacterial	O	O
number	O	O
and	O	O
activity	O	O
between	O	O
E	O	O
and	O	O
NE	O	O
treatments	O	O
(	O	O
p	O	O
>	O	O
0.3008	O	O
)	O	O
.	O	O

For	O	O
NE	O	O
,	O	O
however	O	O
,	O	O
the	O	O
residual	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
bacterial	O	O
cells	O	O
were	O	O
reduced	O	O
(	O	O
p	O	O
=	O	O
0.0027	O	O
)	O	O
,	O	O
while	O	O
the	O	O
activity	O	O
per	O	O
cell	O	O
was	O	O
significantly	O	O
increased	O	O
(	O	O
p	O	O
=	O	O
0.0010	O	O
)	O	O
after	O	O
reentry	O	O
at	O	O
3	O	O
months	O	O
after	O	O
restoration	O	O
.	O	O

This	O	O
effect	O	O
was	O	O
not	O	O
observed	O	O
in	O	O
group	O	O
E.	O	O
Although	O	O
no	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
groups	O	O
,	O	O
this	O	O
study	O	O
suggests	O	O
that	O	O
acid	O	O
etching	O	O
of	O	O
affected	O	O
dentin	O	O
prior	O	O
to	O	O
adhesive	O	O
restoration	O	O
may	O	O
directly	O	O
or	O	O
indirectly	O	O
have	O	O
an	O	O
inhibitive	O	O
effect	O	O
on	O	O
the	O	O
activity	O	O
of	O	O
residual	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

Further	O	O
research	O	O
is	O	O
required	O	O
to	O	O
investigate	O	O
this	O	O
potential	O	O
effect	O	O
.	O	O

Severe	O	O
early	O	O
childhood	O	O
caries	O	O
is	O	O
a	O	O
microbial	O	O
infection	O	O
that	O	O
severely	O	O
compromises	O	O
the	O	O
dentition	O	O
of	O	O
young	O	O
children	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
characterize	O	O
the	O	O
microbiota	O	O
of	O	O
severe	O	O
early	O	O
childhood	O	O
caries	O	O
.	O	O

Dental	O	O
plaque	O	O
samples	O	O
from	O	O
2-	O	O
to	O	O
6-year-old	O	O
children	O	O
were	O	O
analyzed	O	O
using	O	O
16S	O	O
rRNA	O	O
gene	O	O
cloning	O	O
and	O	O
sequencing	O	O
,	O	O
and	O	O
by	O	O
specific	O	O
PCR	O	O
amplification	O	O
for	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Bifidobacteriaceae	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

Children	O	O
with	O	O
severe	O	O
caries	O	O
(	O	O
n	O	O
=	O	O
39	O	O
)	O	O
had	O	O
more	O	O
dental	O	O
plaque	O	O
and	O	O
gingival	O	O
inflammation	O	O
than	O	O
caries-free	O	O
children	O	O
(	O	O
n	O	O
=	O	O
41	O	O
)	O	O
.	O	O

Analysis	O	O
of	O	O
phylotypes	O	O
from	O	O
operational	O	O
taxonomic	O	O
unit	O	O
analysis	O	O
of	O	O
16S	O	O
rRNA	O	O
clonal	O	O
metalibraries	O	O
from	O	O
severe	O	O
caries	O	O
and	O	O
caries-free	O	O
children	O	O
indicated	O	O
that	O	O
while	O	O
libraries	O	O
differed	O	O
significantly	O	O
(	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
,	O	O
there	O	O
was	O	O
increased	O	O
diversity	O	O
than	O	O
detected	O	O
in	O	O
this	O	O
clonal	O	O
analysis	O	O
.	O	O

Using	O	O
the	O	O
Human	O	O
Oral	O	O
Microbiome	O	O
Database	O	O
,	O	O
139	O	O
different	O	O
taxa	O	O
were	O	O
identified	O	O
.	O	O

Within	O	O
the	O	O
limits	O	O
of	O	O
this	O	O
study	O	O
,	O	O
caries-associated	O	O
taxa	O	O
included	O	O
Granulicatella	B-bacteria	B-bacteria
elegans	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
HOT-780	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

The	O	O
species	O	O
associated	O	O
with	O	O
caries-free	O	O
children	O	O
included	O	O
Capnocytophaga	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
Abiotrophia	B-bacteria	B-bacteria
defectiva	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
Lachnospiraceae	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
HOT-100	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

By	O	O
specific	O	O
PCR	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.005	O	O
)	O	O
and	O	O
Bifidobacteriaceae	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
were	O	O
significantly	O	O
associated	O	O
with	O	O
severe	O	O
caries	O	O
.	O	O

Clonal	O	O
analysis	O	O
of	O	O
80	O	O
children	O	O
identified	O	O
a	O	O
diverse	O	O
microbiota	O	O
that	O	O
differed	O	O
between	O	O
severe	O	O
caries	O	O
and	O	O
caries-free	O	O
children	O	O
,	O	O
but	O	O
the	O	O
association	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
with	O	O
caries	O	O
was	O	O
from	O	O
specific	O	O
PCR	O	O
analysis	O	O
,	O	O
not	O	O
from	O	O
clonal	O	O
analysis	O	O
,	O	O
of	O	O
samples	O	O
.	O	O

To	O	O
investigate	O	O
whether	O	O
short-term	O	O
daily	O	O
consumption	O	O
of	O	O
yoghurt	O	O
leads	O	O
to	O	O
colonization	O	O
by	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
in	O	O
a	O	O
group	O	O
of	O	O
human	O	O
subjects	O	O
who	O	O
were	O	O
initially	O	O
totally	O	O
devoid	O	O
of	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
in	O	O
their	O	O
oral	O	O
cavities	O	O
.	O	O

Twenty-three	O	O
volunteers	O	O
consumed	O	O
yogurt	O	O
containing	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
during	O	O
a	O	O
14-day	O	O
trial	O	O
stage	O	O
.	O	O

Oral	O	O
and	O	O
fecal	O	O
samples	O	O
were	O	O
collected	O	O
at	O	O
the	O	O
clearance	O	O
stage	O	O
and	O	O
at	O	O
the	O	O
post-yoghurt	O	O
intake	O	O
stage	O	O
until	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
was	O	O
found	O	O
.	O	O

Standard	O	O
polymerase	O	O
chain	O	O
reaction	O	O
methods	O	O
using	O	O
specific	O	O
primers	O	O
were	O	O
adopted	O	O
for	O	O
the	O	O
detection	O	O
and	O	O
identification	O	O
of	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

The	O	O
isolation	O	O
frequency	O	O
decreased	O	O
rapidly	O	O
72	O	O
h	O	O
after	O	O
stopping	O	O
intake	O	O
of	O	O
yoghurt	O	O
.	O	O

After	O	O
1	O	O
week	O	O
,	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
was	O	O
absent	O	O
in	O	O
all	O	O
oral	O	O
samples	O	O
.	O	O

Non-significant	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
the	O	O
survival	O	O
rates	O	O
of	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
in	O	O
samples	O	O
of	O	O
saliva	O	O
,	O	O
plaque	O	O
,	O	O
tongue	O	O
surface	O	O
,	O	O
and	O	O
buccal	O	O
mucosa	O	O
.	O	O

L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
was	O	O
also	O	O
found	O	O
to	O	O
remain	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
for	O	O
longer	O	O
than	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Allochthonous	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
is	O	O
not	O	O
likely	O	O
to	O	O
permanently	O	O
colonize	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
intestine	O	O
.	O	O

Quorum	O	O
sensing	O	O
is	O	O
defined	O	O
as	O	O
the	O	O
ability	O	O
of	O	O
microorganisms	O	O
to	O	O
sense	O	O
their	O	O
population	O	O
density	O	O
via	O	O
the	O	O
release	O	O
of	O	O
signaling	O	O
molecules	O	O
composed	O	O
of	O	O
acyl-homoserine	O	O
lactone	O	O
(	O	O
AHL	O	O
)	O	O
,	O	O
which	O	O
is	O	O
a	O	O
type	O	O
of	O	O
autoinducer	O	O
(	O	O
AI	O	O
)	O	O
.	O	O

Previous	O	O
structure-activity	O	O
relationship	O	O
(	O	O
SAR	O	O
)	O	O
studies	O	O
demonstrated	O	O
that	O	O
the	O	O
3-oxo	O	O
group	O	O
,	O	O
homoserine	O	O
lactone	O	O
of	O	O
L-form	O	O
,	O	O
and	O	O
long	O	O
acyl	O	O
side	O	O
chain	O	O
have	O	O
crucial	O	O
roles	O	O
in	O	O
apoptosis	O	O
induction	O	O
.	O	O

Various	O	O
types	O	O
of	O	O
synthetic	O	O
AI	O	O
analogs	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
were	O	O
prepared	O	O
,	O	O
and	O	O
SAR	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
determine	O	O
their	O	O
effects	O	O
against	O	O
human	O	O
oral	O	O
squamous	O	O
carcinoma	O	O
cells	O	O
derived	O	O
from	O	O
gingival	O	O
carcinoma	O	O
Ca9-22	O	O
cells	O	O
and	O	O
tongue	O	O
cancer	O	O
SAS	O	O
cells	O	O
.	O	O

Not	O	O
only	O	O
the	O	O
antiproliferative	O	O
potential	O	O
but	O	O
also	O	O
the	O	O
radiation-sensitizing	O	O
effects	O	O
against	O	O
these	O	O
cells	O	O
were	O	O
examined	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
antiproliferative	O	O
activity	O	O
partly	O	O
depended	O	O
on	O	O
HSL	O	O
structure	O	O
and	O	O
acyl	O	O
side	O	O
chain	O	O
length	O	O
.	O	O

Moreover	O	O
,	O	O
a	O	O
few	O	O
compounds	O	O
,	O	O
compound	O	O
5	O	O
and	O	O
87	O	O
,	O	O
showed	O	O
antiproliferative	O	O
effects	O	O
against	O	O
both	O	O
Ca9-22	O	O
and	O	O
SAS	O	O
cells	O	O
,	O	O
and	O	O
also	O	O
induced	O	O
radiation-sensitizing	O	O
effects	O	O
against	O	O
Ca9-22	O	O
cells	O	O
.	O	O

Compound	O	O
5	O	O
alone	O	O
induced	O	O
apoptotic	O	O
cell	O	O
death	O	O
accompanied	O	O
by	O	O
sub-G1	O	O
phase	O	O
accumulation	O	O
in	O	O
cell	O	O
cycle	O	O
and	O	O
caspase-3	O	O
activation	O	O
,	O	O
and	O	O
radiation-sensitizing	O	O
effects	O	O
of	O	O
compound	O	O
5	O	O
could	O	O
be	O	O
attributed	O	O
to	O	O
enhanced	O	O
apoptosis	O	O
induction	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
there	O	O
were	O	O
no	O	O
remarkable	O	O
alterations	O	O
in	O	O
cell	O	O
cycle	O	O
distribution	O	O
in	O	O
Ca9-22	O	O
treated	O	O
with	O	O
compound	O	O
87	O	O
alone	O	O
or	O	O
in	O	O
combination	O	O
.	O	O

However	O	O
,	O	O
both	O	O
compounds	O	O
lack	O	O
3-oxo	O	O
and	O	O
their	O	O
acyl	O	O
side	O	O
chain	O	O
lengths	O	O
are	O	O
not	O	O
necessarily	O	O
long	O	O
.	O	O

This	O	O
SAR	O	O
study	O	O
demonstrated	O	O
that	O	O
HSL	O	O
analogs	O	O
,	O	O
which	O	O
lacked	O	O
the	O	O
recommended	O	O
characteristics	O	O
for	O	O
apoptosis	O	O
induction	O	O
clearly	O	O
showed	O	O
antiproliferative	O	O
and	O	O
radiation-sensitizing	O	O
activity	O	O
in	O	O
Ca9-22	O	O
cells	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
in	O	O
vivo	O	O
and	O	O
in	O	O
vitro	O	O
colonization	O	O
by	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
an	O	O
organism	O	O
highly	O	O
associated	O	O
with	O	O
aggressive	O	O
periodontitis	O	O
.	O	O

Thirteen	O	O
volunteers	O	O
(	O	O
5	O	O
were	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
positive	O	O
for	O	O
buccal	O	O
epithelial	O	O
cells	O	O
[	O	O
BECs	O	O
]	O	O
and	O	O
teeth	O	O
,	O	O
5	O	O
were	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
positive	O	O
for	O	O
teeth	O	O
only	O	O
,	O	O
and	O	O
3	O	O
were	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans-negative	E-bacteria	I-bacteria
controls	O	O
)	O	O
had	O	O
two	O	O
mandibular	O	O
stents	O	O
fabricated	O	O
.	O	O

Each	O	O
stent	O	O
contained	O	O
3	O	O
removable	O	O
hydroxyapatite	O	O
(	O	O
HA	O	O
)	O	O
tooth	O	O
surrogates	O	O
.	O	O

One	O	O
HA	O	O
square	O	O
was	O	O
removed	O	O
from	O	O
a	O	O
stent	O	O
at	O	O
5	O	O
time	O	O
points	O	O
over	O	O
7	O	O
h	O	O
to	O	O
assess	O	O
the	O	O
transfer	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
from	O	O
teeth	O	O
or	O	O
BECs	O	O
to	O	O
HA	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
and	O	O
total	O	O
anaerobic	O	O
counts	O	O
were	O	O
evaluated	O	O
on	O	O
each	O	O
square	O	O
over	O	O
time	O	O
.	O	O

In	O	O
vitro	O	O
experiments	O	O
evaluated	O	O
binding	O	O
,	O	O
desorption	O	O
,	O	O
transfer	O	O
,	O	O
and	O	O
reattachment	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
wild-type	O	O
and	O	O
mutant	O	O
strains	O	O
to	O	O
BECs	O	O
and	O	O
saliva-coated	O	O
HA	O	O
(	O	O
SHA	O	O
)	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
formed	O	O
80	O	O
%	O	O
of	O	O
the	O	O
cultivable	O	O
flora	O	O
on	O	O
HA	O	O
in	O	O
all	O	O
subjects	O	O
.	O	O

Transfer	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
to	O	O
HA	O	O
was	O	O
not	O	O
seen	O	O
in	O	O
subjects	O	O
with	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
on	O	O
teeth	O	O
only	O	O
.	O	O

All	O	O
5	O	O
subjects	O	O
with	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
on	O	O
BECs	O	O
showed	O	O
transfer	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
to	O	O
HA	O	O
.	O	O

In	O	O
vitro	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
desorbed	O	O
from	O	O
BECs	O	O
and	O	O
transferred	O	O
to	O	O
SHA	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
binding	O	O
to	O	O
SHA	O	O
was	O	O
irreversible	O	O
and	O	O
did	O	O
not	O	O
transfer	O	O
to	O	O
BECs	O	O
.	O	O

The	O	O
adhesin	O	O
Aae	O	O
showed	O	O
specificity	O	O
for	O	O
BECs	O	O
.	O	O

Fimbrial	O	O
mutants	O	O
showed	O	O
the	O	O
greatest	O	O
reduction	O	O
in	O	O
binding	O	O
to	O	O
SHA	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
migrated	O	O
from	O	O
BECs	O	O
to	O	O
HA	O	O
in	O	O
vivo	O	O
and	O	O
to	O	O
SHA	O	O
in	O	O
vitro	O	O
;	O	O
however	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
movement	O	O
from	O	O
teeth	O	O
and	O	O
SHA	O	O
to	O	O
BECs	O	O
did	O	O
not	O	O
occur	O	O
.	O	O

In	O	O
vivo	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
colonized	O	O
HA	O	O
within	O	O
6	O	O
h	O	O
and	O	O
thus	O	O
can	O	O
be	O	O
considered	O	O
an	O	O
early	O	O
colonizer	O	O
.	O	O

BECs	O	O
are	O	O
a	O	O
likely	O	O
reservoir	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
tooth	O	O
colonization	O	O
.	O	O

Dental	O	O
caries	O	O
is	O	O
initiated	O	O
by	O	O
demineralization	O	O
of	O	O
the	O	O
tooth	O	O
surface	O	O
through	O	O
acid	O	O
production	O	O
by	O	O
sugar	O	O
metabolism	O	O
of	O	O
supragingival	O	O
plaque	O	O
microflora	O	O
.	O	O

To	O	O
elucidate	O	O
the	O	O
sugar	O	O
metabolic	O	O
system	O	O
,	O	O
we	O	O
used	O	O
CE-MS	O	O
to	O	O
perform	O	O
metabolomics	O	O
of	O	O
the	O	O
central	O	O
carbon	O	O
metabolism	O	O
,	O	O
the	O	O
EMP	O	O
pathway	O	O
,	O	O
the	O	O
pentose-phosphate	O	O
pathway	O	O
,	O	O
and	O	O
the	O	O
TCA	O	O
cycle	O	O
in	O	O
supra-	O	O
gingival	O	O
plaque	O	O
and	O	O
representative	O	O
oral	O	O
bacteria	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
.	O	O

Supragingival	O	O
plaque	O	O
contained	O	O
all	O	O
the	O	O
targeted	O	O
metabolites	O	O
in	O	O
the	O	O
central	O	O
carbon	O	O
metabolism	O	O
,	O	O
except	O	O
erythrose	O	O
4-phosphate	O	O
in	O	O
the	O	O
pentose-phosphate	O	O
pathway	O	O
.	O	O

After	O	O
glucose	O	O
rinse	O	O
,	O	O
glucose	O	O
6-phosphate	O	O
,	O	O
fructose	O	O
6-phosphate	O	O
,	O	O
fructose	O	O
1,6-bisphosphate	O	O
,	O	O
dihydroxyacetone	O	O
phosphate	O	O
,	O	O
and	O	O
pyruvate	O	O
in	O	O
the	O	O
EMP	O	O
pathway	O	O
and	O	O
6-phosphogluconate	O	O
,	O	O
ribulose	O	O
5-phosphate	O	O
,	O	O
and	O	O
sedoheptulose	O	O
7-phosphate	O	O
in	O	O
the	O	O
pentose-phosphate	O	O
pathway	O	O
,	O	O
and	O	O
acetyl	O	O
CoA	O	O
were	O	O
increased	O	O
.	O	O

Meanwhile	O	O
,	O	O
3-phosphoglycerate	O	O
and	O	O
phosphoenolpyruvate	O	O
in	O	O
the	O	O
EMP	O	O
pathway	O	O
and	O	O
succinate	O	O
,	O	O
fumarate	O	O
,	O	O
and	O	O
malate	O	O
in	O	O
the	O	O
TCA	O	O
cycle	O	O
were	O	O
decreased	O	O
.	O	O

These	O	O
pathways	O	O
and	O	O
changes	O	O
in	O	O
metabolites	O	O
observed	O	O
in	O	O
supragingival	O	O
plaque	O	O
were	O	O
similar	O	O
to	O	O
the	O	O
integration	O	O
of	O	O
metabolite	O	O
profiles	O	O
in	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
.	O	O

Supra-	O	O
and	O	O
subgingival	O	O
biofilm	O	O
formation	O	O
is	O	O
considered	O	O
to	O	O
be	O	O
mainly	O	O
responsible	O	O
for	O	O
early	O	O
implant	O	O
failure	O	O
caused	O	O
by	O	O
inflammations	O	O
of	O	O
periimplant	O	O
tissues	O	O
.	O	O

Nevertheless	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
complex	O	O
microbial	O	O
diversity	O	O
and	O	O
interindividual	O	O
similarities	O	O
around	O	O
dental	O	O
implants	O	O
.	O	O

An	O	O
atraumatic	O	O
assessment	O	O
was	O	O
made	O	O
of	O	O
the	O	O
diversity	O	O
of	O	O
microbial	O	O
communities	O	O
around	O	O
titanium	O	O
implants	O	O
by	O	O
single	O	O
strand	O	O
conformation	O	O
polymorphism	O	O
(	O	O
SSCP	O	O
)	O	O
analysis	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
amplicons	O	O
as	O	O
well	O	O
as	O	O
subsequent	O	O
sequence	O	O
analysis	O	O
.	O	O

Samples	O	O
of	O	O
adherent	O	O
supra-	O	O
and	O	O
subgingival	O	O
periimplant	O	O
biofilms	O	O
were	O	O
collected	O	O
from	O	O
ten	O	O
patients	O	O
.	O	O

Additionally	O	O
,	O	O
samples	O	O
of	O	O
sulcusfluid	O	O
were	O	O
taken	O	O
at	O	O
titanium	O	O
implant	O	O
abutments	O	O
and	O	O
remaining	O	O
teeth	O	O
.	O	O

The	O	O
bacteria	O	O
in	O	O
the	O	O
samples	O	O
were	O	O
characterized	O	O
by	O	O
SSCP	O	O
and	O	O
sequence	O	O
analysis	O	O
.	O	O

A	O	O
high	O	O
diversity	O	O
of	O	O
bacteria	O	O
varying	O	O
between	O	O
patients	O	O
and	O	O
within	O	O
one	O	O
patient	O	O
at	O	O
different	O	O
locations	O	O
was	O	O
found	O	O
.	O	O

Bacteria	O	O
characteristic	O	O
for	O	O
sulcusfluid	O	O
and	O	O
supra-	O	O
and	O	O
subgingival	O	O
biofilm	O	O
communities	O	O
were	O	O
identified	O	O
.	O	O

Sulcusfluid	O	O
of	O	O
the	O	O
abutments	O	O
showed	O	O
higher	O	O
abundance	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
than	O	O
from	O	O
residual	O	O
teeth	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
and	O	O
Rothia	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
frequently	O	O
reported	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
were	O	O
not	O	O
detected	O	O
at	O	O
the	O	O
abutments	O	O
suggesting	O	O
a	O	O
role	O	O
as	O	O
late	O	O
colonizers	O	O
.	O	O

Different	O	O
niches	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
are	O	O
characterized	O	O
by	O	O
specific	O	O
groups	O	O
of	O	O
bacteria	O	O
.	O	O

Implant	O	O
abutments	O	O
are	O	O
a	O	O
very	O	O
valuable	O	O
approach	O	O
to	O	O
study	O	O
dental	O	O
biofilm	O	O
development	O	O
in	O	O
vivo	O	O
.	O	O

Interferon	O	O
gamma	O	O
(	O	O
IFN-gamma	O	O
)	O	O
is	O	O
one	O	O
of	O	O
the	O	O
key	O	O
regulatory	O	O
cytokines	O	O
that	O	O
has	O	O
a	O	O
significant	O	O
effect	O	O
on	O	O
immune	O	O
responses	O	O
.	O	O

It	O	O
may	O	O
be	O	O
important	O	O
in	O	O
the	O	O
chronic	O	O
inflammatory	O	O
diseases	O	O
such	O	O
as	O	O
periodontitis	O	O
in	O	O
which	O	O
increased	O	O
IFN-gamma	O	O
levels	O	O
were	O	O
found	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
analyze	O	O
+874A/T	O	O
polymorphism	O	O
in	O	O
the	O	O
IFN-gamma	O	O
gene	O	O
and	O	O
its	O	O
associations	O	O
with	O	O
the	O	O
presence	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
susceptibility	O	O
to	O	O
generalized	O	O
chronic	O	O
periodontitis	O	O
(	O	O
CP	O	O
)	O	O
.	O	O

A	O	O
total	O	O
of	O	O
498	O	O
unrelated	O	O
Czech	O	O
white	O	O
subjects	O	O
were	O	O
included	O	O
in	O	O
the	O	O
present	O	O
study	O	O
.	O	O

Genomic	O	O
DNA	O	O
was	O	O
obtained	O	O
from	O	O
the	O	O
peripheral	O	O
blood	O	O
of	O	O
244	O	O
patients	O	O
with	O	O
CP	O	O
and	O	O
254	O	O
healthy	O	O
subjects	O	O
.	O	O

The	O	O
IFN-gamma	O	O
+874A/T	O	O
polymorphism	O	O
was	O	O
determined	O	O
by	O	O
amplification	O	O
refractory	O	O
mutation	O	O
system-polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
ARMS-PCR	O	O
)	O	O
.	O	O

Subgingival	O	O
bacterial	O	O
colonization	O	O
(	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
micros	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
in	O	O
subgingival	O	O
pockets	O	O
)	O	O
was	O	O
investigated	O	O
by	O	O
the	O	O
DNA-microarray	O	O
based	O	O
periodontal	O	O
pathogen	O	O
detection	O	O
kit	O	O
in	O	O
a	O	O
subgroup	O	O
of	O	O
subjects	O	O
(	O	O
N=110	O	O
)	O	O
.	O	O

Our	O	O
results	O	O
showed	O	O
no	O	O
differences	O	O
in	O	O
the	O	O
allele	O	O
and	O	O
genotype	O	O
frequencies	O	O
of	O	O
the	O	O
IFN-gamma	O	O
+874A/T	O	O
polymorphism	O	O
between	O	O
patients	O	O
with	O	O
CP	O	O
and	O	O
controls	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Although	O	O
we	O	O
found	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
occurrence	O	O
of	O	O
periodontal	O	O
bacteria	O	O
between	O	O
patients	O	O
with	O	O
CP	O	O
and	O	O
healthy	O	O
controls	O	O
(	O	O
from	O	O
P	O	O
<	O	O
0.00001	O	O
to	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
no	O	O
significant	O	O
association	O	O
between	O	O
IFN-gamma	O	O
+874A/T	O	O
polymorphism	O	O
and	O	O
periodontal	O	O
pathogens	O	O
was	O	O
observed	O	O
in	O	O
any	O	O
group	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
these	O	O
findings	O	O
indicate	O	O
that	O	O
putative	O	O
functional	O	O
variant	O	O
in	O	O
the	O	O
IFN-gamma	O	O
is	O	O
not	O	O
associated	O	O
with	O	O
susceptibility	O	O
to	O	O
chronic	O	O
periodontitis	O	O
or	O	O
microbial	O	O
composition	O	O
in	O	O
the	O	O
Czech	O	O
population	O	O
.	O	O

Propolis	O	O
is	O	O
a	O	O
multifunctional	O	O
substance	O	O
used	O	O
by	O	O
bees	O	O
to	O	O
maintain	O	O
the	O	O
safety	O	O
of	O	O
their	O	O
hives	O	O
.	O	O

It	O	O
is	O	O
worldwide	O	O
used	O	O
for	O	O
its	O	O
potential	O	O
therapeutic	O	O
effects	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
Tunisian	O	O
propolis	O	O
ethanol	O	O
extract	O	O
(	O	O
EEP	O	O
)	O	O
was	O	O
tested	O	O
for	O	O
their	O	O
anti-cariogenic	O	O
,	O	O
anti-biofilms	O	O
and	O	O
antiproliferative	O	O
effects	O	O
of	O	O
many	O	O
cell	O	O
lines	O	O
.	O	O

The	O	O
Tunisian	O	O
EEP	O	O
was	O	O
evaluated	O	O
in	O	O
vitro	O	O
against	O	O
33	O	O
oral	O	O
pathogens	O	O
including	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
enterococci	B-bacteria	B-bacteria
using	O	O
broth	O	O
microdilution	O	O
method	O	O
.	O	O

The	O	O
anti-biofilms	O	O
activity	O	O
of	O	O
EEP	O	O
was	O	O
assessed	O	O
via	O	O
Crystal	O	O
Violet	O	O
staining	O	O
and	O	O
MTT	O	O
assays	O	O
.	O	O

The	O	O
Tunisian	O	O
EEP	O	O
antiproliferative	O	O
effect	O	O
was	O	O
evaluated	O	O
on	O	O
normal	O	O
(	O	O
MRC-5	O	O
)	O	O
and	O	O
cancer	O	O
cell	O	O
lines	O	O
(	O	O
HT-29	O	O
,	O	O
A549	O	O
,	O	O
Hep-2	O	O
,	O	O
raw	O	O
264.7	O	O
,	O	O
Vero	O	O
)	O	O
by	O	O
the	O	O
ability	O	O
of	O	O
the	O	O
cells	O	O
to	O	O
metabolically	O	O
reduce	O	O
MTT	O	O
to	O	O
a	O	O
formazan	O	O
dye	O	O
.	O	O

Our	O	O
results	O	O
revealed	O	O
that	O	O
Tunisian	O	O
EEP	O	O
possessed	O	O
excellent	O	O
protective	O	O
effects	O	O
against	O	O
cariogenic	O	O
and	O	O
biofilms	O	O
activity	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Furthermore	O	O
,	O	O
EEP	O	O
showed	O	O
a	O	O
strong	O	O
antiproliferative	O	O
potencies	O	O
against	O	O
all	O	O
studied	O	O
cancer	O	O
cell	O	O
lines	O	O
as	O	O
judged	O	O
by	O	O
IC50	O	O
and	O	O
its	O	O
value	O	O
ranges	O	O
from	O	O
15.7	O	O
+/-	O	O
3.4	O	O
to	O	O
200	O	O
+/-	O	O
22.2	O	O
mug	O	O
mL	O	O
(	O	O
-	O	O
)	O	O
(	O	O
1	O	O
)	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
EEP	O	O
is	O	O
able	O	O
to	O	O
inhibit	O	O
cancer	O	O
cell	O	O
proliferation	O	O
,	O	O
cariogenic	O	O
bacteria	O	O
and	O	O
oral	O	O
biofilms	O	O
formation	O	O
.	O	O

It	O	O
could	O	O
have	O	O
a	O	O
promising	O	O
role	O	O
in	O	O
the	O	O
future	O	O
medicine	O	O
and	O	O
nutrition	O	O
when	O	O
used	O	O
as	O	O
antibiotic	O	O
or	O	O
food	O	O
additive	O	O
.	O	O

Periodontal	O	O
disease	O	O
has	O	O
been	O	O
associated	O	O
with	O	O
atherosclerosis	O	O
,	O	O
suggesting	O	O
that	O	O
bacteria	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
may	O	O
contribute	O	O
to	O	O
the	O	O
development	O	O
of	O	O
atherosclerosis	O	O
and	O	O
cardiovascular	O	O
disease	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
gut	O	O
microbiota	O	O
may	O	O
affect	O	O
obesity	O	O
,	O	O
which	O	O
is	O	O
associated	O	O
with	O	O
atherosclerosis	O	O
.	O	O

Using	O	O
qPCR	O	O
,	O	O
we	O	O
show	O	O
that	O	O
bacterial	O	O
DNA	O	O
was	O	O
present	O	O
in	O	O
the	O	O
atherosclerotic	O	O
plaque	O	O
and	O	O
that	O	O
the	O	O
amount	O	O
of	O	O
DNA	O	O
correlated	O	O
with	O	O
the	O	O
amount	O	O
of	O	O
leukocytes	O	O
in	O	O
the	O	O
atherosclerotic	O	O
plaque	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
atherosclerotic	O	O
plaques	O	O
and	O	O
test	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
oral	O	O
or	O	O
gut	O	O
microbiota	O	O
may	O	O
contribute	O	O
to	O	O
atherosclerosis	O	O
in	O	O
humans	O	O
,	O	O
we	O	O
used	O	O
454	O	O
pyrosequencing	O	O
of	O	O
16S	O	O
rRNA	O	O
genes	O	O
to	O	O
survey	O	O
the	O	O
bacterial	O	O
diversity	O	O
of	O	O
atherosclerotic	O	O
plaque	O	O
,	O	O
oral	O	O
,	O	O
and	O	O
gut	O	O
samples	O	O
of	O	O
15	O	O
patients	O	O
with	O	O
atherosclerosis	O	O
,	O	O
and	O	O
oral	O	O
and	O	O
gut	O	O
samples	O	O
of	O	O
healthy	O	O
controls	O	O
.	O	O

We	O	O
identified	O	O
Chryseomonas	B-bacteria	B-bacteria
in	O	O
all	O	O
atherosclerotic	O	O
plaque	O	O
samples	O	O
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
in	O	O
the	O	O
majority	O	O
.	O	O

Interestingly	O	O
,	O	O
the	O	O
combined	O	O
abundances	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
in	O	O
atherosclerotic	O	O
plaques	O	O
correlated	O	O
with	O	O
their	O	O
abundance	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Moreover	O	O
,	O	O
several	O	O
additional	O	O
bacterial	O	O
phylotypes	O	O
were	O	O
common	O	O
to	O	O
the	O	O
atherosclerotic	O	O
plaque	O	O
and	O	O
oral	O	O
or	O	O
gut	O	O
samples	O	O
within	O	O
the	O	O
same	O	O
individual	O	O
.	O	O

Interestingly	O	O
,	O	O
several	O	O
bacterial	O	O
taxa	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
gut	O	O
correlated	O	O
with	O	O
plasma	O	O
cholesterol	O	O
levels	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
our	O	O
findings	O	O
suggest	O	O
that	O	O
bacteria	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
perhaps	O	O
even	O	O
the	O	O
gut	O	O
,	O	O
may	O	O
correlate	O	O
with	O	O
disease	O	O
markers	O	O
of	O	O
atherosclerosis	O	O
.	O	O

Mother	O	O
's	O	O
milk	O	O
is	O	O
a	O	O
source	O	O
of	O	O
bacteria	O	O
that	O	O
influences	O	O
the	O	O
development	O	O
of	O	O
the	O	O
infant	O	O
commensal	O	O
gut	O	O
microbiota	O	O
.	O	O

To	O	O
date	O	O
,	O	O
the	O	O
species	O	O
diversity	O	O
and	O	O
relative	O	O
abundance	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
the	O	O
milk	O	O
of	O	O
non-human	O	O
primates	O	O
have	O	O
not	O	O
been	O	O
described	O	O
.	O	O

Milk	O	O
samples	O	O
were	O	O
aseptically	O	O
obtained	O	O
from	O	O
54	O	O
female	O	O
rhesus	O	O
monkeys	O	O
(	O	O
Macaca	O	O
mulatta	O	O
)	O	O
at	O	O
peak	O	O
lactation	O	O
.	O	O

Following	O	O
GM17	O	O
and	O	O
MRS	O	O
agar	O	O
plating	O	O
,	O	O
single	O	O
bacterial	O	O
colonies	O	O
were	O	O
isolated	O	O
based	O	O
on	O	O
difference	O	O
in	O	O
morphotypes	O	O
,	O	O
then	O	O
grouped	O	O
based	O	O
on	O	O
whole-cell	O	O
protein	O	O
profiles	O	O
on	O	O
SDS-PAGE	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
isolated	O	O
and	O	O
the	O	O
sequence	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
was	O	O
analyzed	O	O
.	O	O

A	O	O
total	O	O
of	O	O
106	O	O
strains	O	O
of	O	O
19	O	O
distinct	O	O
bacterial	O	O
species	O	O
,	O	O
belonging	O	O
to	O	O
five	O	O
genera	O	O
,	O	O
Bacillus	B-bacteria	B-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
Pediococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
were	O	O
identified	O	O
.	O	O

Maternal	O	O
gut	O	O
and	O	O
oral	O	O
commensal	O	O
bacteria	O	O
may	O	O
be	O	O
translocated	O	O
to	O	O
the	O	O
mammary	O	O
gland	O	O
during	O	O
lactation	O	O
and	O	O
present	O	O
in	O	O
milk	O	O
.	O	O

This	O	O
pathway	O	O
can	O	O
be	O	O
an	O	O
important	O	O
source	O	O
of	O	O
commensal	O	O
bacteria	O	O
to	O	O
the	O	O
infant	O	O
gut	O	O
and	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
study	O	O
the	O	O
plasma	O	O
treatment	O	O
effects	O	O
on	O	O
deactivation	O	O
effectiveness	O	O
of	O	O
oral	O	O
bacteria	O	O
.	O	O

A	O	O
low	O	O
temperature	O	O
atmospheric	O	O
argon	O	O
plasma	O	O
brush	O	O
were	O	O
used	O	O
to	O	O
study	O	O
the	O	O
oral	O	O
bacterial	O	O
deactivation	O	O
effects	O	O
in	O	O
terms	O	O
of	O	O
plasma	O	O
conditions	O	O
,	O	O
plasma	O	O
exposure	O	O
time	O	O
,	O	O
and	O	O
bacterial	O	O
supporting	O	O
media	O	O
.	O	O

Oral	O	O
bacteria	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
with	O	O
an	O	O
initial	O	O
bacterial	O	O
population	O	O
density	O	O
between	O	O
1.0x10	O	O
(	O	O
8	O	O
)	O	O
and	O	O
5.0x10	O	O
(	O	O
8	O	O
)	O	O
cfu/ml	O	O
were	O	O
seeded	O	O
on	O	O
various	O	O
media	O	O
and	O	O
their	O	O
survivability	O	O
with	O	O
plasma	O	O
exposure	O	O
was	O	O
examined	O	O
.	O	O

Scanning	O	O
electron	O	O
microscopy	O	O
was	O	O
used	O	O
to	O	O
examine	O	O
the	O	O
morphological	O	O
changes	O	O
of	O	O
the	O	O
plasma	O	O
treated	O	O
bacteria	O	O
.	O	O

Optical	O	O
absorption	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
leakage	O	O
of	O	O
intracellular	O	O
proteins	O	O
and	O	O
DNAs	O	O
of	O	O
the	O	O
plasma	O	O
treated	O	O
bacteria	O	O
.	O	O

The	O	O
experimental	O	O
data	O	O
indicated	O	O
that	O	O
the	O	O
argon	O	O
atmospheric	O	O
plasma	O	O
brush	O	O
was	O	O
very	O	O
effective	O	O
in	O	O
deactivating	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
plasma	O	O
exposure	O	O
time	O	O
for	O	O
a	O	O
99.9999	O	O
%	O	O
cell	O	O
reduction	O	O
was	O	O
less	O	O
than	O	O
15s	O	O
for	O	O
S.	O	O
mutans	O	O
and	O	O
within	O	O
5	O	O
min	O	O
for	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
the	O	O
plasma	O	O
deactivation	O	O
efficiency	O	O
was	O	O
also	O	O
dependent	O	O
on	O	O
the	O	O
bacterial	O	O
supporting	O	O
media	O	O
.	O	O

With	O	O
plasma	O	O
exposure	O	O
,	O	O
significant	O	O
damages	O	O
to	O	O
bacterial	O	O
cell	O	O
structures	O	O
were	O	O
observed	O	O
with	O	O
both	O	O
bacterium	O	O
species	O	O
.	O	O

Leakage	O	O
of	O	O
intracellular	O	O
proteins	O	O
and	O	O
DNAs	O	O
after	O	O
plasma	O	O
exposure	O	O
was	O	O
observed	O	O
through	O	O
monitoring	O	O
the	O	O
absorbance	O	O
peaks	O	O
at	O	O
wavelengths	O	O
of	O	O
280	O	O
nm	O	O
and	O	O
260	O	O
nm	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
experimental	O	O
results	O	O
from	O	O
this	O	O
study	O	O
indicated	O	O
that	O	O
low	O	O
temperature	O	O
atmospheric	O	O
plasma	O	O
treatment	O	O
was	O	O
very	O	O
effective	O	O
in	O	O
deactivation	O	O
of	O	O
oral	O	O
bacteria	O	O
and	O	O
could	O	O
be	O	O
a	O	O
promising	O	O
technique	O	O
in	O	O
various	O	O
dental	O	O
clinical	O	O
applications	O	O
such	O	O
as	O	O
bacterial	O	O
disinfection	O	O
and	O	O
caries	O	O
early	O	O
prevention	O	O
.	O	O

Enterococci	B-bacteria	B-bacteria
,	O	O
particularly	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
are	O	O
still	O	O
a	O	O
primary	O	O
concern	O	O
in	O	O
endodontic	O	O
infections	O	O
.	O	O

To	O	O
date	O	O
,	O	O
enterococci	B-bacteria	B-bacteria
have	O	O
been	O	O
considered	O	O
to	O	O
be	O	O
only	O	O
transiently	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
whether	O	O
different	O	O
enterococci	B-bacteria	B-bacteria
from	O	O
food	O	O
are	O	O
able	O	O
to	O	O
reside	O	O
in	O	O
oral	O	O
biofilm	O	O
.	O	O

Six	O	O
healthy	O	O
volunteers	O	O
wore	O	O
dental	O	O
splints	O	O
loaded	O	O
with	O	O
enamel	O	O
slabs	O	O
.	O	O

After	O	O
3	O	O
days	O	O
,	O	O
the	O	O
volunteers	O	O
consumed	O	O
cheese	O	O
containing	O	O
enterococci	B-bacteria	B-bacteria
.	O	O

The	O	O
fate	O	O
of	O	O
the	O	O
enterococci	B-bacteria	B-bacteria
was	O	O
analyzed	O	O
by	O	O
culture	O	O
technique	O	O
and	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
.	O	O

All	O	O
isolates	O	O
were	O	O
characterized	O	O
genotypically	O	O
by	O	O
macrorestriction	O	O
analysis	O	O
(	O	O
SmaI	O	O
)	O	O
and	O	O
pulsed-field	O	O
gel	O	O
electrophoresis	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
also	O	O
analyzed	O	O
by	O	O
using	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
avium	E-bacteria	I-bacteria
,	O	O
and	O	O
E.	B-bacteria	B-bacteria
durans	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
the	O	O
initial	O	O
biofilm	O	O
after	O	O
2	O	O
hours	O	O
,	O	O
as	O	O
well	O	O
as	O	O
in	O	O
the	O	O
5-day-old	O	O
oral	O	O
biofilm	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
E.	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
,	O	O
and	O	O
E.	B-bacteria	B-bacteria
avium	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
initial	O	O
biofilm	O	O
and	O	O
from	O	O
the	O	O
5-day-old	O	O
biofilm	O	O
,	O	O
as	O	O
well	O	O
as	O	O
those	O	O
isolated	O	O
from	O	O
cheese	O	O
,	O	O
showed	O	O
genetic	O	O
homogeneity	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecium	E-bacteria	I-bacteria
and	O	O
E.	B-bacteria	B-bacteria
avium	E-bacteria	I-bacteria
had	O	O
integrated	O	O
into	O	O
a	O	O
pre-existing	O	O
3-day-old	O	O
biofilm	O	O
.	O	O

No	O	O
genetic	O	O
similarity	O	O
between	O	O
E.	B-bacteria	B-bacteria
durans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
cheese	O	O
and	O	O
those	O	O
from	O	O
the	O	O
initial	O	O
and	O	O
5-day-old	O	O
oral	O	O
biofilm	O	O
was	O	O
detected	O	O
.	O	O

E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
was	O	O
also	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
biofilm	O	O
by	O	O
using	O	O
FISH	O	O
.	O	O

Food-borne	O	O
enterococci	B-bacteria	B-bacteria
,	O	O
particularly	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
might	O	O
not	O	O
only	O	O
be	O	O
transient	O	O
but	O	O
could	O	O
also	O	O
survive	O	O
in	O	O
the	O	O
oral	O	O
biofilm	O	O
and	O	O
become	O	O
a	O	O
source	O	O
for	O	O
endodontic	O	O
infections	O	O
.	O	O

Moreover	O	O
,	O	O
genotypic	O	O
analysis	O	O
is	O	O
required	O	O
to	O	O
study	O	O
the	O	O
source	O	O
of	O	O
oral	O	O
enterococci	B-bacteria	B-bacteria
.	O	O

Dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
are	O	O
common	O	O
oral	O	O
bacterial	O	O
infectious	O	O
diseases	O	O
.	O	O

Their	O	O
prevention	O	O
and	O	O
treatment	O	O
requires	O	O
control	O	O
of	O	O
the	O	O
causative	O	O
pathogens	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
that	O	O
exist	O	O
within	O	O
dental	O	O
plaque	O	O
.	O	O

As	O	O
one	O	O
of	O	O
the	O	O
attractive	O	O
future	O	O
substitutes	O	O
for	O	O
conventional	O	O
antibiotics	O	O
,	O	O
antimicrobial	O	O
peptides	O	O
(	O	O
AMPs	O	O
)	O	O
,	O	O
both	O	O
natural	O	O
and	O	O
synthetic	O	O
,	O	O
have	O	O
been	O	O
widely	O	O
tested	O	O
and	O	O
used	O	O
for	O	O
controlling	O	O
bacterial	O	O
infections	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
KSL	O	O
(	O	O
KKVVFKVKFK-NH	O	O
(	O	O
2	O	O
)	O	O
)	O	O
,	O	O
a	O	O
novel	O	O
AMP	O	O
,	O	O
against	O	O
several	O	O
major	O	O
cariogenic	O	O
and	O	O
periodontopathogenic	O	O
bacteria	O	O
as	O	O
well	O	O
as	O	O
Candida	O	O
albicans	O	O
in	O	O
vitro	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
causative	O	O
agent	O	O
of	O	O
dental	O	O
caries	O	O
,	O	O
was	O	O
chosen	O	O
for	O	O
in-depth	O	O
testing	O	O
.	O	O

Bacterial	O	O
susceptibility	O	O
and	O	O
time-kill	O	O
assays	O	O
were	O	O
performed	O	O
to	O	O
investigate	O	O
the	O	O
sensitivity	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
KSL	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
KSL	O	O
on	O	O
biofilm	O	O
formation	O	O
and	O	O
on	O	O
pre-formed	O	O
biofilm	O	O
was	O	O
also	O	O
examined	O	O
.	O	O

For	O	O
biofilm	O	O
studies	O	O
,	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
(	O	O
CLSM	O	O
)	O	O
was	O	O
used	O	O
to	O	O
observe	O	O
and	O	O
analyse	O	O
bacterial	O	O
biofilm	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
KSL	O	O
had	O	O
antimicrobial	O	O
activity	O	O
against	O	O
a	O	O
variety	O	O
of	O	O
oral	O	O
bacteria	O	O
and	O	O
fungi	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
susceptible	O	O
strains	O	O
to	O	O
KSL	O	O
peptide	O	O
[	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
of	O	O
0.0625	O	O
mg/mL	O	O
]	O	O
compared	O	O
with	O	O
other	O	O
species	O	O
tested	O	O
(	O	O
MICs	O	O
of	O	O
0.125-1mg/mL	O	O
)	O	O
.	O	O

KSL	O	O
also	O	O
inhibited	O	O
S.	O	O
mutans	O	O
biofilm	O	O
formation	O	O
,	O	O
with	O	O
a	O	O
minimum	O	O
biofilm	O	O
inhibition	O	O
concentration	O	O
of	O	O
0.0625-0.125	O	O
mg/mL	O	O
,	O	O
and	O	O
reduced	O	O
1-day-old	O	O
developed	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilm	O	O
,	O	O
with	O	O
a	O	O
minimum	O	O
biofilm	O	O
reduction	O	O
concentration	O	O
of	O	O
0.25-0.5mg/mL	O	O
.	O	O

CLSM	O	O
images	O	O
showed	O	O
that	O	O
KSL	O	O
significantly	O	O
reduced	O	O
the	O	O
viability	O	O
of	O	O
biofilm	O	O
cells	O	O
.	O	O

This	O	O
study	O	O
suggests	O	O
that	O	O
KSL	O	O
may	O	O
have	O	O
a	O	O
potential	O	O
clinical	O	O
application	O	O
in	O	O
treating	O	O
dental	O	O
caries	O	O
by	O	O
killing	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
within	O	O
dental	O	O
plaque	O	O
.	O	O

Caries	O	O
and	O	O
periodontitis	O	O
are	O	O
important	O	O
human	O	O
diseases	O	O
associated	O	O
with	O	O
formation	O	O
of	O	O
multi-species	O	O
biofilms	O	O
.	O	O

The	O	O
involved	O	O
bacteria	O	O
are	O	O
intensively	O	O
studied	O	O
to	O	O
understand	O	O
the	O	O
molecular	O	O
basis	O	O
of	O	O
the	O	O
interactions	O	O
in	O	O
such	O	O
biofilms	O	O
.	O	O

This	O	O
study	O	O
established	O	O
a	O	O
basic	O	O
in	O	O
vitro	O	O
single	O	O
and	O	O
mixed-species	O	O
culture	O	O
model	O	O
for	O	O
oral	O	O
bacteria	O	O
combining	O	O
three	O	O
complimentary	O	O
methods	O	O
.	O	O

The	O	O
setup	O	O
allows	O	O
a	O	O
rapid	O	O
screening	O	O
for	O	O
effects	O	O
in	O	O
the	O	O
mutual	O	O
species	O	O
interaction	O	O
.	O	O

Furthermore	O	O
,	O	O
it	O	O
is	O	O
easy	O	O
to	O	O
handle	O	O
,	O	O
inexpensive	O	O
,	O	O
and	O	O
reproducible	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
typical	O	O
inhabitants	O	O
of	O	O
the	O	O
healthy	O	O
oral	O	O
cavity	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
as	O	O
main	O	O
carriogenic	O	O
species	O	O
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
as	O	O
periodontitis-associated	O	O
bacteria	O	O
,	O	O
were	O	O
investigated	O	O
for	O	O
their	O	O
biofilm	O	O
forming	O	O
ability	O	O
.	O	O

Different	O	O
liquid	O	O
growth	O	O
media	O	O
were	O	O
evaluated	O	O
.	O	O

Safranin-staining	O	O
allowed	O	O
monitoring	O	O
of	O	O
biofilm	O	O
formation	O	O
under	O	O
the	O	O
chosen	O	O
conditions	O	O
.	O	O

Viable	O	O
counts	O	O
and	O	O
microscopy	O	O
permitted	O	O
investigation	O	O
of	O	O
biofilm	O	O
behavior	O	O
in	O	O
mixed-species	O	O
and	O	O
transwell	O	O
setups	O	O
.	O	O

S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
failed	O	O
to	O	O
form	O	O
biofilm	O	O
structures	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
established	O	O
abundant	O	O
biofilm	O	O
masses	O	O
in	O	O
CDM/sucrose	O	O
.	O	O

A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
formed	O	O
patchy	O	O
monolayers	O	O
.	O	O

For	O	O
in	O	O
depth	O	O
analysis	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
were	O	O
chosen	O	O
,	O	O
because	O	O
i	O	O
)	O	O
they	O	O
are	O	O
representatives	O	O
of	O	O
the	O	O
physiological-	O	O
,	O	O
cariogenic	O	O
and	O	O
periodontitis-associated	O	O
bacterial	O	O
flora	O	O
,	O	O
respectively	O	O
and	O	O
ii	O	O
)	O	O
their	O	O
difference	O	O
in	O	O
their	O	O
biofilm	O	O
forming	O	O
ability	O	O
.	O	O

Microscopic	O	O
analysis	O	O
confirmed	O	O
the	O	O
results	O	O
of	O	O
safranin	O	O
staining	O	O
.	O	O

Investigation	O	O
of	O	O
two	O	O
species	O	O
combinations	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
with	O	O
either	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
or	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
revealed	O	O
bacterial	O	O
interactions	O	O
influencing	O	O
biofilm	O	O
mass	O	O
,	O	O
biofilm	O	O
structure	O	O
and	O	O
cell	O	O
viability	O	O
.	O	O

This	O	O
setup	O	O
shows	O	O
safranin	O	O
staining	O	O
,	O	O
microscopic	O	O
analysis	O	O
and	O	O
viable	O	O
counts	O	O
together	O	O
are	O	O
crucial	O	O
for	O	O
basic	O	O
examination	O	O
and	O	O
evaluation	O	O
of	O	O
biofilms	O	O
.	O	O

Our	O	O
experiment	O	O
generated	O	O
meaningful	O	O
results	O	O
,	O	O
exemplified	O	O
by	O	O
the	O	O
noted	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
influence	O	O
,	O	O
and	O	O
allows	O	O
a	O	O
fast	O	O
decision	O	O
about	O	O
the	O	O
most	O	O
important	O	O
bacterial	O	O
interactions	O	O
which	O	O
should	O	O
be	O	O
investigated	O	O
in	O	O
depth	O	O
.	O	O

Whereas	O	O
periodontal	O	O
disease	O	O
is	O	O
ultimately	O	O
of	O	O
bacterial	O	O
etiology	O	O
,	O	O
from	O	O
multispecies	O	O
biofilms	O	O
of	O	O
gram-negative	O	O
anaerobic	O	O
microorganisms	O	O
,	O	O
much	O	O
of	O	O
the	O	O
deleterious	O	O
effects	O	O
are	O	O
caused	O	O
by	O	O
the	O	O
resultant	O	O
epithelial	O	O
inflammatory	O	O
response	O	O
.	O	O

Hence	O	O
,	O	O
development	O	O
of	O	O
a	O	O
treatment	O	O
that	O	O
combines	O	O
anti-biofilm	O	O
antibiotic	O	O
activity	O	O
with	O	O
anti-inflammatory	O	O
activity	O	O
would	O	O
be	O	O
of	O	O
great	O	O
utility	O	O
.	O	O

Antimicrobial	O	O
peptides	O	O
(	O	O
AMPs	O	O
)	O	O
such	O	O
as	O	O
defensins	O	O
are	O	O
naturally	O	O
occurring	O	O
peptides	O	O
that	O	O
exhibit	O	O
broad-spectrum	O	O
activity	O	O
as	O	O
well	O	O
as	O	O
a	O	O
variety	O	O
of	O	O
immunomodulatory	O	O
activities	O	O
.	O	O

Furthermore	O	O
,	O	O
bacteria	O	O
do	O	O
not	O	O
readily	O	O
develop	O	O
resistance	O	O
to	O	O
these	O	O
agents	O	O
.	O	O

However	O	O
,	O	O
clinical	O	O
studies	O	O
have	O	O
suggested	O	O
that	O	O
they	O	O
do	O	O
not	O	O
represent	O	O
optimal	O	O
candidates	O	O
for	O	O
exogenous	O	O
therapeutic	O	O
agents	O	O
.	O	O

Small-molecule	O	O
mimetics	O	O
of	O	O
these	O	O
AMPs	O	O
exhibit	O	O
similar	O	O
activities	O	O
to	O	O
the	O	O
parent	O	O
peptides	O	O
,	O	O
in	O	O
addition	O	O
to	O	O
having	O	O
low	O	O
toxicity	O	O
,	O	O
high	O	O
stability	O	O
and	O	O
low	O	O
cost	O	O
.	O	O

To	O	O
determine	O	O
whether	O	O
AMP	O	O
mimetics	O	O
have	O	O
the	O	O
potential	O	O
for	O	O
treatment	O	O
of	O	O
periodontal	O	O
disease	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
activity	O	O
of	O	O
one	O	O
mimetic	O	O
,	O	O
mPE	O	O
,	O	O
against	O	O
biofilm	O	O
cultures	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Metabolic	O	O
assays	O	O
as	O	O
well	O	O
as	O	O
culture	O	O
and	O	O
biomass	O	O
measurement	O	O
assays	O	O
demonstrated	O	O
that	O	O
mPE	O	O
exhibits	O	O
potent	O	O
activity	O	O
against	O	O
biofilm	O	O
cultures	O	O
of	O	O
both	O	O
species	O	O
.	O	O

Furthermore	O	O
,	O	O
as	O	O
little	O	O
as	O	O
2	O	O
mug	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
mPE	O	O
was	O	O
sufficient	O	O
to	O	O
inhibit	O	O
interleukin-1beta-induced	O	O
secretion	O	O
of	O	O
interleukin-8	O	O
in	O	O
both	O	O
gingival	O	O
epithelial	O	O
cells	O	O
and	O	O
THP-1	O	O
cells	O	O
.	O	O

This	O	O
anti-inflammatory	O	O
activity	O	O
is	O	O
associated	O	O
with	O	O
a	O	O
reduction	O	O
in	O	O
activation	O	O
of	O	O
nuclear	O	O
factor-kappaB	O	O
,	O	O
suggesting	O	O
that	O	O
mPE	O	O
can	O	O
act	O	O
both	O	O
as	O	O
an	O	O
anti-biofilm	O	O
agent	O	O
in	O	O
an	O	O
anaerobic	O	O
environment	O	O
and	O	O
as	O	O
an	O	O
anti-inflammatory	O	O
agent	O	O
in	O	O
infected	O	O
tissues	O	O
.	O	O

Oral	O	O
lesions	O	O
of	O	O
tuberculosis	O	O
though	O	O
uncommon	O	O
,	O	O
are	O	O
seen	O	O
both	O	O
in	O	O
the	O	O
primary	O	O
as	O	O
well	O	O
as	O	O
the	O	O
secondary	O	O
stages	O	O
of	O	O
the	O	O
disease	O	O
.	O	O

In	O	O
secondary	O	O
tuberculosis	O	O
,	O	O
the	O	O
oral	O	O
manifestations	O	O
are	O	O
accompanied	O	O
by	O	O
lesions	O	O
in	O	O
the	O	O
lung	O	O
,	O	O
lymph	O	O
nodes	O	O
,	O	O
or	O	O
any	O	O
other	O	O
organ	O	O
system	O	O
of	O	O
the	O	O
body	O	O
.	O	O

This	O	O
can	O	O
be	O	O
detected	O	O
by	O	O
the	O	O
usual	O	O
clinical	O	O
history	O	O
and	O	O
systemic	O	O
examination	O	O
.	O	O

Primary	O	O
oral	O	O
tuberculosis	O	O
may	O	O
thus	O	O
present	O	O
as	O	O
a	O	O
diagnostic	O	O
challenge	O	O
to	O	O
the	O	O
clinician	O	O
.	O	O

Amongst	O	O
the	O	O
oral	O	O
lesions	O	O
also	O	O
,	O	O
tongue	O	O
is	O	O
the	O	O
usual	O	O
site	O	O
for	O	O
tubercular	O	O
infection	O	O
,	O	O
with	O	O
the	O	O
upper	O	O
lip	O	O
and	O	O
soft	O	O
palate	O	O
being	O	O
the	O	O
least	O	O
affected	O	O
.	O	O

The	O	O
authors	O	O
report	O	O
two	O	O
rare	O	O
cases	O	O
of	O	O
children	O	O
with	O	O
isolated	O	O
primary	O	O
tuberculosis	O	O
of	O	O
the	O	O
lip	O	O
and	O	O
uvula	O	O
.	O	O

Interestingly	O	O
,	O	O
the	O	O
first	O	O
case	O	O
presenting	O	O
just	O	O
as	O	O
a	O	O
diffuse	O	O
swelling	O	O
of	O	O
the	O	O
upper	O	O
lip	O	O
,	O	O
and	O	O
the	O	O
second	O	O
as	O	O
pain	O	O
in	O	O
throat	O	O
with	O	O
congestion	O	O
and	O	O
granulations	O	O
on	O	O
the	O	O
uvula	O	O
.	O	O

We	O	O
suggest	O	O
a	O	O
distinct	O	O
Indian	O	O
social	O	O
habit	O	O
which	O	O
predisposes	O	O
to	O	O
primary	O	O
lip	O	O
and	O	O
uvular	O	O
tuberculosis	O	O
,	O	O
sites	O	O
not	O	O
common	O	O
in	O	O
the	O	O
rest	O	O
of	O	O
the	O	O
world	O	O
.	O	O

The	O	O
habit	O	O
of	O	O
doing	O	O
``	O	O
datoon	O	O
''	O	O
i.e	O	O
.	O	O

brushing	O	O
of	O	O
the	O	O
teeth	O	O
with	O	O
neem	O	O
twigs	O	O
in	O	O
rural	O	O
India	O	O
,	O	O
which	O	O
at	O	O
times	O	O
causes	O	O
trauma	O	O
on	O	O
the	O	O
palate	O	O
and	O	O
thus	O	O
predisposing	O	O
to	O	O
seedling	O	O
of	O	O
the	O	O
wound	O	O
with	O	O
mycobacterium	B-bacteria	B-bacteria
tuberculosis	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
a	O	O
heterogeneous	O	O
group	O	O
of	O	O
human	O	O
commensals	O	O
,	O	O
with	O	O
a	O	O
potential	O	O
to	O	O
cause	O	O
serious	O	O
infections	O	O
.	O	O

Activation	O	O
of	O	O
plasminogen	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
increase	O	O
the	O	O
virulence	O	O
of	O	O
typical	O	O
human	O	O
pathogenic	O	O
streptococci	B-bacteria	B-bacteria
such	O	O
as	O	O
S.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
.	O	O

One	O	O
important	O	O
factor	O	O
for	O	O
plasminogen	O	O
activation	O	O
is	O	O
the	O	O
streptococcal	O	O
alpha-enolase	O	O
.	O	O

Here	O	O
we	O	O
report	O	O
that	O	O
plasminogen	O	O
activation	O	O
is	O	O
also	O	O
common	O	O
in	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
involved	O	O
in	O	O
clinical	O	O
infection	O	O
and	O	O
that	O	O
it	O	O
depends	O	O
on	O	O
the	O	O
action	O	O
of	O	O
human	O	O
plasminogen	O	O
activators	O	O
.	O	O

The	O	O
ability	O	O
to	O	O
activate	O	O
plasminogen	O	O
did	O	O
not	O	O
require	O	O
full	O	O
conservation	O	O
of	O	O
the	O	O
internal	O	O
plasminogen	O	O
binding	O	O
sequence	O	O
motif	O	O
FYDKERKVY	O	O
of	O	O
alpha-enolase	O	O
that	O	O
was	O	O
previously	O	O
described	O	O
as	O	O
crucial	O	O
for	O	O
increased	O	O
plasminogen	O	O
binding	O	O
,	O	O
activation	O	O
and	O	O
virulence	O	O
.	O	O

Instead	O	O
,	O	O
experiments	O	O
with	O	O
recombinant	O	O
alpha-enolase	O	O
variants	O	O
indicate	O	O
that	O	O
the	O	O
naturally	O	O
occurring	O	O
variations	O	O
do	O	O
not	O	O
impair	O	O
plasminogen	O	O
binding	O	O
.	O	O

In	O	O
spite	O	O
of	O	O
these	O	O
variations	O	O
in	O	O
the	O	O
internal	O	O
plasminogen	O	O
binding	O	O
motif	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
showed	O	O
similar	O	O
activation	O	O
of	O	O
plasminogen	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
the	O	O
pathomechanism	O	O
of	O	O
plasminogen	O	O
activation	O	O
is	O	O
conserved	O	O
in	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
that	O	O
cause	O	O
infections	O	O
in	O	O
human	O	O
.	O	O

This	O	O
may	O	O
contribute	O	O
to	O	O
their	O	O
opportunistic	O	O
pathogenic	O	O
character	O	O
that	O	O
is	O	O
unfurled	O	O
in	O	O
certain	O	O
niches	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
and	O	O
cytotoxicity	O	O
of	O	O
two	O	O
novel	O	O
cross-linking	O	O
antibacterial	O	O
monomers	O	O
,	O	O
2-methacryloxylethyl	O	O
dodecyl	O	O
methyl	O	O
ammonium	O	O
bromide	O	O
(	O	O
MAE-DB	O	O
)	O	O
and	O	O
2-methacryloxylethyl	O	O
hexadecyl	O	O
methyl	O	O
ammonium	O	O
bromide	O	O
(	O	O
MAE-HB	O	O
)	O	O
were	O	O
tested	O	O
in	O	O
this	O	O
study	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
and	O	O
the	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
of	O	O
unpolymerized	O	O
MAE-DB	O	O
and	O	O
MAE-HB	O	O
against	O	O
eight	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
were	O	O
tested	O	O
using	O	O
a	O	O
broth	O	O
dilution	O	O
test	O	O
.	O	O

Time-kill	O	O
determinations	O	O
were	O	O
performed	O	O
to	O	O
examine	O	O
the	O	O
kinetics	O	O
of	O	O
unpolymerized	O	O
MAE-DB	O	O
and	O	O
MAE-HB	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
UA159	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
ATCC6715	E-bacteria	I-bacteria
.	O	O

Bacterial	O	O
morphology	O	O
was	O	O
observed	O	O
using	O	O
a	O	O
field	O	O
emission	O	O
scanning	O	O
electron	O	O
microscope	O	O
(	O	O
Fe-SEM	O	O
)	O	O
.	O	O

The	O	O
cytotoxicity	O	O
of	O	O
unpolymerized	O	O
two	O	O
new	O	O
monomers	O	O
and	O	O
Bis-GMA	O	O
on	O	O
the	O	O
human	O	O
gingival	O	O
fibroblast	O	O
cell	O	O
line	O	O
H2620	O	O
was	O	O
assessed	O	O
using	O	O
a	O	O
methyl	O	O
thiazolyl	O	O
tetrazolium	O	O
assay	O	O
.	O	O

Unpolymerized	O	O
MAE-DB	O	O
and	O	O
MAE-HB	O	O
showed	O	O
strong	O	O
bactericidal	O	O
activity	O	O
against	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
MBC	O	O
value	O	O
of	O	O
MAE-DB	O	O
ranged	O	O
from	O	O
12.2	O	O
to	O	O
24.4mug/ml	O	O
and	O	O
the	O	O
MBC	O	O
value	O	O
of	O	O
MAE-HB	O	O
ranged	O	O
from	O	O
6.2	O	O
to	O	O
48.8mug/ml	O	O
.	O	O

Time-kill	O	O
determinations	O	O
indicated	O	O
that	O	O
unpolymerized	O	O
MAE-DB	O	O
and	O	O
MAE-HB	O	O
had	O	O
rapid	O	O
killing	O	O
effects	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
UA159	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	I-bacteria	I-bacteria
ATCC6715	E-bacteria	I-bacteria
at	O	O
the	O	O
concentration	O	O
of	O	O
4x	O	O
MBC	O	O
.	O	O

The	O	O
Fe-SEM	O	O
observation	O	O
showed	O	O
that	O	O
MAE-DB	O	O
and	O	O
MAE-HB	O	O
could	O	O
disturb	O	O
the	O	O
integrity	O	O
of	O	O
bacteria	O	O
and	O	O
cause	O	O
lysis	O	O
of	O	O
bacterial	O	O
cells	O	O
.	O	O

The	O	O
median	O	O
lethal	O	O
concentration	O	O
values	O	O
on	O	O
human	O	O
gingival	O	O
fibroblast	O	O
for	O	O
both	O	O
monomers	O	O
were	O	O
between	O	O
10	O	O
and	O	O
20mug/ml	O	O
,	O	O
and	O	O
greater	O	O
than	O	O
that	O	O
of	O	O
Bis-GMA	O	O
.	O	O

Unpolymerized	O	O
MAE-DB	O	O
and	O	O
MAE-HB	O	O
monomers	O	O
had	O	O
strong	O	O
bactericidal	O	O
activity	O	O
against	O	O
eight	O	O
strains	O	O
of	O	O
oral	O	O
bacteria	O	O
.	O	O

Their	O	O
cytotoxicities	O	O
were	O	O
less	O	O
than	O	O
that	O	O
of	O	O
Bis-GMA	O	O
.	O	O

The	O	O
gingival	O	O
epithelium	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
protection	O	O
of	O	O
oral	O	O
tissues	O	O
from	O	O
microbial	O	O
challenge	O	O
.	O	O

Oral	O	O
keratinocytes	O	O
form	O	O
various	O	O
cellular	O	O
contacts	O	O
,	O	O
including	O	O
tight	O	O
junctions	O	O
,	O	O
and	O	O
thus	O	O
are	O	O
able	O	O
to	O	O
create	O	O
an	O	O
epithelial	O	O
barrier	O	O
.	O	O

A	O	O
measurable	O	O
indicator	O	O
of	O	O
barrier	O	O
function	O	O
in	O	O
vitro	O	O
is	O	O
the	O	O
transepithelial	O	O
electrical	O	O
resistance	O	O
(	O	O
TER	O	O
)	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
recognized	O	O
as	O	O
a	O	O
major	O	O
aetiologic	O	O
agent	O	O
of	O	O
periodontal	O	O
disease	O	O
and	O	O
exhibits	O	O
a	O	O
variety	O	O
of	O	O
virulence	O	O
factors	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effect	O	O
,	O	O
in	O	O
vitro	O	O
,	O	O
of	O	O
infection	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
gingival	O	O
barriers	O	O
composed	O	O
of	O	O
primary	O	O
and	O	O
immortalized	O	O
human	O	O
keratinocytes	O	O
.	O	O

Primary	O	O
and	O	O
immortalized	O	O
human	O	O
gingival	O	O
keratinocytes	O	O
were	O	O
infected	O	O
with	O	O
different	O	O
strains	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
impact	O	O
of	O	O
the	O	O
bacterial	O	O
challenge	O	O
on	O	O
the	O	O
barrier	O	O
was	O	O
analysed	O	O
by	O	O
measuring	O	O
the	O	O
TER	O	O
.	O	O

The	O	O
destructive	O	O
effects	O	O
of	O	O
gingipains	O	O
were	O	O
blocked	O	O
by	O	O
specific	O	O
enzyme	O	O
inhibitors	O	O
.	O	O

After	O	O
an	O	O
initial	O	O
increase	O	O
of	O	O
about	O	O
20-30	O	O
%	O	O
in	O	O
infected	O	O
wells	O	O
,	O	O
the	O	O
TER	O	O
decreased	O	O
to	O	O
zero	O	O
.	O	O

Gingipain	O	O
inhibitors	O	O
delayed	O	O
the	O	O
destruction	O	O
of	O	O
the	O	O
barrier	O	O
by	O	O
12	O	O
+/-	O	O
4	O	O
h.	O	O
In	O	O
all	O	O
cases	O	O
,	O	O
the	O	O
loss	O	O
of	O	O
TER	O	O
was	O	O
accelerated	O	O
if	O	O
the	O	O
system	O	O
was	O	O
infected	O	O
from	O	O
the	O	O
basolateral	O	O
side	O	O
.	O	O

A	O	O
distinct	O	O
effect	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
the	O	O
epithelial	O	O
barrier	O	O
function	O	O
of	O	O
three-dimensional	O	O
cultured	O	O
epithelial	O	O
cell	O	O
models	O	O
was	O	O
demonstrated	O	O
,	O	O
which	O	O
can	O	O
partly	O	O
be	O	O
attributed	O	O
to	O	O
the	O	O
activity	O	O
of	O	O
gingipains	O	O
.	O	O

Pneumonia	O	O
is	O	O
reported	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
high	O	O
morbidity	O	O
in	O	O
elderly	O	O
and	O	O
compromised	O	O
individuals	O	O
,	O	O
with	O	O
poor	O	O
oral	O	O
health	O	O
demonstrated	O	O
to	O	O
be	O	O
a	O	O
significant	O	O
risk	O	O
factor	O	O
for	O	O
pneumonia	O	O
.	O	O

Several	O	O
opportunistic	O	O
pathogens	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
have	O	O
been	O	O
detected	O	O
in	O	O
patients	O	O
with	O	O
pneumonia	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
prevalence	O	O
of	O	O
opportunistic	O	O
pathogens	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
independent	O	O
living	O	O
Japanese	O	O
elderly	O	O
subjects	O	O
and	O	O
analysed	O	O
factors	O	O
related	O	O
to	O	O
harbouring	O	O
those	O	O
pathogens	O	O
.	O	O

We	O	O
studied	O	O
265	O	O
subjects	O	O
,	O	O
each	O	O
of	O	O
whom	O	O
received	O	O
a	O	O
dental	O	O
examination	O	O
,	O	O
during	O	O
which	O	O
specimens	O	O
were	O	O
collected	O	O
with	O	O
a	O	O
tongue	O	O
swab	O	O
and	O	O
examined	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
10	O	O
oral	O	O
opportunistic	O	O
pathogens	O	O
using	O	O
single	O	O
or	O	O
multiple	O	O
selective	O	O
media	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
occult	O	O
blood	O	O
in	O	O
saliva	O	O
was	O	O
examined	O	O
using	O	O
test	O	O
paper	O	O
strips	O	O
.	O	O

Oral	O	O
opportunistic	O	O
pathogens	O	O
were	O	O
detected	O	O
in	O	O
13.6	O	O
%	O	O
of	O	O
the	O	O
subjects	O	O
.	O	O

Those	O	O
positive	O	O
for	O	O
occult	O	O
blood	O	O
in	O	O
saliva	O	O
had	O	O
a	O	O
significantly	O	O
higher	O	O
rate	O	O
of	O	O
harbouring	O	O
the	O	O
pathogens	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
age	O	O
was	O	O
a	O	O
significant	O	O
factor	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
pathogenic	O	O
microbes	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
(	O	O
p	O	O
=	O	O
0.033	O	O
)	O	O
.	O	O

Positive	O	O
findings	O	O
of	O	O
occult	O	O
blood	O	O
in	O	O
saliva	O	O
and	O	O
older	O	O
age	O	O
are	O	O
suggested	O	O
to	O	O
be	O	O
significant	O	O
factors	O	O
for	O	O
harbouring	O	O
opportunistic	O	O
pathogens	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Data	O	O
concerning	O	O
treatment	O	O
outcomes	O	O
in	O	O
patients	O	O
with	O	O
generalized	O	O
aggressive	O	O
periodontitis	O	O
(	O	O
GAgP	O	O
)	O	O
are	O	O
limited	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
investigate	O	O
6-month	O	O
clinical	O	O
and	O	O
microbiologic	O	O
outcomes	O	O
of	O	O
the	O	O
one-stage	O	O
full-mouth	O	O
disinfection	O	O
(	O	O
OSFMD	O	O
)	O	O
in	O	O
the	O	O
management	O	O
of	O	O
patients	O	O
with	O	O
GAgP	O	O
.	O	O

Twenty-seven	O	O
patients	O	O
with	O	O
advanced	O	O
GAgP	O	O
were	O	O
included	O	O
in	O	O
this	O	O
prospective	O	O
follow-up	O	O
intervention	O	O
study	O	O
.	O	O

Clinical	O	O
and	O	O
microbiologic	O	O
parameters	O	O
were	O	O
collected	O	O
at	O	O
baseline	O	O
and	O	O
3	O	O
and	O	O
6	O	O
months	O	O
after	O	O
the	O	O
OSFMD	O	O
.	O	O

Patient-	O	O
,	O	O
tooth-	O	O
,	O	O
and	O	O
site-level	O	O
analyses	O	O
were	O	O
carried	O	O
out	O	O
.	O	O

Subgingival	O	O
samples	O	O
from	O	O
moderate	O	O
(	O	O
4	O	O
to	O	O
5	O	O
mm	O	O
)	O	O
and	O	O
deep	O	O
(	O	O
>	O	O
/=6	O	O
mm	O	O
)	O	O
pocket	O	O
sites	O	O
were	O	O
analyzed	O	O
using	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
for	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
previously	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

The	O	O
OSFMD	O	O
resulted	O	O
in	O	O
significant	O	O
improvements	O	O
in	O	O
all	O	O
parameters	O	O
.	O	O

After	O	O
6	O	O
months	O	O
,	O	O
the	O	O
whole-mouth	O	O
probing	O	O
depth	O	O
(	O	O
PD	O	O
)	O	O
decreased	O	O
from	O	O
4.2	O	O
+/-	O	O
1.1	O	O
mm	O	O
to	O	O
2.8	O	O
+/-	O	O
0.6	O	O
mm	O	O
,	O	O
and	O	O
the	O	O
clinical	O	O
attachment	O	O
level	O	O
was	O	O
reduced	O	O
from	O	O
4.5	O	O
+/-	O	O
1.2	O	O
mm	O	O
to	O	O
3.4	O	O
+/-	O	O
1.1	O	O
mm	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

When	O	O
data	O	O
were	O	O
analyzed	O	O
based	O	O
on	O	O
the	O	O
frequency	O	O
distribution	O	O
of	O	O
PD	O	O
,	O	O
the	O	O
number	O	O
of	O	O
sites	O	O
with	O	O
PD	O	O
>	O	O
/=5	O	O
mm	O	O
decreased	O	O
by	O	O
61	O	O
%	O	O
from	O	O
baseline	O	O
values	O	O
,	O	O
and	O	O
mean	O	O
PD	O	O
reductions	O	O
of	O	O
1.5	O	O
and	O	O
2.5	O	O
mm	O	O
were	O	O
noted	O	O
in	O	O
moderate	O	O
and	O	O
deep	O	O
pockets	O	O
,	O	O
respectively	O	O
.	O	O

At	O	O
6	O	O
months	O	O
,	O	O
percentages	O	O
of	O	O
moderate	O	O
and	O	O
deep	O	O
sites	O	O
free	O	O
of	O	O
pathogens	O	O
were	O	O
40	O	O
%	O	O
and	O	O
27	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
OSFMD	O	O
may	O	O
be	O	O
a	O	O
viable	O	O
approach	O	O
to	O	O
deal	O	O
with	O	O
severe	O	O
GAgP	O	O
.	O	O

After	O	O
incubation	O	O
of	O	O
saliva	O	O
from	O	O
58	O	O
semi-bedridden	O	O
elderly	O	O
persons	O	O
,	O	O
the	O	O
cultures	O	O
were	O	O
identified	O	O
based	O	O
on	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
base	O	O
sequence	O	O
to	O	O
compare	O	O
the	O	O
identification	O	O
by	O	O
the	O	O
conventional	O	O
culture	O	O
method	O	O
.	O	O

As	O	O
a	O	O
result	O	O
,	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
base	O	O
sequence	O	O
of	O	O
198	O	O
strains	O	O
identified	O	O
by	O	O
the	O	O
culture	O	O
method	O	O
showed	O	O
98.5	O	O
%	O	O
or	O	O
more	O	O
homology	O	O
in	O	O
some	O	O
of	O	O
the	O	O
Human	O	O
Oral	O	O
Microbiome	O	O
database	O	O
,	O	O
and	O	O
the	O	O
identification	O	O
of	O	O
bacterial	O	O
species	O	O
and	O	O
genus	O	O
was	O	O
possible	O	O
.	O	O

When	O	O
an	O	O
organism	O	O
identified	O	O
by	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
method	O	O
was	O	O
compared	O	O
with	O	O
that	O	O
by	O	O
the	O	O
culture	O	O
method	O	O
,	O	O
the	O	O
concordance	O	O
rates	O	O
were	O	O
54.5	O	O
%	O	O
at	O	O
the	O	O
genus	O	O
level	O	O
and	O	O
35.9	O	O
%	O	O
at	O	O
the	O	O
species	O	O
level	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
most	O	O
frequently	O	O
isolated	O	O
from	O	O
saliva	O	O
that	O	O
were	O	O
identified	O	O
by	O	O
the	O	O
culture	O	O
method	O	O
were	O	O
identified	O	O
as	O	O
the	O	O
same	O	O
species	O	O
by	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
method	O	O
(	O	O
32/35	O	O
)	O	O
,	O	O
and	O	O
all	O	O
the	O	O
11	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
identified	O	O
by	O	O
the	O	O
culture	O	O
method	O	O
were	O	O
identified	O	O
as	O	O
the	O	O
same	O	O
species	O	O
by	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
method	O	O
.	O	O

All	O	O
the	O	O
strains	O	O
identified	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
group	O	O
by	O	O
the	O	O
culture	O	O
method	O	O
and	O	O
8	O	O
of	O	O
the	O	O
9	O	O
strains	O	O
identified	O	O
as	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
by	O	O
the	O	O
culture	O	O
method	O	O
were	O	O
identified	O	O
as	O	O
the	O	O
same	O	O
group	O	O
and	O	O
genus	O	O
by	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
method	O	O
.	O	O

When	O	O
an	O	O
oral	O	O
microbial	O	O
flora	O	O
test	O	O
with	O	O
saliva	O	O
samples	O	O
from	O	O
elderly	O	O
persons	O	O
is	O	O
performed	O	O
,	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
identification	O	O
enables	O	O
us	O	O
to	O	O
identify	O	O
major	O	O
indigenous	O	O
bacteria	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
and	O	O
is	O	O
considered	O	O
useful	O	O
as	O	O
a	O	O
means	O	O
of	O	O
supplementing	O	O
the	O	O
conventional	O	O
culture	O	O
method	O	O
.	O	O

The	O	O
focus	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
potential	O	O
use	O	O
of	O	O
the	O	O
predatoryO	O
bacteriaO	O
Bdellovibrio	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
and	O	O
Micavibrio	B-bacteria	B-bacteria
aeruginosavorus	E-bacteria	I-bacteria
to	O	O
control	O	O
the	O	O
pathogens	O	O
associated	O	O
with	O	O
human	O	O
infection	O	O
.	O	O

By	O	O
coculturing	O	O
B.	B-bacteria	B-bacteria
bacteriovorus	I-bacteria	I-bacteria
109J	E-bacteria	I-bacteria
and	O	O
M.	B-bacteria	B-bacteria
aeruginosavorus	I-bacteria	I-bacteria
ARL-13	E-bacteria	I-bacteria
with	O	O
selected	O	O
pathogens	O	O
,	O	O
we	O	O
have	O	O
demonstrated	O	O
that	O	O
predatory	O	O
bacteria	O	O
are	O	O
able	O	O
to	O	O
attack	O	O
bacteria	O	O
from	O	O
the	O	O
genus	O	O
Acinetobacter	B-bacteria	B-bacteria
,	O	O
Aeromonas	B-bacteria	B-bacteria
,	O	O
Bordetella	B-bacteria	B-bacteria
,	O	O
Burkholderia	B-bacteria	B-bacteria
,	O	O
Citrobacter	B-bacteria	B-bacteria
,	O	O
Enterobacter	B-bacteria	B-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
,	O	O
Listonella	B-bacteria	B-bacteria
,	O	O
Morganella	B-bacteria	B-bacteria
,	O	O
Proteus	B-bacteria	B-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
,	O	O
Salmonella	B-bacteria	B-bacteria
,	O	O
Serratia	B-bacteria	B-bacteria
,	O	O
Shigella	B-bacteria	B-bacteria
,	O	O
Vibrio	B-bacteria	B-bacteria
and	O	O
Yersinia	B-bacteria	B-bacteria
.	O	O

Predation	O	O
was	O	O
measured	O	O
in	O	O
single	O	O
and	O	O
multispecies	O	O
microbial	O	O
cultures	O	O
as	O	O
well	O	O
as	O	O
on	O	O
monolayer	O	O
and	O	O
multilayer	O	O
preformed	O	O
biofilms	O	O
.	O	O

Additional	O	O
experiments	O	O
aimed	O	O
at	O	O
assessing	O	O
the	O	O
optimal	O	O
predation	O	O
characteristics	O	O
of	O	O
M.	B-bacteria	B-bacteria
aeruginosavorus	E-bacteria	I-bacteria
demonstrated	O	O
that	O	O
the	O	O
predator	O	O
is	O	O
able	O	O
to	O	O
prey	O	O
at	O	O
temperatures	O	O
of	O	O
25-37	O	O
degrees	O	O
C	O	O
but	O	O
is	O	O
unable	O	O
to	O	O
prey	O	O
under	O	O
oxygen-limiting	O	O
conditions	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
an	O	O
increase	O	O
in	O	O
M.	B-bacteria	B-bacteria
aeruginosavorus	I-bacteria	I-bacteria
ARL-13	E-bacteria	I-bacteria
prey	O	O
range	O	O
was	O	O
also	O	O
observed	O	O
.	O	O

Bdellovibrio	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
and	O	O
M.	B-bacteria	B-bacteria
aeruginosavorus	E-bacteria	I-bacteria
have	O	O
an	O	O
ability	O	O
to	O	O
prey	O	O
and	O	O
reduce	O	O
many	O	O
of	O	O
the	O	O
multidrug-resistant	O	O
pathogens	O	O
associated	O	O
with	O	O
human	O	O
infection	O	O
.	O	O

Infectious	O	O
complications	O	O
caused	O	O
by	O	O
micro-organisms	O	O
that	O	O
have	O	O
become	O	O
resistant	O	O
to	O	O
drug	O	O
therapy	O	O
are	O	O
an	O	O
increasing	O	O
problem	O	O
in	O	O
medicine	O	O
,	O	O
with	O	O
more	O	O
infections	O	O
becoming	O	O
difficult	O	O
to	O	O
treat	O	O
using	O	O
traditional	O	O
antimicrobial	O	O
agents	O	O
.	O	O

The	O	O
work	O	O
presented	O	O
here	O	O
highlights	O	O
the	O	O
potential	O	O
use	O	O
of	O	O
predatory	O	O
bacteria	O	O
as	O	O
a	O	O
biological-based	O	O
agent	O	O
for	O	O
eradicating	O	O
multidrug-resistant	O	O
bacteria	O	O
,	O	O
with	O	O
the	O	O
hope	O	O
of	O	O
paving	O	O
the	O	O
way	O	O
for	O	O
future	O	O
studies	O	O
in	O	O
animal	O	O
models	O	O
.	O	O

During	O	O
the	O	O
past	O	O
few	O	O
years	O	O
there	O	O
has	O	O
been	O	O
a	O	O
global	O	O
spread	O	O
of	O	O
resistant	O	O
gram-negative	O	O
bacteria	O	O
that	O	O
are	O	O
insensitive	O	O
to	O	O
cephalosporins	O	O
and	O	O
carbapenems	O	O
.	O	O

Extended	O	O
spectrum	O	O
beta-lactamase	O	O
(	O	O
ESBL	O	O
)	O	O
-producing	O	O
bacteria	O	O
are	O	O
capable	O	O
of	O	O
inactivating	O	O
the	O	O
newest	O	O
generation	O	O
of	O	O
cephalosporins	O	O
.	O	O

It	O	O
is	O	O
notable	O	O
that	O	O
ESBL-producing	O	O
bacteria	O	O
are	O	O
found	O	O
predominantly	O	O
outside	O	O
the	O	O
hospital	O	O
situation	O	O
in	O	O
the	O	O
environment	O	O
,	O	O
in	O	O
food	O	O
and	O	O
in	O	O
meat	O	O
products	O	O
,	O	O
which	O	O
leads	O	O
to	O	O
the	O	O
presumption	O	O
that	O	O
the	O	O
food	O	O
chain	O	O
is	O	O
contributing	O	O
to	O	O
the	O	O
rapid	O	O
spread	O	O
of	O	O
these	O	O
bacteria	O	O
.	O	O

Several	O	O
types	O	O
of	O	O
carbapenemase-producing	O	O
bacteria	O	O
have	O	O
been	O	O
distinguished	O	O
,	O	O
of	O	O
which	O	O
the	O	O
'New	O	O
Delhi	O	O
metallo	O	O
beta-lactamase	O	O
1	O	O
(	O	O
NDM-1	O	O
)	O	O
'	O	O
type	O	O
seems	O	O
to	O	O
be	O	O
prevalent	O	O
in	O	O
Asia	O	O
outside	O	O
the	O	O
hospital	O	O
situation	O	O
in	O	O
the	O	O
community	O	O
,	O	O
and	O	O
is	O	O
now	O	O
being	O	O
transmitted	O	O
to	O	O
other	O	O
continents	O	O
as	O	O
a	O	O
result	O	O
of	O	O
migration	O	O
and	O	O
tourism	O	O
.	O	O

With	O	O
the	O	O
rise	O	O
of	O	O
ESBL-	O	O
and	O	O
carbapenemase-producing	O	O
gram-negative	O	O
bacteria	O	O
(	O	O
which	O	O
are	O	O
also	O	O
often	O	O
resistant	O	O
to	O	O
most	O	O
other	O	O
antibiotics	O	O
)	O	O
comes	O	O
the	O	O
very	O	O
real	O	O
concern	O	O
that	O	O
treatment	O	O
of	O	O
infections	O	O
such	O	O
as	O	O
urinary	O	O
tract	O	O
infections	O	O
that	O	O
are	O	O
currently	O	O
simple	O	O
to	O	O
treat	O	O
with	O	O
common	O	O
oral	O	O
antibiotics	O	O
will	O	O
be	O	O
problematic	O	O
in	O	O
the	O	O
future	O	O
.	O	O

The	O	O
widespread	O	O
use	O	O
of	O	O
antibiotics	O	O
in	O	O
animal	O	O
husbandry	O	O
is	O	O
an	O	O
important	O	O
factor	O	O
in	O	O
the	O	O
problem	O	O
of	O	O
antibiotic	O	O
resistance	O	O
.	O	O

Since	O	O
economic	O	O
motives	O	O
are	O	O
of	O	O
importance	O	O
,	O	O
a	O	O
coordinated	O	O
approach	O	O
from	O	O
many	O	O
parties	O	O
concerned	O	O
will	O	O
be	O	O
necessary	O	O
,	O	O
not	O	O
just	O	O
from	O	O
the	O	O
medical	O	O
sector	O	O
but	O	O
also	O	O
from	O	O
the	O	O
veterinary	O	O
and	O	O
agricultural	O	O
world	O	O
,	O	O
and	O	O
from	O	O
food	O	O
producers	O	O
and	O	O
pharmaceutical	O	O
companies	O	O
to	O	O
combat	O	O
the	O	O
spread	O	O
of	O	O
multiresistant	O	O
gram-negative	O	O
bacteria	O	O
effectively	O	O
.	O	O

The	O	O
placement	O	O
of	O	O
cadavers	O	O
in	O	O
shallow	O	O
,	O	O
clandestine	O	O
graves	O	O
may	O	O
alter	O	O
the	O	O
microbial	O	O
and	O	O
geochemical	O	O
composition	O	O
of	O	O
the	O	O
underlying	O	O
and	O	O
adjacent	O	O
soils	O	O
.	O	O

Using	O	O
amplicon	O	O
length	O	O
heterogeneity-PCR	O	O
(	O	O
LH-PCR	O	O
)	O	O
the	O	O
microbial	O	O
community	O	O
changes	O	O
in	O	O
these	O	O
soils	O	O
can	O	O
be	O	O
assessed	O	O
.	O	O

In	O	O
this	O	O
investigation	O	O
,	O	O
nine	O	O
different	O	O
grave	O	O
sites	O	O
were	O	O
examined	O	O
over	O	O
a	O	O
period	O	O
of	O	O
16weeks	O	O
.	O	O

The	O	O
results	O	O
indicated	O	O
that	O	O
measurable	O	O
changes	O	O
occurred	O	O
in	O	O
the	O	O
soil	O	O
bacterial	O	O
community	O	O
during	O	O
the	O	O
decomposition	O	O
process	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
amplicons	O	O
corresponding	O	O
to	O	O
anaerobic	O	O
bacteria	O	O
,	O	O
not	O	O
indigenous	O	O
to	O	O
the	O	O
soil	O	O
,	O	O
were	O	O
shown	O	O
to	O	O
produce	O	O
differences	O	O
between	O	O
grave	O	O
sites	O	O
and	O	O
control	O	O
soils	O	O
.	O	O

Among	O	O
the	O	O
bacteria	O	O
linked	O	O
to	O	O
these	O	O
amplicons	O	O
are	O	O
those	O	O
that	O	O
are	O	O
most	O	O
often	O	O
part	O	O
of	O	O
the	O	O
commensal	O	O
flora	O	O
of	O	O
the	O	O
intestines	O	O
,	O	O
mouth	O	O
and	O	O
skin	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
over	O	O
the	O	O
16week	O	O
sampling	O	O
interval	O	O
,	O	O
the	O	O
level	O	O
of	O	O
indicator	O	O
organisms	O	O
(	O	O
i.e.	O	O
,	O	O
nitrogen	O	O
fixing	O	O
bacteria	O	O
)	O	O
dropped	O	O
as	O	O
the	O	O
body	O	O
decomposed	O	O
and	O	O
after	O	O
four	O	O
weeks	O	O
of	O	O
environmental	O	O
exposure	O	O
they	O	O
began	O	O
to	O	O
increase	O	O
again	O	O
;	O	O
thus	O	O
differences	O	O
in	O	O
the	O	O
abundance	O	O
of	O	O
nitrogen	O	O
fixing	O	O
bacteria	O	O
were	O	O
also	O	O
found	O	O
to	O	O
contribute	O	O
to	O	O
the	O	O
variation	O	O
between	O	O
controls	O	O
and	O	O
grave	O	O
soils	O	O
.	O	O

These	O	O
results	O	O
were	O	O
verified	O	O
using	O	O
primers	O	O
that	O	O
specifically	O	O
targeted	O	O
the	O	O
nifH	O	O
gene	O	O
coding	O	O
for	O	O
nitrogenase	O	O
reductase	O	O
.	O	O

LH-PCR	O	O
provides	O	O
a	O	O
fast	O	O
,	O	O
robust	O	O
and	O	O
reproducible	O	O
method	O	O
to	O	O
measure	O	O
microbial	O	O
changes	O	O
in	O	O
soil	O	O
and	O	O
could	O	O
be	O	O
used	O	O
to	O	O
determine	O	O
potential	O	O
cadaveric	O	O
contact	O	O
in	O	O
a	O	O
given	O	O
area	O	O
.	O	O

The	O	O
results	O	O
obtained	O	O
with	O	O
this	O	O
method	O	O
could	O	O
ultimately	O	O
provide	O	O
leads	O	O
to	O	O
investigators	O	O
in	O	O
criminal	O	O
or	O	O
missing	O	O
person	O	O
scenarios	O	O
and	O	O
allow	O	O
for	O	O
further	O	O
analysis	O	O
using	O	O
human	O	O
specific	O	O
DNA	O	O
assays	O	O
to	O	O
establish	O	O
the	O	O
identity	O	O
of	O	O
the	O	O
buried	O	O
body	O	O
.	O	O

Internalin	O	O
A	O	O
(	O	O
InlA	O	O
)	O	O
is	O	O
a	O	O
critical	O	O
virulence	O	O
factor	O	O
which	O	O
mediates	O	O
the	O	O
initiation	O	O
of	O	O
Listeria	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
infection	O	O
by	O	O
the	O	O
oral	O	O
route	O	O
in	O	O
permissive	O	O
hosts	O	O
.	O	O

The	O	O
interaction	O	O
of	O	O
InlA	O	O
with	O	O
the	O	O
host	O	O
cell	O	O
ligand	O	O
E-cadherin	O	O
efficiently	O	O
stimulates	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
entry	O	O
into	O	O
human	O	O
enterocytes	O	O
,	O	O
but	O	O
has	O	O
only	O	O
a	O	O
limited	O	O
interaction	O	O
with	O	O
murine	O	O
cells	O	O
.	O	O

We	O	O
have	O	O
created	O	O
a	O	O
surface	O	O
display	O	O
library	O	O
of	O	O
randomly	O	O
mutated	O	O
InlA	O	O
in	O	O
a	O	O
non-invasive	O	O
heterologous	O	O
host	O	O
Lactococcus	B-bacteria	B-bacteria
lactis	E-bacteria	I-bacteria
in	O	O
order	O	O
to	O	O
create	O	O
and	O	O
screen	O	O
novel	O	O
variants	O	O
of	O	O
this	O	O
invasion	O	O
factor	O	O
.	O	O

After	O	O
sequential	O	O
passage	O	O
through	O	O
a	O	O
murine	O	O
cell	O	O
line	O	O
(	O	O
CT-26	O	O
)	O	O
,	O	O
multiple	O	O
clones	O	O
with	O	O
enhanced	O	O
invasion	O	O
characteristics	O	O
were	O	O
identified	O	O
.	O	O

Competitive	O	O
index	O	O
experiments	O	O
were	O	O
conducted	O	O
in	O	O
mice	O	O
using	O	O
selected	O	O
mutations	O	O
introduced	O	O
into	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
EGD-e	O	O
background	O	O
.	O	O

A	O	O
novel	O	O
single	O	O
amino	O	O
acid	O	O
change	O	O
was	O	O
identified	O	O
which	O	O
enhanced	O	O
virulence	O	O
by	O	O
the	O	O
oral	O	O
route	O	O
in	O	O
the	O	O
murine	O	O
model	O	O
and	O	O
will	O	O
form	O	O
the	O	O
basis	O	O
of	O	O
further	O	O
engineering	O	O
approaches	O	O
.	O	O

As	O	O
a	O	O
control	O	O
a	O	O
previously	O	O
described	O	O
EGD-InlA	O	O
(	O	O
m	O	O
)	O	O
murinized	O	O
strain	O	O
was	O	O
also	O	O
re-created	O	O
as	O	O
part	O	O
of	O	O
this	O	O
study	O	O
with	O	O
minor	O	O
modifications	O	O
and	O	O
designated	O	O
EGD-e	O	O
InlA	O	O
(	O	O
m	O	O
)	O	O
*	O	O
.	O	O

The	O	O
strain	O	O
was	O	O
created	O	O
using	O	O
a	O	O
procedure	O	O
that	O	O
minimizes	O	O
the	O	O
likelihood	O	O
of	O	O
secondary	O	O
mutations	O	O
and	O	O
incorporates	O	O
Listeria-optimized	O	O
codons	O	O
encoding	O	O
the	O	O
altered	O	O
amino	O	O
acids	O	O
.	O	O

L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
EGD-e	O	O
InlA	O	O
(	O	O
m	O	O
)	O	O
*	O	O
yielded	O	O
consistently	O	O
higher	O	O
level	O	O
murine	O	O
infections	O	O
by	O	O
the	O	O
oral	O	O
route	O	O
when	O	O
compared	O	O
to	O	O
EGD-e	O	O
,	O	O
but	O	O
did	O	O
not	O	O
display	O	O
the	O	O
two-fold	O	O
increased	O	O
invasion	O	O
into	O	O
a	O	O
human	O	O
cell	O	O
line	O	O
that	O	O
was	O	O
previously	O	O
described	O	O
for	O	O
the	O	O
EGD-InlA	O	O
(	O	O
m	O	O
)	O	O
strain	O	O
.	O	O

We	O	O
have	O	O
used	O	O
both	O	O
site-directed	O	O
mutagenesis	O	O
and	O	O
directed	O	O
evolution	O	O
to	O	O
create	O	O
variants	O	O
of	O	O
InlA	O	O
which	O	O
may	O	O
inform	O	O
future	O	O
structure-function	O	O
analyses	O	O
of	O	O
this	O	O
protein	O	O
.	O	O

During	O	O
the	O	O
course	O	O
of	O	O
the	O	O
study	O	O
we	O	O
engineered	O	O
a	O	O
murinized	O	O
strain	O	O
of	O	O
L.	B-bacteria	B-bacteria
monocytogenes	E-bacteria	I-bacteria
EGD-e	O	O
which	O	O
shows	O	O
reproducibly	O	O
higher	O	O
infectivity	O	O
in	O	O
the	O	O
intragastric	O	O
murine	O	O
infection	O	O
model	O	O
than	O	O
the	O	O
wild	O	O
type	O	O
,	O	O
but	O	O
does	O	O
not	O	O
display	O	O
enhanced	O	O
entry	O	O
into	O	O
human	O	O
cells	O	O
as	O	O
previously	O	O
observed	O	O
.	O	O

This	O	O
murinized	O	O
L.	B-bacteria	B-bacteria
monocytogenes	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
will	O	O
provide	O	O
a	O	O
useful	O	O
tool	O	O
for	O	O
the	O	O
analysis	O	O
of	O	O
the	O	O
gastrointestinal	O	O
phase	O	O
of	O	O
listeriosis	O	O
.	O	O

Is	O	O
low-concentration	O	O
chlorhexidine	O	O
effective	O	O
against	O	O
reducing	O	O
the	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
in	O	O
saliva	O	O
?	O	O

To	O	O
compare	O	O
the	O	O
efficacy	O	O
of	O	O
different	O	O
concentrations	O	O
of	O	O
chlorhexidine	O	O
mouth	O	O
rinses	O	O
,	O	O
i.e	O	O
.	O	O

0.02	O	O
%	O	O
,	O	O
0.06	O	O
%	O	O
and	O	O
0.12	O	O
%	O	O
,	O	O
in	O	O
reducing	O	O
the	O	O
mutants	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
count	O	O
in	O	O
saliva	O	O
.	O	O

Forty	O	O
subjects	O	O
in	O	O
the	O	O
age	O	O
group	O	O
of	O	O
12-14	O	O
years	O	O
were	O	O
selected	O	O
from	O	O
the	O	O
schools	O	O
of	O	O
Chennai	O	O
and	O	O
were	O	O
equally	O	O
divided	O	O
into	O	O
four	O	O
groups	O	O
.	O	O

The	O	O
first	O	O
three	O	O
were	O	O
study	O	O
groups	O	O
and	O	O
the	O	O
fourth	O	O
group	O	O
was	O	O
the	O	O
control	O	O
group	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
instructed	O	O
to	O	O
rinse	O	O
with	O	O
a	O	O
measured	O	O
amount	O	O
of	O	O
mouth	O	O
rinse	O	O
for	O	O
1	O	O
min	O	O
,	O	O
twice-daily	O	O
,	O	O
for	O	O
1	O	O
week	O	O
.	O	O

Salivary	O	O
samples	O	O
were	O	O
collected	O	O
at	O	O
baseline	O	O
and	O	O
1	O	O
week	O	O
after	O	O
mouth	O	O
rinsing	O	O
with	O	O
various	O	O
concentrations	O	O
and	O	O
were	O	O
cultured	O	O
on	O	O
MSB	O	O
agar	O	O
.	O	O

The	O	O
number	O	O
of	O	O
MS	B-bacteria	B-bacteria
colonies	O	O
was	O	O
counted	O	O
on	O	O
agar	O	O
medium	O	O
under	O	O
anaerobic	O	O
conditions	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
study	O	O
confirmed	O	O
that	O	O
children	O	O
using	O	O
chlorhexidine	O	O
of	O	O
concentration	O	O
0.12	O	O
%	O	O
showed	O	O
the	O	O
maximum	O	O
reduction	O	O
in	O	O
MS	B-bacteria	B-bacteria
when	O	O
compared	O	O
with	O	O
subjects	O	O
using	O	O
0.02	O	O
%	O	O
and	O	O
0.06	O	O
%	O	O
concentrations	O	O
.	O	O

But	O	O
,	O	O
children	O	O
using	O	O
chlorhexidine	O	O
of	O	O
concentration	O	O
0.06	O	O
%	O	O
also	O	O
showed	O	O
significant	O	O
reduction	O	O
in	O	O
MS	B-bacteria	B-bacteria
when	O	O
compared	O	O
with	O	O
the	O	O
control	O	O
group	O	O
.	O	O

From	O	O
the	O	O
above	O	O
study	O	O
,	O	O
we	O	O
conclude	O	O
that	O	O
chlorhexidine	O	O
used	O	O
in	O	O
different	O	O
concentrations	O	O
(	O	O
0.02	O	O
%	O	O
,	O	O
0.06	O	O
%	O	O
,	O	O
0.12	O	O
%	O	O
)	O	O
efficiently	O	O
reduced	O	O
the	O	O
mutans	O	O
count	O	O
.	O	O

Probiotic	O	O
technology	O	O
represents	O	O
a	O	O
breakthrough	O	O
approach	O	O
to	O	O
maintaining	O	O
oral	O	O
health	O	O
by	O	O
utilizing	O	O
natural	O	O
beneficial	O	O
bacteria	O	O
commonly	O	O
found	O	O
in	O	O
healthy	O	O
mouths	O	O
to	O	O
provide	O	O
a	O	O
natural	O	O
defense	O	O
against	O	O
those	O	O
bacteria	O	O
thought	O	O
to	O	O
be	O	O
harmful	O	O
to	O	O
teeth	O	O
and	O	O
gums	O	O
.	O	O

However	O	O
,	O	O
data	O	O
are	O	O
still	O	O
sparse	O	O
on	O	O
the	O	O
probiotic	O	O
action	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
review	O	O
article	O	O
on	O	O
probiotics	O	O
in	O	O
children	O	O
published	O	O
by	O	O
Twetman	O	O
and	O	O
Stecksen-	O	O
Blicks	O	O
in	O	O
2008	O	O
showed	O	O
only	O	O
one	O	O
study	O	O
of	O	O
dental	O	O
interest	O	O
on	O	O
probiotics	O	O
in	O	O
children	O	O
.	O	O

The	O	O
present	O	O
study	O	O
evaluated	O	O
clinically	O	O
the	O	O
efficacy	O	O
of	O	O
a	O	O
probiotic	O	O
and	O	O
chlorhexidine	O	O
mouth	O	O
rinses	O	O
on	O	O
plaque	O	O
and	O	O
gingival	O	O
accumulation	O	O
in	O	O
children	O	O
.	O	O

The	O	O
trial	O	O
design	O	O
is	O	O
a	O	O
double-blind	O	O
parallel	O	O
group	O	O
,	O	O
14	O	O
days	O	O
comparative	O	O
study	O	O
between	O	O
a	O	O
probiotic	O	O
mouth	O	O
rinse	O	O
and	O	O
a	O	O
chlorhexidine	O	O
mouth	O	O
rinse	O	O
,	O	O
which	O	O
included	O	O
45	O	O
healthy	O	O
children	O	O
in	O	O
the	O	O
age	O	O
group	O	O
of	O	O
6-8	O	O
years	O	O
.	O	O

The	O	O
Probiotic	O	O
and	O	O
Chlorhexidine	O	O
groups	O	O
had	O	O
less	O	O
plaque	O	O
accumulations	O	O
compared	O	O
with	O	O
the	O	O
Control	O	O
group	O	O
at	O	O
the	O	O
end	O	O
of	O	O
14	O	O
years	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
and	O	O
P	O	O
<	O	O
0.001	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

But	O	O
,	O	O
unlike	O	O
the	O	O
plaque	O	O
score	O	O
,	O	O
there	O	O
was	O	O
a	O	O
significant	O	O
difference	O	O
in	O	O
the	O	O
Gingival	O	O
Index	O	O
between	O	O
the	O	O
Probiotic	O	O
and	O	O
the	O	O
Chlorhexidine	O	O
groups	O	O
(	O	O
P	O	O
=	O	O
0.009	O	O
)	O	O
,	O	O
Probiotic	O	O
group	O	O
being	O	O
better	O	O
than	O	O
the	O	O
Chlorhexidine	O	O
group	O	O
(	O	O
mean	O	O
=	O	O
0.2300	O	O
and	O	O
0.6805	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

The	O	O
Probiotic	O	O
mouth	O	O
rinse	O	O
was	O	O
found	O	O
effective	O	O
in	O	O
reducing	O	O
plaque	O	O
accumulation	O	O
and	O	O
gingival	O	O
inflammation	O	O
.	O	O

Therefore	O	O
,	O	O
probiotic	O	O
mouth	O	O
rinse	O	O
obviously	O	O
has	O	O
a	O	O
potential	O	O
therapeutic	O	O
value	O	O
and	O	O
further	O	O
long-term	O	O
study	O	O
is	O	O
recommended	O	O
to	O	O
determine	O	O
its	O	O
efficacy	O	O
.	O	O

To	O	O
compare	O	O
the	O	O
use	O	O
of	O	O
the	O	O
Halimeter	O	O
and	O	O
the	O	O
Oral	O	O
Chroma	O	O
to	O	O
assess	O	O
the	O	O
ability	O	O
of	O	O
common	O	O
oral	O	O
anaerobic	O	O
bacteria	O	O
isolated	O	O
from	O	O
the	O	O
Kuwaiti	O	O
population	O	O
to	O	O
produce	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
.	O	O

Broth	O	O
cultures	O	O
of	O	O
common	O	O
anaerobes	O	O
isolated	O	O
from	O	O
supragingival	O	O
plaque	O	O
were	O	O
centrifuged	O	O
and	O	O
pellets	O	O
resuspended	O	O
in	O	O
phosphate	O	O
buffer	O	O
(	O	O
pH	O	O
7.7	O	O
)	O	O
with	O	O
an	O	O
optical	O	O
density	O	O
OD	O	O
(	O	O
550	O	O
)	O	O
of	O	O
0.3	O	O
.	O	O

100	O	O
mul	O	O
of	O	O
this	O	O
suspension	O	O
and	O	O
870	O	O
mul	O	O
of	O	O
buffer	O	O
were	O	O
added	O	O
in	O	O
2	O	O
sterile	O	O
15-ml	O	O
head	O	O
space	O	O
vials	O	O
.	O	O

Reaction	O	O
was	O	O
initiated	O	O
by	O	O
addition	O	O
of	O	O
30	O	O
mul	O	O
of	O	O
33	O	O
mML-methionine	O	O
and	O	O
L-cysteine	O	O
,	O	O
respectively	O	O
,	O	O
in	O	O
each	O	O
vial	O	O
and	O	O
incubation	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
90	O	O
min	O	O
.	O	O

500	O	O
mul	O	O
of	O	O
3	O	O
M	O	O
phosphoric	O	O
acid	O	O
was	O	O
added	O	O
to	O	O
tubes	O	O
and	O	O
was	O	O
kept	O	O
aside	O	O
for	O	O
10	O	O
min	O	O
.	O	O

Production	O	O
of	O	O
VSCs	O	O
was	O	O
measured	O	O
using	O	O
the	O	O
Halimeter	O	O
and	O	O
the	O	O
Oral	O	O
Chroma	O	O
.	O	O

The	O	O
major	O	O
VSC	O	O
producers	O	O
identified	O	O
by	O	O
both	O	O
Halimeter	O	O
and	O	O
Oral	O	O
Chroma	O	O
with	O	O
L-cystenine	O	O
as	O	O
substrate	O	O
were	O	O
Campylobacter	B-bacteria	B-bacteria
ureolyticus	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Gemella	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
.	O	O

The	O	O
concentrations	O	O
of	O	O
hydrogen	O	O
sulfide	O	O
recorded	O	O
by	O	O
both	O	O
Halimeter	O	O
and	O	O
Oral	O	O
Chroma	O	O
were	O	O
essentially	O	O
identical	O	O
.	O	O

With	O	O
L-methionine	O	O
as	O	O
substrate	O	O
,	O	O
both	O	O
Halimeter	O	O
and	O	O
Oral	O	O
Chroma	O	O
identified	O	O
different	O	O
complements	O	O
of	O	O
anaerobes	O	O
with	O	O
C.	B-bacteria	B-bacteria
ureolyticus	E-bacteria	I-bacteria
,	O	O
P	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
as	O	O
major	O	O
VSC	O	O
producers	O	O
.	O	O

The	O	O
concentrations	O	O
of	O	O
methyl	O	O
mercaptan	O	O
recorded	O	O
by	O	O
the	O	O
Halimeter	O	O
were	O	O
lower	O	O
compared	O	O
to	O	O
those	O	O
assessed	O	O
by	O	O
the	O	O
Oral	O	O
Chroma	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
Oral	O	O
Chroma	O	O
may	O	O
produce	O	O
a	O	O
more	O	O
comprehensive	O	O
assessment	O	O
of	O	O
VSC	O	O
production	O	O
by	O	O
oral	O	O
microflora	O	O
than	O	O
the	O	O
Halimeter	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
present	O	O
pilot	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
microbial	O	O
profile	O	O
in	O	O
saliva	O	O
and	O	O
supragingival	O	O
plaque	O	O
samples	O	O
collected	O	O
from	O	O
caries-active	O	O
adolescents	O	O
before	O	O
and	O	O
after	O	O
a	O	O
daily	O	O
short-term	O	O
intake	O	O
of	O	O
milk	O	O
supplemented	O	O
with	O	O
the	O	O
probiotic	O	O
bacteria	O	O
.	O	O

The	O	O
present	O	O
study	O	O
group	O	O
consisted	O	O
of	O	O
18	O	O
caries-active	O	O
adolescents	O	O
of	O	O
both	O	O
sexes	O	O
who	O	O
volunteered	O	O
for	O	O
participation	O	O
giving	O	O
an	O	O
informed	O	O
consent	O	O
.	O	O

The	O	O
study	O	O
has	O	O
a	O	O
randomised	O	O
placebo-controlled	O	O
double-blind	O	O
pilot	O	O
design	O	O
with	O	O
two	O	O
parallel	O	O
arms	O	O
.	O	O

After	O	O
a	O	O
2-week	O	O
run-in	O	O
period	O	O
,	O	O
the	O	O
subjects	O	O
were	O	O
instructed	O	O
to	O	O
drink	O	O
2.5	O	O
dl	O	O
of	O	O
milk	O	O
supplemented	O	O
with	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
LB21	E-bacteria	I-bacteria
(	O	O
107	O	O
CFU/ml	O	O
)	O	O
(	O	O
test	O	O
)	O	O
or	O	O
standard	O	O
control	O	O
milk	O	O
(	O	O
placebo	O	O
)	O	O
once	O	O
daily	O	O
for	O	O
a	O	O
period	O	O
of	O	O
2	O	O
weeks	O	O
(	O	O
intervention	O	O
period	O	O
)	O	O
.	O	O

Samples	O	O
of	O	O
stimulated	O	O
whole	O	O
saliva	O	O
and	O	O
supragingival	O	O
plaque	O	O
were	O	O
collected	O	O
at	O	O
baseline	O	O
(	O	O
after	O	O
run-in	O	O
)	O	O
and	O	O
immediately	O	O
after	O	O
the	O	O
end	O	O
of	O	O
the	O	O
intervention	O	O
period	O	O
(	O	O
follow-up	O	O
)	O	O
.	O	O

The	O	O
salivary	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
were	O	O
estimated	O	O
by	O	O
conventional	O	O
culturing	O	O
on	O	O
selective	O	O
agar	O	O
plates	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
level	O	O
of	O	O
19	O	O
oral	O	O
species	O	O
associated	O	O
with	O	O
the	O	O
caries	O	O
process	O	O
were	O	O
determined	O	O
using	O	O
the	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridisation	O	O
technique	O	O
.	O	O

Differences	O	O
between	O	O
the	O	O
groups	O	O
were	O	O
assessed	O	O
using	O	O
the	O	O
non-parametric	O	O
Wilcoxon-Mann-Whitney	O	O
and	O	O
chi-square	O	O
tests	O	O
.	O	O

The	O	O
mean	O	O
caries	O	O
experience	O	O
was	O	O
high	O	O
with	O	O
an	O	O
average	O	O
of	O	O
7.0	O	O
+/-	O	O
3.8	O	O
proximal	O	O
enamel	O	O
lesions	O	O
.	O	O

The	O	O
most	O	O
prevalent	O	O
dominating	O	O
species	O	O
in	O	O
the	O	O
plaque	O	O
samples	O	O
were	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

The	O	O
saliva	O	O
samples	O	O
displayed	O	O
a	O	O
more	O	O
mixed	O	O
profile	O	O
,	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
curvata	E-bacteria	I-bacteria
being	O	O
frequently	O	O
identified	O	O
species	O	O
.	O	O

All	O	O
of	O	O
the	O	O
subjects	O	O
harboured	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
their	O	O
saliva	O	O
,	O	O
with	O	O
61	O	O
%	O	O
of	O	O
them	O	O
colonised	O	O
with	O	O
salivary	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
microbial	O	O
profiles	O	O
or	O	O
the	O	O
estimated	O	O
counts	O	O
between	O	O
the	O	O
baseline	O	O
and	O	O
follow-up	O	O
samples	O	O
,	O	O
or	O	O
between	O	O
the	O	O
two	O	O
study	O	O
groups	O	O
,	O	O
were	O	O
observed	O	O
.	O	O

The	O	O
present	O	O
study	O	O
showed	O	O
that	O	O
a	O	O
short-term	O	O
daily	O	O
intake	O	O
of	O	O
milk	O	O
supplemented	O	O
with	O	O
the	O	O
probiotic	O	O
bacterium	O	O
L.	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
LB21	E-bacteria	I-bacteria
did	O	O
not	O	O
significantly	O	O
affect	O	O
the	O	O
microbial	O	O
profiles	O	O
or	O	O
the	O	O
levels	O	O
of	O	O
caries-associated	O	O
bacteria	O	O
in	O	O
saliva	O	O
and	O	O
supragingival	O	O
plaque	O	O
samples	O	O
collected	O	O
from	O	O
caries-active	O	O
adolescents	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
Coffea	O	O
canephora	O	O
extract	O	O
was	O	O
evaluated	O	O
in	O	O
vitro	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
.	O	O

The	O	O
viability	O	O
of	O	O
planktonic	O	O
cells	O	O
was	O	O
analysed	O	O
by	O	O
susceptibility	O	O
tests	O	O
(	O	O
MIC	O	O
and	O	O
MBC	O	O
)	O	O
and	O	O
time-kill	O	O
assays	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
the	O	O
extract	O	O
on	O	O
dental	O	O
demineralisation	O	O
was	O	O
also	O	O
investigated	O	O
.	O	O

Primary	O	O
1st	O	O
molar	O	O
fragments	O	O
(	O	O
n=24	O	O
)	O	O
were	O	O
inoculated	O	O
with	O	O
a	O	O
saliva	O	O
pool	O	O
and	O	O
sustained	O	O
in	O	O
a	O	O
multiple	O	O
plaque	O	O
growth	O	O
system	O	O
for	O	O
10	O	O
days	O	O
to	O	O
form	O	O
biofilm	O	O
.	O	O

The	O	O
biofilm	O	O
was	O	O
treated	O	O
with	O	O
light	O	O
roasted	O	O
C.	O	O
canephora	O	O
extract	O	O
at	O	O
20	O	O
%	O	O
,	O	O
Milli-Q	O	O
water	O	O
(	O	O
negative	O	O
control	O	O
)	O	O
and	O	O
chlorhexidine	O	O
(	O	O
positive	O	O
control	O	O
)	O	O
once	O	O
a	O	O
day	O	O
,	O	O
during	O	O
a	O	O
week	O	O
.	O	O

Blank	O	O
controls	O	O
comprised	O	O
fragments	O	O
without	O	O
treatment	O	O
.	O	O

biofilm	O	O
pH	O	O
was	O	O
monitored	O	O
in	O	O
the	O	O
last	O	O
day	O	O
of	O	O
treatment	O	O
.	O	O

Changes	O	O
in	O	O
tooth	O	O
mineralisation	O	O
were	O	O
assessed	O	O
by	O	O
cross-sectional	O	O
microhardness	O	O
(	O	O
CSMH	O	O
)	O	O
test	O	O
.	O	O

MIC	O	O
and	O	O
MBC	O	O
for	O	O
S.	O	O
mutans	O	O
were	O	O
7+/-2	O	O
mg/mL	O	O
and	O	O
160+/-0	O	O
mg/mL	O	O
,	O	O
respectively	O	O
,	O	O
showing	O	O
no	O	O
activity	O	O
for	O	O
S.	O	O
sobrinus	O	O
.	O	O

The	O	O
extract	O	O
produced	O	O
a	O	O
4-log	O	O
reduction	O	O
in	O	O
the	O	O
number	O	O
of	O	O
colonies	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
after	O	O
3-h	O	O
treatment	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
with	O	O
undiluted	O	O
extract	O	O
(	O	O
20	O	O
%	O	O
)	O	O
and	O	O
MBC	O	O
concentration	O	O
(	O	O
16	O	O
%	O	O
)	O	O
.	O	O

There	O	O
was	O	O
no	O	O
difference	O	O
among	O	O
negative/blank	O	O
controls	O	O
and	O	O
coffee	O	O
plaque	O	O
pH	O	O
.	O	O

Differences	O	O
between	O	O
CSMH	O	O
values	O	O
of	O	O
dental	O	O
fragments	O	O
subjected	O	O
to	O	O
the	O	O
coffee	O	O
extract	O	O
and	O	O
to	O	O
chlorhexidine	O	O
were	O	O
not	O	O
significant	O	O
.	O	O

At	O	O
depths	O	O
up	O	O
to	O	O
30	O	O
mum	O	O
from	O	O
the	O	O
enamel	O	O
surface	O	O
,	O	O
coffee	O	O
extract	O	O
and	O	O
chlorhexidine	O	O
promoted	O	O
higher	O	O
CSMH	O	O
values	O	O
when	O	O
compared	O	O
to	O	O
blank/negative	O	O
controls	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Our	O	O
data	O	O
suggest	O	O
that	O	O
light	O	O
roasted	O	O
C.	O	O
canephora	O	O
extract	O	O
is	O	O
beneficial	O	O
as	O	O
an	O	O
anticariogenic	O	O
substance	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
antimicrobial	O	O
efficacies	O	O
of	O	O
two	O	O
toothpaste	O	O
formulations	O	O
containing	O	O
natural	O	O
antimicrobials	O	O
(	O	O
herbal	O	O
extracts	O	O
and	O	O
chitosan	O	O
)	O	O
against	O	O
oral	O	O
biofilms	O	O
of	O	O
different	O	O
composition	O	O
and	O	O
maturational	O	O
status	O	O
.	O	O

Bacteria	O	O
from	O	O
a	O	O
buffer	O	O
suspension	O	O
or	O	O
fresh	O	O
saliva	O	O
were	O	O
adhered	O	O
for	O	O
2h	O	O
to	O	O
a	O	O
salivary	O	O
conditioning	O	O
film	O	O
and	O	O
subsequently	O	O
grown	O	O
for	O	O
16h	O	O
.	O	O

Dual-species	O	O
biofilms	O	O
were	O	O
prepared	O	O
from	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
T14V-J1	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	I-bacteria	I-bacteria
J22	E-bacteria	I-bacteria
,	O	O
whilst	O	O
multi-species	O	O
biofilms	O	O
were	O	O
grown	O	O
from	O	O
freshly	O	O
collected	O	O
human	O	O
saliva	O	O
.	O	O

Biofilms	O	O
were	O	O
exposed	O	O
to	O	O
25wt	O	O
%	O	O
toothpaste	O	O
supernatants	O	O
.	O	O

A	O	O
chlorhexidine-containing	O	O
mouthrinse	O	O
and	O	O
a	O	O
buffer	O	O
were	O	O
used	O	O
as	O	O
positive-	O	O
and	O	O
negative-controls	O	O
,	O	O
respectively	O	O
.	O	O

Antibacterial	O	O
efficacy	O	O
was	O	O
concluded	O	O
from	O	O
acute	O	O
killing	O	O
,	O	O
bacterial	O	O
removal	O	O
,	O	O
prevention	O	O
of	O	O
bacterial	O	O
re-deposition	O	O
and	O	O
continued	O	O
killing	O	O
during	O	O
re-deposition	O	O
.	O	O

The	O	O
herbal-	O	O
and	O	O
chitosan-based	O	O
supernatants	O	O
showed	O	O
immediate	O	O
killing	O	O
of	O	O
oral	O	O
biofilm	O	O
bacteria	O	O
,	O	O
comparable	O	O
with	O	O
chlorhexidine	O	O
.	O	O

Moreover	O	O
,	O	O
exposure	O	O
of	O	O
a	O	O
biofilm	O	O
to	O	O
these	O	O
supernatants	O	O
or	O	O
chlorhexidine	O	O
,	O	O
yielded	O	O
ongoing	O	O
killing	O	O
of	O	O
biofilm	O	O
bacteria	O	O
after	O	O
exposure	O	O
during	O	O
re-deposition	O	O
of	O	O
bacteria	O	O
to	O	O
a	O	O
matured	O	O
16h	O	O
biofilm	O	O
,	O	O
but	O	O
not	O	O
to	O	O
a	O	O
much	O	O
thinner	O	O
initial	O	O
biofilm	O	O
formed	O	O
by	O	O
2h	O	O
adhesion	O	O
only	O	O
.	O	O

This	O	O
suggests	O	O
that	O	O
thicker	O	O
,	O	O
more	O	O
matured	O	O
biofilms	O	O
can	O	O
absorb	O	O
and	O	O
release	O	O
oral	O	O
antimicrobials	O	O
.	O	O

Supernatants	O	O
based	O	O
on	O	O
herbal-	O	O
and	O	O
chitosan-based	O	O
toothpastes	O	O
have	O	O
comparable	O	O
immediate	O	O
and	O	O
ongoing	O	O
antibacterial	O	O
efficacies	O	O
as	O	O
chlorhexidine	O	O
.	O	O

Natural	O	O
antimicrobials	O	O
and	O	O
chlorhexidine	O	O
absorb	O	O
in	O	O
oral	O	O
biofilms	O	O
which	O	O
contributes	O	O
to	O	O
their	O	O
substantive	O	O
action	O	O
.	O	O

The	O	O
composition	O	O
of	O	O
oral	O	O
microbiota	O	O
in	O	O
comatose	O	O
patients	O	O
remains	O	O
uncertain	O	O
.	O	O

Some	O	O
pulmonary	O	O
pathogens	O	O
may	O	O
be	O	O
found	O	O
in	O	O
dental	O	O
biofilms	O	O
or	O	O
as	O	O
part	O	O
of	O	O
the	O	O
saliva	O	O
microbiota	O	O
.	O	O

It	O	O
is	O	O
supposed	O	O
that	O	O
some	O	O
pneumopathogenic	O	O
microorganisms	O	O
may	O	O
overgrow	O	O
in	O	O
the	O	O
mouths	O	O
of	O	O
comatose	O	O
patients	O	O
and	O	O
spread	O	O
to	O	O
their	O	O
lungs	O	O
.	O	O

The	O	O
oral	O	O
colonization	O	O
dynamics	O	O
of	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
yeasts	O	O
in	O	O
nine	O	O
comatose	O	O
patients	O	O
(	O	O
group	O	O
1	O	O
)	O	O
,	O	O
and	O	O
in	O	O
12	O	O
conscious	O	O
patients	O	O
that	O	O
brushed	O	O
their	O	O
teeth	O	O
at	O	O
least	O	O
twice	O	O
a	O	O
day	O	O
(	O	O
group	O	O
2	O	O
)	O	O
was	O	O
evaluated	O	O
.	O	O

Both	O	O
groups	O	O
were	O	O
followed	O	O
up	O	O
for	O	O
7	O	O
days	O	O
after	O	O
hospitalization	O	O
.	O	O

Daily	O	O
samples	O	O
of	O	O
saliva	O	O
were	O	O
obtained	O	O
,	O	O
dispersed	O	O
and	O	O
plated	O	O
on	O	O
selective	O	O
culture	O	O
media	O	O
and	O	O
colony	O	O
forming	O	O
units	O	O
of	O	O
each	O	O
microbial	O	O
group	O	O
were	O	O
obtained	O	O
.	O	O

For	O	O
patients	O	O
in	O	O
group	O	O
1	O	O
,	O	O
the	O	O
counts	O	O
of	O	O
total	O	O
viable	O	O
bacteria	O	O
,	O	O
staphylococci	B-bacteria	B-bacteria
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
yeasts	O	O
progressively	O	O
increased	O	O
in	O	O
a	O	O
time-dependant	O	O
manner	O	O
.	O	O

For	O	O
the	O	O
conscious	O	O
patients	O	O
of	O	O
group	O	O
2	O	O
,	O	O
there	O	O
was	O	O
no	O	O
increase	O	O
.	O	O

It	O	O
would	O	O
appear	O	O
that	O	O
concomitant	O	O
consciousness	O	O
and	O	O
brushing	O	O
teeth	O	O
are	O	O
determinants	O	O
in	O	O
controlling	O	O
the	O	O
selected	O	O
pneumopathogen	O	O
counts	O	O
in	O	O
resting	O	O
saliva	O	O
.	O	O

The	O	O
increase	O	O
in	O	O
microbial	O	O
counts	O	O
in	O	O
comatose	O	O
patients	O	O
is	O	O
understandable	O	O
because	O	O
these	O	O
microorganisms	O	O
could	O	O
spread	O	O
to	O	O
the	O	O
lungs	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
is	O	O
associated	O	O
with	O	O
numerous	O	O
gastroduodenal	O	O
diseases	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
could	O	O
be	O	O
a	O	O
potential	O	O
extragastric	O	O
reservoir	O	O
for	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
,	O	O
and	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
might	O	O
cause	O	O
gastric	O	O
reinfection	O	O
after	O	O
the	O	O
eradication	O	O
therapy	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
and	O	O
to	O	O
examine	O	O
the	O	O
effectiveness	O	O
of	O	O
the	O	O
eradication	O	O
therapy	O	O
against	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
stomach	O	O
and	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Fifty-six	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
and	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
were	O	O
enrolled	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
was	O	O
determined	O	O
using	O	O
(	O	O
13	O	O
)	O	O
C-urea	O	O
breath	O	O
test	O	O
before	O	O
and	O	O
3	O	O
months	O	O
after	O	O
eradication	O	O
therapy	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
the	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
assessed	O	O
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
before	O	O
and	O	O
3	O	O
months	O	O
after	O	O
eradication	O	O
therapy	O	O
.	O	O

The	O	O
1-week	O	O
eradication	O	O
therapy	O	O
consisted	O	O
of	O	O
amoxycilin	O	O
1	O	O
g	O	O
,	O	O
clarithromycin	O	O
500	O	O
mg	O	O
,	O	O
and	O	O
proton	O	O
pump	O	O
inhibitor	O	O
20	O	O
mg	O	O
twice	O	O
a	O	O
day	O	O
.	O	O

Of	O	O
56	O	O
subjects	O	O
with	O	O
gastric	O	O
infection	O	O
,	O	O
23	O	O
(	O	O
41.1	O	O
%	O	O
)	O	O
harbored	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Eradication	O	O
rate	O	O
in	O	O
stomach	O	O
was	O	O
78.3	O	O
%	O	O
,	O	O
whereas	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
not	O	O
detected	O	O
from	O	O
any	O	O
sample	O	O
after	O	O
the	O	O
eradication	O	O
therapy	O	O
.	O	O

Almost	O	O
half	O	O
of	O	O
the	O	O
patients	O	O
with	O	O
gastric	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
harbored	O	O
the	O	O
bacterium	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

After	O	O
the	O	O
eradication	O	O
therapy	O	O
,	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
not	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
what	O	O
suggests	O	O
high	O	O
effectiveness	O	O
of	O	O
the	O	O
therapy	O	O
protocol	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
or	O	O
it	O	O
is	O	O
possible	O	O
that	O	O
oral	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
is	O	O
of	O	O
a	O	O
transient	O	O
character	O	O
.	O	O

Leprosy	O	O
is	O	O
an	O	O
important	O	O
health	O	O
problem	O	O
in	O	O
Brazil	O	O
despite	O	O
extensive	O	O
use	O	O
of	O	O
multidrug	O	O
therapy	O	O
.	O	O

The	O	O
nasal	O	O
mucosa	O	O
is	O	O
the	O	O
preferential	O	O
site	O	O
of	O	O
entry	O	O
and	O	O
exit	O	O
of	O	O
Mycobacterium	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
,	O	O
and	O	O
although	O	O
lesions	O	O
have	O	O
been	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
,	O	O
its	O	O
potential	O	O
involvement	O	O
in	O	O
the	O	O
transmission	O	O
of	O	O
leprosy	O	O
bacilli	O	O
has	O	O
never	O	O
been	O	O
investigated	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
M.	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
DNA	O	O
in	O	O
buccal	O	O
swabs	O	O
of	O	O
leprosy	O	O
patients	O	O
(	O	O
334	O	O
)	O	O
and	O	O
household	O	O
contacts	O	O
(	O	O
1288	O	O
)	O	O
through	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
,	O	O
and	O	O
correlated	O	O
this	O	O
with	O	O
clinical	O	O
and	O	O
laboratorial	O	O
evaluations	O	O
.	O	O

The	O	O
overall	O	O
positivity	O	O
for	O	O
patients	O	O
and	O	O
contacts	O	O
was	O	O
18.26	O	O
%	O	O
and	O	O
6.83	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

Subclinical	O	O
infection	O	O
among	O	O
contacts	O	O
was	O	O
considered	O	O
when	O	O
PCR	O	O
and	O	O
anti-PGL-1	O	O
ELISA	O	O
presented	O	O
positive	O	O
results	O	O
.	O	O

This	O	O
study	O	O
provides	O	O
evidence	O	O
that	O	O
the	O	O
oral	O	O
mucosa	O	O
may	O	O
be	O	O
a	O	O
secondary	O	O
site	O	O
of	O	O
M.	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
transmission	O	O
and	O	O
infection	O	O
,	O	O
and	O	O
contacts	O	O
with	O	O
bacillary	O	O
DNA	O	O
may	O	O
be	O	O
actively	O	O
involved	O	O
in	O	O
transmission	O	O
.	O	O

We	O	O
have	O	O
also	O	O
shown	O	O
that	O	O
bacilli	O	O
DNA	O	O
is	O	O
more	O	O
frequently	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
of	O	O
PB	O	O
patients	O	O
.	O	O

Our	O	O
findings	O	O
have	O	O
great	O	O
epidemiological	O	O
relevance	O	O
and	O	O
indicate	O	O
an	O	O
additional	O	O
strategy	O	O
for	O	O
leprosy	O	O
control	O	O
programmes	O	O
and	O	O
dental	O	O
clinics	O	O
.	O	O

In	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
chronic	O	O
inflammation	O	O
has	O	O
been	O	O
observed	O	O
at	O	O
various	O	O
stages	O	O
of	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinomas	O	O
(	O	O
OSCC	O	O
)	O	O
.	O	O

Such	O	O
inflammation	O	O
could	O	O
result	O	O
from	O	O
persistent	O	O
mucosal	O	O
or	O	O
epithelial	O	O
cell	O	O
colonization	O	O
by	O	O
microorganisms	O	O
.	O	O

There	O	O
is	O	O
increasing	O	O
evidence	O	O
of	O	O
the	O	O
involvement	O	O
of	O	O
oral	O	O
bacteria	O	O
in	O	O
inflammation	O	O
,	O	O
warranting	O	O
further	O	O
studies	O	O
on	O	O
the	O	O
association	O	O
of	O	O
bacteria	O	O
with	O	O
the	O	O
progression	O	O
of	O	O
OSCC	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
diversity	O	O
and	O	O
relative	O	O
abundance	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
subjects	O	O
with	O	O
OSCC	O	O
.	O	O

Using	O	O
454	O	O
parallel	O	O
DNA	O	O
sequencing	O	O
,	O	O
approximately	O	O
58,000	O	O
PCR	O	O
amplicons	O	O
that	O	O
span	O	O
the	O	O
V4-V5	O	O
hypervariable	O	O
region	O	O
of	O	O
rRNAs	O	O
from	O	O
five	O	O
subjects	O	O
were	O	O
sequenced	O	O
.	O	O

Members	O	O
of	O	O
eight	O	O
phyla	O	O
(	O	O
divisions	O	O
)	O	O
of	O	O
bacteria	O	O
were	O	O
detected	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
classified	O	O
sequences	O	O
belonged	O	O
to	O	O
the	O	O
phyla	O	O
Firmicutes	B-bacteria	B-bacteria
(	O	O
45	O	O
%	O	O
)	O	O
and	O	O
Bacteroidetes	B-bacteria	B-bacteria
(	O	O
25	O	O
%	O	O
)	O	O
.	O	O

Further	O	O
,	O	O
52	O	O
different	O	O
genera	O	O
containing	O	O
approximately	O	O
860	O	O
(	O	O
16.51	O	O
%	O	O
)	O	O
known	O	O
species	O	O
were	O	O
identified	O	O
and	O	O
1077	O	O
(	O	O
67	O	O
%	O	O
)	O	O
sequences	O	O
belonging	O	O
to	O	O
various	O	O
uncultured	O	O
bacteria	O	O
or	O	O
unclassified	O	O
groups	O	O
.	O	O

The	O	O
species	O	O
diversity	O	O
estimates	O	O
obtained	O	O
with	O	O
abundance-based	O	O
coverage	O	O
estimators	O	O
and	O	O
Chao1	O	O
were	O	O
greater	O	O
than	O	O
published	O	O
analyses	O	O
of	O	O
other	O	O
microbial	O	O
profiles	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Fifteen	O	O
unique	O	O
phylotypes	O	O
were	O	O
present	O	O
in	O	O
all	O	O
three	O	O
OSCC	O	O
subjects	O	O
.	O	O

Periodontal	O	O
disease	O	O
is	O	O
associated	O	O
with	O	O
specific	O	O
periodontal	O	O
pathogens	O	O
and	O	O
may	O	O
persist	O	O
as	O	O
gingivitis	O	O
or	O	O
progress	O	O
to	O	O
more	O	O
severe	O	O
disease	O	O
.	O	O

The	O	O
bacteria	O	O
involved	O	O
in	O	O
disease	O	O
initiation	O	O
and	O	O
progression	O	O
have	O	O
not	O	O
been	O	O
identified	O	O
.	O	O

We	O	O
used	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
to	O	O
compare	O	O
the	O	O
levels	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
and	O	O
total	O	O
bacteria	O	O
detected	O	O
by	O	O
different	O	O
sampling	O	O
methods	O	O
.	O	O

On	O	O
the	O	O
basis	O	O
of	O	O
the	O	O
results	O	O
of	O	O
clinical	O	O
examinations	O	O
,	O	O
57	O	O
patients	O	O
were	O	O
divided	O	O
into	O	O
3	O	O
groups	O	O
:	O	O
healthy	O	O
group	O	O
(	O	O
group	O	O
A	O	O
)	O	O
,	O	O
gingivitis	O	O
group	O	O
(	O	O
group	O	O
B	O	O
)	O	O
,	O	O
and	O	O
periodontitis	O	O
group	O	O
(	O	O
group	O	O
C	O	O
)	O	O
.	O	O

Bacterial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
saliva	O	O
,	O	O
mouthwash	O	O
,	O	O
and	O	O
by	O	O
paper-point	O	O
sampling	O	O
of	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
(	O	O
GCF	O	O
)	O	O
,	O	O
and	O	O
the	O	O
samples	O	O
were	O	O
analyzed	O	O
with	O	O
quantitative	O	O
PCR	O	O
targeting	O	O
16S	O	O
rRNA	O	O
.	O	O

The	O	O
numbers	O	O
of	O	O
total	O	O
bacteria	O	O
in	O	O
samples	O	O
of	O	O
GCF	O	O
,	O	O
saliva	O	O
,	O	O
and	O	O
mouthwash	O	O
were	O	O
10	O	O
(	O	O
5	O	O
)	O	O
to	O	O
10	O	O
(	O	O
6	O	O
)	O	O
,	O	O
10	O	O
(	O	O
8	O	O
)	O	O
,	O	O
and	O	O
10	O	O
(	O	O
7	O	O
)	O	O
,	O	O
respectively	O	O
,	O	O
per	O	O
milliliter	O	O
.	O	O

The	O	O
number	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
GCF	O	O
samples	O	O
was	O	O
lower	O	O
than	O	O
10	O	O
in	O	O
group	O	O
A	O	O
;	O	O
however	O	O
,	O	O
in	O	O
groups	O	O
B	O	O
and	O	O
C	O	O
,	O	O
the	O	O
values	O	O
were	O	O
10	O	O
(	O	O
3	O	O
)	O	O
and	O	O
10	O	O
(	O	O
4	O	O
)	O	O
,	O	O
respectively	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
number	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
increased	O	O
with	O	O
worsening	O	O
clinical	O	O
status	O	O
.	O	O

Findings	O	O
were	O	O
similar	O	O
in	O	O
the	O	O
samples	O	O
of	O	O
saliva	O	O
and	O	O
mouthwash	O	O
.	O	O

The	O	O
numbers	O	O
of	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
showed	O	O
a	O	O
pattern	O	O
similar	O	O
to	O	O
that	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
all	O	O
3	O	O
samples	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
saliva	O	O
and	O	O
mouthwash	O	O
samples	O	O
are	O	O
clinically	O	O
useful	O	O
for	O	O
bacterial	O	O
testing	O	O
of	O	O
periodontal	O	O
diseases	O	O
by	O	O
quantitative	O	O
PCR	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
mouthwash	O	O
sampling	O	O
is	O	O
more	O	O
feasible	O	O
and	O	O
straightforward	O	O
than	O	O
saliva	O	O
sampling	O	O
.	O	O

The	O	O
epithelial	O	O
cell	O	O
barrier	O	O
is	O	O
the	O	O
first	O	O
line	O	O
of	O	O
host	O	O
defense	O	O
against	O	O
bacterial	O	O
aggression	O	O
in	O	O
periodontal	O	O
sites	O	O
.	O	O

In	O	O
view	O	O
of	O	O
the	O	O
fact	O	O
that	O	O
oral	O	O
epithelial	O	O
cells	O	O
do	O	O
not	O	O
express	O	O
membrane	O	O
CD14	O	O
and	O	O
that	O	O
high	O	O
levels	O	O
of	O	O
the	O	O
soluble	O	O
form	O	O
of	O	O
the	O	O
CD14	O	O
receptor	O	O
have	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
of	O	O
patients	O	O
with	O	O
periodontitis	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
recombinant	O	O
soluble	O	O
CD14	O	O
(	O	O
rsCD14	O	O
)	O	O
,	O	O
alone	O	O
and	O	O
in	O	O
combination	O	O
with	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
on	O	O
the	O	O
inflammatory	O	O
response	O	O
of	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
oral	O	O
epithelial	O	O
cell	O	O
line	O	O
GMSM-K	O	O
was	O	O
stimulated	O	O
with	O	O
rsCD14	O	O
,	O	O
alone	O	O
or	O	O
in	O	O
combination	O	O
with	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
LPS	O	O
,	O	O
and	O	O
the	O	O
levels	O	O
of	O	O
the	O	O
inflammatory	O	O
mediators	O	O
interleukin	O	O
(	O	O
IL	O	O
)	O	O
-6	O	O
,	O	O
IL-8	O	O
and	O	O
chemokine	O	O
(	O	O
C-C	O	O
motif	O	O
)	O	O
ligand	O	O
5	O	O
(	O	O
CCL5	O	O
)	O	O
were	O	O
determined	O	O
using	O	O
ELISAs	O	O
.	O	O

Activation	O	O
of	O	O
the	O	O
transcription	O	O
factors	O	O
nuclear	O	O
factor-kappaB	O	O
(	O	O
NF-kappaB	O	O
)	O	O
and	O	O
activator	O	O
protein-1	O	O
was	O	O
also	O	O
monitored	O	O
using	O	O
ELISAs	O	O
.	O	O

rsCD14	O	O
significantly	O	O
induced	O	O
the	O	O
secretion	O	O
of	O	O
IL-6	O	O
,	O	O
IL-8	O	O
and	O	O
CCL5	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
combination	O	O
of	O	O
rsCD14	O	O
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
LPS	O	O
augmented	O	O
this	O	O
effect	O	O
.	O	O

Activation	O	O
of	O	O
the	O	O
NF-kappaB	O	O
pathway	O	O
was	O	O
significantly	O	O
increased	O	O
in	O	O
epithelial	O	O
cells	O	O
treated	O	O
with	O	O
rsCD14	O	O
compared	O	O
with	O	O
a	O	O
nonstimulated	O	O
control	O	O
,	O	O
whereas	O	O
there	O	O
was	O	O
no	O	O
effect	O	O
on	O	O
the	O	O
activation	O	O
of	O	O
activator	O	O
protein-1	O	O
.	O	O

rsCD14	O	O
stimulated	O	O
the	O	O
inflammation	O	O
cascade	O	O
in	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
both	O	O
alone	O	O
or	O	O
when	O	O
associated	O	O
with	O	O
bacterial	O	O
LPS	O	O
,	O	O
through	O	O
an	O	O
NF-kappaB-dependent	O	O
pathway	O	O
.	O	O

This	O	O
suggests	O	O
that	O	O
the	O	O
presence	O	O
of	O	O
soluble	O	O
CD14	O	O
in	O	O
periodontitis	O	O
lesions	O	O
may	O	O
contribute	O	O
to	O	O
the	O	O
inflammatory	O	O
process	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

Periodontal	O	O
diseases	O	O
are	O	O
multifactorial	O	O
infections	O	O
elicited	O	O
by	O	O
a	O	O
complex	O	O
of	O	O
primarily	O	O
gram-negative	O	O
bacteria	O	O
that	O	O
interact	O	O
with	O	O
host	O	O
tissues	O	O
and	O	O
lead	O	O
to	O	O
the	O	O
destruction	O	O
of	O	O
the	O	O
periodontal	O	O
structures	O	O
.	O	O

Bdellovibrio	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
is	O	O
a	O	O
gram-negative	O	O
bacterium	O	O
that	O	O
preys	O	O
upon	O	O
other	O	O
gram-negative	O	O
bacteria	O	O
.	O	O

It	O	O
was	O	O
previously	O	O
shown	O	O
that	O	O
B.	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
has	O	O
an	O	O
ability	O	O
to	O	O
attack	O	O
and	O	O
remove	O	O
surface-attached	O	O
bacteria	O	O
or	O	O
biofilms	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
host	O	O
specificity	O	O
of	O	O
B.	B-bacteria	B-bacteria
bacteriovorus	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
109J	E-bacteria	I-bacteria
and	O	O
its	O	O
ability	O	O
to	O	O
prey	O	O
on	O	O
oral	O	O
pathogens	O	O
associated	O	O
with	O	O
periodontitis	O	O
,	O	O
including	O	O
;	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
.	O	O

We	O	O
further	O	O
demonstrated	O	O
that	O	O
B.	B-bacteria	B-bacteria
bacteriovorus	I-bacteria	I-bacteria
109J	E-bacteria	I-bacteria
has	O	O
an	O	O
ability	O	O
to	O	O
remove	O	O
biofilms	O	O
of	O	O
Ei	O	O
.	O	O

corrodens	O	O
as	O	O
well	O	O
as	O	O
biofilms	O	O
composed	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

Bdellovibrio	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
was	O	O
able	O	O
to	O	O
remove	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
biofilms	O	O
developed	O	O
on	O	O
hydroxyapatite	O	O
surfaces	O	O
and	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
saliva	O	O
,	O	O
as	O	O
well	O	O
as	O	O
to	O	O
detach	O	O
metabolically	O	O
inactive	O	O
biofilms	O	O
.	O	O

Experiments	O	O
aimed	O	O
at	O	O
enhancing	O	O
the	O	O
biofilm	O	O
removal	O	O
aptitude	O	O
of	O	O
B.	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
with	O	O
the	O	O
aid	O	O
of	O	O
extracellular-polymeric-substance-degrading	O	O
enzymes	O	O
demonstrated	O	O
that	O	O
proteinase-K	O	O
inhibits	O	O
predation	O	O
.	O	O

However	O	O
,	O	O
treating	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
biofilms	O	O
with	O	O
DspB	O	O
,	O	O
a	O	O
poly-N-acetylglucosamine	O	O
(	O	O
PGA	O	O
)	O	O
-hydrolysing	O	O
enzyme	O	O
,	O	O
increased	O	O
biofilm	O	O
removal	O	O
.	O	O

Increased	O	O
biofilm	O	O
removal	O	O
was	O	O
also	O	O
recorded	O	O
when	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
PGA-defective	O	O
mutants	O	O
were	O	O
used	O	O
as	O	O
host	O	O
cells	O	O
,	O	O
suggesting	O	O
that	O	O
PGA	O	O
degradation	O	O
could	O	O
enhance	O	O
the	O	O
removal	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
biofilm	O	O
by	O	O
B.	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
.	O	O

Recently	O	O
,	O	O
the	O	O
predation	O	O
of	O	O
Bdellovibrio	B-bacteria	B-bacteria
bacteriovorus	E-bacteria	I-bacteria
on	O	O
a	O	O
periodontal	O	O
pathogen	O	O
has	O	O
been	O	O
described	O	O
.	O	O

The	O	O
current	O	O
study	O	O
explores	O	O
the	O	O
potential	O	O
antimicrobial	O	O
activity	O	O
of	O	O
a	O	O
range	O	O
of	O	O
predatory	O	O
bacteria	O	O
against	O	O
key	O	O
periodontal	O	O
pathogens	O	O
.	O	O

A	O	O
number	O	O
of	O	O
representatives	O	O
from	O	O
the	O	O
Bdellovibrio	B-bacteria	B-bacteria
,	O	O
Bacteriovorax	B-bacteria	B-bacteria
and	O	O
Peredibacter	B-bacteria	B-bacteria
lineages	O	O
(	O	O
called	O	O
'BALOs	O	O
'	O	O
)	O	O
were	O	O
tested	O	O
for	O	O
their	O	O
activity	O	O
towards	O	O
a	O	O
group	O	O
of	O	O
key	O	O
periodontal	O	O
pathogens	O	O
and	O	O
an	O	O
optimal	O	O
multiplicity	O	O
of	O	O
infection	O	O
was	O	O
established	O	O
.	O	O

As	O	O
the	O	O
oral	O	O
cavity	O	O
contains	O	O
a	O	O
wide	O	O
variety	O	O
of	O	O
bacteria	O	O
that	O	O
are	O	O
not	O	O
preyed	O	O
upon	O	O
,	O	O
it	O	O
was	O	O
investigated	O	O
if	O	O
they	O	O
can	O	O
have	O	O
an	O	O
effect	O	O
on	O	O
the	O	O
predation	O	O
efficiency	O	O
of	O	O
BALOs	O	O
.	O	O

It	O	O
was	O	O
concluded	O	O
that	O	O
a	O	O
number	O	O
of	O	O
important	O	O
variables	O	O
involved	O	O
in	O	O
bacterial	O	O
predation	O	O
are	O	O
found	O	O
to	O	O
be	O	O
compatible	O	O
with	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
.	O	O

This	O	O
finding	O	O
makes	O	O
the	O	O
case	O	O
for	O	O
continued	O	O
study	O	O
of	O	O
the	O	O
potential	O	O
for	O	O
BALOs	O	O
to	O	O
combat	O	O
periodontal	O	O
pathogens	O	O
.	O	O

Oral	O	O
viridans	O	O
group	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
the	O	O
major	O	O
commensal	O	O
bacteria	O	O
of	O	O
the	O	O
supragingival	O	O
oral	O	O
biofilm	O	O
and	O	O
have	O	O
been	O	O
detected	O	O
in	O	O
human	O	O
atheromatous	O	O
plaque	O	O
.	O	O

Atherosclerosis	O	O
involves	O	O
an	O	O
ongoing	O	O
inflammatory	O	O
response	O	O
,	O	O
reportedly	O	O
involving	O	O
chronic	O	O
infection	O	O
caused	O	O
by	O	O
multiple	O	O
pathogens	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
invasion	O	O
of	O	O
human	O	O
aortic	O	O
endothelial	O	O
cells	O	O
(	O	O
HAECs	O	O
)	O	O
by	O	O
oral	O	O
viridans	O	O
group	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
the	O	O
subsequent	O	O
cytokine	O	O
production	O	O
by	O	O
viable	O	O
invaded	O	O
HAECs	O	O
.	O	O

The	O	O
invasion	O	O
of	O	O
HAECs	O	O
by	O	O
bacteria	O	O
was	O	O
examined	O	O
using	O	O
antibiotic	O	O
protection	O	O
assays	O	O
and	O	O
was	O	O
visualized	O	O
by	O	O
confocal	O	O
scanning	O	O
laser	O	O
microscopy	O	O
.	O	O

The	O	O
inhibitory	O	O
effects	O	O
of	O	O
catalase	O	O
and	O	O
cytochalasin	O	O
D	O	O
on	O	O
the	O	O
invasion	O	O
of	O	O
HAECs	O	O
were	O	O
also	O	O
examined	O	O
.	O	O

The	O	O
production	O	O
of	O	O
cytokines	O	O
by	O	O
invaded	O	O
or	O	O
infected	O	O
HAECs	O	O
was	O	O
determined	O	O
using	O	O
enzyme-linked	O	O
immunosorbent	O	O
assays	O	O
,	O	O
and	O	O
a	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
method	O	O
was	O	O
used	O	O
to	O	O
evaluate	O	O
the	O	O
expression	O	O
of	O	O
cytokine	O	O
messenger	O	O
RNA	O	O
.	O	O

The	O	O
oral	O	O
streptococci	O	O
tested	O	O
were	O	O
capable	O	O
of	O	O
invading	O	O
HAECs	O	O
.	O	O

The	O	O
number	O	O
of	O	O
invasive	O	O
bacteria	O	O
increased	O	O
with	O	O
the	O	O
length	O	O
of	O	O
the	O	O
co-culture	O	O
period	O	O
.	O	O

After	O	O
a	O	O
certain	O	O
co-culture	O	O
period	O	O
,	O	O
some	O	O
organisms	O	O
were	O	O
cytotoxic	O	O
to	O	O
the	O	O
HAECs	O	O
.	O	O

Catalase	O	O
and	O	O
cytochalasin	O	O
D	O	O
inhibited	O	O
the	O	O
invasion	O	O
of	O	O
HAECs	O	O
by	O	O
the	O	O
organism	O	O
.	O	O

HAECs	O	O
invaded	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
Xc	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
DL1	E-bacteria	I-bacteria
(	O	O
Challis	B-bacteria	B-bacteria
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
10558	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
13419	E-bacteria	I-bacteria
produced	O	O
more	O	O
cytokine	O	O
(	O	O
s	O	O
)	O	O
(	O	O
interleukin-6	O	O
,	O	O
interleukin-8	O	O
,	O	O
monocyte	O	O
chemoattractant	O	O
protein-1	O	O
)	O	O
than	O	O
non-invaded	O	O
HAECs	O	O
.	O	O

The	O	O
HAECs	O	O
invaded	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
Xc	E-bacteria	I-bacteria
produced	O	O
the	O	O
largest	O	O
amounts	O	O
of	O	O
cytokines	O	O
,	O	O
and	O	O
the	O	O
messenger	O	O
RNA	O	O
expression	O	O
of	O	O
cytokines	O	O
by	O	O
invaded	O	O
HAECs	O	O
increased	O	O
markedly	O	O
compared	O	O
with	O	O
that	O	O
by	O	O
non-invaded	O	O
HAECs	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
may	O	O
participate	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
atherosclerosis	O	O
.	O	O

The	O	O
human	O	O
oral	O	O
microbial	O	O
biota	O	O
represents	O	O
a	O	O
highly	O	O
diverse	O	O
biofilm	O	O
.	O	O

Twenty-five	O	O
species	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
inhabit	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
and	O	O
represent	O	O
about	O	O
20	O	O
%	O	O
of	O	O
the	O	O
total	O	O
oral	O	O
bacteria	O	O
.	O	O

Taxonomy	O	O
of	O	O
these	O	O
bacteria	O	O
is	O	O
complex	O	O
and	O	O
remains	O	O
provisional	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
encompass	O	O
friends	O	O
and	O	O
foes	O	O
bacteria	O	O
.	O	O

Each	O	O
species	O	O
has	O	O
developed	O	O
specific	O	O
properties	O	O
for	O	O
colonizing	O	O
the	O	O
different	O	O
oral	O	O
sites	O	O
subjected	O	O
to	O	O
constantly	O	O
changing	O	O
conditions	O	O
,	O	O
for	O	O
competing	O	O
against	O	O
competitors	O	O
,	O	O
and	O	O
for	O	O
resisting	O	O
external	O	O
agressions	O	O
(	O	O
host	O	O
immune	O	O
system	O	O
,	O	O
physico-chemical	O	O
shocks	O	O
,	O	O
and	O	O
mechanical	O	O
frictions	O	O
)	O	O
.	O	O

Imbalance	O	O
in	O	O
the	O	O
indigenous	O	O
microbial	O	O
biota	O	O
generates	O	O
oral	O	O
diseases	O	O
,	O	O
and	O	O
under	O	O
proper	O	O
conditions	O	O
,	O	O
commensal	O	O
streptococci	O	O
can	O	O
switch	O	O
to	O	O
opportunistic	O	O
pathogens	O	O
that	O	O
initiate	O	O
disease	O	O
in	O	O
and	O	O
damage	O	O
to	O	O
the	O	O
host	O	O
.	O	O

The	O	O
group	O	O
of	O	O
``	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
''	O	O
was	O	O
described	O	O
as	O	O
the	O	O
most	O	O
important	O	O
bacteria	O	O
related	O	O
to	O	O
the	O	O
formation	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
although	O	O
naturally	O	O
present	O	O
among	O	O
the	O	O
human	O	O
oral	O	O
microbiota	O	O
,	O	O
is	O	O
the	O	O
microbial	O	O
species	O	O
most	O	O
strongly	O	O
associated	O	O
with	O	O
carious	O	O
lesions	O	O
.	O	O

This	O	O
minireview	O	O
describes	O	O
the	O	O
oral	O	O
streptococci	O	O
ecology	O	O
and	O	O
their	O	O
biofilm	O	O
life	O	O
style	O	O
by	O	O
focusing	O	O
on	O	O
the	O	O
mutans	O	O
group	O	O
,	O	O
mainly	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Virulence	O	O
traits	O	O
,	O	O
interactions	O	O
in	O	O
the	O	O
biofilm	O	O
,	O	O
and	O	O
influence	O	O
of	O	O
S.	O	O
mutans	O	O
in	O	O
dental	O	O
caries	O	O
etiology	O	O
are	O	O
discussed	O	O
.	O	O

Some	O	O
gastrointestinal	O	O
bacteria	O	O
synthesize	O	O
hydrogen	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
)	O	O
by	O	O
fermentation	O	O
.	O	O

Despite	O	O
the	O	O
presence	O	O
of	O	O
bactericidal	O	O
factors	O	O
in	O	O
human	O	O
saliva	O	O
,	O	O
a	O	O
large	O	O
number	O	O
of	O	O
bacteria	O	O
also	O	O
live	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

It	O	O
has	O	O
never	O	O
been	O	O
shown	O	O
that	O	O
oral	O	O
bacteria	O	O
also	O	O
produce	O	O
H	O	O
(	O	O
2	O	O
)	O	O
or	O	O
what	O	O
role	O	O
H	O	O
(	O	O
2	O	O
)	O	O
might	O	O
play	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

It	O	O
was	O	O
found	O	O
that	O	O
a	O	O
significant	O	O
amount	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
is	O	O
synthesized	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
human	O	O
subjects	O	O
,	O	O
and	O	O
that	O	O
its	O	O
generation	O	O
is	O	O
enhanced	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
glucose	O	O
but	O	O
inhibited	O	O
by	O	O
either	O	O
teeth	O	O
brushing	O	O
or	O	O
sterilization	O	O
with	O	O
povidone	O	O
iodine	O	O
.	O	O

These	O	O
observations	O	O
suggest	O	O
the	O	O
presence	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
-generating	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
screening	O	O
of	O	O
commensal	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
revealed	O	O
that	O	O
a	O	O
variety	O	O
of	O	O
anaerobic	O	O
bacteria	O	O
generate	O	O
H	O	O
(	O	O
2	O	O
)	O	O
.	O	O

Among	O	O
them	O	O
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
(	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
)	O	O
generated	O	O
significantly	O	O
large	O	O
amounts	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
glucose	O	O
.	O	O

Biochemical	O	O
analysis	O	O
revealed	O	O
that	O	O
various	O	O
proteins	O	O
in	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
are	O	O
carbonylated	O	O
under	O	O
standard	O	O
culture	O	O
conditions	O	O
,	O	O
and	O	O
that	O	O
oxidative	O	O
stress	O	O
induced	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
Fe	O	O
(	O	O
++	O	O
)	O	O
and	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
increases	O	O
the	O	O
number	O	O
of	O	O
carbonylated	O	O
proteins	O	O
,	O	O
particularly	O	O
when	O	O
their	O	O
hydrogenase	O	O
activity	O	O
is	O	O
inhibited	O	O
by	O	O
KCN	O	O
.	O	O

Inhibition	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
generation	O	O
markedly	O	O
suppresses	O	O
the	O	O
growth	O	O
of	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
.	O	O

These	O	O
observations	O	O
suggest	O	O
that	O	O
H	O	O
(	O	O
2	O	O
)	O	O
generation	O	O
and/or	O	O
the	O	O
reduction	O	O
of	O	O
oxidative	O	O
stress	O	O
is	O	O
important	O	O
for	O	O
the	O	O
survival	O	O
and	O	O
growth	O	O
of	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
is	O	O
a	O	O
specialized	O	O
ecosystem	O	O
composed	O	O
of	O	O
dentition	O	O
and	O	O
mucosa	O	O
exposed	O	O
to	O	O
the	O	O
effects	O	O
of	O	O
saliva	O	O
and	O	O
gingival	O	O
liquid	O	O
.	O	O

Its	O	O
structure	O	O
provides	O	O
advantageous	O	O
conditions	O	O
for	O	O
various	O	O
microorganisms	O	O
,	O	O
both	O	O
aerobic	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
anaerobic	O	O
bacilli	O	O
.	O	O

The	O	O
dynamic	O	O
balance	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
ecosystem	O	O
can	O	O
be	O	O
threatened	O	O
by	O	O
various	O	O
factors	O	O
.	O	O

Lip	O	O
and	O	O
palatal	O	O
clefts	O	O
are	O	O
the	O	O
most	O	O
frequent	O	O
disorders	O	O
in	O	O
embryonic	O	O
facial	O	O
development	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
whether	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
and	O	O
oral	O	O
cavity	O	O
hygiene	O	O
in	O	O
patients	O	O
with	O	O
cleft	O	O
palate	O	O
treated	O	O
orthodontically	O	O
are	O	O
significantly	O	O
different	O	O
compared	O	O
with	O	O
patients	O	O
without	O	O
these	O	O
congenital	O	O
malformations	O	O
.	O	O

The	O	O
study	O	O
group	O	O
consisted	O	O
of	O	O
200	O	O
patients	O	O
aged	O	O
6-21	O	O
who	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
depending	O	O
on	O	O
the	O	O
presence	O	O
of	O	O
cleft	O	O
palate	O	O
and	O	O
treatment	O	O
method	O	O
.	O	O

Group	O	O
C	O	O
(	O	O
control	O	O
)	O	O
consisted	O	O
of	O	O
50	O	O
orthodontically	O	O
untreated	O	O
patients	O	O
with	O	O
occlusal	O	O
dental	O	O
defects	O	O
.	O	O

The	O	O
performed	O	O
studies	O	O
consisted	O	O
of	O	O
2	O	O
parts	O	O
:	O	O
the	O	O
clinical-laboratory	O	O
part	O	O
and	O	O
statistical	O	O
analysis	O	O
.	O	O

Clinical-laboratory	O	O
part	O	O
High	O	O
bacteria	O	O
levels	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
in	O	O
saliva	O	O
of	O	O
patients	O	O
were	O	O
comparably	O	O
frequent	O	O
between	O	O
groups	O	O
,	O	O
but	O	O
there	O	O
were	O	O
statistically	O	O
significant	O	O
differences	O	O
in	O	O
inter-group	O	O
comparisons	O	O
.	O	O

As	O	O
the	O	O
orthodontic	O	O
treatment	O	O
changes	O	O
the	O	O
oral	O	O
environment	O	O
,	O	O
control	O	O
of	O	O
proper	O	O
hygienic	O	O
behavior	O	O
is	O	O
an	O	O
essential	O	O
element	O	O
of	O	O
health	O	O
education	O	O
.	O	O

Introduction	O	O
of	O	O
preventive	O	O
programs	O	O
is	O	O
also	O	O
very	O	O
important	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
contains	O	O
the	O	O
greatest	O	O
biodiversity	O	O
,	O	O
over	O	O
70	O	O
species	O	O
being	O	O
isolated	O	O
from	O	O
mouth	O	O
mucosa	O	O
,	O	O
saliva	O	O
,	O	O
denture	O	O
surfaces	O	O
and/or	O	O
dental-plaque	O	O
.	O	O

The	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
representing	O	O
over	O	O
80	O	O
%	O	O
of	O	O
the	O	O
mouth	O	O
micro	O	O
flora	O	O
,	O	O
are	O	O
able	O	O
to	O	O
synthesize	O	O
glucosyl-transferases	O	O
,	O	O
enzymes	O	O
involved	O	O
in	O	O
glucans	O	O
production	O	O
.	O	O

Glucans	O	O
are	O	O
involved	O	O
in	O	O
production	O	O
of	O	O
an	O	O
extracellular	O	O
slime	O	O
layer	O	O
promoting	O	O
adhesion	O	O
and	O	O
formation	O	O
of	O	O
a	O	O
dental	O	O
plaque	O	O
biofilm	O	O
.	O	O

The	O	O
43	O	O
isolates	O	O
studied	O	O
obtained	O	O
from	O	O
partially	O	O
and/or	O	O
totally	O	O
edentulous	O	O
,	O	O
were	O	O
identified	O	O
by	O	O
VITEK	O	O
system	O	O
using	O	O
gram-positive	O	O
identification	O	O
cards	O	O
.	O	O

Species-specific	O	O
regions	O	O
within	O	O
the	O	O
genes	O	O
coding	O	O
for	O	O
glucosyl-transferases	O	O
(	O	O
gtf	O	O
genes	O	O
)	O	O
were	O	O
targeted	O	O
for	O	O
PCR	O	O
identification	O	O
of	O	O
isolates	O	O
.	O	O

Sequencing	O	O
of	O	O
16S	O	O
rRNA	O	O
was	O	O
used	O	O
as	O	O
gold	O	O
standard	O	O
for	O	O
strain	O	O
confirmation	O	O
.	O	O

system	O	O
identified	O	O
a	O	O
number	O	O
of	O	O
11	O	O
strains	O	O
as	O	O
S.	B-bacteria	B-bacteria
mitis/oralis	E-bacteria	I-bacteria
,	O	O
12	O	O
strains	O	O
as	O	O
S.	B-bacteria	B-bacteria
anginosus/gordonii	E-bacteria	I-bacteria
,	O	O
12	O	O
strains	O	O
as	O	O
S.	B-bacteria	B-bacteria
sanguinis/parasanguinis	E-bacteria	I-bacteria
,	O	O
3	O	O
strains	O	O
as	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
3	O	O
strains	O	O
as	O	O
S.	B-bacteria	B-bacteria
plurianimalium	E-bacteria	I-bacteria
,	O	O
1	O	O
strain	O	O
as	O	O
S.	B-bacteria	B-bacteria
cristatus	E-bacteria	I-bacteria
and	O	O
1	O	O
strain	O	O
as	O	O
S.	B-bacteria	B-bacteria
alactolyticus	E-bacteria	I-bacteria
,	O	O
respectively	O	O
.	O	O

The	O	O
PCR	O	O
system	O	O
targeting	O	O
gtf	O	O
genes	O	O
was	O	O
able	O	O
to	O	O
identify	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

Sequence	O	O
of	O	O
16S	O	O
rRNA	O	O
discriminated	O	O
among	O	O
streptococci	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
and	O	O
revealed	O	O
16	O	O
strains	O	O
of	O	O
Leuconostoc	B-bacteria	B-bacteria
mesenteroides	E-bacteria	I-bacteria
.	O	O

Many	O	O
studies	O	O
are	O	O
needed	O	O
in	O	O
order	O	O
to	O	O
select	O	O
the	O	O
most	O	O
reliable	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
methods	O	O
in	O	O
order	O	O
to	O	O
improve	O	O
the	O	O
identification	O	O
algorithm	O	O
for	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
used	O	O
by	O	O
clinical	O	O
laboratories	O	O
.	O	O

Their	O	O
accurate	O	O
identification	O	O
is	O	O
mandatory	O	O
for	O	O
better	O	O
understanding	O	O
their	O	O
role	O	O
in	O	O
human	O	O
infections	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
is	O	O
a	O	O
member	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
one	O	O
of	O	O
the	O	O
most	O	O
abundant	O	O
species	O	O
found	O	O
in	O	O
oral	O	O
biofilm	O	O
called	O	O
dental	O	O
plaque	O	O
.	O	O

Colonization	O	O
of	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
on	O	O
the	O	O
tooth	O	O
surface	O	O
depends	O	O
on	O	O
the	O	O
adhesion	O	O
of	O	O
bacteria	O	O
to	O	O
salivary	O	O
components	O	O
adsorbed	O	O
to	O	O
the	O	O
tooth	O	O
surface	O	O
.	O	O

Recently	O	O
,	O	O
we	O	O
identified	O	O
unique	O	O
cell	O	O
surface	O	O
long	O	O
filamentous	O	O
structures	O	O
named	O	O
pili	O	O
in	O	O
this	O	O
species	O	O
.	O	O

Herein	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
role	O	O
of	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
pili	O	O
in	O	O
biofilm	O	O
formation	O	O
.	O	O

We	O	O
found	O	O
that	O	O
pili-deficient	O	O
mutant	O	O
,	O	O
in	O	O
which	O	O
the	O	O
genes	O	O
encoding	O	O
the	O	O
three	O	O
pilus	O	O
proteins	O	O
PilA	O	O
,	O	O
PilB	O	O
and	O	O
PilC	O	O
have	O	O
been	O	O
deleted	O	O
,	O	O
showed	O	O
an	O	O
impaired	O	O
bacterial	O	O
accumulation	O	O
on	O	O
saliva-coated	O	O
surfaces	O	O
.	O	O

Confocal	O	O
microscopic	O	O
observations	O	O
suggested	O	O
that	O	O
the	O	O
mutant	O	O
was	O	O
incapable	O	O
of	O	O
producing	O	O
typical	O	O
three-dimensional	O	O
layer	O	O
of	O	O
biofilm	O	O
.	O	O

Ligand	O	O
blot	O	O
analysis	O	O
showed	O	O
that	O	O
the	O	O
ancillary	O	O
pilus	O	O
proteins	O	O
PilB	O	O
and	O	O
PilC	O	O
bound	O	O
to	O	O
human	O	O
whole	O	O
saliva	O	O
.	O	O

Additional	O	O
analysis	O	O
demonstrated	O	O
that	O	O
PilC	O	O
bound	O	O
to	O	O
multiple	O	O
salivary	O	O
components	O	O
,	O	O
and	O	O
one	O	O
of	O	O
which	O	O
was	O	O
found	O	O
to	O	O
be	O	O
salivary	O	O
alpha-amylase	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
pilus	O	O
proteins	O	O
are	O	O
members	O	O
of	O	O
saliva-binding	O	O
proteins	O	O
of	O	O
oral	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
and	O	O
suggest	O	O
the	O	O
involvement	O	O
of	O	O
pili	O	O
in	O	O
its	O	O
colonization	O	O
on	O	O
saliva-coated	O	O
tooth	O	O
surfaces	O	O
and	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Capnocytophaga	B-bacteria	B-bacteria
canimorsus	E-bacteria	I-bacteria
is	O	O
a	O	O
potentially	O	O
pathogenic	O	O
microorganism	O	O
when	O	O
transmitted	O	O
to	O	O
humans	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
canines	O	O
.	O	O

Although	O	O
there	O	O
is	O	O
some	O	O
knowledge	O	O
about	O	O
the	O	O
frequency	O	O
of	O	O
occurrence	O	O
in	O	O
canines	O	O
,	O	O
it	O	O
is	O	O
uncertain	O	O
whether	O	O
there	O	O
is	O	O
a	O	O
correlation	O	O
between	O	O
its	O	O
occurrence	O	O
and	O	O
lifestyle	O	O
,	O	O
health	O	O
,	O	O
or	O	O
breed	O	O
of	O	O
dog	O	O
.	O	O

Samples	O	O
of	O	O
tooth	O	O
plaque	O	O
from	O	O
a	O	O
total	O	O
of	O	O
131	O	O
canines	O	O
were	O	O
collected	O	O
,	O	O
cultured	O	O
on	O	O
selective	O	O
media	O	O
,	O	O
and	O	O
tested	O	O
using	O	O
physiological	O	O
and	O	O
molecular	O	O
analyses	O	O
to	O	O
help	O	O
discern	O	O
the	O	O
presence	O	O
of	O	O
C.	B-bacteria	B-bacteria
canimorsus	E-bacteria	I-bacteria
.	O	O

Phylogenetic	O	O
analyses	O	O
determined	O	O
that	O	O
49.2	O	O
%	O	O
of	O	O
canines	O	O
sampled	O	O
carried	O	O
a	O	O
species	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
and	O	O
21.7	O	O
%	O	O
of	O	O
the	O	O
canines	O	O
sampled	O	O
in	O	O
this	O	O
study	O	O
carried	O	O
C.	B-bacteria	B-bacteria
canimorsus	E-bacteria	I-bacteria
.	O	O

Statistical	O	O
analyses	O	O
found	O	O
that	O	O
male	O	O
dogs	O	O
and	O	O
those	O	O
that	O	O
are	O	O
neutered	O	O
and	O	O
spayed	O	O
are	O	O
more	O	O
likely	O	O
to	O	O
host	O	O
Capnocytophaga	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
data	O	O
also	O	O
suggested	O	O
that	O	O
breed	O	O
was	O	O
a	O	O
statistically	O	O
significant	O	O
predictor	O	O
of	O	O
C.	B-bacteria	B-bacteria
canimorsus	E-bacteria	I-bacteria
,	O	O
with	O	O
the	O	O
smaller	O	O
breeds	O	O
more	O	O
likely	O	O
to	O	O
carry	O	O
the	O	O
potential	O	O
pathogen	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
three	O	O
``	O	O
human	O	O
''	O	O
species	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
;	O	O
C.	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
,	O	O
C.	B-bacteria	B-bacteria
haemolytica	E-bacteria	I-bacteria
,	O	O
and	O	O
one	O	O
isolate	O	O
of	O	O
either	O	O
C.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
C.	B-bacteria	B-bacteria
granulosa	E-bacteria	I-bacteria
were	O	O
cultured	O	O
from	O	O
five	O	O
canines	O	O
.	O	O

Sixteen	O	O
canines	O	O
sampled	O	O
carried	O	O
an	O	O
unidentified	O	O
Capnocytophaga	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
with	O	O
the	O	O
sequences	O	O
from	O	O
all	O	O
isolates	O	O
forming	O	O
a	O	O
well-defined	O	O
phylogenetic	O	O
clade	O	O
with	O	O
100	O	O
%	O	O
bootstrap	O	O
support	O	O
that	O	O
may	O	O
well	O	O
represent	O	O
a	O	O
new	O	O
species	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
the	O	O
principal	O	O
etiologic	O	O
agents	O	O
of	O	O
caries	O	O
decay	O	O
of	O	O
teeth	O	O
,	O	O
are	O	O
generally	O	O
acquired	O	O
in	O	O
oral	O	O
cavity	O	O
at	O	O
the	O	O
moment	O	O
of	O	O
tooth	O	O
eruption	O	O
.	O	O

However	O	O
,	O	O
as	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
has	O	O
been	O	O
detected	O	O
in	O	O
oral	O	O
cavity	O	O
of	O	O
predentate	O	O
children	O	O
,	O	O
the	O	O
eruption	O	O
of	O	O
teeth	O	O
seems	O	O
not	O	O
to	O	O
be	O	O
a	O	O
necessary	O	O
prerequisite	O	O
,	O	O
suggesting	O	O
that	O	O
this	O	O
species	O	O
may	O	O
be	O	O
not	O	O
confined	O	O
to	O	O
dental	O	O
plaque	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
evaluate	O	O
the	O	O
ability	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
in	O	O
planktonic	O	O
and	O	O
biofilm	O	O
lifestyle	O	O
to	O	O
adhere	O	O
,	O	O
invade	O	O
and	O	O
survive	O	O
within	O	O
human	O	O
gingival	O	O
fibroblast	O	O
(	O	O
HGF-1	O	O
)	O	O
cells	O	O
.	O	O

Planktonic	O	O
and	O	O
biofilm	O	O
streptococci	B-bacteria	B-bacteria
adhered	O	O
and	O	O
invaded	O	O
host	O	O
cells	O	O
to	O	O
different	O	O
extents	O	O
,	O	O
showing	O	O
higher	O	O
efficiencies	O	O
of	O	O
biofilm	O	O
than	O	O
planktonic	O	O
counterparts	O	O
.	O	O

Moreover	O	O
,	O	O
planktonic	O	O
and	O	O
biofilm	O	O
streptococci	B-bacteria	B-bacteria
showed	O	O
the	O	O
same	O	O
percentage	O	O
of	O	O
survival	O	O
within	O	O
host	O	O
cells	O	O
.	O	O

Transmission	O	O
electron	O	O
and	O	O
confocal	O	O
microscopy	O	O
observations	O	O
confirmed	O	O
intracellular	O	O
localization	O	O
of	O	O
planktonic	O	O
and	O	O
biofilm	O	O
bacteria	O	O
.	O	O

The	O	O
adhesion	O	O
,	O	O
invasion	O	O
and	O	O
survival	O	O
abilities	O	O
within	O	O
human	O	O
oral	O	O
cells	O	O
may	O	O
be	O	O
considered	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
virulence	O	O
mechanisms	O	O
to	O	O
colonize	O	O
and	O	O
persist	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
tooth	O	O
surface	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
design	O	O
and	O	O
evaluate	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
(	O	O
FISH	O	O
)	O	O
probes	O	O
for	O	O
the	O	O
single-cell	O	O
detection	O	O
and	O	O
enumeration	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
in	O	O
particular	O	O
organisms	O	O
belonging	O	O
to	O	O
the	O	O
major	O	O
phylogenetic	O	O
groups	O	O
and	O	O
species	O	O
of	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
and	O	O
to	O	O
Abiotrophia/Granulicatella	B-bacteria	B-bacteria
.	O	O

As	O	O
lactobacilli	B-bacteria	B-bacteria
are	O	O
known	O	O
for	O	O
notorious	O	O
resistance	O	O
to	O	O
probe	O	O
penetration	O	O
,	O	O
probe-specific	O	O
assay	O	O
protocols	O	O
were	O	O
experimentally	O	O
developed	O	O
to	O	O
provide	O	O
maximum	O	O
cell	O	O
wall	O	O
permeability	O	O
,	O	O
probe	O	O
accessibility	O	O
,	O	O
hybridization	O	O
stringency	O	O
,	O	O
and	O	O
fluorescence	O	O
intensity	O	O
.	O	O

The	O	O
new	O	O
assays	O	O
were	O	O
then	O	O
applied	O	O
in	O	O
a	O	O
pilot	O	O
study	O	O
to	O	O
three	O	O
biofilm	O	O
samples	O	O
harvested	O	O
from	O	O
variably	O	O
demineralized	O	O
bovine	O	O
enamel	O	O
discs	O	O
that	O	O
had	O	O
been	O	O
carried	O	O
in	O	O
situ	O	O
for	O	O
10	O	O
days	O	O
by	O	O
different	O	O
volunteers	O	O
.	O	O

Best	O	O
probe	O	O
penetration	O	O
and	O	O
fluorescent	O	O
labeling	O	O
of	O	O
reference	O	O
strains	O	O
were	O	O
obtained	O	O
after	O	O
combined	O	O
lysozyme	O	O
and	O	O
achromopeptidase	O	O
treatment	O	O
followed	O	O
by	O	O
exposure	O	O
to	O	O
lipase	O	O
.	O	O

Hybridization	O	O
stringency	O	O
had	O	O
to	O	O
be	O	O
established	O	O
strictly	O	O
for	O	O
each	O	O
probe	O	O
.	O	O

Thereafter	O	O
all	O	O
probes	O	O
showed	O	O
the	O	O
expected	O	O
specificity	O	O
with	O	O
reference	O	O
strains	O	O
and	O	O
labeled	O	O
the	O	O
anticipated	O	O
morphotypes	O	O
in	O	O
dental	O	O
plaques	O	O
.	O	O

Applied	O	O
to	O	O
in	O	O
situ	O	O
grown	O	O
biofilms	O	O
the	O	O
set	O	O
of	O	O
probes	O	O
detected	O	O
only	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
and	O	O
bacteria	O	O
of	O	O
the	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
group	O	O
.	O	O

The	O	O
most	O	O
cariogenic	O	O
biofilm	O	O
contained	O	O
two	O	O
orders	O	O
of	O	O
magnitude	O	O
higher	O	O
L.	O	O
fermentum	O	O
cell	O	O
numbers	O	O
than	O	O
the	O	O
other	O	O
biofilms	O	O
.	O	O

Abiotrophia/Granulicatella	B-bacteria	B-bacteria
and	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
the	O	O
mitis	O	O
group	O	O
were	O	O
found	O	O
in	O	O
all	O	O
samples	O	O
at	O	O
high	O	O
levels	O	O
,	O	O
whereas	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
only	O	O
one	O	O
sample	O	O
in	O	O
very	O	O
low	O	O
numbers	O	O
.	O	O

Application	O	O
of	O	O
these	O	O
new	O	O
group-	O	O
and	O	O
species-specific	O	O
FISH	O	O
probes	O	O
to	O	O
oral	O	O
biofilm-forming	O	O
lactic	B-bacteria	I-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
will	O	O
allow	O	O
a	O	O
clearer	O	O
understanding	O	O
of	O	O
the	O	O
supragingival	O	O
biome	O	O
,	O	O
its	O	O
spatial	O	O
architecture	O	O
and	O	O
of	O	O
structure-function	O	O
relationships	O	O
implicated	O	O
during	O	O
plaque	O	O
homeostasis	O	O
and	O	O
caries	O	O
development	O	O
.	O	O

The	O	O
probes	O	O
should	O	O
prove	O	O
of	O	O
value	O	O
far	O	O
beyond	O	O
the	O	O
field	O	O
of	O	O
oral	O	O
microbiology	O	O
,	O	O
as	O	O
many	O	O
of	O	O
them	O	O
detect	O	O
non-oral	O	O
species	O	O
and	O	O
phylogenetic	O	O
groups	O	O
of	O	O
importance	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
medical	O	O
conditions	O	O
and	O	O
the	O	O
food	O	O
industry	O	O
.	O	O

Gingival	O	O
epithelia	O	O
utilize	O	O
multiple	O	O
signaling	O	O
pathways	O	O
to	O	O
regulate	O	O
innate	O	O
immune	O	O
responses	O	O
to	O	O
various	O	O
oral	O	O
bacteria	O	O
,	O	O
but	O	O
little	O	O
is	O	O
understood	O	O
about	O	O
how	O	O
these	O	O
bacteria	O	O
alter	O	O
epithelial	O	O
epigenetic	O	O
status	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
report	O	O
that	O	O
DNA	O	O
methyltransferase	O	O
(	O	O
DNMT1	O	O
)	O	O
and	O	O
histone	O	O
deacetylase	O	O
expression	O	O
were	O	O
decreased	O	O
in	O	O
gingival	O	O
epithelial	O	O
cells	O	O
treated	O	O
with	O	O
oral	O	O
pathogen	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
nonpathogen	B-bacteria	B-bacteria
Fusobacterium	I-bacteria	I-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Pretreatment	O	O
with	O	O
trichostatin	O	O
A	O	O
and	O	O
sodium	O	O
butyrate	O	O
,	O	O
which	O	O
increase	O	O
acetylation	O	O
of	O	O
chromatin	O	O
histones	O	O
,	O	O
significantly	O	O
enhanced	O	O
the	O	O
gene	O	O
expression	O	O
of	O	O
antimicrobial	O	O
proteins	O	O
human	O	O
beta-defensin	O	O
2	O	O
(	O	O
hBD2	O	O
)	O	O
and	O	O
CC	O	O
chemokine	O	O
ligand	O	O
20	O	O
(	O	O
CCL20	O	O
)	O	O
in	O	O
response	O	O
to	O	O
both	O	O
bacterial	O	O
challenges	O	O
.	O	O

Pretreatment	O	O
with	O	O
DNMT	O	O
inhibitor	O	O
5'-azacytidine	O	O
increased	O	O
hBD2	O	O
and	O	O
CCL20	O	O
expression	O	O
in	O	O
response	O	O
to	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Furthermore	O	O
,	O	O
we	O	O
observed	O	O
a	O	O
differential	O	O
pattern	O	O
of	O	O
protein	O	O
levels	O	O
of	O	O
H3K4me3	O	O
,	O	O
which	O	O
has	O	O
been	O	O
associated	O	O
with	O	O
chromatin	O	O
remodeling	O	O
and	O	O
activation	O	O
of	O	O
gene	O	O
transcription	O	O
,	O	O
in	O	O
response	O	O
to	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
vs.	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

This	O	O
study	O	O
provides	O	O
a	O	O
new	O	O
insight	O	O
into	O	O
the	O	O
bacteria-specific	O	O
innate	O	O
immune	O	O
responses	O	O
via	O	O
epigenetic	O	O
regulation	O	O
.	O	O

Early	O	O
childhood	O	O
caries	O	O
(	O	O
ECC	O	O
)	O	O
is	O	O
a	O	O
virulent	O	O
form	O	O
of	O	O
dental	O	O
caries	O	O
that	O	O
can	O	O
destroy	O	O
the	O	O
primary	O	O
dentition	O	O
of	O	O
toddlers	O	O
and	O	O
preschool	O	O
children	O	O
.	O	O

It	O	O
occurs	O	O
worldwide	O	O
,	O	O
afflicting	O	O
predominantly	O	O
disadvantaged	O	O
children	O	O
.	O	O

Although	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
the	O	O
most	O	O
likely	O	O
causative	O	O
agent	O	O
,	O	O
diet	O	O
also	O	O
plays	O	O
a	O	O
critical	O	O
role	O	O
in	O	O
the	O	O
acquisition	O	O
and	O	O
clinical	O	O
expression	O	O
of	O	O
this	O	O
infection	O	O
.	O	O

Early	O	O
acquisition	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
via	O	O
vertical	O	O
or	O	O
horizontal	O	O
transmission	O	O
is	O	O
a	O	O
key	O	O
event	O	O
in	O	O
the	O	O
natural	O	O
history	O	O
of	O	O
the	O	O
disease	O	O
that	O	O
coupled	O	O
with	O	O
caries	O	O
promoting	O	O
feeding	O	O
behaviours	O	O
results	O	O
in	O	O
accumulation	O	O
of	O	O
these	O	O
organisms	O	O
to	O	O
levels	O	O
exceeding	O	O
30	O	O
%	O	O
of	O	O
the	O	O
total	O	O
cultivable	O	O
plaque	O	O
flora	O	O
,	O	O
which	O	O
in	O	O
turn	O	O
leads	O	O
to	O	O
rapid	O	O
demineralization	O	O
of	O	O
the	O	O
tooth	O	O
structure	O	O
.	O	O

Inflicted	O	O
children	O	O
may	O	O
also	O	O
have	O	O
other	O	O
associated	O	O
health	O	O
problems	O	O
,	O	O
ranging	O	O
from	O	O
local	O	O
infections	O	O
to	O	O
oral	O	O
pain	O	O
that	O	O
manifest	O	O
as	O	O
difficulty	O	O
in	O	O
eating	O	O
and	O	O
sleeping	O	O
,	O	O
reduced	O	O
growth	O	O
and	O	O
altered	O	O
behaviour	O	O
.	O	O

Oral	O	O
rehabilitation	O	O
usually	O	O
consists	O	O
of	O	O
restoration	O	O
or	O	O
surgical	O	O
removal	O	O
of	O	O
carious	O	O
teeth	O	O
along	O	O
with	O	O
recommendations	O	O
regarding	O	O
feeding	O	O
habits	O	O
.	O	O

Although	O	O
treatment	O	O
can	O	O
be	O	O
instituted	O	O
in	O	O
the	O	O
dental	O	O
clinic	O	O
,	O	O
it	O	O
becomes	O	O
costly	O	O
sometimes	O	O
when	O	O
cooperative	O	O
capacity	O	O
of	O	O
babies	O	O
and	O	O
preschool	O	O
children	O	O
necessitates	O	O
the	O	O
use	O	O
of	O	O
general	O	O
anaesthesia	O	O
.	O	O

Primary	O	O
prevention	O	O
of	O	O
ECC	O	O
has	O	O
largely	O	O
been	O	O
restricted	O	O
to	O	O
counselling	O	O
parents	O	O
regarding	O	O
proper	O	O
feeding	O	O
behaviour	O	O
,	O	O
oral	O	O
hygiene	O	O
measures	O	O
and	O	O
new	O	O
strategies	O	O
that	O	O
address	O	O
the	O	O
infectious	O	O
component	O	O
through	O	O
use	O	O
of	O	O
topical	O	O
antimicrobial	O	O
therapy	O	O
in	O	O
order	O	O
to	O	O
defeat	O	O
this	O	O
common	O	O
oral	O	O
affliction	O	O
.	O	O

Chronic	O	O
periodontitis	O	O
is	O	O
associated	O	O
with	O	O
systemic	O	O
diseases	O	O
such	O	O
as	O	O
atherosclerosis	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
evaluated	O	O
the	O	O
efficacy	O	O
of	O	O
serum	O	O
IgG	O	O
antibody	O	O
titer	O	O
to	O	O
periodontal	O	O
bacteria	O	O
for	O	O
prognosis	O	O
of	O	O
periodontitis	O	O
recurrence	O	O
during	O	O
supportive	O	O
periodontal	O	O
therapy	O	O
(	O	O
SPT	O	O
)	O	O
phase	O	O
.	O	O

The	O	O
139	O	O
patients	O	O
during	O	O
SPT	O	O
phase	O	O
were	O	O
selected	O	O
and	O	O
divided	O	O
to	O	O
two	O	O
groups	O	O
as	O	O
follows	O	O
:	O	O
``	O	O
Stable	O	O
''	O	O
and	O	O
``	O	O
Recurrence	O	O
''	O	O
group	O	O
at	O	O
SPT	O	O
phase	O	O
for	O	O
case-control	O	O
study	O	O
:	O	O
``	O	O
High	O	O
IgG	O	O
titer	O	O
''	O	O
and	O	O
``	O	O
Normal	O	O
IgG	O	O
titer	O	O
''	O	O
group	O	O
before	O	O
transition	O	O
to	O	O
SPT	O	O
phase	O	O
for	O	O
cohort	O	O
study	O	O
.	O	O

We	O	O
examined	O	O
whether	O	O
clinical	O	O
findings	O	O
or	O	O
serum	O	O
IgG	O	O
antibody	O	O
titers	O	O
to	O	O
periodontal	O	O
bacteria	O	O
are	O	O
risk	O	O
factors	O	O
for	O	O
the	O	O
development	O	O
of	O	O
periodontitis	O	O
recurrence	O	O
.	O	O

Case-control	O	O
study	O	O
showed	O	O
that	O	O
there	O	O
were	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
stable	O	O
and	O	O
recurrence	O	O
groups	O	O
in	O	O
age	O	O
and	O	O
number	O	O
of	O	O
teeth	O	O
.	O	O

The	O	O
serum	O	O
IgG	O	O
antibody	O	O
titer	O	O
to	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	I-bacteria	I-bacteria
FDC1073	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
SU63	E-bacteria	I-bacteria
,	O	O
and	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	I-bacteria	I-bacteria
ATCC33238	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
in	O	O
the	O	O
recurrence	O	O
group	O	O
.	O	O

Next	O	O
,	O	O
we	O	O
found	O	O
,	O	O
that	O	O
the	O	O
recurrence	O	O
ratio	O	O
in	O	O
the	O	O
high	O	O
IgG	O	O
titer	O	O
group	O	O
to	O	O
Gram-negative	O	O
obligate	O	O
anaerobe	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
and	O	O
C.	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
of	O	O
the	O	O
normal	O	O
IgG	O	O
titer	O	O
group	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
serum	O	O
IgG	O	O
antibody	O	O
titer	O	O
test	O	O
is	O	O
useful	O	O
in	O	O
the	O	O
prognosis	O	O
of	O	O
periodontitis	O	O
recurrence	O	O
during	O	O
the	O	O
SPT	O	O
phase	O	O
.	O	O

There	O	O
are	O	O
few	O	O
in	O	O
vitro	O	O
models	O	O
available	O	O
in	O	O
the	O	O
scientific	O	O
literature	O	O
for	O	O
study	O	O
of	O	O
the	O	O
structure	O	O
,	O	O
formation	O	O
and	O	O
development	O	O
of	O	O
the	O	O
subgingival	O	O
biofilm	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
develop	O	O
and	O	O
validate	O	O
an	O	O
in	O	O
vitro	O	O
biofilm	O	O
model	O	O
,	O	O
using	O	O
representative	O	O
selected	O	O
bacteria	O	O
from	O	O
the	O	O
subgingival	O	O
microbiota	O	O
.	O	O

Six	O	O
standard	O	O
reference	O	O
strains	O	O
were	O	O
used	O	O
to	O	O
develop	O	O
biofilms	O	O
over	O	O
sterile	O	O
ceramic	O	O
calcium	O	O
hydroxyapatite	O	O
discs	O	O
coated	O	O
with	O	O
saliva	O	O
within	O	O
the	O	O
wells	O	O
of	O	O
presterilized	O	O
polystyrene	O	O
tissue	O	O
culture	O	O
plates	O	O
.	O	O

The	O	O
selected	O	O
species	O	O
represent	O	O
initial	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
)	O	O
,	O	O
early	O	O
(	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
)	O	O
,	O	O
secondary	O	O
(	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
)	O	O
and	O	O
late	O	O
colonizers	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
)	O	O
.	O	O

The	O	O
structure	O	O
of	O	O
the	O	O
biofilm	O	O
obtained	O	O
was	O	O
studied	O	O
using	O	O
a	O	O
vital	O	O
fluorescence	O	O
technique	O	O
in	O	O
conjunction	O	O
with	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

The	O	O
biofilm	O	O
bacterial	O	O
kinetics	O	O
were	O	O
studied	O	O
by	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
analysis	O	O
.	O	O

After	O	O
12	O	O
h	O	O
,	O	O
initial	O	O
and	O	O
early	O	O
colonizers	O	O
were	O	O
the	O	O
first	O	O
microorganisms	O	O
detected	O	O
adhering	O	O
to	O	O
the	O	O
calcium	O	O
hydroxyapatite	O	O
discs	O	O
.	O	O

The	O	O
intermediate	O	O
colonizer	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
not	O	O
detected	O	O
in	O	O
the	O	O
model	O	O
until	O	O
24	O	O
h	O	O
of	O	O
incubation	O	O
.	O	O

Late	O	O
colonizers	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
could	O	O
be	O	O
measured	O	O
inside	O	O
the	O	O
biofilm	O	O
after	O	O
48	O	O
h.	O	O
The	O	O
biofilm	O	O
reached	O	O
its	O	O
steady	O	O
state	O	O
between	O	O
72	O	O
and	O	O
96	O	O
h	O	O
after	O	O
inoculation	O	O
,	O	O
with	O	O
bacterial	O	O
vitality	O	O
increasing	O	O
from	O	O
the	O	O
hydroxyapatite	O	O
surface	O	O
to	O	O
the	O	O
central	O	O
part	O	O
of	O	O
the	O	O
biofilm	O	O
.	O	O

An	O	O
in	O	O
vitro	O	O
biofilm	O	O
model	O	O
was	O	O
developed	O	O
and	O	O
validated	O	O
,	O	O
demonstrating	O	O
a	O	O
pattern	O	O
of	O	O
bacterial	O	O
colonization	O	O
and	O	O
maturation	O	O
similar	O	O
to	O	O
the	O	O
in	O	O
vivo	O	O
development	O	O
of	O	O
the	O	O
subgingival	O	O
biofilm	O	O
.	O	O

In	O	O
vitro	O	O
testing	O	O
of	O	O
antimicrobial	O	O
agents	O	O
is	O	O
an	O	O
important	O	O
tool	O	O
in	O	O
the	O	O
testing	O	O
hierarchy	O	O
,	O	O
and	O	O
may	O	O
provide	O	O
interesting	O	O
insights	O	O
into	O	O
their	O	O
potential	O	O
clinical	O	O
efficacy	O	O
.	O	O

Agents	O	O
with	O	O
demonstrable	O	O
in	O	O
vitro	O	O
antimicrobial	O	O
activity	O	O
may	O	O
be	O	O
effective	O	O
against	O	O
the	O	O
same	O	O
microorganisms	O	O
in	O	O
vivo	O	O
,	O	O
whereas	O	O
agents	O	O
without	O	O
demonstrable	O	O
in	O	O
vitro	O	O
antimicrobial	O	O
activity	O	O
are	O	O
unlikely	O	O
to	O	O
exhibit	O	O
in	O	O
vivo	O	O
antimicrobial	O	O
activity	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
these	O	O
methods	O	O
may	O	O
also	O	O
be	O	O
useful	O	O
in	O	O
screening	O	O
antimicrobial	O	O
agents	O	O
in	O	O
product	O	O
formulations	O	O
because	O	O
such	O	O
agents	O	O
with	O	O
both	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
activity	O	O
may	O	O
have	O	O
reduced	O	O
antimicrobial	O	O
effects	O	O
when	O	O
formulated	O	O
into	O	O
a	O	O
dentifrice	O	O
.	O	O

Accordingly	O	O
,	O	O
this	O	O
study	O	O
examined	O	O
the	O	O
in	O	O
vitro	O	O
and	O	O
ex	O	O
vivo	O	O
antimicrobial	O	O
activity	O	O
of	O	O
three	O	O
commercial	O	O
dentifrices	O	O
:	O	O
one	O	O
formulated	O	O
with	O	O
0.243	O	O
%	O	O
sodium	O	O
fluoride	O	O
(	O	O
Crest	O	O
Cavity	O	O
Protection	O	O
Toothpaste-Regular	O	O
)	O	O
;	O	O
one	O	O
with	O	O
0.454	O	O
%	O	O
stannous	O	O
fluoride	O	O
,	O	O
sodium	O	O
hexametaphosphate	O	O
,	O	O
and	O	O
zinc	O	O
lactate	O	O
(	O	O
Crest	O	O
Pro-Health	O	O
)	O	O
,	O	O
and	O	O
one	O	O
with	O	O
0.3	O	O
%	O	O
triclosan	O	O
,	O	O
2.0	O	O
%	O	O
PVM/MA	O	O
copolymer	O	O
,	O	O
and	O	O
0.243	O	O
%	O	O
sodium	O	O
fluoride	O	O
(	O	O
Colgate	O	O
Total	O	O
)	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
of	O	O
each	O	O
dentifrice	O	O
was	O	O
determined	O	O
for	O	O
resident	O	O
oral	O	O
bacterial	O	O
species	O	O
,	O	O
including	O	O
bacteria	O	O
that	O	O
are	O	O
associated	O	O
with	O	O
dental	O	O
caries	O	O
;	O	O
periodontitis	O	O
,	O	O
and	O	O
oral	O	O
halitosis	O	O
.	O	O

Evaluations	O	O
were	O	O
performed	O	O
on	O	O
individual	O	O
laboratory	O	O
strains	O	O
,	O	O
and	O	O
on	O	O
oral	O	O
bacteria	O	O
from	O	O
supragingival	O	O
plaque	O	O
samples	O	O
obtained	O	O
from	O	O
10	O	O
adults	O	O
and	O	O
from	O	O
oral	O	O
rinse	O	O
samples	O	O
obtained	O	O
from	O	O
18	O	O
adults	O	O
.	O	O

The	O	O
lowest	O	O
MICs	O	O
against	O	O
the	O	O
oral	O	O
strains	O	O
and	O	O
human	O	O
samples	O	O
,	O	O
i.e.	O	O
,	O	O
greatest	O	O
antimicrobial	O	O
activity	O	O
,	O	O
were	O	O
seen	O	O
for	O	O
the	O	O
triclosan/	O	O
copolymer	O	O
dentifrice	O	O
.	O	O

There	O	O
was	O	O
,	O	O
in	O	O
general	O	O
,	O	O
a	O	O
four-fold	O	O
difference	O	O
in	O	O
MICs	O	O
between	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
and	O	O
the	O	O
stannous	O	O
fluoride/sodium	O	O
hexametaphosphate/zinc	O	O
lactate	O	O
dentifrice	O	O
.	O	O

The	O	O
triclosan/copolymer	O	O
dentifrice	O	O
significantly	O	O
inhibited	O	O
periodontal	O	O
pathogens	O	O
,	O	O
such	O	O
as	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

In	O	O
ex	O	O
vivo	O	O
tests	O	O
measuring	O	O
antimicrobial	O	O
effects	O	O
,	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
substantially	O	O
inhibited	O	O
bacterial	O	O
growth	O	O
after	O	O
30-	O	O
,	O	O
60-	O	O
,	O	O
and	O	O
120-second	O	O
exposures	O	O
compared	O	O
to	O	O
the	O	O
sodium	O	O
fluoride	O	O
or	O	O
stannous	O	O
fluoride/sodium	O	O
hexametaphosphate/zinc	O	O
lactate	O	O
dentifrices	O	O
.	O	O

Similarly	O	O
,	O	O
in	O	O
ex	O	O
vivo	O	O
tests	O	O
measuring	O	O
antimicrobial	O	O
effects	O	O
on	O	O
supragingival	O	O
plaque	O	O
biofilms	O	O
,	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
substantially	O	O
inhibited	O	O
bacterial	O	O
growth	O	O
compared	O	O
to	O	O
the	O	O
other	O	O
test	O	O
dentifrices	O	O
.	O	O

Different	O	O
in	O	O
vitro	O	O
and	O	O
ex	O	O
vivo	O	O
analyses	O	O
show	O	O
that	O	O
the	O	O
triclosan/copolymer	O	O
dentifrice	O	O
has	O	O
significant	O	O
antimicrobial	O	O
activity	O	O
on	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
species	O	O
causing	O	O
dental	O	O
caries	O	O
,	O	O
periodontitis	O	O
,	O	O
and	O	O
oral	O	O
halitosis	O	O
,	O	O
and	O	O
it	O	O
provides	O	O
superior	O	O
efficacy	O	O
compared	O	O
to	O	O
the	O	O
stannous	O	O
fluoride/sodium	O	O
hexametaphosphate/zinc	O	O
lactate	O	O
dentifrice	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
have	O	O
been	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
stomach	O	O
.	O	O

This	O	O
study	O	O
is	O	O
to	O	O
establish	O	O
whether	O	O
there	O	O
might	O	O
be	O	O
any	O	O
associations	O	O
between	O	O
isolates	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
those	O	O
in	O	O
the	O	O
stomach	O	O
by	O	O
meta-analysis	O	O
.	O	O

Studies	O	O
reporting	O	O
raw	O	O
data	O	O
on	O	O
the	O	O
prevalence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
gastric	O	O
H.	O	O
pylori-positive	O	O
and	O	O
H.	O	O
pylori-negative	O	O
patients	O	O
,	O	O
in	O	O
patients	O	O
with	O	O
gastroesophageal	O	O
diseases	O	O
,	O	O
and	O	O
in	O	O
healthy	O	O
individuals	O	O
and	O	O
studies	O	O
reporting	O	O
data	O	O
on	O	O
the	O	O
eradication	O	O
rate	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
or	O	O
stomach	O	O
,	O	O
published	O	O
in	O	O
the	O	O
English	O	O
language	O	O
,	O	O
were	O	O
identified	O	O
through	O	O
MEDLINE	O	O
and	O	O
EMBASE	O	O
up	O	O
to	O	O
May	O	O
2010	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
H.	O	O
pylori	O	O
infection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
gastric	O	O
H.	O	O
pylori-positive	O	O
patients	O	O
was	O	O
significantly	O	O
higher	O	O
(	O	O
45.0	O	O
%	O	O
)	O	O
than	O	O
that	O	O
in	O	O
gastric	O	O
H.	O	O
pylori-negative	O	O
patients	O	O
(	O	O
23.9	O	O
%	O	O
)	O	O
.	O	O

The	O	O
pooled	O	O
odds	O	O
ration	O	O
(	O	O
OR	O	O
)	O	O
was	O	O
3.61	O	O
and	O	O
the	O	O
95	O	O
%	O	O
CI	O	O
was	O	O
1.91-6.82	O	O
(	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

Different	O	O
diagnostic	O	O
methods	O	O
produced	O	O
different	O	O
pooled	O	O
ORs	O	O
with	O	O
PCR	O	O
the	O	O
highest	O	O
(	O	O
OR	O	O
=	O	O
5.11	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
2.08-12.54	O	O
,	O	O
P	O	O
=	O	O
0.0004	O	O
)	O	O
and	O	O
rapid	O	O
urease	O	O
test	O	O
(	O	O
RUT	O	O
)	O	O
the	O	O
lowest	O	O
(	O	O
OR	O	O
=	O	O
2.00	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
0.80-5.00	O	O
,	O	O
P	O	O
=	O	O
0.14	O	O
)	O	O
.	O	O

The	O	O
44.8	O	O
%	O	O
(	O	O
91/203	O	O
)	O	O
prevalence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
in	O	O
patients	O	O
with	O	O
clinical	O	O
and/or	O	O
histological	O	O
gastroesophageal	O	O
diseases	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
the	O	O
13.2	O	O
%	O	O
(	O	O
21/159	O	O
)	O	O
in	O	O
patients	O	O
with	O	O
non-ulcerous	O	O
dyspepsia	O	O
or	O	O
healthy	O	O
controls	O	O
(	O	O
OR	O	O
=	O	O
5.15	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
2.97-8.92	O	O
,	O	O
P	O	O
<	O	O
0.00001	O	O
)	O	O
.	O	O

The	O	O
eradication	O	O
efficiency	O	O
in	O	O
stomach	O	O
is	O	O
85.8	O	O
%	O	O
(	O	O
187/218	O	O
)	O	O
,	O	O
while	O	O
in	O	O
oral	O	O
cavity	O	O
it	O	O
is	O	O
only	O	O
5.7	O	O
%	O	O
(	O	O
9/158	O	O
)	O	O
.	O	O

The	O	O
OR	O	O
is	O	O
55.59	O	O
,	O	O
P	O	O
<	O	O
0.00001	O	O
.	O	O

There	O	O
is	O	O
a	O	O
close	O	O
relation	O	O
between	O	O
the	O	O
infection	O	O
of	O	O
H.	O	O
pylori	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
stomach	O	O
.	O	O

H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
are	O	O
more	O	O
difficult	O	O
to	O	O
be	O	O
eradicated	O	O
than	O	O
in	O	O
the	O	O
stomach	O	O
.	O	O

It	O	O
may	O	O
be	O	O
a	O	O
source	O	O
of	O	O
reinfection	O	O
.	O	O

Candida	O	O
albicans	O	O
is	O	O
a	O	O
commensal	O	O
organism	O	O
that	O	O
can	O	O
be	O	O
isolated	O	O
from	O	O
the	O	O
majority	O	O
of	O	O
healthy	O	O
individuals	O	O
.	O	O

However	O	O
,	O	O
in	O	O
certain	O	O
susceptible	O	O
individuals	O	O
C.	O	O
albicans	O	O
can	O	O
become	O	O
pathogenic	O	O
leading	O	O
to	O	O
the	O	O
mucocutaneous	O	O
infection	O	O
;	O	O
oral	O	O
candidiasis	O	O
.	O	O

Murine	O	O
models	O	O
and	O	O
in	O	O
vitro	O	O
monolayer	O	O
cultures	O	O
have	O	O
generated	O	O
some	O	O
data	O	O
on	O	O
the	O	O
likely	O	O
virulence	O	O
and	O	O
host	O	O
factors	O	O
that	O	O
contribute	O	O
to	O	O
oral	O	O
candidiasis	O	O
but	O	O
these	O	O
models	O	O
have	O	O
limitations	O	O
.	O	O

Recently	O	O
,	O	O
tissue	O	O
engineered	O	O
oral	O	O
mucosal	O	O
models	O	O
have	O	O
been	O	O
developed	O	O
to	O	O
mimic	O	O
the	O	O
normal	O	O
oral	O	O
mucosa	O	O
but	O	O
little	O	O
information	O	O
is	O	O
available	O	O
on	O	O
their	O	O
true	O	O
representation	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
assessed	O	O
the	O	O
histological	O	O
features	O	O
of	O	O
three	O	O
different	O	O
tissue	O	O
engineered	O	O
oral	O	O
mucosal	O	O
models	O	O
compared	O	O
to	O	O
the	O	O
normal	O	O
oral	O	O
mucosa	O	O
and	O	O
analysed	O	O
both	O	O
cell	O	O
damage	O	O
and	O	O
cytokine	O	O
release	O	O
following	O	O
infection	O	O
with	O	O
C.	O	O
albicans	O	O
.	O	O

Models	O	O
comprised	O	O
of	O	O
normal	O	O
oral	O	O
keratinocytes	O	O
and	O	O
a	O	O
fibroblast-containing	O	O
matrix	O	O
displayed	O	O
more	O	O
similar	O	O
immunohistological	O	O
and	O	O
proliferation	O	O
characteristics	O	O
to	O	O
normal	O	O
mucosa	O	O
,	O	O
compared	O	O
to	O	O
models	O	O
composed	O	O
of	O	O
an	O	O
oral	O	O
carcinoma	O	O
cell	O	O
line	O	O
.	O	O

Although	O	O
all	O	O
models	O	O
were	O	O
invaded	O	O
and	O	O
damaged	O	O
by	O	O
C.	O	O
albicans	O	O
in	O	O
a	O	O
similar	O	O
manner	O	O
,	O	O
the	O	O
cytokine	O	O
response	O	O
was	O	O
much	O	O
more	O	O
pronounced	O	O
in	O	O
models	O	O
containing	O	O
normal	O	O
keratinocytes	O	O
.	O	O

These	O	O
data	O	O
suggest	O	O
that	O	O
models	O	O
based	O	O
on	O	O
normal	O	O
keratinocytes	O	O
atop	O	O
a	O	O
fibroblast-containing	O	O
connective	O	O
tissue	O	O
will	O	O
significantly	O	O
aid	O	O
in	O	O
dissecting	O	O
the	O	O
molecular	O	O
pathogenesis	O	O
of	O	O
oral	O	O
candidiasis	O	O
.	O	O

Metagenomic	O	O
techniques	O	O
are	O	O
used	O	O
to	O	O
analyse	O	O
bacterial	O	O
communities	O	O
allowing	O	O
both	O	O
culturable	O	O
and	O	O
unculturable	O	O
species	O	O
to	O	O
be	O	O
represented	O	O
.	O	O

However	O	O
,	O	O
the	O	O
screening	O	O
of	O	O
oral	O	O
metagenomic	O	O
samples	O	O
can	O	O
be	O	O
hindered	O	O
by	O	O
high	O	O
animal	O	O
host	O	O
DNA	O	O
content	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
methods	O	O
for	O	O
the	O	O
reduction	O	O
of	O	O
human	O	O
DNA	O	O
concentrations	O	O
within	O	O
oral	O	O
metagenomic	O	O
samples	O	O
.	O	O

Plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
27	O	O
patients	O	O
presenting	O	O
with	O	O
periodontal	O	O
disease	O	O
and	O	O
treated	O	O
to	O	O
remove	O	O
human	O	O
DNA	O	O
using	O	O
either	O	O
selective	O	O
lysis	O	O
of	O	O
eukaryotic	O	O
cells	O	O
at	O	O
several	O	O
buffer	O	O
concentrations	O	O
or	O	O
differential	O	O
centrifugation	O	O
after	O	O
treatment	O	O
with	O	O
trypsin	O	O
and/or	O	O
detergents	O	O
.	O	O

Human	O	O
and	O	O
bacterial	O	O
DNA	O	O
levels	O	O
were	O	O
determined	O	O
by	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
qPCR	O	O
)	O	O
.	O	O

The	O	O
human	O	O
DNA	O	O
content	O	O
of	O	O
plaque	O	O
extracts	O	O
was	O	O
significantly	O	O
reduced	O	O
by	O	O
all	O	O
treatments	O	O
compared	O	O
with	O	O
an	O	O
untreated	O	O
control	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

However	O	O
,	O	O
differential	O	O
centrifugation	O	O
simultaneously	O	O
reduced	O	O
the	O	O
bacterial	O	O
DNA	O	O
content	O	O
unless	O	O
samples	O	O
were	O	O
pretreated	O	O
with	O	O
a	O	O
detergent	O	O
.	O	O

Observations	O	O
of	O	O
Gram	O	O
stained	O	O
samples	O	O
that	O	O
were	O	O
processed	O	O
using	O	O
differential	O	O
centrifugation	O	O
without	O	O
detergent	O	O
suggest	O	O
that	O	O
many	O	O
bacteria	O	O
remain	O	O
adhered	O	O
to	O	O
human	O	O
cells	O	O
.	O	O

An	O	O
approach	O	O
that	O	O
uses	O	O
differential	O	O
centrifugation	O	O
in	O	O
parallel	O	O
with	O	O
selective	O	O
lysis	O	O
is	O	O
recommended	O	O
to	O	O
fully	O	O
represent	O	O
the	O	O
oral	O	O
microbiota	O	O
in	O	O
metagenomic	O	O
samples	O	O
,	O	O
including	O	O
those	O	O
tightly	O	O
adhered	O	O
to	O	O
human	O	O
cells	O	O
and	O	O
more	O	O
delicate	O	O
bacteria	O	O
such	O	O
as	O	O
Mycoplasma	B-bacteria	B-bacteria
.	O	O

Smoking	O	O
is	O	O
an	O	O
independent	O	O
risk	O	O
factor	O	O
for	O	O
the	O	O
initiation	O	O
,	O	O
extent	O	O
and	O	O
severity	O	O
of	O	O
periodontal	O	O
disease	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
the	O	O
ability	O	O
of	O	O
the	O	O
host	O	O
immune	O	O
system	O	O
to	O	O
discriminate	O	O
commensal	O	O
oral	O	O
bacteria	O	O
from	O	O
pathogens	O	O
at	O	O
mucosal	O	O
surfaces	O	O
,	O	O
i.e	O	O
.	O	O

oral	O	O
cavity	O	O
.	O	O

Serum	O	O
immunoglobulin	O	O
(	O	O
Ig	O	O
)	O	O
G	O	O
antibody	O	O
reactive	O	O
with	O	O
three	O	O
pathogenic	O	O
and	O	O
five	O	O
commensal	O	O
oral	O	O
bacteria	O	O
in	O	O
301	O	O
current	O	O
smokers	O	O
(	O	O
age	O	O
range	O	O
21-66	O	O
years	O	O
)	O	O
were	O	O
examined	O	O
by	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

Clinical	O	O
features	O	O
of	O	O
periodontal	O	O
health	O	O
were	O	O
used	O	O
as	O	O
measures	O	O
of	O	O
periodontitis	O	O
.	O	O

Antibody	O	O
to	O	O
the	O	O
pathogens	O	O
and	O	O
salivary	O	O
cotinine	O	O
levels	O	O
were	O	O
related	O	O
positively	O	O
to	O	O
disease	O	O
severity	O	O
;	O	O
however	O	O
,	O	O
the	O	O
antibody	O	O
levels	O	O
were	O	O
best	O	O
described	O	O
by	O	O
the	O	O
clinical	O	O
disease	O	O
unrelated	O	O
to	O	O
the	O	O
amount	O	O
of	O	O
smoking	O	O
.	O	O

The	O	O
data	O	O
showed	O	O
a	O	O
greater	O	O
immune	O	O
response	O	O
to	O	O
pathogens	O	O
than	O	O
commensals	O	O
that	O	O
was	O	O
related	O	O
specifically	O	O
to	O	O
disease	O	O
extent	O	O
,	O	O
and	O	O
most	O	O
noted	O	O
in	O	O
black	O	O
males	O	O
.	O	O

Significant	O	O
correlations	O	O
in	O	O
individual	O	O
patient	O	O
responses	O	O
to	O	O
the	O	O
pathogens	O	O
and	O	O
commensals	O	O
were	O	O
lost	O	O
with	O	O
an	O	O
increasing	O	O
extent	O	O
of	O	O
periodontitis	O	O
and	O	O
serum	O	O
antibody	O	O
to	O	O
the	O	O
pathogens	O	O
.	O	O

Antibody	O	O
to	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
particularly	O	O
distinct	O	O
with	O	O
respect	O	O
to	O	O
the	O	O
discriminatory	O	O
nature	O	O
of	O	O
the	O	O
immune	O	O
responses	O	O
in	O	O
recognizing	O	O
the	O	O
pathogens	O	O
.	O	O

Antibody	O	O
responses	O	O
to	O	O
selected	O	O
pathogenic	O	O
and	O	O
commensal	O	O
oral	O	O
microorganisms	O	O
differed	O	O
among	O	O
racial	O	O
groups	O	O
and	O	O
genders	O	O
.	O	O

The	O	O
antibody	O	O
response	O	O
to	O	O
the	O	O
pathogens	O	O
was	O	O
related	O	O
to	O	O
disease	O	O
severity	O	O
.	O	O

The	O	O
level	O	O
of	O	O
antibody	O	O
to	O	O
the	O	O
pathogens	O	O
,	O	O
and	O	O
in	O	O
particular	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
was	O	O
correlated	O	O
with	O	O
disease	O	O
severity	O	O
in	O	O
black	O	O
and	O	O
male	O	O
subsets	O	O
of	O	O
patients	O	O
.	O	O

The	O	O
amount	O	O
of	O	O
smoking	O	O
did	O	O
not	O	O
appear	O	O
to	O	O
impact	O	O
directly	O	O
serum	O	O
antibody	O	O
levels	O	O
to	O	O
these	O	O
oral	O	O
bacteria	O	O
.	O	O

Investigate	O	O
the	O	O
presence	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
in	O	O
saliva	O	O
after	O	O
supplementation	O	O
with	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
and	O	O
the	O	O
probiotic	B-bacteria	B-bacteria
effect	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
on	O	O
plaque	O	O
index	O	O
and	O	O
supra-	O	O
and	O	O
subgingival	O	O
microbiota	O	O
.	O	O

The	O	O
study	O	O
included	O	O
23	O	O
healthy	O	O
individuals	O	O
,	O	O
randomised	O	O
into	O	O
test	O	O
or	O	O
control	O	O
subjects	O	O
.	O	O

At	O	O
baseline	O	O
and	O	O
after	O	O
12	O	O
weeks	O	O
saliva	O	O
samples	O	O
,	O	O
plaque	O	O
index	O	O
and	O	O
supra-	O	O
and	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
obtained	O	O
.	O	O

The	O	O
test	O	O
subjects	O	O
were	O	O
given	O	O
the	O	O
study	O	O
product	O	O
(	O	O
containing	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
,	O	O
ATCC	B-bacteria	B-bacteria
55730	E-bacteria	I-bacteria
and	O	O
ATCC	B-bacteria	B-bacteria
PTA	I-bacteria	I-bacteria
5289	E-bacteria	I-bacteria
)	O	O
and	O	O
the	O	O
control	O	O
subjects	O	O
placebo	O	O
for	O	O
12	O	O
weeks	O	O
.	O	O

Microbiological	O	O
analyses	O	O
were	O	O
done	O	O
by	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
technique	O	O
and	O	O
selective	O	O
culturing	O	O
for	O	O
lactobacilli	B-bacteria	B-bacteria
determination	O	O
.	O	O

A	O	O
significant	O	O
increase	O	O
in	O	O
total	O	O
Lactobacillus	B-bacteria	B-bacteria
counts	O	O
in	O	O
saliva	O	O
occurred	O	O
in	O	O
both	O	O
groups	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
with	O	O
a	O	O
significant	O	O
increase	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
(	O	O
p	O	O
=	O	O
0.008	O	O
)	O	O
in	O	O
the	O	O
test	O	O
group	O	O
.	O	O

Termination	O	O
of	O	O
intervention	O	O
resulted	O	O
in	O	O
a	O	O
wash	O	O
out	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
.	O	O

The	O	O
control	O	O
group	O	O
demonstrated	O	O
a	O	O
statistically	O	O
significant	O	O
increase	O	O
in	O	O
PII	O	O
after	O	O
12	O	O
weeks	O	O
(	O	O
p	O	O
=	O	O
0.023	O	O
)	O	O
whilst	O	O
there	O	O
was	O	O
no	O	O
significant	O	O
change	O	O
in	O	O
the	O	O
test	O	O
group	O	O
.	O	O

A	O	O
significant	O	O
increase	O	O
was	O	O
found	O	O
for	O	O
most	O	O
bacterial	O	O
species	O	O
in	O	O
both	O	O
groups	O	O
in	O	O
supra-	O	O
and	O	O
subgingival	O	O
plaque	O	O
with	O	O
no	O	O
significant	O	O
difference	O	O
for	O	O
any	O	O
of	O	O
the	O	O
species	O	O
between	O	O
the	O	O
groups	O	O
.	O	O

The	O	O
ratio	O	O
between	O	O
``	O	O
bad/good	O	O
''	O	O
supragingival	O	O
bacteria	O	O
decreased	O	O
for	O	O
the	O	O
test	O	O
group	O	O
but	O	O
this	O	O
decrease	O	O
did	O	O
not	O	O
reach	O	O
significance	O	O
.	O	O

The	O	O
corresponding	O	O
ratio	O	O
for	O	O
subgingival	O	O
bacteria	O	O
decreased	O	O
significantly	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

Supplementation	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
resulted	O	O
in	O	O
presence	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
in	O	O
saliva	O	O
but	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
was	O	O
washed	O	O
out	O	O
after	O	O
termination	O	O
of	O	O
intervention	O	O
.	O	O

No	O	O
significant	O	O
effect	O	O
on	O	O
supra-	O	O
or	O	O
subgingival	O	O
microbiota	O	O
was	O	O
observed	O	O
.	O	O

The	O	O
significant	O	O
increase	O	O
in	O	O
PII	O	O
in	O	O
the	O	O
control	O	O
group	O	O
with	O	O
no	O	O
significant	O	O
change	O	O
in	O	O
the	O	O
test	O	O
group	O	O
may	O	O
,	O	O
however	O	O
,	O	O
indicate	O	O
a	O	O
probiotic	O	O
effect	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
in	O	O
this	O	O
study	O	O
population	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
resistance	O	O
to	O	O
antimicrobials	O	O
of	O	O
aerobes	O	O
and	O	O
facultative	O	O
anaerobes	O	O
isolated	O	O
from	O	O
patients	O	O
wearing	O	O
complete	O	O
dentures	O	O
,	O	O
patients	O	O
with	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
,	O	O
and	O	O
periodontally	O	O
health	O	O
subjects	O	O
.	O	O


Three	O	O
hundred	O	O
and	O	O
four	O	O
isolates	O	O
were	O	O
tested	O	O
.	O	O

The	O	O
minimal	O	O
inhibitory	O	O
concentrations	O	O
of	O	O
the	O	O
drugs	O	O
were	O	O
evaluated	O	O
through	O	O
the	O	O
agar	O	O
dilution	O	O
method	O	O
using	O	O
Mueller-Hinton	O	O
agar	O	O
.	O	O

The	O	O
most	O	O
active	O	O
antimicrobial	O	O
drugs	O	O
were	O	O
the	O	O
carbapenems	O	O
(	O	O
meropenem	O	O
and	O	O
imipenem	O	O
)	O	O
,	O	O
and	O	O
resistance	O	O
to	O	O
these	O	O
drugs	O	O
was	O	O
restrict	O	O
to	O	O
1.6-2.3	O	O
%	O	O
of	O	O
the	O	O
isolates	O	O
,	O	O
as	O	O
well	O	O
as	O	O
ciprofloxacin	O	O
and	O	O
rifampin	O	O
.	O	O

Microbial	O	O
resistance	O	O
to	O	O
ampicillin	O	O
,	O	O
amoxicillin/clavulanic	O	O
acid	O	O
,	O	O
cefoxitin	O	O
,	O	O
cephalothin	O	O
,	O	O
amikacin	O	O
,	O	O
chloramphenicol	O	O
and	O	O
nalidixic	O	O
acid	O	O
was	O	O
particularly	O	O
high	O	O
.	O	O

In	O	O
most	O	O
cases	O	O
,	O	O
the	O	O
resistance	O	O
to	O	O
beta-lactams	O	O
was	O	O
mediated	O	O
by	O	O
the	O	O
production	O	O
of	O	O
hydrolytic	O	O
enzymes	O	O
,	O	O
especially	O	O
in	O	O
gram-negative	O	O
enteric	O	O
rods	O	O
,	O	O
while	O	O
enterococci	B-bacteria	B-bacteria
did	O	O
not	O	O
evidence	O	O
production	O	O
of	O	O
these	O	O
enzymes	O	O
.	O	O

The	O	O
association	O	O
amoxicillin/clavulanic	O	O
acid	O	O
was	O	O
not	O	O
effective	O	O
in	O	O
28.3	O	O
%	O	O
of	O	O
the	O	O
tested	O	O
isolates	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
investigation	O	O
confirmed	O	O
that	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
with	O	O
periodontitis	O	O
and	O	O
gingivitis	O	O
,	O	O
and	O	O
particularly	O	O
edentulous	O	O
patients	O	O
wearing	O	O
complete	O	O
dentures	O	O
could	O	O
harbor	O	O
microorganisms	O	O
with	O	O
several	O	O
antimicrobial	O	O
resistance	O	O
markers	O	O
,	O	O
and	O	O
these	O	O
microorganisms	O	O
are	O	O
frequently	O	O
implicated	O	O
in	O	O
multiresistant	O	O
,	O	O
systemic	O	O
,	O	O
oral	O	O
or	O	O
nosocomial	O	O
infections	O	O
.	O	O

Examination	O	O
of	O	O
dental	O	O
deposits	O	O
from	O	O
45	O	O
healthy	O	O
individuals	O	O
detected	O	O
3	O	O
lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
showing	O	O
a	O	O
high	O	O
antagonism	O	O
toward	O	O
test	O	O
cultures	O	O
.	O	O

The	O	O
api	O	O
50	O	O
CH	O	O
``	O	O
bio	O	O
Merieux	O	O
''	O	O
test	O	O
systems	O	O
were	O	O
employed	O	O
to	O	O
identify	O	O
strains	O	O
as	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
39	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
24	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
50	O	O
.	O	O

The	O	O
results	O	O
of	O	O
analyzing	O	O
the	O	O
sequences	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
genes	O	O
of	O	O
the	O	O
test	O	O
strains	O	O
confirmed	O	O
this	O	O
identification	O	O
,	O	O
except	O	O
for	O	O
the	O	O
latter	O	O
strain	O	O
.	O	O

The	O	O
taxonomic	O	O
status	O	O
of	O	O
the	O	O
third	O	O
strain	O	O
L.	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
50	O	O
was	O	O
determined	O	O
by	O	O
the	O	O
bioinformative	O	O
analysis	O	O
of	O	O
the	O	O
nucleotide	O	O
sequence	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
genes	O	O
.	O	O

A	O	O
newly	O	O
acquired	O	O
rhesus	O	O
macaque	O	O
was	O	O
suffering	O	O
from	O	O
rapid	O	O
destruction	O	O
of	O	O
the	O	O
left	O	O
cheek	O	O
caused	O	O
by	O	O
necrotizing	O	O
stomatitis	O	O
.	O	O

To	O	O
restore	O	O
reconstructive	O	O
surgery	O	O
and	O	O
intensive	O	O
care	O	O
with	O	O
antibiotics	O	O
,	O	O
wound	O	O
protection	O	O
,	O	O
wound	O	O
healing	O	O
agents	O	O
,	O	O
and	O	O
debridement	O	O
were	O	O
applied	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
were	O	O
isolated	O	O
from	O	O
the	O	O
culture	O	O
of	O	O
the	O	O
lesion	O	O
,	O	O
and	O	O
the	O	O
antibiotic	O	O
susceptibility	O	O
test	O	O
revealed	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
infection	O	O
.	O	O

Vancomycin	O	O
and	O	O
ampicillin-sulbactam	O	O
effectively	O	O
treated	O	O
the	O	O
bacterial	O	O
infections	O	O
,	O	O
and	O	O
reconstructive	O	O
surgery	O	O
was	O	O
performed	O	O
once	O	O
the	O	O
infection	O	O
was	O	O
cleared	O	O
.	O	O

Topical	O	O
application	O	O
of	O	O
recombinant	O	O
human	O	O
epidermal	O	O
growth	O	O
factor	O	O
(	O	O
rhEGF	O	O
)	O	O
was	O	O
useful	O	O
to	O	O
treat	O	O
exposed	O	O
wound	O	O
of	O	O
the	O	O
noma	O	O
lesion	O	O
.	O	O

Simian	O	O
noma	O	O
associated	O	O
with	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
had	O	O
not	O	O
previously	O	O
been	O	O
reported	O	O
in	O	O
non-human	O	O
primates	O	O
.	O	O

Although	O	O
noma	O	O
associated	O	O
with	O	O
MRSA	B-bacteria	B-bacteria
is	O	O
hard	O	O
to	O	O
cure	O	O
because	O	O
of	O	O
its	O	O
rapid	O	O
and	O	O
destructive	O	O
progress	O	O
,	O	O
the	O	O
aggressive	O	O
therapy	O	O
used	O	O
in	O	O
this	O	O
study	O	O
led	O	O
to	O	O
the	O	O
successful	O	O
resolution	O	O
of	O	O
an	O	O
acute	O	O
necrotic	O	O
stomatitis	O	O
lesion	O	O
in	O	O
a	O	O
rhesus	O	O
macaque	O	O
.	O	O

This	O	O
study	O	O
assessed	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
short-	O	O
,	O	O
medium-	O	O
,	O	O
and	O	O
long-chain	O	O
fatty	O	O
acids	O	O
against	O	O
various	O	O
oral	O	O
microorganisms	O	O
.	O	O

The	O	O
short-chain	O	O
fatty	O	O
acids	O	O
[	O	O
formic	O	O
acid	O	O
(	O	O
C1	O	O
)	O	O
,	O	O
acetic	O	O
acid	O	O
(	O	O
C2	O	O
)	O	O
,	O	O
propionic	O	O
acid	O	O
(	O	O
C3	O	O
)	O	O
,	O	O
butyric	O	O
acid	O	O
(	O	O
C4	O	O
)	O	O
,	O	O
isobutyric	O	O
acid	O	O
(	O	O
C4	O	O
)	O	O
,	O	O
isovaleric	O	O
acid	O	O
(	O	O
C5	O	O
)	O	O
,	O	O
hexanoic	O	O
acid	O	O
(	O	O
C6	O	O
)	O	O
]	O	O
,	O	O
medium-chain	O	O
fatty	O	O
acids	O	O
[	O	O
octanoic	O	O
acid	O	O
(	O	O
C8	O	O
)	O	O
,	O	O
capric	O	O
acid	O	O
(	O	O
C10	O	O
)	O	O
,	O	O
lauric	O	O
acid	O	O
(	O	O
12	O	O
)	O	O
]	O	O
,	O	O
and	O	O
long-chain	O	O
fatty	O	O
acids	O	O
[	O	O
myristic	O	O
acid	O	O
(	O	O
C14	O	O
)	O	O
,	O	O
palmitic	O	O
acid	O	O
(	O	O
C16	O	O
)	O	O
]	O	O
,	O	O
were	O	O
investigated	O	O
for	O	O
antimicrobial	O	O
activity	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
data	O	O
demonstrated	O	O
that	O	O
the	O	O
fatty	O	O
acids	O	O
exhibited	O	O
patterns	O	O
of	O	O
inhibition	O	O
against	O	O
oral	O	O
bacteria	O	O
with	O	O
some	O	O
specificity	O	O
that	O	O
appeared	O	O
related	O	O
more	O	O
to	O	O
the	O	O
bacterial	O	O
species	O	O
that	O	O
the	O	O
general	O	O
structural	O	O
characteristics	O	O
of	O	O
the	O	O
microorganism	O	O
.	O	O

As	O	O
a	O	O
group	O	O
the	O	O
fatty	O	O
acids	O	O
were	O	O
much	O	O
less	O	O
effective	O	O
against	O	O
C.	O	O
albicans	O	O
than	O	O
the	O	O
oral	O	O
bacteria	O	O
,	O	O
with	O	O
effectiveness	O	O
limited	O	O
to	O	O
hexanoic	O	O
,	O	O
octanoic	O	O
,	O	O
and	O	O
lauric	O	O
acids	O	O
.	O	O

Formic	O	O
acid	O	O
,	O	O
capric	O	O
,	O	O
and	O	O
lauric	O	O
acids	O	O
were	O	O
broadly	O	O
inhibitory	O	O
for	O	O
the	O	O
bacteria	O	O
.	O	O

Interestingly	O	O
,	O	O
fatty	O	O
acids	O	O
that	O	O
are	O	O
produced	O	O
at	O	O
metabolic	O	O
end-products	O	O
by	O	O
a	O	O
number	O	O
of	O	O
these	O	O
bacteria	O	O
,	O	O
were	O	O
specifically	O	O
inactive	O	O
against	O	O
the	O	O
producing	O	O
species	O	O
,	O	O
whilst	O	O
substantially	O	O
inhibiting	O	O
the	O	O
growth	O	O
of	O	O
other	O	O
oral	O	O
microorganisms	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
short-chain	O	O
fatty	O	O
acids	O	O
(	O	O
SCFAs	O	O
)	O	O
,	O	O
medium-chain	O	O
fatty	O	O
acids	O	O
(	O	O
MCFAs	O	O
)	O	O
,	O	O
long-chain	O	O
fatty	O	O
acids	O	O
(	O	O
LCFAs	O	O
)	O	O
could	O	O
influence	O	O
the	O	O
microbial	O	O
ecology	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
via	O	O
at	O	O
least	O	O
2	O	O
potential	O	O
pathways	O	O
.	O	O

First	O	O
,	O	O
the	O	O
agents	O	O
delivered	O	O
exogenously	O	O
as	O	O
therapeutic	O	O
adjuncts	O	O
could	O	O
be	O	O
packaged	O	O
to	O	O
enhance	O	O
a	O	O
microbial-regulatory	O	O
environment	O	O
in	O	O
the	O	O
subgingival	O	O
sulcus	O	O
.	O	O

Second	O	O
,	O	O
it	O	O
would	O	O
be	O	O
the	O	O
intrinsic	O	O
nature	O	O
of	O	O
these	O	O
fatty	O	O
acid	O	O
inhibitors	O	O
in	O	O
contributing	O	O
to	O	O
the	O	O
characteristics	O	O
of	O	O
the	O	O
microbial	O	O
biofilms	O	O
,	O	O
their	O	O
evolution	O	O
,	O	O
and	O	O
emergence	O	O
of	O	O
species	O	O
within	O	O
the	O	O
biofilms	O	O
.	O	O

Further	O	O
studies	O	O
on	O	O
these	O	O
functions	O	O
are	O	O
required	O	O
to	O	O
better	O	O
understand	O	O
the	O	O
nature	O	O
of	O	O
these	O	O
potential	O	O
microbial	O	O
interactions	O	O
in	O	O
the	O	O
biofilms	O	O
.	O	O

Studies	O	O
on	O	O
the	O	O
adherence	O	O
properties	O	O
of	O	O
oral	O	O
bacteria	O	O
have	O	O
been	O	O
a	O	O
major	O	O
focus	O	O
in	O	O
microbiology	O	O
research	O	O
for	O	O
several	O	O
decades	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
bacteria	O	O
to	O	O
adhere	O	O
to	O	O
the	O	O
variety	O	O
of	O	O
surfaces	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
to	O	O
become	O	O
integrated	O	O
within	O	O
the	O	O
resident	O	O
microbial	O	O
communities	O	O
,	O	O
confers	O	O
growth	O	O
and	O	O
survival	O	O
properties	O	O
.	O	O

Molecular	O	O
analyses	O	O
have	O	O
revealed	O	O
several	O	O
families	O	O
of	O	O
Gram-positive	O	O
bacterial	O	O
surface	O	O
proteins	O	O
,	O	O
including	O	O
serine-rich	O	O
repeat	O	O
,	O	O
antigen	O	O
I/II	O	O
,	O	O
and	O	O
pilus	O	O
families	O	O
,	O	O
that	O	O
mediate	O	O
adherence	O	O
to	O	O
a	O	O
variety	O	O
of	O	O
salivary	O	O
and	O	O
oral	O	O
bacterial	O	O
receptors	O	O
.	O	O

In	O	O
Gram-negative	O	O
bacteria	O	O
,	O	O
pili	O	O
,	O	O
auto-transporters	O	O
,	O	O
and	O	O
extracellular	O	O
matrix-binding	O	O
proteins	O	O
provide	O	O
components	O	O
for	O	O
host	O	O
tissue	O	O
recognition	O	O
and	O	O
building	O	O
of	O	O
complex	O	O
microbial	O	O
communities	O	O
.	O	O

Future	O	O
studies	O	O
will	O	O
reveal	O	O
in	O	O
greater	O	O
detail	O	O
the	O	O
binding	O	O
pockets	O	O
for	O	O
these	O	O
adhesin	O	O
families	O	O
and	O	O
their	O	O
receptors	O	O
.	O	O

This	O	O
information	O	O
will	O	O
be	O	O
crucial	O	O
for	O	O
the	O	O
development	O	O
of	O	O
new	O	O
inhibitors	O	O
or	O	O
vaccines	O	O
that	O	O
target	O	O
the	O	O
functional	O	O
regions	O	O
of	O	O
bacterial	O	O
proteins	O	O
that	O	O
are	O	O
involved	O	O
in	O	O
colonization	O	O
and	O	O
pathogenesis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
our	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
how	O	O
teenage	O	O
smoking	O	O
affects	O	O
the	O	O
prevalence	O	O
of	O	O
periodontal	O	O
bacteria	O	O
and	O	O
periodontal	O	O
health	O	O
with	O	O
the	O	O
hypothesis	O	O
that	O	O
smoking	O	O
increases	O	O
the	O	O
prevalence	O	O
of	O	O
the	O	O
bacteria	O	O
.	O	O

Oral	O	O
health	O	O
of	O	O
264	O	O
adolescents	O	O
(	O	O
15-	O	O
to	O	O
16-year-olds	O	O
)	O	O
was	O	O
clinically	O	O
examined	O	O
,	O	O
and	O	O
their	O	O
smoking	O	O
history	O	O
was	O	O
recorded	O	O
.	O	O

The	O	O
participants	O	O
also	O	O
filled	O	O
in	O	O
a	O	O
structured	O	O
questionnaire	O	O
recording	O	O
their	O	O
general	O	O
health	O	O
and	O	O
health	O	O
habits	O	O
.	O	O

Pooled	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
for	O	O
polymerase	O	O
chain	O	O
reaction	O	O
analysis	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

The	O	O
prevalence	O	O
of	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
21	O	O
%	O	O
vs.	O	O
4	O	O
%	O	O
,	O	O
p	O	O
=	O	O
0.01	O	O
)	O	O
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
(	O	O
23	O	O
%	O	O
vs.	O	O
8	O	O
%	O	O
,	O	O
p	O	O
<	O	O
0.05	O	O
,	O	O
for	O	O
both	O	O
)	O	O
was	O	O
higher	O	O
among	O	O
female	O	O
smokers	O	O
than	O	O
among	O	O
non-smokers	O	O
.	O	O

T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
more	O	O
often	O	O
associated	O	O
with	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
29	O	O
%	O	O
vs.	O	O
12	O	O
%	O	O
;	O	O
25	O	O
%	O	O
vs.	O	O
10	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
and	O	O
deep	O	O
pockets	O	O
(	O	O
25	O	O
%	O	O
vs.	O	O
15	O	O
%	O	O
;	O	O
23	O	O
%	O	O
vs.	O	O
10	O	O
%	O	O
,	O	O
respectively	O	O
)	O	O
with	O	O
smokers	O	O
than	O	O
non-smokers	O	O
.	O	O

Among	O	O
the	O	O
girls	O	O
,	O	O
a	O	O
significant	O	O
association	O	O
was	O	O
found	O	O
between	O	O
pack-years	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
P.	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.007	O	O
)	O	O
.	O	O

In	O	O
both	O	O
genders	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
rare	O	O
in	O	O
this	O	O
study	O	O
.	O	O

To	O	O
conclude	O	O
,	O	O
periodontal	O	O
bacteria	O	O
were	O	O
associated	O	O
with	O	O
higher	O	O
periodontal	O	O
index	O	O
scores	O	O
among	O	O
all	O	O
teenage	O	O
smokers	O	O
.	O	O

Smoking	O	O
girls	O	O
harbored	O	O
more	O	O
frequently	O	O
certain	O	O
periodontal	O	O
bacteria	O	O
than	O	O
non-smokers	O	O
,	O	O
but	O	O
this	O	O
was	O	O
not	O	O
seen	O	O
in	O	O
boys	O	O
.	O	O

Hence	O	O
,	O	O
our	O	O
study	O	O
hypothesis	O	O
was	O	O
only	O	O
partly	O	O
confirmed	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
ability	O	O
of	O	O
biofilm	O	O
formation	O	O
among	O	O
mutans	O	O
and	O	O
non	O	O
mutans	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
to	O	O
determine	O	O
the	O	O
effect	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	I-bacteria	I-bacteria
DSM	I-bacteria	I-bacteria
20079	E-bacteria	I-bacteria
as	O	O
a	O	O
probiot	O	O
on	O	O
the	O	O
adhesion	O	O
of	O	O
selected	O	O
streptococcal	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
on	O	O
the	O	O
surfaces	O	O
.	O	O

The	O	O
sample	O	O
comprised	O	O
40	O	O
isolates	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
dental	O	O
plaque	O	O
and	O	O
caries	O	O
of	O	O
volunteer	O	O
persons	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC35668	E-bacteria	I-bacteria
(	O	O
no24	O	O
)	O	O
was	O	O
as	O	O
an	O	O
standard	O	O
strain	O	O
.	O	O

The	O	O
probiotic	O	O
strain	O	O
was	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	I-bacteria	I-bacteria
DSM	I-bacteria	I-bacteria
20079	E-bacteria	I-bacteria
.	O	O

The	O	O
ability	O	O
of	O	O
biofilm	O	O
formation	O	O
was	O	O
investigated	O	O
with	O	O
colorimetric	O	O
method	O	O
and	O	O
the	O	O
strongest	O	O
isolates	O	O
were	O	O
selected	O	O
.	O	O

Then	O	O
the	O	O
effect	O	O
of	O	O
probiotic	O	O
strain	O	O
on	O	O
the	O	O
adhesion	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
isolates	O	O
was	O	O
determined	O	O
in	O	O
polystyrene	O	O
microtiter	O	O
plate	O	O
simultaneously	O	O
and	O	O
30	O	O
minutes	O	O
before	O	O
streptococci	B-bacteria	B-bacteria
entrance	O	O
to	O	O
the	O	O
system	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
42	O	O
%	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
were	O	O
strongly	O	O
adherent	O	O
(	O	O
SA	O	O
)	O	O
and	O	O
in	O	O
non	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
only	O	O
23.5	O	O
%	O	O
of	O	O
isolates	O	O
were	O	O
found	O	O
strongly	O	O
adherent	O	O
.	O	O

The	O	O
strong	O	O
biofilm	O	O
forming	O	O
bacterium	O	O
isolated	O	O
was	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strain22	E-bacteria	I-bacteria
.	O	O

In	O	O
the	O	O
next	O	O
step	O	O
,	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
probiotic	O	O
strain	O	O
the	O	O
streptococcal	O	O
adhesion	O	O
were	O	O
reduced	O	O
,	O	O
and	O	O
this	O	O
reduction	O	O
was	O	O
non	O	O
significantly	O	O
stronger	O	O
if	O	O
the	O	O
probiotic	O	O
strain	O	O
was	O	O
inoculated	O	O
to	O	O
the	O	O
system	O	O
before	O	O
the	O	O
oral	O	O
bacteria	O	O
.	O	O

The	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
had	O	O
more	O	O
effect	O	O
on	O	O
adherence	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
than	O	O
non	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
with	O	O
significant	O	O
difference	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Adhesion	O	O
reduction	O	O
is	O	O
likely	O	O
due	O	O
to	O	O
bacterial	O	O
interactions	O	O
and	O	O
colonization	O	O
of	O	O
adhesion	O	O
sites	O	O
with	O	O
probiotic	O	O
strain	O	O
before	O	O
the	O	O
presence	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Adhesion	O	O
reduction	O	O
can	O	O
be	O	O
an	O	O
effective	O	O
way	O	O
on	O	O
decreasing	O	O
cariogenic	O	O
potential	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Novel	O	O
phosphorylated	O	O
dihydroceramide	O	O
(	O	O
PDHC	O	O
)	O	O
lipids	O	O
produced	O	O
by	O	O
the	O	O
periodontal	O	O
pathogen	O	O
Porphyromonas	O	O
gingivalis	O	O
include	O	O
phosphoethanolamine	O	O
(	O	O
PE	O	O
DHC	O	O
)	O	O
and	O	O
phosphoglycerol	O	O
dihydroceramides	O	O
(	O	O
PG	O	O
DHC	O	O
)	O	O
lipids	O	O
.	O	O

These	O	O
PDHC	O	O
lipids	O	O
mediate	O	O
cellular	O	O
effects	O	O
through	O	O
Toll-like	O	O
receptor	O	O
2	O	O
(	O	O
TLR2	O	O
)	O	O
including	O	O
promotion	O	O
of	O	O
IL-6	O	O
secretion	O	O
from	O	O
dendritic	O	O
cells	O	O
and	O	O
inhibition	O	O
of	O	O
osteoblast	O	O
differentiation	O	O
and	O	O
function	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
.	O	O

The	O	O
PE	O	O
DHC	O	O
lipids	O	O
also	O	O
enhance	O	O
(	O	O
TLR2	O	O
)	O	O
-dependent	O	O
murine	O	O
experimental	O	O
autoimmune	O	O
encephalomyelitis	O	O
(	O	O
EAE	O	O
)	O	O
,	O	O
a	O	O
model	O	O
for	O	O
multiple	O	O
sclerosis	O	O
.	O	O

The	O	O
unique	O	O
non-mammalian	O	O
structures	O	O
of	O	O
these	O	O
lipids	O	O
allows	O	O
for	O	O
their	O	O
specific	O	O
quantification	O	O
in	O	O
bacteria	O	O
and	O	O
human	O	O
tissues	O	O
using	O	O
multiple	O	O
reaction	O	O
monitoring	O	O
(	O	O
MRM	O	O
)	O	O
-mass	O	O
spectrometry	O	O
(	O	O
MS	O	O
)	O	O
.	O	O

Synthesis	O	O
of	O	O
these	O	O
lipids	O	O
by	O	O
other	O	O
common	O	O
human	O	O
bacteria	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
these	O	O
lipids	O	O
in	O	O
human	O	O
tissues	O	O
have	O	O
not	O	O
yet	O	O
been	O	O
determined	O	O
.	O	O

We	O	O
now	O	O
report	O	O
that	O	O
synthesis	O	O
of	O	O
these	O	O
lipids	O	O
can	O	O
be	O	O
attributed	O	O
to	O	O
a	O	O
small	O	O
number	O	O
of	O	O
intestinal	O	O
and	O	O
oral	O	O
organisms	O	O
within	O	O
the	O	O
Bacteroides	B-bacteria	B-bacteria
,	O	O
Parabacteroides	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
genera	E-bacteria	I-bacteria
.	O	O

Additionally	O	O
,	O	O
the	O	O
PDHCs	O	O
are	O	O
not	O	O
only	O	O
present	O	O
in	O	O
gingival	O	O
tissues	O	O
,	O	O
but	O	O
are	O	O
also	O	O
present	O	O
in	O	O
human	O	O
blood	O	O
,	O	O
vasculature	O	O
tissues	O	O
and	O	O
brain	O	O
.	O	O

Finally	O	O
,	O	O
the	O	O
distribution	O	O
of	O	O
these	O	O
TLR2-activating	O	O
lipids	O	O
in	O	O
human	O	O
tissues	O	O
varies	O	O
with	O	O
both	O	O
the	O	O
tissue	O	O
site	O	O
and	O	O
disease	O	O
status	O	O
of	O	O
the	O	O
tissue	O	O
suggesting	O	O
a	O	O
role	O	O
for	O	O
PDHCs	O	O
in	O	O
human	O	O
disease	O	O
.	O	O

To	O	O
develop	O	O
a	O	O
convenient	O	O
method	O	O
for	O	O
the	O	O
localization	O	O
and	O	O
quantification	O	O
of	O	O
live	O	O
and	O	O
dead	O	O
bacteria	O	O
in	O	O
human	O	O
ex	O	O
vivo	O	O
mineralized	O	O
dentinal	O	O
tubules	O	O
.	O	O

The	O	O
roots	O	O
from	O	O
human	O	O
single-rooted	O	O
teeth	O	O
(	O	O
n	O	O
=	O	O
12	O	O
)	O	O
were	O	O
infected	O	O
with	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	I-bacteria	I-bacteria
V583	E-bacteria	I-bacteria
and	O	O
either	O	O
treated	O	O
with	O	O
calcium	O	O
hydroxide	O	O
paste	O	O
or	O	O
left	O	O
untreated	O	O
;	O	O
six	O	O
control	O	O
roots	O	O
were	O	O
uninoculated	O	O
and	O	O
untreated	O	O
.	O	O

Following	O	O
further	O	O
incubation	O	O
,	O	O
roots	O	O
were	O	O
stained	O	O
with	O	O
fluorescent	O	O
DNA-binding	O	O
reagents	O	O
,	O	O
washed	O	O
thoroughly	O	O
,	O	O
sectioned	O	O
and	O	O
examined	O	O
by	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

Computer-assisted	O	O
determinations	O	O
of	O	O
fluorescence	O	O
(	O	O
bacterial	O	O
viability	O	O
)	O	O
were	O	O
compared	O	O
statistically	O	O
.	O	O

Bacteria	O	O
were	O	O
distributed	O	O
in	O	O
the	O	O
tubules	O	O
throughout	O	O
the	O	O
length	O	O
of	O	O
the	O	O
roots	O	O
but	O	O
tubule	O	O
penetration	O	O
distance	O	O
was	O	O
slightly	O	O
reduced	O	O
in	O	O
the	O	O
apical	O	O
sections	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
in	O	O
bacterial	O	O
tubule	O	O
penetration	O	O
between	O	O
roots	O	O
from	O	O
different	O	O
teeth	O	O
and	O	O
small	O	O
standard	O	O
deviations	O	O
indicated	O	O
reproducibility	O	O
appropriate	O	O
for	O	O
experimental	O	O
application	O	O
.	O	O

Following	O	O
treatment	O	O
with	O	O
calcium	O	O
hydroxide	O	O
paste	O	O
,	O	O
live	O	O
and	O	O
dead	O	O
bacteria	O	O
were	O	O
readily	O	O
distinguishable	O	O
by	O	O
contrasting	O	O
green	O	O
and	O	O
red	O	O
fluorescence	O	O
.	O	O

Bacterial	O	O
viability	O	O
determinations	O	O
amongst	O	O
roots	O	O
treated	O	O
in	O	O
the	O	O
same	O	O
way	O	O
were	O	O
not	O	O
significantly	O	O
different	O	O
,	O	O
and	O	O
the	O	O
small	O	O
standard	O	O
deviation	O	O
is	O	O
commensurate	O	O
with	O	O
experimental	O	O
application	O	O
.	O	O

Fluorescent	O	O
viability	O	O
staining	O	O
is	O	O
a	O	O
convenient	O	O
,	O	O
accurate	O	O
and	O	O
reproducible	O	O
method	O	O
for	O	O
localizing	O	O
and	O	O
quantifying	O	O
live	O	O
and	O	O
dead	O	O
bacteria	O	O
in	O	O
human	O	O
ex	O	O
vivo	O	O
mineralized	O	O
dentinal	O	O
tubules	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
are	O	O
opportunistic	O	O
microorganisms	O	O
known	O	O
for	O	O
their	O	O
capacity	O	O
to	O	O
develop	O	O
resistance	O	O
against	O	O
antimicrobial	O	O
agents	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
photodynamic	O	O
therapy	O	O
(	O	O
PDT	O	O
)	O	O
on	O	O
20	O	O
Staphylococcus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
including	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
schleiferi	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
capitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
haemolyticus	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
lentus	E-bacteria	I-bacteria
.	O	O

A	O	O
suspension	O	O
of	O	O
each	O	O
Staphylococcus	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
(	O	O
10	O	O
(	O	O
6	O	O
)	O	O
cells/mL	O	O
)	O	O
was	O	O
submitted	O	O
to	O	O
PDT	O	O
using	O	O
methylene	O	O
blue	O	O
and	O	O
a	O	O
low	O	O
power	O	O
laser	O	O
.	O	O

The	O	O
isolated	O	O
effects	O	O
of	O	O
methylene	O	O
blue	O	O
,	O	O
laser	O	O
treatment	O	O
and	O	O
ciprofloxacin	O	O
were	O	O
also	O	O
evaluated	O	O
.	O	O

After	O	O
the	O	O
experimental	O	O
treatments	O	O
,	O	O
0.1	O	O
mL	O	O
aliquots	O	O
of	O	O
the	O	O
suspensions	O	O
were	O	O
seeded	O	O
onto	O	O
BHI	O	O
agar	O	O
for	O	O
determination	O	O
of	O	O
the	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
(	O	O
CFU/mL	O	O
)	O	O
.	O	O

The	O	O
results	O	O
were	O	O
analyzed	O	O
by	O	O
analysis	O	O
of	O	O
variance	O	O
and	O	O
Tukey	O	O
's	O	O
test	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
mean	O	O
reduction	O	O
in	O	O
bacterial	O	O
counts	O	O
of	O	O
the	O	O
strains	O	O
submitted	O	O
to	O	O
PDT	O	O
ranged	O	O
from	O	O
4.89	O	O
to	O	O
6.83	O	O
CFU	O	O
(	O	O
log10	O	O
)	O	O
/mL	O	O
,	O	O
with	O	O
the	O	O
observation	O	O
of	O	O
a	O	O
decreasing	O	O
susceptibility	O	O
to	O	O
treatment	O	O
of	O	O
S.	B-bacteria	B-bacteria
schleiferi	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
haemolyticus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
capitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
lentus	E-bacteria	I-bacteria
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
PDT	O	O
was	O	O
effective	O	O
in	O	O
reducing	O	O
the	O	O
number	O	O
of	O	O
viable	O	O
cells	O	O
of	O	O
all	O	O
clinical	O	O
Staphylococcus	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
studied	O	O
.	O	O

We	O	O
investigated	O	O
in	O	O
a	O	O
nationally	O	O
representative	O	O
sample	O	O
,	O	O
how	O	O
periodontitis	O	O
modifies	O	O
the	O	O
association	O	O
between	O	O
the	O	O
carriage	O	O
of	O	O
periodontal	O	O
pathogens	O	O
and	O	O
serology	O	O
.	O	O

The	O	O
population	O	O
comprised	O	O
1586	O	O
dentate	O	O
subjects	O	O
who	O	O
participated	O	O
in	O	O
an	O	O
interview	O	O
,	O	O
clinical	O	O
and	O	O
radiological	O	O
oral	O	O
health	O	O
examination	O	O
,	O	O
and	O	O
saliva	O	O
collection	O	O
.	O	O

Serum	O	O
immunoglobulin	O	O
A	O	O
(	O	O
IgA	O	O
)	O	O
-	O	O
and	O	O
IgG-class	O	O
antibody	O	O
levels	O	O
against	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
their	O	O
salivary	O	O
occurrence	O	O
were	O	O
determined	O	O
in	O	O
the	O	O
whole	O	O
population	O	O
.	O	O

The	O	O
quantity	O	O
of	O	O
the	O	O
pathogens	O	O
was	O	O
measured	O	O
in	O	O
a	O	O
subpopulation	O	O
.	O	O

In	O	O
the	O	O
univariate	O	O
analyses	O	O
,	O	O
the	O	O
corresponding	O	O
antibody	O	O
levels	O	O
were	O	O
higher	O	O
in	O	O
the	O	O
pathogen	O	O
carriers	O	O
compared	O	O
with	O	O
the	O	O
non-carriers	O	O
,	O	O
and	O	O
clearly	O	O
higher	O	O
in	O	O
the	O	O
carriers	O	O
with	O	O
periodontal	O	O
pockets	O	O
compared	O	O
with	O	O
the	O	O
carriers	O	O
without	O	O
.	O	O

In	O	O
the	O	O
multi-variate	O	O
analyses	O	O
,	O	O
however	O	O
,	O	O
all	O	O
antibody	O	O
levels	O	O
associated	O	O
strongly	O	O
with	O	O
age	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
and	O	O
the	O	O
carriage	O	O
of	O	O
the	O	O
corresponding	O	O
pathogen	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
but	O	O
only	O	O
weakly	O	O
with	O	O
the	O	O
presence	O	O
or	O	O
number	O	O
of	O	O
teeth	O	O
with	O	O
periodontal	O	O
pockets	O	O
.	O	O

In	O	O
the	O	O
subpopulation	O	O
,	O	O
the	O	O
antibody	O	O
levels	O	O
and	O	O
the	O	O
numbers	O	O
of	O	O
corresponding	O	O
bacteria	O	O
in	O	O
saliva	O	O
had	O	O
a	O	O
positive	O	O
association	O	O
,	O	O
which	O	O
was	O	O
not	O	O
affected	O	O
by	O	O
the	O	O
disease	O	O
.	O	O

The	O	O
carriage	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
the	O	O
strongest	O	O
determinant	O	O
of	O	O
the	O	O
systemic	O	O
antibody	O	O
response	O	O
to	O	O
these	O	O
pathogens	O	O
,	O	O
and	O	O
the	O	O
extent	O	O
of	O	O
periodontitis	O	O
has	O	O
at	O	O
most	O	O
a	O	O
modest	O	O
modifying	O	O
effect	O	O
.	O	O

West	O	O
Virginia	O	O
has	O	O
the	O	O
worst	O	O
oral	O	O
health	O	O
in	O	O
the	O	O
United	O	O
States	O	O
,	O	O
but	O	O
the	O	O
reasons	O	O
for	O	O
this	O	O
are	O	O
unclear	O	O
.	O	O

This	O	O
pilot	O	O
study	O	O
explored	O	O
the	O	O
etiology	O	O
of	O	O
this	O	O
disparity	O	O
using	O	O
culture-independent	O	O
analyses	O	O
to	O	O
identify	O	O
bacterial	O	O
species	O	O
associated	O	O
with	O	O
oral	O	O
disease	O	O
.	O	O

Bacteria	O	O
in	O	O
subgingival	O	O
plaque	O	O
samples	O	O
from	O	O
twelve	O	O
participants	O	O
in	O	O
two	O	O
independent	O	O
West	O	O
Virginia	O	O
dental-related	O	O
studies	O	O
were	O	O
characterized	O	O
using	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
and	O	O
Human	O	O
Oral	O	O
Microbe	O	O
Identification	O	O
Microarray	O	O
(	O	O
HOMIM	O	O
)	O	O
analysis	O	O
.	O	O

Unifrac	O	O
analysis	O	O
was	O	O
used	O	O
to	O	O
characterize	O	O
phylogenetic	O	O
differences	O	O
between	O	O
bacterial	O	O
communities	O	O
obtained	O	O
from	O	O
plaque	O	O
of	O	O
participants	O	O
with	O	O
low	O	O
or	O	O
high	O	O
oral	O	O
disease	O	O
,	O	O
which	O	O
was	O	O
further	O	O
evaluated	O	O
using	O	O
clustering	O	O
and	O	O
Principal	O	O
Coordinate	O	O
Analysis	O	O
.	O	O

Statistically	O	O
different	O	O
bacterial	O	O
signatures	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
were	O	O
identified	O	O
in	O	O
subgingival	O	O
plaque	O	O
of	O	O
individuals	O	O
with	O	O
low	O	O
or	O	O
high	O	O
oral	O	O
disease	O	O
in	O	O
West	O	O
Virginia	O	O
based	O	O
on	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
.	O	O

Low	O	O
disease	O	O
contained	O	O
a	O	O
high	O	O
frequency	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
with	O	O
a	O	O
moderate	O	O
number	O	O
of	O	O
Capnocytophaga	B-bacteria	B-bacteria
.	O	O

High	O	O
disease	O	O
exhibited	O	O
substantially	O	O
increased	O	O
bacterial	O	O
diversity	O	O
and	O	O
included	O	O
a	O	O
large	O	O
proportion	O	O
of	O	O
Clostridiales	O	O
cluster	O	O
bacteria	O	O
(	O	O
Selenomonas	B-bacteria	B-bacteria
,	O	O
Eubacterium	B-bacteria	B-bacteria
,	O	O
Dialister	B-bacteria	B-bacteria
)	O	O
.	O	O

Phylogenetic	O	O
trees	O	O
constructed	O	O
using	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
revealed	O	O
that	O	O
Clostridiales	O	O
were	O	O
repeated	O	O
colonizers	O	O
in	O	O
plaque	O	O
associated	O	O
with	O	O
high	O	O
oral	O	O
disease	O	O
,	O	O
providing	O	O
evidence	O	O
that	O	O
the	O	O
oral	O	O
environment	O	O
is	O	O
somehow	O	O
influencing	O	O
the	O	O
bacterial	O	O
signature	O	O
linked	O	O
to	O	O
disease	O	O
.	O	O

Culture-independent	O	O
analyses	O	O
identified	O	O
an	O	O
atypical	O	O
bacterial	O	O
signature	O	O
associated	O	O
with	O	O
high	O	O
oral	O	O
disease	O	O
in	O	O
West	O	O
Virginians	O	O
and	O	O
provided	O	O
evidence	O	O
that	O	O
the	O	O
oral	O	O
environment	O	O
influenced	O	O
this	O	O
signature	O	O
.	O	O

Both	O	O
findings	O	O
provide	O	O
insight	O	O
into	O	O
the	O	O
etiology	O	O
of	O	O
the	O	O
oral	O	O
disparity	O	O
in	O	O
West	O	O
Virginia	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
zirconium	O	O
oxide	O	O
and	O	O
titanium	O	O
alloys	O	O
with	O	O
respect	O	O
to	O	O
their	O	O
tendency	O	O
to	O	O
adhesion	O	O
and	O	O
colonization	O	O
of	O	O
two	O	O
periodontal	O	O
pathogens	O	O
on	O	O
both	O	O
hard	O	O
surfaces	O	O
and	O	O
on	O	O
soft	O	O
tissues	O	O
in	O	O
vivo	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
designed	O	O
as	O	O
a	O	O
prospective	O	O
stratified	O	O
randomized	O	O
controlled	O	O
clinical	O	O
trial	O	O
.	O	O

Patients	O	O
were	O	O
scheduled	O	O
to	O	O
receive	O	O
two	O	O
implants	O	O
with	O	O
different	O	O
types	O	O
of	O	O
abutments	O	O
in	O	O
the	O	O
posterior	O	O
mandible	O	O
.	O	O

Three	O	O
months	O	O
after	O	O
implant	O	O
placement	O	O
,	O	O
titanium	O	O
and	O	O
zirconium	O	O
abutments	O	O
were	O	O
connected	O	O
.	O	O

Five	O	O
weeks	O	O
after	O	O
abutment	O	O
connections	O	O
,	O	O
the	O	O
abutments	O	O
were	O	O
removed	O	O
,	O	O
probing	O	O
depth	O	O
measurements	O	O
were	O	O
recorded	O	O
,	O	O
and	O	O
gingival	O	O
biopsy	O	O
samples	O	O
were	O	O
obtained	O	O
.	O	O

Abutments	O	O
and	O	O
biopsy	O	O
specimens	O	O
were	O	O
analyzed	O	O
by	O	O
reverse-transcriptase	O	O
polymerase	O	O
chain	O	O
reaction	O	O
to	O	O
compare	O	O
the	O	O
DNA	O	O
copy	O	O
numbers	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
total	O	O
bacteria	O	O
.	O	O

The	O	O
surface	O	O
free	O	O
energy	O	O
of	O	O
the	O	O
abutments	O	O
was	O	O
calculated	O	O
by	O	O
sesile	O	O
water	O	O
drop	O	O
before	O	O
replacement	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
probing	O	O
depths	O	O
or	O	O
DNA	O	O
copy	O	O
numbers	O	O
of	O	O
A	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
total	O	O
bacteria	O	O
both	O	O
for	O	O
both	O	O
titanium	O	O
alloys	O	O
and	O	O
zirconium	O	O
oxide	O	O
surfaces	O	O
and	O	O
the	O	O
biops	O	O
specimens	O	O
obtained	O	O
from	O	O
their	O	O
buccal	O	O
gingival	O	O
.	O	O

With	O	O
respect	O	O
to	O	O
the	O	O
surface	O	O
free	O	O
energy	O	O
of	O	O
zirconium	O	O
and	O	O
titanium	O	O
abutments	O	O
,	O	O
zirconium	O	O
abutments	O	O
showed	O	O
lower	O	O
surface	O	O
free	O	O
energy	O	O
than	O	O
titanium	O	O
abutments	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
showed	O	O
that	O	O
zirconium	O	O
oxide	O	O
surfaces	O	O
have	O	O
comparable	O	O
properties	O	O
to	O	O
titanium	O	O
alloy	O	O
surfaces	O	O
in	O	O
their	O	O
tendency	O	O
to	O	O
adhesion	O	O
and	O	O
colonization	O	O
of	O	O
two	O	O
periodontal	O	O
pathogens	O	O
on	O	O
both	O	O
hard	O	O
surfaces	O	O
and	O	O
in	O	O
soft	O	O
tissues	O	O
.	O	O

Epidemiological	O	O
evidence	O	O
suggests	O	O
that	O	O
infections	O	O
may	O	O
contribute	O	O
to	O	O
atherogenesis	O	O
.	O	O

However	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
Chlamydophila	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
cultivable	O	O
bacteria	O	O
have	O	O
not	O	O
been	O	O
recovered	O	O
from	O	O
atherosclerotic	O	O
lesions	O	O
.	O	O

Therefore	O	O
,	O	O
we	O	O
aimed	O	O
at	O	O
developing	O	O
an	O	O
approach	O	O
to	O	O
recover	O	O
uncultivable	O	O
bacteria	O	O
from	O	O
atherectomy	O	O
tissues	O	O
.	O	O

We	O	O
cultured	O	O
homogenates	O	O
from	O	O
atherectomy	O	O
specimens	O	O
from	O	O
seven	O	O
nonseptic	O	O
patients	O	O
undergoing	O	O
surgery	O	O
for	O	O
arterial	O	O
obstruction	O	O
either	O	O
alone	O	O
or	O	O
together	O	O
with	O	O
THP-1	O	O
monocyte-like	O	O
cells	O	O
.	O	O

We	O	O
performed	O	O
16S	O	O
rDNA	O	O
analysis	O	O
,	O	O
biochemical	O	O
tests	O	O
,	O	O
random	O	O
amplification	O	O
of	O	O
polymorphic	O	O
DNA	O	O
PCR	O	O
analysis	O	O
,	O	O
quantitative	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
qPCR	O	O
)	O	O
and	O	O
immunohistofluorescence	O	O
to	O	O
identify	O	O
the	O	O
cultivated	O	O
bacteria	O	O
.	O	O

Wilcoxon	O	O
signed-rank	O	O
tests	O	O
were	O	O
used	O	O
to	O	O
determine	O	O
whether	O	O
THP-1	O	O
treatment	O	O
yielded	O	O
a	O	O
higher	O	O
number	O	O
of	O	O
isolates	O	O
than	O	O
did	O	O
the	O	O
untreated	O	O
controls	O	O
.	O	O

We	O	O
recovered	O	O
more	O	O
bacteria	O	O
from	O	O
cocultures	O	O
of	O	O
atherectomy	O	O
specimens	O	O
with	O	O
THP-1	O	O
cells	O	O
than	O	O
atherectomy	O	O
specimens	O	O
cultured	O	O
alone	O	O
.	O	O

On	O	O
average	O	O
,	O	O
tissue	O	O
homogenates	O	O
incubated	O	O
with	O	O
THP-1	O	O
cells	O	O
versus	O	O
control	O	O
yielded	O	O
124	O	O
vs.	O	O
22	O	O
colony-forming	O	O
units	O	O
,	O	O
a	O	O
median	O	O
of	O	O
140	O	O
vs.	O	O
7	O	O
,	O	O
respectively	O	O
(	O	O
P	O	O
=	O	O
0.02	O	O
)	O	O
.	O	O

We	O	O
recovered	O	O
872	O	O
isolates	O	O
of	O	O
limited	O	O
number	O	O
of	O	O
species	O	O
,	O	O
including	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
infantis	E-bacteria	I-bacteria
and	O	O
the	O	O
fastidious	O	O
anaerobe	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
confirmed	O	O
its	O	O
presence	O	O
in	O	O
tissue	O	O
using	O	O
double	O	O
immunofluorescence	O	O
imaging	O	O
.	O	O

qPCR	O	O
demonstrated	O	O
the	O	O
presence	O	O
of	O	O
>	O	O
/=3.5	O	O
x	O	O
10	O	O
(	O	O
3	O	O
)	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
genomes	O	O
per	O	O
gram	O	O
of	O	O
atheromatous	O	O
tissue	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
viable	O	O
previously	O	O
uncultivable	O	O
bacterial	O	O
species	O	O
are	O	O
present	O	O
within	O	O
atheromas	O	O
.	O	O

Our	O	O
results	O	O
suggest	O	O
revisiting	O	O
the	O	O
hypothesis	O	O
that	O	O
infections	O	O
may	O	O
have	O	O
a	O	O
causative	O	O
role	O	O
in	O	O
atherosclerotic	O	O
inflammation	O	O
and	O	O
have	O	O
implications	O	O
for	O	O
research	O	O
regarding	O	O
novel	O	O
diagnostics	O	O
and	O	O
treatments	O	O
for	O	O
cardiovascular	O	O
disease	O	O
.	O	O

An	O	O
understanding	O	O
of	O	O
the	O	O
relation	O	O
of	O	O
commensal	O	O
microbiota	O	O
to	O	O
health	O	O
is	O	O
essential	O	O
in	O	O
preventing	O	O
disease	O	O
.	O	O

Here	O	O
we	O	O
studied	O	O
the	O	O
oral	O	O
microbial	O	O
composition	O	O
of	O	O
children	O	O
(	O	O
N	O	O
=	O	O
74	O	O
,	O	O
aged	O	O
3	O	O
-	O	O
18	O	O
years	O	O
)	O	O
in	O	O
natural	O	O
transition	O	O
from	O	O
their	O	O
deciduous	O	O
to	O	O
a	O	O
permanent	O	O
dentition	O	O
and	O	O
related	O	O
the	O	O
microbial	O	O
profiles	O	O
to	O	O
their	O	O
oral	O	O
health	O	O
status	O	O
.	O	O

The	O	O
microbial	O	O
composition	O	O
of	O	O
saliva	O	O
was	O	O
assessed	O	O
by	O	O
barcoded	O	O
pyrosequencing	O	O
of	O	O
the	O	O
V5-V6	O	O
hypervariable	O	O
regions	O	O
of	O	O
the	O	O
16	O	O
S	O	O
rRNA	O	O
,	O	O
as	O	O
well	O	O
as	O	O
by	O	O
using	O	O
phylogenetic	O	O
microarrays	O	O
.	O	O

Pyrosequencing	O	O
reads	O	O
(	O	O
126174	O	O
reads	O	O
,	O	O
1045	O	O
unique	O	O
sequences	O	O
)	O	O
represented	O	O
8	O	O
phyla	O	O
and	O	O
113	O	O
higher	O	O
taxa	O	O
in	O	O
saliva	O	O
samples	O	O
.	O	O

Four	O	O
phyla	O	O
--	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Bacteriodetes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
and	O	O
Actinobacteria	B-bacteria	B-bacteria
--	O	O
predominated	O	O
in	O	O
all	O	O
groups	O	O
.	O	O

The	O	O
deciduous	O	O
dentition	O	O
harboured	O	O
a	O	O
higher	O	O
proportion	O	O
of	O	O
Proteobacteria	B-bacteria	B-bacteria
(	O	O
Gammaproteobacteria	B-bacteria	B-bacteria
,	O	O
Moraxellaceae	B-bacteria	B-bacteria
)	O	O
than	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
while	O	O
in	O	O
all	O	O
other	O	O
groups	O	O
Bacteroidetes	B-bacteria	B-bacteria
were	O	O
at	O	O
least	O	O
as	O	O
abundant	O	O
as	O	O
Proteobacteria	B-bacteria	B-bacteria
.	O	O

Bacteroidetes	B-bacteria	B-bacteria
(	O	O
mainly	O	O
genus	B-bacteria	B-bacteria
Prevotella	E-bacteria	I-bacteria
)	O	O
,	O	O
Veillonellaceae	B-bacteria	B-bacteria
family	E-bacteria	I-bacteria
,	O	O
Spirochaetes	B-bacteria	B-bacteria
and	O	O
candidate	O	O
division	O	O
TM7	O	O
increased	O	O
with	O	O
increasing	O	O
age	O	O
,	O	O
reflecting	O	O
maturation	O	O
of	O	O
the	O	O
microbiome	O	O
driven	O	O
by	O	O
biological	O	O
changes	O	O
with	O	O
age	O	O
.	O	O

Microarray	O	O
analysis	O	O
enabled	O	O
further	O	O
analysis	O	O
of	O	O
the	O	O
individual	O	O
salivary	O	O
microbiota	O	O
.	O	O

Of	O	O
350	O	O
microarray	O	O
probes	O	O
,	O	O
156	O	O
gave	O	O
a	O	O
positive	O	O
signal	O	O
with	O	O
,	O	O
on	O	O
average	O	O
,	O	O
77	O	O
(	O	O
range	O	O
48-93	O	O
)	O	O
probes	O	O
per	O	O
individual	O	O
sample	O	O
.	O	O

A	O	O
caries-free	O	O
oral	O	O
status	O	O
significantly	O	O
associated	O	O
with	O	O
the	O	O
higher	O	O
signal	O	O
of	O	O
the	O	O
probes	O	O
targeting	O	O
Porphyromonas	B-bacteria	B-bacteria
catoniae	E-bacteria	I-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
flavescens	E-bacteria	I-bacteria
.	O	O

The	O	O
potential	O	O
role	O	O
of	O	O
P.	B-bacteria	B-bacteria
catoniae	E-bacteria	I-bacteria
and	O	O
N.	B-bacteria	B-bacteria
flavescens	E-bacteria	I-bacteria
as	O	O
oral	O	O
health	O	O
markers	O	O
should	O	O
be	O	O
assessed	O	O
in	O	O
large-scale	O	O
clinical	O	O
studies	O	O
.	O	O

The	O	O
combination	O	O
of	O	O
both	O	O
open-ended	O	O
and	O	O
targeted	O	O
molecular	O	O
approaches	O	O
provides	O	O
us	O	O
with	O	O
information	O	O
that	O	O
will	O	O
increase	O	O
our	O	O
understanding	O	O
of	O	O
the	O	O
interplay	O	O
between	O	O
the	O	O
human	O	O
host	O	O
and	O	O
its	O	O
microbiome	O	O
.	O	O

We	O	O
show	O	O
that	O	O
bacteria	O	O
with	O	O
methylotrophic	O	O
potential	O	O
are	O	O
ubiquitous	O	O
in	O	O
the	O	O
human	O	O
mouth	O	O
microbiota	O	O
.	O	O

Numerous	O	O
strains	O	O
of	O	O
Actinobacteria	B-bacteria	B-bacteria
(	O	O
Brevibacterium	B-bacteria	B-bacteria
,	O	O
Gordonia	B-bacteria	B-bacteria
,	O	O
Leifsonia	B-bacteria	B-bacteria
,	O	O
Microbacterium	B-bacteria	B-bacteria
,	O	O
Micrococcus	B-bacteria	B-bacteria
,	O	O
Rhodococcus	B-bacteria	B-bacteria
)	O	O
and	O	O
Proteobacteria	B-bacteria	B-bacteria
(	O	O
Achromobacter	B-bacteria	B-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
,	O	O
Methylobacterium	B-bacteria	B-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
,	O	O
Ralstonia	B-bacteria	B-bacteria
)	O	O
were	O	O
isolated	O	O
,	O	O
and	O	O
one	O	O
strain	O	O
of	O	O
each	O	O
of	O	O
the	O	O
eleven	O	O
genera	O	O
was	O	O
studied	O	O
in	O	O
detail	O	O
.	O	O

These	O	O
strains	O	O
expressed	O	O
enzymes	O	O
associated	O	O
with	O	O
methylotrophic	O	O
metabolism	O	O
(	O	O
methanol	O	O
,	O	O
methylamine	O	O
,	O	O
and	O	O
formate	O	O
dehydrogenases	O	O
)	O	O
,	O	O
and	O	O
the	O	O
assimilation	O	O
of	O	O
one-carbon	O	O
compounds	O	O
by	O	O
the	O	O
serine	O	O
pathway	O	O
(	O	O
hydroxypyruvate	O	O
reductase	O	O
)	O	O
.	O	O

Methylotrophic	O	O
growth	O	O
of	O	O
the	O	O
strains	O	O
was	O	O
enhanced	O	O
by	O	O
the	O	O
addition	O	O
of	O	O
glass	O	O
beads	O	O
to	O	O
cultures	O	O
,	O	O
suggesting	O	O
that	O	O
they	O	O
may	O	O
naturally	O	O
occur	O	O
in	O	O
biofilms	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
report	O	O
of	O	O
Gordonia	B-bacteria	B-bacteria
,	O	O
Leifsonia	B-bacteria	B-bacteria
,	O	O
and	O	O
Rhodococcus	B-bacteria	B-bacteria
being	O	O
present	O	O
in	O	O
the	O	O
mouth	O	O
and	O	O
of	O	O
the	O	O
unequivocal	O	O
demonstration	O	O
for	O	O
the	O	O
first	O	O
time	O	O
of	O	O
the	O	O
methylotrophic	O	O
potential	O	O
of	O	O
strains	O	O
of	O	O
Gordonia	B-bacteria	B-bacteria
,	O	O
Leifsonia	B-bacteria	B-bacteria
,	O	O
and	O	O
Microbacterium	B-bacteria	B-bacteria
.	O	O

To	O	O
determine	O	O
ability	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
indigenous	O	O
for	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
persons	O	O
to	O	O
adhesion	O	O
,	O	O
autoaggregation	O	O
,	O	O
surface	O	O
hydrophobicity	O	O
,	O	O
coaggregation	O	O
and	O	O
formation	O	O
of	O	O
biofilms	O	O
.	O	O


Twenty-three	O	O
anatagonistically	O	O
active	O	O
isolates	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
including	O	O
5	O	O
strains	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
,	O	O
6	O	O
--	O	O
L.	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
,	O	O
4	O	O
--	O	O
L.	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
,	O	O
and	O	O
8	O	O
--	O	O
L.	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
,	O	O
were	O	O
studied	O	O
.	O	O

Characteristics	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
associated	O	O
with	O	O
adhesion	O	O
,	O	O
autoaggregation	O	O
,	O	O
surface	O	O
hydrophobicity	O	O
,	O	O
coaggregation	O	O
,	O	O
and	O	O
formation	O	O
of	O	O
biofilms	O	O
were	O	O
determined	O	O
.	O	O

Bacteria	O	O
were	O	O
characterized	O	O
by	O	O
high	O	O
and	O	O
intermediate	O	O
level	O	O
of	O	O
adhesion	O	O
,	O	O
autoaggregation	O	O
,	O	O
surface	O	O
hydrophobicity	O	O
,	O	O
expressed	O	O
ability	O	O
to	O	O
form	O	O
biofilms	O	O
and	O	O
different	O	O
coaggregation	O	O
activity	O	O
relative	O	O
to	O	O
test-strains	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
and	O	O
Bacillus	B-bacteria	B-bacteria
subtilis	E-bacteria	I-bacteria
.	O	O

Studied	O	O
characteristics	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
could	O	O
be	O	O
used	O	O
for	O	O
development	O	O
of	O	O
new	O	O
probiotics	O	O
aimed	O	O
at	O	O
stabilization	O	O
of	O	O
oral	O	O
cavity	O	O
normoflora	O	O
.	O	O

The	O	O
loads	O	O
and	O	O
locations	O	O
of	O	O
bacterial	O	O
types	O	O
associated	O	O
with	O	O
oral	O	O
malodour	O	O
on	O	O
the	O	O
tongue	O	O
surface	O	O
and	O	O
gingival	O	O
crevice	O	O
were	O	O
investigated	O	O
in	O	O
man	O	O
and	O	O
the	O	O
dog	O	O
respectively	O	O
.	O	O

In	O	O
the	O	O
human	O	O
study	O	O
,	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
50	O	O
subjects	O	O
with	O	O
brushes	O	O
at	O	O
the	O	O
dorsal	O	O
anterior	O	O
,	O	O
dorsal	O	O
middle	O	O
,	O	O
dorsal	O	O
posterior	O	O
,	O	O
dorsal	O	O
posterior	O	O
to	O	O
the	O	O
circumvallate	O	O
papillae	O	O
(	O	O
DPCP	O	O
)	O	O
,	O	O
lateral	O	O
posterior	O	O
and	O	O
ventral	O	O
posterior	O	O
(	O	O
VP	O	O
)	O	O
surfaces	O	O
,	O	O
and	O	O
cultured	O	O
appropriately	O	O
.	O	O

Malodour	O	O
was	O	O
assessed	O	O
by	O	O
trained	O	O
judges	O	O
.	O	O

Mean	O	O
volatile	O	O
sulfur	O	O
compound	O	O
(	O	O
VSC	O	O
)	O	O
producing	O	O
bacterial	O	O
counts	O	O
(	O	O
colony	O	O
forming	O	O
units/brush	O	O
x	O	O
10	O	O
(	O	O
5	O	O
)	O	O
)	O	O
were	O	O
found	O	O
to	O	O
be	O	O
highest	O	O
(	O	O
88.94	O	O
)	O	O
and	O	O
lowest	O	O
(	O	O
0.33	O	O
)	O	O
at	O	O
the	O	O
DPCP	O	O
and	O	O
VP	O	O
sites	O	O
respectively	O	O
.	O	O

Anaerobic	O	O
,	O	O
gram-negative	O	O
and	O	O
VSC	O	O
counts	O	O
at	O	O
DPCP	O	O
surfaces	O	O
increased	O	O
with	O	O
malodour	O	O
intensity	O	O
,	O	O
whereas	O	O
aerobic	O	O
and	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
counts	O	O
decreased	O	O
.	O	O

The	O	O
prevalence	O	O
and	O	O
populations	O	O
of	O	O
the	O	O
VSC	O	O
producing	O	O
Porphyromonas	B-bacteria	B-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
determined	O	O
in	O	O
the	O	O
dental	O	O
plaque	O	O
from	O	O
34	O	O
dogs	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
were	O	O
present	O	O
in	O	O
68	O	O
%	O	O
and	O	O
44	O	O
%	O	O
of	O	O
dogs	O	O
,	O	O
and	O	O
47	O	O
%	O	O
and	O	O
23	O	O
%	O	O
of	O	O
plaque	O	O
samples	O	O
respectively	O	O
.	O	O

P.	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
and	O	O
Prev	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
intermedia	E-bacteria	I-bacteria
counts	O	O
increased	O	O
with	O	O
plaque	O	O
quantity	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
and	O	O
gingivitis	O	O
(	O	O
P	O	O
<	O	O
0.1	O	O
)	O	O
.	O	O

The	O	O
close	O	O
association	O	O
observed	O	O
between	O	O
canine	O	O
periodontal	O	O
disease	O	O
and	O	O
measurements	O	O
of	O	O
oral	O	O
malodour	O	O
is	O	O
supported	O	O
.	O	O

Pathogens	O	O
related	O	O
to	O	O
systemic	O	O
infections	O	O
have	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
periodontal	O	O
microbiota	O	O
.	O	O

The	O	O
relationship	O	O
amongst	O	O
these	O	O
pathogens	O	O
,	O	O
periodontal	O	O
bacteria	O	O
and	O	O
periodontal	O	O
clinical	O	O
status	O	O
is	O	O
poorly	O	O
understood	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
association	O	O
amongst	O	O
red	O	O
complex	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
A.a	B-bacteria	B-bacteria
)	O	O
and	O	O
non-oral	O	O
pathogenic	O	O
bacteria	O	O
in	O	O
subjects	O	O
with	O	O
good	O	O
periodontal	O	O
health	O	O
(	O	O
PH	O	O
)	O	O
,	O	O
gingivitis	O	O
(	O	O
G	O	O
)	O	O
,	O	O
chronic	O	O
(	O	O
CP	O	O
)	O	O
and	O	O
aggressive	O	O
(	O	O
AP	O	O
)	O	O
periodontitis	O	O
.	O	O

Subgingival	O	O
biofilm	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
51	O	O
PH	O	O
,	O	O
42	O	O
G	O	O
,	O	O
219	O	O
CP	O	O
and	O	O
90	O	O
AP	O	O
subjects	O	O
.	O	O

The	O	O
presence	O	O
and	O	O
levels	O	O
of	O	O
A.a	B-bacteria	B-bacteria
,	O	O
red	O	O
complex	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
)	O	O
,	O	O
Acinetobacter	B-bacteria	B-bacteria
baumannii	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
were	O	O
determined	O	O
by	O	O
DNA	O	O
probes	O	O
and	O	O
DNA-DNA	O	O
hybridization	O	O
technique	O	O
.	O	O

CP	O	O
and	O	O
AP	O	O
subjects	O	O
presented	O	O
significantly	O	O
higher	O	O
prevalence	O	O
and	O	O
levels	O	O
of	O	O
A.a	O	O
,	O	O
red	O	O
complex	O	O
and	O	O
A.	B-bacteria	B-bacteria
baumannii	E-bacteria	I-bacteria
than	O	O
G	O	O
and	O	O
PH	O	O
individuals	O	O
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
whereas	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
lower	O	O
frequency	O	O
and	O	O
counts	O	O
in	O	O
AP	O	O
as	O	O
compared	O	O
to	O	O
the	O	O
other	O	O
groups	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
predictor	O	O
variables	O	O
age	O	O
,	O	O
prevalence	O	O
of	O	O
red	O	O
complex	O	O
,	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
A.	B-bacteria	B-bacteria
baumannii	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
were	O	O
strongly	O	O
associated	O	O
with	O	O
the	O	O
frequency	O	O
of	O	O
sites	O	O
with	O	O
PD	O	O
and	O	O
CAL	O	O
>	O	O
/=5	O	O
mm	O	O
.	O	O

Increasing	O	O
age	O	O
(	O	O
OR	O	O
1.08	O	O
)	O	O
,	O	O
high	O	O
frequency	O	O
of	O	O
red	O	O
complex	O	O
(	O	O
OR	O	O
6.10	O	O
)	O	O
,	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
A.a	O	O
with	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
OR	O	O
1.90	O	O
)	O	O
were	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Subjects	O	O
harbouring	O	O
a	O	O
high	O	O
prevalence	O	O
of	O	O
A.a	B-bacteria	B-bacteria
,	O	O
A.	B-bacteria	B-bacteria
baumannii	E-bacteria	I-bacteria
,	O	O
and	O	O
red	O	O
complex	O	O
with	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
were	O	O
more	O	O
likely	O	O
to	O	O
have	O	O
AP	O	O
than	O	O
CP	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Putative	O	O
periodontal	O	O
pathogens	O	O
and	O	O
non-oral	O	O
bacteria	O	O
alone	O	O
or	O	O
in	O	O
association	O	O
were	O	O
strongly	O	O
associated	O	O
with	O	O
periodontitis	O	O
.	O	O

Prunus	O	O
mume	O	O
is	O	O
a	O	O
common	O	O
fruit	O	O
in	O	O
Asia	O	O
,	O	O
which	O	O
has	O	O
been	O	O
used	O	O
in	O	O
traditional	O	O
Chinese	O	O
medicine	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
focused	O	O
on	O	O
the	O	O
antimicrobial	O	O
properties	O	O
of	O	O
Prunus	O	O
mume	O	O
extract	O	O
against	O	O
oral	O	O
pathogens	O	O
related	O	O
to	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
diseases	O	O
.	O	O

A	O	O
total	O	O
of	O	O
15	O	O
oral	O	O
pathogens	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
species	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Initially	O	O
,	O	O
agar	O	O
diffusion	O	O
assay	O	O
was	O	O
performed	O	O
to	O	O
screen	O	O
the	O	O
antimicrobial	O	O
activities	O	O
of	O	O
Prunus	O	O
mume	O	O
extract	O	O
.	O	O

Minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
and	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
were	O	O
then	O	O
determined	O	O
for	O	O
sensitive	O	O
species	O	O
.	O	O

Effect	O	O
of	O	O
Prunus	O	O
mume	O	O
extract	O	O
on	O	O
human	O	O
oral	O	O
keratinocytes	O	O
(	O	O
HOK	O	O
)	O	O
viability	O	O
was	O	O
also	O	O
tested	O	O
.	O	O

In	O	O
the	O	O
agar	O	O
diffusion	O	O
assay	O	O
,	O	O
drug	O	O
suspension	O	O
of	O	O
2	O	O
g/mL	O	O
was	O	O
able	O	O
to	O	O
inhibit	O	O
all	O	O
the	O	O
bacterial	O	O
species	O	O
tested	O	O
,	O	O
but	O	O
not	O	O
the	O	O
fungal	O	O
species	O	O
.	O	O

MIC	O	O
and	O	O
MBC	O	O
range	O	O
of	O	O
Prunus	O	O
mume	O	O
extract	O	O
against	O	O
the	O	O
oral	O	O
bacteria	O	O
was	O	O
0.15625-0.0003	O	O
g/mL	O	O
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
being	O	O
the	O	O
most	O	O
susceptible	O	O
species	O	O
.	O	O

Prune	O	O
extract	O	O
did	O	O
not	O	O
cause	O	O
any	O	O
detrimental	O	O
effect	O	O
on	O	O
HOK	O	O
.	O	O

Prunus	O	O
mume	O	O
extract	O	O
may	O	O
be	O	O
a	O	O
potential	O	O
candidate	O	O
for	O	O
developing	O	O
an	O	O
oral	O	O
antimicrobial	O	O
agent	O	O
to	O	O
control	O	O
or	O	O
prevent	O	O
dental	O	O
diseases	O	O
associated	O	O
with	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

This	O	O
study	O	O
assessed	O	O
the	O	O
prevalence	O	O
of	O	O
colonization	O	O
by	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
in	O	O
hospital	O	O
housekeepers	O	O
,	O	O
and	O	O
their	O	O
knowledge	O	O
and	O	O
beliefs	O	O
regarding	O	O
this	O	O
problem	O	O
.	O	O

Three	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
and	O	O
a	O	O
questionnaire	O	O
regarding	O	O
knowledge	O	O
and	O	O
beliefs	O	O
was	O	O
applied	O	O
.	O	O

Of	O	O
the	O	O
92	O	O
workers	O	O
,	O	O
63	O	O
(	O	O
68.5	O	O
%	O	O
)	O	O
participated	O	O
in	O	O
the	O	O
study	O	O
;	O	O
20	O	O
were	O	O
not	O	O
and	O	O
43	O	O
were	O	O
colonized	O	O
;	O	O
13	O	O
by	O	O
methicillin	B-bacteria	B-bacteria
resistant	I-bacteria	I-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
30	O	O
by	O	O
methicillin	B-bacteria	B-bacteria
sensitive	I-bacteria	I-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

Persistent	O	O
carrier	O	O
status	O	O
of	O	O
methicillin	B-bacteria	B-bacteria
resistant	I-bacteria	I-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
15.4	O	O
%	O	O
of	O	O
cases	O	O
.	O	O

Low	O	O
knowledge	O	O
and	O	O
perception	O	O
of	O	O
occupational	O	O
risk	O	O
were	O	O
observed	O	O
.	O	O

The	O	O
mouth	O	O
was	O	O
identified	O	O
as	O	O
an	O	O
important	O	O
reservoir	O	O
of	O	O
methicillin	B-bacteria	B-bacteria
resistant	I-bacteria	I-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

Analyzing	O	O
knowledge	O	O
and	O	O
beliefs	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
state	O	O
of	O	O
carrier	O	O
,	O	O
is	O	O
an	O	O
important	O	O
strategy	O	O
to	O	O
be	O	O
added	O	O
to	O	O
educational	O	O
actions	O	O
for	O	O
the	O	O
prevention	O	O
of	O	O
workers	O	O
'	O	O
colonization	O	O
.	O	O

In	O	O
this	O	O
work	O	O
,	O	O
we	O	O
review	O	O
the	O	O
state	O	O
of	O	O
knowledge	O	O
of	O	O
Archaea	O	O
associated	O	O
with	O	O
the	O	O
human	O	O
microbiome	O	O
.	O	O

These	O	O
prokaryotes	O	O
,	O	O
initially	O	O
discovered	O	O
in	O	O
extreme	O	O
environments	O	O
,	O	O
were	O	O
named	O	O
Archaea	O	O
because	O	O
these	O	O
environments	O	O
were	O	O
thought	O	O
to	O	O
be	O	O
the	O	O
most	O	O
primitive	O	O
on	O	O
Earth	O	O
.	O	O

Further	O	O
research	O	O
revealed	O	O
that	O	O
this	O	O
terminology	O	O
is	O	O
misleading	O	O
because	O	O
these	O	O
organisms	O	O
were	O	O
later	O	O
found	O	O
in	O	O
various	O	O
non-extreme	O	O
environments	O	O
,	O	O
including	O	O
the	O	O
human	O	O
host	O	O
.	O	O

Further	O	O
examination	O	O
of	O	O
the	O	O
human	O	O
microbiome	O	O
has	O	O
enabled	O	O
the	O	O
isolation	O	O
of	O	O
three	O	O
archaeal	O	O
species	O	O
,	O	O
Methanobrevibacter	B-bacteria	B-bacteria
smithii	E-bacteria	I-bacteria
,	O	O
Methanosphaera	B-bacteria	B-bacteria
stadtmanae	E-bacteria	I-bacteria
and	O	O
Methanobrevibacter	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
which	O	O
are	O	O
associated	O	O
with	O	O
oral	O	O
,	O	O
intestinal	O	O
and	O	O
vaginal	O	O
mucosae	O	O
in	O	O
humans	O	O
.	O	O

Moreover	O	O
,	O	O
molecular	O	O
studies	O	O
including	O	O
metagenomic	O	O
analyses	O	O
detected	O	O
DNA	O	O
sequences	O	O
indicative	O	O
of	O	O
the	O	O
presence	O	O
of	O	O
additional	O	O
methanogenic	O	O
and	O	O
non-methanogenic	O	O
Archaea	O	O
in	O	O
the	O	O
human	O	O
intestinal	O	O
tract	O	O
.	O	O

All	O	O
three	O	O
culturable	O	O
Archaea	O	O
are	O	O
strict	O	O
anaerobes	O	O
,	O	O
although	O	O
their	O	O
potential	O	O
role	O	O
in	O	O
human	O	O
diseases	O	O
remains	O	O
to	O	O
be	O	O
established	O	O
.	O	O

Future	O	O
research	O	O
aims	O	O
to	O	O
detect	O	O
and	O	O
culture	O	O
additional	O	O
human	O	O
mucosa-associated	O	O
Archaea	O	O
and	O	O
to	O	O
look	O	O
for	O	O
their	O	O
presence	O	O
in	O	O
additional	O	O
human	O	O
tissues	O	O
,	O	O
to	O	O
establish	O	O
their	O	O
role	O	O
in	O	O
human	O	O
infections	O	O
involving	O	O
complex	O	O
flora	O	O
.	O	O

The	O	O
aim	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
presence	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
Pseudomonadaceae	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
HIV-positive	O	O
patients	O	O
.	O	O

Forty-five	O	O
individuals	O	O
diagnosed	O	O
as	O	O
HIV-positive	O	O
by	O	O
ELISA	O	O
and	O	O
Western-blot	O	O
,	O	O
and	O	O
under	O	O
anti-retroviral	O	O
therapy	O	O
for	O	O
at	O	O
least	O	O
1	O	O
year	O	O
,	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

The	O	O
control	O	O
group	O	O
constituted	O	O
45	O	O
systemically	O	O
healthy	O	O
individuals	O	O
matched	O	O
to	O	O
the	O	O
HIV	O	O
patients	O	O
to	O	O
gender	O	O
,	O	O
age	O	O
and	O	O
oral	O	O
conditions	O	O
.	O	O

Oral	O	O
rinses	O	O
were	O	O
collected	O	O
and	O	O
isolates	O	O
were	O	O
identified	O	O
by	O	O
API	O	O
system	O	O
.	O	O

Counts	O	O
of	O	O
microorganisms	O	O
from	O	O
HIV	O	O
and	O	O
control	O	O
groups	O	O
were	O	O
compared	O	O
statistically	O	O
by	O	O
a	O	O
Mann-Whitney	O	O
test	O	O
(	O	O
alpha=5	O	O
%	O	O
)	O	O
.	O	O

The	O	O
percentages	O	O
of	O	O
individuals	O	O
positive	O	O
for	O	O
staphylococci	B-bacteria	B-bacteria
were	O	O
similar	O	O
between	O	O
the	O	O
groups	O	O
(	O	O
p=0.764	O	O
)	O	O
,	O	O
whereas	O	O
for	O	O
Gram-negative	O	O
rods	O	O
,	O	O
a	O	O
higher	O	O
percentage	O	O
was	O	O
observed	O	O
amongst	O	O
HIV-positive	O	O
(	O	O
p=0.001	O	O
)	O	O
.	O	O

There	O	O
was	O	O
no	O	O
difference	O	O
in	O	O
Staphylococcus	B-bacteria	B-bacteria
counts	O	O
between	O	O
HIV	O	O
and	O	O
control	O	O
groups	O	O
(	O	O
p=0.1008	O	O
)	O	O
.	O	O

Counts	O	O
were	O	O
lower	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
patients	O	O
with	O	O
low	O	O
viral	O	O
load	O	O
(	O	O
p=0.021	O	O
)	O	O
,	O	O
and	O	O
no	O	O
difference	O	O
was	O	O
observed	O	O
in	O	O
relation	O	O
to	O	O
CD4	O	O
counts	O	O
(	O	O
p=0.929	O	O
)	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequently	O	O
isolated	O	O
species	O	O
in	O	O
HIV	O	O
group	O	O
,	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
was	O	O
the	O	O
prevalent	O	O
species	O	O
in	O	O
the	O	O
control	O	O
group	O	O
.	O	O

Significantly	O	O
higher	O	O
numbers	O	O
of	O	O
enteric	O	O
bacteria	O	O
and	O	O
pseudomonas	B-bacteria	B-bacteria
were	O	O
detected	O	O
in	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
the	O	O
HIV	O	O
group	O	O
than	O	O
in	O	O
the	O	O
control	O	O
(	O	O
p=0.0001	O	O
)	O	O
.	O	O

Enterobacter	B-bacteria	B-bacteria
cloacae	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequently	O	O
isolated	O	O
species	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

Counts	O	O
of	O	O
enteric	O	O
bacteria	O	O
and	O	O
pseudomonas	B-bacteria	B-bacteria
were	O	O
significantly	O	O
lower	O	O
in	O	O
patients	O	O
with	O	O
low	O	O
CD4	O	O
counts	O	O
(	O	O
p=0.011	O	O
)	O	O
;	O	O
however	O	O
,	O	O
there	O	O
was	O	O
no	O	O
difference	O	O
relating	O	O
to	O	O
viral	O	O
load	O	O
.	O	O

It	O	O
may	O	O
be	O	O
concluded	O	O
that	O	O
HIV	O	O
group	O	O
showed	O	O
greater	O	O
species	O	O
diversity	O	O
and	O	O
a	O	O
higher	O	O
prevalence	O	O
of	O	O
Enterobacteriaceae/Pseudomonadaceae	B-bacteria	B-bacteria
.	O	O

The	O	O
AIDS	O	O
pandemic	O	O
continues	O	O
.	O	O

Little	O	O
is	O	O
understood	O	O
about	O	O
how	O	O
HIV	O	O
gains	O	O
access	O	O
to	O	O
permissive	O	O
cells	O	O
across	O	O
mucosal	O	O
surfaces	O	O
,	O	O
yet	O	O
such	O	O
knowledge	O	O
is	O	O
crucial	O	O
to	O	O
the	O	O
development	O	O
of	O	O
successful	O	O
topical	O	O
anti-HIV-1	O	O
agents	O	O
and	O	O
mucosal	O	O
vaccines	O	O
.	O	O

HIV-1	O	O
rapidly	O	O
internalizes	O	O
and	O	O
integrates	O	O
into	O	O
the	O	O
mucosal	O	O
keratinocyte	O	O
genome	O	O
,	O	O
and	O	O
integrated	O	O
copies	O	O
of	O	O
HIV-1	O	O
persist	O	O
upon	O	O
cell	O	O
passage	O	O
.	O	O

The	O	O
virus	O	O
does	O	O
not	O	O
appear	O	O
to	O	O
replicate	O	O
,	O	O
and	O	O
the	O	O
infection	O	O
may	O	O
become	O	O
latent	O	O
.	O	O

Interactions	O	O
between	O	O
HIV-1	O	O
and	O	O
oral	O	O
keratinocytes	O	O
have	O	O
been	O	O
modeled	O	O
in	O	O
the	O	O
context	O	O
of	O	O
key	O	O
environmental	O	O
factors	O	O
,	O	O
including	O	O
putative	O	O
copathogens	O	O
and	O	O
saliva	O	O
.	O	O

In	O	O
keratinocytes	O	O
,	O	O
HIV-1	O	O
internalizes	O	O
within	O	O
minutes	O	O
;	O	O
in	O	O
saliva	O	O
,	O	O
an	O	O
infectious	O	O
fraction	O	O
escapes	O	O
inactivation	O	O
and	O	O
is	O	O
harbored	O	O
and	O	O
transferable	O	O
to	O	O
permissive	O	O
target	O	O
cells	O	O
for	O	O
up	O	O
to	O	O
48	O	O
hours	O	O
.	O	O

When	O	O
incubated	O	O
with	O	O
the	O	O
common	O	O
oral	O	O
pathogen	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
CCR5-	O	O
oral	O	O
keratinocytes	O	O
signal	O	O
through	O	O
protease-activated	O	O
receptors	O	O
and	O	O
Toll-like	O	O
receptors	O	O
to	O	O
induce	O	O
expression	O	O
of	O	O
CCR5	O	O
,	O	O
which	O	O
increases	O	O
selective	O	O
uptake	O	O
of	O	O
infectious	O	O
R5-tropic	O	O
HIV-1	O	O
into	O	O
oral	O	O
keratinocytes	O	O
and	O	O
transfer	O	O
to	O	O
permissive	O	O
cells	O	O
.	O	O

Hence	O	O
,	O	O
oral	O	O
keratinocytes-like	O	O
squamous	O	O
keratinocytes	O	O
of	O	O
other	O	O
tissues-may	O	O
be	O	O
targets	O	O
for	O	O
low-level	O	O
HIV-1	O	O
internalization	O	O
and	O	O
subsequent	O	O
dissemination	O	O
by	O	O
transfer	O	O
to	O	O
permissive	O	O
cells	O	O
.	O	O

Oral	O	O
biofilms	O	O
such	O	O
as	O	O
dental	O	O
plaque	O	O
cause	O	O
dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
,	O	O
as	O	O
well	O	O
as	O	O
aspiration	O	O
pneumonia	O	O
and	O	O
infectious	O	O
endocarditis	O	O
by	O	O
translocation	O	O
.	O	O

Hence	O	O
,	O	O
the	O	O
suppression	O	O
of	O	O
oral	O	O
biofilm	O	O
formation	O	O
is	O	O
an	O	O
issue	O	O
of	O	O
considerable	O	O
importance	O	O
.	O	O

Mechanical	O	O
removal	O	O
,	O	O
disinfectants	O	O
,	O	O
inhibition	O	O
of	O	O
polysaccharide	O	O
formation	O	O
,	O	O
and	O	O
artificial	O	O
sugar	O	O
have	O	O
been	O	O
used	O	O
for	O	O
the	O	O
reduction	O	O
of	O	O
oral	O	O
biofilm	O	O
.	O	O

From	O	O
the	O	O
viewpoint	O	O
of	O	O
the	O	O
inhibition	O	O
of	O	O
bacterial	O	O
adherence	O	O
,	O	O
we	O	O
investigated	O	O
whether	O	O
aqueous	O	O
biocompatible	O	O
2-methacryloyloxyethyl	O	O
phosphorylcholine	O	O
(	O	O
MPC	O	O
)	O	O
-polymer	O	O
can	O	O
reduce	O	O
streptococcal	O	O
colonization	O	O
and	O	O
biofilm	O	O
formation	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
MPC-polymer	O	O
on	O	O
streptococcal	O	O
adherence	O	O
to	O	O
saliva-coated	O	O
hydroxyapatite	O	O
and	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
and	O	O
the	O	O
adherence	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
streptococcal	B-bacteria	B-bacteria
biofilm	O	O
.	O	O

MPC-polymer	O	O
application	O	O
markedly	O	O
inhibited	O	O
both	O	O
the	O	O
adherence	O	O
and	O	O
biofilm	O	O
formation	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
on	O	O
saliva-coated	O	O
hydroxyapatite	O	O
and	O	O
streptococcal	O	O
adherence	O	O
to	O	O
oral	O	O
epithelial	O	O
cells	O	O
,	O	O
and	O	O
reduced	O	O
the	O	O
adherence	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
streptococcal	O	O
biofilms	O	O
.	O	O

A	O	O
small-scale	O	O
clinical	O	O
trial	O	O
revealed	O	O
that	O	O
mouthrinsing	O	O
with	O	O
MPC-polymer	O	O
inhibited	O	O
the	O	O
increase	O	O
of	O	O
oral	O	O
bacterial	O	O
numbers	O	O
,	O	O
especially	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
MPC-polymer	O	O
is	O	O
a	O	O
potent	O	O
inhibitor	O	O
of	O	O
bacterial	O	O
adherence	O	O
and	O	O
biofilm	O	O
development	O	O
,	O	O
and	O	O
may	O	O
be	O	O
useful	O	O
to	O	O
prevent	O	O
dental-plaque-related	O	O
diseases	O	O
.	O	O

Dental	O	O
caries	O	O
(	O	O
tooth	O	O
decay	O	O
)	O	O
is	O	O
caused	O	O
by	O	O
a	O	O
specific	O	O
group	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
,	O	O
like	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
which	O	O
convert	O	O
dietary	O	O
sugars	O	O
into	O	O
acids	O	O
that	O	O
dissolve	O	O
the	O	O
mineral	O	O
in	O	O
tooth	O	O
structure	O	O
.	O	O

Killing	O	O
cariogenic	O	O
bacteria	O	O
is	O	O
an	O	O
effective	O	O
way	O	O
to	O	O
control	O	O
or	O	O
prevent	O	O
tooth	O	O
decay	O	O
.	O	O

In	O	O
a	O	O
previous	O	O
study	O	O
,	O	O
we	O	O
discovered	O	O
a	O	O
novel	O	O
compound	O	O
(	O	O
Glycyrrhizol	O	O
A	O	O
)	O	O
,	O	O
from	O	O
the	O	O
extraction	O	O
of	O	O
licorice	O	O
roots	O	O
,	O	O
with	O	O
strong	O	O
antimicrobial	O	O
activity	O	O
against	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

In	O	O
the	O	O
current	O	O
study	O	O
,	O	O
we	O	O
developed	O	O
a	O	O
method	O	O
to	O	O
produce	O	O
these	O	O
specific	O	O
herbal	O	O
extracts	O	O
in	O	O
large	O	O
quantities	O	O
,	O	O
and	O	O
then	O	O
used	O	O
these	O	O
extracts	O	O
to	O	O
develop	O	O
a	O	O
sugar-free	O	O
lollipop	O	O
that	O	O
effectively	O	O
kills	O	O
cariogenic	O	O
bacteria	O	O
like	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Further	O	O
studies	O	O
showed	O	O
that	O	O
these	O	O
sugar-free	O	O
lollipops	O	O
are	O	O
safe	O	O
and	O	O
their	O	O
antimicrobial	O	O
activity	O	O
is	O	O
stable	O	O
.	O	O

Two	O	O
pilot	O	O
human	O	O
studies	O	O
indicate	O	O
that	O	O
a	O	O
brief	O	O
application	O	O
of	O	O
these	O	O
lollipops	O	O
(	O	O
twice	O	O
a	O	O
day	O	O
for	O	O
ten	O	O
days	O	O
)	O	O
led	O	O
to	O	O
a	O	O
marked	O	O
reduction	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
oral	O	O
cavity	O	O
among	O	O
most	O	O
human	O	O
subjects	O	O
tested	O	O
.	O	O

This	O	O
herbal	O	O
lollipop	O	O
could	O	O
be	O	O
a	O	O
novel	O	O
tool	O	O
to	O	O
promote	O	O
oral	O	O
health	O	O
through	O	O
functional	O	O
foods	O	O
.	O	O

The	O	O
cytolethal	O	O
distending	O	O
toxin	O	O
(	O	O
Cdt	O	O
)	O	O
,	O	O
expressed	O	O
by	O	O
the	O	O
periodontal	O	O
pathogen	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
inhibits	O	O
the	O	O
proliferation	O	O
of	O	O
cultured	O	O
epithelial	O	O
cells	O	O
by	O	O
arresting	O	O
the	O	O
cell	O	O
cycle	O	O
.	O	O

The	O	O
gingival	O	O
epithelium	O	O
is	O	O
an	O	O
early	O	O
line	O	O
of	O	O
defense	O	O
against	O	O
microbial	O	O
assault	O	O
.	O	O

When	O	O
damaged	O	O
,	O	O
bacteria	O	O
collectively	O	O
gain	O	O
entry	O	O
into	O	O
underlying	O	O
connective	O	O
biofilm	O	O
where	O	O
microbial	O	O
products	O	O
can	O	O
affect	O	O
infiltrating	O	O
inflammatory	O	O
cells	O	O
,	O	O
leading	O	O
to	O	O
the	O	O
destruction	O	O
of	O	O
the	O	O
attachment	O	O
apparatus	O	O
.	O	O

Histological	O	O
evaluation	O	O
of	O	O
rat	O	O
and	O	O
healthy	O	O
human	O	O
gingival	O	O
biofilm	O	O
exposed	O	O
ex	O	O
vivo	O	O
to	O	O
the	O	O
Cdt	O	O
for	O	O
36	O	O
and	O	O
18	O	O
hours	O	O
,	O	O
respectively	O	O
,	O	O
revealed	O	O
extensive	O	O
detachment	O	O
of	O	O
the	O	O
keratinized	O	O
outer	O	O
layer	O	O
and	O	O
distention	O	O
of	O	O
spinous	O	O
and	O	O
basal	O	O
cells	O	O
in	O	O
the	O	O
oral	O	O
epithelium	O	O
.	O	O

Treated	O	O
human	O	O
biofilm	O	O
also	O	O
exhibited	O	O
disruption	O	O
of	O	O
rete	O	O
pegs	O	O
and	O	O
dissolution	O	O
of	O	O
cell	O	O
junctions	O	O
.	O	O

Cells	O	O
in	O	O
the	O	O
connective	O	O
biofilm	O	O
appeared	O	O
unaffected	O	O
.	O	O

Primary	O	O
gingival	O	O
epithelial	O	O
cells	O	O
,	O	O
but	O	O
not	O	O
gingival	O	O
fibroblasts	O	O
,	O	O
isolated	O	O
from	O	O
the	O	O
same	O	O
healthy	O	O
human	O	O
biofilm	O	O
were	O	O
cell-cycle-arrested	O	O
when	O	O
treated	O	O
with	O	O
the	O	O
toxin	O	O
.	O	O

These	O	O
findings	O	O
provide	O	O
new	O	O
evidence	O	O
that	O	O
the	O	O
Cdt	O	O
severely	O	O
damages	O	O
the	O	O
oral	O	O
epithelium	O	O
,	O	O
ex	O	O
vivo	O	O
,	O	O
by	O	O
specifically	O	O
targeting	O	O
epithelial	O	O
cells	O	O
,	O	O
in	O	O
situ	O	O
.	O	O

The	O	O
Cdt	O	O
shows	O	O
preferential	O	O
targeting	O	O
of	O	O
the	O	O
epithelium	O	O
as	O	O
opposed	O	O
to	O	O
connective	O	O
biofilm	O	O
in	O	O
animal	O	O
and	O	O
human	O	O
gingival	O	O
explant	O	O
models	O	O
.	O	O

cytolethal	O	O
distending	O	O
toxin	O	O
(	O	O
Cdt	O	O
)	O	O
,	O	O
connective	O	O
biofilm	O	O
(	O	O
CT	O	O
)	O	O
,	O	O
4',6-diamidino-2-phenylindole	O	O
(	O	O
DAPI	O	O
)	O	O
,	O	O
human	O	O
gingival	O	O
epithelial	O	O
cells	O	O
(	O	O
HGEC	O	O
)	O	O
,	O	O
human	O	O
gingival	O	O
explants	O	O
(	O	O
HGX	O	O
)	O	O
,	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
(	O	O
HGF	O	O
)	O	O
,	O	O
junctional	O	O
epithelium	O	O
(	O	O
JE	O	O
)	O	O
,	O	O
oral	O	O
epithelium	O	O
(	O	O
OE	O	O
)	O	O
,	O	O
rete	O	O
pegs	O	O
(	O	O
RP	O	O
)	O	O
,	O	O
sulcular	O	O
epithelium	O	O
(	O	O
SE	O	O
)	O	O
.	O	O

Cranberry	O	O
juice	O	O
cocktail	O	O
(	O	O
CJC	O	O
)	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
inhibit	O	O
the	O	O
formation	O	O
of	O	O
biofilm	O	O
by	O	O
uropathogenic	B-bacteria	B-bacteria
Escherichia	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
.	O	O

In	O	O
order	O	O
to	O	O
investigate	O	O
whether	O	O
the	O	O
anti-adhesive	O	O
components	O	O
could	O	O
reach	O	O
the	O	O
urinary	O	O
tract	O	O
after	O	O
oral	O	O
consumption	O	O
of	O	O
CJC	O	O
,	O	O
a	O	O
volunteer	O	O
was	O	O
given	O	O
16	O	O
oz	O	O
of	O	O
either	O	O
water	O	O
or	O	O
CJC	O	O
.	O	O

Urine	O	O
samples	O	O
were	O	O
collected	O	O
at	O	O
0	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
6	O	O
,	O	O
and	O	O
8	O	O
hours	O	O
after	O	O
consumption	O	O
of	O	O
a	O	O
single	O	O
dose	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
compounds	O	O
in	O	O
the	O	O
urine	O	O
to	O	O
influence	O	O
bacterial	O	O
adhesion	O	O
was	O	O
tested	O	O
for	O	O
six	O	O
clinical	O	O
uropathogenic	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
including	O	O
four	O	O
P-fimbriated	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
(	O	O
B37	B-bacteria	B-bacteria
,	O	O
CFT073	B-bacteria	B-bacteria
,	O	O
BF1023	B-bacteria	B-bacteria
,	O	O
and	O	O
J96	B-bacteria	B-bacteria
)	O	O
and	O	O
two	O	O
strains	O	O
not	O	O
expressing	O	O
P-fimbriae	O	O
but	O	O
exhibiting	O	O
mannose-resistant	O	O
hemagglutination	O	O
(	O	O
B73	O	O
and	O	O
B78	O	O
)	O	O
.	O	O

A	O	O
non-fimbriated	O	O
strain	O	O
,	O	O
HB101	B-bacteria	B-bacteria
,	O	O
was	O	O
used	O	O
as	O	O
a	O	O
control	O	O
.	O	O

Atomic	O	O
force	O	O
microscopy	O	O
(	O	O
AFM	O	O
)	O	O
was	O	O
used	O	O
to	O	O
measure	O	O
the	O	O
adhesion	O	O
force	O	O
between	O	O
a	O	O
silicon	O	O
nitride	O	O
probe	O	O
and	O	O
bacteria	O	O
treated	O	O
with	O	O
urine	O	O
samples	O	O
.	O	O

Within	O	O
2	O	O
hours	O	O
after	O	O
CJC	O	O
consumption	O	O
,	O	O
bacteria	O	O
of	O	O
the	O	O
clinical	O	O
strains	O	O
treated	O	O
with	O	O
the	O	O
corresponding	O	O
urine	O	O
sample	O	O
demonstrated	O	O
lower	O	O
adhesion	O	O
forces	O	O
than	O	O
those	O	O
treated	O	O
with	O	O
urine	O	O
collected	O	O
before	O	O
CJC	O	O
consumption	O	O
.	O	O

The	O	O
adhesion	O	O
forces	O	O
continued	O	O
decreasing	O	O
with	O	O
time	O	O
after	O	O
CJC	O	O
consumption	O	O
over	O	O
the	O	O
8-hour	O	O
measurement	O	O
period	O	O
.	O	O

The	O	O
adhesion	O	O
forces	O	O
of	O	O
bacteria	O	O
after	O	O
exposure	O	O
to	O	O
urine	O	O
collected	O	O
following	O	O
water	O	O
consumption	O	O
did	O	O
not	O	O
change	O	O
.	O	O

HB101	O	O
showed	O	O
low	O	O
adhesion	O	O
forces	O	O
following	O	O
both	O	O
water	O	O
and	O	O
CJC	O	O
consumption	O	O
,	O	O
and	O	O
these	O	O
did	O	O
not	O	O
change	O	O
over	O	O
time	O	O
.	O	O

The	O	O
AFM	O	O
adhesion	O	O
force	O	O
measurements	O	O
were	O	O
consistent	O	O
with	O	O
the	O	O
results	O	O
of	O	O
a	O	O
hemagglutination	O	O
assay	O	O
,	O	O
confirming	O	O
that	O	O
oral	O	O
consumption	O	O
of	O	O
CJC	O	O
could	O	O
act	O	O
against	O	O
adhesion	O	O
of	O	O
uropathogenic	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
.	O	O

To	O	O
investigate	O	O
the	O	O
root	O	O
canal	O	O
microbiota	O	O
of	O	O
primary	O	O
teeth	O	O
with	O	O
apical	O	O
periodontitis	O	O
and	O	O
the	O	O
in	O	O
vivo	O	O
antimicrobial	O	O
effects	O	O
of	O	O
a	O	O
calcium	O	O
hydroxide/chlorhexidine	O	O
paste	O	O
used	O	O
as	O	O
root	O	O
canal	O	O
dressing	O	O
.	O	O

Baseline	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
30	O	O
root	O	O
canals	O	O
of	O	O
primary	O	O
teeth	O	O
with	O	O
apical	O	O
periodontitis	O	O
.	O	O

Then	O	O
,	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
filled	O	O
with	O	O
a	O	O
calcium	O	O
hydroxide	O	O
paste	O	O
containing	O	O
1	O	O
%	O	O
chlorhexidine	O	O
for	O	O
14	O	O
days	O	O
and	O	O
the	O	O
second	O	O
bacteriologic	O	O
samples	O	O
were	O	O
taken	O	O
prior	O	O
to	O	O
root	O	O
canal	O	O
filling	O	O
.	O	O

Samples	O	O
were	O	O
submitted	O	O
to	O	O
microbiologic	O	O
culture	O	O
procedure	O	O
to	O	O
detect	O	O
root	O	O
canal	O	O
bacteria	O	O
and	O	O
processed	O	O
for	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Baseline	O	O
microbial	O	O
culture	O	O
revealed	O	O
high	O	O
prevalence	O	O
and	O	O
cfu	O	O
number	O	O
of	O	O
anaerobic	O	O
,	O	O
black-pigmented	O	O
bacteroides	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
aerobic	O	O
microorganisms	O	O
.	O	O

Following	O	O
root	O	O
canal	O	O
dressing	O	O
,	O	O
the	O	O
overall	O	O
number	O	O
of	O	O
cfu	O	O
was	O	O
dramatically	O	O
diminished	O	O
compared	O	O
to	O	O
initial	O	O
contamination	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
although	O	O
prevalence	O	O
did	O	O
not	O	O
change	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Of	O	O
35	O	O
probes	O	O
used	O	O
for	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
,	O	O
31	O	O
(	O	O
88.57	O	O
%	O	O
)	O	O
were	O	O
present	O	O
at	O	O
baseline	O	O
,	O	O
and	O	O
following	O	O
root	O	O
canal	O	O
dressing	O	O
,	O	O
the	O	O
number	O	O
of	O	O
positive	O	O
probes	O	O
reduced	O	O
to	O	O
13	O	O
(	O	O
37.14	O	O
%	O	O
)	O	O
.	O	O

Similarly	O	O
,	O	O
the	O	O
number	O	O
of	O	O
bacterial	O	O
cells	O	O
diminished	O	O
folowing	O	O
application	O	O
of	O	O
calcium	O	O
hydroxide/chlorhexidine	O	O
root	O	O
canal	O	O
dressing	O	O
(	O	O
P	O	O
=	O	O
0.006	O	O
)	O	O
.	O	O

Apical	O	O
periodontitis	O	O
is	O	O
caused	O	O
by	O	O
a	O	O
polymicrobial	O	O
infection	O	O
,	O	O
and	O	O
a	O	O
calcium	O	O
hydroxide/chlorhexidine	O	O
paste	O	O
is	O	O
effective	O	O
in	O	O
reducing	O	O
the	O	O
number	O	O
of	O	O
bacteria	O	O
inside	O	O
root	O	O
canals	O	O
when	O	O
applied	O	O
as	O	O
a	O	O
root	O	O
canal	O	O
dressing	O	O
.	O	O

Information	O	O
on	O	O
co-adherence	O	O
of	O	O
different	O	O
oral	O	O
bacterial	O	O
species	O	O
is	O	O
important	O	O
for	O	O
understanding	O	O
interspecies	O	O
interactions	O	O
within	O	O
oral	O	O
microbial	O	O
community	O	O
.	O	O

Current	O	O
knowledge	O	O
on	O	O
this	O	O
topic	O	O
is	O	O
heavily	O	O
based	O	O
on	O	O
pariwise	O	O
coaggregation	O	O
of	O	O
known	O	O
,	O	O
cultivable	O	O
species	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
employed	O	O
a	O	O
membrane	O	O
binding	O	O
assay	O	O
coupled	O	O
with	O	O
polymerase	O	O
chain	O	O
reaction-denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
PCR-DGGE	O	O
)	O	O
to	O	O
systematically	O	O
analyze	O	O
the	O	O
co-adherence	O	O
profiles	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
,	O	O
and	O	O
achieved	O	O
a	O	O
more	O	O
profound	O	O
knowledge	O	O
beyond	O	O
pairwise	O	O
coaggregation	O	O
.	O	O

Two	O	O
oral	O	O
bacterial	O	O
species	O	O
were	O	O
selected	O	O
to	O	O
serve	O	O
as	O	O
``	O	O
bait	O	O
''	O	O
:	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
)	O	O
whose	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
a	O	O
multitude	O	O
of	O	O
oral	O	O
bacterial	O	O
species	O	O
has	O	O
been	O	O
extensively	O	O
studied	O	O
for	O	O
pairwise	O	O
interactions	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
)	O	O
whose	O	O
interacting	O	O
partners	O	O
are	O	O
largely	O	O
unknown	O	O
.	O	O

To	O	O
enable	O	O
screening	O	O
of	O	O
interacting	O	O
partner	O	O
species	O	O
within	O	O
bacterial	O	O
mixtures	O	O
,	O	O
cells	O	O
of	O	O
the	O	O
``	O	O
bait	O	O
''	O	O
oral	O	O
bacterium	O	O
were	O	O
immobilized	O	O
on	O	O
nitrocellulose	O	O
membranes	O	O
which	O	O
were	O	O
washed	O	O
and	O	O
blocked	O	O
to	O	O
prevent	O	O
unspecific	O	O
binding	O	O
.	O	O

The	O	O
``	O	O
prey	O	O
''	O	O
bacterial	O	O
mixtures	O	O
(	O	O
including	O	O
known	O	O
species	O	O
or	O	O
natural	O	O
saliva	O	O
samples	O	O
)	O	O
were	O	O
added	O	O
,	O	O
unbound	O	O
cells	O	O
were	O	O
washed	O	O
off	O	O
after	O	O
the	O	O
incubation	O	O
period	O	O
and	O	O
the	O	O
remaining	O	O
cells	O	O
were	O	O
eluted	O	O
using	O	O
0.2	O	O
mol	O	O
x	O	O
L	O	O
(	O	O
-1	O	O
)	O	O
glycine	O	O
.	O	O

Genomic	O	O
DNA	O	O
was	O	O
extracted	O	O
,	O	O
subjected	O	O
to	O	O
16S	O	O
rRNA	O	O
PCR	O	O
amplification	O	O
and	O	O
separation	O	O
of	O	O
the	O	O
resulting	O	O
PCR	O	O
products	O	O
by	O	O
DGGE	O	O
.	O	O

Selected	O	O
bands	O	O
were	O	O
recovered	O	O
from	O	O
the	O	O
gel	O	O
,	O	O
sequenced	O	O
and	O	O
identified	O	O
via	O	O
Nucleotide	O	O
searches	O	O
against	O	O
different	O	O
databases	O	O
.	O	O

While	O	O
few	O	O
bacterial	O	O
species	O	O
bound	O	O
to	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
consistent	O	O
with	O	O
previous	O	O
findings	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
adhered	O	O
to	O	O
a	O	O
variety	O	O
of	O	O
bacterial	O	O
species	O	O
including	O	O
uncultivable	O	O
and	O	O
uncharacterized	O	O
ones	O	O
.	O	O

This	O	O
new	O	O
approach	O	O
can	O	O
more	O	O
effectively	O	O
analyze	O	O
the	O	O
co-adherence	O	O
profiles	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
and	O	O
could	O	O
facilitate	O	O
the	O	O
systematic	O	O
study	O	O
of	O	O
interbacterial	O	O
binding	O	O
of	O	O
oral	O	O
microbial	O	O
species	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
confirm	O	O
the	O	O
association	O	O
among	O	O
oral	O	O
health	O	O
behaviors	O	O
,	O	O
periodontitis	O	O
,	O	O
and	O	O
preeclampsia	O	O
in	O	O
Korean	O	O
women	O	O
.	O	O

This	O	O
study	O	O
is	O	O
designed	O	O
as	O	O
a	O	O
case-control	O	O
study	O	O
.	O	O

Sixteen	O	O
women	O	O
with	O	O
preeclampsia	O	O
and	O	O
48	O	O
without	O	O
preeclampsia	O	O
post-delivery	O	O
were	O	O
included	O	O
in	O	O
this	O	O
study	O	O
from	O	O
November	O	O
2007	O	O
to	O	O
January	O	O
2010	O	O
.	O	O

Information	O	O
was	O	O
collected	O	O
on	O	O
demographics	O	O
,	O	O
health	O	O
behaviors	O	O
,	O	O
and	O	O
obstetric	O	O
and	O	O
systemic	O	O
diseases	O	O
that	O	O
may	O	O
influence	O	O
the	O	O
periodontal	O	O
condition	O	O
and	O	O
preeclampsia	O	O
.	O	O

Full-mouth	O	O
periodontal	O	O
probing	O	O
was	O	O
conducted	O	O
by	O	O
one	O	O
trained	O	O
examiner	O	O
(	O	O
KHB	O	O
)	O	O
.	O	O

Localized	O	O
periodontitis	O	O
was	O	O
defined	O	O
as	O	O
periodontal	O	O
clinical	O	O
attachment	O	O
loss	O	O
(	O	O
AL	O	O
)	O	O
>	O	O
/=	O	O
3.5	O	O
mm	O	O
on	O	O
two	O	O
or	O	O
three	O	O
sites	O	O
not	O	O
on	O	O
the	O	O
same	O	O
tooth	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
generalized	O	O
periodontitis	O	O
was	O	O
defined	O	O
as	O	O
clinical	O	O
AL	O	O
>	O	O
/=	O	O
3.5	O	O
mm	O	O
on	O	O
>	O	O
/=	O	O
4	O	O
sites	O	O
not	O	O
on	O	O
the	O	O
same	O	O
tooth	O	O
.	O	O

Gingival	O	O
crevicular	O	O
fluid	O	O
was	O	O
collected	O	O
using	O	O
a	O	O
sterilized	O	O
paper	O	O
point	O	O
for	O	O
quantitative	O	O
analysis	O	O
of	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
Pi	B-bacteria	B-bacteria
)	O	O
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
.	O	O

After	O	O
adjusting	O	O
for	O	O
confounders	O	O
,	O	O
the	O	O
adjusted	O	O
odds	O	O
ratio	O	O
(	O	O
OR	O	O
)	O	O
was	O	O
4.79	O	O
(	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
[	O	O
CI	O	O
]	O	O
:	O	O
1.02	O	O
to	O	O
29.72	O	O
)	O	O
for	O	O
localized	O	O
periodontitis	O	O
and	O	O
6.60	O	O
(	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
1.25	O	O
to	O	O
41.61	O	O
)	O	O
for	O	O
generalized	O	O
periodontitis	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
proportion	O	O
of	O	O
floss	O	O
or	O	O
interdental	O	O
brush	O	O
users	O	O
in	O	O
women	O	O
with	O	O
preeclampsia	O	O
was	O	O
lower	O	O
than	O	O
that	O	O
in	O	O
women	O	O
without	O	O
(	O	O
adjusted	O	O
OR	O	O
:	O	O
0.21	O	O
;	O	O
95	O	O
%	O	O
CI	O	O
:	O	O
0.02	O	O
to	O	O
0.93	O	O
)	O	O
.	O	O

Pi	B-bacteria	B-bacteria
was	O	O
significantly	O	O
more	O	O
prevalent	O	O
in	O	O
women	O	O
with	O	O
preeclampsia	O	O
(	O	O
P	O	O
=	O	O
0.028	O	O
)	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
preeclampsia	O	O
could	O	O
be	O	O
associated	O	O
with	O	O
the	O	O
maternal	O	O
periodontal	O	O
condition	O	O
and	O	O
interdental	O	O
cleaning	O	O
.	O	O

Recent	O	O
studies	O	O
showed	O	O
that	O	O
qPCR	O	O
could	O	O
detect	O	O
bacteria	O	O
related	O	O
to	O	O
periodontitis	O	O
and	O	O
peri-implantitis	O	O
in	O	O
a	O	O
low	O	O
concentration	O	O
after	O	O
full-mouth	O	O
tooth	O	O
extraction	O	O
.	O	O

This	O	O
study	O	O
monitored	O	O
the	O	O
microbiota	O	O
from	O	O
tooth	O	O
extraction	O	O
,	O	O
over	O	O
9	O	O
months	O	O
of	O	O
full	O	O
edentulism	O	O
,	O	O
up	O	O
to	O	O
1	O	O
year	O	O
after	O	O
abutment	O	O
connection	O	O
.	O	O

Ten	O	O
patients	O	O
with	O	O
severe	O	O
periodontitis	O	O
were	O	O
recruited	O	O
.	O	O

Six	O	O
months	O	O
after	O	O
tooth	O	O
extraction	O	O
,	O	O
implants	O	O
were	O	O
inserted	O	O
.	O	O

Three	O	O
to	O	O
6	O	O
months	O	O
later	O	O
,	O	O
they	O	O
were	O	O
connected	O	O
to	O	O
abutments	O	O
.	O	O

Plaque	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
tongue	O	O
dorsum	O	O
,	O	O
saliva	O	O
,	O	O
and	O	O
subgingival	O	O
area	O	O
(	O	O
teeth/implants	O	O
)	O	O
before	O	O
extraction	O	O
up	O	O
to	O	O
1	O	O
year	O	O
after	O	O
abutment	O	O
connection	O	O
,	O	O
and	O	O
analysed	O	O
via	O	O
culture	O	O
,	O	O
qPCR	O	O
,	O	O
and	O	O
checkerboard	O	O
technology	O	O
.	O	O

A	O	O
reduction	O	O
in	O	O
the	O	O
total	O	O
amount	O	O
of	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
CFU/ml	O	O
was	O	O
observed	O	O
.	O	O

The	O	O
concentration	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
qPCR	O	O
and	O	O
checkerboard	O	O
)	O	O
in	O	O
the	O	O
saliva	O	O
and	O	O
,	O	O
to	O	O
a	O	O
lower	O	O
extent	O	O
,	O	O
on	O	O
the	O	O
tongue	O	O
dorsum	O	O
reduced	O	O
.	O	O

For	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
changes	O	O
were	O	O
negligible	O	O
and	O	O
no	O	O
changes	O	O
could	O	O
be	O	O
detected	O	O
for	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O

The	O	O
pristine	O	O
subgingival	O	O
niches	O	O
were	O	O
quickly	O	O
colonized	O	O
by	O	O
key	O	O
pathogens	O	O
.	O	O

Their	O	O
final	O	O
concentration	O	O
remained	O	O
low	O	O
,	O	O
while	O	O
the	O	O
detection	O	O
frequencies	O	O
remained	O	O
very	O	O
high	O	O
over	O	O
time	O	O
.	O	O

Complete	O	O
edentulation	O	O
results	O	O
in	O	O
a	O	O
significant	O	O
reduction	O	O
of	O	O
bacteria	O	O
related	O	O
to	O	O
periodontitis	O	O
and	O	O
peri-implantitis	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
which	O	O
might	O	O
indicate	O	O
that	O	O
key	O	O
pathogens	O	O
can	O	O
survive	O	O
without	O	O
pockets	O	O
.	O	O

To	O	O
monitor	O	O
microbial	O	O
shifts	O	O
during	O	O
dental	O	O
biofilm	O	O
re-development	O	O
.	O	O

Supra-	O	O
and	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
separately	O	O
from	O	O
28	O	O
teeth	O	O
in	O	O
38	O	O
healthy	O	O
and	O	O
17	O	O
periodontitis	O	O
subjects	O	O
at	O	O
baseline	O	O
and	O	O
immediately	O	O
after	O	O
tooth	O	O
cleaning	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
again	O	O
from	O	O
seven	O	O
teeth	O	O
in	O	O
randomly	O	O
selected	O	O
quadrants	O	O
during	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
and	O	O
7	O	O
days	O	O
of	O	O
no	O	O
oral	O	O
hygiene	O	O
.	O	O

Samples	O	O
were	O	O
analysed	O	O
using	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Species	O	O
counts	O	O
were	O	O
averaged	O	O
within	O	O
subjects	O	O
at	O	O
each	O	O
time	O	O
point	O	O
.	O	O

Significant	O	O
differences	O	O
in	O	O
the	O	O
counts	O	O
between	O	O
healthy	O	O
and	O	O
periodontitis	O	O
subjects	O	O
were	O	O
determined	O	O
using	O	O
the	O	O
Mann-Whitney	O	O
test	O	O
.	O	O

The	O	O
total	O	O
supra-	O	O
and	O	O
subgingival	O	O
counts	O	O
were	O	O
significantly	O	O
higher	O	O
in	O	O
periodontitis	O	O
on	O	O
entry	O	O
and	O	O
reached	O	O
or	O	O
exceeded	O	O
the	O	O
baseline	O	O
values	O	O
after	O	O
day	O	O
2	O	O
.	O	O

Supragingival	O	O
counts	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
ss	I-bacteria	I-bacteria
vincentii	E-bacteria	I-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
mucosa	E-bacteria	I-bacteria
increased	O	O
from	O	O
2	O	O
to	O	O
7	O	O
days	O	O
.	O	O

Subgingival	O	O
counts	O	O
were	O	O
greater	O	O
for	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
green	O	O
and	O	O
orange	O	O
complex	O	O
species	O	O
.	O	O

Significant	O	O
differences	O	O
between	O	O
groups	O	O
in	O	O
supragingival	O	O
counts	O	O
occurred	O	O
for	O	O
17	O	O
of	O	O
41	O	O
species	O	O
at	O	O
entry	O	O
,	O	O
0	O	O
at	O	O
day	O	O
7	O	O
;	O	O
for	O	O
subgingival	O	O
plaque	O	O
,	O	O
these	O	O
values	O	O
were	O	O
39/41	O	O
taxa	O	O
at	O	O
entry	O	O
,	O	O
17/41	O	O
at	O	O
day	O	O
7	O	O
.	O	O

Supragingival	O	O
plaque	O	O
re-development	O	O
was	O	O
similar	O	O
in	O	O
periodontitis	O	O
and	O	O
health	O	O
,	O	O
but	O	O
subgingival	O	O
species	O	O
recolonization	O	O
was	O	O
more	O	O
marked	O	O
in	O	O
periodontitis	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
the	O	O
occurrence	O	O
of	O	O
enteric	O	O
bacteria	O	O
and	O	O
pseudomonads	O	O
resistant	O	O
to	O	O
tetracycline	O	O
and	O	O
beta-lactams	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
patients	O	O
exhibiting	O	O
gingivitis	O	O
(	O	O
n=89	O	O
)	O	O
,	O	O
periodontitis	O	O
(	O	O
n=79	O	O
)	O	O
,	O	O
periodontally	O	O
healthy	O	O
(	O	O
n=50	O	O
)	O	O
and	O	O
wearing	O	O
complete	O	O
dentures	O	O
(	O	O
n=41	O	O
)	O	O
.	O	O

Microbial	O	O
identification	O	O
and	O	O
presence	O	O
of	O	O
resistance	O	O
markers	O	O
associated	O	O
with	O	O
the	O	O
production	O	O
of	O	O
beta-lactamases	O	O
and	O	O
tetracycline	O	O
resistance	O	O
were	O	O
performed	O	O
by	O	O
using	O	O
biochemical	O	O
tests	O	O
and	O	O
PCR	O	O
.	O	O

Susceptibility	O	O
tests	O	O
were	O	O
carried	O	O
out	O	O
in	O	O
201	O	O
isolates	O	O
of	O	O
enteric	O	O
cocci	O	O
and	O	O
rods	O	O
.	O	O

Resistance	O	O
to	O	O
ampicillin	O	O
,	O	O
amoxicillin/clavulanic	O	O
acid	O	O
,	O	O
imipenem	O	O
,	O	O
meropenem	O	O
and	O	O
tetracycline	O	O
was	O	O
detected	O	O
in	O	O
57.4	O	O
%	O	O
,	O	O
34.6	O	O
%	O	O
,	O	O
2.4	O	O
%	O	O
,	O	O
1.9	O	O
%	O	O
and	O	O
36.5	O	O
%	O	O
of	O	O
the	O	O
isolates	O	O
,	O	O
respectively	O	O
.	O	O

beta-lactamase	O	O
production	O	O
was	O	O
observed	O	O
in	O	O
41.2	O	O
%	O	O
of	O	O
tested	O	O
microorganisms	O	O
,	O	O
while	O	O
the	O	O
most	O	O
commonly	O	O
found	O	O
beta-lactamase	O	O
genetic	O	O
determinant	O	O
was	O	O
gene	O	O
blaTEM	O	O
.	O	O

Tetracycline	O	O
resistance	O	O
was	O	O
disseminated	O	O
and	O	O
a	O	O
wide	O	O
scope	O	O
of	O	O
tet	O	O
genes	O	O
were	O	O
detected	O	O
in	O	O
all	O	O
studied	O	O
microbial	O	O
genus	O	O
.	O	O

Disseminated	O	O
histoplasmosis	O	O
caused	O	O
by	O	O
Histoplasma	B-bacteria	B-bacteria
capsulatum	E-bacteria	I-bacteria
,	O	O
a	O	O
zoonotic	O	O
fungal	O	O
organism	O	O
,	O	O
is	O	O
an	O	O
important	O	O
disease	O	O
in	O	O
animals	O	O
and	O	O
humans	O	O
,	O	O
particularly	O	O
those	O	O
with	O	O
compromised	O	O
immune	O	O
systems	O	O
.	O	O

Reports	O	O
of	O	O
disseminated	O	O
histoplasmosis	O	O
in	O	O
an	O	O
avian	O	O
species	O	O
are	O	O
not	O	O
available	O	O
within	O	O
the	O	O
current	O	O
literature	O	O
.	O	O

Candida	O	O
albicans	O	O
,	O	O
another	O	O
fungal	O	O
agent	O	O
with	O	O
zoonotic	O	O
importance	O	O
,	O	O
is	O	O
a	O	O
commensal	O	O
of	O	O
the	O	O
avian	O	O
digestive	O	O
tract	O	O
that	O	O
is	O	O
often	O	O
associated	O	O
with	O	O
opportunistic	O	O
infections	O	O
particularly	O	O
in	O	O
young	O	O
or	O	O
immunocompromised	O	O
birds	O	O
.	O	O

This	O	O
report	O	O
describes	O	O
a	O	O
case	O	O
of	O	O
concomitant	O	O
histoplasmosis	O	O
and	O	O
candidiasis	O	O
in	O	O
an	O	O
Eclectus	O	O
parrot	O	O
(	O	O
Eclectus	O	O
roratus	O	O
)	O	O
characterized	O	O
by	O	O
severe	O	O
granulomatous	O	O
glossitis	O	O
,	O	O
blepharitis	O	O
and	O	O
osteomyelitis	O	O
with	O	O
numerous	O	O
intrahistiocytic	O	O
and	O	O
extracellular	O	O
yeasts	O	O
(	O	O
H.	B-bacteria	B-bacteria
capsulatum	E-bacteria	I-bacteria
)	O	O
as	O	O
well	O	O
as	O	O
intralesional	O	O
hyphae	O	O
,	O	O
pseudohyphae	O	O
and	O	O
conidia	O	O
(	O	O
C.	O	O
albicans	O	O
)	O	O
.	O	O

To	O	O
our	O	O
knowledge	O	O
,	O	O
co-infection	O	O
with	O	O
H.	B-bacteria	B-bacteria
capsulatum	E-bacteria	I-bacteria
and	O	O
C.	O	O
albicans	O	O
has	O	O
not	O	O
been	O	O
reported	O	O
in	O	O
an	O	O
avian	O	O
species	O	O
.	O	O

The	O	O
highly	O	O
antagonistic	O	O
lactobacillus	O	O
strains	O	O
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
human	O	O
individuals	O	O
were	O	O
genetically	O	O
passported	O	O
as	O	O
L.	B-bacteria	B-bacteria
fermentum	I-bacteria	I-bacteria
39	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
50	E-bacteria	I-bacteria
,	O	O
and	O	O
L.	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
24	E-bacteria	I-bacteria
,	O	O
by	O	O
applying	O	O
the	O	O
RAPD-PCR	O	O
technique	O	O
with	O	O
two	O	O
types	O	O
of	O	O
primers	O	O
(	O	O
M13	O	O
,	O	O
MSP	O	O
)	O	O
.	O	O

These	O	O
lactobacillus	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
showed	O	O
high	O	O
degrees	O	O
of	O	O
autoaggregation	O	O
,	O	O
surface	O	O
hydrophobicity	O	O
,	O	O
coaggregation	O	O
,	O	O
and	O	O
adhesion	O	O
.	O	O

These	O	O
characteristics	O	O
determine	O	O
the	O	O
obvious	O	O
capacity	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
to	O	O
form	O	O
biofilms	O	O
,	O	O
which	O	O
may	O	O
be	O	O
used	O	O
to	O	O
design	O	O
new	O	O
probiotic	O	O
agents	O	O
.	O	O

Samples	O	O
were	O	O
taken	O	O
under	O	O
strictly	O	O
anaerobic	O	O
conditions	O	O
from	O	O
the	O	O
root	O	O
canals	O	O
of	O	O
22	O	O
patients	O	O
having	O	O
a	O	O
tooth	O	O
in	O	O
which	O	O
necrotic	O	O
pulp	O	O
was	O	O
associated	O	O
with	O	O
an	O	O
inflammatory	O	O
peri-apical	O	O
lesion	O	O
an	O	O
optical	O	O
periodontitis	O	O
.	O	O

In	O	O
the	O	O
majority	O	O
of	O	O
cases	O	O
(	O	O
85	O	O
%	O	O
)	O	O
,	O	O
these	O	O
lesions	O	O
were	O	O
chronic	O	O
and	O	O
the	O	O
pulp	O	O
chamber	O	O
was	O	O
closed	O	O
.	O	O

One	O	O
hundred	O	O
and	O	O
two	O	O
strains	O	O
were	O	O
isolated	O	O
,	O	O
71.7	O	O
%	O	O
of	O	O
the	O	O
bacteria	O	O
being	O	O
obligate	O	O
anaerobes	O	O
and	O	O
49.8	O	O
%	O	O
being	O	O
Gram-negative	O	O
bacilli	O	O
.	O	O

Their	O	O
ability	O	O
to	O	O
produce	O	O
beta-lactamases	O	O
was	O	O
tested	O	O
and	O	O
8.8	O	O
%	O	O
gave	O	O
a	O	O
positive	O	O
reaction	O	O
in	O	O
a	O	O
cefinase	O	O
test	O	O
.	O	O

These	O	O
cefinase	O	O
positive	O	O
strains	O	O
were	O	O
nevertheless	O	O
susceptible	O	O
to	O	O
3rd-generation	O	O
cephalosporins	O	O
(	O	O
cefoxitin	O	O
)	O	O
and	O	O
to	O	O
amoxicillin-clavulanate	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
M.	B-bacteria	B-bacteria
Morganii	E-bacteria	I-bacteria
.	O	O

Microbial	O	O
agents	O	O
in	O	O
root	O	O
canal	O	O
systems	O	O
can	O	O
induce	O	O
periodontal	O	O
inflammation	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
are	O	O
to	O	O
detect	O	O
anaerobic	O	O
microorganisms	O	O
in	O	O
endodontic-periodontal	O	O
lesions	O	O
,	O	O
determine	O	O
the	O	O
genetic	O	O
diversity	O	O
among	O	O
them	O	O
,	O	O
and	O	O
assess	O	O
the	O	O
simultaneous	O	O
colonization	O	O
of	O	O
the	O	O
pulp	O	O
and	O	O
periodontal	O	O
microenvironments	O	O
by	O	O
a	O	O
single	O	O
clone	O	O
.	O	O

Twenty-seven	O	O
teeth	O	O
of	O	O
patients	O	O
with	O	O
endodontic-periodontal	O	O
lesions	O	O
were	O	O
selected	O	O
.	O	O

Samples	O	O
were	O	O
spread	O	O
on	O	O
an	O	O
agar-blood	O	O
medium	O	O
,	O	O
the	O	O
detection	O	O
of	O	O
each	O	O
species	O	O
was	O	O
performed	O	O
using	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
,	O	O
and	O	O
the	O	O
determination	O	O
of	O	O
the	O	O
simultaneous	O	O
presence	O	O
of	O	O
the	O	O
same	O	O
species	O	O
in	O	O
the	O	O
microenvironments	O	O
by	O	O
one	O	O
or	O	O
more	O	O
clones	O	O
was	O	O
determined	O	O
using	O	O
arbitrarily	O	O
primed	O	O
PCR	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
(	O	O
Pi	B-bacteria	B-bacteria
)	O	O
was	O	O
the	O	O
most	O	O
prevalent	O	O
species	O	O
of	O	O
the	O	O
colonies	O	O
in	O	O
periodontal	O	O
pockets	O	O
,	O	O
whereas	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
and	O	O
Pi	B-bacteria	B-bacteria
were	O	O
the	O	O
more	O	O
prevalent	O	O
in	O	O
root	O	O
canals	O	O
.	O	O

Isolates	O	O
of	O	O
Pi	B-bacteria	B-bacteria
and	O	O
Pg	B-bacteria	B-bacteria
were	O	O
simultaneously	O	O
identified	O	O
in	O	O
root	O	O
canals	O	O
and	O	O
periodontal	O	O
pockets	O	O
.	O	O

Eighteen	O	O
percent	O	O
of	O	O
teeth	O	O
exhibited	O	O
the	O	O
simultaneous	O	O
colonization	O	O
by	O	O
Pg	B-bacteria	B-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
previously	O	O
T.	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
)	O	O
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	E-bacteria	I-bacteria
in	O	O
the	O	O
pulp	O	O
and	O	O
periodontal	O	O
microenvironments	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
these	O	O
species	O	O
was	O	O
noted	O	O
even	O	O
in	O	O
niches	O	O
from	O	O
which	O	O
no	O	O
colonies	O	O
were	O	O
isolated	O	O
.	O	O

Seventeen	O	O
different	O	O
genotypes	O	O
were	O	O
found	O	O
in	O	O
periodontal	O	O
and	O	O
pulp	O	O
sites	O	O
,	O	O
with	O	O
the	O	O
majority	O	O
of	O	O
sites	O	O
colonized	O	O
by	O	O
one	O	O
or	O	O
two	O	O
different	O	O
genotypes	O	O
.	O	O

A	O	O
high	O	O
degree	O	O
of	O	O
genotype	O	O
similarity	O	O
was	O	O
found	O	O
for	O	O
samples	O	O
of	O	O
Pg	B-bacteria	B-bacteria
isolated	O	O
from	O	O
only	O	O
one	O	O
site	O	O
as	O	O
well	O	O
as	O	O
for	O	O
those	O	O
isolated	O	O
from	O	O
both	O	O
microenvironments	O	O
.	O	O

Different	O	O
clones	O	O
of	O	O
Pi	B-bacteria	B-bacteria
and	O	O
Pg	B-bacteria	B-bacteria
with	O	O
a	O	O
high	O	O
intraspecific	O	O
genotype	O	O
similarity	O	O
were	O	O
found	O	O
to	O	O
colonize	O	O
the	O	O
same	O	O
anatomic	O	O
sites	O	O
in	O	O
endodontic-periodontal	O	O
infections	O	O
.	O	O

A	O	O
variety	O	O
of	O	O
oral	O	O
topical	O	O
agents	O	O
have	O	O
been	O	O
used	O	O
for	O	O
prevention	O	O
and	O	O
management	O	O
of	O	O
radiotherapy-induced	O	O
adverse	O	O
effects	O	O
.	O	O

The	O	O
antimicrobial	O	O
nature	O	O
of	O	O
some	O	O
of	O	O
the	O	O
commonly	O	O
used	O	O
agents	O	O
is	O	O
unknown	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
antimicrobial	O	O
efficacies	O	O
of	O	O
various	O	O
oral	O	O
topical	O	O
agents	O	O
on	O	O
common	O	O
microorganisms	O	O
associated	O	O
with	O	O
radiated	O	O
head	O	O
and	O	O
neck	O	O
cancer	O	O
patients	O	O
.	O	O

Seven	O	O
commonly	O	O
used	O	O
topical	O	O
oral	O	O
agents-0.12	O	O
%	O	O
chlorhexidine	O	O
with	O	O
alcohol	O	O
,	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
without	O	O
alcohol	O	O
,	O	O
baking	O	O
soda-salt	O	O
rinse	O	O
,	O	O
0.4	O	O
%	O	O
stannous	O	O
fluoride	O	O
gel	O	O
,	O	O
0.63	O	O
%	O	O
stannous	O	O
fluoride	O	O
rinse	O	O
,	O	O
calcium	O	O
phosphate	O	O
mouthrinse	O	O
,	O	O
and	O	O
acemannan	O	O
hydrogel	O	O
(	O	O
aloe	O	O
vera	O	O
)	O	O
rinse-were	O	O
evaluated	O	O
in	O	O
vitro	O	O
for	O	O
their	O	O
antimicrobial	O	O
efficacies	O	O
against	O	O
four	O	O
common	O	O
microorganisms	O	O
.	O	O

A	O	O
combination	O	O
of	O	O
baking	O	O
soda-salt	O	O
rinse	O	O
and	O	O
0.4	O	O
%	O	O
stannous	O	O
fluoride	O	O
gel	O	O
was	O	O
evaluated	O	O
as	O	O
the	O	O
eighth	O	O
agent	O	O
.	O	O

The	O	O
microorganisms	O	O
used	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
group	B-bacteria	B-bacteria
B	I-bacteria	I-bacteria
Streptococcus	E-bacteria	I-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
.	O	O

An	O	O
ELISA	O	O
reader	O	O
was	O	O
used	O	O
to	O	O
measure	O	O
the	O	O
turbidity	O	O
of	O	O
microbial	O	O
culture	O	O
wells	O	O
and	O	O
optical	O	O
density	O	O
(	O	O
OD	O	O
)	O	O
values	O	O
for	O	O
each	O	O
of	O	O
the	O	O
960	O	O
wells	O	O
recorded	O	O
.	O	O

Mean	O	O
OD	O	O
values	O	O
were	O	O
rank	O	O
ordered	O	O
based	O	O
on	O	O
their	O	O
turbidity	O	O
.	O	O

One-way	O	O
ANOVA	O	O
with	O	O
Tukey	O	O
HSD	O	O
post	O	O
hoc	O	O
analysis	O	O
was	O	O
used	O	O
to	O	O
study	O	O
differences	O	O
in	O	O
OD	O	O
values	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
.	O	O

Mean	O	O
OD	O	O
values	O	O
classified	O	O
for	O	O
topical	O	O
agents	O	O
from	O	O
lowest	O	O
to	O	O
highest	O	O
were	O	O
chlorhexidine	O	O
with	O	O
alcohol	O	O
,	O	O
chlorhexidine	O	O
without	O	O
alcohol	O	O
,	O	O
baking	O	O
soda-	O	O
salt	O	O
,	O	O
calcium	O	O
phosphate	O	O
rinse	O	O
,	O	O
and	O	O
the	O	O
combination	O	O
of	O	O
baking	O	O
soda-salt	O	O
and	O	O
stannous	O	O
fluoride	O	O
gel	O	O
.	O	O

Mean	O	O
OD	O	O
values	O	O
classified	O	O
for	O	O
microorganisms	O	O
from	O	O
lowest	O	O
to	O	O
highest	O	O
were	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
group	B-bacteria	B-bacteria
B	I-bacteria	I-bacteria
Streptococcus	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
.	O	O

A	O	O
significant	O	O
difference	O	O
among	O	O
the	O	O
antimicrobial	O	O
efficacies	O	O
of	O	O
topical	O	O
agents	O	O
was	O	O
evident	O	O
for	O	O
each	O	O
of	O	O
four	O	O
microorganisms	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
.	O	O

There	O	O
was	O	O
also	O	O
a	O	O
significant	O	O
difference	O	O
among	O	O
the	O	O
antimicrobial	O	O
efficacies	O	O
of	O	O
the	O	O
same	O	O
topical	O	O
agent	O	O
on	O	O
the	O	O
four	O	O
microorganisms	O	O
tested	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
.	O	O

Dental	O	O
implants	O	O
and	O	O
peri-implant	O	O
tissue	O	O
are	O	O
susceptible	O	O
to	O	O
disease	O	O
conditions	O	O
that	O	O
may	O	O
lead	O	O
to	O	O
implant	O	O
loss	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
describe	O	O
teeth	O	O
and	O	O
implant	O	O
surroundings	O	O
as	O	O
well	O	O
as	O	O
clinical	O	O
health	O	O
indices	O	O
and	O	O
oral	O	O
microbiologic	O	O
parameters	O	O
.	O	O

A	O	O
group	O	O
of	O	O
83	O	O
adults	O	O
(	O	O
42	O	O
men	O	O
and	O	O
41	O	O
women	O	O
)	O	O
were	O	O
enrolled	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Clinical	O	O
assessments	O	O
of	O	O
dental	O	O
implants	O	O
and	O	O
contralateral	O	O
natural	O	O
teeth	O	O
included	O	O
dental	O	O
plaque	O	O
,	O	O
gingival	O	O
inflammation	O	O
,	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
.	O	O

Microbiologic	O	O
assessments	O	O
included	O	O
bacterial	O	O
culture	O	O
,	O	O
light	O	O
and	O	O
phase	O	O
contrast	O	O
microscopy	O	O
,	O	O
and	O	O
DNA	O	O
probe	O	O
hybridization	O	O
for	O	O
a	O	O
panel	O	O
of	O	O
14	O	O
target	O	O
microorganisms	O	O
.	O	O

Clinical	O	O
and	O	O
microbiologic	O	O
data	O	O
were	O	O
compared	O	O
by	O	O
paired	O	O
t	O	O
test	O	O
and	O	O
ANOVA	O	O
.	O	O

P	O	O
<	O	O
.05	O	O
was	O	O
considered	O	O
statistically	O	O
significant	O	O
.	O	O

The	O	O
Plaque	O	O
Index	O	O
for	O	O
the	O	O
implants	O	O
was	O	O
1.85	O	O
+/-	O	O
0.47	O	O
,	O	O
whereas	O	O
the	O	O
score	O	O
for	O	O
natural	O	O
teeth	O	O
was	O	O
significantly	O	O
higher	O	O
,	O	O
2.15	O	O
+/-	O	O
0.52	O	O
.	O	O

Compared	O	O
to	O	O
the	O	O
samples	O	O
obtained	O	O
from	O	O
the	O	O
dental	O	O
implants	O	O
,	O	O
the	O	O
samples	O	O
from	O	O
natural	O	O
teeth	O	O
demonstrated	O	O
significantly	O	O
higher	O	O
total	O	O
bacterial	O	O
cell	O	O
numbers	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
.	O	O

Consistent	O	O
with	O	O
the	O	O
clinical	O	O
measures	O	O
of	O	O
dental	O	O
plaque	O	O
,	O	O
significantly	O	O
higher	O	O
numbers	O	O
of	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
bacteria	O	O
,	O	O
were	O	O
found	O	O
in	O	O
dental	O	O
plaque	O	O
samples	O	O
from	O	O
teeth	O	O
(	O	O
aerobic	O	O
5.648	O	O
+/-	O	O
0.512	O	O
,	O	O
anaerobic	O	O
6.243	O	O
+/-	O	O
0.535	O	O
,	O	O
P	O	O
<	O	O
.0001	O	O
)	O	O
compared	O	O
to	O	O
implants	O	O
(	O	O
aerobic	O	O
5.430	O	O
+/-	O	O
0.541	O	O
,	O	O
anaerobic	O	O
5.917	O	O
+/-	O	O
0.523	O	O
,	O	O
P	O	O
<	O	O
.0001	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
there	O	O
were	O	O
significantly	O	O
higher	O	O
numbers	O	O
of	O	O
anaerobic	O	O
(	O	O
6.243	O	O
+/-	O	O
0.535	O	O
and	O	O
5.917	O	O
+/-	O	O
0.523	O	O
,	O	O
P	O	O
<	O	O
.0001	O	O
)	O	O
than	O	O
aerobic	O	O
(	O	O
5.648	O	O
+/-	O	O
0.512	O	O
and	O	O
5.430	O	O
+/-	O	O
0.541	O	O
,	O	O
P	O	O
<	O	O
.008	O	O
)	O	O
bacteria	O	O
for	O	O
samples	O	O
from	O	O
teeth	O	O
and	O	O
implants	O	O
,	O	O
respectively	O	O
.	O	O

Clinical	O	O
and	O	O
microbiologic	O	O
analyses	O	O
provide	O	O
consistent	O	O
findings	O	O
that	O	O
suggest	O	O
differences	O	O
in	O	O
quantity	O	O
of	O	O
plaque	O	O
and	O	O
bacterial	O	O
species	O	O
between	O	O
teeth	O	O
and	O	O
dental	O	O
implants	O	O
.	O	O

For	O	O
long-term	O	O
treatment	O	O
success	O	O
,	O	O
the	O	O
importance	O	O
of	O	O
plaque	O	O
control	O	O
and	O	O
oral	O	O
hygiene	O	O
of	O	O
both	O	O
periodontal	O	O
and	O	O
dental	O	O
implant	O	O
therapy	O	O
is	O	O
emphasized	O	O
.	O	O

Topical	O	O
tetracyclines	O	O
,	O	O
such	O	O
as	O	O
minocycline	O	O
ointment	O	O
,	O	O
are	O	O
frequently	O	O
used	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
periodontal	O	O
infection	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
influence	O	O
of	O	O
minocycline	O	O
ointment	O	O
use	O	O
on	O	O
oral	O	O
bacteria	O	O
,	O	O
using	O	O
supragingival	O	O
plaque	O	O
samples	O	O
from	O	O
adults	O	O
who	O	O
had	O	O
not	O	O
taken	O	O
any	O	O
antibiotics	O	O
for	O	O
6	O	O
months	O	O
.	O	O

Initially	O	O
we	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
topical	O	O
minocycline	O	O
administration	O	O
on	O	O
the	O	O
emergence	O	O
of	O	O
tetracycline-resistant	O	O
oral	O	O
bacteria	O	O
in	O	O
four	O	O
healthy	O	O
adults	O	O
.	O	O

The	O	O
isolation	O	O
frequency	O	O
of	O	O
tetracycline-resistant	O	O
oral	O	O
bacteria	O	O
to	O	O
total	O	O
viable	O	O
bacteria	O	O
increased	O	O
substantially	O	O
on	O	O
day	O	O
6	O	O
after	O	O
treatment	O	O
,	O	O
although	O	O
it	O	O
returned	O	O
to	O	O
baseline	O	O
on	O	O
day	O	O
25	O	O
.	O	O

Subsequently	O	O
we	O	O
investigated	O	O
the	O	O
isolation	O	O
frequency	O	O
of	O	O
tetracycline-resistant	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
TOS	B-bacteria	B-bacteria
)	O	O
as	O	O
a	O	O
representative	O	O
oral	O	O
bacterium	O	O
,	O	O
using	O	O
samples	O	O
from	O	O
41	O	O
subjects	O	O
with	O	O
periodontal	O	O
diseases	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
TOS	B-bacteria	B-bacteria
(	O	O
of	O	O
the	O	O
total	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
)	O	O
increased	O	O
significantly	O	O
(	O	O
from	O	O
11.9+/-15.6	O	O
%	O	O
to	O	O
34.2+/-24.0	O	O
%	O	O
)	O	O
after	O	O
minocycline	O	O
treatment	O	O
.	O	O

Various	O	O
TOS	B-bacteria	B-bacteria
species	O	O
were	O	O
identified	O	O
;	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
were	O	O
frequently	O	O
isolated	O	O
.	O	O

PCR	O	O
and	O	O
Southern	O	O
blotting	O	O
allowed	O	O
us	O	O
to	O	O
identify	O	O
tetM	O	O
on	O	O
the	O	O
Tn916-like	O	O
elements	O	O
as	O	O
the	O	O
gene	O	O
responsible	O	O
for	O	O
tetracycline-resistance	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
the	O	O
potential	O	O
risk	O	O
of	O	O
the	O	O
spread	O	O
of	O	O
similar	O	O
genetic	O	O
elements	O	O
through	O	O
bacteria	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
should	O	O
be	O	O
considered	O	O
.	O	O

Autism	O	O
of	O	O
the	O	O
regressive	O	O
variety	O	O
is	O	O
selected	O	O
as	O	O
an	O	O
example	O	O
of	O	O
the	O	O
importance	O	O
of	O	O
intestinal	O	O
bacterial	O	O
microflora	O	O
in	O	O
disease	O	O
other	O	O
than	O	O
classical	O	O
infection	O	O
.	O	O

Our	O	O
studies	O	O
have	O	O
indicated	O	O
that	O	O
intestinal	O	O
bacteria	O	O
play	O	O
a	O	O
role	O	O
in	O	O
this	O	O
disease	O	O
since	O	O
it	O	O
responds	O	O
to	O	O
oral	O	O
vancomycin	O	O
,	O	O
a	O	O
drug	O	O
that	O	O
is	O	O
not	O	O
absorbed	O	O
from	O	O
the	O	O
GI	O	O
tract	O	O
.	O	O

Pyrosequencing	O	O
studies	O	O
document	O	O
an	O	O
abnormal	O	O
gut	O	O
microflora	O	O
in	O	O
regressive	O	O
autism	O	O
subjects	O	O
as	O	O
compared	O	O
to	O	O
controls	O	O
.	O	O

Finally	O	O
,	O	O
we	O	O
present	O	O
preliminary	O	O
evidence	O	O
suggesting	O	O
that	O	O
Desulfovibrio	B-bacteria	B-bacteria
may	O	O
play	O	O
a	O	O
key	O	O
role	O	O
in	O	O
this	O	O
disease	O	O
.	O	O

The	O	O
hygiene	O	O
hypothesis	O	O
contends	O	O
that	O	O
fewer	O	O
opportunities	O	O
for	O	O
infections	O	O
and	O	O
microbial	O	O
exposures	O	O
have	O	O
resulted	O	O
in	O	O
more	O	O
widespread	O	O
asthma	O	O
and	O	O
atopic	O	O
disease	O	O
.	O	O

Consistent	O	O
with	O	O
that	O	O
hypothesis	O	O
,	O	O
decreases	O	O
in	O	O
infectious	O	O
oral	O	O
diseases	O	O
over	O	O
the	O	O
past	O	O
half	O	O
century	O	O
have	O	O
coincided	O	O
with	O	O
increases	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
asthma	O	O
and	O	O
other	O	O
allergic	O	O
diseases	O	O
.	O	O

This	O	O
observation	O	O
has	O	O
led	O	O
some	O	O
researchers	O	O
to	O	O
speculate	O	O
that	O	O
exposures	O	O
to	O	O
oral	O	O
bacteria	O	O
,	O	O
including	O	O
pathogens	O	O
associated	O	O
with	O	O
periodontal	O	O
diseases	O	O
,	O	O
such	O	O
as	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
,	O	O
might	O	O
play	O	O
a	O	O
protective	O	O
role	O	O
in	O	O
the	O	O
development	O	O
of	O	O
asthma	O	O
and	O	O
allergy	O	O
.	O	O

Colonization	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
with	O	O
bacteria	O	O
,	O	O
including	O	O
some	O	O
species	O	O
of	O	O
periodontal	O	O
pathogens	O	O
,	O	O
begins	O	O
shortly	O	O
after	O	O
birth	O	O
,	O	O
and	O	O
the	O	O
detection	O	O
of	O	O
serum	O	O
antibodies	O	O
to	O	O
oral	O	O
pathogens	O	O
in	O	O
early	O	O
childhood	O	O
provides	O	O
evidence	O	O
of	O	O
an	O	O
early	O	O
immune	O	O
response	O	O
to	O	O
these	O	O
bacteria	O	O
.	O	O

Current	O	O
knowledge	O	O
of	O	O
the	O	O
immune	O	O
response	O	O
to	O	O
oral	O	O
bacteria	O	O
and	O	O
the	O	O
immunologic	O	O
pathogenesis	O	O
of	O	O
periodontal	O	O
diseases	O	O
suggests	O	O
biologically	O	O
plausible	O	O
mechanisms	O	O
by	O	O
which	O	O
oral	O	O
pathogens	O	O
could	O	O
influence	O	O
the	O	O
risk	O	O
of	O	O
allergic	O	O
disease	O	O
.	O	O

However	O	O
,	O	O
studies	O	O
investigating	O	O
the	O	O
association	O	O
between	O	O
oral	O	O
pathogen	O	O
exposures	O	O
and	O	O
allergic	O	O
disease	O	O
are	O	O
few	O	O
in	O	O
number	O	O
and	O	O
limited	O	O
by	O	O
cross-sectional	O	O
or	O	O
case-control	O	O
design	O	O
,	O	O
exclusion	O	O
of	O	O
young	O	O
children	O	O
,	O	O
and	O	O
use	O	O
of	O	O
surrogate	O	O
measures	O	O
of	O	O
oral	O	O
bacterial	O	O
colonization	O	O
.	O	O

Additional	O	O
studies	O	O
,	O	O
particularly	O	O
well-designed	O	O
case-control	O	O
studies	O	O
among	O	O
very	O	O
young	O	O
children	O	O
and	O	O
prospective	O	O
birth	O	O
cohort	O	O
studies	O	O
,	O	O
are	O	O
needed	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
contains	O	O
almost	O	O
half	O	O
of	O	O
the	O	O
commensal	O	O
bacterial	O	O
population	O	O
present	O	O
in	O	O
the	O	O
human	O	O
body	O	O
.	O	O

An	O	O
increase	O	O
in	O	O
the	O	O
number	O	O
of	O	O
these	O	O
microorganisms	O	O
may	O	O
result	O	O
in	O	O
systemic	O	O
diseases	O	O
such	O	O
as	O	O
infective	O	O
endocarditis	O	O
and	O	O
aspiration	O	O
pneumonia	O	O
as	O	O
well	O	O
as	O	O
oral	O	O
infections	O	O
.	O	O

It	O	O
is	O	O
essential	O	O
to	O	O
control	O	O
the	O	O
total	O	O
numbers	O	O
of	O	O
these	O	O
microorganisms	O	O
in	O	O
order	O	O
to	O	O
suppress	O	O
disease	O	O
onset	O	O
.	O	O

Thus	O	O
,	O	O
we	O	O
examined	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
a	O	O
newly	O	O
developed	O	O
gel-entrapped	O	O
catechin	O	O
(	O	O
GEC	O	O
)	O	O
preparation	O	O
against	O	O
oral	O	O
microorganisms	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
of	O	O
GEC	O	O
was	O	O
determined	O	O
based	O	O
on	O	O
the	O	O
relationship	O	O
between	O	O
a	O	O
modified	O	O
agar	O	O
diffusion	O	O
method	O	O
and	O	O
a	O	O
broth	O	O
microdilution	O	O
method	O	O
.	O	O

GEC	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
the	O	O
Actinomyces	O	O
,	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
Candida	O	O
strains	O	O
tested	O	O
,	O	O
but	O	O
did	O	O
not	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
that	O	O
are	O	O
important	O	O
in	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
.	O	O

Commercially	O	O
available	O	O
moisture	O	O
gels	O	O
containing	O	O
antimicrobial	O	O
components	O	O
showed	O	O
antimicrobial	O	O
activity	O	O
against	O	O
all	O	O
of	O	O
the	O	O
tested	O	O
strains	O	O
.	O	O

After	O	O
a	O	O
series	O	O
of	O	O
washes	O	O
and	O	O
after	O	O
a	O	O
24-h	O	O
incubation	O	O
,	O	O
GEC	O	O
retained	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
the	O	O
catechins	O	O
.	O	O

Catalase	O	O
prevented	O	O
GEC-induced	O	O
growth	O	O
inhibition	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
suggesting	O	O
that	O	O
hydrogen	O	O
peroxide	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
catechins	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
GEC	O	O
may	O	O
be	O	O
useful	O	O
for	O	O
controlling	O	O
oral	O	O
microorganism	O	O
populations	O	O
and	O	O
reducing	O	O
the	O	O
accumulation	O	O
of	O	O
dental	O	O
plaque	O	O
,	O	O
thereby	O	O
helping	O	O
to	O	O
prevent	O	O
periodontal	O	O
disease	O	O
and	O	O
oral	O	O
candidiasis	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
genetic	O	O
diversity	O	O
and	O	O
possible	O	O
origin	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
found	O	O
in	O	O
the	O	O
oral	O	O
biofilm	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
a	O	O
biofilm	O	O
model	O	O
,	O	O
formed	O	O
in	O	O
situ	O	O
prior	O	O
to	O	O
and	O	O
during	O	O
a	O	O
period	O	O
of	O	O
exposure	O	O
to	O	O
20	O	O
%	O	O
sucrose	O	O
solution	O	O
(	O	O
28	O	O
days	O	O
)	O	O
,	O	O
using	O	O
Rogosa	O	O
Agar	O	O
.	O	O

The	O	O
lactobacillus	B-bacteria	B-bacteria
colonies	O	O
were	O	O
randomly	O	O
selected	O	O
(	O	O
n	O	O
=	O	O
222	O	O
)	O	O
and	O	O
subcultured	O	O
.	O	O

The	O	O
isolates	O	O
were	O	O
identified	O	O
using	O	O
pheS	O	O
or	O	O
rpoA	O	O
gene	O	O
sequence	O	O
analysis	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
identified	O	O
as	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
paracasei	E-bacteria	I-bacteria
(	O	O
n	O	O
=	O	O
75	O	O
)	O	O
were	O	O
subjected	O	O
to	O	O
multilocus	O	O
sequencing	O	O
typing	O	O
(	O	O
MLST	O	O
)	O	O
analysis	O	O
by	O	O
determining	O	O
partial	O	O
sequences	O	O
of	O	O
seven	O	O
housekeeping	O	O
genes	O	O
fusA	O	O
,	O	O
ileS	O	O
,	O	O
lepA	O	O
,	O	O
leuS	O	O
,	O	O
pyrG	O	O
,	O	O
recA	O	O
and	O	O
recG	O	O
.	O	O

An	O	O
increase	O	O
recovery	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
after	O	O
sucrose	O	O
phase	O	O
compared	O	O
with	O	O
nonsucrose	O	O
period	O	O
was	O	O
observed	O	O
(	O	O
31	O	O
prior	O	O
to	O	O
and	O	O
191	O	O
following	O	O
a	O	O
sucrose	O	O
exposure	O	O
period	O	O
)	O	O
.	O	O

Seven	O	O
subjects	O	O
harboured	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
paracasei	E-bacteria	I-bacteria
and	O	O
these	O	O
represented	O	O
14	O	O
sequence	O	O
types	O	O
(	O	O
ST	O	O
)	O	O
.	O	O

Comparison	O	O
of	O	O
the	O	O
STs	O	O
showed	O	O
that	O	O
unrelated	O	O
subjects	O	O
may	O	O
harbour	O	O
the	O	O
same	O	O
ST	O	O
and	O	O
that	O	O
individuals	O	O
harbour	O	O
multiple	O	O
STs	O	O
.	O	O

Three	O	O
subjects	O	O
harboured	O	O
STs	O	O
previously	O	O
isolated	O	O
from	O	O
dairy	O	O
products	O	O
.	O	O

The	O	O
present	O	O
data	O	O
supports	O	O
the	O	O
hypothesis	O	O
that	O	O
oral	O	O
lactobacilli	B-bacteria	B-bacteria
may	O	O
be	O	O
of	O	O
exogenous	O	O
origin	O	O
.	O	O

The	O	O
study	O	O
allow	O	O
us	O	O
to	O	O
gain	O	O
insight	O	O
into	O	O
the	O	O
genetic	O	O
diversity	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
in	O	O
oral	O	O
biofilm	O	O
.	O	O

The	O	O
interaction	O	O
between	O	O
Lactobacillus	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
,	O	O
a	O	O
probiotic	O	O
bacterium	O	O
,	O	O
and	O	O
oral	O	O
pathogenic	O	O
bacteria	O	O
have	O	O
not	O	O
been	O	O
studied	O	O
adequately	O	O
.	O	O

This	O	O
study	O	O
examined	O	O
the	O	O
effects	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
on	O	O
the	O	O
proliferation	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
including	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
on	O	O
the	O	O
formation	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

Human-derived	O	O
L.	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
(	O	O
KCTC	B-bacteria	B-bacteria
3594	E-bacteria	I-bacteria
and	O	O
KCTC	B-bacteria	B-bacteria
3678	E-bacteria	I-bacteria
)	O	O
and	O	O
rat-derived	O	O
L.	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
KCTC	I-bacteria	I-bacteria
3679	E-bacteria	I-bacteria
were	O	O
used	O	O
.	O	O

All	O	O
strains	O	O
exhibited	O	O
significant	O	O
inhibitory	O	O
effects	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
the	O	O
formation	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

These	O	O
antibacterial	O	O
activities	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
were	O	O
attributed	O	O
to	O	O
the	O	O
production	O	O
of	O	O
organic	O	O
acids	O	O
,	O	O
hydrogen	O	O
peroxide	O	O
,	O	O
and	O	O
a	O	O
bacteriocin-like	O	O
compound	O	O
.	O	O

Reuterin	O	O
,	O	O
an	O	O
antimicrobial	O	O
factor	O	O
,	O	O
was	O	O
produced	O	O
only	O	O
by	O	O
L.	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
KCTC	I-bacteria	I-bacteria
3594	E-bacteria	I-bacteria
.	O	O

In	O	O
addition	O	O
,	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
inhibited	O	O
the	O	O
production	O	O
of	O	O
methyl	O	O
mercaptan	O	O
by	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

Overall	O	O
,	O	O
these	O	O
results	O	O
suggest	O	O
that	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
may	O	O
be	O	O
useful	O	O
as	O	O
a	O	O
probiotic	O	O
agent	O	O
for	O	O
improving	O	O
oral	O	O
health	O	O
.	O	O

As	O	O
peri-implantitis	O	O
is	O	O
an	O	O
emerging	O	O
problem	O	O
,	O	O
the	O	O
development	O	O
of	O	O
validated	O	O
animal	O	O
models	O	O
is	O	O
mandatory	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
pilot	O	O
study	O	O
was	O	O
to	O	O
provide	O	O
a	O	O
first	O	O
step	O	O
in	O	O
describing	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
of	O	O
minipigs	O	O
.	O	O

In	O	O
five	O	O
minipigs	O	O
,	O	O
samples	O	O
of	O	O
the	O	O
oral	O	O
flora	O	O
were	O	O
collected	O	O
with	O	O
sterile	O	O
cotton	O	O
swabs	O	O
from	O	O
the	O	O
buccal	O	O
gingiva	O	O
of	O	O
the	O	O
lower	O	O
jaw	O	O
.	O	O

Two	O	O
swabs	O	O
per	O	O
animal	O	O
were	O	O
collected	O	O
,	O	O
followed	O	O
by	O	O
bacterial	O	O
isolation	O	O
under	O	O
both	O	O
aerobe	O	O
and	O	O
anaerobe	O	O
conditions	O	O
.	O	O

Microbiological	O	O
analyses	O	O
included	O	O
biochemical	O	O
tests	O	O
,	O	O
matrix-assisted	O	O
laser	O	O
desorption/ionization	O	O
time-of-flight	O	O
mass	O	O
spectrometry	O	O
and	O	O
16S	O	O
rDNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
.	O	O

A	O	O
total	O	O
of	O	O
61	O	O
taxa	O	O
were	O	O
detected	O	O
,	O	O
14-21	O	O
different	O	O
bacterial	O	O
taxa	O	O
from	O	O
each	O	O
minipig	O	O
.	O	O

Among	O	O
the	O	O
Gram-positive	O	O
cocci	O	O
,	O	O
mainly	O	O
staphylococcal	B-bacteria	B-bacteria
and	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
identified	O	O
.	O	O

Different	O	O
Actinomyces	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
abundant	O	O
taxa	O	O
in	O	O
the	O	O
group	O	O
of	O	O
Gram-positive	O	O
rods	O	O
.	O	O

Among	O	O
the	O	O
anaerobic	O	O
bacteria	O	O
,	O	O
the	O	O
Gram-negative	O	O
genera	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Bacteroides	B-bacteria	B-bacteria
and	O	O
Prevotella	B-bacteria	B-bacteria
were	O	O
the	O	O
most	O	O
often	O	O
observed	O	O
taxa	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
study	O	O
which	O	O
begins	O	O
to	O	O
describe	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
in	O	O
minipigs	O	O
in	O	O
cultures	O	O
to	O	O
allow	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
a	O	O
broad	O	O
spectrum	O	O
.	O	O

Several	O	O
bacterial	O	O
species	O	O
identified	O	O
are	O	O
different	O	O
from	O	O
human	O	O
ones	O	O
.	O	O

No	O	O
specific	O	O
species	O	O
for	O	O
peri-implantitis	O	O
could	O	O
be	O	O
detected	O	O
in	O	O
that	O	O
healthy	O	O
sample	O	O
.	O	O

Membrane-anchored	O	O
complement	O	O
regulatory	O	O
proteins	O	O
(	O	O
CRPs	O	O
)	O	O
,	O	O
including	O	O
CD46	O	O
,	O	O
CD55	O	O
,	O	O
and	O	O
CD59	O	O
,	O	O
protect	O	O
host	O	O
cells	O	O
from	O	O
complement	O	O
attack	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
whether	O	O
periodontopathogen	O	O
lipopolysaccharide	O	O
and	O	O
proinflammatory	O	O
cytokines	O	O
modulate	O	O
CRP	O	O
gene/protein	O	O
expression	O	O
in	O	O
human	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
lipopolysaccharide	O	O
of	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
were	O	O
the	O	O
most	O	O
potent	O	O
for	O	O
increasing	O	O
the	O	O
gene	O	O
expression	O	O
of	O	O
CD55	O	O
and	O	O
CD59	O	O
,	O	O
and	O	O
to	O	O
a	O	O
lesser	O	O
extent	O	O
CD46	O	O
,	O	O
after	O	O
a	O	O
48-h	O	O
stimulation	O	O
.	O	O

An	O	O
lipopolysaccharide-induced	O	O
upregulation	O	O
of	O	O
epithelial	O	O
cell-surface	O	O
CRP	O	O
was	O	O
also	O	O
demonstrated	O	O
.	O	O

The	O	O
stimulation	O	O
of	O	O
epithelial	O	O
cells	O	O
with	O	O
lipopolysaccharide	O	O
was	O	O
associated	O	O
with	O	O
interleukin-6	O	O
(	O	O
IL-6	O	O
)	O	O
and	O	O
IL-8	O	O
secretion	O	O
.	O	O

Although	O	O
these	O	O
two	O	O
cytokines	O	O
had	O	O
no	O	O
effect	O	O
on	O	O
CD46	O	O
and	O	O
CD55	O	O
gene	O	O
expression	O	O
in	O	O
epithelial	O	O
cells	O	O
,	O	O
IL-1beta	O	O
and	O	O
tumor	O	O
necrosis	O	O
factor-alpha	O	O
induced	O	O
a	O	O
significant	O	O
upregulation	O	O
.	O	O

The	O	O
cell-surface	O	O
expression	O	O
of	O	O
CRP	O	O
was	O	O
also	O	O
increased	O	O
by	O	O
the	O	O
stimulation	O	O
of	O	O
epithelial	O	O
cells	O	O
with	O	O
cytokines	O	O
.	O	O

The	O	O
CD46	O	O
,	O	O
CD55	O	O
,	O	O
and	O	O
CD59	O	O
gene/protein	O	O
expression	O	O
was	O	O
upregulated	O	O
by	O	O
periodontopathogen	O	O
lipopolysaccharide	O	O
and	O	O
proinflammatory	O	O
cytokines	O	O
.	O	O

It	O	O
can	O	O
be	O	O
hypothesized	O	O
that	O	O
,	O	O
when	O	O
faced	O	O
with	O	O
bacterial	O	O
challenges	O	O
and	O	O
inflammatory	O	O
conditions	O	O
associated	O	O
with	O	O
active	O	O
periodontal	O	O
sites	O	O
,	O	O
oral	O	O
epithelial	O	O
cells	O	O
may	O	O
respond	O	O
by	O	O
increasing	O	O
CRP	O	O
gene/protein	O	O
expression	O	O
to	O	O
avoid	O	O
cell	O	O
lysis	O	O
by	O	O
the	O	O
complement	O	O
system	O	O
,	O	O
which	O	O
is	O	O
activated	O	O
during	O	O
periodontitis	O	O
.	O	O

Primary	O	O
gingival	O	O
epithelial	O	O
cells	O	O
were	O	O
cultured	O	O
in	O	O
multilayers	O	O
as	O	O
a	O	O
model	O	O
for	O	O
the	O	O
study	O	O
of	O	O
interactions	O	O
with	O	O
oral	O	O
bacteria	O	O
associated	O	O
with	O	O
health	O	O
and	O	O
periodontal	O	O
disease	O	O
.	O	O

Multilayers	O	O
maintained	O	O
at	O	O
an	O	O
air-liquid	O	O
interface	O	O
in	O	O
low-calcium	O	O
medium	O	O
displayed	O	O
differentiation	O	O
and	O	O
cytokeratin	O	O
properties	O	O
characteristic	O	O
of	O	O
junctional	O	O
epithelium	O	O
.	O	O

Multilayers	O	O
were	O	O
infected	O	O
with	O	O
fluorescently	O	O
labeled	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
or	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
and	O	O
bacterial	O	O
association	O	O
was	O	O
determined	O	O
by	O	O
confocal	O	O
microscopy	O	O
and	O	O
quantitative	O	O
image	O	O
analysis	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
invaded	O	O
intracellularly	O	O
and	O	O
spread	O	O
from	O	O
cell	O	O
to	O	O
cell	O	O
;	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
remained	O	O
extracellular	O	O
and	O	O
showed	O	O
intercellular	O	O
movement	O	O
through	O	O
the	O	O
multilayer	O	O
;	O	O
whereas	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
remained	O	O
extracellular	O	O
and	O	O
predominantly	O	O
associated	O	O
with	O	O
the	O	O
superficial	O	O
cell	O	O
layer	O	O
.	O	O

None	O	O
of	O	O
the	O	O
bacterial	O	O
species	O	O
disrupted	O	O
barrier	O	O
function	O	O
as	O	O
measured	O	O
by	O	O
transepithelial	O	O
electrical	O	O
resistance	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
did	O	O
not	O	O
elicit	O	O
secretion	O	O
of	O	O
proinflammatory	O	O
cytokines	O	O
.	O	O

However	O	O
,	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
induced	O	O
interleukin-1beta	O	O
(	O	O
IL-1beta	O	O
)	O	O
,	O	O
tumor	O	O
necrosis	O	O
factor-alpha	O	O
(	O	O
TNF-alpha	O	O
)	O	O
,	O	O
IL-6	O	O
and	O	O
IL-8	O	O
secretion	O	O
;	O	O
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
stimulated	O	O
production	O	O
of	O	O
IL-1beta	O	O
and	O	O
TNF-alpha	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
but	O	O
not	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
increased	O	O
levels	O	O
of	O	O
apoptosis	O	O
after	O	O
24	O	O
h	O	O
infection	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
organisms	O	O
with	O	O
pathogenic	O	O
potential	O	O
were	O	O
able	O	O
to	O	O
traverse	O	O
the	O	O
epithelium	O	O
,	O	O
whereas	O	O
the	O	O
commensal	O	O
bacteria	O	O
did	O	O
not	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
distinct	O	O
host	O	O
responses	O	O
characterized	O	O
the	O	O
interaction	O	O
between	O	O
the	O	O
junctional	O	O
epithelium	O	O
and	O	O
oral	O	O
bacteria	O	O
.	O	O

In	O	O
the	O	O
oral	O	O
biofilm	O	O
,	O	O
the	O	O
'mitis	B-bacteria	B-bacteria
'	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
are	O	O
among	O	O
the	O	O
first	O	O
group	O	O
of	O	O
organisms	O	O
to	O	O
colonize	O	O
the	O	O
tooth	O	O
surface	O	O
.	O	O

Their	O	O
proliferation	O	O
is	O	O
thought	O	O
to	O	O
be	O	O
an	O	O
important	O	O
factor	O	O
required	O	O
for	O	O
antagonizing	O	O
the	O	O
growth	O	O
of	O	O
cariogenic	O	O
species	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
used	O	O
a	O	O
three-species	O	O
mixed	O	O
culture	O	O
to	O	O
demonstrate	O	O
that	O	O
another	O	O
ubiquitous	O	O
early	O	O
colonizing	O	O
species	O	O
,	O	O
Veillonella	B-bacteria	B-bacteria
parvula	B-bacteria	B-bacteria
,	O	O
can	O	O
greatly	O	O
affect	O	O
the	O	O
outcome	O	O
of	O	O
the	O	O
competition	O	O
between	O	O
a	O	O
pair	O	O
of	O	O
antagonists	O	O
such	O	O
as	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

Transcriptome	O	O
analysis	O	O
further	O	O
revealed	O	O
that	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
responds	O	O
differentially	O	O
to	O	O
its	O	O
friend	O	O
(	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
)	O	O
and	O	O
foe	O	O
(	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
)	O	O
.	O	O

In	O	O
the	O	O
mixed	O	O
culture	O	O
with	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
all	O	O
but	O	O
one	O	O
of	O	O
the	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
sugar	O	O
uptake	O	O
and	O	O
metabolic	O	O
genes	O	O
were	O	O
downregulated	O	O
,	O	O
while	O	O
genes	O	O
for	O	O
alternative	O	O
energy	O	O
source	O	O
utilization	O	O
and	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
tolerance	O	O
were	O	O
upregulated	O	O
,	O	O
resulting	O	O
in	O	O
a	O	O
slower	O	O
but	O	O
persistent	O	O
growth	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
when	O	O
cultured	O	O
with	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
grew	O	O
equally	O	O
well	O	O
or	O	O
better	O	O
than	O	O
in	O	O
monoculture	O	O
and	O	O
exhibited	O	O
relatively	O	O
few	O	O
changes	O	O
within	O	O
its	O	O
transcriptome	O	O
.	O	O

When	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
was	O	O
introduced	O	O
into	O	O
the	O	O
mixed	O	O
culture	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
it	O	O
rescued	O	O
the	O	O
growth	O	O
inhibition	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

In	O	O
this	O	O
three-species	O	O
environment	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
increased	O	O
the	O	O
expression	O	O
of	O	O
genes	O	O
required	O	O
for	O	O
the	O	O
uptake	O	O
and	O	O
metabolism	O	O
of	O	O
minor	O	O
sugars	O	O
,	O	O
while	O	O
genes	O	O
required	O	O
for	O	O
oxidative	O	O
stress	O	O
tolerance	O	O
were	O	O
downregulated	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
the	O	O
major	O	O
factors	O	O
that	O	O
affect	O	O
the	O	O
competition	O	O
between	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
are	O	O
carbohydrate	O	O
utilization	O	O
and	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
resistance	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
in	O	O
the	O	O
tri-species	O	O
culture	O	O
mitigates	O	O
these	O	O
two	O	O
major	O	O
factors	O	O
and	O	O
allows	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
proliferate	O	O
,	O	O
despite	O	O
the	O	O
presence	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

Despite	O	O
the	O	O
targeted	O	O
and	O	O
incidental	O	O
exposure	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
to	O	O
probiotic	O	O
bacteria	O	O
,	O	O
relatively	O	O
little	O	O
information	O	O
is	O	O
available	O	O
concerning	O	O
their	O	O
bacteriological	O	O
effects	O	O
or	O	O
ecological	O	O
fate	O	O
in	O	O
this	O	O
environment	O	O
.	O	O

We	O	O
have	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
an	O	O
oral	O	O
probiotic	O	O
bacterium	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
on	O	O
salivary	O	O
biofilm	O	O
microcosms	O	O
.	O	O

Nascent	O	O
in	O	O
vitro	O	O
plaques	O	O
in	O	O
hydroxyapatite	O	O
disc	O	O
model	O	O
and	O	O
mature	O	O
continuous	O	O
culture	O	O
plaques	O	O
within	O	O
constant	O	O
depth	O	O
film	O	O
fermenters	O	O
(	O	O
CDFFs	O	O
)	O	O
were	O	O
exposed	O	O
to	O	O
probiotic	O	O
strains	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
.	O	O

Microbial	O	O
composition	O	O
was	O	O
assessed	O	O
using	O	O
differential	O	O
viable	O	O
counting	O	O
and	O	O
CDFF	O	O
plaques	O	O
were	O	O
additionally	O	O
characterised	O	O
using	O	O
qPCR	O	O
and	O	O
PCR-DGGE	O	O
.	O	O

Probiotic	O	O
dosing	O	O
of	O	O
nascent	O	O
plaques	O	O
was	O	O
associated	O	O
with	O	O
significant	O	O
increases	O	O
in	O	O
lactobacilli	B-bacteria	B-bacteria
and	O	O
Gram-negative	O	O
anaerobes	O	O
in	O	O
both	O	O
biofilm	O	O
and	O	O
planktonic	O	O
phases	O	O
,	O	O
and	O	O
with	O	O
elevated	O	O
counts	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
the	O	O
planktonic	O	O
phase	O	O
that	O	O
were	O	O
not	O	O
accompanied	O	O
by	O	O
decreases	O	O
in	O	O
pH	O	O
.	O	O

In	O	O
mature	O	O
CDFF	O	O
plaques	O	O
,	O	O
differential	O	O
culture	O	O
indicated	O	O
that	O	O
whilst	O	O
significant	O	O
increases	O	O
in	O	O
lactobacillus	B-bacteria	B-bacteria
counts	O	O
occurred	O	O
during	O	O
dosing	O	O
,	O	O
numbers	O	O
of	O	O
other	O	O
bacterial	O	O
groups	O	O
and	O	O
pH	O	O
did	O	O
not	O	O
significantly	O	O
change	O	O
.	O	O

Monitoring	O	O
the	O	O
probiotic	O	O
strain	O	O
in	O	O
CDFFs	O	O
using	O	O
selective	O	O
culture	O	O
and	O	O
qPCR	O	O
indicated	O	O
that	O	O
the	O	O
exogenous	O	O
bacterium	O	O
reached	O	O
and	O	O
maintained	O	O
c.	O	O
5	O	O
log	O	O
(	O	O
10	O	O
)	O	O
CFU/mm	O	O
(	O	O
2	O	O
)	O	O
during	O	O
dosing	O	O
and	O	O
20	O	O
days	O	O
after	O	O
cessation	O	O
.	O	O

The	O	O
apparent	O	O
lack	O	O
of	O	O
marked	O	O
bacterial	O	O
inhibition	O	O
by	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
in	O	O
both	O	O
model	O	O
systems	O	O
was	O	O
supported	O	O
by	O	O
the	O	O
absence	O	O
of	O	O
antagonism	O	O
in	O	O
binary	O	O
antagonism	O	O
assays	O	O
.	O	O

The	O	O
largest	O	O
compositional	O	O
changes	O	O
occurred	O	O
in	O	O
nascent	O	O
plaques	O	O
where	O	O
the	O	O
addition	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
caused	O	O
significant	O	O
increases	O	O
in	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
Gram-negative	O	O
anaerobes	O	O
,	O	O
the	O	O
latter	O	O
possibly	O	O
via	O	O
lactate	O	O
syntrophy	O	O
.	O	O

Exogenous	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
persisted	O	O
in	O	O
mature	O	O
plaque	O	O
microcosms	O	O
after	O	O
dosing	O	O
ceased	O	O
.	O	O

The	O	O
present	O	O
study	O	O
aimed	O	O
to	O	O
develop	O	O
an	O	O
innovative	O	O
,	O	O
strain-specific	O	O
means	O	O
of	O	O
identifying	O	O
the	O	O
probiotic	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
TMC0356	E-bacteria	I-bacteria
and	O	O
to	O	O
determine	O	O
whether	O	O
orally	O	O
administered	O	O
TMC0356	B-bacteria	B-bacteria
could	O	O
be	O	O
recovered	O	O
from	O	O
the	O	O
human	O	O
intestine	O	O
.	O	O

High	O	O
molecular	O	O
weight	O	O
genomic	O	O
DNA	O	O
was	O	O
isolated	O	O
from	O	O
TMC0356	B-bacteria	B-bacteria
and	O	O
14	O	O
reference	O	O
strains	O	O
of	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
,	O	O
including	O	O
the	O	O
type	O	O
strain	O	O
.	O	O

The	O	O
DNA	O	O
samples	O	O
were	O	O
digested	O	O
with	O	O
the	O	O
selected	O	O
rare-cutting	O	O
restriction	O	O
endonucleases	O	O
SmaI	O	O
,	O	O
SacII	O	O
and	O	O
ApaI	O	O
and	O	O
the	O	O
resulting	O	O
fragments	O	O
separated	O	O
by	O	O
pulsed-field	O	O
gel	O	O
electrophoresis	O	O
(	O	O
PFGE	O	O
)	O	O
in	O	O
a	O	O
size	O	O
range	O	O
between	O	O
20	O	O
to	O	O
290	O	O
kb	O	O
.	O	O

TMC0356	B-bacteria	B-bacteria
could	O	O
be	O	O
distinguished	O	O
from	O	O
the	O	O
other	O	O
L.	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
on	O	O
the	O	O
basis	O	O
of	O	O
the	O	O
SmaI	O	O
and	O	O
SacII	O	O
macrorestriction	O	O
patterns	O	O
.	O	O

Furthermore	O	O
,	O	O
L.	B-bacteria	B-bacteria
gasseri	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
feces	O	O
of	O	O
subjects	O	O
who	O	O
had	O	O
ingested	O	O
TMC0356	B-bacteria	B-bacteria
were	O	O
identical	O	O
to	O	O
TMC0356	B-bacteria	B-bacteria
in	O	O
the	O	O
SmaI	O	O
,	O	O
SacII	O	O
and	O	O
ApaI	O	O
macrorestriction	O	O
fragments	O	O
of	O	O
digested	O	O
DNA	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
PFGE	O	O
of	O	O
genomic	O	O
DNA	O	O
digested	O	O
with	O	O
SmaI	O	O
,	O	O
SacII	O	O
,	O	O
could	O	O
be	O	O
a	O	O
practical	O	O
means	O	O
of	O	O
identification	O	O
of	O	O
TMC0356	B-bacteria	B-bacteria
.	O	O

Furthermore	O	O
,	O	O
these	O	O
results	O	O
indicate	O	O
that	O	O
ingested	O	O
TMC0356	B-bacteria	B-bacteria
can	O	O
survive	O	O
in	O	O
,	O	O
and	O	O
colonize	O	O
,	O	O
the	O	O
human	O	O
intestine	O	O
.	O	O

The	O	O
present	O	O
study	O	O
focused	O	O
on	O	O
the	O	O
antibacterial	O	O
and	O	O
biofilm	O	O
inhibitory	O	O
potential	O	O
of	O	O
4-epi-pimaric	O	O
acid	O	O
isolated	O	O
from	O	O
aerial	O	O
parts	O	O
(	O	O
stem	O	O
and	O	O
leaves	O	O
)	O	O
of	O	O
Aralia	O	O
cachemirica	O	O
L.	O	O
(	O	O
Araliaceae	O	O
)	O	O
against	O	O
oral	O	O
cavity	O	O
pathogens	O	O
.	O	O

4-epi-Pimaric	O	O
acid	O	O
exhibited	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
in	O	O
the	O	O
range	O	O
of	O	O
4-16	O	O
mug/ml	O	O
and	O	O
minimum	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
two-	O	O
to	O	O
four-folds	O	O
higher	O	O
than	O	O
MIC	O	O
.	O	O

There	O	O
was	O	O
significant	O	O
inhibition	O	O
in	O	O
the	O	O
biofilm	O	O
formation	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
on	O	O
the	O	O
saliva	O	O
coated	O	O
surface	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
confocal	O	O
microscopy	O	O
revealed	O	O
that	O	O
4-epi-pimaric	O	O
acid	O	O
inhibited	O	O
the	O	O
clumping	O	O
and	O	O
attachment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

At	O	O
8	O	O
x	O	O
MIC	O	O
concentration	O	O
,	O	O
it	O	O
significantly	O	O
prevented	O	O
the	O	O
pH	O	O
drop	O	O
and	O	O
reduced	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Increased	O	O
propidium	O	O
iodide	O	O
staining	O	O
and	O	O
leakage	O	O
of	O	O
260-	O	O
and	O	O
280-nm	O	O
absorbing	O	O
material	O	O
by	O	O
4-epi-pimaric	O	O
acid	O	O
treated	O	O
cells	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
suggested	O	O
that	O	O
it	O	O
probably	O	O
causes	O	O
disruption	O	O
of	O	O
the	O	O
cytoplasmic	O	O
membrane	O	O
structure	O	O
.	O	O

It	O	O
also	O	O
exhibited	O	O
significant	O	O
suppression	O	O
of	O	O
TNF-alpha	O	O
expression	O	O
in	O	O
human	O	O
neutrophils	O	O
,	O	O
suggestive	O	O
of	O	O
its	O	O
anti-inflammatory	O	O
activity	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
compound	O	O
was	O	O
found	O	O
to	O	O
be	O	O
significantly	O	O
safe	O	O
(	O	O
IC	O	O
(	O	O
50	O	O
)	O	O
>	O	O
100	O	O
mug/ml	O	O
)	O	O
in	O	O
the	O	O
MTT	O	O
assay	O	O
on	O	O
AML-12	O	O
cell	O	O
lines	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
4-epi-pimaric	O	O
acid	O	O
showed	O	O
promising	O	O
antibacterial	O	O
,	O	O
anti-biofilm	O	O
and	O	O
anti-inflammatory	O	O
potency	O	O
and	O	O
this	O	O
compound	O	O
can	O	O
be	O	O
exploited	O	O
for	O	O
therapeutic	O	O
application	O	O
in	O	O
oral	O	O
microbial	O	O
infections	O	O
.	O	O

Research	O	O
using	O	O
low	O	O
frequency	O	O
atmospheric	O	O
pressure	O	O
plasma	O	O
jets	O	O
(	O	O
LF	O	O
jet	O	O
)	O	O
is	O	O
becoming	O	O
increasingly	O	O
more	O	O
common	O	O
.	O	O

We	O	O
carried	O	O
out	O	O
experiments	O	O
to	O	O
evaluate	O	O
the	O	O
sterilizing	O	O
effects	O	O
of	O	O
this	O	O
technology	O	O
on	O	O
oral	O	O
pathogenic	O	O
microorganisms	O	O
(	O	O
S.mutans	B-bacteria	B-bacteria
,	O	O
C.albicans	O	O
and	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
)	O	O
and	O	O
to	O	O
determine	O	O
its	O	O
potential	O	O
for	O	O
clinical	O	O
application	O	O
.	O	O

We	O	O
performed	O	O
the	O	O
direct	O	O
exposure	O	O
test	O	O
on	O	O
a	O	O
solid	O	O
surface	O	O
,	O	O
indirect	O	O
exposure	O	O
test	O	O
on	O	O
a	O	O
liquid	O	O
phase	O	O
,	O	O
and	O	O
ROS	O	O
(	O	O
reactive	O	O
oxygen	O	O
species	O	O
)	O	O
inhibitory	O	O
test	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
the	O	O
LF	O	O
jet	O	O
had	O	O
microbicidal	O	O
effects	O	O
on	O	O
oral	O	O
pathogens	O	O
,	O	O
and	O	O
that	O	O
the	O	O
ROS	O	O
influenced	O	O
this	O	O
sterilization	O	O
effect	O	O
.	O	O

The	O	O
experiments	O	O
of	O	O
this	O	O
study	O	O
revealed	O	O
that	O	O
LF	O	O
jet	O	O
had	O	O
a	O	O
sterilizing	O	O
effect	O	O
on	O	O
oral	O	O
pathogenic	O	O
microorganisms	O	O
present	O	O
in	O	O
both	O	O
the	O	O
solid	O	O
and	O	O
liquid	O	O
phases	O	O
.	O	O

The	O	O
sterilizing	O	O
mechanism	O	O
was	O	O
considered	O	O
to	O	O
be	O	O
related	O	O
to	O	O
the	O	O
effect	O	O
of	O	O
superoxide	O	O
anion	O	O
radicals	O	O
.	O	O

These	O	O
results	O	O
indicate	O	O
that	O	O
LF	O	O
jets	O	O
may	O	O
represent	O	O
a	O	O
novel	O	O
technology	O	O
that	O	O
can	O	O
be	O	O
applied	O	O
to	O	O
the	O	O
field	O	O
of	O	O
clinical	O	O
dentistry	O	O
.	O	O

Suppression	O	O
of	O	O
immune	O	O
system	O	O
in	O	O
treated	O	O
cancer	O	O
patients	O	O
may	O	O
lead	O	O
to	O	O
secondary	O	O
infections	O	O
that	O	O
obviate	O	O
the	O	O
need	O	O
of	O	O
antibiotics	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
an	O	O
attempt	O	O
was	O	O
made	O	O
to	O	O
understand	O	O
the	O	O
occurrence	O	O
of	O	O
secondary	O	O
infections	O	O
in	O	O
immuno-suppressed	O	O
patients	O	O
along	O	O
with	O	O
herbal	O	O
control	O	O
of	O	O
these	O	O
infections	O	O
with	O	O
the	O	O
following	O	O
objectives	O	O
to	O	O
:	O	O
(	O	O
a	O	O
)	O	O
isolate	O	O
the	O	O
microbial	O	O
species	O	O
from	O	O
the	O	O
treated	O	O
oral	O	O
cancer	O	O
patients	O	O
along	O	O
with	O	O
the	O	O
estimation	O	O
of	O	O
absolute	O	O
neutrophile	O	O
counts	O	O
of	O	O
patients	O	O
(	O	O
b	O	O
)	O	O
assess	O	O
the	O	O
in	O	O
vitro	O	O
antimicrobial	O	O
activity	O	O
medicinal	O	O
plants	O	O
against	O	O
the	O	O
above	O	O
clinical	O	O
isolates	O	O
.	O	O

Blood	O	O
and	O	O
oral	O	O
swab	O	O
cultures	O	O
were	O	O
taken	O	O
from	O	O
40	O	O
oral	O	O
cancer	O	O
patients	O	O
undergoing	O	O
treatment	O	O
in	O	O
the	O	O
radiotherapy	O	O
unit	O	O
of	O	O
Regional	O	O
Cancer	O	O
Institute	O	O
,	O	O
Pt	O	O
.	O	O
B.D.S	O	O
.	O	O

Health	O	O
University	O	O
,	O	O
Rohtak	O	O
,	O	O
Haryana	O	O
.	O	O

Clinical	O	O
isolates	O	O
were	O	O
identified	O	O
by	O	O
following	O	O
general	O	O
microbiological	O	O
,	O	O
staining	O	O
and	O	O
biochemical	O	O
methods	O	O
.	O	O

The	O	O
absolute	O	O
neutrophile	O	O
counts	O	O
were	O	O
done	O	O
by	O	O
following	O	O
the	O	O
standard	O	O
methods	O	O
.	O	O

The	O	O
medicinal	O	O
plants	O	O
selected	O	O
for	O	O
antimicrobial	O	O
activity	O	O
analysis	O	O
were	O	O
Asphodelus	O	O
tenuifolius	O	O
Cav.	O	O
,	O	O
Asparagus	O	O
racemosus	O	O
Willd.	O	O
,	O	O
Balanites	O	O
aegyptiaca	O	O
L.	O	O
,	O	O
Cestrum	O	O
diurnum	O	O
L.	O	O
,	O	O
Cordia	O	O
dichotoma	O	O
G.	O	O
Forst	O	O
,	O	O
Eclipta	O	O
alba	O	O
L.	O	O
,	O	O
Murraya	O	O
koenigii	O	O
(	O	O
L.	O	O
)	O	O
Spreng	O	O
.	O	O

,	O	O
Pedalium	O	O
murex	O	O
L.	O	O
,	O	O
Ricinus	O	O
communis	O	O
L.	O	O
and	O	O
Trigonella	O	O
foenum	O	O
graecum	O	O
L.	O	O
The	O	O
antimicrobial	O	O
efficacy	O	O
of	O	O
medicinal	O	O
plants	O	O
was	O	O
evaluated	O	O
by	O	O
modified	O	O
Kirby-Bauer	O	O
disc	O	O
diffusion	O	O
method	O	O
.	O	O

MIC	O	O
and	O	O
MFC	O	O
were	O	O
investigated	O	O
by	O	O
serial	O	O
two	O	O
fold	O	O
microbroth	O	O
dilution	O	O
method	O	O
.	O	O

Prevalent	O	O
bacterial	O	O
pathogens	O	O
isolated	O	O
were	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
23.2	O	O
%	O	O
)	O	O
,	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
(	O	O
15.62	O	O
%	O	O
)	O	O
,	O	O
Staphylococcus	B-bacteria	B-bacteria
epidermidis	E-bacteria	I-bacteria
(	O	O
12.5	O	O
%	O	O
)	O	O
,	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
9.37	O	O
%	O	O
)	O	O
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumonia	E-bacteria	I-bacteria
(	O	O
7.81	O	O
%	O	O
)	O	O
,	O	O
Proteus	B-bacteria	B-bacteria
mirabilis	E-bacteria	I-bacteria
(	O	O
3.6	O	O
%	O	O
)	O	O
,	O	O
Proteus	B-bacteria	B-bacteria
vulgaris	E-bacteria	I-bacteria
(	O	O
4.2	O	O
%	O	O
)	O	O
and	O	O
the	O	O
fungal	O	O
pathogens	O	O
were	O	O
Candida	O	O
albicans	O	O
(	O	O
14.6	O	O
%	O	O
)	O	O
,	O	O
Aspergillus	O	O
fumigatus	O	O
(	O	O
9.37	O	O
%	O	O
)	O	O
.	O	O

Out	O	O
of	O	O
40	O	O
cases	O	O
,	O	O
35	O	O
(	O	O
87.5	O	O
%	O	O
)	O	O
were	O	O
observed	O	O
as	O	O
neutropenic	O	O
.	O	O

Eight	O	O
medicinal	O	O
plants	O	O
(	O	O
A.	O	O
tenuifolius	O	O
,	O	O
A.	O	O
racemosus	O	O
,	O	O
B.	O	O
aegyptiaca	O	O
,	O	O
E.	O	O
alba	O	O
,	O	O
M.	O	O
koenigii	O	O
,	O	O
P.	O	O
murex	O	O
R.	O	O
communis	O	O
and	O	O
T.	O	O
foenum	O	O
graecum	O	O
)	O	O
showed	O	O
significant	O	O
antimicrobial	O	O
activity	O	O
(	O	O
P	O	O
<	O	O
.05	O	O
)	O	O
against	O	O
most	O	O
of	O	O
the	O	O
isolates	O	O
.	O	O

The	O	O
MIC	O	O
and	O	O
MFC	O	O
values	O	O
were	O	O
ranged	O	O
from	O	O
31	O	O
to	O	O
500	O	O
mug/ml	O	O
.	O	O

P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
was	O	O
observed	O	O
highest	O	O
susceptible	O	O
bacteria	O	O
(	O	O
46.6	O	O
%	O	O
)	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
susceptible	O	O
index	O	O
.	O	O

It	O	O
can	O	O
be	O	O
concluded	O	O
that	O	O
treated	O	O
oral	O	O
cancer	O	O
patients	O	O
were	O	O
neutropenic	O	O
and	O	O
prone	O	O
to	O	O
secondary	O	O
infection	O	O
of	O	O
microbes	O	O
.	O	O

The	O	O
medicinal	O	O
plant	O	O
can	O	O
prove	O	O
as	O	O
effective	O	O
antimicrobial	O	O
agent	O	O
to	O	O
check	O	O
the	O	O
secondary	O	O
infections	O	O
in	O	O
treated	O	O
cancer	O	O
patients	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
quantify	O	O
nine	O	O
selected	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
plaque	O	O
from	O	O
sound	O	O
root	O	O
surfaces	O	O
and	O	O
initial	O	O
carious	O	O
root	O	O
lesions	O	O
using	O	O
TaqMan	O	O
PCR	O	O
and	O	O
to	O	O
analyse	O	O
a	O	O
putative	O	O
dependence	O	O
on	O	O
the	O	O
kind	O	O
of	O	O
initial	O	O
periodontal	O	O
treatment	O	O
.	O	O

Fifty-four	O	O
subjects	O	O
with	O	O
generalized	O	O
chronic	O	O
periodontitis	O	O
were	O	O
randomly	O	O
allocated	O	O
to	O	O
one	O	O
of	O	O
the	O	O
following	O	O
initial	O	O
periodontal	O	O
therapies	O	O
:	O	O
full-mouth	O	O
disinfection	O	O
,	O	O
full-mouth	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
or	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
within	O	O
7	O	O
days	O	O
.	O	O

Plaque	O	O
samples	O	O
were	O	O
taken	O	O
before	O	O
and	O	O
after	O	O
periodontal	O	O
treatment	O	O
and	O	O
analysed	O	O
by	O	O
TaqMan	O	O
PCR	O	O
.	O	O

The	O	O
quantity	O	O
of	O	O
the	O	O
cariogenic	O	O
bacteria	O	O
Actinomyces	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Lactobacilllus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
dentocariosa	E-bacteria	I-bacteria
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
mucosa	E-bacteria	I-bacteria
were	O	O
significantly	O	O
higher	O	O
,	O	O
while	O	O
the	O	O
quantity	O	O
of	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
was	O	O
significantly	O	O
lower	O	O
on	O	O
initial	O	O
carious	O	O
lesions	O	O
than	O	O
on	O	O
the	O	O
sound	O	O
surfaces	O	O
both	O	O
before	O	O
and	O	O
after	O	O
periodontal	O	O
therapy	O	O
.	O	O

No	O	O
significant	O	O
differences	O	O
could	O	O
be	O	O
found	O	O
in	O	O
any	O	O
of	O	O
the	O	O
tested	O	O
bacteria	O	O
except	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
on	O	O
initial	O	O
carious	O	O
lesions	O	O
and	O	O
sound	O	O
surfaces	O	O
for	O	O
both	O	O
examinations	O	O
between	O	O
the	O	O
groups	O	O
.	O	O

All	O	O
the	O	O
nine	O	O
species	O	O
analysed	O	O
were	O	O
found	O	O
to	O	O
be	O	O
present	O	O
in	O	O
initial	O	O
carious	O	O
root	O	O
lesions	O	O
as	O	O
well	O	O
as	O	O
sound	O	O
root	O	O
surfaces	O	O
but	O	O
in	O	O
different	O	O
quantities	O	O
,	O	O
independent	O	O
of	O	O
the	O	O
different	O	O
periodontal	O	O
therapies	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
effect	O	O
of	O	O
PG0839	O	O
gene	O	O
form	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
on	O	O
inflammatory	O	O
cytokine	O	O
expression	O	O
in	O	O
human	O	O
oral	O	O
epidermoid	O	O
carcinoma	O	O
KB	O	O
cell	O	O
.	O	O

A	O	O
mutant	O	O
in	O	O
the	O	O
PG0839	O	O
gene	O	O
of	O	O
Pg	B-bacteria	B-bacteria
was	O	O
created	O	O
by	O	O
insertional	O	O
inactivation	O	O
.	O	O

Group	O	O
1	O	O
was	O	O
chanllenged	O	O
with	O	O
PgW83	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
,	O	O
group	O	O
2	O	O
with	O	O
PG0839-defective	B-bacteria	B-bacteria
mutant	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
control	O	O
group	O	O
with	O	O
Dulbecco	O	O
's	O	O
modified	O	O
Eagle's	O	O
medium	O	O
only	O	O
.	O	O

KB	O	O
cells	O	O
were	O	O
co-cultured	O	O
with	O	O
presence	O	O
of	O	O
bacteria	O	O
for	O	O
24	O	O
h.	O	O
At	O	O
the	O	O
time	O	O
point	O	O
of	O	O
0.5	O	O
,	O	O
2	O	O
,	O	O
6	O	O
,	O	O
12	O	O
and	O	O
24	O	O
h	O	O
,	O	O
cells	O	O
were	O	O
stored	O	O
in	O	O
Trizol	O	O
.	O	O

The	O	O
mRNA	O	O
expression	O	O
of	O	O
interleukin-1beta	O	O
(	O	O
IL-1beta	O	O
)	O	O
and	O	O
Toll	O	O
like	O	O
recepector-4	O	O
(	O	O
TLR-4	O	O
)	O	O
was	O	O
examined	O	O
by	O	O
reverse	O	O
transcription	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

At	O	O
2	O	O
h	O	O
and	O	O
6	O	O
h	O	O
,	O	O
IL-1beta	O	O
mRNA	O	O
expression	O	O
was	O	O
lower	O	O
in	O	O
group	O	O
2	O	O
than	O	O
in	O	O
group	O	O
1	O	O
(	O	O
2	O	O
h	O	O
:	O	O
0.31	O	O
+/-	O	O
0.11	O	O
versus	O	O
0.95	O	O
+/-	O	O
0.48	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
;	O	O
6	O	O
h	O	O
:	O	O
0.57	O	O
+/-	O	O
0.20	O	O
versus	O	O
1.29	O	O
+/-	O	O
0.55	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

At	O	O
0.5	O	O
h	O	O
and	O	O
6	O	O
h	O	O
,	O	O
TLR-4	O	O
mRNA	O	O
expression	O	O
was	O	O
lower	O	O
in	O	O
group	O	O
2	O	O
than	O	O
in	O	O
group	O	O
1	O	O
(	O	O
0.5	O	O
h	O	O
:	O	O
0.20	O	O
+/-	O	O
0.09	O	O
versus	O	O
0.58	O	O
+/-	O	O
0.09	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
;	O	O
6	O	O
h	O	O
:	O	O
0.34	O	O
+/-	O	O
0.04	O	O
versus	O	O
0.71	O	O
+/-	O	O
0.18	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

PG0839	O	O
gene	O	O
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
Pg-induced	O	O
inflammatory	O	O
effects	O	O
of	O	O
KB	O	O
cell	O	O
.	O	O

Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
a	O	O
Gram-negative	O	O
anaerobe	O	O
implicated	O	O
in	O	O
periodontitis	O	O
,	O	O
has	O	O
been	O	O
detected	O	O
within	O	O
human	O	O
buccal	O	O
epithelial	O	O
cells	O	O
and	O	O
shown	O	O
to	O	O
invade	O	O
oral	O	O
epithelial	O	O
cells	O	O
in	O	O
vitro	O	O
.	O	O

We	O	O
have	O	O
previously	O	O
shown	O	O
that	O	O
this	O	O
bacterium	O	O
triggers	O	O
host	O	O
tyrosine	O	O
kinase-dependent	O	O
phosphorylation	O	O
and	O	O
actin-dependent	O	O
cytoskeleton	O	O
reorganization	O	O
for	O	O
invasion	O	O
.	O	O

On	O	O
the	O	O
bacterial	O	O
side	O	O
,	O	O
the	O	O
leucine-rich	O	O
repeat	O	O
cell-surface	O	O
BspA	O	O
protein	O	O
is	O	O
important	O	O
for	O	O
entry	O	O
.	O	O

The	O	O
present	O	O
study	O	O
was	O	O
undertaken	O	O
to	O	O
identify	O	O
host	O	O
signalling	O	O
molecules	O	O
during	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
entry	O	O
into	O	O
human	O	O
oral	O	O
and	O	O
cervical	O	O
epithelial	O	O
cells	O	O
.	O	O

Specifically	O	O
,	O	O
the	O	O
roles	O	O
of	O	O
phosphatidylinositol	O	O
3-kinase	O	O
(	O	O
PI3K	O	O
)	O	O
,	O	O
Rho-family	O	O
GTPases	O	O
,	O	O
cholesterol-rich	O	O
membrane	O	O
microdomains	O	O
and	O	O
the	O	O
endocytic	O	O
protein	O	O
clathrin	O	O
were	O	O
investigated	O	O
.	O	O

For	O	O
this	O	O
purpose	O	O
,	O	O
cell	O	O
lines	O	O
were	O	O
pretreated	O	O
with	O	O
chemical	O	O
inhibitors	O	O
or	O	O
small	O	O
interfering	O	O
RNAs	O	O
(	O	O
siRNAs	O	O
)	O	O
that	O	O
target	O	O
PI3Ks	O	O
,	O	O
Rho	O	O
GTPases	O	O
,	O	O
clathrin	O	O
and	O	O
cholesterol	O	O
(	O	O
a	O	O
critical	O	O
component	O	O
of	O	O
'lipid	O	O
rafts	O	O
'	O	O
)	O	O
,	O	O
and	O	O
the	O	O
resulting	O	O
effects	O	O
on	O	O
T.	O	O
forsythia	O	O
uptake	O	O
were	O	O
determined	O	O
.	O	O

Our	O	O
studies	O	O
revealed	O	O
that	O	O
T.	O	O
forsythia	O	O
entry	O	O
is	O	O
dependent	O	O
on	O	O
host	O	O
PI3K	O	O
signalling	O	O
,	O	O
and	O	O
that	O	O
purified	O	O
BspA	O	O
protein	O	O
causes	O	O
activation	O	O
of	O	O
this	O	O
lipid	O	O
kinase	O	O
.	O	O

Bacterial	O	O
entry	O	O
also	O	O
requires	O	O
the	O	O
cooperation	O	O
of	O	O
host	O	O
Rac1	O	O
GTPase	O	O
.	O	O

Finally	O	O
,	O	O
our	O	O
findings	O	O
indicate	O	O
an	O	O
important	O	O
role	O	O
for	O	O
clathrin	O	O
and	O	O
cholesterol-rich	O	O
lipid	O	O
microdomains	O	O
in	O	O
the	O	O
internalization	O	O
process	O	O
.	O	O

Cumulative	O	O
interceptive	O	O
supportive	O	O
therapy	O	O
(	O	O
CIST	O	O
)	O	O
is	O	O
currently	O	O
used	O	O
as	O	O
a	O	O
guideline	O	O
for	O	O
treating	O	O
peri-implant	O	O
diseases	O	O
.	O	O

The	O	O
objectives	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
determine	O	O
the	O	O
detection	O	O
rate	O	O
and	O	O
measure	O	O
the	O	O
number	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
lesions	O	O
of	O	O
different	O	O
CIST	O	O
levels	O	O
and	O	O
thereby	O	O
characterize	O	O
peri-implant	O	O
disease	O	O
from	O	O
a	O	O
bacteriological	O	O
viewpoint	O	O
.	O	O

This	O	O
study	O	O
included	O	O
105	O	O
patients	O	O
who	O	O
had	O	O
both	O	O
residual	O	O
natural	O	O
teeth	O	O
and	O	O
implants	O	O
with	O	O
peri-implant	O	O
disease	O	O
.	O	O

A	O	O
total	O	O
of	O	O
105	O	O
implants	O	O
were	O	O
divided	O	O
into	O	O
levels	O	O
A	O	O
,	O	O
B	O	O
,	O	O
C	O	O
and	O	O
D	O	O
according	O	O
to	O	O
the	O	O
CIST	O	O
classification	O	O
.	O	O

Bacterial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
peri-implant	O	O
pockets	O	O
and	O	O
four	O	O
periodontopathic	O	O
bacteria	O	O
were	O	O
measured	O	O
by	O	O
PCR	O	O
and	O	O
PCR-Invader	O	O
assay	O	O
.	O	O

The	O	O
number	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
increased	O	O
in	O	O
line	O	O
with	O	O
CIST	O	O
level	O	O
,	O	O
and	O	O
the	O	O
detection	O	O
rate	O	O
was	O	O
also	O	O
associated	O	O
with	O	O
CIST	O	O
level	O	O
.	O	O

However	O	O
,	O	O
no	O	O
difference	O	O
was	O	O
found	O	O
in	O	O
the	O	O
bacterial	O	O
detection	O	O
rate	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
between	O	O
CIST-B	O	O
and	O	O
CIST-C	O	O
.	O	O

There	O	O
was	O	O
a	O	O
higher	O	O
detection	O	O
rate	O	O
of	O	O
all	O	O
periodontopathic	O	O
bacteria	O	O
for	O	O
CIST-D	O	O
.	O	O

The	O	O
number	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
detection	O	O
rate	O	O
increased	O	O
as	O	O
peri-implant	O	O
disease	O	O
advanced	O	O
.	O	O

However	O	O
,	O	O
there	O	O
were	O	O
no	O	O
major	O	O
differences	O	O
in	O	O
the	O	O
detection	O	O
rate	O	O
between	O	O
CIST-B	O	O
and	O	O
CIST-C.	O	O
On	O	O
the	O	O
other	O	O
hand	O	O
,	O	O
a	O	O
higher	O	O
detection	O	O
rate	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
was	O	O
seen	O	O
for	O	O
CIST-D	O	O
.	O	O

The	O	O
mitis	B-bacteria	B-bacteria
group	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MGS	B-bacteria	B-bacteria
)	O	O
are	O	O
widespread	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
are	O	O
traditionally	O	O
associated	O	O
with	O	O
oral	O	O
health	O	O
.	O	O

However	O	O
,	O	O
these	O	O
organisms	O	O
have	O	O
many	O	O
attributes	O	O
that	O	O
contribute	O	O
to	O	O
the	O	O
development	O	O
of	O	O
pathogenic	O	O
oral	O	O
communities	O	O
.	O	O

MGS	B-bacteria	B-bacteria
adhere	O	O
rapidly	O	O
to	O	O
saliva-coated	O	O
tooth	O	O
surfaces	O	O
,	O	O
thereby	O	O
providing	O	O
an	O	O
attachment	O	O
substratum	O	O
for	O	O
more	O	O
overtly	O	O
pathogenic	O	O
organisms	O	O
such	O	O
as	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
the	O	O
two	O	O
species	O	O
assemble	O	O
into	O	O
heterotypic	O	O
communities	O	O
.	O	O

Close	O	O
physical	O	O
association	O	O
facilitates	O	O
physiologic	O	O
support	O	O
,	O	O
and	O	O
pathogens	O	O
such	O	O
as	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
display	O	O
resource	O	O
partitioning	O	O
to	O	O
favour	O	O
carbon	O	O
sources	O	O
generated	O	O
by	O	O
streptococcal	O	O
metabolism	O	O
.	O	O

MGS	B-bacteria	B-bacteria
exchange	O	O
information	O	O
with	O	O
community	O	O
members	O	O
through	O	O
a	O	O
number	O	O
of	O	O
interspecies	O	O
signalling	O	O
systems	O	O
including	O	O
AI-2	O	O
and	O	O
contact	O	O
dependent	O	O
mechanisms	O	O
.	O	O

Signal	O	O
transduction	O	O
systems	O	O
induced	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
are	O	O
based	O	O
on	O	O
protein	O	O
dephosphorylation	O	O
mediated	O	O
by	O	O
the	O	O
tyrosine	O	O
phosphatase	O	O
Ltp1	O	O
,	O	O
and	O	O
converge	O	O
on	O	O
a	O	O
LuxR-family	O	O
transcriptional	O	O
regulator	O	O
,	O	O
CdhR	O	O
.	O	O

Phenotypic	O	O
responses	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
include	O	O
regulation	O	O
of	O	O
hemin	O	O
uptake	O	O
systems	O	O
and	O	O
gingipain	O	O
activity	O	O
,	O	O
processes	O	O
that	O	O
are	O	O
intimately	O	O
linked	O	O
to	O	O
the	O	O
virulence	O	O
of	O	O
the	O	O
organism	O	O
.	O	O

Furthermore	O	O
,	O	O
communities	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
with	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
are	O	O
more	O	O
pathogenic	O	O
in	O	O
animal	O	O
models	O	O
than	O	O
the	O	O
constituent	O	O
species	O	O
alone	O	O
.	O	O

We	O	O
propose	O	O
that	O	O
MGS	B-bacteria	B-bacteria
should	O	O
be	O	O
considered	O	O
accessory	O	O
pathogens	O	O
,	O	O
organisms	O	O
whose	O	O
pathogenic	O	O
potential	O	O
only	O	O
becomes	O	O
evident	O	O
in	O	O
the	O	O
context	O	O
of	O	O
a	O	O
heterotypic	O	O
microbial	O	O
community	O	O
.	O	O

Early	O	O
in	O	O
life	O	O
,	O	O
vaginally	O	O
delivered	O	O
infants	O	O
exhibit	O	O
a	O	O
different	O	O
composition	O	O
of	O	O
the	O	O
gut	O	O
flora	O	O
compared	O	O
with	O	O
infants	O	O
delivered	O	O
by	O	O
caesarean	O	O
section	O	O
(	O	O
C-section	O	O
)	O	O
;	O	O
however	O	O
,	O	O
it	O	O
is	O	O
unclear	O	O
whether	O	O
this	O	O
also	O	O
applies	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

AIM	O	O
.	O	O

To	O	O
investigate	O	O
and	O	O
compare	O	O
the	O	O
oral	O	O
microbial	O	O
profile	O	O
between	O	O
infants	O	O
delivered	O	O
vaginally	O	O
and	O	O
by	O	O
C-section	O	O
.	O	O

This	O	O
is	O	O
a	O	O
cross-sectional	O	O
case-control	O	O
study	O	O
.	O	O

Eighty-four	O	O
infants	O	O
delivered	O	O
either	O	O
vaginally	O	O
(	O	O
n	O	O
=	O	O
42	O	O
)	O	O
or	O	O
by	O	O
C-section	O	O
(	O	O
n	O	O
=	O	O
42	O	O
)	O	O
were	O	O
randomly	O	O
selected	O	O
from	O	O
the	O	O
2009	O	O
birth	O	O
cohort	O	O
at	O	O
the	O	O
County	O	O
Hospital	O	O
in	O	O
Halmstad	O	O
,	O	O
Sweden	O	O
.	O	O

Medically	O	O
compromised	O	O
and	O	O
premature	O	O
children	O	O
(	O	O
<	O	O
32	O	O
weeks	O	O
)	O	O
were	O	O
excluded	O	O
.	O	O

The	O	O
mean	O	O
age	O	O
was	O	O
8.25	O	O
months	O	O
(	O	O
range	O	O
6-10	O	O
months	O	O
)	O	O
,	O	O
and	O	O
parents	O	O
were	O	O
asked	O	O
to	O	O
complete	O	O
a	O	O
questionnaire	O	O
on	O	O
socioeconomic	O	O
factors	O	O
,	O	O
lifestyle	O	O
,	O	O
and	O	O
hygiene	O	O
habits	O	O
.	O	O

Saliva	O	O
was	O	O
collected	O	O
and	O	O
analysed	O	O
using	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

RESULTS	O	O
.	O	O

A	O	O
higher	O	O
prevalence	O	O
of	O	O
salivary	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
curvata	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
and	O	O
Lactobacuillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
infants	O	O
delivered	O	O
vaginally	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
caries-associated	O	O
bacteria	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
63	O	O
%	O	O
and	O	O
59	O	O
%	O	O
of	O	O
all	O	O
children	O	O
,	O	O
respectively	O	O
.	O	O

A	O	O
significantly	O	O
higher	O	O
prevalence	O	O
of	O	O
certain	O	O
strains	O	O
of	O	O
health-related	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
was	O	O
found	O	O
in	O	O
vaginally	O	O
delivered	O	O
infants	O	O
compared	O	O
with	O	O
infants	O	O
delivered	O	O
by	O	O
C-section	O	O
.	O	O

The	O	O
possible	O	O
long-term	O	O
effects	O	O
on	O	O
oral	O	O
health	O	O
need	O	O
to	O	O
be	O	O
further	O	O
investigated	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
inhibitory	O	O
effect	O	O
of	O	O
a	O	O
commercially	O	O
available	O	O
essential	O	O
oil-containing	O	O
mouth	O	O
rinse	O	O
12	O	O
hours	O	O
after	O	O
a	O	O
single	O	O
rinse	O	O
and	O	O
two	O	O
weeks	O	O
of	O	O
twice	O	O
daily	O	O
rinsing	O	O
,	O	O
on	O	O
volatile	O	O
sulphur		O	O
compounds	O	O
(	O	O
VSC	O	O
)	O	O
producing	O	O
bacteria	O	O
on	O	O
the	O	O
tongue	O	O
.	O	O

The	O	O
study	O	O
was	O	O
a	O	O
randomized	O	O
,	O	O
double-blind	O	O
,	O	O
controlled	O	O
crossover	O	O
design	O	O
.	O	O

Thirty-six	O	O
healthy	O	O
subjects	O	O
,	O	O
aged	O	O
20-48	O	O
years	O	O
,	O	O
volunteered	O	O
to	O	O
participate	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Subjects	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
rinse	O	O
twice	O	O
daily	O	O
with	O	O
either	O	O
an	O	O
essential	O	O
oil-containing	O	O
mouth	O	O
rinse	O	O
(	O	O
Cool	O	O
Mint	O	O
Listerine	O	O
Antiseptic	O	O
)	O	O
or	O	O
a	O	O
negative	O	O
control	O	O
rinse	O	O
.	O	O

Bacteria	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
at	O	O
baseline	O	O
,	O	O
after	O	O
the	O	O
first	O	O
rinse	O	O
and	O	O
two	O	O
weeks	O	O
later	O	O
.	O	O

They	O	O
were	O	O
plated	O	O
on	O	O
OOPS	O	O
medium	O	O
to	O	O
enumerate	O	O
the	O	O
VSC-producing	O	O
bacteria	O	O
.	O	O

Intergroup	O	O
comparisons	O	O
of	O	O
log10	O	O
transformed	O	O
colony-forming	O	O
units	O	O
of	O	O
the	O	O
samples	O	O
were	O	O
made	O	O
using	O	O
analysis	O	O
of	O	O
covariance	O	O
.	O	O

Each	O	O
comparison	O	O
was	O	O
performed	O	O
at	O	O
a	O	O
5	O	O
%	O	O
significance	O	O
level	O	O
.	O	O

The	O	O
mean	O	O
VSC-producing	O	O
bacteria	O	O
in	O	O
subjects	O	O
using	O	O
the	O	O
essential	O	O
oil	O	O
mouth	O	O
rinse	O	O
were	O	O
significantly	O	O
lower	O	O
than	O	O
those	O	O
using	O	O
the	O	O
control	O	O
rinse	O	O
twice	O	O
daily	O	O
.	O	O

In	O	O
healthy	O	O
subjects	O	O
,	O	O
rinsing	O	O
with	O	O
an	O	O
essential	O	O
oil-containing	O	O
mouth	O	O
rinse	O	O
can	O	O
have	O	O
a	O	O
significant	O	O
effect	O	O
on	O	O
VSC-producing	O	O
bacteria	O	O
on	O	O
the	O	O
tongue	O	O
and	O	O
may	O	O
be	O	O
useful	O	O
for	O	O
controlling	O	O
intrinsic	O	O
oral	O	O
malodor	O	O
over	O	O
prolonged	O	O
periods	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
lead	O	O
(	O	O
Pb	O	O
)	O	O
on	O	O
growth	O	O
of	O	O
bacterial	O	O
species	O	O
related	O	O
to	O	O
dental	O	O
diseases	O	O
in	O	O
vitro	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
lead	O	O
acetate	O	O
on	O	O
representative	O	O
species	O	O
of	O	O
the	O	O
oral	O	O
flora	O	O
were	O	O
examined	O	O
at	O	O
0.1-10	O	O
mmol	O	O
l	O	O
(	O	O
-1	O	O
)	O	O
and	O	O
compared	O	O
with	O	O
the	O	O
effect	O	O
of	O	O
silver	O	O
nitrate	O	O
and	O	O
ferrous	O	O
sulfate	O	O
.	O	O

The	O	O
minimal	O	O
inhibitory	O	O
concentration	O	O
of	O	O
lead	O	O
acetate	O	O
was	O	O
between	O	O
0.15	O	O
and	O	O
5	O	O
mmol	O	O
l	O	O
(	O	O
-1	O	O
)	O	O
for	O	O
the	O	O
bacterial	O	O
strains	O	O
tested	O	O
.	O	O

The	O	O
minimal	O	O
bactericidal	O	O
concentration	O	O
of	O	O
lead	O	O
acetate	O	O
for	O	O
most	O	O
oral	O	O
species	O	O
was	O	O
detected	O	O
in	O	O
the	O	O
range	O	O
of	O	O
5-10	O	O
mmol	O	O
l	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

Silver	O	O
nitrate	O	O
at	O	O
a	O	O
concentration	O	O
of	O	O
1.25	O	O
mmol	O	O
l	O	O
(	O	O
-1	O	O
)	O	O
was	O	O
sufficient	O	O
to	O	O
exhibit	O	O
antibacterial	O	O
activity	O	O
against	O	O
almost	O	O
all	O	O
bacteria	O	O
tested	O	O
.	O	O

Ferrous	O	O
sulfate	O	O
had	O	O
the	O	O
lowest	O	O
effect	O	O
.	O	O

The	O	O
study	O	O
indicated	O	O
a	O	O
general	O	O
antimicrobial	O	O
effect	O	O
of	O	O
lead	O	O
on	O	O
oral	O	O
bacterial	O	O
species	O	O
in	O	O
the	O	O
range	O	O
of	O	O
0.15-10	O	O
mmol	O	O
l	O	O
(	O	O
-1	O	O
)	O	O
.	O	O

The	O	O
toxicity	O	O
of	O	O
silver	O	O
nitrate	O	O
was	O	O
the	O	O
highest	O	O
,	O	O
whereas	O	O
that	O	O
of	O	O
ferrous	O	O
sulfate	O	O
was	O	O
the	O	O
lowest	O	O
.	O	O

Gram-positive	O	O
species	O	O
had	O	O
a	O	O
tendency	O	O
to	O	O
be	O	O
less	O	O
susceptible	O	O
for	O	O
metals	O	O
than	O	O
Gram-negatives	O	O
.	O	O

The	O	O
study	O	O
shows	O	O
that	O	O
it	O	O
is	O	O
possible	O	O
that	O	O
microbiological	O	O
changes	O	O
may	O	O
occur	O	O
in	O	O
the	O	O
dental	O	O
plaque	O	O
in	O	O
children	O	O
because	O	O
of	O	O
toxic	O	O
exposure	O	O
of	O	O
environmental	O	O
lead	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
of	O	O
humans	O	O
is	O	O
inhabited	O	O
by	O	O
hundreds	O	O
of	O	O
bacterial	O	O
species	O	O
and	O	O
some	O	O
of	O	O
them	O	O
have	O	O
a	O	O
key	O	O
role	O	O
in	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
diseases	O	O
,	O	O
mainly	O	O
dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
.	O	O

We	O	O
describe	O	O
for	O	O
the	O	O
first	O	O
time	O	O
the	O	O
metagenome	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
under	O	O
health	O	O
and	O	O
diseased	O	O
conditions	O	O
,	O	O
with	O	O
a	O	O
focus	O	O
on	O	O
supragingival	O	O
dental	O	O
plaque	O	O
and	O	O
cavities	O	O
.	O	O

Direct	O	O
pyrosequencing	O	O
of	O	O
eight	O	O
samples	O	O
with	O	O
different	O	O
oral-health	O	O
status	O	O
produced	O	O
1	O	O
Gbp	O	O
of	O	O
sequence	O	O
without	O	O
the	O	O
biases	O	O
imposed	O	O
by	O	O
PCR	O	O
or	O	O
cloning	O	O
.	O	O

These	O	O
data	O	O
show	O	O
that	O	O
cavities	O	O
are	O	O
not	O	O
dominated	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
the	O	O
species	O	O
originally	O	O
identified	O	O
as	O	O
the	O	O
ethiological	O	O
agent	O	O
of	O	O
dental	O	O
caries	O	O
)	O	O
but	O	O
are	O	O
in	O	O
fact	O	O
a	O	O
complex	O	O
community	O	O
formed	O	O
by	O	O
tens	O	O
of	O	O
bacterial	O	O
species	O	O
,	O	O
in	O	O
agreement	O	O
with	O	O
the	O	O
view	O	O
that	O	O
caries	O	O
is	O	O
a	O	O
polymicrobial	O	O
disease	O	O
.	O	O

The	O	O
analysis	O	O
of	O	O
the	O	O
reads	O	O
indicated	O	O
that	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
functionally	O	O
a	O	O
different	O	O
environment	O	O
from	O	O
the	O	O
gut	O	O
,	O	O
with	O	O
many	O	O
functional	O	O
categories	O	O
enriched	O	O
in	O	O
one	O	O
of	O	O
the	O	O
two	O	O
environments	O	O
and	O	O
depleted	O	O
in	O	O
the	O	O
other	O	O
.	O	O

Individuals	O	O
who	O	O
had	O	O
never	O	O
suffered	O	O
from	O	O
dental	O	O
caries	O	O
showed	O	O
an	O	O
over-representation	O	O
of	O	O
several	O	O
functional	O	O
categories	O	O
,	O	O
like	O	O
genes	O	O
for	O	O
antimicrobial	O	O
peptides	O	O
and	O	O
quorum	O	O
sensing	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
they	O	O
did	O	O
not	O	O
have	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
but	O	O
displayed	O	O
high	O	O
recruitment	O	O
of	O	O
other	O	O
species	O	O
.	O	O

Several	O	O
isolates	O	O
belonging	O	O
to	O	O
these	O	O
dominant	O	O
bacteria	O	O
in	O	O
healthy	O	O
individuals	O	O
were	O	O
cultured	O	O
and	O	O
shown	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
,	O	O
suggesting	O	O
the	O	O
use	O	O
of	O	O
these	O	O
commensal	O	O
bacterial	O	O
strains	O	O
as	O	O
probiotics	O	O
to	O	O
promote	O	O
oral	O	O
health	O	O
and	O	O
prevent	O	O
dental	O	O
caries	O	O
.	O	O

The	O	O
etiology	O	O
of	O	O
dental	O	O
caries	O	O
remains	O	O
elusive	O	O
because	O	O
of	O	O
our	O	O
limited	O	O
understanding	O	O
of	O	O
the	O	O
complex	O	O
oral	O	O
microbiomes	O	O
.	O	O

The	O	O
current	O	O
methodologies	O	O
have	O	O
been	O	O
limited	O	O
by	O	O
insufficient	O	O
depth	O	O
and	O	O
breadth	O	O
of	O	O
microbial	O	O
sampling	O	O
,	O	O
paucity	O	O
of	O	O
data	O	O
for	O	O
diseased	O	O
hosts	O	O
particularly	O	O
at	O	O
the	O	O
population	O	O
level	O	O
,	O	O
inconsistency	O	O
of	O	O
sampled	O	O
sites	O	O
and	O	O
the	O	O
inability	O	O
to	O	O
distinguish	O	O
the	O	O
underlying	O	O
microbial	O	O
factors	O	O
.	O	O

By	O	O
cross-validating	O	O
16S	O	O
rRNA	O	O
gene	O	O
amplicon-based	O	O
and	O	O
whole-genome-based	O	O
deep-sequencing	O	O
technologies	O	O
,	O	O
we	O	O
report	O	O
the	O	O
most	O	O
in-depth	O	O
,	O	O
comprehensive	O	O
and	O	O
collaborated	O	O
view	O	O
to	O	O
date	O	O
of	O	O
the	O	O
adult	O	O
saliva	O	O
microbiomes	O	O
in	O	O
pilot	O	O
populations	O	O
of	O	O
19	O	O
caries-active	O	O
and	O	O
26	O	O
healthy	O	O
human	O	O
hosts	O	O
.	O	O

We	O	O
found	O	O
that	O	O
:	O	O
first	O	O
,	O	O
saliva	O	O
microbiomes	O	O
in	O	O
human	O	O
population	O	O
were	O	O
featured	O	O
by	O	O
a	O	O
vast	O	O
phylogenetic	O	O
diversity	O	O
yet	O	O
a	O	O
minimal	O	O
organismal	O	O
core	O	O
;	O	O
second	O	O
,	O	O
caries	O	O
microbiomes	O	O
were	O	O
significantly	O	O
more	O	O
variable	O	O
in	O	O
community	O	O
structure	O	O
whereas	O	O
the	O	O
healthy	O	O
ones	O	O
were	O	O
relatively	O	O
conserved	O	O
;	O	O
third	O	O
,	O	O
abundance	O	O
changes	O	O
of	O	O
certain	O	O
taxa	O	O
such	O	O
as	O	O
overabundance	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
Genus	E-bacteria	I-bacteria
distinguished	O	O
caries	O	O
microbiota	O	O
from	O	O
healthy	O	O
ones	O	O
,	O	O
and	O	O
furthermore	O	O
,	O	O
caries-active	O	O
and	O	O
normal	O	O
individuals	O	O
carried	O	O
different	O	O
arrays	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
;	O	O
and	O	O
finally	O	O
,	O	O
no	O	O
'caries-specific	O	O
'	O	O
operational	O	O
taxonomic	O	O
units	O	O
(	O	O
OTUs	O	O
)	O	O
were	O	O
detected	O	O
,	O	O
yet	O	O
147	O	O
OTUs	O	O
were	O	O
'caries	O	O
associated	O	O
'	O	O
,	O	O
that	O	O
is	O	O
,	O	O
differentially	O	O
distributed	O	O
yet	O	O
present	O	O
in	O	O
both	O	O
healthy	O	O
and	O	O
caries-active	O	O
populations	O	O
.	O	O

These	O	O
findings	O	O
underscored	O	O
the	O	O
necessity	O	O
of	O	O
species-	O	O
and	O	O
strain-level	O	O
resolution	O	O
for	O	O
caries	O	O
prognosis	O	O
,	O	O
and	O	O
were	O	O
consistent	O	O
with	O	O
the	O	O
ecological	O	O
hypothesis	O	O
where	O	O
the	O	O
shifts	O	O
in	O	O
community	O	O
structure	O	O
,	O	O
instead	O	O
of	O	O
the	O	O
presence	O	O
or	O	O
absence	O	O
of	O	O
particular	O	O
groups	O	O
of	O	O
microbes	O	O
,	O	O
underlie	O	O
the	O	O
cariogenesis	O	O
.	O	O

Aerobic	O	O
and	O	O
facultatively	O	O
anaerobic	O	O
gram-negative	O	O
bacilli	O	O
(	O	O
AGNB	O	O
)	O	O
are	O	O
opportunistic	O	O
pathogens	O	O
and	O	O
continue	O	O
to	O	O
cause	O	O
a	O	O
large	O	O
number	O	O
of	O	O
hospital-acquired	O	O
infections	O	O
.	O	O

AGNB	O	O
residing	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
oropharynx	O	O
have	O	O
been	O	O
linked	O	O
to	O	O
nosocomial	O	O
pneumonia	O	O
and	O	O
septicemia	O	O
.	O	O

Although	O	O
AGNB	O	O
are	O	O
not	O	O
considered	O	O
members	O	O
of	O	O
the	O	O
normal	O	O
oral	O	O
and	O	O
oropharyngeal	O	O
flora	O	O
,	O	O
medically	O	O
compromised	O	O
patients	O	O
have	O	O
been	O	O
demonstrated	O	O
to	O	O
be	O	O
susceptible	O	O
to	O	O
AGNB	O	O
colonization	O	O
.	O	O

A	O	O
literature	O	O
search	O	O
was	O	O
conducted	O	O
to	O	O
retrieve	O	O
articles	O	O
that	O	O
evaluated	O	O
the	O	O
effectiveness	O	O
of	O	O
oral	O	O
hygiene	O	O
interventions	O	O
in	O	O
reducing	O	O
the	O	O
oral	O	O
and	O	O
oropharyngeal	O	O
carriage	O	O
of	O	O
AGNB	O	O
in	O	O
medically	O	O
compromised	O	O
patients	O	O
.	O	O

Few	O	O
studies	O	O
have	O	O
documented	O	O
the	O	O
use	O	O
of	O	O
mechanical	O	O
oral	O	O
hygiene	O	O
interventions	O	O
alone	O	O
against	O	O
AGNB	O	O
.	O	O

Although	O	O
a	O	O
number	O	O
of	O	O
studies	O	O
have	O	O
employed	O	O
oral	O	O
hygiene	O	O
interventions	O	O
complemented	O	O
by	O	O
antiseptic	O	O
agents	O	O
such	O	O
as	O	O
chlorhexidine	O	O
and	O	O
povidone	O	O
iodine	O	O
,	O	O
there	O	O
appears	O	O
to	O	O
be	O	O
a	O	O
discrepancy	O	O
between	O	O
their	O	O
in	O	O
vitro	O	O
and	O	O
in	O	O
vivo	O	O
effectiveness	O	O
.	O	O

With	O	O
the	O	O
recognition	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
oropharynx	O	O
as	O	O
a	O	O
reservoir	O	O
of	O	O
AGNB	O	O
and	O	O
the	O	O
recent	O	O
emergence	O	O
of	O	O
multidrug	O	O
and	O	O
pandrug	O	O
resistance	O	O
in	O	O
hospital	O	O
settings	O	O
,	O	O
there	O	O
is	O	O
a	O	O
pressing	O	O
need	O	O
for	O	O
additional	O	O
high-quality	O	O
randomized	O	O
controlled	O	O
trials	O	O
to	O	O
determine	O	O
which	O	O
oral	O	O
hygiene	O	O
interventions	O	O
or	O	O
combination	O	O
of	O	O
interventions	O	O
are	O	O
most	O	O
effective	O	O
in	O	O
eliminating	O	O
or	O	O
reducing	O	O
AGNB	O	O
carriage	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
is	O	O
naturally	O	O
a	O	O
predominant	O	O
member	O	O
of	O	O
the	O	O
human	O	O
oropharynx	O	O
and	O	O
the	O	O
commercial	O	O
probiotic	O	O
strain	O	O
K12	B-bacteria	B-bacteria
has	O	O
been	O	O
consumed	O	O
for	O	O
more	O	O
than	O	O
a	O	O
decade	O	O
.	O	O

The	O	O
present	O	O
study	O	O
examines	O	O
the	O	O
health	O	O
responses	O	O
of	O	O
human	O	O
volunteers	O	O
to	O	O
oral	O	O
ingestion	O	O
of	O	O
high	O	O
doses	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
.	O	O

A	O	O
randomized	O	O
group	O	O
of	O	O
53	O	O
subjects	O	O
received	O	O
a	O	O
dose	O	O
of	O	O
1	O	O
x	O	O
10	O	O
(	O	O
10	O	O
)	O	O
cfu	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
(	O	O
N=25	O	O
)	O	O
or	O	O
placebo	O	O
(	O	O
N=28	O	O
)	O	O
for	O	O
28	O	O
days	O	O
,	O	O
followed	O	O
by	O	O
a	O	O
28-day	O	O
wash	O	O
out	O	O
period	O	O
.	O	O

Blood	O	O
,	O	O
urine	O	O
and	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
at	O	O
baseline	O	O
and	O	O
following	O	O
treatment	O	O
and	O	O
analyzed	O	O
,	O	O
while	O	O
the	O	O
oral	O	O
and	O	O
gastrointestinal	O	O
tolerance	O	O
of	O	O
the	O	O
subjects	O	O
to	O	O
the	O	O
dosing	O	O
regimen	O	O
was	O	O
determined	O	O
by	O	O
use	O	O
of	O	O
questionnaires	O	O
.	O	O

Adverse	O	O
events	O	O
(	O	O
AE	O	O
)	O	O
s	O	O
were	O	O
recorded	O	O
for	O	O
both	O	O
groups	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
probiotic	O	O
and	O	O
placebo	O	O
treated	O	O
groups	O	O
were	O	O
detected	O	O
in	O	O
either	O	O
the	O	O
blood	O	O
clinical	O	O
chemistry	O	O
or	O	O
hematology	O	O
results	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
questionnaire	O	O
responses	O	O
of	O	O
the	O	O
subjects	O	O
indicated	O	O
that	O	O
both	O	O
treatments	O	O
were	O	O
well	O	O
tolerated	O	O
.	O	O

The	O	O
frequency	O	O
and	O	O
intensity	O	O
of	O	O
AEs	O	O
was	O	O
similar	O	O
in	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

This	O	O
data	O	O
demonstrates	O	O
that	O	O
the	O	O
daily	O	O
ingestion	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
over	O	O
a	O	O
28-day	O	O
period	O	O
does	O	O
not	O	O
adversely	O	O
affect	O	O
the	O	O
human	O	O
host	O	O
and	O	O
supports	O	O
the	O	O
safety	O	O
of	O	O
its	O	O
oral	O	O
delivery	O	O
in	O	O
a	O	O
food-based	O	O
carrier	O	O
.	O	O

The	O	O
up-regulation	O	O
of	O	O
the	O	O
B7-H1	O	O
receptors	O	O
in	O	O
host	O	O
cells	O	O
might	O	O
influence	O	O
the	O	O
chronicity	O	O
of	O	O
inflammatory	O	O
disorders	O	O
that	O	O
frequently	O	O
precede	O	O
the	O	O
development	O	O
of	O	O
human	O	O
cancers	O	O
.	O	O

B7-H1	O	O
expression	O	O
has	O	O
been	O	O
detected	O	O
in	O	O
the	O	O
majority	O	O
of	O	O
human	O	O
cancers	O	O
,	O	O
leading	O	O
to	O	O
anergy	O	O
and	O	O
apoptosis	O	O
of	O	O
activated	O	O
T	O	O
cells	O	O
,	O	O
and	O	O
enabling	O	O
tumor	O	O
cells	O	O
to	O	O
overcome	O	O
host	O	O
response	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
,	O	O
a	O	O
putative	O	O
periodontal	O	O
pathogen	O	O
,	O	O
is	O	O
an	O	O
etiologic	O	O
agent	O	O
of	O	O
periodontitis	O	O
and	O	O
expresses	O	O
a	O	O
variety	O	O
of	O	O
virulence	O	O
factors	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
expression	O	O
of	O	O
B7-H1	O	O
and	O	O
B7-DC	O	O
receptors	O	O
on	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
cells	O	O
SCC-25	O	O
and	O	O
BHY	O	O
and	O	O
primary	O	O
human	O	O
gingival	O	O
keratinocytes	O	O
(	O	O
PHGK	O	O
)	O	O
was	O	O
analyzed	O	O
after	O	O
infection	O	O
with	O	O
two	O	O
virulent	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
in	O	O
vitro	O	O
.	O	O

After	O	O
48h	O	O
,	O	O
the	O	O
cells	O	O
were	O	O
stained	O	O
with	O	O
antibodies	O	O
for	O	O
human	O	O
B7-H1	O	O
and	O	O
B7-DC	O	O
and	O	O
further	O	O
analyzed	O	O
by	O	O
flow	O	O
cytometry	O	O
.	O	O

RNA	O	O
was	O	O
extracted	O	O
and	O	O
gene	O	O
expression	O	O
of	O	O
B7-H1	O	O
or	O	O
B7-DC	O	O
was	O	O
quantified	O	O
by	O	O
real	O	O
time	O	O
PCR	O	O
.	O	O

After	O	O
infection	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
both	O	O
B7-H1	O	O
and	O	O
B7-DC	O	O
receptors	O	O
were	O	O
up-regulated	O	O
.	O	O

The	O	O
mean	O	O
fluorescence	O	O
intensity	O	O
(	O	O
MFI	O	O
)	O	O
increased	O	O
from	O	O
4.5	O	O
to	O	O
9.9	O	O
(	O	O
B7-H1	O	O
)	O	O
and	O	O
from	O	O
6.9	O	O
to	O	O
15.0	O	O
(	O	O
B7-DC	O	O
)	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
,	O	O
respectively	O	O
)	O	O
in	O	O
SCC-25	O	O
cells	O	O
.	O	O

PHGK	O	O
showed	O	O
an	O	O
increase	O	O
from	O	O
4.8	O	O
to	O	O
12.4	O	O
(	O	O
B7-H1	O	O
)	O	O
and	O	O
from	O	O
5.5	O	O
to	O	O
15.6	O	O
(	O	O
B7-DC	O	O
)	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
,	O	O
a	O	O
commensal	O	O
bacterium	O	O
,	O	O
caused	O	O
no	O	O
up-regulation	O	O
.	O	O

After	O	O
24h	O	O
,	O	O
the	O	O
expression	O	O
of	O	O
B7H1	O	O
and	O	O
B7-DC	O	O
mRNA	O	O
in	O	O
infected	O	O
cells	O	O
,	O	O
normalized	O	O
to	O	O
GAPDH	O	O
and	O	O
in	O	O
relation	O	O
to	O	O
non-infected	O	O
cells	O	O
,	O	O
was	O	O
6.4	O	O
fold	O	O
(	O	O
B7-H1	O	O
)	O	O
and	O	O
8.6	O	O
fold	O	O
(	O	O
B7-DC	O	O
)	O	O
higher	O	O
.	O	O

In	O	O
PHGK	O	O
B7-H1/DC	O	O
mRNA	O	O
expression	O	O
increased	O	O
8.2	O	O
fold	O	O
(	O	O
B7-H1	O	O
)	O	O
and	O	O
5.9	O	O
fold	O	O
(	O	O
B7DC	O	O
)	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
respectively	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
study	O	O
demonstrate	O	O
that	O	O
in	O	O
contrast	O	O
to	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
virulent	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
are	O	O
able	O	O
to	O	O
induce	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
B7-H1	O	O
and	O	O
B7-DC	O	O
receptors	O	O
in	O	O
squamous	O	O
carcinoma	O	O
cells	O	O
and	O	O
human	O	O
gingival	O	O
keratinocytes	O	O
,	O	O
which	O	O
might	O	O
facilitate	O	O
immune	O	O
evasion	O	O
by	O	O
oral	O	O
cancers	O	O
.	O	O

Products	O	O
have	O	O
been	O	O
developed	O	O
to	O	O
provide	O	O
palliation	O	O
for	O	O
persons	O	O
with	O	O
dry	O	O
mouth	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
mouth-wetting	O	O
agents	O	O
,	O	O
some	O	O
products	O	O
incorporate	O	O
antimicrobial	O	O
constituents	O	O
with	O	O
the	O	O
goal	O	O
of	O	O
improving	O	O
oral	O	O
microbial	O	O
defenses	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
in	O	O
vitro	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
potential	O	O
antimicrobial	O	O
and	O	O
antifungal	O	O
effects	O	O
of	O	O
two	O	O
commercially	O	O
available	O	O
saliva	O	O
substitutes	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
by	O	O
using	O	O
the	O	O
agar-well	O	O
diffusion	O	O
method	O	O
.	O	O

Antimicrobial	O	O
activity	O	O
as	O	O
measured	O	O
by	O	O
the	O	O
size	O	O
of	O	O
the	O	O
inhibition	O	O
zone	O	O
growth	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
was	O	O
observed	O	O
only	O	O
with	O	O
Biotene	O	O
Dry	O	O
Mouth	O	O
Oral	O	O
Rinse	O	O
(	O	O
R	O	O
)	O	O
and	O	O
BioXtra	O	O
(	O	O
R	O	O
)	O	O
gel	O	O
.	O	O

The	O	O
zone	O	O
of	O	O
inhibition	O	O
of	O	O
Biotene	O	O
Dry	O	O
Mouth	O	O
Oral	O	O
Rinse	O	O
was	O	O
larger	O	O
than	O	O
that	O	O
of	O	O
BioXtra	O	O
gel	O	O
(	O	O
p=	O	O
0.00	O	O
,	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

No	O	O
anticandidal	O	O
effect	O	O
was	O	O
seen	O	O
with	O	O
any	O	O
of	O	O
the	O	O
test	O	O
products	O	O
.	O	O

The	O	O
pH	O	O
of	O	O
the	O	O
preparations	O	O
,	O	O
the	O	O
variations	O	O
between	O	O
the	O	O
amount	O	O
of	O	O
active	O	O
ingredients	O	O
within	O	O
the	O	O
products	O	O
,	O	O
and	O	O
the	O	O
potential	O	O
antimicrobial	O	O
effects	O	O
of	O	O
inactive	O	O
ingredients	O	O
should	O	O
be	O	O
investigated	O	O
to	O	O
determine	O	O
the	O	O
factors	O	O
that	O	O
impacted	O	O
microbial	O	O
inhibition	O	O
.	O	O

The	O	O
mechanisms	O	O
by	O	O
which	O	O
intestinal	O	O
bacteria	O	O
achieve	O	O
their	O	O
associated	O	O
health	O	O
benefits	O	O
can	O	O
be	O	O
complex	O	O
and	O	O
multifaceted	O	O
.	O	O

In	O	O
this	O	O
respect	O	O
,	O	O
the	O	O
diverse	O	O
microbial	O	O
composition	O	O
of	O	O
the	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
(	O	O
GIT	O	O
)	O	O
provides	O	O
an	O	O
almost	O	O
unlimited	O	O
potential	O	O
source	O	O
of	O	O
bioactive	O	O
substances	O	O
(	O	O
pharmabiotics	O	O
)	O	O
which	O	O
can	O	O
directly	O	O
or	O	O
indirectly	O	O
affect	O	O
human	O	O
health	O	O
.	O	O

Bacteriocins	O	O
and	O	O
fatty	O	O
acids	O	O
are	O	O
just	O	O
two	O	O
examples	O	O
of	O	O
pharmabiotic	O	O
substances	O	O
which	O	O
may	O	O
contribute	O	O
to	O	O
probiotic	O	O
functionality	O	O
within	O	O
the	O	O
mammalian	O	O
GIT	O	O
.	O	O

Bacteriocin	O	O
production	O	O
is	O	O
believed	O	O
to	O	O
confer	O	O
producing	O	O
strains	O	O
with	O	O
a	O	O
competitive	O	O
advantage	O	O
within	O	O
complex	O	O
microbial	O	O
environments	O	O
as	O	O
a	O	O
consequence	O	O
of	O	O
their	O	O
associated	O	O
antimicrobial	O	O
activity	O	O
.	O	O

This	O	O
has	O	O
the	O	O
potential	O	O
to	O	O
enable	O	O
the	O	O
establishment	O	O
and	O	O
prevalence	O	O
of	O	O
producing	O	O
strains	O	O
as	O	O
well	O	O
as	O	O
directly	O	O
inhibiting	O	O
pathogens	O	O
within	O	O
the	O	O
GIT	O	O
.	O	O

Consequently	O	O
,	O	O
these	O	O
antimicrobial	O	O
peptides	O	O
and	O	O
the	O	O
associated	O	O
intestinal	O	O
producing	O	O
strains	O	O
may	O	O
be	O	O
exploited	O	O
to	O	O
beneficially	O	O
influence	O	O
microbial	O	O
populations	O	O
.	O	O

Intestinal	O	O
bacteria	O	O
are	O	O
also	O	O
known	O	O
to	O	O
produce	O	O
a	O	O
diverse	O	O
array	O	O
of	O	O
health-promoting	O	O
fatty	O	O
acids	O	O
.	O	O

Indeed	O	O
,	O	O
certain	O	O
strains	O	O
of	O	O
intestinal	O	O
bifidobacteria	B-bacteria	B-bacteria
have	O	O
been	O	O
shown	O	O
to	O	O
produce	O	O
conjugated	O	O
linoleic	O	O
acid	O	O
(	O	O
CLA	O	O
)	O	O
,	O	O
a	O	O
fatty	O	O
acid	O	O
which	O	O
has	O	O
been	O	O
associated	O	O
with	O	O
a	O	O
variety	O	O
of	O	O
systemic	O	O
health-promoting	O	O
effects	O	O
.	O	O

Recently	O	O
,	O	O
the	O	O
ability	O	O
to	O	O
modulate	O	O
the	O	O
fatty	O	O
acid	O	O
composition	O	O
of	O	O
the	O	O
liver	O	O
and	O	O
adipose	O	O
tissue	O	O
of	O	O
the	O	O
host	O	O
upon	O	O
oral	O	O
administration	O	O
of	O	O
CLA-producing	O	O
bifidobacteria	B-bacteria	B-bacteria
and	O	O
lactobacilli	B-bacteria	B-bacteria
was	O	O
demonstrated	O	O
in	O	O
a	O	O
murine	O	O
model	O	O
.	O	O

Importantly	O	O
,	O	O
this	O	O
implies	O	O
a	O	O
potential	O	O
therapeutic	O	O
role	O	O
for	O	O
probiotics	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
certain	O	O
metabolic	O	O
and	O	O
immunoinflammatory	O	O
disorders	O	O
.	O	O

Such	O	O
examples	O	O
serve	O	O
to	O	O
highlight	O	O
the	O	O
potential	O	O
contribution	O	O
of	O	O
pharmabiotic	O	O
production	O	O
to	O	O
probiotic	O	O
functionality	O	O
in	O	O
relation	O	O
to	O	O
human	O	O
health	O	O
maintenance	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
(	O	O
HP	B-bacteria	B-bacteria
)	O	O
infection	O	O
usually	O	O
occurs	O	O
in	O	O
childhood	O	O
.	O	O

While	O	O
there	O	O
are	O	O
various	O	O
studies	O	O
on	O	O
the	O	O
prevalence	O	O
of	O	O
HP	B-bacteria	B-bacteria
in	O	O
dental	O	O
plaque	O	O
,	O	O
ours	O	O
is	O	O
the	O	O
first	O	O
to	O	O
analyze	O	O
its	O	O
prevalence	O	O
during	O	O
orthodontic	O	O
therapy	O	O
and	O	O
its	O	O
interaction	O	O
with	O	O
competitive	O	O
bacteria	O	O
in	O	O
adolescents	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
HP	B-bacteria	B-bacteria
was	O	O
examined	O	O
before	O	O
and	O	O
during	O	O
the	O	O
first	O	O
12	O	O
weeks	O	O
of	O	O
orthodontic	O	O
therapy	O	O
with	O	O
fixed	O	O
appliances	O	O
in	O	O
11	O	O
patients	O	O
with	O	O
a	O	O
mean	O	O
age	O	O
of	O	O
12.7	O	O
years	O	O
.	O	O

A	O	O
total	O	O
of	O	O
93	O	O
plaque	O	O
samples	O	O
were	O	O
analyzed	O	O
using	O	O
PCR	O	O
.	O	O

The	O	O
data	O	O
acquired	O	O
at	O	O
every	O	O
consultation	O	O
were	O	O
the	O	O
following	O	O
:	O	O
PCR	O	O
analysis	O	O
of	O	O
dental	O	O
plaque	O	O
and	O	O
(	O	O
13	O	O
)	O	O
C	O	O
urea	O	O
breath	O	O
tests	O	O
for	O	O
HP	B-bacteria	B-bacteria
,	O	O
quantitative	O	O
analyses	O	O
of	O	O
saliva	O	O
for	O	O
Lactobacilli	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
interproximal	O	O
plaque	O	O
index	O	O
(	O	O
API	O	O
)	O	O
,	O	O
and	O	O
sulcus	O	O
bleeding	O	O
index	O	O
(	O	O
SBI	O	O
)	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
HP	B-bacteria	B-bacteria
in	O	O
plaque	O	O
was	O	O
82	O	O
%	O	O
before	O	O
orthodontic	O	O
therapy	O	O
,	O	O
dropping	O	O
to	O	O
54	O	O
%	O	O
during	O	O
therapy	O	O
(	O	O
t	O	O
test	O	O
,	O	O
p	O	O
<	O	O
/=0.05	O	O
)	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
HP	B-bacteria	B-bacteria
's	O	O
prevalence	O	O
,	O	O
the	O	O
Lactobacilli	B-bacteria	B-bacteria
count	O	O
rose	O	O
(	O	O
p	O	O
<	O	O
/=0.05	O	O
)	O	O
.	O	O

The	O	O
number	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
in	O	O
saliva	O	O
decreased	O	O
during	O	O
orthodontic	O	O
therapy	O	O
(	O	O
p	O	O
<	O	O
/=0.05	O	O
)	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
HP	B-bacteria	B-bacteria
in	O	O
dental	O	O
plaque	O	O
amounted	O	O
to	O	O
82	O	O
%	O	O
.	O	O

Orthodontic	O	O
treatment	O	O
did	O	O
not	O	O
reduce	O	O
its	O	O
prevalence	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
was	O	O
inversely	O	O
proportional	O	O
to	O	O
that	O	O
of	O	O
HP	B-bacteria	B-bacteria
.	O	O

To	O	O
assess	O	O
and	O	O
compare	O	O
the	O	O
effect	O	O
of	O	O
0.2	O	O
%	O	O
Chlorhexidine	O	O
mouth	O	O
rinse	O	O
,	O	O
Listerine	O	O
mouth	O	O
rinse	O	O
and	O	O
4	O	O
%	O	O
Tulsi	O	O
extract	O	O
mouth	O	O
rinse	O	O
on	O	O
salivary	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
level	O	O
.	O	O

The	O	O
present	O	O
study	O	O
is	O	O
an	O	O
experimental	O	O
study	O	O
of	O	O
cross	O	O
over	O	O
type	O	O
,	O	O
employing	O	O
Latin	O	O
square	O	O
design	O	O
.	O	O

45	O	O
school	O	O
children	O	O
aged	O	O
14-15	O	O
years	O	O
were	O	O
divided	O	O
into	O	O
three	O	O
groups/blocks	O	O
.	O	O

The	O	O
baseline	O	O
unstimulated	O	O
saliva	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
each	O	O
group	O	O
and	O	O
assessed	O	O
for	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
counts	O	O
.	O	O

The	O	O
study	O	O
was	O	O
divided	O	O
in	O	O
to	O	O
three	O	O
phases	O	O
,	O	O
each	O	O
phase	O	O
lasted	O	O
for	O	O
8	O	O
days	O	O
separated	O	O
by	O	O
a	O	O
washout	O	O
period	O	O
of	O	O
15	O	O
days	O	O
in	O	O
between	O	O
them	O	O
.	O	O

Groups	O	O
A	O	O
,	O	O
B	O	O
and	O	O
C	O	O
were	O	O
treated	O	O
with	O	O
0.2	O	O
%	O	O
Chlorhexidine	O	O
,	O	O
Listerine	O	O
and	O	O
4	O	O
%	O	O
Tulsi	O	O
extract	O	O
mouth	O	O
rinses	O	O
respectively	O	O
in	O	O
the	O	O
phase	O	O
I	O	O
.	O	O

The	O	O
study	O	O
subjects	O	O
were	O	O
instructed	O	O
to	O	O
use	O	O
the	O	O
assigned	O	O
mouth	O	O
rinse	O	O
twice	O	O
daily	O	O
for	O	O
1	O	O
min	O	O
for	O	O
7	O	O
days	O	O
.	O	O

On	O	O
day	O	O
8th	O	O
the	O	O
subjects	O	O
were	O	O
instructed	O	O
to	O	O
use	O	O
the	O	O
mouth	O	O
rinse	O	O
only	O	O
once	O	O
in	O	O
the	O	O
morning	O	O
.	O	O

The	O	O
follow	O	O
up	O	O
unstimulated	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
1h	O	O
after	O	O
the	O	O
use	O	O
of	O	O
the	O	O
assigned	O	O
mouth	O	O
rinse	O	O
and	O	O
assessed	O	O
for	O	O
salivary	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
counts	O	O
.	O	O

After	O	O
phase	O	O
I	O	O
,	O	O
mouth	O	O
rinses	O	O
were	O	O
crossed	O	O
over	O	O
as	O	O
dictated	O	O
by	O	O
the	O	O
Latin	O	O
square	O	O
design	O	O
in	O	O
phase	O	O
II	O	O
and	O	O
III	O	O
.	O	O

All	O	O
the	O	O
three	O	O
mouth	O	O
rinses	O	O
have	O	O
individually	O	O
shown	O	O
a	O	O
statistically	O	O
significant	O	O
reduction	O	O
in	O	O
the	O	O
salivary	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
counts	O	O
.	O	O

When	O	O
the	O	O
three	O	O
mouth	O	O
rinses	O	O
were	O	O
compared	O	O
the	O	O
difference	O	O
did	O	O
not	O	O
reach	O	O
statistical	O	O
significance	O	O
.	O	O

Tulsi	O	O
has	O	O
stood	O	O
the	O	O
test	O	O
and	O	O
is	O	O
as	O	O
effective	O	O
as	O	O
Chlorhexidine	O	O
and	O	O
Listerine	O	O
in	O	O
reducing	O	O
the	O	O
salivary	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
levels	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
major	O	O
pathogens	O	O
of	O	O
infective	O	O
endocarditis	O	O
.	O	O

Prophylactic	O	O
antibiotics	O	O
are	O	O
commonly	O	O
given	O	O
to	O	O
subjects	O	O
with	O	O
certain	O	O
kinds	O	O
of	O	O
heart	O	O
disorders	O	O
when	O	O
invasive	O	O
dental	O	O
treatments	O	O
are	O	O
performed	O	O
,	O	O
with	O	O
amoxicillin	O	O
(	O	O
AMPC	O	O
)	O	O
being	O	O
widely	O	O
used	O	O
for	O	O
this	O	O
purpose	O	O
.	O	O

However	O	O
,	O	O
there	O	O
is	O	O
little	O	O
information	O	O
regarding	O	O
AMPC-resistant	B-bacteria	B-bacteria
oral	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Here	O	O
,	O	O
a	O	O
total	O	O
of	O	O
344	O	O
dental	O	O
plaque	O	O
specimens	O	O
collected	O	O
from	O	O
253	O	O
healthy	O	O
Japanese	O	O
children	O	O
,	O	O
adolescents	O	O
and	O	O
young	O	O
adults	O	O
(	O	O
aged	O	O
2-22	O	O
years	O	O
)	O	O
were	O	O
diluted	O	O
and	O	O
streaked	O	O
onto	O	O
culture	O	O
medium	O	O
containing	O	O
high-dose	O	O
AMPC	O	O
.	O	O

The	O	O
MICs	O	O
for	O	O
the	O	O
isolated	O	O
strains	O	O
were	O	O
evaluated	O	O
using	O	O
a	O	O
macrodilution	O	O
broth	O	O
method	O	O
described	O	O
by	O	O
the	O	O
Clinical	O	O
and	O	O
Laboratory	O	O
Standards	O	O
Institute	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
extracted	O	O
from	O	O
each	O	O
strain	O	O
and	O	O
the	O	O
entire	O	O
sequences	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
were	O	O
compared	O	O
with	O	O
those	O	O
in	O	O
GenBank	O	O
to	O	O
identify	O	O
the	O	O
species	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
strains	O	O
with	O	O
AMPC	O	O
MICs	O	O
>	O	O
16	O	O
microg	O	O
ml	O	O
(	O	O
-1	O	O
)	O	O
were	O	O
isolated	O	O
from	O	O
18	O	O
specimens	O	O
from	O	O
14	O	O
patients	O	O
.	O	O

Analyses	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
of	O	O
these	O	O
strains	O	O
identified	O	O
them	O	O
as	O	O
major	O	O
oral	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
including	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
.	O	O

These	O	O
findings	O	O
indicate	O	O
that	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
with	O	O
elevated	O	O
MICs	O	O
for	O	O
AMPC	O	O
exist	O	O
in	O	O
certain	O	O
small	O	O
populations	O	O
of	O	O
healthy	O	O
children	O	O
,	O	O
and	O	O
highlight	O	O
the	O	O
need	O	O
for	O	O
further	O	O
studies	O	O
to	O	O
determine	O	O
risk	O	O
factors	O	O
that	O	O
lead	O	O
to	O	O
the	O	O
appearance	O	O
of	O	O
such	O	O
strains	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
inhibitory	O	O
effect	O	O
of	O	O
oral	O	O
Lactobacillus	B-bacteria	B-bacteria
against	O	O
putative	O	O
oral	O	O
pathogens	O	O
.	O	O

Total	O	O
357	O	O
strains	O	O
comprising	O	O
10	O	O
species	O	O
of	O	O
oral	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
(	O	O
195	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
(	O	O
53	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
(	O	O
20	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
(	O	O
18	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
(	O	O
14	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
(	O	O
12	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
mucosae	E-bacteria	I-bacteria
(	O	O
12	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
oris	E-bacteria	I-bacteria
(	O	O
12	O	O
)	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
(	O	O
11	O	O
)	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
vaginalis	E-bacteria	I-bacteria
(	O	O
10	O	O
)	O	O
were	O	O
used	O	O
as	O	O
producer	O	O
strains	O	O
.	O	O

Inhibitory	O	O
effect	O	O
against	O	O
a	O	O
panel	O	O
of	O	O
indicators	O	O
,	O	O
periodontitis-	O	O
and	O	O
caries-related	O	O
pathogens	O	O
,	O	O
was	O	O
assessed	O	O
.	O	O

Most	O	O
oral	O	O
Lactobacillus	B-bacteria	B-bacteria
was	O	O
able	O	O
to	O	O
inhibit	O	O
the	O	O
growth	O	O
of	O	O
both	O	O
periodontitis-	O	O
and	O	O
caries-related	O	O
pathogens	O	O
.	O	O

The	O	O
strongest	O	O
inhibitory	O	O
activity	O	O
was	O	O
associated	O	O
with	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
paracasei	E-bacteria	I-bacteria
,	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
plantarum	E-bacteria	I-bacteria
,	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
rhamnosus	E-bacteria	I-bacteria
,	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
casei	E-bacteria	I-bacteria
and	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
salivarius	B-bacteria	B-bacteria
.	O	O

Lactobacillus	B-bacteria	B-bacteria
SD1-SD6	E-bacteria	I-bacteria
,	O	O
representing	O	O
the	O	O
six	O	O
species	O	O
with	O	O
the	O	O
strong	O	O
inhibitory	O	O
effect	O	O
,	O	O
inhibited	O	O
growth	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
25175	E-bacteria	I-bacteria
in	O	O
the	O	O
biofilm	O	O
model	O	O
.	O	O

Also	O	O
,	O	O
it	O	O
was	O	O
demonstrated	O	O
that	O	O
growth	O	O
of	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
inhibited	O	O
in	O	O
a	O	O
mixture	O	O
with	O	O
Lact	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
paracasei	I-bacteria	I-bacteria
SD1	E-bacteria	I-bacteria
.	O	O

The	O	O
inhibition	O	O
was	O	O
enhanced	O	O
in	O	O
acidic	O	O
condition	O	O
and	O	O
5	O	O
%	O	O
glucose	O	O
.	O	O

The	O	O
results	O	O
have	O	O
shown	O	O
that	O	O
oral	O	O
Lactobacillus	B-bacteria	B-bacteria
SD1-SD6	E-bacteria	I-bacteria
showed	O	O
a	O	O
strong	O	O
inhibitory	O	O
effect	O	O
against	O	O
Strep	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
,	O	O
Gram-negative	O	O
periodontal	O	O
pathogens	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
.	O	O


The	O	O
results	O	O
indicated	O	O
that	O	O
Lactobacillus	B-bacteria	B-bacteria
may	O	O
be	O	O
of	O	O
benefit	O	O
as	O	O
probiotics	O	O
for	O	O
the	O	O
prevention	O	O
of	O	O
oral	O	O
diseases	O	O
.	O	O

Complex	O	O
and	O	O
highly	O	O
variable	O	O
site-dependent	O	O
bacterial	O	O
ecosystems	O	O
exist	O	O
throughout	O	O
the	O	O
length	O	O
of	O	O
the	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

Until	O	O
relatively	O	O
recently	O	O
,	O	O
the	O	O
majority	O	O
of	O	O
our	O	O
information	O	O
on	O	O
intestinal	O	O
microbiotas	O	O
has	O	O
come	O	O
from	O	O
studies	O	O
on	O	O
feces	O	O
,	O	O
or	O	O
from	O	O
aspirates	O	O
taken	O	O
from	O	O
the	O	O
upper	O	O
gut	O	O
.	O	O

However	O	O
,	O	O
there	O	O
is	O	O
evidence	O	O
showing	O	O
that	O	O
mucosal	O	O
bacteria	O	O
growing	O	O
in	O	O
biofilms	O	O
on	O	O
surfaces	O	O
lining	O	O
the	O	O
gut	O	O
differ	O	O
from	O	O
luminal	O	O
populations	O	O
,	O	O
and	O	O
that	O	O
due	O	O
to	O	O
their	O	O
proximity	O	O
to	O	O
the	O	O
epithelial	O	O
surface	O	O
,	O	O
these	O	O
organisms	O	O
may	O	O
be	O	O
important	O	O
in	O	O
modulating	O	O
the	O	O
host's	O	O
immune	O	O
system	O	O
and	O	O
contributing	O	O
to	O	O
some	O	O
chronic	O	O
inflammatory	O	O
diseases	O	O
.	O	O

Over	O	O
the	O	O
past	O	O
decade	O	O
,	O	O
increasing	O	O
interest	O	O
in	O	O
mucosal	O	O
bacteria	O	O
,	O	O
coupled	O	O
with	O	O
advances	O	O
in	O	O
molecular	O	O
approaches	O	O
for	O	O
assessing	O	O
microbial	O	O
diversity	O	O
,	O	O
has	O	O
begun	O	O
to	O	O
provide	O	O
some	O	O
insight	O	O
into	O	O
the	O	O
complexity	O	O
of	O	O
these	O	O
mucosa-associated	O	O
communities	O	O
.	O	O

In	O	O
gastrointestinal	O	O
conditions	O	O
such	O	O
as	O	O
inflammatory	O	O
bowel	O	O
diseases	O	O
(	O	O
ulcerative	O	O
colitis	O	O
,	O	O
Crohn	O	O
's	O	O
disease	O	O
)	O	O
,	O	O
it	O	O
has	O	O
been	O	O
shown	O	O
that	O	O
a	O	O
dysbiosis	O	O
exists	O	O
in	O	O
microbial	O	O
community	O	O
structure	O	O
,	O	O
and	O	O
that	O	O
there	O	O
is	O	O
a	O	O
reduction	O	O
in	O	O
putatively	O	O
protective	O	O
mucosal	O	O
organisms	O	O
such	O	O
as	O	O
bifidobacteria	B-bacteria	B-bacteria
.	O	O

Therefore	O	O
,	O	O
manipulation	O	O
of	O	O
mucosal	O	O
communities	O	O
may	O	O
be	O	O
beneficial	O	O
in	O	O
restoring	O	O
normal	O	O
functionality	O	O
in	O	O
the	O	O
gut	O	O
,	O	O
thereby	O	O
improving	O	O
the	O	O
immune	O	O
status	O	O
and	O	O
general	O	O
health	O	O
of	O	O
the	O	O
host	O	O
.	O	O

Biofilm	O	O
structure	O	O
and	O	O
function	O	O
has	O	O
been	O	O
studied	O	O
intensively	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
as	O	O
a	O	O
consequence	O	O
,	O	O
mucosal	O	O
communities	O	O
in	O	O
the	O	O
mouth	O	O
will	O	O
not	O	O
be	O	O
covered	O	O
in	O	O
this	O	O
chapter	O	O
.	O	O

This	O	O
review	O	O
addresses	O	O
our	O	O
current	O	O
knowledge	O	O
of	O	O
mucosal	O	O
populations	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
,	O	O
changes	O	O
that	O	O
can	O	O
occur	O	O
in	O	O
community	O	O
structure	O	O
in	O	O
disease	O	O
,	O	O
and	O	O
therapeutic	O	O
modulation	O	O
of	O	O
biofilm	O	O
composition	O	O
by	O	O
antibiotics	O	O
,	O	O
prebiotics	O	O
,	O	O
and	O	O
probiotics	O	O
.	O	O

Enteral	O	O
tube	O	O
feeding	O	O
is	O	O
widely	O	O
used	O	O
to	O	O
maintain	O	O
nutrition	O	O
for	O	O
elderly	O	O
adults	O	O
with	O	O
eating	O	O
difficulties	O	O
,	O	O
but	O	O
its	O	O
long-term	O	O
use	O	O
alters	O	O
the	O	O
environment	O	O
of	O	O
the	O	O
oral	O	O
ecosystem	O	O
.	O	O

This	O	O
study	O	O
characterized	O	O
the	O	O
tongue	O	O
microbiota	O	O
of	O	O
tube-fed	O	O
elderly	O	O
adults	O	O
by	O	O
analyzing	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

The	O	O
terminal	O	O
restriction	O	O
fragment	O	O
length	O	O
polymorphism	O	O
(	O	O
T-RFLP	O	O
)	O	O
profiles	O	O
of	O	O
44	O	O
tube-fed	O	O
subjects	O	O
were	O	O
compared	O	O
with	O	O
those	O	O
of	O	O
54	O	O
subjects	O	O
fed	O	O
orally	O	O
(	O	O
average	O	O
age	O	O
,	O	O
86.4	O	O
+/-	O	O
6.9	O	O
years	O	O
)	O	O
.	O	O

Bar-coded	O	O
pyrosequencing	O	O
data	O	O
were	O	O
also	O	O
obtained	O	O
for	O	O
a	O	O
subset	O	O
of	O	O
the	O	O
subjects	O	O
from	O	O
each	O	O
group	O	O
(	O	O
15	O	O
tube-fed	O	O
subjects	O	O
and	O	O
16	O	O
subjects	O	O
fed	O	O
orally	O	O
)	O	O
.	O	O

The	O	O
T-RFLP	O	O
profiles	O	O
demonstrated	O	O
that	O	O
the	O	O
microbiota	O	O
of	O	O
the	O	O
tube-fed	O	O
subjects	O	O
was	O	O
distinct	O	O
from	O	O
that	O	O
of	O	O
the	O	O
subjects	O	O
fed	O	O
orally	O	O
(	O	O
permutational	O	O
multivariate	O	O
analysis	O	O
of	O	O
variance	O	O
[	O	O
perMANOVA	O	O
]	O	O
,	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
pyrosequencing	O	O
data	O	O
revealed	O	O
that	O	O
22	O	O
bacterial	O	O
genera	O	O
,	O	O
including	O	O
Corynebacterium	B-bacteria	B-bacteria
,	O	O
Peptostreptococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
were	O	O
significantly	O	O
more	O	O
predominant	O	O
in	O	O
tube-fed	O	O
subjects	O	O
,	O	O
whereas	O	O
the	O	O
dominant	O	O
genera	O	O
in	O	O
the	O	O
subjects	O	O
fed	O	O
orally	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
were	O	O
present	O	O
in	O	O
much	O	O
lower	O	O
proportions	O	O
.	O	O

Opportunistic	O	O
pathogens	O	O
rarely	O	O
detected	O	O
in	O	O
the	O	O
normal	O	O
oral	O	O
microbiota	O	O
,	O	O
such	O	O
as	O	O
Corynebacterium	B-bacteria	B-bacteria
striatum	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
agalactiae	E-bacteria	I-bacteria
,	O	O
were	O	O
often	O	O
found	O	O
in	O	O
high	O	O
proportions	O	O
in	O	O
tube-fed	O	O
subjects	O	O
.	O	O

The	O	O
oral	O	O
indigenous	O	O
microbiota	O	O
is	O	O
disrupted	O	O
by	O	O
the	O	O
use	O	O
of	O	O
enteral	O	O
feeding	O	O
,	O	O
allowing	O	O
health-threatening	O	O
bacteria	O	O
to	O	O
thrive	O	O
.	O	O

The	O	O
human	O	O
oral	O	O
microbiome	O	O
is	O	O
potentially	O	O
related	O	O
to	O	O
diverse	O	O
health	O	O
conditions	O	O
and	O	O
high-throughput	O	O
technology	O	O
provides	O	O
the	O	O
possibility	O	O
of	O	O
surveying	O	O
microbial	O	O
community	O	O
structure	O	O
at	O	O
high	O	O
resolution	O	O
.	O	O

We	O	O
compared	O	O
two	O	O
oral	O	O
microbiome	O	O
survey	O	O
methods	O	O
:	O	O
broad-based	O	O
microbiome	O	O
identification	O	O
by	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequencing	O	O
and	O	O
targeted	O	O
characterization	O	O
of	O	O
microbes	O	O
by	O	O
custom	O	O
DNA	O	O
microarray	O	O
.	O	O

Oral	O	O
wash	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
20	O	O
individuals	O	O
at	O	O
Memorial	O	O
Sloan-Kettering	O	O
Cancer	O	O
Center	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
survey	O	O
was	O	O
performed	O	O
by	O	O
454	O	O
pyrosequencing	O	O
of	O	O
the	O	O
V3-V5	O	O
region	O	O
(	O	O
450	O	O
bp	O	O
)	O	O
.	O	O

Targeted	O	O
identification	O	O
by	O	O
DNA	O	O
microarray	O	O
was	O	O
carried	O	O
out	O	O
with	O	O
the	O	O
Human	O	O
Oral	O	O
Microbe	O	O
Identification	O	O
Microarray	O	O
(	O	O
HOMIM	O	O
)	O	O
.	O	O

Correlations	O	O
and	O	O
relative	O	O
abundance	O	O
were	O	O
compared	O	O
at	O	O
phylum	O	O
and	O	O
genus	O	O
level	O	O
,	O	O
between	O	O
16S	O	O
rRNA	O	O
sequence	O	O
read	O	O
ratio	O	O
and	O	O
HOMIM	O	O
hybridization	O	O
intensity	O	O
.	O	O

The	O	O
major	O	O
phyla	O	O
,	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
Bacteroidetes	B-bacteria	B-bacteria
,	O	O
Actinobacteria	B-bacteria	B-bacteria
,	O	O
and	O	O
Fusobacteria	B-bacteria	B-bacteria
were	O	O
identified	O	O
with	O	O
high	O	O
correlation	O	O
by	O	O
the	O	O
two	O	O
methods	O	O
(	O	O
r	O	O
=	O	O
0.70	O	O
approximately	O	O
0.86	O	O
)	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
pyrosequencing	O	O
identified	O	O
77	O	O
genera	O	O
and	O	O
HOMIM	O	O
identified	O	O
49	O	O
,	O	O
with	O	O
37	O	O
genera	O	O
detected	O	O
by	O	O
both	O	O
methods	O	O
;	O	O
more	O	O
than	O	O
98	O	O
%	O	O
of	O	O
classified	O	O
bacteria	O	O
were	O	O
assigned	O	O
in	O	O
these	O	O
37	O	O
genera	O	O
.	O	O

Concordance	O	O
by	O	O
the	O	O
two	O	O
assays	O	O
(	O	O
presence/absence	O	O
)	O	O
and	O	O
correlations	O	O
were	O	O
high	O	O
for	O	O
common	O	O
genera	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Leptotrichia	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
and	O	O
Haemophilus	B-bacteria	B-bacteria
;	O	O
Correlation	O	O
=	O	O
0.70-0.84	O	O
)	O	O
.	O	O

Microbiome	O	O
community	O	O
profiles	O	O
assessed	O	O
by	O	O
16S	O	O
rRNA	O	O
pyrosequencing	O	O
and	O	O
HOMIM	O	O
were	O	O
highly	O	O
correlated	O	O
at	O	O
the	O	O
phylum	O	O
level	O	O
and	O	O
,	O	O
when	O	O
comparing	O	O
the	O	O
more	O	O
commonly	O	O
detected	O	O
taxa	O	O
,	O	O
also	O	O
at	O	O
the	O	O
genus	O	O
level	O	O
.	O	O

Both	O	O
methods	O	O
are	O	O
currently	O	O
suitable	O	O
for	O	O
high-throughput	O	O
epidemiologic	O	O
investigations	O	O
relating	O	O
identified	O	O
and	O	O
more	O	O
common	O	O
oral	O	O
microbial	O	O
taxa	O	O
to	O	O
disease	O	O
risk	O	O
;	O	O
yet	O	O
,	O	O
pyrosequencing	O	O
may	O	O
provide	O	O
a	O	O
broader	O	O
spectrum	O	O
of	O	O
taxa	O	O
identification	O	O
,	O	O
a	O	O
distinct	O	O
sequence-read	O	O
record	O	O
,	O	O
and	O	O
greater	O	O
detection	O	O
sensitivity	O	O
.	O	O

Extracellular	O	O
matrix	O	O
metalloproteinase	O	O
inducer	O	O
(	O	O
EMMPRIN	O	O
)	O	O
or	O	O
CD147	O	O
is	O	O
a	O	O
transmembrane	O	O
glycoprotein	O	O
expressed	O	O
by	O	O
various	O	O
cell	O	O
types	O	O
,	O	O
including	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Recent	O	O
studies	O	O
have	O	O
brought	O	O
evidence	O	O
that	O	O
EMMPRIN	O	O
plays	O	O
a	O	O
role	O	O
in	O	O
periodontitis	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
a	O	O
major	O	O
pathogen	O	O
in	O	O
chronic	O	O
periodontitis	O	O
,	O	O
on	O	O
the	O	O
shedding	O	O
of	O	O
membrane-anchored	O	O
EMMPRIN	O	O
and	O	O
on	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
EMMPRIN	O	O
gene	O	O
by	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

A	O	O
potential	O	O
contribution	O	O
of	O	O
shed	O	O
EMMPRIN	O	O
to	O	O
the	O	O
inflammatory	O	O
process	O	O
of	O	O
periodontitis	O	O
was	O	O
analyzed	O	O
by	O	O
evaluating	O	O
the	O	O
effect	O	O
of	O	O
recombinant	O	O
EMMPRIN	O	O
on	O	O
cytokine	O	O
and	O	O
matrix	O	O
metalloproteinase	O	O
(	O	O
MMP	O	O
)	O	O
secretion	O	O
by	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
.	O	O

ELISA	O	O
and	O	O
immunofluorescence	O	O
analyses	O	O
revealed	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
mediated	O	O
the	O	O
shedding	O	O
of	O	O
epithelial	O	O
cell-surface	O	O
EMMPRIN	O	O
in	O	O
a	O	O
dose-	O	O
and	O	O
time-dependent	O	O
manner	O	O
.	O	O

Cysteine	O	O
proteinase	O	O
(	O	O
gingipain	O	O
)	O	O
-deficient	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
mutants	O	O
were	O	O
used	O	O
to	O	O
demonstrate	O	O
that	O	O
both	O	O
Arg-	O	O
and	O	O
Lys-gingipain	O	O
activities	O	O
are	O	O
involved	O	O
in	O	O
EMMPRIN	O	O
shedding	O	O
.	O	O

Real-time	O	O
PCR	O	O
showed	O	O
that	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
had	O	O
no	O	O
significant	O	O
effect	O	O
on	O	O
the	O	O
expression	O	O
of	O	O
the	O	O
EMMPRIN	O	O
gene	O	O
in	O	O
epithelial	O	O
cells	O	O
.	O	O

Recombinant	O	O
EMMPRIN	O	O
induced	O	O
the	O	O
secretion	O	O
of	O	O
IL-6	O	O
and	O	O
MMP-3	O	O
by	O	O
gingival	O	O
fibroblasts	O	O
,	O	O
a	O	O
phenomenon	O	O
that	O	O
appears	O	O
to	O	O
involve	O	O
mitogen	O	O
activated	O	O
protein	O	O
kinases	O	O
.	O	O

The	O	O
present	O	O
study	O	O
brought	O	O
to	O	O
light	O	O
a	O	O
new	O	O
mechanism	O	O
by	O	O
which	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
can	O	O
promote	O	O
the	O	O
inflammatory	O	O
response	O	O
during	O	O
periodontitis	O	O
.	O	O

Indigenous	O	O
microbes	O	O
are	O	O
known	O	O
to	O	O
influence	O	O
human	O	O
health	O	O
outcomes	O	O
and	O	O
various	O	O
approaches	O	O
are	O	O
now	O	O
being	O	O
made	O	O
to	O	O
positively	O	O
modulate	O	O
these	O	O
microbe-induced	O	O
outcomes	O	O
via	O	O
the	O	O
administration	O	O
of	O	O
probiotics	O	O
.	O	O

The	O	O
application	O	O
of	O	O
probiotics	O	O
that	O	O
are	O	O
specific	O	O
to	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
a	O	O
relatively	O	O
undeveloped	O	O
field	O	O
,	O	O
and	O	O
their	O	O
emergence	O	O
has	O	O
largely	O	O
occurred	O	O
as	O	O
a	O	O
reasoned	O	O
follow-up	O	O
to	O	O
initial	O	O
studies	O	O
in	O	O
which	O	O
probiotics	O	O
that	O	O
had	O	O
already	O	O
been	O	O
developed	O	O
and	O	O
obtained	O	O
regulatory	O	O
approval	O	O
for	O	O
intestinal	O	O
applications	O	O
were	O	O
then	O	O
also	O	O
evaluated	O	O
for	O	O
their	O	O
putative	O	O
influence	O	O
on	O	O
oral	O	O
microbiota	O	O
functionality	O	O
.	O	O

These	O	O
attempts	O	O
to	O	O
extend	O	O
the	O	O
application	O	O
of	O	O
existing	O	O
probiotics	O	O
were	O	O
probably	O	O
at	O	O
least	O	O
in	O	O
part	O	O
motivated	O	O
by	O	O
recognition	O	O
of	O	O
the	O	O
substantial	O	O
safety	O	O
and	O	O
regulatory	O	O
hurdles	O	O
that	O	O
must	O	O
be	O	O
overcome	O	O
prior	O	O
to	O	O
the	O	O
introduction	O	O
of	O	O
a	O	O
novel	O	O
probiotic	O	O
agent	O	O
.	O	O

Nevertheless	O	O
,	O	O
from	O	O
an	O	O
efficacy	O	O
perspective	O	O
it	O	O
appears	O	O
more	O	O
logical	O	O
to	O	O
develop	O	O
microbes	O	O
of	O	O
oral	O	O
origin	O	O
as	O	O
the	O	O
specific	O	O
providers	O	O
of	O	O
probiotic	O	O
solutions	O	O
for	O	O
oral	O	O
diseases	O	O
,	O	O
rather	O	O
than	O	O
attempting	O	O
to	O	O
adapt	O	O
intestinally-derived	O	O
strains	O	O
for	O	O
this	O	O
role	O	O
.	O	O

Oral	O	O
bacteria	O	O
and	O	O
their	O	O
bioactive	O	O
molecules	O	O
have	O	O
evolved	O	O
to	O	O
operate	O	O
optimally	O	O
in	O	O
this	O	O
environment	O	O
and	O	O
in	O	O
some	O	O
cases	O	O
are	O	O
known	O	O
to	O	O
persist	O	O
only	O	O
in	O	O
oral	O	O
sites	O	O
.	O	O

Amongst	O	O
the	O	O
bacteria	O	O
of	O	O
more	O	O
than	O	O
700	O	O
species	O	O
now	O	O
identified	O	O
within	O	O
the	O	O
human	O	O
oral	O	O
microbiota	O	O
,	O	O
it	O	O
is	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
that	O	O
are	O	O
numerically	O	O
predominant	O	O
.	O	O

Although	O	O
this	O	O
review	O	O
highlights	O	O
the	O	O
development	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
bacterium	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
as	O	O
an	O	O
oral	O	O
probiotic	O	O
,	O	O
a	O	O
number	O	O
of	O	O
other	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
have	O	O
also	O	O
been	O	O
shown	O	O
to	O	O
have	O	O
considerable	O	O
potential	O	O
as	O	O
probiotic	O	O
candidates	O	O
.	O	O

Posttympanostomy	O	O
tube	O	O
otorrhea	O	O
(	O	O
PTTO	O	O
)	O	O
results	O	O
in	O	O
significant	O	O
health	O	O
care	O	O
cost	O	O
and	O	O
decreased	O	O
satisfaction	O	O
with	O	O
care	O	O
.	O	O

The	O	O
authors	O	O
reviewed	O	O
PTTO	O	O
failing	O	O
initial	O	O
ototopical	O	O
and/or	O	O
oral	O	O
antibiotic	O	O
therapy	O	O
and	O	O
microbiology/susceptibility	O	O
data	O	O
from	O	O
cultures	O	O
.	O	O

Case	O	O
series	O	O
with	O	O
chart	O	O
review	O	O
.	O	O

A	O	O
community	O	O
university	O	O
satellite	O	O
ambulatory	O	O
clinic	O	O
and	O	O
the	O	O
outpatient	O	O
clinic	O	O
of	O	O
a	O	O
children	O	O
's	O	O
hospital	O	O
.	O	O

Review	O	O
of	O	O
202	O	O
patients	O	O
with	O	O
228	O	O
discrete	O	O
episodes	O	O
of	O	O
culture-positive	O	O
otorrhea	O	O
from	O	O
January	O	O
2004	O	O
to	O	O
January	O	O
2009	O	O
.	O	O

PTTO	O	O
occurred	O	O
an	O	O
average	O	O
of	O	O
13	O	O
months	O	O
after	O	O
tube	O	O
placement	O	O
.	O	O

Median	O	O
otorrhea	O	O
duration	O	O
was	O	O
21	O	O
days	O	O
(	O	O
mean	O	O
,	O	O
42	O	O
days	O	O
)	O	O
.	O	O

A	O	O
mean	O	O
of	O	O
1.6	O	O
visits	O	O
(	O	O
range	O	O
,	O	O
1-6	O	O
)	O	O
to	O	O
the	O	O
pediatric	O	O
otolaryngology	O	O
office	O	O
was	O	O
required	O	O
for	O	O
PTTO	O	O
resolution	O	O
.	O	O

Ototopical	O	O
therapy	O	O
was	O	O
reported	O	O
used	O	O
in	O	O
198	O	O
of	O	O
228	O	O
(	O	O
87	O	O
%	O	O
)	O	O
episodes	O	O
of	O	O
otorrhea	O	O
prior	O	O
to	O	O
pediatric	O	O
otolaryngology	O	O
visit	O	O
.	O	O

Nearly	O	O
50	O	O
%	O	O
of	O	O
patients	O	O
were	O	O
prescribed	O	O
at	O	O
least	O	O
1	O	O
or	O	O
more	O	O
courses	O	O
of	O	O
systemic	O	O
antibiotics	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
accounted	O	O
for	O	O
52	O	O
%	O	O
of	O	O
the	O	O
organisms	O	O
cultured	O	O
,	O	O
with	O	O
57	O	O
%	O	O
methicillin-resistant	B-bacteria	B-bacteria
S	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
.	O	O

S	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
resistance	O	O
to	O	O
clindamycin	O	O
was	O	O
high	O	O
(	O	O
49	O	O
%	O	O
)	O	O
and	O	O
resistance	O	O
to	O	O
levofloxacin	O	O
was	O	O
low	O	O
(	O	O
1.8	O	O
%	O	O
)	O	O
.	O	O

MRSA	B-bacteria	B-bacteria
was	O	O
68	O	O
%	O	O
clindamycin	O	O
resistant	O	O
,	O	O
much	O	O
higher	O	O
than	O	O
both	O	O
ours	O	O
and	O	O
the	O	O
children	O	O
's	O	O
hospital	O	O
's	O	O
clindamycin	O	O
resistance	O	O
rate	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
cultured	O	O
from	O	O
all	O	O
other	O	O
body	O	O
sites	O	O
.	O	O

PTTO	O	O
that	O	O
presents	O	O
as	O	O
having	O	O
failed	O	O
ototopical	O	O
and/or	O	O
oral	O	O
antibiotics	O	O
most	O	O
commonly	O	O
consists	O	O
of	O	O
S	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
and	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
.	O	O

MRSA	B-bacteria	B-bacteria
is	O	O
highly	O	O
prevalent	O	O
in	O	O
this	O	O
population	O	O
.	O	O

It	O	O
is	O	O
not	O	O
necessary	O	O
to	O	O
culture	O	O
PTTO	O	O
that	O	O
presents	O	O
to	O	O
an	O	O
otolaryngology	O	O
office	O	O
,	O	O
as	O	O
resistance	O	O
to	O	O
levofloxacin	O	O
was	O	O
only	O	O
1.8	O	O
%	O	O
.	O	O

It	O	O
is	O	O
unclear	O	O
why	O	O
the	O	O
same	O	O
fluoroquinolone	O	O
ototopical	O	O
therapy	O	O
that	O	O
failed	O	O
initially	O	O
is	O	O
often	O	O
successful	O	O
in	O	O
treating	O	O
PTTO	O	O
after	O	O
otolaryngologist	O	O
visit	O	O
.	O	O

Five	O	O
species	O	O
of	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
V.	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
,	O	O
V.	B-bacteria	B-bacteria
denticariosi	E-bacteria	I-bacteria
,	O	O
V.	B-bacteria	B-bacteria
dispar	E-bacteria	I-bacteria
,	O	O
V.	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
,	O	O
and	O	O
V.	B-bacteria	B-bacteria
rogosae	E-bacteria	I-bacteria
,	O	O
have	O	O
been	O	O
suggested	O	O
to	O	O
be	O	O
early	O	O
colonizers	O	O
of	O	O
dental	O	O
biofilm	O	O
and	O	O
causes	O	O
of	O	O
opportunistic	O	O
infections	O	O
and	O	O
oral	O	O
mucosa	O	O
.	O	O

However	O	O
,	O	O
the	O	O
pathogenicity	O	O
and	O	O
the	O	O
distribution	O	O
of	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
have	O	O
not	O	O
been	O	O
clarified	O	O
.	O	O

Previously	O	O
,	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
were	O	O
identified	O	O
by	O	O
using	O	O
16S	O	O
rDNA	O	O
sequence	O	O
analysis	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
recently	O	O
,	O	O
Veillonella	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
from	O	O
human	O	O
tongue	O	O
biofilm	O	O
were	O	O
identified	O	O
by	O	O
rpoB	O	O
gene	O	O
sequences	O	O
,	O	O
but	O	O
these	O	O
procedures	O	O
are	O	O
time-consuming	O	O
and	O	O
complex	O	O
.	O	O

To	O	O
overcome	O	O
this	O	O
problem	O	O
,	O	O
Igarashi	O	O
et	O	O
al	O	O
.	O	O

have	O	O
designed	O	O
species-specific	O	O
primer	O	O
sets	O	O
for	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
by	O	O
using	O	O
a	O	O
highly	O	O
variable	O	O
region	O	O
in	O	O
the	O	O
rpoB	O	O
gene	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
the	O	O
distribution	O	O
and	O	O
frequency	O	O
of	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
in	O	O
the	O	O
tongue	O	O
biofilm	O	O
of	O	O
healthy	O	O
adults	O	O
in	O	O
their	O	O
20s	O	O
were	O	O
examined	O	O
by	O	O
using	O	O
these	O	O
species-specific	O	O
primer	O	O
sets	O	O
.	O	O

Tongue	O	O
biofilm	O	O
of	O	O
these	O	O
subjects	O	O
were	O	O
found	O	O
to	O	O
be	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
based	O	O
on	O	O
the	O	O
distribution	O	O
and	O	O
frequency	O	O
of	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

In	O	O
one	O	O
group	O	O
,	O	O
V.	B-bacteria	B-bacteria
rogosae	E-bacteria	I-bacteria
was	O	O
the	O	O
predominant	O	O
species	O	O
;	O	O
the	O	O
other	O	O
group	O	O
consisted	O	O
of	O	O
mainly	O	O
V.	B-bacteria	B-bacteria
dispar	E-bacteria	I-bacteria
and	O	O
V.	B-bacteria	B-bacteria
atypica	E-bacteria	I-bacteria
.	O	O

Multiple	O	O
factors	O	O
may	O	O
influence	O	O
these	O	O
differences	O	O
in	O	O
distribution	O	O
and	O	O
frequency	O	O
of	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
in	O	O
tongue	O	O
biofilm	O	O
.	O	O

This	O	O
is	O	O
the	O	O
first	O	O
report	O	O
also	O	O
demonstrating	O	O
the	O	O
availability	O	O
of	O	O
the	O	O
species-specific	O	O
primer	O	O
sets	O	O
for	O	O
PCR	O	O
to	O	O
determine	O	O
the	O	O
distribution	O	O
and	O	O
frequency	O	O
of	O	O
oral	O	O
Veillonella	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
in	O	O
the	O	O
tongue	O	O
biofilm	O	O
of	O	O
healthy	O	O
adults	O	O
in	O	O
their	O	O
20s	O	O
.	O	O

Bacterial	O	O
contribution	O	O
to	O	O
oral	O	O
disease	O	O
has	O	O
been	O	O
studied	O	O
in	O	O
young	O	O
children	O	O
,	O	O
but	O	O
there	O	O
is	O	O
a	O	O
lack	O	O
of	O	O
data	O	O
addressing	O	O
the	O	O
developmental	O	O
perspective	O	O
in	O	O
edentulous	O	O
infants	O	O
.	O	O

Our	O	O
primary	O	O
objectives	O	O
were	O	O
to	O	O
use	O	O
pyrosequencing	O	O
to	O	O
phylogenetically	O	O
characterize	O	O
the	O	O
salivary	O	O
bacterial	O	O
microbiome	O	O
of	O	O
edentulous	O	O
infants	O	O
and	O	O
to	O	O
make	O	O
comparisons	O	O
against	O	O
their	O	O
mothers	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
5	O	O
edentulous	O	O
infants	O	O
(	O	O
mean	O	O
age	O	O
=	O	O
4.6+/-1.2	O	O
mo	O	O
old	O	O
)	O	O
and	O	O
their	O	O
mothers	O	O
or	O	O
primary	O	O
care	O	O
givers	O	O
(	O	O
mean	O	O
age	O	O
=	O	O
30.8+/-9.5	O	O
y	O	O
old	O	O
)	O	O
.	O	O

Salivary	O	O
DNA	O	O
was	O	O
extracted	O	O
,	O	O
used	O	O
to	O	O
generate	O	O
DNA	O	O
amplicons	O	O
of	O	O
the	O	O
V4-V6	O	O
hypervariable	O	O
region	O	O
of	O	O
the	O	O
bacterial	O	O
16S	O	O
rDNA	O	O
gene	O	O
,	O	O
and	O	O
subjected	O	O
to	O	O
454-pyrosequencing	O	O
.	O	O

On	O	O
average	O	O
,	O	O
over	O	O
80,000	O	O
sequences	O	O
per	O	O
sample	O	O
were	O	O
generated	O	O
.	O	O

High	O	O
bacterial	O	O
diversity	O	O
was	O	O
noted	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
adults	O	O
[	O	O
1012	O	O
operational	O	O
taxonomical	O	O
units	O	O
(	O	O
OTU	O	O
)	O	O
at	O	O
3	O	O
%	O	O
divergence	O	O
]	O	O
and	O	O
infants	O	O
(	O	O
578	O	O
OTU	O	O
at	O	O
3	O	O
%	O	O
divergence	O	O
)	O	O
.	O	O

Firmicutes	B-bacteria	B-bacteria
,	O	O
Proteobacteria	B-bacteria	B-bacteria
,	O	O
Actinobacteria	B-bacteria	B-bacteria
,	O	O
and	O	O
Fusobacteria	B-bacteria	B-bacteria
were	O	O
predominant	O	O
bacterial	O	O
phyla	O	O
present	O	O
in	O	O
all	O	O
samples	O	O
.	O	O

A	O	O
total	O	O
of	O	O
397	O	O
bacterial	O	O
genera	O	O
were	O	O
present	O	O
in	O	O
our	O	O
dataset	O	O
.	O	O

Of	O	O
the	O	O
28	O	O
genera	O	O
different	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
between	O	O
infants	O	O
and	O	O
adults	O	O
,	O	O
27	O	O
had	O	O
a	O	O
greater	O	O
prevalence	O	O
in	O	O
adults	O	O
.	O	O

The	O	O
exception	O	O
was	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
which	O	O
was	O	O
the	O	O
predominant	O	O
genera	O	O
in	O	O
infant	O	O
saliva	O	O
(	O	O
62.2	O	O
%	O	O
in	O	O
infants	O	O
vs.	O	O
20.4	O	O
%	O	O
in	O	O
adults	O	O
;	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Veillonella	B-bacteria	B-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Leptotrichia	B-bacteria	B-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
were	O	O
also	O	O
predominant	O	O
genera	O	O
in	O	O
infant	O	O
samples	O	O
,	O	O
while	O	O
Haemophilus	B-bacteria	B-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Oribacterium	B-bacteria	B-bacteria
,	O	O
Rothia	B-bacteria	B-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
were	O	O
predominant	O	O
in	O	O
adults	O	O
.	O	O

Our	O	O
data	O	O
demonstrate	O	O
that	O	O
although	O	O
the	O	O
adult	O	O
saliva	O	O
bacterial	O	O
microbiome	O	O
had	O	O
a	O	O
greater	O	O
OTU	O	O
count	O	O
than	O	O
infants	O	O
,	O	O
a	O	O
rich	O	O
bacterial	O	O
community	O	O
exists	O	O
in	O	O
the	O	O
infant	O	O
oral	O	O
cavity	O	O
prior	O	O
to	O	O
tooth	O	O
eruption	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
and	O	O
Neisseria	B-bacteria	B-bacteria
are	O	O
the	O	O
predominant	O	O
bacterial	O	O
genera	O	O
present	O	O
in	O	O
infants	O	O
.	O	O

Further	O	O
research	O	O
is	O	O
required	O	O
to	O	O
characterize	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
microbiota	O	O
early	O	O
in	O	O
life	O	O
and	O	O
identify	O	O
environmental	O	O
factors	O	O
that	O	O
impact	O	O
colonization	O	O
and	O	O
oral	O	O
and	O	O
gastrointestinal	O	O
disease	O	O
risk	O	O
.	O	O

Recent	O	O
evidence	O	O
suggests	O	O
that	O	O
smoking	O	O
affects	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
disease-associated	O	O
subgingival	O	O
biofilm	O	O
,	O	O
yet	O	O
little	O	O
is	O	O
known	O	O
about	O	O
its	O	O
effects	O	O
during	O	O
the	O	O
formation	O	O
of	O	O
this	O	O
biofilm	O	O
.	O	O

The	O	O
present	O	O
investigation	O	O
was	O	O
undertaken	O	O
to	O	O
examine	O	O
the	O	O
contributions	O	O
of	O	O
smoking	O	O
to	O	O
the	O	O
composition	O	O
and	O	O
proinflammatory	O	O
characteristics	O	O
of	O	O
the	O	O
biofilm	O	O
during	O	O
de	O	O
novo	O	O
plaque	O	O
formation	O	O
.	O	O

Marginal	O	O
and	O	O
subgingival	O	O
plaque	O	O
and	O	O
gingival	O	O
crevicular	O	O
fluid	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
15	O	O
current	O	O
smokers	O	O
and	O	O
from	O	O
15	O	O
individuals	O	O
who	O	O
had	O	O
never	O	O
smoked	O	O
(	O	O
nonsmokers	O	O
)	O	O
following	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
and	O	O
7	O	O
days	O	O
of	O	O
undisturbed	O	O
plaque	O	O
formation	O	O
.	O	O

16S	O	O
rRNA	O	O
gene	O	O
cloning	O	O
and	O	O
sequencing	O	O
were	O	O
used	O	O
for	O	O
bacterial	O	O
identification	O	O
,	O	O
and	O	O
multiplex	O	O
bead-based	O	O
flow	O	O
cytometry	O	O
was	O	O
used	O	O
to	O	O
quantify	O	O
the	O	O
levels	O	O
of	O	O
27	O	O
immune	O	O
mediators	O	O
.	O	O

Smokers	O	O
demonstrated	O	O
a	O	O
highly	O	O
diverse	O	O
,	O	O
relatively	O	O
unstable	O	O
initial	O	O
colonization	O	O
of	O	O
both	O	O
marginal	O	O
and	O	O
subgingival	O	O
biofilms	O	O
,	O	O
with	O	O
lower	O	O
niche	O	O
saturation	O	O
than	O	O
that	O	O
seen	O	O
in	O	O
nonsmokers	O	O
.	O	O

Periodontal	O	O
pathogens	O	O
belonging	O	O
to	O	O
the	O	O
genera	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Cardiobacterium	B-bacteria	B-bacteria
,	O	O
Synergistes	B-bacteria	B-bacteria
,	O	O
and	O	O
Selenomonas	B-bacteria	B-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
respiratory	O	O
pathogens	O	O
belonging	O	O
to	O	O
the	O	O
genera	O	O
Haemophilus	B-bacteria	B-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
,	O	O
colonized	O	O
the	O	O
early	O	O
biofilms	O	O
of	O	O
smokers	O	O
and	O	O
continued	O	O
to	O	O
persist	O	O
over	O	O
the	O	O
observation	O	O
period	O	O
,	O	O
suggesting	O	O
that	O	O
smoking	O	O
favors	O	O
early	O	O
acquisition	O	O
and	O	O
colonization	O	O
of	O	O
pathogens	O	O
in	O	O
oral	O	O
biofilms	O	O
.	O	O

Smokers	O	O
also	O	O
demonstrated	O	O
an	O	O
early	O	O
proinflammatory	O	O
response	O	O
to	O	O
this	O	O
colonization	O	O
,	O	O
which	O	O
persisted	O	O
over	O	O
7	O	O
days	O	O
.	O	O

Further	O	O
,	O	O
a	O	O
positive	O	O
correlation	O	O
between	O	O
proinflammatory	O	O
cytokine	O	O
levels	O	O
and	O	O
commensal	O	O
bacteria	O	O
was	O	O
observed	O	O
in	O	O
smokers	O	O
but	O	O
not	O	O
in	O	O
nonsmokers	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
the	O	O
data	O	O
suggest	O	O
that	O	O
smoking	O	O
influences	O	O
both	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
nascent	O	O
biofilm	O	O
and	O	O
the	O	O
host	O	O
response	O	O
to	O	O
this	O	O
colonization	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
major	O	O
etiological	O	O
agent	O	O
of	O	O
dental	O	O
caries	O	O
,	O	O
has	O	O
a	O	O
measurable	O	O
impact	O	O
on	O	O
domestic	O	O
and	O	O
global	O	O
health	O	O
care	O	O
costs	O	O
.	O	O

Though	O	O
persistent	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
despite	O	O
conventional	O	O
oral	O	O
hygiene	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
can	O	O
be	O	O
excluded	O	O
from	O	O
intact	O	O
oral	O	O
biofilms	O	O
through	O	O
competitive	O	O
exclusion	O	O
by	O	O
other	O	O
microorganisms	O	O
.	O	O

This	O	O
suggests	O	O
that	O	O
therapies	O	O
capable	O	O
of	O	O
selectively	O	O
eliminating	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
while	O	O
limiting	O	O
the	O	O
damage	O	O
to	O	O
the	O	O
normal	O	O
oral	O	O
flora	O	O
might	O	O
be	O	O
effective	O	O
long-term	O	O
interventions	O	O
to	O	O
fight	O	O
cariogenesis	O	O
.	O	O

To	O	O
meet	O	O
this	O	O
challenge	O	O
,	O	O
we	O	O
designed	O	O
C16G2	O	O
,	O	O
a	O	O
novel	O	O
synthetic	O	O
specifically	O	O
targeted	O	O
antimicrobial	O	O
peptide	O	O
with	O	O
specificity	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

C16G2	O	O
consists	O	O
of	O	O
a	O	O
S.	O	O
mutans-selective	O	O
'targeting	O	O
region	O	O
'	O	O
comprised	O	O
of	O	O
a	O	O
fragment	O	O
from	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
competence	O	O
stimulation	O	O
peptide	O	O
(	O	O
CSP	O	O
)	O	O
conjoined	O	O
to	O	O
a	O	O
'killing	O	O
region	O	O
'	O	O
consisting	O	O
of	O	O
a	O	O
broad-spectrum	O	O
antimicrobial	O	O
peptide	O	O
(	O	O
G2	O	O
)	O	O
.	O	O

In	O	O
vitro	O	O
studies	O	O
have	O	O
indicated	O	O
that	O	O
C16G2	O	O
has	O	O
robust	O	O
efficacy	O	O
and	O	O
selectivity	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
not	O	O
other	O	O
oral	O	O
bacteria	O	O
,	O	O
and	O	O
affects	O	O
targeted	O	O
bacteria	O	O
within	O	O
seconds	O	O
of	O	O
contact	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
evaluated	O	O
C16G2	O	O
for	O	O
clinical	O	O
utility	O	O
in	O	O
vitro	O	O
,	O	O
followed	O	O
by	O	O
a	O	O
pilot	O	O
efficacy	O	O
study	O	O
to	O	O
examine	O	O
the	O	O
impact	O	O
of	O	O
a	O	O
0.04	O	O
%	O	O
(	O	O
w/v	O	O
)	O	O
C16G2	O	O
rinse	O	O
in	O	O
an	O	O
intra-oral	O	O
remineralization/demineralization	O	O
model	O	O
.	O	O


C16G2	O	O
rinse	O	O
usage	O	O
was	O	O
associated	O	O
with	O	O
reductions	O	O
in	O	O
plaque	O	O
and	O	O
salivary	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
lactic	O	O
acid	O	O
production	O	O
,	O	O
and	O	O
enamel	O	O
demineralization	O	O
.	O	O

The	O	O
impact	O	O
on	O	O
total	O	O
plaque	O	O
bacteria	O	O
was	O	O
minimal	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
C16G2	O	O
is	O	O
effective	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
vivo	O	O
and	O	O
should	O	O
be	O	O
evaluated	O	O
further	O	O
in	O	O
the	O	O
clinic	O	O
.	O	O

In	O	O
view	O	O
of	O	O
the	O	O
morbidity	O	O
potential	O	O
of	O	O
oral	O	O
complications	O	O
in	O	O
patients	O	O
with	O	O
leukemia	O	O
,	O	O
this	O	O
study	O	O
evaluated	O	O
the	O	O
clinical	O	O
and	O	O
microbiological	O	O
alterations	O	O
that	O	O
occur	O	O
in	O	O
the	O	O
oral	O	O
mucosa	O	O
of	O	O
children	O	O
with	O	O
acute	O	O
lymphoblastic	O	O
leukemia	O	O
(	O	O
ALL	O	O
)	O	O
undergoing	O	O
antineoplastic	O	O
chemotherapy	O	O
and	O	O
prophylactic	O	O
administration	O	O
of	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
.	O	O

The	O	O
sample	O	O
consisted	O	O
of	O	O
17	O	O
children	O	O
aged	O	O
2	O	O
to	O	O
12	O	O
years	O	O
that	O	O
underwent	O	O
clinical	O	O
examination	O	O
of	O	O
the	O	O
oral	O	O
mucosa	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
oral	O	O
lesions	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
biological	O	O
material	O	O
was	O	O
collected	O	O
from	O	O
labial	O	O
and	O	O
buccal	O	O
mucosa	O	O
for	O	O
microbiological	O	O
analysis	O	O
.	O	O

Oral	O	O
mucositis	O	O
was	O	O
observed	O	O
in	O	O
only	O	O
5	O	O
(	O	O
29.4	O	O
%	O	O
)	O	O
patients	O	O
.	O	O

Microbiological	O	O
analysis	O	O
revealed	O	O
a	O	O
reduced	O	O
number	O	O
of	O	O
potentially	O	O
pathogenic	O	O
microorganisms	O	O
,	O	O
such	O	O
as	O	O
coagulase-negative	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
(	O	O
47	O	O
%	O	O
)	O	O
,	O	O
Candida	O	O
albicans	O	O
(	O	O
35.3	O	O
%	O	O
)	O	O
,	O	O
Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
(	O	O
5.9	O	O
%	O	O
)	O	O
,	O	O
enteropathogenic	B-bacteria	B-bacteria
Escherichia	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
(	O	O
5.9	O	O
%	O	O
)	O	O
,	O	O
and	O	O
Stenotrophomonas	B-bacteria	B-bacteria
maltophilia	E-bacteria	I-bacteria
(	O	O
5.9	O	O
%	O	O
)	O	O
.	O	O

Patients	O	O
with	O	O
oral	O	O
mucositis	O	O
showed	O	O
a	O	O
higher	O	O
frequency	O	O
of	O	O
coagulase-negative	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
(	O	O
80	O	O
%	O	O
)	O	O
when	O	O
compared	O	O
with	O	O
patients	O	O
with	O	O
normal	O	O
oral	O	O
mucosa	O	O
(	O	O
33.3	O	O
%	O	O
)	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
the	O	O
results	O	O
of	O	O
the	O	O
present	O	O
study	O	O
suggest	O	O
that	O	O
the	O	O
prophylactic	O	O
use	O	O
of	O	O
0.12	O	O
%	O	O
chlorhexidine	O	O
gluconate	O	O
reduces	O	O
the	O	O
frequency	O	O
of	O	O
oral	O	O
mucositis	O	O
and	O	O
oral	O	O
pathogens	O	O
in	O	O
children	O	O
with	O	O
ALL	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
present	O	O
findings	O	O
suggest	O	O
a	O	O
possible	O	O
relationship	O	O
between	O	O
coagulase-negative	B-bacteria	B-bacteria
staphylococci	E-bacteria	I-bacteria
and	O	O
the	O	O
development	O	O
of	O	O
oral	O	O
mucositis	O	O
.	O	O

We	O	O
compared	O	O
the	O	O
clinical	O	O
efficacy	O	O
,	O	O
the	O	O
bactericidal	O	O
effects	O	O
,	O	O
effect	O	O
on	O	O
the	O	O
oral	O	O
microbial	O	O
flora	O	O
,	O	O
and	O	O
adverse	O	O
reactions	O	O
between	O	O
cefditoren	O	O
pivoxil	O	O
(	O	O
CDTR-PI	O	O
)	O	O
for	O	O
5	O	O
days	O	O
and	O	O
amoxicillin	O	O
(	O	O
AMPC	O	O
)	O	O
for	O	O
10	O	O
days	O	O
in	O	O
children	O	O
with	O	O
acute	O	O
group	B-bacteria	B-bacteria
A	I-bacteria	I-bacteria
beta-hemolytic	I-bacteria	I-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
GAS	B-bacteria	B-bacteria
)	O	O
tonsillopharyngitis	O	O
,	O	O
and	O	O
simultaneously	O	O
examined	O	O
the	O	O
emm	O	O
genotype	O	O
and	O	O
drug	O	O
susceptibility	O	O
of	O	O
the	O	O
isolated	O	O
GAS	B-bacteria	B-bacteria
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
the	O	O
clinical	O	O
efficacy	O	O
was	O	O
100	O	O
%	O	O
for	O	O
CDTR-PI	O	O
and	O	O
97.9	O	O
%	O	O
for	O	O
AMPC	O	O
,	O	O
with	O	O
no	O	O
difference	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
,	O	O
and	O	O
the	O	O
bacterial	O	O
elimination	O	O
rate	O	O
was	O	O
100	O	O
%	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

No	O	O
serious	O	O
adverse	O	O
event	O	O
was	O	O
noted	O	O
in	O	O
either	O	O
group	O	O
.	O	O

On	O	O
the	O	O
other	O	O
hand	O	O
,	O	O
concerning	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
microbial	O	O
flora	O	O
between	O	O
before	O	O
and	O	O
after	O	O
treatment	O	O
,	O	O
the	O	O
amount	O	O
of	O	O
bacteria	O	O
showed	O	O
no	O	O
change	O	O
in	O	O
the	O	O
CDTR-PI	O	O
group	O	O
(	O	O
p	O	O
=	O	O
0.5761	O	O
)	O	O
but	O	O
clearly	O	O
decreased	O	O
in	O	O
the	O	O
AMPC	O	O
group	O	O
(	O	O
p	O	O
=	O	O
0.0049	O	O
)	O	O
.	O	O

This	O	O
indicates	O	O
that	O	O
CDTR-PI	O	O
does	O	O
not	O	O
disturb	O	O
the	O	O
oral	O	O
microbial	O	O
flora	O	O
compared	O	O
with	O	O
AMPC	O	O
.	O	O

Also	O	O
,	O	O
the	O	O
emm	O	O
types	O	O
determined	O	O
in	O	O
the	O	O
112	O	O
GAS	O	O
strains	O	O
isolated	O	O
in	O	O
this	O	O
study	O	O
were	O	O
similar	O	O
to	O	O
those	O	O
that	O	O
have	O	O
recently	O	O
been	O	O
isolated	O	O
frequently	O	O
in	O	O
Japan	O	O
.	O	O

Concerning	O	O
the	O	O
drug	O	O
resistance	O	O
,	O	O
none	O	O
of	O	O
the	O	O
isolates	O	O
showed	O	O
resistance	O	O
to	O	O
beta-lactam	O	O
antibiotics	O	O
,	O	O
but	O	O
45	O	O
%	O	O
of	O	O
them	O	O
were	O	O
resistant	O	O
to	O	O
macrolides	O	O
.	O	O

The	O	O
advantages	O	O
of	O	O
short-term	O	O
treatment	O	O
are	O	O
considered	O	O
to	O	O
include	O	O
a	O	O
lower	O	O
cost	O	O
,	O	O
improvement	O	O
in	O	O
drug	O	O
compliance	O	O
,	O	O
decrease	O	O
in	O	O
the	O	O
frequency	O	O
of	O	O
the	O	O
occurrence	O	O
of	O	O
adverse	O	O
reactions	O	O
,	O	O
decrease	O	O
in	O	O
the	O	O
frequency	O	O
of	O	O
the	O	O
appearance	O	O
of	O	O
drug-resistant	O	O
strains	O	O
,	O	O
and	O	O
alleviation	O	O
of	O	O
the	O	O
psychological	O	O
burden	O	O
of	O	O
patients	O	O
and	O	O
their	O	O
parents	O	O
.	O	O

For	O	O
these	O	O
reasons	O	O
,	O	O
we	O	O
conclude	O	O
that	O	O
CDTR-PI	O	O
for	O	O
5	O	O
days	O	O
is	O	O
a	O	O
useful	O	O
option	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
acute	O	O
GAS	O	O
tonsillopharyngitis	O	O
in	O	O
children	O	O
.	O	O

Oral	O	O
cancer	O	O
is	O	O
the	O	O
most	O	O
common	O	O
cancer	O	O
diagnosed	O	O
in	O	O
Indian	O	O
men	O	O
and	O	O
is	O	O
the	O	O
leading	O	O
cause	O	O
of	O	O
cancer	O	O
deaths	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
have	O	O
been	O	O
reported	O	O
to	O	O
be	O	O
present	O	O
in	O	O
0-40	O	O
%	O	O
of	O	O
the	O	O
cases	O	O
with	O	O
head	O	O
neck	O	O
cancer	O	O
.	O	O

A	O	O
higher	O	O
percentage	O	O
has	O	O
been	O	O
identified	O	O
in	O	O
laryngeal	O	O
and	O	O
pharangeal	O	O
cancer	O	O
.	O	O

We	O	O
here	O	O
carried	O	O
out	O	O
a	O	O
hospital-based	O	O
,	O	O
case-	O	O
control	O	O
study	O	O
of	O	O
20	O	O
patients	O	O
with	O	O
newly	O	O
diagnosed	O	O
oral	O	O
cancer	O	O
and	O	O
20	O	O
healthy	O	O
controls	O	O
without	O	O
any	O	O
cancer	O	O
to	O	O
evaluate	O	O
associations	O	O
between	O	O
H	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
infection	O	O
and	O	O
oral	O	O
cancer	O	O
using	O	O
culture	O	O
and	O	O
16sRNA	O	O
PCR	O	O
technique	O	O
for	O	O
bacterial	O	O
identification	O	O
.	O	O

H	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
was	O	O
isolated	O	O
from	O	O
the	O	O
culture	O	O
of	O	O
three	O	O
cases	O	O
and	O	O
one	O	O
control	O	O
,	O	O
while	O	O
three	O	O
cases	O	O
and	O	O
two	O	O
control	O	O
showed	O	O
PCR	O	O
positivity	O	O
for	O	O
H	B-bacteria	B-bacteria
Pylori	E-bacteria	I-bacteria
16sRNA	O	O
.	O	O

The	O	O
odds	O	O
ratio	O	O
by	O	O
culture	O	O
was	O	O
3.0	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
0.34-	O	O
26.4	O	O
and	O	O
1.5	O	O
,	O	O
95	O	O
%	O	O
CI	O	O
0.28-8.03	O	O
by	O	O
PCR	O	O
.	O	O

None	O	O
of	O	O
the	O	O
observed	O	O
odds	O	O
ratio	O	O
was	O	O
statistically	O	O
significant	O	O
.	O	O

However	O	O
,	O	O
the	O	O
results	O	O
of	O	O
this	O	O
pilot	O	O
study	O	O
suggest	O	O
a	O	O
possible	O	O
association	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
with	O	O
an	O	O
increased	O	O
risk	O	O
of	O	O
oral	O	O
cancer	O	O
.	O	O

Additional	O	O
studies	O	O
in	O	O
larger	O	O
populations	O	O
are	O	O
necessary	O	O
to	O	O
confirm	O	O
and	O	O
to	O	O
quantify	O	O
this	O	O
possible	O	O
association	O	O
more	O	O
accurately	O	O
.	O	O

Oral	O	O
lesions	O	O
are	O	O
rarely	O	O
reported	O	O
in	O	O
paucibacillary	O	O
forms	O	O
of	O	O
leprosy	O	O
.	O	O

We	O	O
report	O	O
here	O	O
a	O	O
case	O	O
with	O	O
an	O	O
erythematous	O	O
hyposensitive	O	O
lesion	O	O
in	O	O
the	O	O
palate	O	O
and	O	O
no	O	O
skin	O	O
lesions	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
routine	O	O
tests	O	O
,	O	O
biopsies	O	O
of	O	O
the	O	O
lesion	O	O
in	O	O
the	O	O
palate	O	O
and	O	O
of	O	O
clinically	O	O
normal	O	O
surrounding	O	O
areas	O	O
were	O	O
performed	O	O
and	O	O
subjected	O	O
to	O	O
real-time	O	O
PCR	O	O
for	O	O
detection	O	O
of	O	O
Mycobacterium	B-bacteria	B-bacteria
leprae	E-bacteria	I-bacteria
DNA	O	O
.	O	O

The	O	O
biopsy	O	O
of	O	O
the	O	O
oral	O	O
lesion	O	O
was	O	O
positive	O	O
for	O	O
bacilli	O	O
DNA	O	O
,	O	O
followed	O	O
by	O	O
positive	O	O
serum	O	O
anti-PGL-1	O	O
and	O	O
Mitsuda	O	O
test	O	O
,	O	O
but	O	O
with	O	O
negative	O	O
histopathology	O	O
.	O	O

The	O	O
patient	O	O
was	O	O
diagnosed	O	O
with	O	O
a	O	O
borderline	O	O
tuberculoid	O	O
form	O	O
.	O	O

After	O	O
multidrug	O	O
therapy	O	O
the	O	O
lesion	O	O
had	O	O
significantly	O	O
regressed	O	O
and	O	O
the	O	O
bacilli	O	O
DNA	O	O
detection	O	O
in	O	O
the	O	O
former	O	O
lesion	O	O
was	O	O
negative	O	O
.	O	O

The	O	O
bacilli	O	O
DNA	O	O
detection	O	O
in	O	O
an	O	O
oral	O	O
lesion	O	O
by	O	O
real-time	O	O
PCR	O	O
not	O	O
only	O	O
improved	O	O
leprosy	O	O
diagnosis	O	O
,	O	O
but	O	O
also	O	O
helped	O	O
in	O	O
the	O	O
classification	O	O
of	O	O
clinical	O	O
form	O	O
,	O	O
and	O	O
in	O	O
the	O	O
establishment	O	O
of	O	O
the	O	O
appropriate	O	O
therapeutic	O	O
regime	O	O
.	O	O

It	O	O
is	O	O
a	O	O
well-established	O	O
fact	O	O
that	O	O
colonization	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
occurs	O	O
early	O	O
in	O	O
life	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
determine	O	O
the	O	O
correlation	O	O
between	O	O
mode	O	O
of	O	O
delivery	O	O
and	O	O
other	O	O
associating	O	O
factors	O	O
with	O	O
colonization	O	O
of	O	O
oral	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
the	O	O
infants	O	O
.	O	O

The	O	O
newborns	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
according	O	O
to	O	O
the	O	O
mode	O	O
of	O	O
delivery	O	O
:	O	O
Infants	O	O
who	O	O
were	O	O
delivered	O	O
by	O	O
either	O	O
caesarean	O	O
section	O	O
(	O	O
Group-C	O	O
)	O	O
or	O	O
vaginally	O	O
(	O	O
Group-V	O	O
)	O	O
.	O	O

A	O	O
total	O	O
number	O	O
of	O	O
60	O	O
mother-infant	O	O
pairs	O	O
were	O	O
included	O	O
and	O	O
followed	O	O
for	O	O
1	O	O
year	O	O
.	O	O

The	O	O
swab	O	O
samples	O	O
were	O	O
collected	O	O
for	O	O
the	O	O
detection	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Analysis	O	O
of	O	O
data	O	O
demonstrated	O	O
the	O	O
possible	O	O
influence	O	O
of	O	O
prolonged	O	O
bottle	O	O
feeding	O	O
(	O	O
P	O	O
=	O	O
0.007	O	O
)	O	O
,	O	O
socioeconomic	O	O
status	O	O
(	O	O
P	O	O
=	O	O
0.00030	O	O
)	O	O
and	O	O
tasting	O	O
of	O	O
food	O	O
by	O	O
the	O	O
mothers	O	O
(	O	O
P	O	O
=	O	O
0.0065	O	O
)	O	O
on	O	O
the	O	O
initial	O	O
acquisition	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
infants	O	O
.	O	O

The	O	O
causes	O	O
for	O	O
initial	O	O
acquisition	O	O
of	O	O
oral	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
infants	O	O
were	O	O
postnatal	O	O
factors	O	O
like	O	O
feeding	O	O
and	O	O
oral	O	O
hygiene	O	O
practices	O	O
.	O	O

Previous	O	O
reports	O	O
have	O	O
associated	O	O
salivary	O	O
beta-galactosidase	O	O
activity	O	O
with	O	O
non-periodontopathic	O	O
oral	O	O
malodour	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
localization	O	O
of	O	O
beta-galactosidase	O	O
and	O	O
elucidated	O	O
the	O	O
relationship	O	O
between	O	O
its	O	O
enzymatic	O	O
activity	O	O
and	O	O
physiological	O	O
oral	O	O
malodour	O	O
.	O	O

Fifty-six	O	O
patients	O	O
complaining	O	O
of	O	O
halitosis	O	O
were	O	O
separated	O	O
into	O	O
two	O	O
groups	O	O
:	O	O
periodontally	O	O
healthy	O	O
and	O	O
periodontitis	O	O
.	O	O

Saliva	O	O
samples	O	O
from	O	O
the	O	O
subjects	O	O
were	O	O
separated	O	O
by	O	O
centrifugation	O	O
,	O	O
and	O	O
the	O	O
level	O	O
of	O	O
beta-galactosidase	O	O
activity	O	O
was	O	O
measured	O	O
in	O	O
the	O	O
supernatant	O	O
,	O	O
pellet	O	O
lysate	O	O
,	O	O
and	O	O
whole	O	O
saliva	O	O
using	O	O
the	O	O
chromogenic	O	O
substrate	O	O
o-nitrophenyl-beta-d-galactopyranoside	O	O
.	O	O

The	O	O
correlation	O	O
of	O	O
salivary	O	O
beta-galactosidase	O	O
activity	O	O
with	O	O
breath	O	O
odour	O	O
and	O	O
associated	O	O
parameters	O	O
was	O	O
examined	O	O
.	O	O

Similar	O	O
levels	O	O
of	O	O
beta-galactosidase	O	O
activity	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
pellet	O	O
lysate	O	O
and	O	O
whole	O	O
saliva	O	O
,	O	O
but	O	O
not	O	O
in	O	O
the	O	O
saliva	O	O
supernatant	O	O
.	O	O

Positive	O	O
correlations	O	O
were	O	O
observed	O	O
between	O	O
the	O	O
beta-galactosidase	O	O
activity	O	O
in	O	O
whole	O	O
saliva	O	O
and	O	O
oral	O	O
malodour	O	O
levels	O	O
in	O	O
the	O	O
periodontally	O	O
healthy	O	O
group	O	O
,	O	O
but	O	O
not	O	O
in	O	O
the	O	O
periodontitis	O	O
group	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
plaque	O	O
index	O	O
and	O	O
tongue	O	O
coating	O	O
score	O	O
were	O	O
positively	O	O
correlated	O	O
with	O	O
beta-galactosidase	O	O
activity	O	O
in	O	O
the	O	O
periodontally	O	O
healthy	O	O
group	O	O
.	O	O

Overall	O	O
,	O	O
stimulated	O	O
salivary	O	O
flow	O	O
and	O	O
salivary	O	O
pH	O	O
were	O	O
negatively	O	O
correlated	O	O
with	O	O
enzyme	O	O
activity	O	O
.	O	O

The	O	O
amounts	O	O
of	O	O
total	O	O
bacteria	O	O
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
were	O	O
positively	O	O
associated	O	O
with	O	O
beta-galactosidase	O	O
activity	O	O
in	O	O
the	O	O
periodontally	O	O
healthy	O	O
group	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
amounts	O	O
of	O	O
total	O	O
bacteria	O	O
and	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
were	O	O
positively	O	O
associated	O	O
with	O	O
the	O	O
amount	O	O
of	O	O
volatile	O	O
sulphur	O	O
compounds	O	O
.	O	O

Our	O	O
results	O	O
indicate	O	O
that	O	O
beta-galactosidase	O	O
is	O	O
located	O	O
on	O	O
the	O	O
cell	O	O
surface	O	O
of	O	O
oral	O	O
bacteria	O	O
derived	O	O
from	O	O
dental	O	O
plaque	O	O
and	O	O
tongue	O	O
coating	O	O
,	O	O
and	O	O
it	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
producing	O	O
the	O	O
malodour	O	O
underlying	O	O
physiological	O	O
oral	O	O
malodour	O	O
.	O	O

Campylobacter	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
infections	O	O
of	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
can	O	O
be	O	O
accompanied	O	O
by	O	O
diarrhea	O	O
and	O	O
inflammation	O	O
,	O	O
whereas	O	O
colonization	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
might	O	O
have	O	O
a	O	O
commensal	O	O
nature	O	O
.	O	O

We	O	O
focus	O	O
on	O	O
the	O	O
pathophysiology	O	O
of	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
and	O	O
the	O	O
effects	O	O
of	O	O
different	O	O
clinical	O	O
oral	O	O
and	O	O
fecal	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
strains	O	O
on	O	O
human	O	O
HT-29/B6	O	O
colon	O	O
cells	O	O
.	O	O

Six	O	O
oral	O	O
and	O	O
eight	O	O
fecal	O	O
strains	O	O
of	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
were	O	O
isolated	O	O
.	O	O

Mucus-producing	O	O
HT-29/B6	O	O
epithelial	O	O
monolayers	O	O
were	O	O
infected	O	O
with	O	O
the	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

Transepithelial	O	O
electrical	O	O
resistance	O	O
(	O	O
R	O	O
(	O	O
t	O	O
)	O	O
)	O	O
and	O	O
tracer	O	O
fluxes	O	O
of	O	O
different	O	O
molecule	O	O
size	O	O
were	O	O
measured	O	O
in	O	O
Ussing	O	O
chambers	O	O
.	O	O

Tight	O	O
junction	O	O
(	O	O
TJ	O	O
)	O	O
protein	O	O
expression	O	O
was	O	O
determined	O	O
by	O	O
Western	O	O
blotting	O	O
,	O	O
and	O	O
subcellular	O	O
TJ	O	O
distribution	O	O
was	O	O
analyzed	O	O
by	O	O
confocal	O	O
laser-scanning	O	O
microscopy	O	O
.	O	O

Apoptosis	O	O
induction	O	O
was	O	O
examined	O	O
by	O	O
TUNEL-staining	O	O
and	O	O
Western	O	O
blot	O	O
of	O	O
caspase-3	O	O
activation	O	O
.	O	O

All	O	O
strains	O	O
invaded	O	O
confluent	O	O
HT-29/B6	O	O
cells	O	O
and	O	O
impaired	O	O
epithelial	O	O
barrier	O	O
function	O	O
,	O	O
characterized	O	O
by	O	O
a	O	O
time-	O	O
and	O	O
dose-dependent	O	O
decrease	O	O
in	O	O
R	O	O
(	O	O
t	O	O
)	O	O
either	O	O
after	O	O
infection	O	O
from	O	O
the	O	O
apical	O	O
side	O	O
but	O	O
even	O	O
more	O	O
from	O	O
the	O	O
basolateral	O	O
compartment	O	O
.	O	O

TJ	O	O
protein	O	O
expression	O	O
changes	O	O
were	O	O
sparse	O	O
,	O	O
only	O	O
in	O	O
apoptotic	O	O
areas	O	O
of	O	O
infected	O	O
monolayers	O	O
TJ	O	O
proteins	O	O
were	O	O
redistributed	O	O
.	O	O

Solely	O	O
the	O	O
barrier-forming	O	O
TJ	O	O
protein	O	O
claudin-5	O	O
showed	O	O
a	O	O
reduced	O	O
expression	O	O
level	O	O
to	O	O
66+/-8	O	O
%	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
by	O	O
expression	O	O
regulation	O	O
from	O	O
the	O	O
gene	O	O
.	O	O

Concomitantly	O	O
,	O	O
Lactate	O	O
dehydrogenase	O	O
release	O	O
was	O	O
elevated	O	O
to	O	O
3.1+/-0.3	O	O
%	O	O
versus	O	O
0.7+/-0.1	O	O
%	O	O
in	O	O
control	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
,	O	O
suggesting	O	O
cytotoxic	O	O
effects	O	O
.	O	O

Furthermore	O	O
,	O	O
oral	O	O
and	O	O
fecal	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
elevated	O	O
apoptotic	O	O
events	O	O
to	O	O
5-fold	O	O
.	O	O

C.	O	O
concisus-infected	O	O
monolayers	O	O
revealed	O	O
an	O	O
increased	O	O
permeability	O	O
for	O	O
332	O	O
Da	O	O
fluorescein	O	O
(	O	O
1.74+/-0.13	O	O
vs.	O	O
0.56+/-0.17	O	O
10	O	O
(	O	O
-6	O	O
)	O	O
cm/s	O	O
in	O	O
control	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
but	O	O
showed	O	O
no	O	O
difference	O	O
in	O	O
permeability	O	O
for	O	O
4	O	O
kDa	O	O
FITC-dextran	O	O
(	O	O
FD-4	O	O
)	O	O
.	O	O

The	O	O
same	O	O
was	O	O
true	O	O
in	O	O
camptothecin-exposed	O	O
monolayers	O	O
,	O	O
where	O	O
camptothecin	O	O
was	O	O
used	O	O
for	O	O
apoptosis	O	O
induction.In	O	O
conclusion	O	O
,	O	O
epithelial	O	O
barrier	O	O
dysfunction	O	O
by	O	O
oral	O	O
and	O	O
fecal	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
could	O	O
mainly	O	O
be	O	O
assigned	O	O
to	O	O
apoptotic	O	O
leaks	O	O
together	O	O
with	O	O
moderate	O	O
TJ	O	O
changes	O	O
,	O	O
demonstrating	O	O
a	O	O
leak-flux	O	O
mechanism	O	O
that	O	O
parallels	O	O
the	O	O
clinical	O	O
manifestation	O	O
of	O	O
diarrhea	O	O
.	O	O

Halitosis	O	O
has	O	O
been	O	O
correlated	O	O
with	O	O
the	O	O
concentration	O	O
of	O	O
volatile	O	O
sulfur	O	O
compounds	O	O
(	O	O
VSCs	O	O
)	O	O
produced	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
by	O	O
metabolic	O	O
activity	O	O
of	O	O
bacteria	O	O
colonizing	O	O
the	O	O
periodontal	O	O
pockets	O	O
and	O	O
the	O	O
dorsum	O	O
of	O	O
the	O	O
tongue	O	O
.	O	O

It	O	O
has	O	O
been	O	O
assumed	O	O
that	O	O
there	O	O
is	O	O
a	O	O
relationship	O	O
between	O	O
periodontal	O	O
disease	O	O
and	O	O
diabetes	O	O
mellitus	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
malodor	O	O
using	O	O
the	O	O
organoleptic	O	O
method	O	O
and	O	O
tanita	O	O
device	O	O
;	O	O
to	O	O
quantify	O	O
odoriferous	O	O
microorganisms	O	O
of	O	O
subgingival	O	O
plaque	O	O
and	O	O
tongue	O	O
coating	O	O
,	O	O
such	O	O
as	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
(	O	O
Tf	B-bacteria	B-bacteria
)	O	O
,	O	O
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
Fn	B-bacteria	B-bacteria
)	O	O
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
in	O	O
nondiabetic	O	O
and	O	O
diabetic	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
.	O	O


Thirty	O	O
chronic	O	O
periodontitis	O	O
patients	O	O
(	O	O
with	O	O
and	O	O
without	O	O
diabetes	O	O
)	O	O
with	O	O
5-7	O	O
mm	O	O
pocket	O	O
depth	O	O
,	O	O
radiographic	O	O
evidence	O	O
of	O	O
bone	O	O
loss	O	O
,	O	O
and	O	O
presence	O	O
of	O	O
oral	O	O
malodor	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Subjective	O	O
assessment	O	O
of	O	O
mouth	O	O
air	O	O
was	O	O
done	O	O
organoleptically	O	O
and	O	O
by	O	O
using	O	O
a	O	O
portable	O	O
sulfide	O	O
monitor	O	O
.	O	O

Tongue	O	O
coating	O	O
was	O	O
also	O	O
assessed	O	O
.	O	O

The	O	O
scores	O	O
of	O	O
plaque	O	O
index	O	O
,	O	O
gingival	O	O
index	O	O
,	O	O
gingival	O	O
bleeding	O	O
index	O	O
,	O	O
VSC	O	O
levels	O	O
,	O	O
and	O	O
tongue	O	O
coating	O	O
between	O	O
the	O	O
nondiabetic	O	O
and	O	O
diabetic	O	O
patients	O	O
were	O	O
not	O	O
significant	O	O
(	O	O
P	O	O
>	O	O
0.5	O	O
)	O	O
.	O	O

In	O	O
nondiabetic	O	O
patients	O	O
,	O	O
Fn	O	O
was	O	O
found	O	O
to	O	O
be	O	O
significantly	O	O
(	O	O
P	O	O
<	O	O
0.5	O	O
)	O	O
more	O	O
in	O	O
tongue	O	O
samples	O	O
,	O	O
whereas	O	O
Pg	B-bacteria	B-bacteria
and	O	O
Tf	B-bacteria	B-bacteria
have	O	O
not	O	O
shown	O	O
significant	O	O
values	O	O
(	O	O
P	O	O
>	O	O
0.5	O	O
)	O	O
.	O	O

In	O	O
diabetic	O	O
patients	O	O
,	O	O
Fn	O	O
and	O	O
Tf	O	O
have	O	O
shown	O	O
significant	O	O
(	O	O
P	O	O
<	O	O
0.5	O	O
)	O	O
an	O	O
increase	O	O
in	O	O
subgingival	O	O
and	O	O
tongue	O	O
samples	O	O
,	O	O
respectively	O	O
,	O	O
whereas	O	O
Pg	B-bacteria	B-bacteria
has	O	O
not	O	O
shown	O	O
significant	O	O
difference	O	O
between	O	O
subgingival	O	O
and	O	O
tongue	O	O
samples	O	O
.	O	O

The	O	O
results	O	O
confirm	O	O
that	O	O
there	O	O
is	O	O
no	O	O
difference	O	O
in	O	O
clinical	O	O
parameters	O	O
between	O	O
nondiabetic	O	O
and	O	O
diabetic	O	O
periodontitis	O	O
patients	O	O
,	O	O
but	O	O
the	O	O
odoriferous	O	O
microbial	O	O
profiles	O	O
in	O	O
tongue	O	O
samples	O	O
of	O	O
diabetic	O	O
patients	O	O
were	O	O
found	O	O
to	O	O
be	O	O
high	O	O
.	O	O

However	O	O
,	O	O
there	O	O
is	O	O
a	O	O
weak	O	O
positive	O	O
correlation	O	O
between	O	O
VSC	O	O
levels	O	O
,	O	O
clinical	O	O
parameters	O	O
,	O	O
and	O	O
odoriferous	O	O
microbial	O	O
profiles	O	O
.	O	O

There	O	O
has	O	O
been	O	O
a	O	O
paradigm	O	O
shift	O	O
toward	O	O
ecological	O	O
and	O	O
microbial	O	O
community-based	O	O
approach	O	O
in	O	O
understanding	O	O
oral	O	O
diseases	O	O
.	O	O

A	O	O
marked	O	O
improvement	O	O
in	O	O
gastrointestinal	O	O
health	O	O
has	O	O
been	O	O
reported	O	O
after	O	O
using	O	O
probiotic	O	O
bacteria	O	O
and/or	O	O
prebiotic	O	O
supplements	O	O
,	O	O
which	O	O
has	O	O
prompted	O	O
much	O	O
interest	O	O
in	O	O
the	O	O
use	O	O
of	O	O
this	O	O
approach	O	O
for	O	O
oral	O	O
applications	O	O
.	O	O

Treatment	O	O
of	O	O
periodontal	O	O
disease	O	O
in	O	O
recent	O	O
years	O	O
has	O	O
moved	O	O
toward	O	O
an	O	O
antibiotic/antimicrobial	O	O
model	O	O
of	O	O
disease	O	O
management	O	O
.	O	O

With	O	O
increase	O	O
in	O	O
the	O	O
incidence	O	O
of	O	O
resistance	O	O
to	O	O
antibiotics	O	O
,	O	O
probiotics	O	O
may	O	O
be	O	O
a	O	O
promising	O	O
area	O	O
of	O	O
research	O	O
in	O	O
periodontal	O	O
therapy	O	O
.	O	O

This	O	O
paper	O	O
reviews	O	O
the	O	O
evidences	O	O
for	O	O
the	O	O
use	O	O
of	O	O
probiotics	O	O
or	O	O
prebiotics	O	O
for	O	O
the	O	O
prevention	O	O
of	O	O
dental	O	O
caries	O	O
or	O	O
periodontal	O	O
diseases	O	O
,	O	O
and	O	O
also	O	O
adresses	O	O
the	O	O
risk	O	O
associated	O	O
with	O	O
their	O	O
prolonged	O	O
use	O	O
.	O	O

Many	O	O
questions	O	O
have	O	O
been	O	O
raised	O	O
pertaining	O	O
to	O	O
the	O	O
benefits	O	O
of	O	O
probiotic	O	O
administration	O	O
,	O	O
as	O	O
the	O	O
role	O	O
of	O	O
probiotics	O	O
in	O	O
periodontics	O	O
is	O	O
still	O	O
in	O	O
infancy	O	O
,	O	O
and	O	O
a	O	O
complete	O	O
understanding	O	O
of	O	O
the	O	O
broad	O	O
ecological	O	O
changes	O	O
induced	O	O
in	O	O
the	O	O
mouth	O	O
by	O	O
probiotics	O	O
or	O	O
prebiotics	O	O
is	O	O
essential	O	O
to	O	O
assess	O	O
their	O	O
long-term	O	O
consequences	O	O
for	O	O
oral	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
if	O	O
three	O	O
strains	O	O
of	O	O
bacteria	O	O
could	O	O
impact	O	O
the	O	O
mechanical	O	O
or	O	O
surface	O	O
properties	O	O
of	O	O
a	O	O
dental	O	O
resin	O	O
material	O	O
.	O	O

Resin	O	O
material	O	O
specimens	O	O
were	O	O
incubated	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
in	O	O
sterile	O	O
saline	O	O
,	O	O
tryptic	O	O
soy	O	O
broth	O	O
supplemented	O	O
with	O	O
sucrose	O	O
(	O	O
TSBS	O	O
)	O	O
,	O	O
or	O	O
TSBS	O	O
inoculated	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
or	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
.	O	O

The	O	O
specimens	O	O
were	O	O
subjected	O	O
to	O	O
Fourier	O	O
transform	O	O
infrared	O	O
spectroscopy	O	O
before	O	O
and	O	O
after	O	O
incubation	O	O
.	O	O

The	O	O
flexural	O	O
strength	O	O
test	O	O
was	O	O
performed	O	O
once	O	O
a	O	O
week	O	O
for	O	O
6	O	O
weeks	O	O
.	O	O

Microhardness	O	O
and	O	O
scanning	O	O
electron	O	O
microscopy	O	O
(	O	O
SEM	O	O
)	O	O
was	O	O
performed	O	O
on	O	O
specimens	O	O
at	O	O
1	O	O
and	O	O
6	O	O
weeks	O	O
.	O	O

Differences	O	O
in	O	O
the	O	O
area	O	O
under	O	O
the	O	O
carbonyl	O	O
peak	O	O
were	O	O
statistically	O	O
significant	O	O
for	O	O
the	O	O
specimens	O	O
incubated	O	O
in	O	O
the	O	O
media	O	O
inoculated	O	O
with	O	O
either	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
or	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

To	O	O
determine	O	O
why	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
did	O	O
not	O	O
produce	O	O
changes	O	O
as	O	O
the	O	O
other	O	O
bacteria	O	O
did	O	O
,	O	O
triethylene	O	O
glycol	O	O
dimethacrylate	O	O
,	O	O
methacrylic	O	O
acid	O	O
,	O	O
and	O	O
triethylene	O	O
glycol	O	O
were	O	O
added	O	O
to	O	O
bacterial	O	O
cultures	O	O
at	O	O
increasing	O	O
concentrations	O	O
.	O	O

Both	O	O
methacrylic	O	O
acid	O	O
and	O	O
triethylene	O	O
glycol	O	O
reduced	O	O
the	O	O
number	O	O
of	O	O
colony-forming	O	O
units	O	O
of	O	O
S.	O	O
sanguis	O	O
.	O	O

Specimens	O	O
incubated	O	O
in	O	O
TSBS	O	O
,	O	O
saline	O	O
or	O	O
in	O	O
culture	O	O
with	O	O
S.	O	O
sanguis	O	O
demonstrated	O	O
a	O	O
decrease	O	O
in	O	O
peak	O	O
stress	O	O
in	O	O
week	O	O
1	O	O
of	O	O
the	O	O
flexure	O	O
strength	O	O
test	O	O
.	O	O

SEM	O	O
demonstrated	O	O
that	O	O
surface	O	O
topology	O	O
changed	O	O
for	O	O
those	O	O
specimens	O	O
incubated	O	O
in	O	O
culture	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
or	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

The	O	O
changes	O	O
in	O	O
surface	O	O
topology	O	O
demonstrated	O	O
here	O	O
could	O	O
contribute	O	O
to	O	O
the	O	O
secondary	O	O
caries	O	O
and	O	O
changes	O	O
in	O	O
esthetic	O	O
properties	O	O
seen	O	O
clinically	O	O
with	O	O
the	O	O
use	O	O
of	O	O
resin	O	O
materials	O	O
in	O	O
dental	O	O
restorations	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
commensal	O	O
bacteria	O	O
that	O	O
have	O	O
long	O	O
been	O	O
recognized	O	O
as	O	O
probiotic	O	O
microbes	O	O
and	O	O
are	O	O
generally	O	O
regarded	O	O
as	O	O
safe	O	O
(	O	O
GRAS	O	O
)	O	O
for	O	O
human	O	O
consumption	O	O
.	O	O

We	O	O
have	O	O
investigated	O	O
the	O	O
use	O	O
of	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
as	O	O
a	O	O
vaccine	O	O
vector	O	O
for	O	O
oral	O	O
immunization	O	O
against	O	O
mucosal	O	O
pathogens	O	O
.	O	O

Recent	O	O
research	O	O
has	O	O
shown	O	O
that	O	O
the	O	O
immune	O	O
response	O	O
to	O	O
different	O	O
lactobacilli	B-bacteria	B-bacteria
can	O	O
vary	O	O
widely	O	O
depending	O	O
on	O	O
the	O	O
species	O	O
or	O	O
subspecies	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
being	O	O
studied	O	O
.	O	O

While	O	O
some	O	O
lactobacilli	B-bacteria	B-bacteria
seem	O	O
to	O	O
induce	O	O
oral	O	O
tolerance	O	O
,	O	O
others	O	O
induce	O	O
an	O	O
adaptive	O	O
immune	O	O
response	O	O
.	O	O

This	O	O
study	O	O
characterized	O	O
the	O	O
systemic	O	O
and	O	O
mucosal	O	O
immune	O	O
response	O	O
to	O	O
wild-type	O	O
and	O	O
genetically	O	O
modified	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
.	O	O

L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
primarily	O	O
activates	O	O
TLR2/6	O	O
,	O	O
with	O	O
additional	O	O
activation	O	O
through	O	O
the	O	O
TLR2	O	O
homodimer	O	O
.	O	O

To	O	O
expand	O	O
the	O	O
Toll-like	O	O
receptor	O	O
(	O	O
TLR	O	O
)	O	O
activation	O	O
profile	O	O
of	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
and	O	O
the	O	O
immunogenicity	O	O
of	O	O
the	O	O
vector	O	O
,	O	O
a	O	O
plasmid	O	O
containing	O	O
fliC	O	O
,	O	O
the	O	O
gene	O	O
encoding	O	O
bacterial	O	O
flagellin	O	O
,	O	O
was	O	O
introduced	O	O
which	O	O
resulted	O	O
in	O	O
the	O	O
strong	O	O
activation	O	O
of	O	O
TLR5	O	O
.	O	O

The	O	O
treatment	O	O
of	O	O
human	O	O
myeloid	O	O
dendritic	O	O
cells	O	O
with	O	O
recombinant	O	O
lactobacilli	B-bacteria	B-bacteria
expressing	O	O
flagellin	O	O
triggered	O	O
phenotypic	O	O
maturation	O	O
and	O	O
the	O	O
release	O	O
of	O	O
proinflammatory	O	O
cytokines	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
bacterial	O	O
treatment	O	O
also	O	O
resulted	O	O
in	O	O
a	O	O
statistically	O	O
significant	O	O
increase	O	O
in	O	O
IL-10	O	O
production	O	O
.	O	O

In	O	O
vivo	O	O
studies	O	O
established	O	O
that	O	O
treatment	O	O
with	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
led	O	O
to	O	O
a	O	O
diversification	O	O
of	O	O
B-cell	O	O
populations	O	O
in	O	O
the	O	O
lamina	O	O
propria	O	O
of	O	O
the	O	O
murine	O	O
colon	O	O
.	O	O

Furthermore	O	O
,	O	O
treatment	O	O
with	O	O
genetically	O	O
modified	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
led	O	O
to	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
the	O	O
percentage	O	O
of	O	O
FoxP3	O	O
(	O	O
+	O	O
)	O	O
colonic	O	O
lymphocytes	O	O
.	O	O

Taken	O	O
together	O	O
,	O	O
these	O	O
data	O	O
clarify	O	O
the	O	O
interaction	O	O
of	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
with	O	O
the	O	O
host	O	O
immune	O	O
system	O	O
and	O	O
support	O	O
further	O	O
investigation	O	O
of	O	O
the	O	O
in	O	O
vivo	O	O
immunogenicity	O	O
of	O	O
L.	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
expressing	O	O
both	O	O
flagellin	O	O
and	O	O
candidate	O	O
vaccine	O	O
antigens	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
bactericidal	O	O
effects	O	O
and	O	O
bactericidal	O	O
time	O	O
of	O	O
an	O	O
acidified	O	O
sodium	O	O
chlorite	O	O
compound	O	O
gel	O	O
(	O	O
ASC-Gel	O	O
)	O	O
on	O	O
bacteria	O	O
isolated	O	O
from	O	O
the	O	O
peri-implant	O	O
sulci	O	O
of	O	O
10	O	O
patients	O	O
who	O	O
received	O	O
implants	O	O
3-27	O	O
years	O	O
previously	O	O
,	O	O
and	O	O
the	O	O
depth	O	O
of	O	O
each	O	O
peri-implant	O	O
sulcus	O	O
was	O	O
5	O	O
mm	O	O
or	O	O
less	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
ATCC33277	B-bacteria	B-bacteria
)	O	O
was	O	O
used	O	O
as	O	O
the	O	O
control	O	O
bacterium	O	O
.	O	O

Five	O	O
ASC-Gel	O	O
preparations	O	O
were	O	O
created	O	O
by	O	O
adding	O	O
3.3	O	O
%	O	O
,	O	O
5.0	O	O
%	O	O
,	O	O
7.0	O	O
%	O	O
,	O	O
9.0	O	O
%	O	O
,	O	O
and	O	O
11.0	O	O
%	O	O
citric	O	O
acid	O	O
(	O	O
CA	O	O
)	O	O
(	O	O
condition	O	O
a	O	O
,	O	O
b	O	O
,	O	O
c	O	O
,	O	O
d	O	O
,	O	O
and	O	O
e	O	O
,	O	O
respectively	O	O
)	O	O
into	O	O
an	O	O
oral	O	O
moisturizing	O	O
gel	O	O
containing	O	O
sodium	O	O
chlorite	O	O
.	O	O

The	O	O
concentrations	O	O
of	O	O
chlorine	O	O
dioxide	O	O
(	O	O
ClO2	O	O
)	O	O
generated	O	O
in	O	O
ASC-Gel	O	O
under	O	O
conditions	O	O
(	O	O
a	O	O
)	O	O
to	O	O
(	O	O
e	O	O
)	O	O
were	O	O
12.1	O	O
,	O	O
14.1	O	O
,	O	O
17.2	O	O
,	O	O
21.2	O	O
,	O	O
and	O	O
39.3	O	O
ppm	O	O
,	O	O
respectively	O	O
.	O	O

We	O	O
examined	O	O
the	O	O
bactericidal	O	O
effects	O	O
of	O	O
the	O	O
5	O	O
ASC-Gel	O	O
preparations	O	O
at	O	O
volumes	O	O
of	O	O
0.5	O	O
,	O	O
1.0	O	O
,	O	O
and	O	O
2.0	O	O
mL	O	O
,	O	O
and	O	O
measured	O	O
the	O	O
bactericidal	O	O
time	O	O
when	O	O
2.0	O	O
mL	O	O
of	O	O
ASC-Gel	O	O
was	O	O
used	O	O
under	O	O
condition	O	O
(	O	O
e	O	O
)	O	O
.	O	O

The	O	O
bactericidal	O	O
effects	O	O
of	O	O
ASC-Gel	O	O
became	O	O
significantly	O	O
greater	O	O
with	O	O
increased	O	O
concentrations	O	O
of	O	O
CA	O	O
and	O	O
ClO2	O	O
and	O	O
with	O	O
increased	O	O
usage	O	O
(	O	O
0.5-2.0	O	O
mL	O	O
)	O	O
of	O	O
the	O	O
gel	O	O
.	O	O

All	O	O
bacteria	O	O
were	O	O
killed	O	O
by	O	O
using	O	O
2.0	O	O
mL	O	O
of	O	O
ASC-Gel	O	O
under	O	O
condition	O	O
(	O	O
e	O	O
)	O	O
.	O	O

ASC-Gel	O	O
also	O	O
needed	O	O
between	O	O
45	O	O
and	O	O
90	O	O
minutes	O	O
to	O	O
kill	O	O
all	O	O
microbes	O	O
under	O	O
condition	O	O
(	O	O
e	O	O
)	O	O
.	O	O

Within	O	O
the	O	O
limits	O	O
of	O	O
the	O	O
present	O	O
investigation	O	O
,	O	O
these	O	O
results	O	O
suggest	O	O
that	O	O
ASC-Gel	O	O
is	O	O
useful	O	O
as	O	O
a	O	O
chemical	O	O
disinfectant	O	O
against	O	O
bacteria	O	O
in	O	O
the	O	O
peri-implant	O	O
sulcus	O	O
.	O	O

Further	O	O
studies	O	O
are	O	O
also	O	O
required	O	O
to	O	O
protect	O	O
teeth	O	O
,	O	O
the	O	O
surface	O	O
of	O	O
hydroxyapatite-coated	O	O
implants	O	O
,	O	O
and	O	O
the	O	O
surrounding	O	O
soft	O	O
tissues	O	O
from	O	O
effects	O	O
of	O	O
chemical	O	O
dissolution	O	O
such	O	O
as	O	O
acid	O	O
erosion	O	O
due	O	O
to	O	O
the	O	O
low	O	O
pH	O	O
of	O	O
ASC-Gel	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
impact	O	O
on	O	O
microbiologic	O	O
variables	O	O
of	O	O
full-mouth	O	O
scaling	O	O
(	O	O
FMS	O	O
)	O	O
and	O	O
conventional	O	O
scaling	O	O
and	O	O
root	O	O
planing	O	O
(	O	O
cSRP	O	O
)	O	O
after	O	O
12	O	O
months	O	O
.	O	O

In	O	O
a	O	O
prospective	O	O
randomized	O	O
controlled	O	O
clinical	O	O
study	O	O
,	O	O
37	O	O
volunteers	O	O
with	O	O
moderate	O	O
chronic	O	O
periodontitis	O	O
were	O	O
treated	O	O
by	O	O
FMS	O	O
or	O	O
by	O	O
cSRP	O	O
in	O	O
two	O	O
sessions	O	O
at	O	O
4-week	O	O
intervals	O	O
.	O	O

Clinical	O	O
attachment	O	O
level	O	O
,	O	O
probing	O	O
depth	O	O
,	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
were	O	O
recorded	O	O
at	O	O
baseline	O	O
as	O	O
well	O	O
as	O	O
at	O	O
6	O	O
and	O	O
12	O	O
months	O	O
.	O	O

Four	O	O
subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
the	O	O
deepest	O	O
sites	O	O
in	O	O
premolars	O	O
and	O	O
molars	O	O
at	O	O
baseline	O	O
and	O	O
after	O	O
12	O	O
months	O	O
.	O	O

Pooled	O	O
sample	O	O
analysis	O	O
was	O	O
performed	O	O
using	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
for	O	O
the	O	O
identification	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

At	O	O
baseline	O	O
,	O	O
the	O	O
bacterial	O	O
load	O	O
of	O	O
A	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
in	O	O
the	O	O
cSRP	O	O
group	O	O
compared	O	O
to	O	O
the	O	O
FMS	O	O
group	O	O
(	O	O
P	O	O
=	O	O
.042	O	O
)	O	O
.	O	O

In	O	O
the	O	O
cSRP	O	O
group	O	O
,	O	O
this	O	O
load	O	O
decreased	O	O
significantly	O	O
(	O	O
P	O	O
=	O	O
.011	O	O
)	O	O
,	O	O
leading	O	O
to	O	O
similar	O	O
quantities	O	O
of	O	O
A	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
in	O	O
both	O	O
groups	O	O
.	O	O

Further	O	O
,	O	O
significant	O	O
reductions	O	O
in	O	O
frequency	O	O
were	O	O
found	O	O
in	O	O
the	O	O
FMS	O	O
group	O	O
for	O	O
T	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
P	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
in	O	O
the	O	O
cSRP	O	O
group	O	O
for	O	O
A	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
T	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

The	O	O
data	O	O
suggest	O	O
that	O	O
both	O	O
therapy	O	O
modalities	O	O
lead	O	O
to	O	O
similar	O	O
effects	O	O
on	O	O
target	O	O
periodontal	O	O
pathogen	O	O
species	O	O
.	O	O

FMS	O	O
compared	O	O
to	O	O
cSRP	O	O
was	O	O
not	O	O
favorable	O	O
in	O	O
reduction	O	O
of	O	O
periodontopathogens	O	O
.	O	O

Changes	O	O
in	O	O
the	O	O
microbial	O	O
flora	O	O
on	O	O
the	O	O
oral	O	O
mucosa	O	O
after	O	O
cancerous	O	O
alteration	O	O
may	O	O
lead	O	O
to	O	O
both	O	O
local	O	O
and	O	O
systemic	O	O
infections	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
assessed	O	O
the	O	O
microbial	O	O
flora	O	O
associated	O	O
with	O	O
the	O	O
surfaces	O	O
of	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
.	O	O

A	O	O
comparative	O	O
evaluation	O	O
of	O	O
these	O	O
microbial	O	O
contents	O	O
was	O	O
made	O	O
with	O	O
that	O	O
of	O	O
the	O	O
contralateral	O	O
healthy	O	O
mucosa	O	O
and	O	O
control	O	O
(	O	O
healthy	O	O
)	O	O
mucosa	O	O
.	O	O

We	O	O
also	O	O
assessed	O	O
the	O	O
microbial	O	O
flora	O	O
from	O	O
the	O	O
saliva	O	O
culture	O	O
in	O	O
subjects	O	O
with	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
and	O	O
healthy	O	O
controls	O	O
.	O	O

The	O	O
case	O	O
control	O	O
study	O	O
was	O	O
made	O	O
up	O	O
of	O	O
30	O	O
subjects	O	O
with	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
as	O	O
the	O	O
study	O	O
group	O	O
;	O	O
30	O	O
healthy	O	O
age-	O	O
,	O	O
sex-	O	O
,	O	O
habit-	O	O
,	O	O
and	O	O
dentition-matched	O	O
subjects	O	O
served	O	O
as	O	O
the	O	O
control	O	O
group	O	O
.	O	O

In	O	O
the	O	O
study	O	O
group	O	O
,	O	O
microbial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
carcinoma	O	O
site	O	O
,	O	O
contralateral	O	O
healthy	O	O
mucosa	O	O
,	O	O
and	O	O
saliva	O	O
,	O	O
whereas	O	O
in	O	O
the	O	O
control	O	O
group	O	O
,	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
the	O	O
healthy	O	O
mucosa	O	O
and	O	O
saliva	O	O
.	O	O

These	O	O
samples	O	O
were	O	O
stored	O	O
on	O	O
ice	O	O
and	O	O
subsequently	O	O
transported	O	O
to	O	O
the	O	O
laboratory	O	O
in	O	O
2	O	O
mL	O	O
of	O	O
thioglycollate	O	O
transport	O	O
media	O	O
,	O	O
where	O	O
the	O	O
microbial	O	O
cultures	O	O
were	O	O
carried	O	O
out	O	O
.	O	O

Oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
sites	O	O
harbor	O	O
significantly	O	O
more	O	O
microbial	O	O
flora	O	O
(	O	O
bacteria	O	O
and	O	O
yeasts	O	O
)	O	O
compared	O	O
to	O	O
those	O	O
of	O	O
healthy	O	O
mucosa	O	O
(	O	O
control	O	O
group	O	O
)	O	O
.	O	O

The	O	O
microbial	O	O
flora	O	O
predominantly	O	O
isolated	O	O
from	O	O
the	O	O
carcinoma	O	O
site	O	O
were	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Moraxella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
feacalis	E-bacteria	I-bacteria
,	O	O
Aerobic	O	O
spore	O	O
bearers	O	O
,	O	O
Klebsiella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Citrobacter	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Proteus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
Pseudomonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
and	O	O
Candida	O	O
albicans	O	O
.	O	O

The	O	O
median	O	O
number	O	O
of	O	O
colony	O	O
forming	O	O
units	O	O
(	O	O
CFU	O	O
)	O	O
/mL	O	O
at	O	O
carcinoma	O	O
sites	O	O
(	O	O
3.85	O	O
x	O	O
105	O	O
CFU/mL	O	O
)	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
of	O	O
the	O	O
healthy	O	O
mucosa	O	O
(	O	O
0.571	O	O
x	O	O
105	O	O
CFU/mL	O	O
;	O	O
P	O	O
=	O	O
.0000	O	O
,	O	O
Wilcoxon	O	O
nonparametric	O	O
test	O	O
)	O	O
.	O	O

Similarly	O	O
,	O	O
in	O	O
saliva	O	O
of	O	O
carcinoma	O	O
subjects	O	O
,	O	O
the	O	O
median	O	O
number	O	O
of	O	O
CFU/mL	O	O
(	O	O
2.408	O	O
x	O	O
105	O	O
CFU/mL	O	O
)	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
of	O	O
saliva	O	O
in	O	O
control	O	O
subjects	O	O
(	O	O
0.78	O	O
x	O	O
105	O	O
CFU/mL	O	O
;	O	O
P	O	O
=	O	O
.0000	O	O
,	O	O
Wilcoxon	O	O
nonparametric	O	O
test	O	O
)	O	O
.	O	O

The	O	O
present	O	O
study	O	O
clearly	O	O
indicates	O	O
that	O	O
the	O	O
subjects	O	O
with	O	O
oral	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
harbor	O	O
significantly	O	O
more	O	O
microbial	O	O
flora	O	O
.	O	O

Emphasis	O	O
has	O	O
to	O	O
be	O	O
given	O	O
to	O	O
preventing	O	O
microbial	O	O
flora	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
treating	O	O
these	O	O
patients	O	O
with	O	O
appropriate	O	O
antimicrobial	O	O
agents	O	O
,	O	O
thus	O	O
reducing	O	O
their	O	O
morbidity	O	O
.	O	O

There	O	O
are	O	O
many	O	O
studies	O	O
on	O	O
the	O	O
effect	O	O
of	O	O
preprocedural	O	O
mouth	O	O
rinses	O	O
in	O	O
adults	O	O
,	O	O
but	O	O
there	O	O
is	O	O
a	O	O
dearth	O	O
of	O	O
the	O	O
literature	O	O
on	O	O
the	O	O
effects	O	O
of	O	O
these	O	O
mouth	O	O
rinses	O	O
in	O	O
children	O	O
.	O	O

This	O	O
study	O	O
aims	O	O
to	O	O
evaluate	O	O
the	O	O
efficacy	O	O
of	O	O
two	O	O
commercially	O	O
available	O	O
brands	O	O
,	O	O
one	O	O
containing	O	O
chlorhexidine	O	O
0.12	O	O
%	O	O
(	O	O
Colgate	O	O
Periogard	O	O
)	O	O
and	O	O
the	O	O
other	O	O
containing	O	O
cetylpyridinium	O	O
chloride	O	O
0.05	O	O
%	O	O
(	O	O
Johnson	O	O
and	O	O
Johnson	O	O
's	O	O
Reach	O	O
)	O	O
used	O	O
as	O	O
preprocedural	O	O
mouth	O	O
rinses	O	O
in	O	O
children	O	O
.	O	O

The	O	O
study	O	O
was	O	O
conducted	O	O
on	O	O
18	O	O
patients	O	O
in	O	O
the	O	O
age	O	O
group	O	O
of	O	O
10-15	O	O
years	O	O
.	O	O

A	O	O
crossover	O	O
design	O	O
was	O	O
used	O	O
with	O	O
the	O	O
random	O	O
assignment	O	O
of	O	O
the	O	O
first	O	O
rinse	O	O
tested	O	O
and	O	O
a	O	O
wash	O	O
out	O	O
period	O	O
of	O	O
at	O	O
least	O	O
1	O	O
week	O	O
before	O	O
the	O	O
second	O	O
rinse	O	O
was	O	O
used	O	O
.	O	O

The	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
prerinse	O	O
,	O	O
2	O	O
min	O	O
,	O	O
30	O	O
min	O	O
,	O	O
and	O	O
60	O	O
min	O	O
after	O	O
rinsing	O	O
with	O	O
the	O	O
solution	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
inoculated	O	O
and	O	O
cultured	O	O
for	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
microorganisms	O	O
.	O	O

After	O	O
48	O	O
h	O	O
,	O	O
the	O	O
resultant	O	O
bacterial	O	O
colonies	O	O
were	O	O
counted	O	O
.	O	O

Statistical	O	O
analysis	O	O
was	O	O
done	O	O
using	O	O
Wilcoxon	O	O
's	O	O
signed	O	O
rank	O	O
test	O	O
,	O	O
ANOVA	O	O
,	O	O
and	O	O
Newman-Keul	O	O
's	O	O
studentized	O	O
range	O	O
test	O	O
.	O	O

Periogard	O	O
had	O	O
the	O	O
highest	O	O
percentage	O	O
reduction	O	O
in	O	O
both	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
microorganisms	O	O
followed	O	O
by	O	O
Reach	O	O
and	O	O
the	O	O
least	O	O
effective	O	O
was	O	O
normal	O	O
saline	O	O
which	O	O
was	O	O
used	O	O
as	O	O
a	O	O
control	O	O
.	O	O

Periogard	O	O
is	O	O
comparatively	O	O
better	O	O
as	O	O
a	O	O
preprocedural	O	O
mouth	O	O
rinse	O	O
than	O	O
Reach	O	O
.	O	O

Commercially	O	O
available	O	O
photodynamic	O	O
therapy	O	O
for	O	O
periodontal	O	O
diseases	O	O
utilizes	O	O
methylene	O	O
blue	O	O
as	O	O
a	O	O
photosensitizer	O	O
.	O	O

Here	O	O
we	O	O
propose	O	O
a	O	O
novel	O	O
photosensitizer	O	O
dye	O	O
,	O	O
indocyanine	O	O
green	O	O
(	O	O
ICG	O	O
)	O	O
,	O	O
because	O	O
it	O	O
can	O	O
be	O	O
readily	O	O
activated	O	O
by	O	O
commercially	O	O
available	O	O
dental	O	O
810	O	O
nm	O	O
diode	O	O
lasers	O	O
and	O	O
has	O	O
an	O	O
established	O	O
safety	O	O
record	O	O
as	O	O
an	O	O
intravascular	O	O
agent	O	O
in	O	O
cardiac	O	O
imaging	O	O
and	O	O
ophthalmologic	O	O
photodynamic	O	O
therapy	O	O
.	O	O

Therefore	O	O
,	O	O
we	O	O
aim	O	O
to	O	O
characterize	O	O
ICG	O	O
uptake	O	O
and	O	O
killing	O	O
of	O	O
key	O	O
periodontal	O	O
pathogens	O	O
to	O	O
explore	O	O
its	O	O
potential	O	O
as	O	O
a	O	O
periodontal	O	O
photodynamic	O	O
therapy	O	O
agent	O	O
.	O	O

We	O	O
tested	O	O
ICG	O	O
uptake	O	O
by	O	O
spectroscopy	O	O
in	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
381	E-bacteria	I-bacteria
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
in	O	O
addition	O	O
to	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
DH5alpha	E-bacteria	I-bacteria
and	O	O
a	O	O
human	O	O
gingival	O	O
epithelial	O	O
cell	O	O
line	O	O
,	O	O
HepG	O	O
,	O	O
in	O	O
relation	O	O
to	O	O
ICG	O	O
dose	O	O
and	O	O
exposure	O	O
time	O	O
.	O	O

We	O	O
then	O	O
measured	O	O
killing	O	O
of	O	O
bacteria	O	O
by	O	O
determining	O	O
viable	O	O
bacteria	O	O
counts	O	O
before	O	O
and	O	O
after	O	O
exposure	O	O
to	O	O
ICG	O	O
and	O	O
810	O	O
nm	O	O
diode	O	O
laser	O	O
light	O	O
(	O	O
0-0.5	O	O
W	O	O
output	O	O
settings	O	O
,	O	O
0-5	O	O
seconds	O	O
)	O	O
.	O	O

ICG	O	O
was	O	O
also	O	O
applied	O	O
to	O	O
extracted	O	O
,	O	O
restored	O	O
teeth	O	O
,	O	O
and	O	O
the	O	O
teeth	O	O
inspected	O	O
visually	O	O
for	O	O
staining	O	O
after	O	O
rinsing	O	O
with	O	O
saline	O	O
.	O	O

We	O	O
found	O	O
rapid	O	O
and	O	O
significant	O	O
uptake	O	O
of	O	O
indocyanine	O	O
green	O	O
into	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
381	E-bacteria	I-bacteria
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	I-bacteria	I-bacteria
67	E-bacteria	I-bacteria
,	O	O
compared	O	O
to	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
DH5alpha	E-bacteria	I-bacteria
and	O	O
HepG	O	O
gingival	O	O
cell	O	O
line	O	O
.	O	O

This	O	O
correlated	O	O
with	O	O
significant	O	O
killing	O	O
of	O	O
strains	O	O
381	O	O
and	O	O
67	O	O
compared	O	O
to	O	O
E.coli	B-bacteria	B-bacteria
,	O	O
with	O	O
less	O	O
than	O	O
10	O	O
%	O	O
survival	O	O
.	O	O

ICG	O	O
does	O	O
not	O	O
appear	O	O
to	O	O
stain	O	O
tooth	O	O
surfaces	O	O
and	O	O
materials	O	O
except	O	O
calculus	O	O
.	O	O

ICG	O	O
combined	O	O
with	O	O
an	O	O
810	O	O
nm	O	O
diode	O	O
laser	O	O
may	O	O
be	O	O
useful	O	O
as	O	O
a	O	O
photodynamic	O	O
adjunct	O	O
for	O	O
reduction	O	O
of	O	O
bacterial	O	O
load	O	O
in	O	O
periodontal	O	O
pockets	O	O
.	O	O

Periodontal	O	O
diseases	O	O
are	O	O
known	O	O
to	O	O
be	O	O
major	O	O
diseases	O	O
in	O	O
humans	O	O
,	O	O
and	O	O
are	O	O
also	O	O
common	O	O
in	O	O
dogs	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
analyze	O	O
the	O	O
distribution	O	O
of	O	O
periodontitis-related	O	O
bacterial	O	O
species	O	O
using	O	O
oral	O	O
swab	O	O
specimens	O	O
collected	O	O
from	O	O
26	O	O
pet	O	O
dogs	O	O
.	O	O

The	O	O
distribution	O	O
of	O	O
an	O	O
animal	O	O
gingival	O	O
organism	O	O
Porphyromonas	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
,	O	O
in	O	O
addition	O	O
to	O	O
10	O	O
human	O	O
periodontitis-related	O	O
bacterial	O	O
species	O	O
,	O	O
including	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
ochracea	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
sputigena	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
nigrescens	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
and	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
were	O	O
evaluated	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
with	O	O
species-specific	O	O
sets	O	O
of	O	O
primers	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
almost	O	O
all	O	O
dogs	O	O
analyzed	O	O
,	O	O
all	O	O
of	O	O
which	O	O
should	O	O
be	O	O
regarded	O	O
as	O	O
common	O	O
members	O	O
of	O	O
oral	O	O
flora	O	O
in	O	O
dogs	O	O
.	O	O

Then	O	O
,	O	O
isolation	O	O
and	O	O
identification	O	O
of	O	O
the	O	O
Porphyromonas	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
swab	O	O
specimens	O	O
were	O	O
performed	O	O
.	O	O

There	O	O
were	O	O
35	O	O
strains	O	O
isolated	O	O
from	O	O
22	O	O
dogs	O	O
,	O	O
and	O	O
broad-range	O	O
polymerase	O	O
chain	O	O
reaction	O	O
and	O	O
sequencing	O	O
methods	O	O
revealed	O	O
that	O	O
approximately	O	O
70	O	O
%	O	O
of	O	O
them	O	O
were	O	O
Porphyromonas	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
frequency	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
extremely	O	O
low	O	O
.	O	O

These	O	O
findings	O	O
indicate	O	O
the	O	O
presence	O	O
of	O	O
specific	O	O
periodontitis-related	O	O
pathogens	O	O
in	O	O
pet	O	O
dogs	O	O
,	O	O
especially	O	O
Porphyromonas	B-bacteria	B-bacteria
gulae	E-bacteria	I-bacteria
.	O	O

For	O	O
paediatric	O	O
dentists	O	O
,	O	O
an	O	O
indicator	O	O
to	O	O
assess	O	O
caries	O	O
risk	O	O
of	O	O
infants	O	O
is	O	O
very	O	O
important	O	O
.	O	O

Conventionally	O	O
,	O	O
the	O	O
number	O	O
and/or	O	O
proportions	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
have	O	O
been	O	O
employed	O	O
as	O	O
risk	O	O
indicator	O	O
;	O	O
however	O	O
,	O	O
because	O	O
such	O	O
figures	O	O
reflect	O	O
the	O	O
existing	O	O
situation	O	O
,	O	O
they	O	O
are	O	O
not	O	O
suitable	O	O
for	O	O
assessing	O	O
caries	O	O
risk	O	O
of	O	O
infants	O	O
that	O	O
have	O	O
not	O	O
yet	O	O
been	O	O
infected	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Thus	O	O
,	O	O
we	O	O
searched	O	O
for	O	O
an	O	O
indicator	O	O
for	O	O
the	O	O
establishment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

To	O	O
evaluate	O	O
the	O	O
changes	O	O
caused	O	O
by	O	O
the	O	O
establishment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
the	O	O
microbiota	O	O
of	O	O
the	O	O
infant	O	O
oral	O	O
cavity	O	O
,	O	O
we	O	O
monitored	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
microbiota	O	O
of	O	O
two	O	O
pre-dentate	O	O
infants	O	O
over	O	O
a	O	O
3-year	O	O
period	O	O
and	O	O
in	O	O
a	O	O
cross-sectional	O	O
study	O	O
of	O	O
40	O	O
nursery	O	O
school-aged	O	O
children	O	O
by	O	O
cultivation	O	O
of	O	O
saliva	O	O
on	O	O
nonselective	O	O
blood	O	O
agar	O	O
,	O	O
Mitis-Salivarius	O	O
agar	O	O
,	O	O
and	O	O
Mitis-Salivarius	O	O
agar	O	O
supplemented	O	O
with	O	O
bacitracin	O	O
combined	O	O
with	O	O
identification	O	O
of	O	O
selected	O	O
isolates	O	O
.	O	O

Two	O	O
longitudinal	O	O
observations	O	O
suggested	O	O
that	O	O
the	O	O
establishment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
would	O	O
induce	O	O
a	O	O
decrease	O	O
in	O	O
alpha-haemolytic	O	O
bacteria	O	O
in	O	O
the	O	O
microbial	O	O
population	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

This	O	O
suggestion	O	O
was	O	O
compensated	O	O
with	O	O
the	O	O
results	O	O
of	O	O
cross-sectional	O	O
study	O	O
,	O	O
and	O	O
it	O	O
was	O	O
revealed	O	O
that	O	O
the	O	O
establishment	O	O
of	O	O
10	O	O
(	O	O
3	O	O
)	O	O
CFU/mL	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
in	O	O
saliva	O	O
might	O	O
be	O	O
predicted	O	O
by	O	O
a	O	O
microbiota	O	O
comprising	O	O
less	O	O
than	O	O
approximately	O	O
55	O	O
%	O	O
of	O	O
alpha-haemolytic	O	O
.	O	O

Decrease	O	O
in	O	O
the	O	O
proportion	O	O
of	O	O
alpha-haemolytic	O	O
bacteria	O	O
in	O	O
saliva	O	O
of	O	O
infant	O	O
was	O	O
found	O	O
to	O	O
be	O	O
applicable	O	O
as	O	O
an	O	O
indicator	O	O
to	O	O
predict	O	O
the	O	O
establishment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
to	O	O
assess	O	O
dental	O	O
caries	O	O
risk	O	O
as	O	O
a	O	O
background	O	O
for	O	O
planning	O	O
of	O	O
dental	O	O
care	O	O
and	O	O
treatment	O	O
in	O	O
the	O	O
infants	O	O
before	O	O
infection	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

We	O	O
report	O	O
the	O	O
age-related	O	O
prevalence	O	O
of	O	O
red	O	O
complex	O	O
periodontal	O	O
pathogens	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	B-bacteria	B-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
along	O	O
with	O	O
four	O	O
strains	O	O
of	O	O
orange	O	O
complex	O	O
pathogens	O	O
.	O	O

The	O	O
bacteria	O	O
present	O	O
in	O	O
samples	O	O
isolated	O	O
from	O	O
tongue	O	O
,	O	O
cheek	O	O
,	O	O
and	O	O
subgingival	O	O
sulcus	O	O
in	O	O
edentulous	O	O
newborns	O	O
and	O	O
children	O	O
with	O	O
mixed	O	O
dentition	O	O
were	O	O
monitored	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
was	O	O
not	O	O
detected	O	O
in	O	O
any	O	O
site	O	O
of	O	O
any	O	O
subject	O	O
in	O	O
the	O	O
two	O	O
groups	O	O
tested	O	O
.	O	O

However	O	O
,	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
not	O	O
only	O	O
found	O	O
in	O	O
the	O	O
6-13	O	O
years	O	O
age	O	O
group	O	O
,	O	O
but	O	O
also	O	O
in	O	O
edentulous	O	O
newborns	O	O
at	O	O
a	O	O
relatively	O	O
high	O	O
prevalence	O	O
,	O	O
indicating	O	O
non-dentition-related	O	O
colonization	O	O
by	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
.	O	O

Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
Eikenella	B-bacteria	B-bacteria
corrodens	E-bacteria	I-bacteria
,	O	O
and	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
were	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
most	O	O
subjects	O	O
belonging	O	O
to	O	O
the	O	O
6-13	O	O
years	O	O
age	O	O
group	O	O
compared	O	O
to	O	O
newborns	O	O
.	O	O

This	O	O
suggested	O	O
a	O	O
pronounced	O	O
association	O	O
between	O	O
these	O	O
colonizing	O	O
bacteria	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
teeth	O	O
.	O	O

There	O	O
was	O	O
also	O	O
a	O	O
strong	O	O
relation	O	O
between	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
for	O	O
their	O	O
prevalence	O	O
in	O	O
the	O	O
subgingival	O	O
sulcus	O	O
of	O	O
the	O	O
6-13	O	O
years	O	O
age	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.0001	O	O
)	O	O
,	O	O
but	O	O
not	O	O
in	O	O
the	O	O
other	O	O
sites	O	O
tested	O	O
,	O	O
suggesting	O	O
that	O	O
the	O	O
colonization	O	O
of	O	O
dentition-related	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
may	O	O
be	O	O
associated	O	O
with	O	O
the	O	O
increased	O	O
prevalence	O	O
of	O	O
non-dentition-related	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
the	O	O
subgingival	O	O
sulcus	O	O
.	O	O

Overall	O	O
,	O	O
these	O	O
results	O	O
suggest	O	O
that	O	O
dentition	O	O
is	O	O
a	O	O
key	O	O
determinant	O	O
of	O	O
bacterial	O	O
colonization	O	O
,	O	O
especially	O	O
orange	O	O
complex	O	O
bacteria	O	O
and	O	O
the	O	O
red	O	O
complex	O	O
bacterium	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
colonisation	O	O
by	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
the	O	O
sites	O	O
of	O	O
colonisation	O	O
in	O	O
elderly	O	O
upper	O	O
and	O	O
lower	O	O
complete	O	O
denture	O	O
wearers	O	O
.	O	O

We	O	O
also	O	O
investigated	O	O
the	O	O
relationship	O	O
between	O	O
level	O	O
of	O	O
oral	O	O
hygiene	O	O
and	O	O
colonisation	O	O
by	O	O
periodontopathic	O	O
bacteria	O	O
.	O	O


Forty	O	O
edentulous	O	O
and	O	O
37	O	O
dentate	O	O
volunteers	O	O
participated	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
whole	O	O
saliva	O	O
,	O	O
and	O	O
levels	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
were	O	O
determined	O	O
by	O	O
PCR	O	O
Invader	O	O
technology	O	O
.	O	O

Detection	O	O
of	O	O
these	O	O
species	O	O
on	O	O
oral	O	O
mucosal	O	O
and	O	O
denture	O	O
surfaces	O	O
was	O	O
performed	O	O
by	O	O
PCR	O	O
.	O	O

Fisher	O	O
's	O	O
exact	O	O
test	O	O
was	O	O
used	O	O
for	O	O
the	O	O
statistical	O	O
analysis	O	O
.	O	O

Cluster	O	O
analysis	O	O
was	O	O
employed	O	O
to	O	O
investigate	O	O
trends	O	O
in	O	O
the	O	O
periodontopathic	O	O
bacteria	O	O
flora	O	O
in	O	O
each	O	O
sampling	O	O
area	O	O
.	O	O

Detection	O	O
rates	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
in	O	O
whole	O	O
saliva	O	O
were	O	O
lower	O	O
under	O	O
edentulous	O	O
conditions	O	O
than	O	O
under	O	O
dentulous	O	O
conditions	O	O
,	O	O
except	O	O
for	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Detection	O	O
rate	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
the	O	O
highest	O	O
in	O	O
all	O	O
areas	O	O
.	O	O

A	O	O
positive	O	O
correlation	O	O
was	O	O
observed	O	O
between	O	O
DNA	O	O
quantification	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
number	O	O
of	O	O
Candida	O	O
species	O	O
in	O	O
saliva	O	O
.	O	O

Cluster	O	O
analysis	O	O
of	O	O
the	O	O
test	O	O
species	O	O
identified	O	O
two	O	O
clusters	O	O
.	O	O

Tongue-coating	O	O
status	O	O
was	O	O
associated	O	O
with	O	O
the	O	O
detection	O	O
rate	O	O
of	O	O
all	O	O
periodontopathic	O	O
bacteria	O	O
investigated	O	O
,	O	O
and	O	O
denture	O	O
plaque	O	O
status	O	O
was	O	O
associated	O	O
with	O	O
the	O	O
detection	O	O
rate	O	O
of	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Results	O	O
indicate	O	O
the	O	O
presence	O	O
of	O	O
periodontopathic	O	O
bacteria	O	O
under	O	O
edentulous	O	O
conditions	O	O
and	O	O
that	O	O
the	O	O
status	O	O
of	O	O
oral	O	O
hygiene	O	O
of	O	O
the	O	O
mucosal	O	O
or	O	O
denture	O	O
surfaces	O	O
affects	O	O
colonisation	O	O
by	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Carbonic	O	O
anhydrase	O	O
VI	O	O
(	O	O
CA	O	O
VI	O	O
)	O	O
,	O	O
encoded	O	O
by	O	O
type	O	O
A	O	O
transcripts	O	O
of	O	O
the	O	O
gene	O	O
Car6	O	O
,	O	O
is	O	O
a	O	O
secretory	O	O
product	O	O
of	O	O
salivary	O	O
glands	O	O
and	O	O
is	O	O
found	O	O
in	O	O
the	O	O
enamel	O	O
pellicle	O	O
.	O	O

Because	O	O
higher	O	O
caries	O	O
prevalence	O	O
is	O	O
associated	O	O
with	O	O
lower	O	O
salivary	O	O
concentrations	O	O
of	O	O
CA	O	O
VI	O	O
in	O	O
humans	O	O
,	O	O
we	O	O
tested	O	O
whether	O	O
CA	O	O
VI	O	O
protects	O	O
enamel	O	O
surfaces	O	O
from	O	O
caries	O	O
induced	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
using	O	O
Car6	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
,	O	O
in	O	O
which	O	O
salivary	O	O
CA	O	O
VI	O	O
expression	O	O
is	O	O
absent	O	O
.	O	O

We	O	O
detected	O	O
aberrant	O	O
Car6	O	O
type	O	O
A	O	O
transcripts	O	O
in	O	O
Car6	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
,	O	O
likely	O	O
targets	O	O
for	O	O
nonsense-mediated	O	O
mRNA	O	O
decay	O	O
.	O	O

Expression	O	O
of	O	O
the	O	O
intracellular	O	O
stress-induced	O	O
isoform	O	O
of	O	O
CA	O	O
VI	O	O
encoded	O	O
by	O	O
type	O	O
B	O	O
transcripts	O	O
was	O	O
restricted	O	O
to	O	O
parotid	O	O
and	O	O
submandibular	O	O
glands	O	O
of	O	O
wild	O	O
type	O	O
mice	O	O
.	O	O

The	O	O
salivary	O	O
function	O	O
of	O	O
Car6	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
was	O	O
normal	O	O
as	O	O
assessed	O	O
by	O	O
the	O	O
histology	O	O
and	O	O
protein/glycoprotein	O	O
profiles	O	O
of	O	O
glands	O	O
,	O	O
salivary	O	O
flow	O	O
rates	O	O
and	O	O
protein/glycoprotein	O	O
compositions	O	O
of	O	O
saliva	O	O
.	O	O

Surprisingly	O	O
,	O	O
total	O	O
smooth	O	O
surface	O	O
caries	O	O
and	O	O
sulcal	O	O
caries	O	O
in	O	O
Car6	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
were	O	O
more	O	O
than	O	O
6-fold	O	O
and	O	O
2-fold	O	O
lower	O	O
than	O	O
in	O	O
wild	O	O
type	O	O
mice	O	O
after	O	O
infection	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
UA159	E-bacteria	I-bacteria
.	O	O

Recoveries	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
total	O	O
microbiota	O	O
from	O	O
molars	O	O
were	O	O
also	O	O
lower	O	O
in	O	O
Car6	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
.	O	O

To	O	O
explore	O	O
possible	O	O
mechanisms	O	O
for	O	O
increased	O	O
caries	O	O
susceptibility	O	O
,	O	O
we	O	O
found	O	O
no	O	O
differences	O	O
in	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
adherence	O	O
to	O	O
salivary	O	O
pellicles	O	O
,	O	O
in	O	O
vitro	O	O
.	O	O

Interestingly	O	O
,	O	O
higher	O	O
levels	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
murinus	E-bacteria	I-bacteria
and	O	O
an	O	O
unidentified	O	O
Streptococcus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
cultivated	O	O
from	O	O
the	O	O
oral	O	O
microbiota	O	O
of	O	O
Car6	O	O
(	O	O
-/-	O	O
)	O	O
mice	O	O
.	O	O

Collective	O	O
results	O	O
suggest	O	O
salivary	O	O
CA	O	O
VI	O	O
may	O	O
promote	O	O
caries	O	O
by	O	O
modulating	O	O
the	O	O
oral	O	O
microbiota	O	O
to	O	O
favor	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
colonization	O	O
and/or	O	O
by	O	O
the	O	O
enzymatic	O	O
production	O	O
of	O	O
acid	O	O
within	O	O
plaque	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
the	O	O
inhibitory	O	O
effects	O	O
of	O	O
herbal	O	O
extracts	O	O
on	O	O
caries-related	O	O
bacteria	O	O
,	O	O
glucan	O	O
and	O	O
biofilm	O	O
in	O	O
vitro	O	O
.	O	O

Sensitive	O	O
tests	O	O
of	O	O
bacteria	O	O
were	O	O
carried	O	O
out	O	O
by	O	O
broth	O	O
dilution	O	O
method	O	O
on	O	O
a	O	O
96-microwell	O	O
plate	O	O
.	O	O

Glucan	O	O
inhibition	O	O
tests	O	O
were	O	O
carried	O	O
out	O	O
using	O	O
the	O	O
phenol	O	O
sulphate	O	O
method	O	O
.	O	O

A	O	O
minimum	O	O
biofilm	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MBIC	O	O
)	O	O
test	O	O
was	O	O
performed	O	O
in	O	O
an	O	O
artificial	O	O
mouth	O	O
model	O	O
.	O	O

The	O	O
results	O	O
of	O	O
the	O	O
MBIC	O	O
of	O	O
agents	O	O
were	O	O
8	O	O
,	O	O
16	O	O
and	O	O
32	O	O
mg	O	O
mL	O	O
(	O	O
-1	O	O
)	O	O
for	O	O
eugenol	O	O
,	O	O
tannic	O	O
acid	O	O
and	O	O
magnolol	O	O
,	O	O
respectively	O	O
.	O	O

For	O	O
the	O	O
results	O	O
of	O	O
glucan	O	O
inhibition	O	O
tests	O	O
,	O	O
over	O	O
63	O	O
%	O	O
,	O	O
28	O	O
%	O	O
and	O	O
27	O	O
%	O	O
inhibition	O	O
occurred	O	O
on	O	O
insoluble	O	O
glucan	O	O
syntheses	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
for	O	O
eugenol	O	O
,	O	O
magnolol	O	O
and	O	O
tannic	O	O
acid	O	O
,	O	O
respectively	O	O
.	O	O

Over	O	O
46	O	O
%	O	O
,	O	O
16	O	O
%	O	O
and	O	O
13	O	O
%	O	O
inhibition	O	O
on	O	O
soluble	O	O
glucan	O	O
syntheses	O	O
for	O	O
eugenol	O	O
,	O	O
magnolol	O	O
and	O	O
tannic	O	O
acid	O	O
,	O	O
respectively	O	O
,	O	O
were	O	O
also	O	O
observed	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
the	O	O
inhibition	O	O
of	O	O
eugenol	O	O
on	O	O
glucan	O	O
is	O	O
essential	O	O
for	O	O
the	O	O
biofilm	O	O
inhibition	O	O
effect	O	O
on	O	O
caries-related	O	O
biofilm	O	O
in	O	O
an	O	O
artificial	O	O
mouth	O	O
model	O	O
in	O	O
vitro	O	O
.	O	O

Gluten	O	O
proteins	O	O
,	O	O
prominent	O	O
constituents	O	O
of	O	O
barley	O	O
,	O	O
wheat	O	O
and	O	O
rye	O	O
,	O	O
cause	O	O
celiac	O	O
disease	O	O
in	O	O
genetically	O	O
predisposed	O	O
subjects	O	O
.	O	O

Gluten	O	O
is	O	O
notoriously	O	O
difficult	O	O
to	O	O
digest	O	O
by	O	O
mammalian	O	O
proteolytic	O	O
enzymes	O	O
and	O	O
the	O	O
protease-resistant	O	O
domains	O	O
contain	O	O
multiple	O	O
immunogenic	O	O
epitopes	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
novel	O	O
sources	O	O
of	O	O
gluten-digesting	O	O
microbial	O	O
enzymes	O	O
from	O	O
the	O	O
upper	O	O
gastro-intestinal	O	O
tract	O	O
with	O	O
the	O	O
potential	O	O
to	O	O
neutralize	O	O
gluten	O	O
epitopes	O	O
.	O	O

Oral	O	O
microorganisms	O	O
with	O	O
gluten-degrading	O	O
capacity	O	O
were	O	O
obtained	O	O
by	O	O
a	O	O
selective	O	O
plating	O	O
strategy	O	O
using	O	O
gluten	O	O
agar	O	O
.	O	O

Microbial	O	O
speciations	O	O
were	O	O
carried	O	O
out	O	O
by	O	O
16S	O	O
rDNA	O	O
gene	O	O
sequencing	O	O
.	O	O

Enzyme	O	O
activities	O	O
were	O	O
assessed	O	O
using	O	O
gliadin-derived	O	O
enzymatic	O	O
substrates	O	O
,	O	O
gliadins	O	O
in	O	O
solution	O	O
,	O	O
gliadin	O	O
zymography	O	O
,	O	O
and	O	O
33-mer	O	O
alpha-gliadin	O	O
and	O	O
26-mer	O	O
gamma-gliadin	O	O
immunogenic	O	O
peptides	O	O
.	O	O

Fragments	O	O
of	O	O
the	O	O
gliadin	O	O
peptides	O	O
were	O	O
separated	O	O
by	O	O
RP-HPLC	O	O
and	O	O
structurally	O	O
characterized	O	O
by	O	O
mass	O	O
spectrometry	O	O
.	O	O

Strains	O	O
with	O	O
high	O	O
activity	O	O
towards	O	O
gluten	O	O
were	O	O
typed	O	O
as	O	O
Rothia	O	O
mucilaginosa	O	O
and	O	O
Rothia	B-bacteria	B-bacteria
aeria	E-bacteria	I-bacteria
.	O	O

Gliadins	O	O
(	O	O
250	O	O
microg/ml	O	O
)	O	O
added	O	O
to	O	O
Rothia	B-bacteria	B-bacteria
cell	O	O
suspensions	O	O
(	O	O
OD	O	O
(	O	O
620	O	O
)	O	O
1.2	O	O
)	O	O
were	O	O
degraded	O	O
by	O	O
50	O	O
%	O	O
after	O	O
approximately	O	O
30	O	O
min	O	O
of	O	O
incubation	O	O
.	O	O

Importantly	O	O
,	O	O
the	O	O
33-mer	O	O
and	O	O
26-mer	O	O
immunogenic	O	O
peptides	O	O
were	O	O
also	O	O
cleaved	O	O
,	O	O
primarily	O	O
C-terminal	O	O
to	O	O
Xaa-Pro-Gln	O	O
(	O	O
XPQ	O	O
)	O	O
and	O	O
Xaa-Pro-Tyr	O	O
(	O	O
XPY	O	O
)	O	O
.	O	O

The	O	O
major	O	O
gliadin-degrading	O	O
enzymes	O	O
produced	O	O
by	O	O
the	O	O
Rothia	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
approximately	O	O
70-75	O	O
kDa	O	O
in	O	O
size	O	O
,	O	O
and	O	O
the	O	O
enzyme	O	O
expressed	O	O
by	O	O
Rothia	B-bacteria	B-bacteria
aeria	E-bacteria	I-bacteria
was	O	O
active	O	O
over	O	O
a	O	O
wide	O	O
pH	O	O
range	O	O
(	O	O
pH	O	O
3-10	O	O
)	O	O
.	O	O

While	O	O
the	O	O
human	O	O
digestive	O	O
enzyme	O	O
system	O	O
lacks	O	O
the	O	O
capacity	O	O
to	O	O
cleave	O	O
immunogenic	O	O
gluten	O	O
,	O	O
such	O	O
activities	O	O
are	O	O
naturally	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
microbial	O	O
enzyme	O	O
repertoire	O	O
.	O	O

The	O	O
identified	O	O
bacteria	O	O
may	O	O
be	O	O
exploited	O	O
for	O	O
physiologic	O	O
degradation	O	O
of	O	O
harmful	O	O
gluten	O	O
peptides	O	O
.	O	O

Gelclair	O	O
is	O	O
an	O	O
oral	O	O
lubricating	O	O
gel	O	O
used	O	O
in	O	O
the	O	O
management	O	O
of	O	O
oral	O	O
mucositis	O	O
(	O	O
OM	O	O
)	O	O
.	O	O

We	O	O
evaluated	O	O
its	O	O
efficacy	O	O
,	O	O
tolerance	O	O
and	O	O
impact	O	O
on	O	O
oral	O	O
cavity	O	O
microbial	O	O
colonization	O	O
in	O	O
patients	O	O
with	O	O
OM	O	O
after	O	O
allogeneic	O	O
hematopoietic	O	O
stem	O	O
cells	O	O
transplantation	O	O
.	O	O

Gelclair	O	O
was	O	O
administered	O	O
in	O	O
a	O	O
group	O	O
of	O	O
22	O	O
patients	O	O
with	O	O
active	O	O
OM	O	O
.	O	O

A	O	O
control	O	O
group	O	O
of	O	O
15	O	O
patients	O	O
used	O	O
other	O	O
rinsing	O	O
solutions	O	O
(	O	O
chlorhexidine	O	O
,	O	O
benzydamine	O	O
,	O	O
salvia	O	O
)	O	O
.	O	O

Tests	O	O
with	O	O
oral	O	O
cavity	O	O
swabs	O	O
for	O	O
microbiology	O	O
analysis	O	O
were	O	O
performed	O	O
once	O	O
a	O	O
week	O	O
.	O	O

The	O	O
characteristics	O	O
of	O	O
OM	O	O
in	O	O
both	O	O
groups	O	O
were	O	O
comparable	O	O
,	O	O
and	O	O
rinsing	O	O
solutions	O	O
had	O	O
satisfactory	O	O
tolerability	O	O
.	O	O

There	O	O
was	O	O
no	O	O
difference	O	O
in	O	O
the	O	O
median	O	O
improvement	O	O
of	O	O
oral	O	O
intake	O	O
and	O	O
OM-related	O	O
pain	O	O
relief	O	O
,	O	O
which	O	O
was	O	O
assessed	O	O
mostly	O	O
as	O	O
``	O	O
slight	O	O
effect	O	O
''	O	O
.	O	O

In	O	O
the	O	O
Gelclair	O	O
group	O	O
,	O	O
the	O	O
effect	O	O
duration	O	O
was	O	O
longer	O	O
(	O	O
median	O	O
3	O	O
[	O	O
0-5	O	O
]	O	O
vs.	O	O
1	O	O
[	O	O
0-3	O	O
]	O	O
hours	O	O
,	O	O
p	O	O
=	O	O
0.001	O	O
)	O	O
.	O	O

There	O	O
was	O	O
significant	O	O
increase	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
Candida	O	O
sp	O	O
.	O	O

colonization	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
over	O	O
the	O	O
course	O	O
of	O	O
the	O	O
hospitalization	O	O
and	O	O
significantly	O	O
reduced	O	O
incidence	O	O
of	O	O
such	O	O
colonization	O	O
in	O	O
patients	O	O
with	O	O
OM	O	O
in	O	O
the	O	O
Gelclair	O	O
group	O	O
:	O	O
1/22	O	O
(	O	O
5	O	O
%	O	O
)	O	O
vs.	O	O
6/15	O	O
(	O	O
40	O	O
%	O	O
)	O	O
,	O	O
p	O	O
=	O	O
0.01	O	O
.	O	O

In	O	O
vitro	O	O
tests	O	O
showed	O	O
inhibited	O	O
growth	O	O
of	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
and	O	O
Candida	O	O
sp	O	O
.	O	O

colonies	O	O
within	O	O
the	O	O
area	O	O
of	O	O
the	O	O
Gelclair	O	O
application	O	O
.	O	O

Gelclair	O	O
may	O	O
be	O	O
individually	O	O
helpful	O	O
in	O	O
the	O	O
management	O	O
of	O	O
OM	O	O
and	O	O
pain	O	O
in	O	O
patients	O	O
after	O	O
allogeneic	O	O
stem	O	O
cells	O	O
transplantation	O	O
.	O	O

Its	O	O
use	O	O
did	O	O
not	O	O
lead	O	O
to	O	O
worsened	O	O
oral	O	O
bacterial	O	O
and	O	O
yeast	O	O
colonization	O	O
and	O	O
probably	O	O
even	O	O
helped	O	O
to	O	O
protect	O	O
mucosa	O	O
from	O	O
Enterococcus	B-bacteria	B-bacteria
and	O	O
Candida	O	O
sp	O	O
.	O	O

Further	O	O
studies	O	O
based	O	O
on	O	O
larger	O	O
cohorts	O	O
are	O	O
needed	O	O
.	O	O

Lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
(	O	O
LAB	B-bacteria	B-bacteria
)	O	O
might	O	O
offer	O	O
opportunities	O	O
as	O	O
oral	O	O
probiotics	O	O
provided	O	O
candidate	O	O
strains	O	O
persist	O	O
in	O	O
the	O	O
mouth	O	O
.	O	O

After	O	O
intake	O	O
of	O	O
a	O	O
mixture	O	O
of	O	O
69	O	O
LAB	B-bacteria	B-bacteria
,	O	O
strains	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
were	O	O
especially	O	O
recovered	O	O
.	O	O

Coaggregation	O	O
with	O	O
other	O	O
microbes	O	O
is	O	O
likely	O	O
not	O	O
a	O	O
prerequisite	O	O
for	O	O
persistence	O	O
since	O	O
L.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
strongly	O	O
coaggregated	O	O
with	O	O
typical	O	O
oral	O	O
cavity	O	O
isolates	O	O
,	O	O
whereas	O	O
L.	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
failed	O	O
to	O	O
display	O	O
this	O	O
phenotype	O	O
.	O	O

The	O	O
aims	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
a	O	O
self-etching	O	O
adhesive	O	O
system	O	O
containing	O	O
an	O	O
antibacterial	O	O
monomer	O	O
on	O	O
periodontal	O	O
health	O	O
and	O	O
subgingival	O	O
microbiologic	O	O
composition	O	O
in	O	O
orthodontic	O	O
patients	O	O
and	O	O
to	O	O
compare	O	O
it	O	O
with	O	O
a	O	O
conventional	O	O
adhesive	O	O
system	O	O
.	O	O

A	O	O
split-mouth	O	O
design	O	O
was	O	O
chosen	O	O
,	O	O
and	O	O
15	O	O
patients	O	O
were	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Brackets	O	O
in	O	O
contralateral	O	O
quadrants	O	O
were	O	O
bonded	O	O
with	O	O
either	O	O
a	O	O
conventional	O	O
adhesive	O	O
system	O	O
(	O	O
control	O	O
)	O	O
or	O	O
a	O	O
self-etching	O	O
adhesive	O	O
system	O	O
that	O	O
contained	O	O
an	O	O
antibacterial	O	O
monomer	O	O
.	O	O

Clinical	O	O
periodontal	O	O
parameters	O	O
including	O	O
plaque	O	O
index	O	O
,	O	O
gingival	O	O
index	O	O
,	O	O
probing	O	O
depths	O	O
,	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
were	O	O
determined	O	O
.	O	O

Subgingival	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
before	O	O
bracket	O	O
placement	O	O
(	O	O
T0	O	O
)	O	O
and	O	O
at	O	O
the	O	O
6-month	O	O
follow-up	O	O
(	O	O
T1	O	O
)	O	O
.	O	O

The	O	O
real-time	O	O
TaqMan	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assay	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
subgingival	O	O
counts	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
.	O	O

For	O	O
clinical	O	O
periodontal	O	O
parameters	O	O
,	O	O
analysis	O	O
of	O	O
covariance	O	O
(	O	O
ANCOVA	O	O
)	O	O
and	O	O
,	O	O
for	O	O
bacterial	O	O
counts	O	O
,	O	O
Wilcoxon	O	O
tests	O	O
were	O	O
used	O	O
for	O	O
statistical	O	O
comparisons	O	O
at	O	O
the	O	O
P	O	O
<	O	O
0.05	O	O
level	O	O
.	O	O

Clinical	O	O
periodontal	O	O
parameters	O	O
were	O	O
not	O	O
changed	O	O
,	O	O
and	O	O
they	O	O
were	O	O
not	O	O
different	O	O
between	O	O
the	O	O
groups	O	O
from	O	O
T0	O	O
to	O	O
T1	O	O
.	O	O

T	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
and	O	O
F	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
increased	O	O
during	O	O
the	O	O
treatment	O	O
period	O	O
in	O	O
both	O	O
groups	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
majority	O	O
of	O	O
the	O	O
bacteria	O	O
were	O	O
T	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
at	O	O
T0	O	O
and	O	O
T1	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

Changes	O	O
in	O	O
bacterial	O	O
load	O	O
from	O	O
T0	O	O
to	O	O
T1	O	O
were	O	O
not	O	O
different	O	O
between	O	O
groups	O	O
except	O	O
for	O	O
T	B-bacteria	B-bacteria
forsythensis	E-bacteria	I-bacteria
and	O	O
F	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
use	O	O
of	O	O
an	O	O
antibacterial	O	O
monomer	O	O
did	O	O
not	O	O
have	O	O
an	O	O
additional	O	O
positive	O	O
effect	O	O
on	O	O
clinical	O	O
periodontal	O	O
parameters	O	O
.	O	O

When	O	O
used	O	O
in	O	O
bonding	O	O
orthodontic	O	O
brackets	O	O
,	O	O
the	O	O
antibacterial	O	O
monomer	O	O
failed	O	O
to	O	O
reduce	O	O
periodontopathogenic	O	O
bacteria	O	O
when	O	O
compared	O	O
with	O	O
the	O	O
conventional	O	O
adhesive	O	O
system	O	O
during	O	O
a	O	O
6-month	O	O
treatment	O	O
period	O	O
.	O	O

Preterm	O	O
birth	O	O
significantly	O	O
impacts	O	O
on	O	O
neonatal	O	O
morbidity	O	O
and	O	O
mortality	O	O
and	O	O
is	O	O
apparently	O	O
increasing	O	O
world-wide	O	O
.	O	O

Several	O	O
studies	O	O
have	O	O
attempted	O	O
to	O	O
define	O	O
a	O	O
causative	O	O
role	O	O
for	O	O
periodontal	O	O
disease	O	O
in	O	O
adverse	O	O
pregnancy	O	O
outcomes	O	O
but	O	O
few	O	O
have	O	O
focused	O	O
on	O	O
the	O	O
microbiology	O	O
of	O	O
periodontal	O	O
disease	O	O
in	O	O
relation	O	O
to	O	O
these	O	O
outcomes	O	O
.	O	O

The	O	O
evidence	O	O
for	O	O
a	O	O
positive	O	O
correlation	O	O
is	O	O
strong	O	O
,	O	O
supported	O	O
by	O	O
microbiological	O	O
and	O	O
immunological	O	O
findings	O	O
.	O	O

Conflicting	O	O
results	O	O
are	O	O
often	O	O
associated	O	O
with	O	O
uncontrolled	O	O
confounding	O	O
factors	O	O
.	O	O


A	O	O
literature	O	O
search	O	O
was	O	O
conducted	O	O
in	O	O
order	O	O
to	O	O
establish	O	O
whether	O	O
or	O	O
not	O	O
a	O	O
role	O	O
exists	O	O
for	O	O
oral	O	O
Gram-negative	O	O
bacteria	O	O
in	O	O
adverse	O	O
pregnancy	O	O
outcomes	O	O
.	O	O

Association	O	O
and	O	O
intervention	O	O
studies	O	O
are	O	O
summarized	O	O
along	O	O
with	O	O
pathogenic	O	O
potential	O	O
of	O	O
the	O	O
Gram-negative	O	O
bacteria	O	O
most	O	O
frequently	O	O
implicated	O	O
in	O	O
periodontal	O	O
disease	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
is	O	O
one	O	O
of	O	O
the	O	O
most	O	O
common	O	O
anaerobic	O	O
bacteria	O	O
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
is	O	O
often	O	O
isolated	O	O
from	O	O
infections	O	O
involving	O	O
other	O	O
body	O	O
sites	O	O
.	O	O

To	O	O
characterise	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
from	O	O
patients	O	O
attending	O	O
a	O	O
teaching	O	O
hospital	O	O
in	O	O
Nigeria	O	O
in	O	O
order	O	O
to	O	O
provide	O	O
information	O	O
on	O	O
the	O	O
methods	O	O
for	O	O
accurate	O	O
identification	O	O
of	O	O
anaerobes	O	O
in	O	O
clinical	O	O
specimen	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
specie	O	O
from	O	O
50	O	O
patients	O	O
presenting	O	O
with	O	O
oro-facial	O	O
infections	O	O
were	O	O
studied	O	O
by	O	O
culture	O	O
on	O	O
Fusobacterium	B-bacteria	B-bacteria
selective	O	O
agar	O	O
and	O	O
fastidious	O	O
anaerobe	O	O
agar	O	O
.	O	O

The	O	O
isolates	O	O
were	O	O
characterised	O	O
based	O	O
on	O	O
colonial	O	O
morphology	O	O
,	O	O
microscopy	O	O
,	O	O
lipase	O	O
production	O	O
,	O	O
susceptibility	O	O
to	O	O
kanamycin	O	O
and	O	O
colistin	O	O
and	O	O
resistance	O	O
to	O	O
vancomycin	O	O
.	O	O

Biochemical	O	O
tests	O	O
were	O	O
performed	O	O
using	O	O
a	O	O
commercial	O	O
test	O	O
kit	O	O
.	O	O

The	O	O
identity	O	O
of	O	O
the	O	O
isolates	O	O
was	O	O
confirmed	O	O
based	O	O
on	O	O
molecular	O	O
characterization	O	O
performed	O	O
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
analysis	O	O
.	O	O

Forty-eight	O	O
(	O	O
96	O	O
%	O	O
)	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
were	O	O
obtained	O	O
from	O	O
the	O	O
50	O	O
patients	O	O
by	O	O
culture	O	O
and	O	O
all	O	O
the	O	O
isolates	O	O
were	O	O
identified	O	O
by	O	O
colonial	O	O
appearance	O	O
and	O	O
microscopy	O	O
based	O	O
on	O	O
their	O	O
unique	O	O
spindle	O	O
shape	O	O
with	O	O
tapered	O	O
ends	O	O
.	O	O

Only	O	O
26	O	O
(	O	O
54.2	O	O
%	O	O
)	O	O
of	O	O
the	O	O
48	O	O
isolates	O	O
were	O	O
identified	O	O
by	O	O
commercial	O	O
API	O	O
20A	O	O
test	O	O
kit	O	O
while	O	O
PCR	O	O
confirmed	O	O
the	O	O
identity	O	O
of	O	O
all	O	O
the	O	O
isolates	O	O
.	O	O

Anaerobes	O	O
are	O	O
involved	O	O
in	O	O
human	O	O
infections	O	O
and	O	O
their	O	O
study	O	O
is	O	O
quite	O	O
cumbersome	O	O
due	O	O
to	O	O
tedious	O	O
nature	O	O
and	O	O
high	O	O
cost	O	O
of	O	O
the	O	O
techniques	O	O
involved	O	O
.	O	O

Cultural	O	O
method	O	O
is	O	O
reliable	O	O
in	O	O
the	O	O
isolation	O	O
and	O	O
identification	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
species	E-bacteria	I-bacteria
.	O	O

PCR	O	O
is	O	O
a	O	O
rapid	O	O
and	O	O
simple	O	O
method	O	O
that	O	O
can	O	O
complement	O	O
the	O	O
phenotypic	O	O
identification	O	O
of	O	O
anaerobes	O	O
and	O	O
would	O	O
assist	O	O
in	O	O
their	O	O
full	O	O
identification	O	O
.	O	O

Oral	O	O
pathology	O	O
is	O	O
a	O	O
commonly	O	O
reported	O	O
extraintestinal	O	O
manifestation	O	O
of	O	O
Crohn	O	O
's	O	O
disease	O	O
(	O	O
CD	O	O
)	O	O
.	O	O

The	O	O
host-microbe	O	O
interaction	O	O
has	O	O
been	O	O
implicated	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
inflammatory	O	O
bowel	O	O
disease	O	O
(	O	O
IBD	O	O
)	O	O
in	O	O
genetically	O	O
susceptible	O	O
hosts	O	O
,	O	O
yet	O	O
limited	O	O
information	O	O
exists	O	O
about	O	O
oral	O	O
microbes	O	O
in	O	O
IBD	O	O
.	O	O

We	O	O
hypothesize	O	O
that	O	O
the	O	O
microbiology	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
may	O	O
differ	O	O
in	O	O
patients	O	O
with	O	O
IBD	O	O
.	O	O

Our	O	O
laboratory	O	O
has	O	O
developed	O	O
a	O	O
16S	O	O
rRNA-based	O	O
technique	O	O
known	O	O
as	O	O
the	O	O
Human	O	O
Oral	O	O
Microbe	O	O
Identification	O	O
Microarray	O	O
(	O	O
HOMIM	O	O
)	O	O
to	O	O
study	O	O
the	O	O
oral	O	O
microbiome	O	O
of	O	O
children	O	O
and	O	O
young	O	O
adults	O	O
with	O	O
IBD	O	O
.	O	O

Tongue	O	O
and	O	O
buccal	O	O
mucosal	O	O
brushings	O	O
from	O	O
healthy	O	O
controls	O	O
,	O	O
CD	O	O
,	O	O
and	O	O
ulcerative	O	O
colitis	O	O
(	O	O
UC	O	O
)	O	O
patients	O	O
were	O	O
analyzed	O	O
using	O	O
HOMIM	O	O
.	O	O

Shannon	O	O
Diversity	O	O
Index	O	O
(	O	O
SDI	O	O
)	O	O
and	O	O
Principal	O	O
Component	O	O
Analysis	O	O
(	O	O
PCA	O	O
)	O	O
were	O	O
employed	O	O
to	O	O
compare	O	O
population	O	O
and	O	O
phylum-level	O	O
changes	O	O
among	O	O
our	O	O
study	O	O
groups	O	O
.	O	O

In	O	O
all	O	O
,	O	O
114	O	O
unique	O	O
subjects	O	O
from	O	O
the	O	O
Children	O	O
's	O	O
Hospital	O	O
Boston	O	O
were	O	O
enrolled	O	O
.	O	O

Tongue	O	O
samples	O	O
from	O	O
patients	O	O
with	O	O
CD	O	O
showed	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
overall	O	O
microbial	O	O
diversity	O	O
as	O	O
compared	O	O
with	O	O
the	O	O
same	O	O
location	O	O
in	O	O
healthy	O	O
controls	O	O
(	O	O
P	O	O
=	O	O
0.015	O	O
)	O	O
with	O	O
significant	O	O
changes	O	O
seen	O	O
in	O	O
Fusobacteria	B-bacteria	B-bacteria
(	O	O
P	O	O
<	O	O
0.0002	O	O
)	O	O
and	O	O
Firmicutes	B-bacteria	B-bacteria
(	O	O
P	O	O
=	O	O
0.022	O	O
)	O	O
.	O	O

Tongue	O	O
samples	O	O
from	O	O
patients	O	O
with	O	O
UC	O	O
did	O	O
not	O	O
show	O	O
a	O	O
significant	O	O
change	O	O
in	O	O
overall	O	O
microbial	O	O
diversity	O	O
as	O	O
compared	O	O
with	O	O
healthy	O	O
controls	O	O
(	O	O
P	O	O
=	O	O
0.418	O	O
)	O	O
.	O	O

As	O	O
detected	O	O
by	O	O
HOMIM	O	O
,	O	O
we	O	O
found	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
overall	O	O
diversity	O	O
in	O	O
the	O	O
oral	O	O
microbiome	O	O
of	O	O
pediatric	O	O
CD	O	O
.	O	O

Considering	O	O
the	O	O
proposed	O	O
microbe-host	O	O
interaction	O	O
in	O	O
IBD	O	O
,	O	O
the	O	O
ease	O	O
of	O	O
visualization	O	O
and	O	O
direct	O	O
oral	O	O
mucosal	O	O
sampling	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
further	O	O
study	O	O
of	O	O
the	O	O
oral	O	O
microbiome	O	O
in	O	O
IBD	O	O
is	O	O
of	O	O
potential	O	O
diagnostic	O	O
and	O	O
prognostic	O	O
value	O	O
.	O	O

To	O	O
test	O	O
the	O	O
hypothesis	O	O
whether	O	O
microbiota	O	O
in	O	O
oral	O	O
biofilm	O	O
is	O	O
linked	O	O
with	O	O
obesity	O	O
in	O	O
adolescents	O	O
we	O	O
designed	O	O
this	O	O
cross-sectional	O	O
study	O	O
.	O	O

Obese	O	O
adolescents	O	O
(	O	O
n	O	O
=	O	O
29	O	O
)	O	O
with	O	O
a	O	O
mean	O	O
age	O	O
of	O	O
14.7	O	O
years	O	O
and	O	O
normal	O	O
weight	O	O
subjects	O	O
(	O	O
n	O	O
=	O	O
58	O	O
)	O	O
matched	O	O
by	O	O
age	O	O
and	O	O
gender	O	O
were	O	O
examined	O	O
with	O	O
respect	O	O
to	O	O
visible	O	O
plaque	O	O
index	O	O
(	O	O
VPI	O	O
%	O	O
)	O	O
and	O	O
gingival	O	O
inflammation	O	O
(	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
BOP	O	O
%	O	O
)	O	O
)	O	O
.	O	O

Stimulated	O	O
saliva	O	O
was	O	O
collected	O	O
.	O	O

They	O	O
answered	O	O
a	O	O
questionnaire	O	O
concerning	O	O
medical	O	O
history	O	O
,	O	O
medication	O	O
,	O	O
oral	O	O
hygiene	O	O
habits	O	O
,	O	O
smoking	O	O
habits	O	O
,	O	O
and	O	O
sociodemographic	O	O
background	O	O
.	O	O

Microbiological	O	O
samples	O	O
taken	O	O
from	O	O
the	O	O
gingival	O	O
crevice	O	O
was	O	O
analyzed	O	O
by	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
technique	O	O
.	O	O

The	O	O
sum	O	O
of	O	O
bacterial	O	O
cells	O	O
in	O	O
subgingival	O	O
biofilm	O	O
was	O	O
significantly	O	O
associated	O	O
with	O	O
obesity	O	O
(	O	O
P	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
link	O	O
between	O	O
sum	O	O
of	O	O
bacterial	O	O
cells	O	O
and	O	O
obesity	O	O
was	O	O
not	O	O
confounded	O	O
by	O	O
any	O	O
of	O	O
the	O	O
studied	O	O
variables	O	O
(	O	O
chronic	O	O
disease	O	O
,	O	O
medication	O	O
,	O	O
VPI	O	O
%	O	O
,	O	O
BOP	O	O
%	O	O
,	O	O
flow	O	O
rate	O	O
of	O	O
whole	O	O
saliva	O	O
,	O	O
or	O	O
meal	O	O
frequency	O	O
)	O	O
.	O	O

Totally	O	O
23	O	O
bacterial	O	O
species	O	O
were	O	O
present	O	O
in	O	O
approximately	O	O
threefold	O	O
higher	O	O
amounts	O	O
,	O	O
on	O	O
average	O	O
,	O	O
in	O	O
obese	O	O
subjects	O	O
compared	O	O
with	O	O
normal	O	O
weight	O	O
controls	O	O
.	O	O

Of	O	O
the	O	O
Proteobacteria	B-bacteria	B-bacteria
phylum	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
rectus	E-bacteria	I-bacteria
and	O	O
Neisseria	B-bacteria	B-bacteria
mucosa	E-bacteria	I-bacteria
were	O	O
present	O	O
in	O	O
sixfold	O	O
higher	O	O
amounts	O	O
among	O	O
obese	O	O
subjects	O	O
.	O	O

The	O	O
association	O	O
between	O	O
obesity	O	O
and	O	O
sum	O	O
of	O	O
bacterial	O	O
cells	O	O
in	O	O
oral	O	O
subgingival	O	O
biofilm	O	O
indicates	O	O
a	O	O
possible	O	O
link	O	O
between	O	O
oral	O	O
microbiota	O	O
and	O	O
obesity	O	O
in	O	O
adolescents	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
the	O	O
key	O	O
causative	O	O
agent	O	O
of	O	O
caries	O	O
and	O	O
infective	O	O
endocarditis	O	O
.	O	O

The	O	O
first	O	O
step	O	O
in	O	O
biofilm	O	O
development	O	O
and	O	O
the	O	O
consequent	O	O
initiation	O	O
of	O	O
further	O	O
disease	O	O
is	O	O
bacterial	O	O
adherence	O	O
to	O	O
host	O	O
cell	O	O
surfaces	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
inhibitory	O	O
effect	O	O
of	O	O
curcumin	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
adherence	O	O
to	O	O
extracellular	O	O
matrices	O	O
and	O	O
tooth	O	O
surfaces	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
curcumin	O	O
on	O	O
the	O	O
ability	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
adhere	O	O
to	O	O
glass	O	O
surfaces	O	O
coated	O	O
with	O	O
collagen	O	O
and	O	O
fibronectin	O	O
was	O	O
tested	O	O
in	O	O
order	O	O
to	O	O
determine	O	O
whether	O	O
the	O	O
decrease	O	O
of	O	O
the	O	O
bacterial	O	O
adhesion	O	O
by	O	O
curcumin	O	O
is	O	O
achieved	O	O
by	O	O
hindering	O	O
the	O	O
bacteria	O	O
in	O	O
adhering	O	O
to	O	O
collagen	O	O
and/or	O	O
fibronectin	O	O
.	O	O

Also	O	O
,	O	O
human	O	O
teeth	O	O
inoculated	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
treated	O	O
with	O	O
curcumin	O	O
in	O	O
vitro	O	O
in	O	O
order	O	O
to	O	O
assess	O	O
the	O	O
relevance	O	O
of	O	O
the	O	O
anti-adhesive	O	O
effect	O	O
to	O	O
oral	O	O
conditions	O	O
in	O	O
vivo	O	O
.	O	O

The	O	O
minimum	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
at	O	O
which	O	O
curcumin	O	O
completely	O	O
inhibited	O	O
bacterial	O	O
growth	O	O
was	O	O
128	O	O
mug/mL	O	O
.	O	O

The	O	O
addition	O	O
of	O	O
curcumin	O	O
below	O	O
the	O	O
MIC	O	O
diminished	O	O
bacterial	O	O
adherence	O	O
onto	O	O
both	O	O
collagen-	O	O
and	O	O
fibronectin-coated	O	O
glass	O	O
surfaces	O	O
and	O	O
human	O	O
tooth	O	O
surfaces	O	O
.	O	O

It	O	O
appears	O	O
that	O	O
the	O	O
anti-adhesive	O	O
effect	O	O
of	O	O
curcumin	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
mediated	O	O
through	O	O
collagen	O	O
and	O	O
fibronectin	O	O
.	O	O

These	O	O
results	O	O
support	O	O
the	O	O
widespread	O	O
use	O	O
of	O	O
curcumin	O	O
as	O	O
a	O	O
food-based	O	O
antimicrobial	O	O
agent	O	O
.	O	O

Both	O	O
oral	O	O
cavity	O	O
and	O	O
subgingival	O	O
pocket	O	O
are	O	O
ecological	O	O
niches	O	O
conducive	O	O
to	O	O
hosting	O	O
microorganisms	O	O
that	O	O
may	O	O
act	O	O
as	O	O
opportunistic	O	O
pathogens	O	O
,	O	O
such	O	O
as	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
especially	O	O
methicillin-resistant	B-bacteria	B-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
.	O	O

Early	O	O
detection	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
is	O	O
a	O	O
matter	O	O
of	O	O
concern	O	O
to	O	O
Public	O	O
Health	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
our	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
phenotypic	O	O
and	O	O
genotypic	O	O
detection	O	O
of	O	O
methicillin	O	O
resistance	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
in	O	O
oral	O	O
mucosa	O	O
and	O	O
subgingival	O	O
pocket	O	O
in	O	O
102	O	O
patients	O	O
with	O	O
gingivitis-periodontitis	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
10.8	O	O
%	O	O
(	O	O
n	O	O
=	O	O
11	O	O
)	O	O
in	O	O
subgingival	O	O
pocket	O	O
and	O	O
19.6	O	O
%	O	O
(	O	O
n	O	O
=	O	O
20	O	O
)	O	O
in	O	O
oral	O	O
mucosa	O	O
.	O	O

We	O	O
obtained	O	O
31	O	O
isolates	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
of	O	O
which	O	O
13	O	O
were	O	O
mecA	O	O
positive	O	O
and	O	O
18	O	O
were	O	O
mecA	O	O
negative	O	O
.	O	O

Detection	O	O
of	O	O
mecA	O	O
gene	O	O
by	O	O
PCR	O	O
was	O	O
used	O	O
as	O	O
the	O	O
reference	O	O
method	O	O
to	O	O
compare	O	O
the	O	O
results	O	O
of	O	O
phenotypic	O	O
methods	O	O
to	O	O
determine	O	O
methicillin	O	O
resistance	O	O
.	O	O

Early	O	O
,	O	O
accurate	O	O
detection	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
through	O	O
phenotyping	O	O
and	O	O
genotyping	O	O
methods	O	O
is	O	O
crucial	O	O
for	O	O
assessing	O	O
the	O	O
colonization	O	O
and	O	O
preventing	O	O
the	O	O
spread	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
.	O	O

To	O	O
determine	O	O
the	O	O
relation	O	O
between	O	O
presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	B-bacteria	B-bacteria
in	O	O
supra-gingival	O	O
dental	O	O
plaque	O	O
with	O	O
oral	O	O
hygiene	O	O
habits	O	O
and	O	O
oral	O	O
health	O	O
status	O	O
of	O	O
patients	O	O
suffering	O	O
from	O	O
symptomatic	O	O
dyspepsia	O	O
.	O	O

Descriptive	O	O
study	O	O
.	O	O

The	O	O
Department	O	O
of	O	O
Oral	O	O
Health	O	O
Sciences	O	O
,	O	O
Shaikh	O	O
Zayed	O	O
FPGMI	O	O
,	O	O
Lahore	O	O
,	O	O
from	O	O
September	O	O
2008	O	O
to	O	O
August	O	O
2009	O	O
.	O	O

One	O	O
hundred	O	O
and	O	O
fifty	O	O
dyspeptic	O	O
subjects	O	O
with	O	O
dental	O	O
plaque	O	O
were	O	O
enrolled	O	O
.	O	O

After	O	O
recording	O	O
brushing	O	O
frequency	O	O
,	O	O
oral	O	O
health	O	O
status	O	O
and	O	O
plaque	O	O
load	O	O
,	O	O
the	O	O
supra-gingival	O	O
dental	O	O
plaque	O	O
samples	O	O
were	O	O
collected	O	O
by	O	O
sterile	O	O
curettes	O	O
.	O	O

Helicobacter	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
were	O	O
detected	O	O
in	O	O
dental	O	O
plaque	O	O
samples	O	O
through	O	O
PCR	O	O
assay	O	O
.	O	O

Presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
dental	O	O
plaque	O	O
was	O	O
found	O	O
to	O	O
be	O	O
37.5	O	O
%	O	O
in	O	O
the	O	O
sample	O	O
.	O	O

Most	O	O
of	O	O
the	O	O
subjects	O	O
brushed	O	O
once	O	O
daily	O	O
,	O	O
had	O	O
plaque	O	O
index	O	O
score	O	O
of	O	O
1	O	O
and	O	O
had	O	O
fair	O	O
to	O	O
poor	O	O
oral	O	O
hygiene	O	O
status	O	O
.	O	O

Approximately	O	O
35	O	O
%	O	O
of	O	O
the	O	O
individuals	O	O
who	O	O
brushed	O	O
once	O	O
or	O	O
twice	O	O
a	O	O
day	O	O
harbored	O	O
the	O	O
bacterium	O	O
in	O	O
their	O	O
dental	O	O
plaque	O	O
.	O	O

There	O	O
was	O	O
no	O	O
difference	O	O
between	O	O
bacterial	O	O
detection	O	O
rates	O	O
among	O	O
different	O	O
categories	O	O
of	O	O
plaque	O	O
index	O	O
and	O	O
oral	O	O
health	O	O
status	O	O
of	O	O
the	O	O
study	O	O
subjects	O	O
.	O	O

Presence	O	O
of	O	O
H.	B-bacteria	B-bacteria
pylori	E-bacteria	I-bacteria
in	O	O
dental	O	O
plaque	O	O
was	O	O
found	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
neither	O	O
brushing	O	O
frequency	O	O
nor	O	O
with	O	O
the	O	O
plaque	O	O
load	O	O
nor	O	O
with	O	O
the	O	O
oral	O	O
health	O	O
status	O	O
of	O	O
individuals	O	O
suffering	O	O
from	O	O
symptomatic	O	O
dyspepsia	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
are	O	O
present	O	O
in	O	O
the	O	O
intestine	O	O
and	O	O
oral	O	O
cavity	O	O
of	O	O
most	O	O
adults	O	O
.	O	O

Secretory	O	O
IgA	O	O
in	O	O
mucosal	O	O
secretions	O	O
may	O	O
provide	O	O
carbohydrate	O	O
receptors	O	O
for	O	O
bacterial	O	O
adhesins	O	O
.	O	O

Here	O	O
,	O	O
oral	O	O
and	O	O
faecal	O	O
samples	O	O
from	O	O
33	O	O
IgA-deficient	O	O
individuals	O	O
and	O	O
34	O	O
controls	O	O
were	O	O
cultured	O	O
for	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
which	O	O
were	O	O
identified	O	O
using	O	O
species-specific	O	O
PCR	O	O
or	O	O
partial	O	O
16S	O	O
rDNA	O	O
sequencing	O	O
and	O	O
tested	O	O
for	O	O
expression	O	O
of	O	O
mannose-specific	O	O
adhesins	O	O
.	O	O

Lactobacilli	B-bacteria	B-bacteria
were	O	O
found	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
76	O	O
%	O	O
of	O	O
IgA-deficient	O	O
and	O	O
85	O	O
%	O	O
of	O	O
control	O	O
individuals	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
paracasei	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
gasseri	E-bacteria	I-bacteria
dominated	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

Lactobacillus	B-bacteria	B-bacteria
fermentum	E-bacteria	I-bacteria
was	O	O
less	O	O
common	O	O
in	O	O
IgA-deficient	O	O
individuals	O	O
than	O	O
in	O	O
controls	O	O
(	O	O
p=0.0055	O	O
)	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
was	O	O
less	O	O
common	O	O
in	O	O
symptomatic	O	O
than	O	O
in	O	O
healthy	O	O
IgA-deficient	O	O
individuals	O	O
(	O	O
p=0.0051	O	O
)	O	O
.	O	O

Faecal	O	O
samples	O	O
yielded	O	O
lactobacilli	B-bacteria	B-bacteria
in	O	O
most	O	O
individuals	O	O
.	O	O

L.	O	O
paracasei	O	O
was	O	O
most	O	O
frequent	O	O
,	O	O
followed	O	O
by	O	O
L.	O	O
gasseri	O	O
and	O	O
Lactobacillus	B-bacteria	B-bacteria
plantarum	E-bacteria	I-bacteria
.	O	O

Mannose-specific	O	O
adhesins	O	O
were	O	O
expressed	O	O
more	O	O
frequently	O	O
by	O	O
oral	O	O
than	O	O
by	O	O
faecal	O	O
isolates	O	O
(	O	O
p=0.032	O	O
)	O	O
and	O	O
oral	O	O
isolates	O	O
adhered	O	O
in	O	O
higher	O	O
numbers	O	O
than	O	O
faecal	O	O
isolates	O	O
(	O	O
46	O	O
vs.	O	O
14	O	O
bacteria/cell	O	O
,	O	O
p=0.0038	O	O
)	O	O
.	O	O

Faecal	O	O
isolates	O	O
from	O	O
IgA-deficient	O	O
individuals	O	O
more	O	O
frequently	O	O
expressed	O	O
mannose-specific	O	O
adhesins	O	O
than	O	O
faecal	O	O
isolates	O	O
from	O	O
controls	O	O
(	O	O
p=0.039	O	O
)	O	O
.	O	O

Mannose-specific	O	O
adhesins	O	O
may	O	O
be	O	O
a	O	O
colonisation	O	O
factor	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
secretory	O	O
IgA	O	O
may	O	O
modify	O	O
adhesin	O	O
expression	O	O
.	O	O

However	O	O
,	O	O
secretory	O	O
IgA	O	O
seems	O	O
to	O	O
have	O	O
little	O	O
influence	O	O
on	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
distribution	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
present	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
dogs	O	O
and	O	O
the	O	O
relationship	O	O
of	O	O
those	O	O
organisms	O	O
with	O	O
gastric	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
to	O	O
better	O	O
define	O	O
the	O	O
potential	O	O
for	O	O
dog-human	O	O
and	O	O
dog-dog	O	O
transmission	O	O
.	O	O


:	O	O
Saliva	O	O
and	O	O
dental	O	O
plaque	O	O
from	O	O
28	O	O
dogs	O	O
and	O	O
gastric	O	O
biopsy	O	O
specimens	O	O
from	O	O
a	O	O
subset	O	O
of	O	O
8	O	O
dogs	O	O
.	O	O

PCR-based	O	O
screening	O	O
for	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
was	O	O
conducted	O	O
on	O	O
samples	O	O
obtained	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
28	O	O
dogs	O	O
.	O	O

Comparative	O	O
analysis	O	O
was	O	O
conducted	O	O
on	O	O
Helicobacteraceae	B-bacteria	B-bacteria
16S	O	O
rDNA	O	O
clone	O	O
libraries	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
stomach	O	O
of	O	O
a	O	O
subset	O	O
of	O	O
8	O	O
dogs	O	O
(	O	O
5	O	O
vomiting	O	O
and	O	O
3	O	O
healthy	O	O
)	O	O
that	O	O
had	O	O
positive	O	O
PCR	O	O
results	O	O
for	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
.	O	O

Helicobacteraceae	B-bacteria	B-bacteria
DNA	O	O
was	O	O
identified	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
24	O	O
of	O	O
28	O	O
dogs	O	O
.	O	O

Analysis	O	O
of	O	O
cloned	O	O
16S	O	O
rDNA	O	O
amplicons	O	O
from	O	O
8	O	O
dogs	O	O
revealed	O	O
that	O	O
Wolinella	O	O
spp	O	O
was	O	O
the	O	O
most	O	O
common	O	O
(	O	O
8/8	O	O
dogs	O	O
)	O	O
and	O	O
abundant	O	O
(	O	O
52/57	O	O
[	O	O
91	O	O
%	O	O
]	O	O
clones	O	O
)	O	O
member	O	O
of	O	O
the	O	O
Helicobacteraceae	B-bacteria	B-bacteria
family	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Only	O	O
2	O	O
of	O	O
8	O	O
dogs	O	O
harbored	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
and	O	O
1	O	O
of	O	O
those	O	O
was	O	O
coinfected	O	O
with	O	O
Helicobacter	B-bacteria	B-bacteria
heilmannii	E-bacteria	I-bacteria
and	O	O
Helicobacter	B-bacteria	B-bacteria
felis	E-bacteria	I-bacteria
in	O	O
samples	O	O
obtained	O	O
from	O	O
the	O	O
stomach	O	O
and	O	O
saliva	O	O
.	O	O

Evaluation	O	O
of	O	O
oral	O	O
cavity	O	O
DNA	O	O
with	O	O
Wolinella-specific	O	O
PCR	O	O
primers	O	O
yielded	O	O
positive	O	O
results	O	O
for	O	O
16	O	O
of	O	O
20	O	O
other	O	O
dogs	O	O
(	O	O
24/28	O	O
samples	O	O
were	O	O
positive	O	O
for	O	O
Wolinella	O	O
spp	O	O
)	O	O
.	O	O

Wolinella	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
rather	O	O
than	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
were	O	O
the	O	O
predominant	O	O
Helicobacteraceae	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
dogs	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
of	O	O
dogs	O	O
was	O	O
apparently	O	O
not	O	O
a	O	O
zoonotically	O	O
important	O	O
reservoir	O	O
of	O	O
Helicobacter	B-bacteria	B-bacteria
spp	E-bacteria	I-bacteria
that	O	O
were	O	O
non-Helicobacter	O	O
pylori	O	O
organisms	O	O
.	O	O

The	O	O
mechanism	O	O
of	O	O
Cronobacter	B-bacteria	B-bacteria
pathogenesis	O	O
in	O	O
neonatal	O	O
meningitis	O	O
and	O	O
potential	O	O
virulence	O	O
factors	O	O
(	O	O
aside	O	O
from	O	O
host	O	O
cell	O	O
invasion	O	O
ability	O	O
)	O	O
remain	O	O
largely	O	O
unknown	O	O
.	O	O

To	O	O
ascertain	O	O
whether	O	O
Cronobacter	B-bacteria	B-bacteria
can	O	O
invade	O	O
and	O	O
transcytose	O	O
across	O	O
intestinal	O	O
epithelial	O	O
cells	O	O
,	O	O
enter	O	O
into	O	O
the	O	O
blood	O	O
stream	O	O
and	O	O
then	O	O
transcytose	O	O
across	O	O
the	O	O
blood-brain-barrier	O	O
,	O	O
we	O	O
have	O	O
utilized	O	O
human	O	O
intestinal	O	O
INT407	O	O
and	O	O
Caco-2	O	O
cells	O	O
and	O	O
brain	O	O
microvascular	O	O
endothelial	O	O
cell	O	O
(	O	O
HBMEC	O	O
)	O	O
monolayers	O	O
on	O	O
Transwell	O	O
filters	O	O
as	O	O
experimental	O	O
model	O	O
systems	O	O
.	O	O

Our	O	O
data	O	O
indicate	O	O
a	O	O
wide	O	O
range	O	O
of	O	O
heterogeneity	O	O
with	O	O
respect	O	O
to	O	O
invasion	O	O
efficiency	O	O
among	O	O
twenty-three	O	O
Cronobacter	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
screened	O	O
.	O	O

For	O	O
selected	O	O
isolates	O	O
,	O	O
we	O	O
observed	O	O
significant	O	O
levels	O	O
of	O	O
transcytosis	O	O
for	O	O
Cronobacter	B-bacteria	B-bacteria
sakazakii	E-bacteria	I-bacteria
across	O	O
tight	O	O
monolayers	O	O
of	O	O
both	O	O
Caco-2	O	O
and	O	O
HBMEC	O	O
,	O	O
mimicking	O	O
in	O	O
vivo	O	O
ability	O	O
to	O	O
cross	O	O
the	O	O
intestine	O	O
as	O	O
well	O	O
as	O	O
the	O	O
blood	O	O
brain	O	O
barrier	O	O
,	O	O
and	O	O
at	O	O
a	O	O
frequency	O	O
equivalent	O	O
to	O	O
that	O	O
of	O	O
a	O	O
control	O	O
meningitis-causing	O	O
Escherichia	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
K1	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
.	O	O

Finally	O	O
,	O	O
EM	O	O
analysis	O	O
demonstrated	O	O
intracellular	O	O
Cronobacter	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
within	O	O
host	O	O
vacuoles	O	O
in	O	O
HBMEC	O	O
,	O	O
as	O	O
well	O	O
as	O	O
transcytosed	O	O
bacteria	O	O
at	O	O
the	O	O
basolateral	O	O
surface	O	O
.	O	O

These	O	O
data	O	O
reveal	O	O
that	O	O
certain	O	O
Cronobacter	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
can	O	O
invade	O	O
and	O	O
translocate	O	O
across	O	O
both	O	O
cultured	O	O
human	O	O
intestinal	O	O
epithelial	O	O
cells	O	O
and	O	O
HBMEC	O	O
,	O	O
thus	O	O
demonstrating	O	O
a	O	O
potential	O	O
path	O	O
for	O	O
neonatal	O	O
infections	O	O
of	O	O
the	O	O
central	O	O
nervous	O	O
system	O	O
(	O	O
CNS	O	O
)	O	O
following	O	O
oral	O	O
ingestion	O	O
.	O	O

Clinical	O	O
benefits	O	O
of	O	O
probiotics	O	O
have	O	O
been	O	O
clearly	O	O
reported	O	O
in	O	O
different	O	O
gastrointestinal	O	O
disorders	O	O
,	O	O
many	O	O
of	O	O
them	O	O
caused	O	O
by	O	O
enterobacteria	B-bacteria	B-bacteria
.	O	O

The	O	O
oral	O	O
cavity	O	O
is	O	O
a	O	O
port	O	O
of	O	O
entry	O	O
and	O	O
can	O	O
be	O	O
an	O	O
important	O	O
reservoir	O	O
of	O	O
these	O	O
microorganisms	O	O
.	O	O

This	O	O
work	O	O
evaluated	O	O
whether	O	O
consumption	O	O
of	O	O
probiotics	O	O
was	O	O
able	O	O
to	O	O
influence	O	O
the	O	O
presence	O	O
of	O	O
enterobacteria	B-bacteria	B-bacteria
in	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
the	O	O
specific	O	O
secretory	O	O
response	O	O
against	O	O
these	O	O
microorganisms	O	O
.	O	O

Saliva	O	O
samples	O	O
of	O	O
healthy	O	O
individuals	O	O
were	O	O
collected	O	O
and	O	O
plated	O	O
in	O	O
MacConkey	O	O
agar	O	O
.	O	O

Carriers	O	O
of	O	O
Gram-negative	O	O
,	O	O
rod-shaped	O	O
microorganisms	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
were	O	O
selected	O	O
and	O	O
instructed	O	O
to	O	O
use	O	O
the	B-bacteria	B-bacteria
probiotic	B-bacteria	B-bacteria
Yakult	B-bacteria	B-bacteria
LB	E-bacteria	I-bacteria
for	O	O
20	O	O
days	O	O
.	O	O

Saliva	O	O
was	O	O
then	O	O
collected	O	O
and	O	O
enterobacteria	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
were	O	O
identified	O	O
using	O	O
the	O	O
API	O	O
20	O	O
E	O	O
system	O	O
and	O	O
by	O	O
ELISA	O	O
using	O	O
anti-enterobacteria	O	O
IgA	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
reduction	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
enterobacteria	B-bacteria	B-bacteria
,	O	O
but	O	O
no	O	O
significant	O	O
changes	O	O
in	O	O
enterobacterial	O	O
counts	O	O
(	O	O
log	O	O
CFU/mL	O	O
;	O	O
p	O	O
=	O	O
0.3457	O	O
)	O	O
.	O	O

The	O	O
species	O	O
most	O	O
frequently	O	O
isolated	O	O
were	O	O
Enterobacter	B-bacteria	B-bacteria
cloacae	E-bacteria	I-bacteria
and	O	O
Klebsiella	B-bacteria	B-bacteria
oxytoca	E-bacteria	I-bacteria
,	O	O
both	O	O
before	O	O
and	O	O
after	O	O
probiotic	O	O
consumption	O	O
.	O	O

No	O	O
significant	O	O
changes	O	O
were	O	O
observed	O	O
in	O	O
anti-enterobacteria	O	O
IgA	O	O
levels	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
probiotic	O	O
consumption	O	O
had	O	O
some	O	O
influence	O	O
on	O	O
enterobacterial	O	O
presence	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
but	O	O
did	O	O
not	O	O
affect	O	O
enterobacterial	O	O
counts	O	O
or	O	O
the	O	O
specific	O	O
immune	O	O
secretory	O	O
response	O	O
against	O	O
them	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
is	O	O
a	O	O
Gram-positive	O	O
bacterial	O	O
commensal	O	O
and	O	O
pioneer	O	O
colonizer	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Many	O	O
strains	O	O
produce	O	O
ribosomally	O	O
synthesized	O	O
proteinaceous	O	O
antibiotics	O	O
(	O	O
bacteriocins	O	O
)	O	O
,	O	O
and	O	O
some	O	O
strains	O	O
have	O	O
been	O	O
developed	O	O
for	O	O
use	O	O
as	O	O
oral	O	O
probiotics	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
present	O	O
the	O	O
draft	O	O
genome	O	O
sequence	O	O
of	O	O
the	O	O
bacteriocin-producing	O	O
oral	O	O
probiotic	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
M18	E-bacteria	I-bacteria
.	O	O

We	O	O
sought	O	O
to	O	O
develop	O	O
Bifidobacterium	B-bacteria	B-bacteria
infantis	E-bacteria	I-bacteria
(	O	O
BI	B-bacteria	B-bacteria
)	O	O
as	O	O
a	O	O
vehicle	O	O
for	O	O
the	O	O
expression	O	O
of	O	O
heterologous	O	O
antigens	O	O
.	O	O

Two	O	O
proteins	O	O
of	O	O
enterotoxigenic	B-bacteria	B-bacteria
Escherichia	I-bacteria	I-bacteria
coli	E-bacteria	I-bacteria
(	O	O
ETEC	B-bacteria	B-bacteria
)	O	O
were	O	O
expressed	O	O
in	O	O
BI	B-bacteria	B-bacteria
:	O	O
CfaB	O	O
,	O	O
a	O	O
major	O	O
fimbrial	O	O
subunit	O	O
protein	O	O
,	O	O
and	O	O
LTB	O	O
,	O	O
the	O	O
B	O	O
subunit	O	O
of	O	O
heat-labile	O	O
enterotoxin	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
CfaB	O	O
and	O	O
LTB	O	O
in	O	O
BI	B-bacteria	B-bacteria
was	O	O
verified	O	O
by	O	O
electrophoretic	O	O
analysis	O	O
.	O	O

Sprague-Dawley	O	O
rats	O	O
were	O	O
then	O	O
subjected	O	O
to	O	O
intragastric	O	O
immunization	O	O
with	O	O
BI-CfaB	O	O
and	O	O
BI-LTB	O	O
systems	O	O
both	O	O
separately	O	O
and	O	O
together	O	O
.	O	O

ELISA	O	O
was	O	O
used	O	O
to	O	O
characterize	O	O
the	O	O
serum	O	O
and	O	O
mucosal	O	O
immune	O	O
responses	O	O
against	O	O
ETEC	O	O
antigens	O	O
.	O	O

The	O	O
immunized	O	O
rats	O	O
were	O	O
intraperitoneally	O	O
challenged	O	O
with	O	O
wild-type	O	O
ETEC	B-bacteria	B-bacteria
H10407	E-bacteria	I-bacteria
to	O	O
study	O	O
the	O	O
immune	O	O
response	O	O
in	O	O
vivo	O	O
.	O	O

The	O	O
serum	O	O
titres	O	O
of	O	O
IgG	O	O
and	O	O
faecal	O	O
IgA	O	O
antibodies	O	O
in	O	O
the	O	O
BI-CfaB	O	O
plus	O	O
BI-LTB	O	O
mixed	O	O
vaccination	O	O
group	O	O
were	O	O
significantly	O	O
greater	O	O
than	O	O
those	O	O
in	O	O
the	O	O
other	O	O
two	O	O
groups	O	O
,	O	O
which	O	O
were	O	O
immunized	O	O
with	O	O
a	O	O
single	O	O
vaccine	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

However	O	O
,	O	O
no	O	O
significant	O	O
difference	O	O
was	O	O
seen	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
that	O	O
received	O	O
a	O	O
single	O	O
immunization	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
expressing	O	O
CfaB	O	O
and	O	O
LTB	O	O
in	O	O
BI	B-bacteria	B-bacteria
provides	O	O
a	O	O
probiotic	O	O
system	O	O
with	O	O
immunogenic	O	O
properties	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
expression	O	O
of	O	O
LTB	O	O
in	O	O
BI	B-bacteria	B-bacteria
preserved	O	O
its	O	O
mucosal	O	O
adjuvant	O	O
effect	O	O
.	O	O

So	O	O
this	O	O
study	O	O
confirms	O	O
that	O	O
BI	B-bacteria	B-bacteria
can	O	O
be	O	O
used	O	O
as	O	O
a	O	O
novel	O	O
oral	O	O
vaccine	O	O
expression	O	O
system	O	O
for	O	O
a	O	O
heterologous	O	O
antigen	O	O
and	O	O
BI-LTB	O	O
can	O	O
provide	O	O
mucosal	O	O
adjuvant	O	O
properties	O	O
.	O	O

Native	O	O
bees	O	O
of	O	O
the	O	O
tribe	O	O
Meliponini	O	O
produce	O	O
a	O	O
distinct	O	O
kind	O	O
of	O	O
propolis	O	O
called	O	O
geopropolis	O	O
.	O	O

Although	O	O
many	O	O
pharmacological	O	O
activities	O	O
of	O	O
propolis	O	O
have	O	O
already	O	O
been	O	O
demonstrated	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
geopropolis	O	O
,	O	O
particularly	O	O
regarding	O	O
its	O	O
antimicrobial	O	O
activity	O	O
against	O	O
oral	O	O
pathogens	O	O
.	O	O

The	O	O
present	O	O
study	O	O
aimed	O	O
at	O	O
investigating	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
M.	O	O
fasciculata	O	O
geopropolis	O	O
against	O	O
oral	O	O
pathogens	O	O
,	O	O
its	O	O
effects	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
,	O	O
and	O	O
the	O	O
chemical	O	O
contents	O	O
of	O	O
the	O	O
extracts	O	O
.	O	O

A	O	O
gel	O	O
prepared	O	O
with	O	O
a	O	O
geopropolis	O	O
extract	O	O
was	O	O
also	O	O
analyzed	O	O
for	O	O
its	O	O
activity	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
its	O	O
immunotoxicological	O	O
potential	O	O
.	O	O

Antimicrobial	O	O
activities	O	O
of	O	O
three	O	O
hydroalcoholic	O	O
extracts	O	O
(	O	O
HAEs	O	O
)	O	O
of	O	O
geopropolis	O	O
,	O	O
and	O	O
hexane	O	O
and	O	O
chloroform	O	O
fractions	O	O
of	O	O
one	O	O
extract	O	O
,	O	O
were	O	O
evaluated	O	O
using	O	O
the	O	O
agar	O	O
diffusion	O	O
method	O	O
and	O	O
the	O	O
broth	O	O
dilution	O	O
technique	O	O
.	O	O

Ethanol	O	O
(	O	O
70	O	O
%	O	O
,	O	O
v/v	O	O
)	O	O
and	O	O
chlorhexidine	O	O
(	O	O
0.12	O	O
%	O	O
,	O	O
w/w	O	O
)	O	O
were	O	O
used	O	O
as	O	O
negative	O	O
and	O	O
positive	O	O
controls	O	O
,	O	O
respectively	O	O
.	O	O

Total	O	O
phenol	O	O
and	O	O
flavonoid	O	O
concentrations	O	O
were	O	O
assayed	O	O
by	O	O
spectrophotometry	O	O
.	O	O

Immunotoxicity	O	O
was	O	O
evaluated	O	O
in	O	O
mice	O	O
by	O	O
topical	O	O
application	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
followed	O	O
by	O	O
quantification	O	O
of	O	O
biochemical	O	O
and	O	O
immunological	O	O
parameters	O	O
,	O	O
and	O	O
macro-microscopic	O	O
analysis	O	O
of	O	O
animal	O	O
organs	O	O
.	O	O

Two	O	O
extracts	O	O
,	O	O
HAE-2	O	O
and	O	O
HAE-3	O	O
,	O	O
showed	O	O
inhibition	O	O
zones	O	O
ranging	O	O
from	O	O
9	O	O
to	O	O
13	O	O
mm	O	O
in	O	O
diameter	O	O
for	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
C.	O	O
albicans	O	O
,	O	O
but	O	O
presented	O	O
no	O	O
activity	O	O
against	O	O
L.	B-bacteria	B-bacteria
acidophilus	E-bacteria	I-bacteria
.	O	O

The	O	O
MBCs	O	O
for	O	O
HAE-2	O	O
and	O	O
HAE-3	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
6.25	O	O
mg/mL	O	O
and	O	O
12.5	O	O
mg/mL	O	O
,	O	O
respectively	O	O
.	O	O

HAE-2	O	O
was	O	O
fractionated	O	O
,	O	O
and	O	O
its	O	O
chloroform	O	O
fraction	O	O
had	O	O
an	O	O
MBC	O	O
of	O	O
14.57	O	O
mg/mL	O	O
.	O	O

HAE-2	O	O
also	O	O
exhibited	O	O
bactericidal	O	O
effects	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
after	O	O
3	O	O
h	O	O
of	O	O
treatment	O	O
.	O	O

Significant	O	O
differences	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
total	O	O
phenol	O	O
and	O	O
flavonoid	O	O
concentrations	O	O
were	O	O
observed	O	O
among	O	O
the	O	O
samples	O	O
.	O	O

Signs	O	O
toxic	O	O
effects	O	O
were	O	O
not	O	O
observed	O	O
after	O	O
application	O	O
of	O	O
the	O	O
geopropolis-based	O	O
gel	O	O
,	O	O
but	O	O
an	O	O
increase	O	O
in	O	O
the	O	O
production	O	O
of	O	O
IL-4	O	O
and	O	O
IL-10	O	O
,	O	O
anti-inflammatory	O	O
cytokines	O	O
,	O	O
was	O	O
detected	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
geopropolis	O	O
produced	O	O
by	O	O
M.	O	O
fasciculata	O	O
can	O	O
exert	O	O
antimicrobial	O	O
action	O	O
against	O	O
S.	O	O
mutans	O	O
and	O	O
C.	O	O
albicans	O	O
,	O	O
with	O	O
significant	O	O
inhibitory	O	O
activity	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

The	O	O
extract	O	O
with	O	O
the	O	O
highest	O	O
flavonoid	O	O
concentration	O	O
,	O	O
HAE-2	O	O
,	O	O
presented	O	O
the	O	O
highest	O	O
antimicrobial	O	O
activity	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
a	O	O
geopropolis-based	O	O
gel	O	O
is	O	O
not	O	O
toxic	O	O
in	O	O
an	O	O
animal	O	O
model	O	O
and	O	O
displays	O	O
anti-inflammatory	O	O
effect	O	O
.	O	O

As	O	O
part	O	O
of	O	O
the	O	O
human	O	O
gastrointestinal	O	O
tract	O	O
,	O	O
the	O	O
oral	O	O
cavity	O	O
represents	O	O
a	O	O
complex	O	O
biological	O	O
system	O	O
and	O	O
harbors	O	O
diverse	O	O
bacterial	O	O
species	O	O
.	O	O

Unlike	O	O
the	O	O
gut	O	O
microbiota	O	O
,	O	O
which	O	O
is	O	O
often	O	O
considered	O	O
a	O	O
health	O	O
asset	O	O
,	O	O
studies	O	O
of	O	O
the	O	O
oral	O	O
commensal	O	O
microbiota	O	O
have	O	O
been	O	O
largely	O	O
limited	O	O
to	O	O
their	O	O
implication	O	O
in	O	O
oral	O	O
conditions	O	O
such	O	O
as	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
.	O	O

Less	O	O
emphasis	O	O
has	O	O
been	O	O
given	O	O
to	O	O
their	O	O
potential	O	O
beneficial	O	O
roles	O	O
,	O	O
especially	O	O
the	O	O
protective	O	O
effects	O	O
against	O	O
oral	O	O
colonization	O	O
by	O	O
foreign	O	O
or	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
used	O	O
salivary	O	O
microbiota	O	O
derived	O	O
from	O	O
healthy	O	O
human	O	O
subjects	O	O
to	O	O
investigate	O	O
protective	O	O
effects	O	O
against	O	O
colonization	O	O
and	O	O
integration	O	O
of	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa`E-bacteria	O	I-bacteria
,	O	O
an	O	O
opportunistic	O	O
bacterial	O	O
pathogen	O	O
,	O	O
into	O	O
developing	O	O
or	O	O
pre-formed	O	O
salivary	O	O
biofilms	O	O
.	O	O

When	O	O
co-cultivated	O	O
in	O	O
saliva	O	O
medium	O	O
,	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
persisted	O	O
in	O	O
the	O	O
planktonic	O	O
phase	O	O
,	O	O
but	O	O
failed	O	O
to	O	O
integrate	O	O
into	O	O
the	O	O
salivary	O	O
microbial	O	O
community	O	O
during	O	O
biofilm	O	O
formation	O	O
.	O	O

Furthermore	O	O
,	O	O
in	O	O
saliva	O	O
medium	O	O
supplemented	O	O
with	O	O
sucrose	O	O
,	O	O
the	O	O
oral	O	O
microbiota	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
by	O	O
producing	O	O
lactic	O	O
acid	O	O
.	O	O

More	O	O
interestingly	O	O
,	O	O
while	O	O
pre-formed	O	O
salivary	O	O
biofilms	O	O
were	O	O
able	O	O
to	O	O
prevent	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
colonization	O	O
,	O	O
the	O	O
same	O	O
biofilms	O	O
recovered	O	O
from	O	O
mild	O	O
chlorhexidine	O	O
gluconate	O	O
treatment	O	O
displayed	O	O
a	O	O
shift	O	O
in	O	O
microbial	O	O
composition	O	O
and	O	O
showed	O	O
a	O	O
drastic	O	O
reduction	O	O
in	O	O
protection	O	O
.	O	O

Our	O	O
study	O	O
indicates	O	O
that	O	O
normal	O	O
oral	O	O
communities	O	O
with	O	O
balanced	O	O
microbial	O	O
compositions	O	O
could	O	O
be	O	O
important	O	O
in	O	O
effectively	O	O
preventing	O	O
the	O	O
integration	O	O
of	O	O
foreign	O	O
or	O	O
pathogenic	O	O
bacterial	O	O
species	O	O
,	O	O
such	O	O
as	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
.	O	O

Probiotics	B-bacteria	B-bacteria
have	O	O
been	O	O
proven	O	O
effective	O	O
for	O	O
preventing	O	O
caries	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
probiotics	O	O
on	O	O
improving	O	O
oral	O	O
diseases	O	O
such	O	O
as	O	O
gingivitis	O	O
,	O	O
periodontitis	O	O
and	O	O
halitosis	O	O
has	O	O
been	O	O
less	O	O
explored	O	O
.	O	O

To	O	O
perform	O	O
a	O	O
screening	O	O
of	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
according	O	O
to	O	O
international	O	O
guidelines	O	O
for	O	O
the	O	O
evaluation	O	O
of	O	O
probiotics	O	O
,	O	O
in	O	O
order	O	O
to	O	O
select	O	O
candidate	O	O
probiotic	O	O
strains	O	O
for	O	O
preventing	O	O
oral	O	O
disorders	O	O
.	O	O

The	O	O
strains	O	O
were	O	O
isolated	O	O
from	O	O
healthy	O	O
children	O	O
and	O	O
were	O	O
subjected	O	O
to	O	O
a	O	O
variety	O	O
of	O	O
in	O	O
vitro	O	O
tests	O	O
in	O	O
order	O	O
to	O	O
show	O	O
their	O	O
functionality	O	O
.	O	O

The	O	O
safety	O	O
of	O	O
the	O	O
strains	O	O
was	O	O
assessed	O	O
by	O	O
determining	O	O
antibiotic	O	O
susceptibility	O	O
and	O	O
production	O	O
of	O	O
lactic	O	O
acid	O	O
.	O	O

Forty-six	O	O
of	O	O
the	O	O
100	O	O
new	O	O
isolates	O	O
were	O	O
assigned	O	O
to	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
genera	O	O
after	O	O
a	O	O
biochemical	O	O
characterization	O	O
.	O	O

Most	O	O
of	O	O
the	O	O
new	O	O
isolated	O	O
strains	O	O
seem	O	O
to	O	O
be	O	O
resistant	O	O
to	O	O
oral	O	O
conditions	O	O
,	O	O
have	O	O
great	O	O
ability	O	O
to	O	O
form	O	O
aggregates	O	O
and	O	O
have	O	O
high	O	O
antagonistic	O	O
activity	O	O
against	O	O
oral	O	O
pathogens	O	O
.	O	O

None	O	O
of	O	O
the	O	O
strains	O	O
produced	O	O
unpleasant	O	O
volatile	O	O
compounds	O	O
.	O	O

The	O	O
strains	O	O
showed	O	O
high	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
oral	O	O
tissues	O	O
and	O	O
they	O	O
do	O	O
not	O	O
present	O	O
any	O	O
antibiotic	O	O
resistance	O	O
.	O	O

Moreover	O	O
,	O	O
an	O	O
increased	O	O
risk	O	O
of	O	O
developing	O	O
caries	O	O
due	O	O
to	O	O
their	O	O
ability	O	O
to	O	O
produce	O	O
lactic	O	O
acid	O	O
was	O	O
discarded	O	O
in	O	O
seven	O	O
pre-selected	O	O
probiotic	O	O
candidates	O	O
.	O	O

These	O	O
lactic	B-bacteria	B-bacteria
acid	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
show	O	O
promising	O	O
properties	O	O
to	O	O
be	O	O
used	O	O
as	O	O
potential	O	O
probiotics	O	O
for	O	O
improving	O	O
oral	O	O
health	O	O
.	O	O

Cytotoxic	O	O
chemotherapy	O	O
induces	O	O
changes	O	O
in	O	O
the	O	O
oral	O	O
microflora	O	O
that	O	O
may	O	O
cause	O	O
oral	O	O
and	O	O
systemic	O	O
infections	O	O
in	O	O
myelosuppressed	O	O
cancer	O	O
patients	O	O
.	O	O

These	O	O
complications	O	O
prompted	O	O
us	O	O
to	O	O
assess	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
a	O	O
topical	O	O
Iseganan	O	O
HCl	O	O
mouthwash	O	O
vs.	O	O
placebo	O	O
on	O	O
the	O	O
aerobic	O	O
and	O	O
facultatively	O	O
anaerobic	O	O
oral	O	O
flora	O	O
in	O	O
these	O	O
patients	O	O
.	O	O

Two	O	O
hundred	O	O
and	O	O
twenty-five	O	O
chemotherapy	O	O
patients	O	O
were	O	O
recruited	O	O
into	O	O
a	O	O
randomized	O	O
,	O	O
double-blind	O	O
,	O	O
placebo-controlled	O	O
trial	O	O
,	O	O
conducted	O	O
at	O	O
multiple	O	O
centers	O	O
.	O	O

The	O	O
study	O	O
compared	O	O
the	O	O
antimicrobial	O	O
efficacy	O	O
of	O	O
Iseganan	O	O
HCl	O	O
vs.	O	O
placebo	O	O
(	O	O
95	O	O
%	O	O
of	O	O
the	O	O
Iseganan	O	O
and	O	O
97	O	O
%	O	O
of	O	O
the	O	O
control	O	O
group	O	O
received	O	O
myeloablative	O	O
chemotherapy	O	O
)	O	O
.	O	O

Iseganan	O	O
HCl	O	O
9	O	O
mg/3	O	O
ml	O	O
was	O	O
administered	O	O
as	O	O
a	O	O
swish	O	O
and	O	O
swallow	O	O
solution	O	O
,	O	O
six	O	O
times	O	O
daily	O	O
for	O	O
21-28	O	O
days	O	O
.	O	O

Microbial	O	O
cultures	O	O
were	O	O
made	O	O
before	O	O
and	O	O
after	O	O
the	O	O
daily	O	O
Iseganan	O	O
mouth	O	O
rinse	O	O
on	O	O
the	O	O
first	O	O
and	O	O
final	O	O
days	O	O
of	O	O
chemotherapy	O	O
.	O	O

The	O	O
reduction	O	O
in	O	O
total	O	O
microbial	O	O
load	O	O
after	O	O
the	O	O
first	O	O
day	O	O
of	O	O
treatment	O	O
was	O	O
statistically	O	O
significant	O	O
(	O	O
1.59	O	O
vs.	O	O
0.18	O	O
log10	O	O
CFU	O	O
for	O	O
the	O	O
Iseganan	O	O
HCl	O	O
and	O	O
placebo	O	O
groups	O	O
,	O	O
respectively	O	O
,	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
.	O	O

Iseganan	O	O
HCl	O	O
rinse	O	O
had	O	O
a	O	O
cumulative	O	O
effect	O	O
demonstrated	O	O
by	O	O
the	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
on	O	O
the	O	O
last	O	O
day	O	O
of	O	O
the	O	O
study	O	O
(	O	O
i.e	O	O
.	O	O

completion	O	O
of	O	O
Iseganan	O	O
daily	O	O
treatment	O	O
)	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
reduction	O	O
was	O	O
mainly	O	O
due	O	O
to	O	O
decreased	O	O
densities	O	O
of	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
non-hemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
and	O	O
yeasts	O	O
.	O	O

The	O	O
minimal	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
of	O	O
Iseganan	O	O
HCl	O	O
remained	O	O
the	O	O
same	O	O
throughout	O	O
the	O	O
course	O	O
of	O	O
treatment	O	O
.	O	O

Topical	O	O
Iseganan	O	O
HCl	O	O
significantly	O	O
reduces	O	O
the	O	O
total	O	O
oral	O	O
aerobic	O	O
bacterial	O	O
,	O	O
streptococcal	O	O
,	O	O
and	O	O
yeast	O	O
load	O	O
.	O	O

Its	O	O
potential	O	O
as	O	O
an	O	O
oral	O	O
antimicrobial	O	O
agent	O	O
in	O	O
preventing	O	O
these	O	O
types	O	O
of	O	O
infections	O	O
is	O	O
clear	O	O
.	O	O

The	O	O
co-aggregation	O	O
of	O	O
oral	O	O
bacteria	O	O
leads	O	O
to	O	O
their	O	O
clearance	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Poor	O	O
oral	O	O
hygiene	O	O
and	O	O
high	O	O
saliva	O	O
viscosity	O	O
are	O	O
common	O	O
amongst	O	O
the	O	O
elderly	O	O
;	O	O
thus	O	O
,	O	O
they	O	O
frequently	O	O
suffer	O	O
from	O	O
pneumonia	O	O
caused	O	O
by	O	O
the	O	O
aspiration	O	O
of	O	O
oral	O	O
microorganisms	O	O
.	O	O

To	O	O
examine	O	O
the	O	O
direct	O	O
effect	O	O
of	O	O
saliva	O	O
viscosity	O	O
on	O	O
the	O	O
co-aggregation	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
with	O	O
actinomyces	B-bacteria	B-bacteria
.	O	O

Fifteen	O	O
oral	O	O
streptococcal	B-bacteria	B-bacteria
and	O	O
a	O	O
single	O	O
actinomyces	B-bacteria	B-bacteria
strain	E-bacteria	I-bacteria
were	O	O
used	O	O
.	O	O

Co-aggregation	O	O
was	O	O
assessed	O	O
by	O	O
a	O	O
visual	O	O
assay	O	O
in	O	O
phosphate	O	O
buffer	O	O
and	O	O
a	O	O
spectrophotometric	O	O
assay	O	O
in	O	O
the	O	O
same	O	O
buffer	O	O
containing	O	O
0-60	O	O
%	O	O
glycerol	O	O
or	O	O
whole	O	O
saliva	O	O
.	O	O

Nine	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
co-aggregated	O	O
with	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	I-bacteria	I-bacteria
ATCC12104	E-bacteria	I-bacteria
in	O	O
the	O	O
visual	O	O
assay	O	O
and	O	O
were	O	O
subsequently	O	O
used	O	O
for	O	O
the	O	O
spectrophotometric	O	O
analysis	O	O
.	O	O

All	O	O
tested	O	O
strains	O	O
displayed	O	O
a	O	O
decrease	O	O
in	O	O
co-aggregation	O	O
with	O	O
increasing	O	O
amounts	O	O
of	O	O
glycerol	O	O
in	O	O
the	O	O
buffer	O	O
.	O	O

The	O	O
co-aggregation	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
with	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
recovered	O	O
to	O	O
baseline	O	O
level	O	O
following	O	O
the	O	O
removal	O	O
of	O	O
glycerol	O	O
.	O	O

The	O	O
per	O	O
cent	O	O
co-aggregation	O	O
of	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
with	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
was	O	O
significantly	O	O
correlated	O	O
with	O	O
the	O	O
viscosity	O	O
in	O	O
unstimulated	O	O
and	O	O
stimulated	O	O
whole	O	O
saliva	O	O
samples	O	O
(	O	O
correlation	O	O
coefficients	O	O
:	O	O
-0.52	O	O
and	O	O
-0.48	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

This	O	O
study	O	O
suggests	O	O
that	O	O
saliva	O	O
viscosity	O	O
affects	O	O
the	O	O
co-aggregation	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
with	O	O
actinomyces	B-bacteria	B-bacteria
and	O	O
that	O	O
bacterial	O	O
co-aggregation	O	O
decreases	O	O
with	O	O
increasing	O	O
saliva	O	O
viscosity	O	O
.	O	O

Ethanol	O	O
,	O	O
human	O	O
papilloma	O	O
virus	O	O
(	O	O
HPV	O	O
)	O	O
,	O	O
and	O	O
poor	O	O
oral	O	O
hygiene	O	O
are	O	O
risk	O	O
factors	O	O
that	O	O
have	O	O
been	O	O
attributed	O	O
to	O	O
oral	O	O
carcinogenesis	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
and	O	O
HPV	O	O
infections	O	O
are	O	O
common	O	O
in	O	O
the	O	O
head	O	O
and	O	O
neck	O	O
,	O	O
often	O	O
associated	O	O
with	O	O
sexual	O	O
activity	O	O
.	O	O

Although	O	O
HPV	O	O
is	O	O
linked	O	O
to	O	O
head	O	O
and	O	O
neck	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
,	O	O
it	O	O
is	O	O
unclear	O	O
whether	O	O
there	O	O
is	O	O
a	O	O
similar	O	O
role	O	O
for	O	O
Streptococci	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

This	O	O
cell	O	O
study	O	O
examines	O	O
whether	O	O
Streptococci	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
and	O	O
HPV-16	O	O
with	O	O
exposure	O	O
to	O	O
ethyl	O	O
alcohol	O	O
(	O	O
ETOH	O	O
)	O	O
can	O	O
act	O	O
as	O	O
cofactors	O	O
in	O	O
the	O	O
malignant	O	O
transformation	O	O
of	O	O
oral	O	O
keratinocytes	O	O
.	O	O

ETOH	O	O
(	O	O
0.1	O	O
%	O	O
-20	O	O
%	O	O
vol/vol	O	O
)	O	O
was	O	O
used	O	O
to	O	O
investigate	O	O
Streptococci	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
attachment	O	O
with	O	O
immortalized	O	O
E6-expressing	O	O
HPV/HOK-16B	O	O
cells	O	O
,	O	O
human	O	O
oral	O	O
buccal	O	O
keratinocytes	O	O
,	O	O
and	O	O
foreskin	O	O
keratinocytes	O	O
.	O	O

Streptococci	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
(	O	O
Streptococci	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
[	O	O
LT11	O	O
]	O	O
)	O	O
and	O	O
various	O	O
strains	O	O
of	O	O
acetaldehyde	O	O
(	O	O
AA	O	O
)	O	O
producer	O	O
and	O	O
nonproducer	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
(	O	O
110-1	O	O
,	O	O
109-2	O	O
,	O	O
101-7	O	O
,	O	O
and	O	O
107-1	O	O
)	O	O
and	O	O
a	O	O
lactic	O	O
acid	O	O
producer	O	O
bacterium	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
(	O	O
24-1	O	O
and	O	O
25-2	O	O
)	O	O
,	O	O
were	O	O
examined	O	O
for	O	O
interactions	O	O
with	O	O
keratinocytes	O	O
by	O	O
use	O	O
of	O	O
a	O	O
green	O	O
dye	O	O
(	O	O
percent	O	O
of	O	O
cells	O	O
with	O	O
colonies	O	O
after	O	O
24	O	O
hours	O	O
)	O	O
.	O	O

Carcinogens	O	O
,	O	O
AA	O	O
,	O	O
malondialdehyde	O	O
,	O	O
DNA	O	O
damage	O	O
,	O	O
and	O	O
proliferation	O	O
(	O	O
5'-bromo-2-deoxyuridine	O	O
)	O	O
among	O	O
keratinocytes	O	O
were	O	O
also	O	O
quantified	O	O
.	O	O

AA	O	O
and	O	O
malondialdehyde	O	O
production	O	O
from	O	O
permissible	O	O
Streptococci	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
significantly	O	O
increased	O	O
with	O	O
attachment	O	O
to	O	O
keratinocytes	O	O
,	O	O
whereas	O	O
L	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
did	O	O
not	O	O
significantly	O	O
attach	O	O
to	O	O
keratinocytes	O	O
.	O	O

This	O	O
attachment	O	O
was	O	O
associated	O	O
with	O	O
enhanced	O	O
levels	O	O
of	O	O
AA	O	O
adduct	O	O
formation	O	O
,	O	O
proliferation	O	O
(	O	O
5'-bromo-2-deoxyuridine	O	O
incorporation	O	O
)	O	O
,	O	O
and	O	O
enhanced	O	O
migration	O	O
through	O	O
integrin-coated	O	O
basement	O	O
membrane	O	O
by	O	O
HPV	O	O
oral	O	O
keratinocytes	O	O
,	O	O
which	O	O
are	O	O
characteristics	O	O
of	O	O
a	O	O
malignant	O	O
phenotype	O	O
.	O	O

These	O	O
cell	O	O
studies	O	O
suggest	O	O
that	O	O
oral	O	O
Streptococci	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
and	O	O
HPV	O	O
(	O	O
HPV-16	O	O
)	O	O
cooperate	O	O
to	O	O
transform	O	O
oral	O	O
keratinocytes	O	O
after	O	O
low-level	O	O
ETOH	O	O
(	O	O
1	O	O
%	O	O
)	O	O
exposure	O	O
.	O	O

These	O	O
results	O	O
appear	O	O
to	O	O
suggest	O	O
a	O	O
significant	O	O
clinical	O	O
interaction	O	O
,	O	O
but	O	O
further	O	O
validation	O	O
is	O	O
warranted	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
rectum	O	O
may	O	O
be	O	O
an	O	O
important	O	O
reservoir	O	O
for	O	O
vaginal	O	O
colonisation	O	O
by	O	O
Lactobacillus	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

We	O	O
included	O	O
60	O	O
pregnant	O	O
women	O	O
aged	O	O
18-35	O	O
years	O	O
and	O	O
80	O	O
postmenopausal	O	O
women	O	O
aged	O	O
55-65	O	O
years	O	O
in	O	O
this	O	O
cross-sectional	O	O
observational	O	O

.	O	O

Participants	O	O
had	O	O
to	O	O
be	O	O
without	O	O
clinical	O	O
signs	O	O
of	O	O
vaginal	O	O
infection	O	O
and	O	O
without	O	O
hormone	O	O
replacement	O	O
therapy	O	O
.	O	O

Only	O	O
women	O	O
with	O	O
normal	O	O
vaginal	O	O
microflora	O	O
(	O	O
Nugent	O	O
scores	O	O
0-3	O	O
)	O	O
were	O	O
included	O	O
in	O	O
the	O	O
evaluation	O	O
.	O	O

The	O	O
first	O	O
oral	O	O
,	O	O
vaginal	O	O
,	O	O
and	O	O
rectal	O	O
smears	O	O
were	O	O
taken	O	O
for	O	O
the	O	O
enumeration	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
by	O	O
cultural	O	O
methods	O	O
and	O	O
identification	O	O
of	O	O
dominating	O	O
lactobacilli	B-bacteria	B-bacteria
based	O	O
on	O	O
multiplex	O	O
polymerase	O	O
chain	O	O
reaction	O	O
(	O	O
PCR	O	O
)	O	O
.	O	O

The	O	O
second	O	O
oral	O	O
,	O	O
vaginal	O	O
,	O	O
and	O	O
rectal	O	O
smears	O	O
were	O	O
taken	O	O
for	O	O
molecular	O	O
lactobacilli	B-bacteria	B-bacteria
profiling	O	O
using	O	O
PCR	O	O
denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
DGGE	O	O
)	O	O
.	O	O

30	O	O
pregnant	O	O
and	O	O
30	O	O
postmenopausal	O	O
women	O	O
were	O	O
evaluated	O	O
.	O	O

On	O	O
multiplex	O	O
PCR	O	O
,	O	O
99	O	O
colonies	O	O
isolated	O	O
from	O	O
30	O	O
pregnant	O	O
women	O	O
and	O	O
37	O	O
colonies	O	O
isolated	O	O
from	O	O
30	O	O
postmenopausal	O	O
women	O	O
were	O	O
identified	O	O
as	O	O
being	O	O
members	O	O
of	O	O
the	O	O
genus	O	O
Lactobacillus	B-bacteria	B-bacteria
:	O	O
50	O	O
%	O	O
of	O	O
pregnant	O	O
and	O	O
33	O	O
%	O	O
of	O	O
postmenopausal	O	O
women	O	O
had	O	O
one	O	O
or	O	O
more	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
recovered	O	O
from	O	O
their	O	O
oral	O	O
specimens	O	O
.	O	O

Around	O	O
80	O	O
%	O	O
of	O	O
pregnant	O	O
and	O	O
40	O	O
%	O	O
of	O	O
postmenopausal	O	O
women	O	O
harboured	O	O
one	O	O
or	O	O
more	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
in	O	O
the	O	O
vagina	O	O
and	O	O
rectum	O	O
.	O	O

On	O	O
PCR-DGGE	O	O
,	O	O
80	O	O
%	O	O
of	O	O
pregnant	O	O
and	O	O
40	O	O
%	O	O
of	O	O
postmenopausal	O	O
women	O	O
harboured	O	O
the	O	O
same	O	O
lactobacilli	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
in	O	O
both	O	O
the	O	O
vagina	O	O
and	O	O
rectum	O	O
.	O	O

This	O	O
supports	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
rectum	O	O
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
as	O	O
a	O	O
reservoir	O	O
for	O	O
some	O	O
strains	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
that	O	O
colonise	O	O
the	O	O
vagina	O	O
.	O	O

Molecular	O	O
method	O	O
of	O	O
16S	O	O
rRNA	O	O
sequencing	O	O
is	O	O
reported	O	O
to	O	O
be	O	O
helpful	O	O
in	O	O
the	O	O
accurate	O	O
identification	O	O
of	O	O
organisms	O	O
with	O	O
ambiguous	O	O
phenotypic	O	O
profiles	O	O
.	O	O

We	O	O
analyzed	O	O
the	O	O
use	O	O
of	O	O
16S	O	O
rRNA	O	O
sequencing	O	O
method	O	O
to	O	O
identify	O	O
clinically	O	O
significant	O	O
,	O	O
``	O	O
difficult-to-identify	O	O
''	O	O
bacteria	O	O
recovered	O	O
from	O	O
clinical	O	O
specimens	O	O
,	O	O
and	O	O
evaluated	O	O
its	O	O
role	O	O
in	O	O
patient	O	O
management	O	O
and	O	O
consequent	O	O
clinical	O	O
outcome	O	O
.	O	O

Among	O	O
the	O	O
172	O	O
``	O	O
difficult-to-identify	O	O
''	O	O
bacteria	O	O
recovered	O	O
over	O	O
a	O	O
4-year	O	O
period	O	O
,	O	O
140	O	O
were	O	O
gram-positive	O	O
cocci	O	O
or	O	O
gram-negative		O	O
bacilli	O	O
;	O	O
identification	O	O
by	O	O
16S	O	O
rRNA	O	O
did	O	O
not	O	O
play	O	O
a	O	O
role	O	O
in	O	O
the	O	O
management	O	O
of	O	O
patients	O	O
infected	O	O
with	O	O
these	O	O
bacteria	O	O
.	O	O

From	O	O
32	O	O
patients	O	O
,	O	O
33	O	O
``	O	O
difficult-to-identify	O	O
''	O	O
gram-positive	O	O
bacilli	O	O
were	O	O
identified	O	O
;	O	O
the	O	O
organisms	O	O
were	O	O
mycobacteria	B-bacteria	B-bacteria
,	O	O
Nocardia	B-bacteria	B-bacteria
,	O	O
Tsukamurella	B-bacteria	B-bacteria
,	O	O
Rhodococcus	B-bacteria	B-bacteria
,	O	O
and	O	O
Gordonia	B-bacteria	B-bacteria
.	O	O

In	O	O
24	O	O
patients	O	O
for	O	O
whom	O	O
clinical	O	O
data	O	O
were	O	O
available	O	O
,	O	O
results	O	O
from	O	O
the	O	O
16S	O	O
rRNA	O	O
sequencing	O	O
method	O	O
led	O	O
to	O	O
treatment	O	O
change	O	O
in	O	O
14	O	O
immunocompromised	O	O
patients	O	O
(	O	O
including	O	O
7	O	O
hematopoietic	O	O
stem	O	O
cell	O	O
recipients	O	O
and	O	O
1	O	O
liver	O	O
transplant	O	O
recipient	O	O
)	O	O
.	O	O

Therapy	O	O
was	O	O
modified	O	O
in	O	O
9	O	O
patients	O	O
,	O	O
initiated	O	O
in	O	O
3	O	O
patients	O	O
,	O	O
and	O	O
discontinued	O	O
in	O	O
2	O	O
patients	O	O
.	O	O

Most	O	O
patients	O	O
'	O	O
therapy	O	O
was	O	O
switched	O	O
to	O	O
oral	O	O
antibiotics	O	O
with	O	O
discontinuation	O	O
of	O	O
intravascular	O	O
catheters	O	O
,	O	O
facilitating	O	O
early	O	O
hospital	O	O
discharge	O	O
.	O	O

All	O	O
14	O	O
patients	O	O
were	O	O
alive	O	O
30	O	O
days	O	O
after	O	O
infection	O	O
onset	O	O
.	O	O

The	O	O
present	O	O
study	O	O
demonstrates	O	O
the	O	O
clinical	O	O
application	O	O
of	O	O
16S	O	O
rRNA	O	O
sequencing	O	O
method	O	O
to	O	O
identify	O	O
``	O	O
difficult-to-identify	O	O
''	O	O
mycobacteria	B-bacteria	B-bacteria
and	O	O
other	O	O
gram-positive	O	O
bacilli	O	O
in	O	O
clinical	O	O
specimens	O	O
,	O	O
particularly	O	O
in	O	O
immunocompromised	O	O
hosts	O	O
.	O	O

Denture	O	O
adhesives	O	O
increase	O	O
the	O	O
retention	O	O
and	O	O
stability	O	O
of	O	O
dentures	O	O
in	O	O
edentulous	O	O
patients	O	O
,	O	O
especially	O	O
in	O	O
cases	O	O
where	O	O
salivary	O	O
flow	O	O
is	O	O
impaired	O	O
or	O	O
in	O	O
the	O	O
management	O	O
of	O	O
traumatised	O	O
oral	O	O
mucosa	O	O
.	O	O

The	O	O
effect	O	O
of	O	O
a	O	O
denture	O	O
adhesive	O	O
on	O	O
the	O	O
oral	O	O
flora	O	O
at	O	O
different	O	O
time	O	O
intervals	O	O
.	O	O

Thirty	O	O
denture-wearing	O	O
patients	O	O
were	O	O
involved	O	O
in	O	O
this	O	O
study	O	O
.	O	O

While	O	O
half	O	O
of	O	O
the	O	O
group	O	O
received	O	O
a	O	O
denture	O	O
adhesive	O	O
,	O	O
the	O	O
other	O	O
half	O	O
did	O	O
not	O	O
.	O	O

At	O	O
baseline	O	O
,	O	O
1	O	O
and	O	O
2	O	O
months	O	O
after	O	O
delivering	O	O
the	O	O
dentures	O	O
,	O	O
smear	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
the	O	O
saliva	O	O
,	O	O
palate	O	O
and	O	O
the	O	O
dentures	O	O
.	O	O

Candida	O	O
albicans	O	O
,	O	O
Candida	O	O
krusei	O	O
,	O	O
Candida	O	O
glabrata	O	O
,	O	O
Candida	O	O
spp.	O	O
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
Moraxella	B-bacteria	B-bacteria
catarrhalis	E-bacteria	I-bacteria
,	O	O
alpha-haemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
beta-haemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
Pneumococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
anginosus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
intermedius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
constellatus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
and	O	O
yeasts	O	O
were	O	O
investigated	O	O
.	O	O

The	O	O
data	O	O
were	O	O
statistically	O	O
analysed	O	O
using	O	O
anova	O	O
and	O	O
repeated	O	O
measures	O	O
.	O	O

Most	O	O
types	O	O
of	O	O
the	O	O
micro-organisms	O	O
were	O	O
not	O	O
seen	O	O
and	O	O
could	O	O
not	O	O
be	O	O
analysed	O	O
statistically	O	O
except	O	O
alpha-haemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
C.	O	O
albicans	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
difference	O	O
was	O	O
found	O	O
for	O	O
alpha-haemolytic	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
C.	O	O
albicans	O	O
in	O	O
saliva	O	O
,	O	O
palate	O	O
and	O	O
the	O	O
denture	O	O
at	O	O
all	O	O
time	O	O
intervals	O	O
.	O	O

Prolonged	O	O
use	O	O
of	O	O
the	O	O
denture	O	O
adhesive	O	O
tested	O	O
up	O	O
to	O	O
2	O	O
months	O	O
did	O	O
not	O	O
yield	O	O
to	O	O
increase	O	O
in	O	O
micro-organisms	O	O
of	O	O
the	O	O
oral	O	O
flora	O	O
.	O	O

The	O	O
antimicrobial	O	O
activity	O	O
of	O	O
four	O	O
labdane-type	O	O
diterpenes	O	O
isolated	O	O
from	O	O
the	O	O
oleoresin	O	O
of	O	O
Copaifera	O	O
langsdorffii	O	O
as	O	O
well	O	O
as	O	O
of	O	O
two	O	O
commercially	O	O
available	O	O
diterpenes	O	O
(	O	O
sclareol	O	O
and	O	O
manool	O	O
)	O	O
was	O	O
investigated	O	O
against	O	O
a	O	O
representative	O	O
panel	O	O
of	O	O
microorganisms	O	O
responsible	O	O
for	O	O
periodontitis	O	O
.	O	O

Among	O	O
all	O	O
the	O	O
evaluated	O	O
compounds	O	O
,	O	O
(	O	O
-	O	O
)	O	O
-copalic	O	O
acid	O	O
(	O	O
CA	O	O
)	O	O
was	O	O
the	O	O
most	O	O
active	O	O
,	O	O
displaying	O	O
a	O	O
very	O	O
promising	O	O
MIC	O	O
value	O	O
(	O	O
3.1	O	O
microg	O	O
mL-1	O	O
;	O	O
10.2	O	O
microM	O	O
)	O	O
against	O	O
the	O	O
key	O	O
pathogen	O	O
(	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
involved	O	O
in	O	O
this	O	O
infectious	O	O
disease	O	O
.	O	O

Moreover	O	O
,	O	O
CA	O	O
did	O	O
not	O	O
exhibit	O	O
cytotoxicity	O	O
when	O	O
tested	O	O
in	O	O
human	O	O
fibroblasts	O	O
.	O	O

Time-kill	O	O
curve	O	O
assays	O	O
performed	O	O
with	O	O
CA	O	O
against	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
revealed	O	O
that	O	O
this	O	O
compound	O	O
only	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
the	O	O
inoculums	O	O
in	O	O
the	O	O
first	O	O
12	O	O
h	O	O
(	O	O
bacteriostatic	O	O
effect	O	O
)	O	O
.	O	O

However	O	O
,	O	O
its	O	O
bactericidal	O	O
effect	O	O
was	O	O
clearly	O	O
noted	O	O
thereafter	O	O
(	O	O
between	O	O
12	O	O
and	O	O
24	O	O
h	O	O
)	O	O
.	O	O

It	O	O
was	O	O
also	O	O
possible	O	O
to	O	O
verify	O	O
an	O	O
additive	O	O
effect	O	O
when	O	O
CA	O	O
and	O	O
chlorhexidine	O	O
dihydrochloride	O	O
(	O	O
CHD	O	O
,	O	O
positive	O	O
control	O	O
)	O	O
were	O	O
associated	O	O
at	O	O
their	O	O
MBC	O	O
values	O	O
.	O	O

The	O	O
time	O	O
curve	O	O
profile	O	O
resulting	O	O
from	O	O
this	O	O
combination	O	O
showed	O	O
that	O	O
this	O	O
association	O	O
needed	O	O
only	O	O
six	O	O
hours	O	O
for	O	O
the	O	O
bactericidal	O	O
effect	O	O
to	O	O
be	O	O
noted	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
CA	O	O
has	O	O
shown	O	O
to	O	O
be	O	O
an	O	O
important	O	O
metabolite	O	O
for	O	O
the	O	O
control	O	O
of	O	O
periodontal	O	O
diseases	O	O
.	O	O

Moreover	O	O
,	O	O
the	O	O
use	O	O
of	O	O
standardized	O	O
extracts	O	O
based	O	O
on	O	O
copaiba	O	O
oleoresin	O	O
with	O	O
high	O	O
CA	O	O
contents	O	O
can	O	O
be	O	O
an	O	O
important	O	O
strategy	O	O
in	O	O
the	O	O
development	O	O
of	O	O
novel	O	O
oral	O	O
care	O	O
products	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
work	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
thyme	O	O
essential	O	O
oil	O	O
against	O	O
clinical	O	O
multidrug	O	O
resistant	O	O
strains	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
Enterococcus	B-bacteria	B-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
,	O	O
and	O	O
Pseudomonas	B-bacteria	B-bacteria
genus	O	O
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
oil	O	O
was	O	O
tested	O	O
against	O	O
standard	O	O
strains	O	O
of	O	O
bacteria	O	O
and	O	O
120	O	O
clinical	O	O
strains	O	O
isolated	O	O
from	O	O
patients	O	O
with	O	O
infections	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
,	O	O
abdominal	O	O
cavity	O	O
,	O	O
respiratory	O	O
and	O	O
genitourinary	O	O
tracts	O	O
,	O	O
skin	O	O
,	O	O
and	O	O
from	O	O
the	O	O
hospital	O	O
environment	O	O
.	O	O

Agar	O	O
diffusion	O	O
was	O	O
used	O	O
to	O	O
determine	O	O
the	O	O
microbial	O	O
growth	O	O
inhibition	O	O
of	O	O
bacterial	O	O
growth	O	O
at	O	O
various	O	O
concentrations	O	O
of	O	O
oil	O	O
from	O	O
Thymus	O	O
vulgaris	O	O
.	O	O

Susceptibility	O	O
testing	O	O
to	O	O
antibiotics	O	O
was	O	O
carried	O	O
out	O	O
using	O	O
disk	O	O
diffusion	O	O
.	O	O

Thyme	O	O
essential	O	O
oil	O	O
strongly	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
the	O	O
clinical	O	O
strains	O	O
of	O	O
bacteria	O	O
tested	O	O
.	O	O

The	O	O
use	O	O
of	O	O
phytopharmaceuticals	O	O
based	O	O
on	O	O
an	O	O
investigated	O	O
essential	O	O
oil	O	O
from	O	O
thyme	O	O
in	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
various	O	O
human	O	O
infections	O	O
may	O	O
be	O	O
reasonable	O	O
.	O	O

Candida	O	O
albicans	O	O
is	O	O
a	O	O
commensal	O	O
colonizer	O	O
of	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
of	O	O
humans	O	O
,	O	O
where	O	O
it	O	O
coexists	O	O
with	O	O
highly	O	O
diverse	O	O
bacterial	O	O
communities	O	O
.	O	O

It	O	O
is	O	O
not	O	O
clear	O	O
whether	O	O
this	O	O
interaction	O	O
limits	O	O
or	O	O
promotes	O	O
the	O	O
potential	O	O
of	O	O
C.	O	O
albicans	O	O
to	O	O
become	O	O
an	O	O
opportunistic	O	O
pathogen	O	O
.	O	O

Here	O	O
we	O	O
investigate	O	O
the	O	O
interaction	O	O
between	O	O
C.	O	O
albicans	O	O
and	O	O
three	O	O
species	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
the	O	O
viridans	O	O
group	O	O
,	O	O
which	O	O
are	O	O
ubiquitous	O	O
and	O	O
abundant	O	O
oral	O	O
commensal	O	O
bacteria	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
C.	O	O
albicans	O	O
to	O	O
form	O	O
biofilm	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
or	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
was	O	O
investigated	O	O
using	O	O
flow	O	O
cell	O	O
devices	O	O
that	O	O
allow	O	O
abiotic	O	O
biofilm	O	O
formation	O	O
under	O	O
salivary	O	O
flow	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
we	O	O
designed	O	O
a	O	O
novel	O	O
flow	O	O
cell	O	O
system	O	O
that	O	O
allows	O	O
mucosal	O	O
biofilm	O	O
formation	O	O
under	O	O
conditions	O	O
that	O	O
mimic	O	O
the	O	O
environment	O	O
in	O	O
the	O	O
oral	O	O
and	O	O
esophageal	O	O
mucosae	O	O
.	O	O

It	O	O
was	O	O
observed	O	O
that	O	O
C.	O	O
albicans	O	O
and	O	O
streptococci	B-bacteria	B-bacteria
formed	O	O
a	O	O
synergistic	O	O
partnership	O	O
where	O	O
C.	O	O
albicans	O	O
promoted	O	O
the	O	O
ability	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
form	O	O
biofilm	O	O
on	O	O
abiotic	O	O
surfaces	O	O
or	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
an	O	O
oral	O	O
mucosa	O	O
analogue	O	O
.	O	O

The	O	O
increased	O	O
ability	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
to	O	O
form	O	O
biofilm	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
C.	O	O
albicans	O	O
could	O	O
not	O	O
be	O	O
explained	O	O
by	O	O
a	O	O
growth-stimulatory	O	O
effect	O	O
since	O	O
the	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
unaffected	O	O
in	O	O
their	O	O
growth	O	O
in	O	O
planktonic	O	O
coculture	O	O
with	O	O
C.	O	O
albicans	O	O
.	O	O

Conversely	O	O
,	O	O
the	O	O
presence	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
increased	O	O
the	O	O
ability	O	O
of	O	O
C.	O	O
albicans	O	O
to	O	O
invade	O	O
organotypic	O	O
models	O	O
of	O	O
the	O	O
oral	O	O
and	O	O
esophageal	O	O
mucosae	O	O
under	O	O
conditions	O	O
of	O	O
salivary	O	O
flow	O	O
.	O	O

Moreover	O	O
,	O	O
characterization	O	O
of	O	O
mucosal	O	O
invasion	O	O
by	O	O
the	O	O
biofilm	O	O
microorganisms	O	O
suggested	O	O
that	O	O
the	O	O
esophageal	O	O
mucosa	O	O
is	O	O
more	O	O
permissive	O	O
to	O	O
invasion	O	O
than	O	O
the	O	O
oral	O	O
mucosa	O	O
.	O	O

In	O	O
summary	O	O
,	O	O
C.	O	O
albicans	O	O
and	O	O
commensal	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
display	O	O
a	O	O
synergistic	O	O
interaction	O	O
with	O	O
implications	O	O
for	O	O
the	O	O
pathogenic	O	O
potential	O	O
of	O	O
C.	O	O
albicans	O	O
in	O	O
the	O	O
upper	O	O
gastrointestinal	O	O
tract	O	O
.	O	O

Propionibacterium	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
is	O	O
a	O	O
Gram-positive	O	O
bacterium	O	O
that	O	O
forms	O	O
part	O	O
of	O	O
the	O	O
normal	O	O
flora	O	O
of	O	O
the	O	O
skin	O	O
,	O	O
oral	O	O
cavity	O	O
,	O	O
large	O	O
intestine	O	O
,	O	O
the	O	O
conjunctiva	O	O
and	O	O
the	O	O
external	O	O
ear	O	O
canal	O	O
.	O	O

Although	O	O
primarily	O	O
recognized	O	O
for	O	O
its	O	O
role	O	O
in	O	O
acne	O	O
,	O	O
P.	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
is	O	O
an	O	O
opportunistic	O	O
pathogen	O	O
,	O	O
causing	O	O
a	O	O
range	O	O
of	O	O
postoperative	O	O
and	O	O
device-related	O	O
infections	O	O
.	O	O

These	O	O
include	O	O
infections	O	O
of	O	O
the	O	O
bones	O	O
and	O	O
joints	O	O
,	O	O
mouth	O	O
,	O	O
eye	O	O
and	O	O
brain	O	O
.	O	O

Device-related	O	O
infections	O	O
include	O	O
those	O	O
of	O	O
joint	O	O
prostheses	O	O
,	O	O
shunts	O	O
and	O	O
prosthetic	O	O
heart	O	O
valves	O	O
.	O	O

P.	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
may	O	O
play	O	O
a	O	O
role	O	O
in	O	O
other	O	O
conditions	O	O
,	O	O
including	O	O
inflammation	O	O
of	O	O
the	O	O
prostate	O	O
leading	O	O
to	O	O
cancer	O	O
,	O	O
SAPHO	O	O
(	O	O
synovitis	O	O
,	O	O
acne	O	O
,	O	O
pustulosis	O	O
,	O	O
hyperostosis	O	O
,	O	O
osteitis	O	O
)	O	O
syndrome	O	O
,	O	O
sarcoidosis	O	O
and	O	O
sciatica	O	O
.	O	O

If	O	O
an	O	O
active	O	O
role	O	O
in	O	O
these	O	O
conditions	O	O
is	O	O
established	O	O
there	O	O
are	O	O
major	O	O
implications	O	O
for	O	O
diagnosis	O	O
,	O	O
treatment	O	O
and	O	O
protection	O	O
.	O	O

Genome	O	O
sequencing	O	O
of	O	O
the	O	O
organism	O	O
has	O	O
provided	O	O
an	O	O
insight	O	O
into	O	O
the	O	O
pathogenic	O	O
potential	O	O
and	O	O
virulence	O	O
of	O	O
P.	B-bacteria	B-bacteria
acnes	E-bacteria	I-bacteria
.	O	O

The	O	O
antibacterial	O	O
activity	O	O
of	O	O
Casbane	O	O
Diterpene	O	O
(	O	O
CD	O	O
)	O	O
was	O	O
evaluated	O	O
in	O	O
vitro	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
.	O	O

The	O	O
viability	O	O
of	O	O
planktonic	O	O
cells	O	O
was	O	O
analysed	O	O
by	O	O
susceptibility	O	O
tests	O	O
(	O	O
MIC	O	O
and	O	O
MBC	O	O
)	O	O
and	O	O
antibiofilm	O	O
action	O	O
was	O	O
assayed	O	O
.	O	O

The	O	O
minimal	O	O
inhibitory	O	O
and	O	O
bactericidal	O	O
concentrations	O	O
(	O	O
MIC	O	O
and	O	O
MBC	O	O
)	O	O
of	O	O
oral	O	O
Streptococcus	B-bacteria	B-bacteria
were	O	O
evaluated	O	O
through	O	O
microdilution	O	O
tests	O	O
.	O	O

To	O	O
assay	O	O
antibiofilm	O	O
activity	O	O
,	O	O
biofilms	O	O
were	O	O
generated	O	O
on	O	O
96-wells	O	O
polystyrene	O	O
plates	O	O
under	O	O
the	O	O
presence	O	O
of	O	O
CD	O	O
and	O	O
quantified	O	O
by	O	O
a	O	O
crystal	O	O
violet	O	O
technique	O	O
and	O	O
colonies	O	O
forming	O	O
units	O	O
counting	O	O
.	O	O

The	O	O
CD	O	O
isolated	O	O
from	O	O
Croton	O	O
nepetaefolius	O	O
showed	O	O
antimicrobial	O	O
effect	O	O
on	O	O
planktonic	O	O
forms	O	O
and	O	O
biofilms	O	O
of	O	O
oral	O	O
pathogens	O	O
,	O	O
with	O	O
MIC	O	O
values	O	O
of	O	O
62.5	O	O
mug/mL	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
values	O	O
between	O	O
125	O	O
and	O	O
500	O	O
mug/mL	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
.	O	O

CD	O	O
showed	O	O
an	O	O
inhibitory	O	O
effect	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilm	O	O
formation	O	O
at	O	O
250	O	O
mug/mL	O	O
,	O	O
and	O	O
a	O	O
decrease	O	O
on	O	O
viable	O	O
cell	O	O
of	O	O
94.28	O	O
%	O	O
compared	O	O
to	O	O
the	O	O
normal	O	O
biofilm	O	O
growth	O	O
.	O	O

The	O	O
compound	O	O
CD	O	O
can	O	O
be	O	O
considered	O	O
as	O	O
a	O	O
promising	O	O
molecule	O	O
for	O	O
the	O	O
treatment	O	O
against	O	O
oral	O	O
pathogens	O	O
responsible	O	O
for	O	O
dental	O	O
biofilm	O	O
.	O	O

The	O	O
study	O	O
of	O	O
initial	O	O
microbial	O	O
colonization	O	O
on	O	O
dental	O	O
surfaces	O	O
is	O	O
a	O	O
field	O	O
of	O	O
intensive	O	O
research	O	O
because	O	O
of	O	O
the	O	O
aetiological	O	O
role	O	O
of	O	O
biofilms	O	O
in	O	O
oral	O	O
diseases	O	O
.	O	O

Most	O	O
previous	O	O
studies	O	O
of	O	O
de	O	O
novo	O	O
accumulation	O	O
and	O	O
composition	O	O
of	O	O
dental	O	O
biofilms	O	O
in	O	O
vivo	O	O
do	O	O
not	O	O
differentiate	O	O
between	O	O
biofilms	O	O
formed	O	O
during	O	O
day	O	O
and	O	O
night	O	O
.	O	O

This	O	O
study	O	O
hypothesized	O	O
that	O	O
there	O	O
is	O	O
a	O	O
diurnal	O	O
variation	O	O
in	O	O
the	O	O
rate	O	O
of	O	O
accumulation	O	O
of	O	O
bacteria	O	O
on	O	O
solid	O	O
surfaces	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
situ	O	O
biofilm	O	O
from	O	O
healthy	O	O
individuals	O	O
was	O	O
collected	O	O
for	O	O
12	O	O
h	O	O
during	O	O
day	O	O
and	O	O
night	O	O
,	O	O
respectively	O	O
,	O	O
subjected	O	O
to	O	O
fluorescent	O	O
in	O	O
situ	O	O
hybridization	O	O
and	O	O
visualized	O	O
using	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
biofilms	O	O
using	O	O
stereological	O	O
methods	O	O
and	O	O
digital	O	O
image	O	O
analysis	O	O
revealed	O	O
a	O	O
consistent	O	O
statistically	O	O
significant	O	O
difference	O	O
between	O	O
both	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
and	O	O
the	O	O
biovolume	O	O
in	O	O
the	O	O
two	O	O
12-h	O	O
groups	O	O
(	O	O
p	O	O
=	O	O
0.012	O	O
)	O	O
,	O	O
with	O	O
the	O	O
highest	O	O
accumulation	O	O
of	O	O
bacteria	O	O
during	O	O
daytime	O	O
(	O	O
a	O	O
factor	O	O
of	O	O
8.8	O	O
and	O	O
6.1	O	O
higher	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Hybridization	O	O
with	O	O
probes	O	O
specific	O	O
for	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
indicated	O	O
a	O	O
higher	O	O
proportion	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
biofilms	O	O
grown	O	O
during	O	O
daytime	O	O
as	O	O
compared	O	O
to	O	O
night-time	O	O
.	O	O

No	O	O
differences	O	O
could	O	O
be	O	O
observed	O	O
for	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
.	O	O

The	O	O
degree	O	O
of	O	O
microbial	O	O
coverage	O	O
and	O	O
the	O	O
bacterial	O	O
composition	O	O
varied	O	O
considerably	O	O
between	O	O
different	O	O
individuals	O	O
.	O	O

The	O	O
data	O	O
provide	O	O
firm	O	O
evidence	O	O
that	O	O
initial	O	O
biofilm	O	O
formation	O	O
decreases	O	O
during	O	O
the	O	O
night	O	O
,	O	O
which	O	O
may	O	O
reflect	O	O
differences	O	O
in	O	O
the	O	O
availability	O	O
of	O	O
salivary	O	O
nutrients	O	O
.	O	O

This	O	O
finding	O	O
is	O	O
of	O	O
significant	O	O
importance	O	O
when	O	O
studying	O	O
population	O	O
dynamics	O	O
during	O	O
experimental	O	O
dental	O	O
biofilm	O	O
formation	O	O
.	O	O

The	O	O
oral	O	O
cavity	O	O
serves	O	O
as	O	O
a	O	O
reservoir	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	O	O
for	O	O
infection	O	O
of	O	O
the	O	O
lower	O	O
respiratory	O	O
tract	O	O
and	O	O
cross-infection	O	O
to	O	O
other	O	O
patients	O	O
.	O	O

This	O	O
systematic	O	O
review	O	O
was	O	O
designed	O	O
to	O	O
examine	O	O
the	O	O
effectiveness	O	O
of	O	O
oral	O	O
health	O	O
promotion	O	O
interventions	O	O
on	O	O
this	O	O
pathogen	O	O
.	O	O

The	O	O
PubMed	O	O
,	O	O
ISI	O	O
Web	O	O
of	O	O
Science	O	O
,	O	O
and	O	O
Cochrane	O	O
Library	O	O
databases	O	O
were	O	O
searched	O	O
for	O	O
clinical	O	O
trials	O	O
assessing	O	O
the	O	O
effect	O	O
of	O	O
oral	O	O
health	O	O
promotion	O	O
interventions	O	O
on	O	O
oral	O	O
and	O	O
oropharyngeal	O	O
carriage	O	O
of	O	O
S.	O	O
aureus	O	O
.	O	O

Oral	O	O
health	O	O
promotion	O	O
interventions	O	O
on	O	O
oral	O	O
reservoirs	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
in	O	O
both	O	O
systemically	O	O
healthy	O	O
and	O	O
medically	O	O
compromised	O	O
groups	O	O
consisted	O	O
of	O	O
oral	O	O
hygiene	O	O
interventions	O	O
only	O	O
.	O	O

There	O	O
was	O	O
a	O	O
lack	O	O
of	O	O
evidence	O	O
pertaining	O	O
to	O	O
the	O	O
effectiveness	O	O
of	O	O
mechanical	O	O
oral	O	O
hygiene	O	O
interventions	O	O
against	O	O
this	O	O
pathogen	O	O
.	O	O

Chlorhexidine	O	O
delivered	O	O
in	O	O
oral	O	O
hygiene	O	O
products	O	O
such	O	O
as	O	O
mouthrinses	O	O
,	O	O
gels	O	O
,	O	O
and	O	O
sprays	O	O
appeared	O	O
to	O	O
have	O	O
some	O	O
utility	O	O
against	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
although	O	O
some	O	O
studies	O	O
found	O	O
equivocal	O	O
effects	O	O
.	O	O

There	O	O
was	O	O
a	O	O
dearth	O	O
of	O	O
studies	O	O
investigating	O	O
the	O	O
efficacy	O	O
of	O	O
other	O	O
chemical	O	O
agents	O	O
.	O	O

Although	O	O
many	O	O
chemical	O	O
agents	O	O
contained	O	O
in	O	O
oral	O	O
hygiene	O	O
products	O	O
have	O	O
proven	O	O
in	O	O
vitro	O	O
activity	O	O
against	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
their	O	O
clinical	O	O
effectiveness	O	O
and	O	O
potential	O	O
role	O	O
as	O	O
adjuncts	O	O
or	O	O
alternative	O	O
therapies	O	O
to	O	O
conventional	O	O
treatment	O	O
remain	O	O
to	O	O
be	O	O
confirmed	O	O
by	O	O
further	O	O
high-quality	O	O
randomized	O	O
controlled	O	O
trials	O	O
.	O	O

There	O	O
is	O	O
little	O	O
information	O	O
about	O	O
the	O	O
microbiologic	O	O
profiles	O	O
of	O	O
periodontal	O	O
lesions	O	O
in	O	O
Papillon-Lefevre	O	O
syndrome	O	O
(	O	O
PLS	O	O
)	O	O
and	O	O
the	O	O
significance	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontitis	O	O
in	O	O
these	O	O
patients	O	O
.	O	O

This	O	O
comprehensive	O	O
analysis	O	O
of	O	O
the	O	O
subgingival	O	O
microbiota	O	O
in	O	O
patients	O	O
with	O	O
PLS	O	O
used	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
(	O	O
rRNA	O	O
)	O	O
clonal	O	O
analysis	O	O
and	O	O
the	O	O
16S	O	O
rRNA-based	O	O
Human	O	O
Oral	O	O
Microbe	O	O
Identification	O	O
Microarray	O	O
(	O	O
HOMIM	O	O
)	O	O
.	O	O

Thirteen	O	O
patients	O	O
with	O	O
PLS	O	O
from	O	O
seven	O	O
unrelated	O	O
families	O	O
volunteered	O	O
for	O	O
this	O	O
microbiologic	O	O
study	O	O
.	O	O

Subgingival	O	O
plaque	O	O
was	O	O
collected	O	O
with	O	O
sterile	O	O
paper	O	O
points	O	O
from	O	O
multiple	O	O
sites	O	O
with	O	O
>	O	O
/=5	O	O
mm	O	O
probing	O	O
depth	O	O
,	O	O
and	O	O
whole	O	O
genomic	O	O
DNA	O	O
was	O	O
extracted	O	O
.	O	O

The	O	O
16S	O	O
rRNA	O	O
genes	O	O
were	O	O
amplified	O	O
,	O	O
cloned	O	O
,	O	O
and	O	O
sequenced	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
then	O	O
probed	O	O
for	O	O
approximately	O	O
300	O	O
predominant	O	O
oral	O	O
bacterial	O	O
species	O	O
using	O	O
the	O	O
HOMIM	O	O
.	O	O

The	O	O
most	O	O
commonly	O	O
detected	O	O
phylotypes	O	O
in	O	O
the	O	O
clonal	O	O
analysis	O	O
were	O	O
Gemella	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
haemolysans	E-bacteria	I-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
adiacens	E-bacteria	I-bacteria
,	O	O
Lachnospiraceae	B-bacteria	B-bacteria
OT	O	O
100	O	O
(	O	O
EI074	O	O
)	O	O
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
Selenomonas	B-bacteria	B-bacteria
noxia	E-bacteria	I-bacteria
,	O	O
and	O	O
Veillonella	B-bacteria	B-bacteria
parvula	E-bacteria	I-bacteria
.	O	O

As	O	O
a	O	O
group	O	O
,	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
commonly	O	O
detected	O	O
in	O	O
these	O	O
individuals	O	O
.	O	O

In	O	O
the	O	O
HOMIM	O	O
analysis	O	O
,	O	O
a	O	O
total	O	O
of	O	O
170	O	O
bacterial	O	O
species/phylotypes	O	O
were	O	O
detected	O	O
,	O	O
with	O	O
a	O	O
range	O	O
of	O	O
40	O	O
to	O	O
80	O	O
species	O	O
per	O	O
patient	O	O
with	O	O
PLS	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
12	O	O
bacterial	O	O
species	O	O
were	O	O
detected	O	O
in	O	O
medium	O	O
to	O	O
high	O	O
levels	O	O
in	O	O
>	O	O
/=50	O	O
%	O	O
of	O	O
the	O	O
individuals	O	O
.	O	O

The	O	O
high-frequency	O	O
strains	O	O
were	O	O
clustered	O	O
into	O	O
eight	O	O
groups	O	O
:	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Campylobacter	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
granulosa	E-bacteria	I-bacteria
,	O	O
G.	B-bacteria	B-bacteria
morbillorum	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
spp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
.	O	O

The	O	O
subgingival	O	O
microbiota	O	O
in	O	O
PLS	O	O
is	O	O
diverse	O	O
.	O	O

Periodontal	O	O
pathogens	O	O
commonly	O	O
associated	O	O
with	O	O
chronic	O	O
and	O	O
aggressive	O	O
periodontitis	O	O
and	O	O
opportunistic	O	O
pathogens	O	O
may	O	O
be	O	O
associated	O	O
with	O	O
the	O	O
development	O	O
of	O	O
severe	O	O
periodontitis	O	O
in	O	O
patients	O	O
with	O	O
PLS	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
association	O	O
of	O	O
red	O	O
complex	O	O
(	O	O
RC	O	O
)	O	O
bacteria	O	O
that	O	O
include	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
with	O	O
acute	O	O
,	O	O
exacerbated	O	O
or	O	O
chronic	O	O
apical	O	O
periodontitis	O	O
was	O	O
evaluated	O	O
.	O	O

Seventy-one	O	O
patients	O	O
with	O	O
periapical	O	O
disease	O	O
were	O	O
evaluated	O	O
by	O	O
clinical	O	O
examination	O	O
and	O	O
microbiological	O	O
samples	O	O
obtained	O	O
from	O	O
the	O	O
root	O	O
canals	O	O
were	O	O
analyzed	O	O
by	O	O
a	O	O
polymerase	O	O
chain	O	O
reaction	O	O
assay	O	O
.	O	O

Twenty-one	O	O
(	O	O
29.6	O	O
%	O	O
)	O	O
samples	O	O
were	O	O
positive	O	O
for	O	O
RC	O	O
bacteria	O	O
,	O	O
with	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
T.	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
being	O	O
detected	O	O
in	O	O
14	O	O
(	O	O
19.7	O	O
%	O	O
)	O	O
,	O	O
10	O	O
(	O	O
14.1	O	O
%	O	O
)	O	O
and	O	O
6	O	O
(	O	O
8.5	O	O
%	O	O
)	O	O
samples	O	O
,	O	O
respectively	O	O
.	O	O

RC	O	O
bacteria	O	O
were	O	O
mainly	O	O
associated	O	O
with	O	O
acute	O	O
apical	O	O
periodontitis	O	O
(	O	O
29.2	O	O
%	O	O
)	O	O
and	O	O
phoenix	O	O
abscess	O	O
(	O	O
63.2	O	O
%	O	O
)	O	O
,	O	O
while	O	O
they	O	O
were	O	O
only	O	O
sporadically	O	O
detected	O	O
(	O	O
7.1	O	O
%	O	O
)	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
apical	O	O
periodontitis	O	O
.	O	O

Generally	O	O
,	O	O
RC	O	O
bacteria	O	O
were	O	O
associated	O	O
with	O	O
pain	O	O
and	O	O
a	O	O
higher	O	O
frequency	O	O
of	O	O
intracanalar/intrasulcular	O	O
pus	O	O
drainage	O	O
.	O	O

Involvement	O	O
of	O	O
RC	O	O
bacteria	O	O
in	O	O
symptomatic	O	O
periapical	O	O
disease	O	O
should	O	O
be	O	O
suspected	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
particularly	O	O
severe	O	O
clinical	O	O
pain	O	O
and	O	O
pus	O	O
drainage	O	O
.	O	O

Enteromorpha	O	O
linza	O	O
,	O	O
a	O	O
green	O	O
alga	O	O
,	O	O
has	O	O
been	O	O
recognized	O	O
as	O	O
a	O	O
potential	O	O
source	O	O
of	O	O
natural	O	O
antimicrobial	O	O
and	O	O
antifungal	O	O
compounds	O	O
.	O	O

We	O	O
previously	O	O
reported	O	O
that	O	O
an	O	O
E.	O	O
linza	O	O
extract	O	O
strongly	O	O
inhibited	O	O
the	O	O
growth	O	O
of	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
.	O	O

The	O	O
principal	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
clinical	O	O
effect	O	O
of	O	O
a	O	O
mouth	O	O
rinse	O	O
containing	O	O
the	O	O
E.	O	O
linza	O	O
extract	O	O
on	O	O
gingivitis	O	O
disease	O	O
,	O	O
as	O	O
measured	O	O
by	O	O
the	O	O
plaque	O	O
index	O	O
(	O	O
PI	O	O
)	O	O
,	O	O
gingival	O	O
index	O	O
(	O	O
GI	O	O
)	O	O
,	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
(	O	O
BOP	O	O
)	O	O
,	O	O
and	O	O
on	O	O
two	O	O
bacterial	O	O
strains	O	O
(	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
,	O	O
in	O	O
comparison	O	O
with	O	O
Listerine	O	O
(	O	O
(	O	O
R	O	O
)	O	O
)	O	O
(	O	O
Listerine-Korea	O	O
,	O	O
Seoul	O	O
,	O	O
Korea	O	O
)	O	O
,	O	O
which	O	O
was	O	O
used	O	O
as	O	O
a	O	O
positive	O	O
control	O	O
.	O	O

In	O	O
total	O	O
,	O	O
55	O	O
subjects	O	O
were	O	O
recruited	O	O
into	O	O
active	O	O
participation	O	O
in	O	O
this	O	O
clinical	O	O
study	O	O
.	O	O

The	O	O
PI	O	O
,	O	O
GI	O	O
,	O	O
BOP	O	O
,	O	O
and	O	O
bacterial	O	O
strains	O	O
were	O	O
then	O	O
evaluated	O	O
over	O	O
a	O	O
test	O	O
period	O	O
of	O	O
6	O	O
weeks	O	O
.	O	O

After	O	O
1	O	O
,	O	O
2	O	O
,	O	O
4	O	O
,	O	O
and	O	O
6	O	O
weeks	O	O
,	O	O
the	O	O
same	O	O
clinical	O	O
indices	O	O
were	O	O
recorded	O	O
,	O	O
and	O	O
the	O	O
levels	O	O
of	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
were	O	O
quantified	O	O
via	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

At	O	O
the	O	O
end	O	O
of	O	O
the	O	O
study	O	O
,	O	O
the	O	O
group	O	O
using	O	O
the	O	O
mouth	O	O
rinse	O	O
containing	O	O
the	O	O
E.	O	O
linza	O	O
extract	O	O
evidenced	O	O
significant	O	O
reductions	O	O
in	O	O
the	O	O
clinical	O	O
indices	O	O
(	O	O
PI	O	O
,	O	O
GI	O	O
,	O	O
and	O	O
BOP	O	O
)	O	O
and	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
compared	O	O
with	O	O
baseline	O	O
values	O	O
.	O	O

Moreover	O	O
,	O	O
E.	O	O
linza	O	O
extract	O	O
containing	O	O
mouth	O	O
rinse	O	O
produced	O	O
effects	O	O
similar	O	O
to	O	O
those	O	O
of	O	O
Listerine	O	O
.	O	O

Overall	O	O
,	O	O
these	O	O
results	O	O
indicate	O	O
that	O	O
a	O	O
mouth	O	O
rinse	O	O
containing	O	O
E.	O	O
linza	O	O
extract	O	O
significantly	O	O
reduces	O	O
plaque	O	O
,	O	O
improves	O	O
the	O	O
condition	O	O
of	O	O
gingival	O	O
tissues	O	O
,	O	O
and	O	O
reduces	O	O
bleeding	O	O
.	O	O

Additionally	O	O
,	O	O
E.	O	O
linza	O	O
extract	O	O
mouth	O	O
rinse	O	O
significantly	O	O
inhibits	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
.	O	O

Thus	O	O
,	O	O
this	O	O
clinical	O	O
study	O	O
demonstrated	O	O
that	O	O
the	O	O
twice-daily	O	O
use	O	O
of	O	O
an	O	O
E.	O	O
linza	O	O
extract	O	O
mouth	O	O
rinse	O	O
can	O	O
inhibit	O	O
and	O	O
prevent	O	O
gingivitis	O	O
.	O	O

Modifications	O	O
of	O	O
titanium	O	O
(	O	O
Ti	O	O
)	O	O
implant	O	O
surfaces	O	O
have	O	O
a	O	O
significant	O	O
effect	O	O
on	O	O
early	O	O
biofilm	O	O
formation	O	O
and	O	O
the	O	O
outcome	O	O
of	O	O
implant	O	O
procedures	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
examine	O	O
the	O	O
role	O	O
of	O	O
plasma	O	O
proteins	O	O
and	O	O
electrostatic	O	O
forces	O	O
in	O	O
the	O	O
adhesion	O	O
mechanism	O	O
of	O	O
oral	O	O
bacteria	O	O
to	O	O
modified	O	O
Ti	O	O
surfaces	O	O
.	O	O

Ti	O	O
discs	O	O
with	O	O
three	O	O
different	O	O
types	O	O
of	O	O
surface	O	O
modifications	O	O
,	O	O
machined	O	O
,	O	O
acid-etched	O	O
,	O	O
and	O	O
acid-etched	O	O
and	O	O
blasted	O	O
,	O	O
were	O	O
examined	O	O
for	O	O
adhesion	O	O
of	O	O
oral	O	O
bacteria	O	O
:	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Following	O	O
pretreatment	O	O
of	O	O
the	O	O
Ti	O	O
with	O	O
ion	O	O
rich	O	O
solutions	O	O
or	O	O
coating	O	O
by	O	O
human	O	O
serum	O	O
albumin	O	O
or	O	O
fibronectin	O	O
,	O	O
bacterial	O	O
adhesion	O	O
was	O	O
examined	O	O
by	O	O
scanning	O	O
electron	O	O
microscopy	O	O
and	O	O
assessed	O	O
quantitatively	O	O
by	O	O
DNA	O	O
analysis	O	O
.	O	O

Ti	O	O
coating	O	O
by	O	O
proteins	O	O
as	O	O
well	O	O
as	O	O
bacterial	O	O
adhesion	O	O
and	O	O
their	O	O
interrelationships	O	O
were	O	O
further	O	O
investigated	O	O
through	O	O
confocal	O	O
scanning	O	O
laser	O	O
microscopy	O	O
.	O	O

Acid-etched	O	O
and	O	O
blasted	O	O
Ti	O	O
surfaces	O	O
exhibited	O	O
significantly	O	O
higher	O	O
amounts	O	O
of	O	O
bacteria	O	O
adhesion	O	O
than	O	O
the	O	O
other	O	O
two	O	O
surfaces	O	O
.	O	O

Calcium	O	O
was	O	O
found	O	O
to	O	O
serve	O	O
as	O	O
a	O	O
bridging	O	O
agent	O	O
in	O	O
the	O	O
adhesion	O	O
process	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
to	O	O
Ti	O	O
surfaces	O	O
.	O	O

Although	O	O
albumin	O	O
coating	O	O
of	O	O
the	O	O
Ti	O	O
reduced	O	O
the	O	O
adhesion	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
to	O	O
all	O	O
surfaces	O	O
,	O	O
it	O	O
had	O	O
no	O	O
influence	O	O
on	O	O
the	O	O
adhesion	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
or	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

Coating	O	O
the	O	O
Ti	O	O
with	O	O
fibronectin	O	O
enhanced	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
and	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
adhesion	O	O
.	O	O

Bacterial	O	O
adhesion	O	O
to	O	O
Ti	O	O
surfaces	O	O
is	O	O
roughness-dependent	O	O
,	O	O
and	O	O
the	O	O
adhesion	O	O
mechanism	O	O
is	O	O
influenced	O	O
by	O	O
ions	O	O
and	O	O
proteins	O	O
of	O	O
the	O	O
initial	O	O
coating	O	O
derived	O	O
from	O	O
the	O	O
blood	O	O
.	O	O

Microbial	O	O
communities	O	O
inhabiting	O	O
human	O	O
mouth	O	O
are	O	O
associated	O	O
with	O	O
oral	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

Previous	O	O
studies	O	O
have	O	O
indicated	O	O
the	O	O
general	O	O
prevalence	O	O
of	O	O
adult	O	O
gingivitis	O	O
in	O	O
China	O	O
to	O	O
be	O	O
high	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
characterize	O	O
in	O	O
depth	O	O
the	O	O
oral	O	O
microbiota	O	O
of	O	O
Chinese	O	O
adults	O	O
with	O	O
or	O	O
without	O	O
gingivitis	O	O
,	O	O
by	O	O
defining	O	O
the	O	O
microbial	O	O
phylogenetic	O	O
diversity	O	O
and	O	O
community-structure	O	O
using	O	O
highly	O	O
paralleled	O	O
pyrosequencing	O	O
.	O	O

Six	O	O
non-smoking	O	O
Chinese	O	O
,	O	O
three	O	O
with	O	O
and	O	O
three	O	O
without	O	O
gingivitis	O	O
(	O	O
age	O	O
range	O	O
21-39	O	O
years	O	O
,	O	O
4	O	O
females	O	O
and	O	O
2	O	O
males	O	O
)	O	O
were	O	O
enrolled	O	O
in	O	O
the	O	O
present	O	O
cross-sectional	O	O
study	O	O
.	O	O

Gingival	O	O
parameters	O	O
of	O	O
inflammation	O	O
and	O	O
bleeding	O	O
on	O	O
probing	O	O
were	O	O
characterized	O	O
by	O	O
a	O	O
clinician	O	O
using	O	O
the	O	O
Mazza	O	O
Gingival	O	O
Index	O	O
(	O	O
MGI	O	O
)	O	O
.	O	O

Plaque	O	O
(	O	O
sampled	O	O
separately	O	O
from	O	O
four	O	O
different	O	O
oral	O	O
sites	O	O
)	O	O
and	O	O
salivary	O	O
samples	O	O
were	O	O
obtained	O	O
from	O	O
each	O	O
subject	O	O
.	O	O

Sequences	O	O
and	O	O
relative	O	O
abundance	O	O
of	O	O
the	O	O
bacterial	O	O
16	O	O
S	O	O
rDNA	O	O
PCR-amplicons	O	O
were	O	O
determined	O	O
via	O	O
pyrosequencing	O	O
that	O	O
produced	O	O
400	O	O
bp-long	O	O
reads	O	O
.	O	O

The	O	O
sequence	O	O
data	O	O
were	O	O
analyzed	O	O
via	O	O
a	O	O
computational	O	O
pipeline	O	O
customized	O	O
for	O	O
human	O	O
oral	O	O
microbiome	O	O
analyses	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
relative	O	O
abundances	O	O
of	O	O
selected	O	O
microbial	O	O
groups	O	O
were	O	O
validated	O	O
using	O	O
quantitative	O	O
PCR	O	O
.	O	O

The	O	O
oral	O	O
microbiomes	O	O
from	O	O
gingivitis	O	O
and	O	O
healthy	O	O
subjects	O	O
could	O	O
be	O	O
distinguished	O	O
based	O	O
on	O	O
the	O	O
distinct	O	O
community	O	O
structures	O	O
of	O	O
plaque	O	O
microbiomes	O	O
,	O	O
but	O	O
not	O	O
the	O	O
salivary	O	O
microbiomes	O	O
.	O	O

Contributions	O	O
of	O	O
community	O	O
members	O	O
to	O	O
community	O	O
structure	O	O
divergence	O	O
were	O	O
statistically	O	O
accessed	O	O
at	O	O
the	O	O
phylum	O	O
,	O	O
genus	O	O
and	O	O
species-like	O	O
levels	O	O
.	O	O

Eight	O	O
predominant	O	O
taxa	O	O
were	O	O
found	O	O
associated	O	O
with	O	O
gingivitis	O	O
:	O	O
TM7	O	O
,	O	O
Leptotrichia	B-bacteria	B-bacteria
,	O	O
Selenomonas	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Lautropia	B-bacteria	B-bacteria
,	O	O
and	O	O
Haemophilus	B-bacteria	B-bacteria
.	O	O

Furthermore	O	O
,	O	O
98	O	O
species-level	O	O
OTUs	O	O
were	O	O
identified	O	O
to	O	O
be	O	O
gingivitis-associated	O	O
,	O	O
which	O	O
provided	O	O
microbial	O	O
features	O	O
of	O	O
gingivitis	O	O
at	O	O
a	O	O
species	O	O
resolution	O	O
.	O	O

Finally	O	O
,	O	O
for	O	O
the	O	O
two	O	O
selected	O	O
genera	O	O
Streptococcus	B-bacteria	B-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Real-Time	O	O
PCR	O	O
based	O	O
quantification	O	O
of	O	O
relative	O	O
bacterial	O	O
abundance	O	O
validated	O	O
the	O	O
pyrosequencing-based	O	O
results	O	O
.	O	O

This	O	O
methods	O	O
study	O	O
suggests	O	O
that	O	O
oral	O	O
samples	O	O
from	O	O
this	O	O
patient	O	O
population	O	O
of	O	O
gingivitis	O	O
can	O	O
be	O	O
characterized	O	O
via	O	O
plaque	O	O
microbiome	O	O
by	O	O
pyrosequencing	O	O
the	O	O
16	O	O
S	O	O
rDNA	O	O
genes	O	O
.	O	O

Further	O	O
studies	O	O
that	O	O
characterize	O	O
serial	O	O
samples	O	O
from	O	O
subjects	O	O
(	O	O
longitudinal	O	O
study	O	O
design	O	O
)	O	O
with	O	O
a	O	O
larger	O	O
population	O	O
size	O	O
may	O	O
provide	O	O
insight	O	O
into	O	O
the	O	O
temporal	O	O
and	O	O
ecological	O	O
features	O	O
of	O	O
oral	O	O
microbial	O	O
communities	O	O
in	O	O
clinically-defined	O	O
states	O	O
of	O	O
gingivitis	O	O
.	O	O

There	O	O
is	O	O
growing	O	O
evidence	O	O
that	O	O
the	O	O
role	O	O
of	O	O
lipids	O	O
in	O	O
innate	O	O
immunity	O	O
is	O	O
more	O	O
important	O	O
than	O	O
previously	O	O
realized	O	O
.	O	O

How	O	O
lipids	O	O
interact	O	O
with	O	O
bacteria	O	O
to	O	O
achieve	O	O
a	O	O
level	O	O
of	O	O
protection	O	O
,	O	O
however	O	O
,	O	O
is	O	O
still	O	O
poorly	O	O
understood	O	O
.	O	O

To	O	O
begin	O	O
to	O	O
address	O	O
the	O	O
mechanisms	O	O
of	O	O
antibacterial	O	O
activity	O	O
,	O	O
we	O	O
determined	O	O
MICs	O	O
and	O	O
minimum	O	O
bactericidal	O	O
concentrations	O	O
(	O	O
MBCs	O	O
)	O	O
of	O	O
lipids	O	O
common	O	O
to	O	O
the	O	O
skin	O	O
and	O	O
oral	O	O
cavity	O	O
--	O	O
the	O	O
sphingoid	O	O
bases	O	O
D-sphingosine	O	O
,	O	O
phytosphingosine	O	O
,	O	O
and	O	O
dihydrosphingosine	O	O
and	O	O
the	O	O
fatty	O	O
acids	O	O
sapienic	O	O
acid	O	O
and	O	O
lauric	O	O
acid	O	O
--	O	O
against	O	O
four	O	O
Gram-negative	O	O
bacteria	O	O
and	O	O
seven	O	O
Gram-positive	O	O
bacteria	O	O
.	O	O

Exact	O	O
Kruskal-Wallis	O	O
tests	O	O
of	O	O
these	O	O
values	O	O
showed	O	O
differences	O	O
among	O	O
lipid	O	O
treatments	O	O
(	O	O
P	O	O
<	O	O
0.0001	O	O
)	O	O
for	O	O
each	O	O
bacterial	O	O
species	O	O
except	O	O
Serratia	B-bacteria	B-bacteria
marcescens	E-bacteria	I-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
.	O	O

D-sphingosine	O	O
(	O	O
MBC	O	O
range	O	O
,	O	O
0.3	O	O
to	O	O
19.6	O	O
mug/ml	O	O
)	O	O
,	O	O
dihydrosphingosine	O	O
(	O	O
MBC	O	O
range	O	O
,	O	O
0.6	O	O
to	O	O
39.1	O	O
mug/ml	O	O
)	O	O
,	O	O
and	O	O
phytosphingosine	O	O
(	O	O
MBC	O	O
range	O	O
,	O	O
3.3	O	O
to	O	O
62.5	O	O
mug/ml	O	O
)	O	O
were	O	O
active	O	O
against	O	O
all	O	O
bacteria	O	O
except	O	O
S.	B-bacteria	B-bacteria
marcescens	E-bacteria	I-bacteria
and	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
MBC	O	O
>	O	O
500	O	O
mug/ml	O	O
)	O	O
.	O	O

Sapienic	O	O
acid	O	O
(	O	O
MBC	O	O
range	O	O
,	O	O
31.3	O	O
to	O	O
375.0	O	O
mug/ml	O	O
)	O	O
was	O	O
active	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
but	O	O
not	O	O
active	O	O
against	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
marcescens	E-bacteria	I-bacteria
,	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
,	O	O
Corynebacterium	B-bacteria	B-bacteria
bovis	E-bacteria	I-bacteria
,	O	O
Corynebacterium	B-bacteria	B-bacteria
striatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Corynebacterium	B-bacteria	B-bacteria
jeikeium	E-bacteria	I-bacteria
(	O	O
MBC	O	O
>	O	O
500	O	O
mug/ml	O	O
)	O	O
.	O	O

Lauric	O	O
acid	O	O
(	O	O
MBC	O	O
range	O	O
,	O	O
6.8	O	O
to	O	O
375.0	O	O
mug/ml	O	O
)	O	O
was	O	O
active	O	O
against	O	O
all	O	O
bacteria	O	O
except	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
marcescens	E-bacteria	I-bacteria
,	O	O
and	O	O
P.	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
(	O	O
MBC	O	O
>	O	O
500	O	O
mug/ml	O	O
)	O	O
.	O	O

Complete	O	O
killing	O	O
was	O	O
achieved	O	O
as	O	O
early	O	O
as	O	O
0.5	O	O
h	O	O
for	O	O
some	O	O
lipids	O	O
but	O	O
took	O	O
as	O	O
long	O	O
as	O	O
24	O	O
h	O	O
for	O	O
others	O	O
.	O	O

Hence	O	O
,	O	O
sphingoid	O	O
bases	O	O
and	O	O
fatty	O	O
acids	O	O
have	O	O
different	O	O
antibacterial	O	O
activities	O	O
and	O	O
may	O	O
have	O	O
potential	O	O
for	O	O
prophylactic	O	O
or	O	O
therapeutic	O	O
intervention	O	O
in	O	O
infection	O	O
.	O	O

Viruses	O	O
are	O	O
the	O	O
most	O	O
abundant	O	O
known	O	O
infectious	O	O
agents	O	O
on	O	O
the	O	O
planet	O	O
and	O	O
are	O	O
significant	O	O
drivers	O	O
of	O	O
diversity	O	O
in	O	O
a	O	O
variety	O	O
of	O	O
ecosystems	O	O
.	O	O

Although	O	O
there	O	O
have	O	O
been	O	O
numerous	O	O
studies	O	O
of	O	O
viral	O	O
communities	O	O
,	O	O
few	O	O
have	O	O
focused	O	O
on	O	O
viruses	O	O
within	O	O
the	O	O
indigenous	O	O
human	O	O
microbiota	O	O
.	O	O

We	O	O
analyzed	O	O
2	O	O
267	O	O
695	O	O
virome	O	O
reads	O	O
from	O	O
viral	O	O
particles	O	O
and	O	O
compared	O	O
them	O	O
with	O	O
263	O	O
516	O	O
bacterial	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequences	O	O
from	O	O
the	O	O
saliva	O	O
of	O	O
five	O	O
healthy	O	O
human	O	O
subjects	O	O
over	O	O
a	O	O
2-	O	O
to	O	O
3-month	O	O
period	O	O
,	O	O
in	O	O
order	O	O
to	O	O
improve	O	O
our	O	O
understanding	O	O
of	O	O
the	O	O
role	O	O
viruses	O	O
have	O	O
in	O	O
the	O	O
complex	O	O
oral	O	O
ecosystem	O	O
.	O	O

Our	O	O
data	O	O
reveal	O	O
viral	O	O
communities	O	O
in	O	O
human	O	O
saliva	O	O
dominated	O	O
by	O	O
bacteriophages	O	O
whose	O	O
constituents	O	O
are	O	O
temporally	O	O
distinct	O	O
.	O	O

The	O	O
preponderance	O	O
of	O	O
shared	O	O
homologs	O	O
between	O	O
the	O	O
salivary	O	O
viral	O	O
communities	O	O
in	O	O
two	O	O
unrelated	O	O
subjects	O	O
in	O	O
the	O	O
same	O	O
household	O	O
suggests	O	O
that	O	O
environmental	O	O
factors	O	O
are	O	O
determinants	O	O
of	O	O
community	O	O
membership	O	O
.	O	O

When	O	O
comparing	O	O
salivary	O	O
viromes	O	O
to	O	O
those	O	O
from	O	O
human	O	O
stool	O	O
and	O	O
the	O	O
respiratory	O	O
tract	O	O
,	O	O
each	O	O
group	O	O
was	O	O
distinct	O	O
,	O	O
further	O	O
indicating	O	O
that	O	O
habitat	O	O
is	O	O
of	O	O
substantial	O	O
importance	O	O
in	O	O
shaping	O	O
human	O	O
viromes	O	O
.	O	O

Compared	O	O
with	O	O
coexisting	O	O
bacteria	O	O
,	O	O
there	O	O
was	O	O
concordance	O	O
among	O	O
certain	O	O
predicted	O	O
host-virus	O	O
pairings	O	O
such	O	O
as	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
whereas	O	O
there	O	O
was	O	O
discordance	O	O
among	O	O
others	O	O
such	O	O
as	O	O
Actinomyces	B-bacteria	B-bacteria
.	O	O

We	O	O
identified	O	O
122	O	O
728	O	O
virulence	O	O
factor	O	O
homologs	O	O
,	O	O
suggesting	O	O
that	O	O
salivary	O	O
viruses	O	O
may	O	O
serve	O	O
as	O	O
reservoirs	O	O
for	O	O
pathogenic	O	O
gene	O	O
function	O	O
in	O	O
the	O	O
oral	O	O
environment	O	O
.	O	O

That	O	O
the	O	O
vast	O	O
majority	O	O
of	O	O
human	O	O
oral	O	O
viruses	O	O
are	O	O
bacteriophages	O	O
whose	O	O
putative	O	O
gene	O	O
function	O	O
signifies	O	O
some	O	O
have	O	O
a	O	O
prominent	O	O
role	O	O
in	O	O
lysogeny	O	O
,	O	O
suggests	O	O
these	O	O
viruses	O	O
may	O	O
have	O	O
an	O	O
important	O	O
role	O	O
in	O	O
helping	O	O
shape	O	O
the	O	O
microbial	O	O
diversity	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Implants	O	O
can	O	O
be	O	O
colonized	O	O
by	O	O
microorganisms	O	O
from	O	O
oral	O	O
biofilms	O	O
and	O	O
may	O	O
affect	O	O
peri-implant	O	O
tissues	O	O
health	O	O
.	O	O

Among	O	O
these	O	O
bacteria	O	O
,	O	O
pathogens	O	O
typically	O	O
associated	O	O
with	O	O
periodontitis	O	O
can	O	O
be	O	O
found	O	O
,	O	O
such	O	O
as	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
as	O	O
well	O	O
as	O	O
Gram	O	O
negative	O	O
enteric	O	O
bacilli	O	O
not	O	O
typically	O	O
associated	O	O
with	O	O
periodontal	O	O
diseases	O	O
.	O	O

Superinfecting	O	O
bacteria	O	O
were	O	O
characterized	O	O
from	O	O
peri-implant	O	O
lesions	O	O
in	O	O
patients	O	O
with	O	O
history	O	O
of	O	O
periodontitis	O	O
.	O	O

Sixty-eight	O	O
implants	O	O
were	O	O
studied	O	O
in	O	O
55	O	O
patients	O	O
;	O	O
the	O	O
average	O	O
patient	O	O
age	O	O
was	O	O
56	O	O
years	O	O
.	O	O

Forty-nine	O	O
implants	O	O
had	O	O
peri-implant	O	O
lesions	O	O
and	O	O
19	O	O
were	O	O
considered	O	O
stable	O	O
.	O	O

Subgingival	O	O
samples	O	O
were	O	O
obtained	O	O
in	O	O
affected	O	O
and	O	O
stable	O	O
implants	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
streaked	O	O
on	O	O
Mac-Conkey	O	O
agar	O	O
and	O	O
incubated	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
for	O	O
24	O	O
hours	O	O
.	O	O

The	O	O
colonies	O	O
were	O	O
identified	O	O
with	O	O
the	O	O
kit-BD	O	O
BBL	O	O
Crystal	O	O
E/NF	O	O
(	O	O
R	O	O
)	O	O
.	O	O

Superinfecting	O	O
organisms	O	O
were	O	O
detected	O	O
in	O	O
20	O	O
patients	O	O
--	O	O
they	O	O
were	O	O
seen	O	O
more	O	O
frequently	O	O
at	O	O
diseased	O	O
implants	O	O
(	O	O
n=15	O	O
)	O	O
than	O	O
at	O	O
healthy	O	O
implants	O	O
(	O	O
n=5	O	O
)	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
superinfecting	O	O
bacteria	O	O
on	O	O
the	O	O
selected	O	O
implants	O	O
was	O	O
33.8	O	O
%	O	O
(	O	O
n=23/68	O	O
)	O	O
.	O	O

These	O	O
bacteria	O	O
were	O	O
more	O	O
prevalent	O	O
among	O	O
affected	O	O
implants	O	O
(	O	O
n=17	O	O
or	O	O
25	O	O
%	O	O
)	O	O
than	O	O
those	O	O
with	O	O
stable	O	O
implants	O	O
n=6	O	O
(	O	O
8.8	O	O
%	O	O
)	O	O
.	O	O

Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
frequent	O	O
Gram	O	O
negative	O	O
rod	O	O
detected	O	O
(	O	O
n=12	O	O
)	O	O
.	O	O

One-third	O	O
of	O	O
the	O	O
implants	O	O
had	O	O
superinfecting	O	O
organisms	O	O
.	O	O

Implants	O	O
with	O	O
a	O	O
peri-implant	O	O
lesion	O	O
had	O	O
a	O	O
higher	O	O
frequency	O	O
of	O	O
superinfecting	O	O
bacteria	O	O
.	O	O

Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
common	O	O
superinfecting	O	O
organism	O	O
isolated	O	O
.	O	O

A	O	O
multiple	O	O
infection	O	O
caused	O	O
by	O	O
superinfecting	O	O
bacteria	O	O
was	O	O
present	O	O
only	O	O
at	O	O
diseased	O	O
implants	O	O
.	O	O

These	O	O
microbial	O	O
agents	O	O
potentially	O	O
affect	O	O
implant	O	O
stability	O	O
.	O	O

To	O	O
profile	O	O
plaque	O	O
microflora	O	O
on	O	O
root-caries	O	O
lesions	O	O
,	O	O
and	O	O
to	O	O
examine	O	O
the	O	O
protein-denaturing	O	O
activity	O	O
as	O	O
a	O	O
pilot	O	O

.	O	O

Six	O	O
subjects	O	O
with	O	O
root-caries	O	O
were	O	O
investigated	O	O
.	O	O

Plaque	O	O
samples	O	O
on	O	O
root	O	O
caries	O	O
lesions	O	O
(	O	O
R	O	O
)	O	O
,	O	O
as	O	O
well	O	O
as	O	O
from	O	O
healthy	O	O
supragingival	O	O
sites	O	O
(	O	O
S	O	O
)	O	O
and	O	O
periodontal	O	O
pockets	O	O
(	O	O
>	O	O
or	O	O
=	O	O
5	O	O
mm	O	O
)	O	O
(	O	O
P	O	O
)	O	O
were	O	O
collected	O	O
and	O	O
cultured	O	O
anaerobically	O	O
on	O	O
blood	O	O
agar	O	O
plates	O	O
.	O	O

The	O	O
isolated	O	O
bacteria	O	O
were	O	O
identified	O	O
by	O	O
16S	O	O
rRNA	O	O
sequencing	O	O
analysis	O	O
,	O	O
and	O	O
examined	O	O
for	O	O
the	O	O
protein-denaturing	O	O
activity	O	O
using	O	O
the	O	O
skim-milk	O	O
plates	O	O
and	O	O
the	O	O
SDS-PAGE	O	O
,	O	O
and	O	O
for	O	O
the	O	O
acidogenicity	O	O
using	O	O
the	O	O
FAB	O	O
broth	O	O
containing	O	O
1	O	O
%	O	O
glucose	O	O
.	O	O

Propionibacterium	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
were	O	O
predominant	O	O
in	O	O
R	O	O
,	O	O
while	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Capnocytophaga	B-bacteria	B-bacteria
in	O	O
S	O	O
,	O	O
and	O	O
Actinomyces	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Actinobaculum	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Olsenella	B-bacteria	B-bacteria
and	O	O
Eubacterium	B-bacteria	B-bacteria
were	O	O
predominant	B-bacteria	B-bacteria
in	O	O
P.	B-bacteria	B-bacteria
Proteolytic	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
comprised	O	O
40	O	O
%	O	O
,	O	O
26	O	O
%	O	O
and	O	O
57	O	O
%	O	O
of	O	O
microflora	O	O
in	O	O
R	O	O
,	O	O
S	O	O
and	O	O
P	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
skim-milk	O	O
plates	O	O
distinguished	O	O
between	O	O
protein-degrading	O	O
and	O	O
protein-coagulating	O	O
bacteria	O	O
,	O	O
which	O	O
comprised	O	O
7	O	O
and	O	O
33	O	O
%	O	O
,	O	O
0	O	O
and	O	O
26	O	O
%	O	O
,	O	O
and	O	O
17	O	O
and	O	O
40	O	O
%	O	O
of	O	O
microflora	O	O
,	O	O
in	O	O
R	O	O
,	O	O
S	O	O
and	O	O
P	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
SDS-PAGE	O	O
analysis	O	O
revealed	O	O
that	O	O
protein-degrading	O	O
isolates	O	O
were	O	O
capable	O	O
of	O	O
degrading	O	O
collagen	O	O
molecules	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
final	O	O
culture	O	O
pHs	O	O
of	O	O
protein-degrading	O	O
and	O	O
-coagulating	O	O
bacteria	O	O
were	O	O
5.0-5.4	O	O
and	O	O
3.8-3.9	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
latter	O	O
pH	O	O
was	O	O
low	O	O
enough	O	O
to	O	O
denature	O	O
proteins	O	O
in	O	O
skim	O	O
milk	O	O
.	O	O

The	O	O
microbial	O	O
composition	O	O
of	O	O
R	O	O
was	O	O
distinct	O	O
from	O	O
those	O	O
of	O	O
S	O	O
and	O	O
P	O	O
.	O	O

Deoxyribonucleic	O	O
acids	O	O
(	O	O
DNA	O	O
)	O	O
of	O	O
periodontal	O	O
pathogens	O	O
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
(	O	O
Pg	B-bacteria	B-bacteria
)	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
stimulate	O	O
cytokine	O	O
production	O	O
in	O	O
human	O	O
monocytic	O	O
cells	O	O
(	O	O
THP-1	O	O
)	O	O
through	O	O
Toll-like	O	O
receptor	O	O
9	O	O
(	O	O
TLR-9	O	O
)	O	O
and	O	O
nuclear	O	O
factor-kappaB	O	O
signaling	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
(	O	O
Fn	B-bacteria	B-bacteria
)	O	O
is	O	O
one	O	O
of	O	O
the	O	O
most	O	O
frequently	O	O
isolated	O	O
bacteria	O	O
in	O	O
periodontally	O	O
diseased	O	O
tissues	O	O
and	O	O
is	O	O
reported	O	O
to	O	O
synergize	O	O
with	O	O
Pg	B-bacteria	B-bacteria
,	O	O
enhancing	O	O
the	O	O
pathogenicity	O	O
.	O	O

We	O	O
investigate	O	O
inflammatory	O	O
mediator	O	O
production	O	O
in	O	O
THP-1	O	O
cells	O	O
challenged	O	O
with	O	O
Fn	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
(	O	O
Ss	B-bacteria	B-bacteria
)	O	O
DNA	O	O
,	O	O
a	O	O
non-pathogenic	O	O
oral	O	O
bacteria	O	O
,	O	O
and	O	O
further	O	O
assess	O	O
whether	O	O
cytokines	O	O
triggered	O	O
by	O	O
whole	O	O
pathogens	O	O
or	O	O
Pg	O	O
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
are	O	O
affected	O	O
by	O	O
TLR-9	O	O
signaling	O	O
inhibitors	O	O
(	O	O
chloroquine	O	O
)	O	O
.	O	O

THP-1	O	O
cells	O	O
were	O	O
stimulated	O	O
with	O	O
Pg-DNA	O	O
(	O	O
100	O	O
ng/muL	O	O
)	O	O
,	O	O
Fn-DNA	O	O
(	O	O
100	O	O
ng/muL	O	O
)	O	O
,	O	O
Ss-DNA	O	O
(	O	O
100	O	O
ng/muL	O	O
)	O	O
,	O	O
Pg-LPS	O	O
(	O	O
10	O	O
ng/muL	O	O
)	O	O
,	O	O
and	O	O
heat-killed	O	O
whole	O	O
bacteria	O	O
(	O	O
multiplicity	O	O
of	O	O
infection	O	O
,	O	O
1:100	O	O
)	O	O
for	O	O
16	O	O
hours	O	O
with	O	O
or	O	O
without	O	O
chloroquine	O	O
pretreatment	O	O
(	O	O
10	O	O
mug/mL	O	O
)	O	O
.	O	O

Interleukin	O	O
(	O	O
IL	O	O
)	O	O
-1beta	O	O
,	O	O
IL-6	O	O
,	O	O
IL-8	O	O
,	O	O
and	O	O
tumor	O	O
necrosis	O	O
factor-alpha	O	O
levels	O	O
were	O	O
determined	O	O
using	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
.	O	O

Statistical	O	O
analyses	O	O
included	O	O
analysis	O	O
of	O	O
variance	O	O
with	O	O
multiple	O	O
comparisons	O	O
using	O	O
Dunnett	O	O
or	O	O
Tukey	O	O
methods	O	O
and	O	O
paired	O	O
t	O	O
test	O	O
.	O	O

A	O	O
value	O	O
of	O	O
P	O	O
<	O	O
0.05	O	O
was	O	O
significant	O	O
.	O	O

Inflammatory	O	O
mediator	O	O
levels	O	O
were	O	O
increased	O	O
in	O	O
response	O	O
to	O	O
all	O	O
the	O	O
stimuli	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
Ss-DNA	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Chloroquine	O	O
pretreatment	O	O
significantly	O	O
decreased	O	O
cytokine	O	O
production	O	O
from	O	O
THP-1	O	O
cells	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
IL-6	O	O
production	O	O
triggered	O	O
by	O	O
whole	O	O
Fn	O	O
and	O	O
Ss	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Differences	O	O
exist	O	O
among	O	O
oral	O	O
bacterial	O	O
DNA	O	O
in	O	O
inducing	O	O
immune	O	O
responses	O	O
.	O	O

By	O	O
altering	O	O
the	O	O
conditions	O	O
in	O	O
cytosolic	O	O
compartments	O	O
,	O	O
we	O	O
can	O	O
interfere	O	O
with	O	O
cellular	O	O
responses	O	O
triggered	O	O
by	O	O
extracellular	O	O
receptor	O	O
activation	O	O
.	O	O

Thus	O	O
,	O	O
alternative	O	O
treatment	O	O
approaches	O	O
targeted	O	O
to	O	O
intracellular	O	O
receptors	O	O
might	O	O
be	O	O
of	O	O
benefit	O	O
in	O	O
controlling	O	O
periodontal	O	O
inflammation	O	O
.	O	O

The	O	O
fimbriae-associated	O	O
protein	O	O
1	O	O
(	O	O
Fap1	O	O
)	O	O
is	O	O
a	O	O
major	O	O
adhesin	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
parasanguinis	E-bacteria	I-bacteria
,	O	O
a	O	O
primary	O	O
colonizer	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
that	O	O
plays	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
formation	O	O
of	O	O
dental	O	O
plaque	O	O
.	O	O

Fap1	O	O
is	O	O
an	O	O
extracellular	O	O
adhesive	O	O
surface	O	O
fibre	O	O
belonging	O	O
to	O	O
the	O	O
serine-rich	O	O
repeat	O	O
protein	O	O
(	O	O
SRRP	O	O
)	O	O
family	O	O
,	O	O
which	O	O
plays	O	O
a	O	O
central	O	O
role	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
and	O	O
staphylococci	B-bacteria	B-bacteria
.	O	O

The	O	O
N-terminal	O	O
adhesive	O	O
region	O	O
of	O	O
Fap1	O	O
(	O	O
Fap1-NR	O	O
)	O	O
is	O	O
composed	O	O
of	O	O
two	O	O
domains	O	O
(	O	O
Fap1-NR	O	O
(	O	O
alpha	O	O
)	O	O
and	O	O
Fap1-NR	O	O
(	O	O
beta	O	O
)	O	O
)	O	O
and	O	O
is	O	O
projected	O	O
away	O	O
from	O	O
the	O	O
bacterial	O	O
surface	O	O
via	O	O
the	O	O
extensive	O	O
serine-rich	O	O
repeat	O	O
region	O	O
,	O	O
for	O	O
adhesion	O	O
to	O	O
the	O	O
salivary	O	O
pellicle	O	O
.	O	O

The	O	O
adhesive	O	O
properties	O	O
of	O	O
Fap1	O	O
are	O	O
modulated	O	O
through	O	O
a	O	O
pH	O	O
switch	O	O
in	O	O
which	O	O
a	O	O
reduction	O	O
in	O	O
pH	O	O
results	O	O
in	O	O
a	O	O
rearrangement	O	O
between	O	O
the	O	O
Fap1-NR	O	O
(	O	O
alpha	O	O
)	O	O
and	O	O
Fap1-NR	O	O
(	O	O
beta	O	O
)	O	O
domains	O	O
,	O	O
which	O	O
assists	O	O
in	O	O
the	O	O
survival	O	O
of	O	O
S.	B-bacteria	B-bacteria
parasanguinis	E-bacteria	I-bacteria
in	O	O
acidic	O	O
environments	O	O
.	O	O

We	O	O
have	O	O
solved	O	O
the	O	O
structure	O	O
of	O	O
Fap1-NR	O	O
(	O	O
alpha	O	O
)	O	O
at	O	O
pH	O	O
5.0	O	O
at	O	O
3.0A	O	O
resolution	O	O
and	O	O
reveal	O	O
how	O	O
subtle	O	O
rearrangements	O	O
of	O	O
the	O	O
3-helix	O	O
bundle	O	O
combined	O	O
with	O	O
a	O	O
change	O	O
in	O	O
electrostatic	O	O
potential	O	O
mediates	O	O
'opening	O	O
'	O	O
and	O	O
activation	O	O
of	O	O
the	O	O
adhesive	O	O
region	O	O
.	O	O

Further	O	O
,	O	O
we	O	O
show	O	O
that	O	O
pH-dependent	O	O
changes	O	O
are	O	O
critical	O	O
for	O	O
biofilm	O	O
formation	O	O
and	O	O
present	O	O
an	O	O
atomic	O	O
model	O	O
for	O	O
the	O	O
inter-Fap1-NR	O	O
interactions	O	O
which	O	O
have	O	O
been	O	O
assigned	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
biofilm	O	O
formation	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
identify	O	O
a	O	O
group	O	O
of	O	O
patients	O	O
at	O	O
high	O	O
risk	O	O
of	O	O
methicillin	B-bacteria	B-bacteria
resistant	I-bacteria	I-bacteria
Staphylococcus	I-bacteria	I-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
MRSA	B-bacteria	B-bacteria
)	O	O
infection	O	O
following	O	O
surgical	O	O
procedures	O	O
involving	O	O
oral	O	O
cavity	O	O
,	O	O
head	O	O
and	O	O
neck	O	O
.	O	O

A	O	O
retrospective	O	O
analysis	O	O
of	O	O
demographic	O	O
,	O	O
clinical	O	O
and	O	O
laboratory	O	O
data	O	O
was	O	O
performed	O	O
.	O	O

A	O	O
manual	O	O
search	O	O
of	O	O
laboratory	O	O
records	O	O
for	O	O
a	O	O
five	O	O
years	O	O
period	O	O
(	O	O
2005-2009	O	O
)	O	O
was	O	O
performed	O	O
for	O	O
specimens	O	O
submitted	O	O
to	O	O
the	O	O
diagnostic	O	O
microbiology	O	O
laboratory	O	O
from	O	O
patients	O	O
admitted	O	O
to	O	O
the	O	O
Cranio-Maxillofacial	O	O
and	O	O
Oncologic	O	O
Surgery	O	O
Department	O	O
.	O	O

Methicillin	O	O
resistant	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
identified	O	O
in	O	O
26	O	O
cases	O	O
.	O	O

Most	O	O
commonly	O	O
it	O	O
was	O	O
isolated	O	O
from	O	O
tongue	O	O
swabs	O	O
in	O	O
patients	O	O
following	O	O
extensive	O	O
oncological	O	O
surgical	O	O
procedures	O	O
involving	O	O
oral	O	O
cavity	O	O
.	O	O

Most	O	O
common	O	O
risk	O	O
factors	O	O
were	O	O
:	O	O
age	O	O
above	O	O
65	O	O
years	O	O
,	O	O
neoplasms	O	O
,	O	O
multisite	O	O
trauma	O	O
with	O	O
loss	O	O
of	O	O
consciousness	O	O
,	O	O
cigarette	O	O
smoking	O	O
,	O	O
alcohol	O	O
abuse	O	O
,	O	O
tobacco	O	O
addiction	O	O
,	O	O
antibiotic	O	O
therapy	O	O
immediately	O	O
before	O	O
hospitalization	O	O
.	O	O

More	O	O
than	O	O
half	O	O
of	O	O
patients	O	O
with	O	O
MRSA	B-bacteria	B-bacteria
infection	O	O
required	O	O
surgical	O	O
treatment	O	O
except	O	O
for	O	O
pharmacological	O	O
treatment	O	O
.	O	O

Monitoring	O	O
of	O	O
postoperative	O	O
wounds	O	O
is	O	O
of	O	O
great	O	O
importance	O	O
with	O	O
regard	O	O
to	O	O
he	O	O
risk	O	O
of	O	O
MRSA	B-bacteria	B-bacteria
infection	O	O
.	O	O

The	O	O
intensities	O	O
and	O	O
specificities	O	O
of	O	O
salivary	O	O
IgA	O	O
antibody	O	O
responses	O	O
to	O	O
antigens	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
main	O	O
pathogen	O	O
of	O	O
dental	O	O
caries	O	O
,	O	O
may	O	O
influence	O	O
colonization	O	O
by	O	O
these	O	O
organisms	O	O
during	O	O
the	O	O
first	O	O
1.5	O	O
year	O	O
of	O	O
life	O	O
.	O	O

Thus	O	O
,	O	O
the	O	O
ontogeny	O	O
of	O	O
salivary	O	O
IgA	O	O
responses	O	O
to	O	O
oral	O	O
colonizers	O	O
continues	O	O
to	O	O
warrant	O	O
investigation	O	O
,	O	O
especially	O	O
with	O	O
regard	O	O
to	O	O
the	O	O
influence	O	O
of	O	O
birth	O	O
conditions	O	O
,	O	O
e.g	O	O
.	O	O

prematurity	O	O
,	O	O
on	O	O
the	O	O
ability	O	O
of	O	O
children	O	O
to	O	O
efficiently	O	O
respond	O	O
to	O	O
oral	O	O
microorganisms	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
characterised	O	O
the	O	O
salivary	O	O
antibody	O	O
responses	O	O
to	O	O
two	O	O
bacterial	O	O
species	O	O
which	O	O
are	O	O
prototypes	O	O
of	O	O
pioneer	O	O
and	O	O
pathogenic	O	O
microorganisms	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
respectively	O	O
)	O	O
in	O	O
fullterm	O	O
(	O	O
FT	O	O
)	O	O
and	O	O
preterm	O	O
(	O	O
PT	O	O
)	O	O
newborn	O	O
children	O	O
.	O	O

Salivas	O	O
from	O	O
123	O	O
infants	O	O
(	O	O
70	O	O
FT	O	O
and	O	O
53	O	O
PT	O	O
)	O	O
were	O	O
collected	O	O
during	O	O
the	O	O
first	O	O
10h	O	O
after	O	O
birth	O	O
and	O	O
levels	O	O
of	O	O
IgA	O	O
and	O	O
IgM	O	O
antibodies	O	O
and	O	O
the	O	O
presence	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
were	O	O
analysed	O	O
respectively	O	O
by	O	O
ELISA	O	O
and	O	O
by	O	O
chequerboard	O	O
DNA-DNA	O	O
hybridization	O	O
.	O	O

Two	O	O
subgroups	O	O
of	O	O
24	O	O
FT	O	O
and	O	O
24	O	O
PT	O	O
children	O	O
were	O	O
compared	O	O
with	O	O
respect	O	O
to	O	O
patterns	O	O
of	O	O
antibody	O	O
specificities	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
antigens	O	O
,	O	O
using	O	O
Western	O	O
blot	O	O
assays	O	O
.	O	O

Cross-adsorption	O	O
of	O	O
10	O	O
infant	O	O
's	O	O
saliva	O	O
was	O	O
tested	O	O
to	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
antigens	O	O
.	O	O

Salivary	O	O
levels	O	O
of	O	O
IgA	O	O
at	O	O
birth	O	O
were	O	O
2.5-fold	O	O
higher	O	O
in	O	O
FT	O	O
than	O	O
in	O	O
PT	O	O
children	O	O
(	O	O
Mann-Whitney	O	O
;	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Salivary	O	O
IgA	O	O
antibodies	O	O
reactive	O	O
with	O	O
several	O	O
antigens	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
detected	O	O
at	O	O
birth	O	O
in	O	O
children	O	O
with	O	O
undetectable	O	O
levels	O	O
of	O	O
those	O	O
bacteria	O	O
.	O	O

Adsorption	O	O
of	O	O
infant	O	O
saliva	O	O
with	O	O
cells	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
produced	O	O
a	O	O
reduction	O	O
of	O	O
antibodies	O	O
recognizing	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
antigens	O	O
in	O	O
half	O	O
of	O	O
the	O	O
neonates	O	O
.	O	O

The	O	O
diversity	O	O
and	O	O
intensity	O	O
of	O	O
IgA	O	O
responses	O	O
were	O	O
lower	O	O
in	O	O
PT	O	O
compared	O	O
to	O	O
FT	O	O
children	O	O
,	O	O
although	O	O
those	O	O
differences	O	O
were	O	O
not	O	O
significant	O	O
.	O	O

These	O	O
data	O	O
provide	O	O
evidence	O	O
that	O	O
children	O	O
have	O	O
salivary	O	O
IgA	O	O
antibodies	O	O
shortly	O	O
after	O	O
birth	O	O
,	O	O
which	O	O
might	O	O
influence	O	O
the	O	O
establishment	O	O
of	O	O
the	O	O
oral	O	O
microbiota	O	O
,	O	O
and	O	O
that	O	O
the	O	O
levels	O	O
of	O	O
salivary	O	O
antibody	O	O
might	O	O
be	O	O
related	O	O
to	O	O
prematurity	O	O
.	O	O

Periodontitis	O	O
has	O	O
a	O	O
polymicrobial	O	O
etiology	O	O
within	O	O
the	O	O
framework	O	O
of	O	O
a	O	O
complex	O	O
microbial	O	O
ecosystem	O	O
.	O	O

With	O	O
advances	O	O
in	O	O
sequencing	O	O
technologies	O	O
,	O	O
comprehensive	O	O
studies	O	O
to	O	O
elucidate	O	O
bacterial	O	O
community	O	O
differences	O	O
have	O	O
recently	O	O
become	O	O
possible	O	O
.	O	O

We	O	O
used	O	O
454	O	O
sequencing	O	O
of	O	O
16S	O	O
rRNA	O	O
genes	O	O
to	O	O
compare	O	O
subgingival	O	O
bacterial	O	O
communities	O	O
from	O	O
29	O	O
periodontally	O	O
healthy	O	O
controls	O	O
and	O	O
29	O	O
subjects	O	O
with	O	O
chronic	O	O
periodontitis	O	O
.	O	O

Amplicons	O	O
from	O	O
both	O	O
the	O	O
V1-2	O	O
and	O	O
V4	O	O
regions	O	O
of	O	O
the	O	O
16S	O	O
gene	O	O
were	O	O
sequenced	O	O
,	O	O
yielding	O	O
1,393,579	O	O
sequences	O	O
.	O	O

They	O	O
were	O	O
identified	O	O
by	O	O
BLAST	O	O
against	O	O
a	O	O
curated	O	O
oral	O	O
16S	O	O
database	O	O
,	O	O
and	O	O
mapped	O	O
to	O	O
16	O	O
phyla	O	O
,	O	O
106	O	O
genera	O	O
,	O	O
and	O	O
596	O	O
species	O	O
.	O	O

81	O	O
%	O	O
of	O	O
sequences	O	O
could	O	O
be	O	O
mapped	O	O
to	O	O
cultivated	O	O
species	O	O
.	O	O

Differences	O	O
between	O	O
health-	O	O
and	O	O
periodontitis-associated	O	O
bacterial	O	O
communities	O	O
were	O	O
observed	O	O
at	O	O
all	O	O
phylogenetic	O	O
levels	O	O
,	O	O
and	O	O
UniFrac	O	O
and	O	O
principal	O	O
coordinates	O	O
analysis	O	O
showed	O	O
distinct	O	O
community	O	O
profiles	O	O
in	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

Community	O	O
diversity	O	O
was	O	O
higher	O	O
in	O	O
disease	O	O
,	O	O
and	O	O
123	O	O
species	O	O
were	O	O
identified	O	O
that	O	O
were	O	O
significantly	O	O
more	O	O
abundant	O	O
in	O	O
disease	O	O
,	O	O
and	O	O
53	O	O
in	O	O
health	O	O
.	O	O

Spirochaetes	B-bacteria	B-bacteria
,	O	O
Synergistetes	B-bacteria	B-bacteria
and	O	O
Bacteroidetes	B-bacteria	B-bacteria
were	O	O
more	O	O
abundant	O	O
in	O	O
disease	O	O
,	O	O
whereas	O	O
the	O	O
Proteobacteria	B-bacteria	B-bacteria
were	O	O
found	O	O
at	O	O
higher	O	O
levels	O	O
in	O	O
healthy	O	O
controls	O	O
.	O	O

Within	O	O
the	O	O
phylum	O	O
Firmicutes	B-bacteria	B-bacteria
,	O	O
the	O	O
class	O	O
Bacilli	B-bacteria	B-bacteria
was	O	O
health-associated	O	O
,	O	O
whereas	O	O
the	O	O
Clostridia	B-bacteria	B-bacteria
,	O	O
Negativicutes	B-bacteria	B-bacteria
and	O	O
Erysipelotrichia	B-bacteria	B-bacteria
were	O	O
associated	O	O
with	O	O
disease	O	O
.	O	O

These	O	O
results	O	O
implicate	O	O
a	O	O
number	O	O
of	O	O
taxa	O	O
that	O	O
will	O	O
be	O	O
targets	O	O
for	O	O
future	O	O
research	O	O
.	O	O

Some	O	O
,	O	O
such	O	O
as	O	O
Filifactor	B-bacteria	B-bacteria
alocis	E-bacteria	I-bacteria
and	O	O
many	O	O
Spirochetes	B-bacteria	B-bacteria
were	O	O
represented	O	O
by	O	O
a	O	O
large	O	O
fraction	O	O
of	O	O
sequences	O	O
as	O	O
compared	O	O
with	O	O
previously	O	O
identified	O	O
targets	O	O
.	O	O

Elucidation	O	O
of	O	O
these	O	O
differences	O	O
in	O	O
community	O	O
composition	O	O
provides	O	O
a	O	O
basis	O	O
for	O	O
further	O	O
understanding	O	O
the	O	O
pathogenesis	O	O
of	O	O
periodontitis	O	O
.	O	O

Salivary	O	O
host-defence	O	O
peptides	O	O
include	O	O
defensins	O	O
,	O	O
histatins	O	O
and	O	O
cathelicidin	O	O
.	O	O

We	O	O
have	O	O
investigated	O	O
the	O	O
effects	O	O
of	O	O
these	O	O
peptides	O	O
on	O	O
the	O	O
microbial	O	O
composition	O	O
of	O	O
dental	O	O
plaques	O	O
.	O	O

Salivary	O	O
consortia	O	O
,	O	O
established	O	O
within	O	O
hydroxyapatite	O	O
disc	O	O
models	O	O
,	O	O
were	O	O
exposed	O	O
during	O	O
development	O	O
to	O	O
physiological	O	O
levels	O	O
of	O	O
human	O	O
neutrophil	O	O
proteins	O	O
(	O	O
HNP	O	O
)	O	O
1	O	O
and	O	O
2	O	O
;	O	O
human	O	O
beta	O	O
defensins	O	O
(	O	O
hbetaD	O	O
)	O	O
1	O	O
,	O	O
2	O	O
and	O	O
3	O	O
;	O	O
histatins	O	O
(	O	O
His	O	O
)	O	O
5	O	O
and	O	O
8	O	O
;	O	O
and	O	O
cathelicidin	O	O
(	O	O
LL37	O	O
)	O	O
.	O	O

Effects	O	O
on	O	O
aggregation	O	O
and	O	O
microbial	O	O
composition	O	O
were	O	O
determined	O	O
using	O	O
fluorescence	O	O
microscopy	O	O
;	O	O
and	O	O
differential	O	O
culture	O	O
with	O	O
PCR-DGGE	O	O
,	O	O
respectively	O	O
.	O	O

LIVE/DEAD	O	O
microscopic	O	O
analysis	O	O
indicated	O	O
that	O	O
HDPs	O	O
decreased	O	O
total	O	O
bacterial	O	O
viability	O	O
,	O	O
whilst	O	O
beta	O	O
defensins	O	O
,	O	O
paired	O	O
HNPs	O	O
,	O	O
His	O	O
5	O	O
,	O	O
His	O	O
8	O	O
and	O	O
the	O	O
HDPs	O	O
combined	O	O
inhibited	O	O
bacterial	O	O
aggregation	O	O
.	O	O

According	O	O
to	O	O
differential	O	O
culture	O	O
,	O	O
all	O	O
test	O	O
HDPs	O	O
(	O	O
except	O	O
His	O	O
5	O	O
)	O	O
significantly	O	O
decreased	O	O
the	O	O
abundance	O	O
of	O	O
Gram-negative	O	O
anaerobes	O	O
and	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
except	O	O
HNP	O	O
2	O	O
,	O	O
hbetaD	O	O
1	O	O
,	O	O
paired	O	O
HNPs	O	O
and	O	O
His	O	O
5	O	O
)	O	O
.	O	O

Combined	O	O
HNPs	O	O
and	O	O
paired	O	O
hbetaD	O	O
1	O	O
and	O	O
3	O	O
inhibited	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
whereas	O	O
HNP	O	O
1	O	O
,	O	O
hbetaD	O	O
1	O	O
,	O	O
hbetaD	O	O
3	O	O
,	O	O
His	O	O
5	O	O
and	O	O
LL37	O	O
increased	O	O
streptococcal	B-bacteria	B-bacteria
numbers	O	O
.	O	O

According	O	O
to	O	O
cluster	O	O
analyses	O	O
of	O	O
DGGE	O	O
profiles	O	O
,	O	O
HDP-exposed	O	O
plaques	O	O
were	O	O
compositionally	O	O
distinct	O	O
from	O	O
undosed	O	O
controls	O	O
.	O	O

Thus	O	O
,	O	O
whilst	O	O
HDPs	O	O
reportedly	O	O
exhibit	O	O
variable	O	O
potency	O	O
against	O	O
oral	O	O
bacteria	O	O
in	O	O
endpoint	O	O
susceptibly	O	O
tests	O	O
,	O	O
exposure	O	O
of	O	O
nascent	O	O
plaques	O	O
can	O	O
markedly	O	O
influence	O	O
bacterial	O	O
viability	O	O
,	O	O
composition	O	O
and	O	O
microbial	O	O
aggregation	O	O
.	O	O

To	O	O
assess	O	O
the	O	O
effectiveness	O	O
of	O	O
selective	O	O
digestive	O	O
decontamination	O	O
(	O	O
SDD	O	O
)	O	O
for	O	O
eradicating	O	O
carbapenem-resistant	B-bacteria	B-bacteria
Klebsiella	I-bacteria	I-bacteria
pneumoniae	E-bacteria	I-bacteria
(	O	O
CRKP	B-bacteria	B-bacteria
)	O	O
oropharyngeal	O	O
and	O	O
gastrointestinal	O	O
carriage	O	O
.	O	O

A	O	O
randomized	O	O
,	O	O
double-blind	O	O
,	O	O
placebo-controlled	O	O
trial	O	O
with	O	O
7	O	O
weeks	O	O
of	O	O
follow-up	O	O
per	O	O
patient	O	O
.	O	O

A	O	O
1,000-bed	O	O
tertiary-care	O	O
university	O	O
hospital	O	O
.	O	O

Adults	O	O
with	O	O
CRKP-positive	O	O
rectal	O	O
swab	O	O
cultures	O	O
.	O	O

Patients	O	O
were	O	O
blindly	O	O
randomized	O	O
(	O	O
1	O	O
:1	O	O
)	O	O
over	O	O
a	O	O
20-month	O	O
period	O	O
.	O	O

The	O	O
SDD	O	O
arm	O	O
received	O	O
oral	O	O
gentamicin	O	O
and	O	O
polymyxin	O	O
E	O	O
gel	O	O
(	O	O
0.5	O	O
g	O	O
4	O	O
times	O	O
per	O	O
day	O	O
)	O	O
and	O	O
oral	O	O
solutions	O	O
of	O	O
gentamicin	O	O
(	O	O
80	O	O
mg	O	O
4	O	O
times	O	O
per	O	O
day	O	O
)	O	O
and	O	O
polymyxin	O	O
E	O	O
(	O	O
1	O	O
x	O	O
10	O	O
(	O	O
6	O	O
)	O	O
units	O	O
4	O	O
times	O	O
per	O	O
day	O	O
for	O	O
7	O	O
days	O	O
)	O	O
.	O	O

The	O	O
placebo	O	O
arm	O	O
received	O	O
oral	O	O
placebo	O	O
gel	O	O
4	O	O
times	O	O
per	O	O
day	O	O
and	O	O
2	O	O
placebo	O	O
oral	O	O
solutions	O	O
4	O	O
times	O	O
per	O	O
day	O	O
for	O	O
7	O	O
days	O	O
.	O	O

Strict	O	O
contact	O	O
precautions	O	O
were	O	O
applied	O	O
.	O	O

Samples	O	O
obtained	O	O
from	O	O
the	O	O
throat	O	O
,	O	O
groin	O	O
,	O	O
and	O	O
urine	O	O
were	O	O
also	O	O
cultured	O	O
.	O	O

Forty	O	O
patients	O	O
(	O	O
mean	O	O
age	O	O
+/-	O	O
standard	O	O
deviation	O	O
,	O	O
71	O	O
+/-	O	O
16	O	O
years	O	O
;	O	O
65	O	O
%	O	O
male	O	O
)	O	O
were	O	O
included	O	O
.	O	O

At	O	O
screening	O	O
,	O	O
greater	O	O
than	O	O
or	O	O
equal	O	O
to	O	O
30	O	O
%	O	O
of	O	O
oropharyngeal	O	O
,	O	O
greater	O	O
than	O	O
or	O	O
equal	O	O
to	O	O
60	O	O
%	O	O
of	O	O
skin	O	O
,	O	O
and	O	O
greater	O	O
than	O	O
or	O	O
equal	O	O
to	O	O
35	O	O
%	O	O
of	O	O
urine	O	O
cultures	O	O
yielded	O	O
CRKP	B-bacteria	B-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

All	O	O
throat	O	O
cultures	O	O
became	O	O
negative	O	O
in	O	O
the	O	O
SDD	O	O
arm	O	O
after	O	O
3	O	O
days	O	O
(	O	O
P	O	O
<	O	O
.0001	O	O
)	O	O
.	O	O

The	O	O
percentages	O	O
of	O	O
rectal	O	O
cultures	O	O
that	O	O
were	O	O
positive	O	O
for	O	O
CRKP	B-bacteria	B-bacteria
were	O	O
significantly	O	O
reduced	O	O
at	O	O
2	O	O
weeks	O	O
.	O	O

At	O	O
that	O	O
time	O	O
,	O	O
16.1	O	O
%	O	O
of	O	O
rectal	O	O
cultures	O	O
in	O	O
the	O	O
placebo	O	O
arm	O	O
and	O	O
61.1	O	O
%	O	O
in	O	O
the	O	O
SDD	O	O
arm	O	O
were	O	O
negative	O	O
(	O	O
odds	O	O
ratio	O	O
,	O	O
0.13	O	O
;	O	O
95	O	O
%	O	O
confidence	O	O
interval	O	O
,	O	O
0.02-0.74	O	O
;	O	O
P	O	O
<	O	O
.0016	O	O
)	O	O
.	O	O

A	O	O
difference	O	O
between	O	O
the	O	O
percentages	O	O
in	O	O
the	O	O
2	O	O
arms	O	O
was	O	O
still	O	O
maintained	O	O
at	O	O
6	O	O
weeks	O	O
(	O	O
33.3	O	O
%	O	O
vs	O	O
58.5	O	O
%	O	O
)	O	O
.	O	O

Groin	O	O
colonization	O	O
prevalence	O	O
did	O	O
not	O	O
change	O	O
in	O	O
either	O	O
arm	O	O
,	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
urine	O	O
colonization	O	O
increased	O	O
in	O	O
the	O	O
placebo	O	O
arm	O	O
.	O	O

This	O	O
SDD	O	O
regimen	O	O
could	O	O
be	O	O
a	O	O
suitable	O	O
decolonization	O	O
therapy	O	O
for	O	O
selected	O	O
patients	O	O
colonized	O	O
with	O	O
CRKP	B-bacteria	B-bacteria
,	O	O
such	O	O
as	O	O
transplant	O	O
recipients	O	O
or	O	O
immunocompromised	O	O
patients	O	O
pending	O	O
chemotherapy	O	O
and	O	O
patients	O	O
who	O	O
require	O	O
major	O	O
intestinal	O	O
or	O	O
oropharyngeal	O	O
surgery	O	O
.	O	O

Moreover	O	O
,	O	O
in	O	O
outbreaks	O	O
caused	O	O
by	O	O
CRKP	B-bacteria	B-bacteria
infections	O	O
that	O	O
are	O	O
uncontrolled	O	O
by	O	O
routine	O	O
infection	O	O
control	O	O
measures	O	O
,	O	O
SDD	O	O
could	O	O
provide	O	O
additional	O	O
infection	O	O
containment	O	O
.	O	O

Clinical	O	O
observations	O	O
and	O	O
epidemiologic	O	O
studies	O	O
suggest	O	O
that	O	O
the	O	O
incidence	O	O
of	O	O
head	O	O
and	O	O
neck	O	O
squamous	O	O
cell	O	O
carcinoma	O	O
(	O	O
HNSCC	O	O
)	O	O
correlates	O	O
with	O	O
dental	O	O
hygiene	O	O
,	O	O
implying	O	O
a	O	O
role	O	O
for	O	O
bacteria-induced	O	O
inflammation	O	O
in	O	O
its	O	O
pathogenesis	O	O
.	O	O

Here	O	O
we	O	O
begin	O	O
to	O	O
explore	O	O
the	O	O
pilot	O	O
hypothesis	O	O
that	O	O
specific	O	O
microbial	O	O
populations	O	O
may	O	O
contribute	O	O
to	O	O
HNSCC	O	O
pathogenesis	O	O
via	O	O
epigenetic	O	O
modifications	O	O
in	O	O
inflammatory-	O	O
and	O	O
HNSCC-associated	O	O
genes	O	O
.	O	O

Microbiomic	O	O
profiling	O	O
by	O	O
16S	O	O
rRNA	O	O
sequencing	O	O
of	O	O
matched	O	O
tumor	O	O
and	O	O
adjacent	O	O
normal	O	O
tissue	O	O
specimens	O	O
in	O	O
42	O	O
individuals	O	O
with	O	O
HNSCC	O	O
demonstrate	O	O
a	O	O
significant	O	O
association	O	O
of	O	O
specific	O	O
bacterial	O	O
subpopulations	O	O
with	O	O
HNSCC	O	O
over	O	O
normal	O	O
tissue	O	O
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Furthermore	O	O
,	O	O
microbial	O	O
populations	O	O
can	O	O
separate	O	O
tumors	O	O
by	O	O
tobacco	O	O
status	O	O
(	O	O
P	O	O
<	O	O
0.008	O	O
)	O	O
,	O	O
but	O	O
not	O	O
by	O	O
alcohol	O	O
status	O	O
(	O	O
P	O	O
=	O	O
0.41	O	O
)	O	O
.	O	O

If	O	O
our	O	O
subhypothesis	O	O
regarding	O	O
a	O	O
mechanistic	O	O
link	O	O
from	O	O
microorganism	O	O
to	O	O
carcinogenesis	O	O
via	O	O
inflammation	O	O
and	O	O
consequent	O	O
aberrant	O	O
DNA	O	O
methylation	O	O
is	O	O
correct	O	O
,	O	O
then	O	O
we	O	O
should	O	O
see	O	O
hypermethylation	O	O
of	O	O
relevant	O	O
genes	O	O
associate	O	O
with	O	O
specific	O	O
microbiomic	O	O
profiles	O	O
.	O	O

Methylation	O	O
analysis	O	O
in	O	O
four	O	O
genes	O	O
(	O	O
MDR1	O	O
,	O	O
IL8	O	O
,	O	O
RARB	O	O
,	O	O
TGFBR2	O	O
)	O	O
previously	O	O
linked	O	O
to	O	O
HNSCC	O	O
or	O	O
inflammation	O	O
shows	O	O
significantly	O	O
increased	O	O
methylation	O	O
in	O	O
tumor	O	O
samples	O	O
compared	O	O
with	O	O
normal	O	O
oral	O	O
mucosa	O	O
.	O	O

Of	O	O
these	O	O
,	O	O
MDR1	O	O
promoter	O	O
methylation	O	O
associates	O	O
with	O	O
specific	O	O
microbiomic	O	O
profiles	O	O
in	O	O
tumor	O	O
over	O	O
normal	O	O
mucosa	O	O
.	O	O

Additionally	O	O
,	O	O
we	O	O
report	O	O
that	O	O
MDR1	O	O
methylation	O	O
correlates	O	O
with	O	O
regional	O	O
nodal	O	O
metastases	O	O
in	O	O
the	O	O
context	O	O
of	O	O
two	O	O
specific	O	O
bacterial	O	O
subpopulations	O	O
,	O	O
Enterobacteriaceae	B-bacteria	B-bacteria
and	O	O
Tenericutes	B-bacteria	B-bacteria
(	O	O
P	O	O
<	O	O
0.001	O	O
for	O	O
each	O	O
)	O	O
.	O	O

These	O	O
associations	O	O
may	O	O
lead	O	O
to	O	O
a	O	O
different	O	O
,	O	O
and	O	O
potentially	O	O
more	O	O
comprehensive	O	O
,	O	O
perspective	O	O
on	O	O
the	O	O
pathogenesis	O	O
of	O	O
HNSCC	O	O
,	O	O
and	O	O
support	O	O
further	O	O
exploration	O	O
of	O	O
mechanistic	O	O
linkage	O	O
and	O	O
,	O	O
if	O	O
so	O	O
,	O	O
novel	O	O
therapeutic	O	O
strategies	O	O
such	O	O
as	O	O
demethylating	O	O
agents	O	O
and	O	O
probiotic	O	O
adjuncts	O	O
,	O	O
particularly	O	O
for	O	O
patients	O	O
with	O	O
advanced	O	O
or	O	O
refractory	O	O
disease	O	O
.	O	O

The	O	O
dog	O	O
has	O	O
been	O	O
used	O	O
extensively	O	O
for	O	O
experimental	O	O
and	O	O
microbiological	O	O
studies	O	O
on	O	O
periodontitis	O	O
and	O	O
peri-implantitis	O	O
without	O	O
detailed	O	O
knowledge	O	O
about	O	O
the	O	O
predominant	O	O
flora	O	O
of	O	O
the	O	O
subgingival	O	O
plaque	O	O
.	O	O

This	O	O
study	O	O
was	O	O
designed	O	O
to	O	O
evaluate	O	O
the	O	O
predominant	O	O
cultivable	O	O
bacterial	O	O
species	O	O
in	O	O
dogs	O	O
and	O	O
compare	O	O
them	O	O
phenotypically	O	O
and	O	O
genotypically	O	O
with	O	O
corresponding	O	O
human	O	O
species	O	O
.	O	O

Four	O	O
subgingival	O	O
samples	O	O
were	O	O
taken	O	O
from	O	O
two	O	O
upper	O	O
premolars	O	O
in	O	O
each	O	O
of	O	O
six	O	O
Labrador	O	O
retrievers	O	O
.	O	O

The	O	O
samples	O	O
from	O	O
each	O	O
dog	O	O
were	O	O
processed	O	O
for	O	O
anaerobic	O	O
culture	O	O
.	O	O

From	O	O
the	O	O
samples	O	O
of	O	O
each	O	O
dog	O	O
,	O	O
the	O	O
five	O	O
or	O	O
six	O	O
predominating	O	O
bacteria	O	O
based	O	O
on	O	O
colony	O	O
morphology	O	O
were	O	O
selected	O	O
and	O	O
pure	O	O
cultured	O	O
.	O	O

Each	O	O
of	O	O
the	O	O
strains	O	O
was	O	O
characterized	O	O
by	O	O
Gram	O	O
stain	O	O
,	O	O
anaerobic/aerobic	O	O
growth	O	O
and	O	O
API-ZYM	O	O
test	O	O
.	O	O

Eighteen	O	O
strains	O	O
showing	O	O
clear-cut	O	O
phenotypic	O	O
differences	O	O
were	O	O
further	O	O
classified	O	O
based	O	O
on	O	O
DNA	O	O
sequencing	O	O
technology	O	O
.	O	O

Cross-reactions	O	O
of	O	O
DNA	O	O
probes	O	O
from	O	O
human	O	O
and	O	O
dog	O	O
strains	O	O
were	O	O
also	O	O
tested	O	O
against	O	O
a	O	O
panel	O	O
of	O	O
both	O	O
human	O	O
and	O	O
dog	O	O
bacterial	O	O
species	O	O
.	O	O

Thirty-one	O	O
strains	O	O
in	O	O
the	O	O
dogs	O	O
were	O	O
isolated	O	O
and	O	O
characterized	O	O
.	O	O

They	O	O
represented	O	O
21	O	O
different	O	O
species	O	O
,	O	O
of	O	O
which	O	O
six	O	O
belonged	O	O
to	O	O
the	O	O
genus	O	O
Porphyromonas	B-bacteria	B-bacteria
.	O	O

No	O	O
species	O	O
was	O	O
found	O	O
consistently	O	O
in	O	O
the	O	O
predominant	O	O
flora	O	O
of	O	O
all	O	O
six	O	O
dogs	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
crevioricanis	E-bacteria	I-bacteria
and	O	O
Fusobacterium	B-bacteria	B-bacteria
canifelinum	E-bacteria	I-bacteria
were	O	O
the	O	O
two	O	O
most	O	O
prevalent	O	O
species	O	O
in	O	O
predominant	O	O
flora	O	O
in	O	O
dogs	O	O
.	O	O

DNA	O	O
probes	O	O
from	O	O
human	O	O
and	O	O
dog	O	O
species	O	O
cross-reacted	O	O
to	O	O
some	O	O
extent	O	O
with	O	O
related	O	O
strains	O	O
from	O	O
humans	O	O
and	O	O
dogs	O	O
;	O	O
however	O	O
,	O	O
distinct	O	O
exceptions	O	O
were	O	O
found	O	O
.	O	O

The	O	O
predominant	O	O
cultural	O	O
subgingival	O	O
flora	O	O
in	O	O
dogs	O	O
shows	O	O
great	O	O
similarities	O	O
with	O	O
the	O	O
subgingival	O	O
bacteria	O	O
from	O	O
humans	O	O
at	O	O
the	O	O
genus	O	O
level	O	O
,	O	O
but	O	O
distinct	O	O
differences	O	O
at	O	O
the	O	O
species	O	O
level	O	O
;	O	O
however	O	O
,	O	O
a	O	O
genetic	O	O
relatedness	O	O
could	O	O
be	O	O
disclosed	O	O
for	O	O
most	O	O
strains	O	O
investigated	O	O
.	O	O

To	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
chewing	O	O
gums	O	O
containing	O	O
probiotic	O	O
bacteria	O	O
on	O	O
oral	O	O
malodour	O	O
.	O	O

The	O	O
null	O	O
hypothesis	O	O
was	O	O
that	O	O
no	O	O
difference	O	O
would	O	O
be	O	O
displayed	O	O
compared	O	O
with	O	O
placebo	O	O
gums	O	O
.	O	O

Twenty-five	O	O
healthy	O	O
young	O	O
adults	O	O
with	O	O
self-reported	O	O
malodorous	O	O
morning	O	O
breath	O	O
completed	O	O
this	O	O
randomized	O	O
double-blind	O	O
placebo-controlled	O	O
cross-over	O	O
trial	O	O
.	O	O

The	O	O
design	O	O
included	O	O
run-in	O	O
and	O	O
wash-out	O	O
periods	O	O
interspersed	O	O
by	O	O
two	O	O
intervention	O	O
periods	O	O
of	O	O
14	O	O
days	O	O
each	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
instructed	O	O
to	O	O
chew	O	O
one	O	O
gum	O	O
in	O	O
the	O	O
morning	O	O
and	O	O
one	O	O
in	O	O
the	O	O
evening	O	O
containing	O	O
either	O	O
two	O	O
strains	O	O
of	O	O
probiotic	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
L.	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
DSM	I-bacteria	I-bacteria
17938	E-bacteria	I-bacteria
and	O	O
L.	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
PTA	I-bacteria	I-bacteria
5289	E-bacteria	I-bacteria
)	O	O
or	O	O
placebo	O	O
.	O	O

The	O	O
outcome	O	O
measures	O	O
were	O	O
(	O	O
i	O	O
)	O	O
organoleptic	O	O
scores	O	O
(	O	O
0-5	O	O
)	O	O
by	O	O
a	O	O
certified	O	O
test	O	O
panel	O	O
,	O	O
(	O	O
ii	O	O
)	O	O
concentration	O	O
of	O	O
volatile	O	O
sulphur	O	O
compounds	O	O
(	O	O
VSC	O	O
)	O	O
measured	O	O
with	O	O
a	O	O
Halimeter	O	O
and	O	O
(	O	O
iii	O	O
)	O	O
concentration	O	O
of	O	O
VSC	O	O
after	O	O
a	O	O
cysteine	O	O
rinse	O	O
.	O	O

Registrations	O	O
were	O	O
made	O	O
at	O	O
baseline	O	O
and	O	O
after	O	O
each	O	O
intervention	O	O
period	O	O
.	O	O

Differences	O	O
between	O	O
the	O	O
groups	O	O
were	O	O
assessed	O	O
by	O	O
non-parametric	O	O
paired	O	O
statistics	O	O
and	O	O
chi-square	O	O
test	O	O
.	O	O

The	O	O
median	O	O
organoleptic	O	O
score	O	O
was	O	O
similar	O	O
(	O	O
score	O	O
2	O	O
)	O	O
in	O	O
both	O	O
groups	O	O
at	O	O
baseline	O	O
.	O	O

After	O	O
14	O	O
days	O	O
of	O	O
treatment	O	O
,	O	O
the	O	O
organoleptic	O	O
scores	O	O
were	O	O
significantly	O	O
lower	O	O
in	O	O
the	O	O
probiotic	O	O
group	O	O
compared	O	O
with	O	O
the	O	O
placebo	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Assessments	O	O
of	O	O
the	O	O
VSC	O	O
levels	O	O
displayed	O	O
no	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
groups	O	O
,	O	O
either	O	O
before	O	O
or	O	O
after	O	O
rinsing	O	O
with	O	O
L-cysteine	O	O
.	O	O

No	O	O
adverse	O	O
effects	O	O
were	O	O
registered	O	O
.	O	O

The	O	O
results	O	O
demonstrated	O	O
that	O	O
probiotic	O	O
chewing	O	O
gums	O	O
may	O	O
have	O	O
some	O	O
beneficial	O	O
effect	O	O
on	O	O
oral	O	O
malodour	O	O
assessed	O	O
by	O	O
organoleptic	O	O
scores	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
the	O	O
probiotic	O	O
gum	O	O
may	O	O
affect	O	O
bacteria	O	O
that	O	O
produce	O	O
malodourous	O	O
compounds	O	O
other	O	O
than	O	O
VSCs	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
have	O	O
been	O	O
associated	O	O
with	O	O
systemic	O	O
diseases	O	O
,	O	O
including	O	O
infective	O	O
endocarditis	O	O
and	O	O
neutropenic	O	O
bacteremia	O	O
.	O	O

We	O	O
analyzed	O	O
58	O	O
recent	O	O
oral	O	O
streptococcal	O	O
bloodstream	O	O
isolates	O	O
,	O	O
and	O	O
we	O	O
obtained	O	O
clinical	O	O
and	O	O
demographic	O	O
data	O	O
for	O	O
source	O	O
patients	O	O
.	O	O

The	O	O
sodA	O	O
gene	O	O
was	O	O
found	O	O
to	O	O
be	O	O
a	O	O
better	O	O
target	O	O
than	O	O
the	O	O
16S-23S	O	O
rRNA	O	O
internal	O	O
transcribed	O	O
spacer	O	O
for	O	O
DNA	O	O
sequence-based	O	O
species	O	O
identification	O	O
.	O	O

Together	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
were	O	O
significantly	O	O
more	O	O
likely	O	O
than	O	O
the	O	O
12	O	O
combined	O	O
remaining	O	O
species	O	O
to	O	O
be	O	O
isolated	O	O
from	O	O
neutropenic	O	O
patients	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
specific	O	O
parameters	O	O
of	O	O
low-level	O	O
laser	O	O
therapy	O	O
(	O	O
LLLT	O	O
)	O	O
on	O	O
biofilms	O	O
formed	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Candida	O	O
albicans	O	O
or	O	O
an	O	O
association	O	O
of	O	O
both	O	O
species	O	O
.	O	O

Single	O	O
and	O	O
dual-species	O	O
biofilms	O	O
--	O	O
SSB	O	O
and	O	O
DSB	O	O
--	O	O
were	O	O
exposed	O	O
to	O	O
laser	O	O
doses	O	O
of	O	O
5	O	O
,	O	O
10	O	O
or	O	O
20	O	O
J/cm	O	O
(	O	O
2	O	O
)	O	O
from	O	O
a	O	O
near	O	O
infrared	O	O
InGaAsP	O	O
diode	O	O
laser	O	O
prototype	O	O
(	O	O
LASERTable	O	O
;	O	O
780	O	O
+/-	O	O
3	O	O
nm	O	O
,	O	O
0.04	O	O
W	O	O
)	O	O
.	O	O

After	O	O
irradiation	O	O
,	O	O
the	O	O
analysis	O	O
of	O	O
biobilm	O	O
viability	O	O
(	O	O
MTT	O	O
assay	O	O
)	O	O
,	O	O
biofilm	O	O
growth	O	O
(	O	O
cfu/mL	O	O
)	O	O
and	O	O
cell	O	O
morphology	O	O
(	O	O
SEM	O	O
)	O	O
showed	O	O
that	O	O
LLLT	O	O
reduced	O	O
cell	O	O
viability	O	O
as	O	O
well	O	O
as	O	O
the	O	O
growth	O	O
of	O	O
biofilms	O	O
.	O	O

The	O	O
response	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
SSB	O	O
)	O	O
to	O	O
irradiation	O	O
was	O	O
similar	O	O
for	O	O
all	O	O
laser	O	O
doses	O	O
and	O	O
the	O	O
biofilm	O	O
growth	O	O
was	O	O
dose	O	O
dependent	O	O
.	O	O

However	O	O
,	O	O
when	O	O
associated	O	O
with	O	O
C.	O	O
albicans	O	O
(	O	O
DSB	O	O
)	O	O
,	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
resistant	O	O
to	O	O
LLLT	O	O
.	O	O

For	O	O
C.	O	O
albicans	O	O
,	O	O
the	O	O
association	O	O
with	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
DSB	O	O
)	O	O
caused	O	O
a	O	O
significant	O	O
decrease	O	O
in	O	O
biofilm	O	O
growth	O	O
in	O	O
a	O	O
dose-dependent	O	O
fashion	O	O
.	O	O

The	O	O
morphology	O	O
of	O	O
the	O	O
microorganisms	O	O
in	O	O
the	O	O
SSB	O	O
was	O	O
not	O	O
altered	O	O
by	O	O
LLLT	O	O
,	O	O
while	O	O
the	O	O
association	O	O
of	O	O
microbial	O	O
species	O	O
(	O	O
DSB	O	O
)	O	O
promoted	O	O
a	O	O
reduction	O	O
in	O	O
the	O	O
formation	O	O
of	O	O
C.	O	O
albicans	O	O
hyphae	O	O
.	O	O

LLLT	O	O
had	O	O
an	O	O
inhibitory	O	O
effect	O	O
on	O	O
the	O	O
microorganisms	O	O
,	O	O
and	O	O
this	O	O
capacity	O	O
can	O	O
be	O	O
altered	O	O
according	O	O
to	O	O
the	O	O
interactions	O	O
between	O	O
different	O	O
microbial	O	O
species	O	O
.	O	O

Oral	O	O
polymicrobial	O	O
interactions	O	O
and	O	O
biofilm	O	O
formation	O	O
are	O	O
associated	O	O
with	O	O
initiation	O	O
and	O	O
progression	O	O
of	O	O
caries	O	O
,	O	O
gingivitis	O	O
,	O	O
and	O	O
periodontitis	O	O
.	O	O

Transcriptome	O	O
studies	O	O
of	O	O
such	O	O
interactions	O	O
,	O	O
allowing	O	O
a	O	O
first	O	O
mechanistic	O	O
insight	O	O
,	O	O
are	O	O
hampered	O	O
by	O	O
current	O	O
single-species	O	O
array	O	O
designs	O	O
.	O	O

In	O	O
this	O	O
study	O	O
we	O	O
used	O	O
385	O	O
K	O	O
NimbleGene	O	O
technology	O	O
for	O	O
design	O	O
and	O	O
evaluation	O	O
of	O	O
an	O	O
array	O	O
covering	O	O
the	O	O
full	O	O
genomes	O	O
of	O	O
5	O	O
important	O	O
physiological-	O	O
,	O	O
cariogenic-	O	O
,	O	O
and	O	O
periodontitis-associated	O	O
microorganisms	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
)	O	O
.	O	O

Array	O	O
hybridization	O	O
was	O	O
done	O	O
with	O	O
cDNA	O	O
from	O	O
cultures	O	O
grown	O	O
for	O	O
24	O	O
h	O	O
anaerobically	O	O
.	O	O

Single	O	O
species	O	O
experiments	O	O
identified	O	O
cross-species	O	O
hybridizing	O	O
array	O	O
probes	O	O
.	O	O

These	O	O
probes	O	O
could	O	O
be	O	O
neglected	O	O
in	O	O
a	O	O
mixed-species	O	O
experimental	O	O
setting	O	O
without	O	O
the	O	O
need	O	O
to	O	O
exclude	O	O
the	O	O
whole	O	O
genes	O	O
from	O	O
the	O	O
analysis	O	O
.	O	O

Between	O	O
69	O	O
%	O	O
and	O	O
almost	O	O
99	O	O
%	O	O
of	O	O
the	O	O
genomes	O	O
were	O	O
actively	O	O
transcribed	O	O
under	O	O
the	O	O
mono-species	O	O
planktonic	O	O
,	O	O
monolayer	O	O
,	O	O
and	O	O
biofilm	O	O
conditions	O	O
.	O	O

The	O	O
influence	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
(	O	O
not	O	O
represented	O	O
on	O	O
the	O	O
array	O	O
)	O	O
on	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
gene	O	O
transcription	O	O
was	O	O
determined	O	O
as	O	O
a	O	O
test	O	O
for	O	O
a	O	O
dual-species	O	O
mixed	O	O
biofilm	O	O
setup	O	O
.	O	O

Phenotypically	O	O
,	O	O
under	O	O
the	O	O
influence	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
an	O	O
increase	O	O
in	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilm	O	O
mass	O	O
and	O	O
a	O	O
decrease	O	O
in	O	O
media	O	O
pH-value	O	O
were	O	O
noticed	O	O
,	O	O
thereby	O	O
confirming	O	O
previously	O	O
published	O	O
data	O	O
.	O	O

Employing	O	O
a	O	O
stringent	O	O
cut-off	O	O
(	O	O
2-fold	O	O
,	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
,	O	O
19	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
transcripts	O	O
were	O	O
identified	O	O
with	O	O
increased	O	O
abundance	O	O
,	O	O
and	O	O
11	O	O
with	O	O
decreased	O	O
abundance	O	O
compared	O	O
to	O	O
a	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
mono-species	O	O
biofilm	O	O
.	O	O

Several	O	O
of	O	O
these	O	O
genes	O	O
have	O	O
previously	O	O
been	O	O
found	O	O
differentially	O	O
regulated	O	O
under	O	O
general	O	O
and	O	O
acid	O	O
stress	O	O
,	O	O
thereby	O	O
confirming	O	O
the	O	O
value	O	O
of	O	O
this	O	O
array	O	O
.	O	O

This	O	O
new	O	O
array	O	O
allows	O	O
transcriptome	O	O
studies	O	O
on	O	O
multi-species	O	O
oral	O	O
biofilm	O	O
interactions	O	O
.	O	O

It	O	O
may	O	O
become	O	O
an	O	O
important	O	O
asset	O	O
in	O	O
future	O	O
oral	O	O
biofilm	O	O
and	O	O
inhibitor/therapy	O	O
studies	O	O
.	O	O

The	O	O
development	O	O
of	O	O
multispecies	O	O
oral	O	O
microbial	O	O
communities	O	O
involves	O	O
complex	O	O
intra-	O	O
and	O	O
interspecies	O	O
interactions	O	O
at	O	O
various	O	O
levels	O	O
.	O	O

The	O	O
ability	O	O
to	O	O
adhere	O	O
to	O	O
the	O	O
resident	O	O
bacteria	O	O
or	O	O
the	O	O
biofilm	O	O
matrix	O	O
and	O	O
overcome	O	O
community	O	O
resistance	O	O
are	O	O
among	O	O
the	O	O
key	O	O
factors	O	O
that	O	O
determine	O	O
whether	O	O
a	O	O
bacterium	O	O
can	O	O
integrate	O	O
into	O	O
a	O	O
community	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
is	O	O
a	O	O
prevalent	O	O
Gram-negative	O	O
oral	O	O
bacterial	O	O
species	O	O
that	O	O
is	O	O
able	O	O
to	O	O
adhere	O	O
to	O	O
a	O	O
variety	O	O
of	O	O
oral	O	O
microbes	O	O
and	O	O
has	O	O
been	O	O
implicated	O	O
in	O	O
playing	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
establishment	O	O
of	O	O
multispecies	O	O
oral	O	O
microbial	O	O
community	O	O
.	O	O

However	O	O
,	O	O
the	O	O
majority	O	O
of	O	O
experiments	O	O
thus	O	O
far	O	O
has	O	O
focused	O	O
on	O	O
the	O	O
physical	O	O
adherence	O	O
between	O	O
two	O	O
species	O	O
as	O	O
measured	O	O
by	O	O
in	O	O
vitro	O	O
co-aggregation	O	O
assays	O	O
,	O	O
while	O	O
the	O	O
community-based	O	O
effects	O	O
on	O	O
the	O	O
integration	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
into	O	O
multispecies	O	O
microbial	O	O
community	O	O
remains	O	O
to	O	O
be	O	O
investigated	O	O
.	O	O

In	O	O
this	O	O
,	O	O
we	O	O
focus	O	O
on	O	O
community	O	O
integration	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
.	O	O

We	O	O
demonstrated	O	O
using	O	O
an	O	O
established	O	O
in	O	O
vitro	O	O
mice	O	O
oral	O	O
microbiota	O	O
(	O	O
O-mix	O	O
)	O	O
that	O	O
the	O	O
viability	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
significantly	O	O
reduced	O	O
upon	O	O
addition	O	O
to	O	O
the	O	O
O-mix	O	O
due	O	O
to	O	O
cell	O	O
contact-dependent	O	O
induction	O	O
of	O	O
hydrogen	O	O
peroxide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
)	O	O
production	O	O
by	O	O
oral	O	O
community	O	O
.	O	O

Interestingly	O	O
,	O	O
this	O	O
inhibitory	O	O
effect	O	O
was	O	O
significantly	O	O
alleviated	O	O
when	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
allowed	O	O
to	O	O
adhere	O	O
to	O	O
its	O	O
known	O	O
interacting	O	O
partner	O	O
species	O	O
(	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
)	O	O
prior	O	O
to	O	O
addition	O	O
.	O	O

Furthermore	O	O
,	O	O
this	O	O
aggregate	O	O
formation-dependent	O	O
protection	O	O
was	O	O
absent	O	O
in	O	O
the	O	O
F.	B-bacteria	B-bacteria
nucleatum	I-bacteria	I-bacteria
mutant	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
DeltaFn1526	E-bacteria	I-bacteria
that	O	O
is	O	O
unable	O	O
to	O	O
bind	O	O
to	O	O
a	O	O
number	O	O
of	O	O
Gram-positive	O	O
species	O	O
.	O	O

More	O	O
importantly	O	O
,	O	O
this	O	O
protective	O	O
effect	O	O
was	O	O
also	O	O
observed	O	O
during	O	O
integration	O	O
of	O	O
F.	O	O
nucleatum	O	O
into	O	O
a	O	O
human	O	O
salivary	O	O
microbial	O	O
community	O	O
(	O	O
S-mix	O	O
)	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
by	O	O
adhering	O	O
to	O	O
other	O	O
oral	O	O
microbes	O	O
,	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
is	O	O
able	O	O
to	O	O
mask	O	O
the	O	O
surface	O	O
components	O	O
that	O	O
are	O	O
recognized	O	O
by	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
producing	O	O
oral	O	O
community	O	O
members	O	O
.	O	O

This	O	O
evasion	O	O
strategy	O	O
prevents	O	O
detection	O	O
by	O	O
antagonistic	O	O
oral	O	O
bacteria	O	O
and	O	O
allows	O	O
integration	O	O
into	O	O
the	O	O
developing	O	O
oral	O	O
microbial	O	O
community	O	O
.	O	O

Salmonella	B-bacteria	B-bacteria
enterica	I-bacteria	I-bacteria
serovar	I-bacteria	I-bacteria
Choleraesuis	E-bacteria	I-bacteria
(	O	O
S.	B-bacteria	B-bacteria
Choleraesuis	E-bacteria	I-bacteria
)	O	O
is	O	O
a	O	O
highly	O	O
invasive	O	O
zoonotic	O	O
pathogen	O	O
that	O	O
causes	O	O
bacteremia	O	O
in	O	O
humans	O	O
and	O	O
pigs	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
S.	B-bacteria	B-bacteria
Choleraesuis	E-bacteria	I-bacteria
in	O	O
man	O	O
has	O	O
gradually	O	O
decreased	O	O
since	O	O
the	O	O
outbreak	O	O
of	O	O
foot	O	O
and	O	O
mouth	O	O
disease	O	O
in	O	O
pigs	O	O
in	O	O
1997	O	O
in	O	O
southern	O	O
Taiwan	O	O
.	O	O

The	O	O
goal	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
change	O	O
in	O	O
prevalence	O	O
of	O	O
S.	B-bacteria	B-bacteria
Choleraesuis	E-bacteria	I-bacteria
carrying	O	O
the	O	O
virulence	O	O
plasmid	O	O
(	O	O
pSCV	O	O
)	O	O
in	O	O
human	O	O
and	O	O
swine	O	O
isolates	O	O
collected	O	O
in	O	O
1995-2005	O	O
and	O	O
characterize	O	O
these	O	O
.	O	O

380	O	O
isolates	O	O
were	O	O
collected	O	O
from	O	O
human	O	O
and	O	O
swine	O	O
blood	O	O
samples	O	O
.	O	O

Large	O	O
pSCVs	O	O
were	O	O
determined	O	O
by	O	O
PCR	O	O
and	O	O
Southern	O	O
blot	O	O
analysis	O	O
.	O	O

Antimicrobial	O	O
susceptibility	O	O
and	O	O
resistance	O	O
genes	O	O
,	O	O
and	O	O
the	O	O
phylogenetic	O	O
association	O	O
of	O	O
these	O	O
large	O	O
pSCV	O	O
were	O	O
analyzed	O	O
.	O	O

The	O	O
number	O	O
of	O	O
isolates	O	O
harboring	O	O
the	O	O
large	O	O
pSCV	O	O
was	O	O
significantly	O	O
reduced	O	O
,	O	O
and	O	O
their	O	O
prevalence	O	O
differed	O	O
between	O	O
human	O	O
and	O	O
swine	O	O
isolates	O	O
.	O	O

These	O	O
large	O	O
pSCVs	O	O
were	O	O
a	O	O
recombinant	O	O
of	O	O
original	O	O
50-kb	O	O
pSCV	O	O
and	O	O
R	O	O
plasmid	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
some	O	O
large	O	O
pSCVs	O	O
lacked	O	O
two	O	O
pSCV-specific	O	O
deletion	O	O
regions	O	O
from	O	O
pef	O	O
to	O	O
repC	O	O
and	O	O
from	O	O
traT	O	O
to	O	O
samA	O	O
.	O	O

These	O	O
large	O	O
pSCVs	O	O
carried	O	O
the	O	O
resistance	O	O
genes	O	O
bla	O	O
(	O	O
TEM	O	O
,	O	O
)	O	O
aadA2	O	O
,	O	O
and	O	O
sulI	O	O
,	O	O
as	O	O
well	O	O
as	O	O
class	O	O
I	O	O
integrons	O	O
of	O	O
0.65	O	O
and/or	O	O
1.9	O	O
kb	O	O
in	O	O
size	O	O
,	O	O
but	O	O
were	O	O
inconjugatible	O	O
.	O	O

Phylogenetic	O	O
analysis	O	O
demonstrated	O	O
that	O	O
the	O	O
large	O	O
pSCV	O	O
evolves	O	O
independently	O	O
in	O	O
human	O	O
and	O	O
swine	O	O
isolates	O	O
.	O	O

S.	B-bacteria	B-bacteria
Choleraesuis	E-bacteria	I-bacteria
with	O	O
large	O	O
pSCV	O	O
was	O	O
significantly	O	O
reduced	O	O
after	O	O
the	O	O
foot	O	O
and	O	O
mouth	O	O
disease	O	O
outbreak	O	O
and	O	O
may	O	O
evolve	O	O
in	O	O
human	O	O
and	O	O
swine	O	O
specific	O	O
isolates	O	O
.	O	O

White	O	O
Sponge	O	O
Nevus	O	O
(	O	O
WSN	O	O
)	O	O
is	O	O
a	O	O
rare	O	O
pathology	O	O
with	O	O
a	O	O
pathogenesis	O	O
on	O	O
genetic	O	O
basis	O	O
,	O	O
a	O	O
benign	O	O
course	O	O
and	O	O
a	O	O
localization	O	O
affecting	O	O
the	O	O
mucosal	O	O
keratin.	O	O

WSN	O	O
is	O	O
usually	O	O
a	O	O
symptomless	O	O
pathology	O	O
:	O	O
when	O	O
pain	O	O
is	O	O
present	O	O
,	O	O
some	O	O
authors	O	O
reported	O	O
reduction	O	O
of	O	O
symptoms	O	O
by	O	O
taking	O	O
penicillin	O	O
or	O	O
oral	O	O
tetracycline	O	O
rinses	O	O
,	O	O
suggesting	O	O
that	O	O
a	O	O
bacterial	O	O
overinfection	O	O
could	O	O
be	O	O
at	O	O
the	O	O
base	O	O
of	O	O
possible	O	O
painful	O	O
symptoms	O	O
.	O	O

We	O	O
describe	O	O
2	O	O
patients	O	O
affected	O	O
by	O	O
WSN	O	O
,	O	O
father	O	O
and	O	O
son	O	O
:	O	O
they	O	O
presented	O	O
two	O	O
different	O	O
oral	O	O
diseases	O	O
associated	O	O
with	O	O
an	O	O
infection	O	O
by	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

So	O	O
,	O	O
we	O	O
have	O	O
performed	O	O
a	O	O
careful	O	O
oral	O	O
hygiene	O	O
to	O	O
reduce	O	O
infection	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
the	O	O
following	O	O
days	O	O
we	O	O
prescribed	O	O
2	O	O
rinses	O	O
a	O	O
day	O	O
with	O	O
a	O	O
mouthwash	O	O
containing	O	O
chlorhexidine	O	O
digluconate	O	O
at	O	O
two	O	O
different	O	O
percentages	O	O
.	O	O

Early	O	O
diagnosis	O	O
of	O	O
this	O	O
lesion	O	O
is	O	O
important	O	O
,	O	O
because	O	O
it	O	O
allows	O	O
us	O	O
to	O	O
exclude	O	O
other	O	O
more	O	O
serious	O	O
diseases	O	O
.	O	O

In	O	O
the	O	O
most	O	O
part	O	O
of	O	O
cases	O	O
,	O	O
WSN	O	O
requires	O	O
no	O	O
treatment	O	O
because	O	O
of	O	O
its	O	O
benign	O	O
and	O	O
asymptomatic	O	O
behaviour	O	O
:	O	O
up	O	O
to	O	O
now	O	O
,	O	O
no	O	O
protocol	O	O
of	O	O
treatment	O	O
for	O	O
this	O	O
condition	O	O
was	O	O
standardized	O	O
.	O	O

Even	O	O
if	O	O
WSN	O	O
is	O	O
a	O	O
painless	O	O
condition	O	O
,	O	O
sometime	O	O
a	O	O
correlated	O	O
painful	O	O
symptomatology	O	O
was	O	O
reported	O	O
.	O	O

In	O	O
our	O	O
experience	O	O
,	O	O
we	O	O
have	O	O
achieved	O	O
excellent	O	O
results	O	O
even	O	O
with	O	O
chlorhexidine	O	O
digluconate	O	O
rinses	O	O
,	O	O
considering	O	O
that	O	O
our	O	O
treated	O	O
cases	O	O
were	O	O
both	O	O
infected	O	O
by	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

We	O	O
hypothesize	O	O
that	O	O
the	O	O
corrugated	O	O
plaques	O	O
and	O	O
the	O	O
altered	O	O
texture	O	O
of	O	O
the	O	O
mucosa	O	O
create	O	O
the	O	O
right	O	O
conditions	O	O
for	O	O
the	O	O
colonization	O	O
and	O	O
the	O	O
development	O	O
of	O	O
microbial	O	O
species	O	O
such	O	O
as	O	O
saprophytic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
or	O	O
fungal	O	O
species	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
metabolize	O	O
carbohydrates	O	O
,	O	O
such	O	O
as	O	O
glucose	O	O
and	O	O
sucrose	O	O
,	O	O
to	O	O
produce	O	O
acid	O	O
and	O	O
enhance	O	O
biofilm	O	O
formation	O	O
with	O	O
the	O	O
early	O	O
colonizing	O	O
bacteria	O	O
to	O	O
induce	O	O
dental	O	O
caries	O	O
.	O	O

Xylitol	O	O
has	O	O
been	O	O
used	O	O
as	O	O
a	O	O
reliable	O	O
substitute	O	O
for	O	O
carbohydrate	O	O
to	O	O
inhibit	O	O
the	O	O
acid	O	O
production	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

However	O	O
,	O	O
long-term	O	O
xylitol	O	O
consumption	O	O
leads	O	O
to	O	O
the	O	O
emergence	O	O
of	O	O
xylitol-resistance	O	O
in	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
cariogenic	O	O
trait	O	O
of	O	O
Xylitol-resistant	O	O
(	O	O
X	O	O
(		O	O
R	O	O
)	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
using	O	O
biofilm	O	O
formation	O	O
and	O	O
coaggregation	O	O
of	O	O
xylitol-sensitive	O	O
(	O	O
X	O	O
(	O	O
S	O	O
)	O	O
)	O	O
and	O	O
X	O	O
(	O	O
R	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
with	O	O
salivary	O	O
bacteria	O	O
and	O	O
their	O	O
glucosyltransferases	O	O
expression	O	O
.	O	O

When	O	O
X	O	O
(	O	O
S	O	O
)	O	O
or	O	O
X	O	O
(	O	O
R	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
incubated	O	O
in	O	O
brain	O	O
heart	O	O
infusion	O	O
broth	O	O
with	O	O
bacteria	O	O
from	O	O
human	O	O
saliva	O	O
,	O	O
X	O	O
(	O	O
R	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
exhibited	O	O
reduction	O	O
in	O	O
biofilm	O	O
formation	O	O
in	O	O
comparison	O	O
to	O	O
X	O	O
(	O	O
S	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

The	O	O
coaggregation	O	O
between	O	O
X	O	O
(	O	O
R	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
S	B-bacteria	B-bacteria
,	I-bacteria	I-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
or	O	O
S.	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
was	O	O
less	O	O
pronounced	O	O
than	O	O
that	O	O
of	O	O
X	O	O
(	O	O
S	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
the	O	O
presence	O	O
of	O	O
sucrose	O	O
.	O	O

However	O	O
,	O	O
there	O	O
was	O	O
no	O	O
difference	O	O
in	O	O
the	O	O
coaggregation	O	O
between	O	O
X	O	O
(	O	O
R	O	O
)	O	O
and	O	O
X	O	O
(	O	O
S	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
the	O	O
sucrose-free	O	O
condition	O	O
.	O	O

The	O	O
level	O	O
of	O	O
gtfB	O	O
and	O	O
gtfC	O	O
mRNA	O	O
expression	O	O
of	O	O
X	O	O
(	O	O
R	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
X	O	O
(	O	O
S	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
whilst	O	O
the	O	O
level	O	O
of	O	O
gtfD	O	O
mRNA	O	O
expression	O	O
did	O	O
not	O	O
differ	O	O
between	O	O
the	O	O
two	O	O
strains	O	O
.	O	O

The	O	O
reduction	O	O
of	O	O
biofilm	O	O
formation	O	O
in	O	O
X	O	O
(	O	O
S	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
due	O	O
to	O	O
decrease	O	O
in	O	O
glucosyltransferases	O	O
expression	O	O
suggests	O	O
that	O	O
X	O	O
(	O	O
R	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
may	O	O
be	O	O
less	O	O
cariogenic	O	O
than	O	O
X	O	O
(	O	O
S	O	O
)	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

The	O	O
present	O	O
investigation	O	O
aimed	O	O
to	O	O
analyse	O	O
clinical	O	O
and	O	O
microbiological	O	O
effects	O	O
of	O	O
systemic	O	O
administration	O	O
of	O	O
metronidazole	O	O
and	O	O
amoxicillin	O	O
combined	O	O
with	O	O
the	O	O
One-Stage-Full-Mouth-Disinfection	O	O
protocol	O	O
(	O	O
OSFMD	O	O
)	O	O
in	O	O
generalized	O	O
aggressive	O	O
periodontitis	O	O
patients	O	O
(	O	O
G-AgP	O	O
)	O	O
.	O	O

Thirty-nine	O	O
systemically	O	O
healthy	O	O
patients	O	O
with	O	O
G-AgP	O	O
were	O	O
consecutively	O	O
included	O	O
.	O	O

The	O	O
test	O	O
group	O	O
(	O	O
n	O	O
=	O	O
19	O	O
)	O	O
received	O	O
amoxicillin-metronidazole	O	O
combination	O	O
(	O	O
500	O	O
mg	O	O
of	O	O
each	O	O
,	O	O
three	O	O
times	O	O
a	O	O
day	O	O
for	O	O
7	O	O
days	O	O
)	O	O
and	O	O
the	O	O
OSFMD	O	O
,	O	O
the	O	O
control	O	O
group	O	O
(	O	O
n	O	O
=	O	O
20	O	O
)	O	O
received	O	O
the	O	O
OSFMD	O	O
and	O	O
a	O	O
placebo	O	O
.	O	O

In	O	O
addition	O	O
to	O	O
clinical	O	O
parameters	O	O
subgingival	O	O
plaque	O	O
samples	O	O
from	O	O
moderate	O	O
(	O	O
4-5	O	O
mm	O	O
)	O	O
and	O	O
deep	O	O
(	O	O
>	O	O
/=	O	O
6	O	O
mm	O	O
)	O	O
pocket	O	O
sites	O	O
were	O	O
analysed	O	O
for	O	O
the	O	O
presence	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
,	O	O
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
using	O	O
polymerase	O	O
chain	O	O
reaction	O	O
.	O	O

Both	O	O
therapies	O	O
led	O	O
to	O	O
a	O	O
statistically	O	O
significant	O	O
decrease	O	O
in	O	O
clinical	O	O
and	O	O
microbiological	O	O
parameters	O	O
compared	O	O
to	O	O
baseline	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
most	O	O
beneficial	O	O
changes	O	O
were	O	O
observed	O	O
in	O	O
the	O	O
test	O	O
group	O	O
which	O	O
showed	O	O
significantly	O	O
greater	O	O
improvements	O	O
in	O	O
probing	O	O
depth	O	O
and	O	O
clinical	O	O
attachment	O	O
level	O	O
and	O	O
a	O	O
lower	O	O
prevalence	O	O
of	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
,	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
,	O	O
and	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	E-bacteria	I-bacteria
compared	O	O
to	O	O
the	O	O
control	O	O
one	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Systemic	O	O
administration	O	O
of	O	O
metronidazole	O	O
and	O	O
amoxicillin	O	O
as	O	O
an	O	O
adjunct	O	O
to	O	O
OSFMD	O	O
therapy	O	O
significantly	O	O
improved	O	O
clinical	O	O
and	O	O
microbiological	O	O
outcomes	O	O
in	O	O
patients	O	O
with	O	O
G-AgP	O	O
over	O	O
a	O	O
6-month	O	O
period	O	O
.	O	O

As	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
regarded	O	O
as	O	O
a	O	O
relevant	O	O
site	O	O
for	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
colonization	O	O
and	O	O
interhuman	O	O
transmission	O	O
,	O	O
this	O	O
study	O	O
aimed	O	O
to	O	O
investigate	O	O
whether	O	O
different	O	O
oral	O	O
conditions	O	O
influence	O	O
the	O	O
rates	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
oral	O	O
carriage	O	O
and	O	O
genetic	O	O
characters	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
.	O	O

Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
searched	O	O
in	O	O
samples	O	O
collected	O	O
from	O	O
cheek	O	O
,	O	O
gingival	O	O
margin	O	O
,	O	O
and	O	O
anterior	O	O
nares	O	O
of	O	O
45	O	O
healthy	O	O
subjects	O	O
,	O	O
27	O	O
periodontitis	O	O
affected	O	O
subjects	O	O
,	O	O
and	O	O
29	O	O
subjects	O	O
with	O	O
fixed	O	O
prosthetic	O	O
restorations	O	O
.	O	O

Isolates	O	O
were	O	O
screened	O	O
for	O	O
17	O	O
genetic	O	O
determinants	O	O
,	O	O
and	O	O
Partial	O	O
Least	O	O
Square	O	O
Discriminant	O	O
Analysis	O	O
was	O	O
performed	O	O
to	O	O
evaluate	O	O
whether	O	O
specific	O	O
characters	O	O
correlated	O	O
with	O	O
oral	O	O
condition	O	O
or	O	O
site	O	O
of	O	O
isolation	O	O
.	O	O

The	O	O
three	O	O
subject	O	O
groups	O	O
showed	O	O
comparable	O	O
nasal	O	O
carriage	O	O
rates	O	O
but	O	O
,	O	O
both	O	O
the	O	O
periodontitis	O	O
and	O	O
prosthetic	O	O
restoration	O	O
groups	O	O
showed	O	O
significantly	O	O
higher	O	O
oral	O	O
carriage	O	O
rates	O	O
,	O	O
as	O	O
compared	O	O
to	O	O
healthy	O	O
subjects	O	O
(	O	O
P	O	O
=	O	O
0.01	O	O
and	O	O
0.02	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

Moreover	O	O
,	O	O
periodontitis	O	O
affected	O	O
subjects	O	O
hosted	O	O
strains	O	O
possessing	O	O
a	O	O
distinct	O	O
genotypic	O	O
and	O	O
phenotypic	O	O
background	O	O
,	O	O
characterized	O	O
by	O	O
the	O	O
presence	O	O
of	O	O
a	O	O
larger	O	O
number	O	O
of	O	O
exotoxins	O	O
encoding	O	O
genes	O	O
.	O	O

These	O	O
data	O	O
confirm	O	O
that	O	O
the	O	O
oral	O	O
cavity	O	O
is	O	O
an	O	O
important	O	O
site	O	O
of	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
colonization	O	O
and	O	O
demonstrate	O	O
that	O	O
conditions	O	O
modifying	O	O
the	O	O
oral	O	O
environment	O	O
,	O	O
as	O	O
the	O	O
presence	O	O
of	O	O
periodontitis	O	O
and	O	O
of	O	O
fixed	O	O
prosthetic	O	O
restorations	O	O
,	O	O
promote	O	O
S.	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
carriage	O	O
and	O	O
may	O	O
favor	O	O
the	O	O
spread	O	O
of	O	O
more	O	O
pathogenic	O	O
strains	O	O
.	O	O

A	O	O
low	O	O
pH	O	O
environment	O	O
is	O	O
created	O	O
by	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

This	O	O
study	O	O
was	O	O
aimed	O	O
to	O	O
measure	O	O
pH	O	O
of	O	O
carious	O	O
lesions	O	O
intraorally	O	O
using	O	O
a	O	O
micro-pH	O	O
sensor	O	O
,	O	O
and	O	O
assess	O	O
predominant	O	O
acid-producing	O	O
cariogens	O	O
by	O	O
qPCR	O	O
to	O	O
differentiate	O	O
caries	O	O
activities	O	O
.	O	O

103	O	O
dentine	O	O
lesions	O	O
classified	O	O
as	O	O
active	O	O
or	O	O
arrested	O	O
caries	O	O
based	O	O
on	O	O
the	O	O
clinical	O	O
and	O	O
radiological	O	O
examinations	O	O
were	O	O
collected	O	O
from	O	O
patients	O	O
after	O	O
intraoral	O	O
measurement	O	O
of	O	O
the	O	O
lesion	O	O
surface	O	O
pH	O	O
using	O	O
a	O	O
micro-pH	O	O
sensor	O	O
.	O	O

Quantitative	O	O
detection	O	O
of	O	O
genomic	O	O
DNA	O	O
copies	O	O
of	O	O
target	O	O
cariogenic	O	O
bacteria	O	O
(	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
and	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
)	O	O
in	O	O
each	O	O
lesion	O	O
was	O	O
performed	O	O
using	O	O
real-time	O	O
PCR	O	O
.	O	O

Correlation	O	O
between	O	O
the	O	O
pH	O	O
ranges	O	O
and	O	O
the	O	O
number	O	O
of	O	O
bacterial	O	O
species	O	O
was	O	O
examined	O	O
by	O	O
Spearman	O	O
test	O	O
.	O	O

50	O	O
samples	O	O
were	O	O
diagnosed	O	O
as	O	O
active	O	O
and	O	O
53	O	O
as	O	O
arrested	O	O
lesions	O	O
.	O	O

Statistically	O	O
significant	O	O
difference	O	O
was	O	O
observed	O	O
on	O	O
average	O	O
surface	O	O
pH	O	O
value	O	O
between	O	O
active	O	O
and	O	O
arrested	O	O
lesions	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Prevalence	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
was	O	O
higher	O	O
in	O	O
active	O	O
lesions	O	O
than	O	O
in	O	O
arrested	O	O
lesions	O	O
(	O	O
76	O	O
%	O	O
vs.	O	O
58	O	O
%	O	O
of	O	O
samples	O	O
,	O	O
respectively	O	O
)	O	O
.	O	O

When	O	O
the	O	O
carious	O	O
lesions	O	O
were	O	O
categorised	O	O
into	O	O
four	O	O
different	O	O
pH	O	O
ranges	O	O
(	O	O
up	O	O
to	O	O
5.5	O	O
,	O	O
from	O	O
5.6	O	O
to	O	O
5.8	O	O
,	O	O
from	O	O
5.9	O	O
to	O	O
6.1	O	O
and	O	O
6.2	O	O
or	O	O
above	O	O
)	O	O
,	O	O
increased	O	O
prevalence	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
was	O	O
observed	O	O
with	O	O
decrease	O	O
of	O	O
pH	O	O
levels	O	O
.	O	O

A	O	O
significant	O	O
negative	O	O
relationship	O	O
was	O	O
found	O	O
between	O	O
pH	O	O
value	O	O
and	O	O
number	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
(	O	O
r=-0.209	O	O
,	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
but	O	O
no	O	O
such	O	O
correlation	O	O
was	O	O
found	O	O
for	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
.	O	O

Intraoral	O	O
pH	O	O
measurement	O	O
might	O	O
be	O	O
clinically	O	O
useful	O	O
to	O	O
determine	O	O
acidity	O	O
of	O	O
the	O	O
local	O	O
environment	O	O
of	O	O
carious	O	O
lesions	O	O
as	O	O
one	O	O
aspect	O	O
of	O	O
the	O	O
caries	O	O
activity	O	O
assessment	O	O
.	O	O

The	O	O
population	O	O
of	O	O
certain	O	O
bacteria	O	O
may	O	O
indicate	O	O
activity	O	O
of	O	O
carious	O	O
lesions	O	O
.	O	O

Intraoral	O	O
pH	O	O
measurement	O	O
of	O	O
the	O	O
carious	O	O
lesions	O	O
using	O	O
a	O	O
micro-pH	O	O
sensor	O	O
may	O	O
be	O	O
a	O	O
clinically	O	O
feasible	O	O
method	O	O
for	O	O
assessment	O	O
of	O	O
lesion	O	O
acidity	O	O
.	O	O

One	O	O
of	O	O
the	O	O
major	O	O
components	O	O
of	O	O
dental	O	O
polymerized	O	O
resin-based	O	O
restorative	O	O
materials	O	O
is	O	O
2-hydroxyethyl	O	O
methacrylate	O	O
(	O	O
HEMA	O	O
)	O	O
and	O	O
its	O	O
release	O	O
in	O	O
monomeric	O	O
form	O	O
interferes	O	O
with	O	O
the	O	O
oral	O	O
cavity	O	O
environment	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
evaluate	O	O
HEMA	O	O
monomeric	O	O
effects	O	O
on	O	O
the	O	O
co-culture	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
and	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
(	O	O
HGFs	O	O
)	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
DS12	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
6249	E-bacteria	I-bacteria
were	O	O
co-cultivated	O	O
with	O	O
HGF	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
HEMA	O	O
(	O	O
3	O	O
mM	O	O
)	O	O
,	O	O
for	O	O
48	O	O
and	O	O
72	O	O
h	O	O
;	O	O
the	O	O
amount	O	O
of	O	O
sessile	O	O
and	O	O
planktonic	O	O
cells	O	O
,	O	O
as	O	O
well	O	O
as	O	O
the	O	O
prokaryotic	O	O
and	O	O
eukaryotic	O	O
cell	O	O
viability	O	O
were	O	O
analyzed	O	O
in	O	O
treated	O	O
and	O	O
untreated	O	O
samples	O	O
.	O	O

The	O	O
treatment	O	O
of	O	O
S.	B-bacteria	B-bacteria
mitis/HGFs	E-bacteria	I-bacteria
with	O	O
HEMA	O	O
did	O	O
not	O	O
produce	O	O
significant	O	O
effects	O	O
on	O	O
the	O	O
bacterial	O	O
adhesion	O	O
and	O	O
induced	O	O
an	O	O
increase	O	O
in	O	O
planktonic	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
6249	E-bacteria	I-bacteria
population	O	O
after	O	O
48	O	O
and	O	O
72	O	O
h.	O	O
HEMA	O	O
increased	O	O
significantly	O	O
the	O	O
planktonic	O	O
S.	B-bacteria	B-bacteria
mitis	I-bacteria	I-bacteria
ATCC	I-bacteria	I-bacteria
6249	E-bacteria	I-bacteria
viability	O	O
when	O	O
co-cultured	O	O
with	O	O
HGFs	O	O
,	O	O
while	O	O
a	O	O
cytotoxic	O	O
effect	O	O
on	O	O
HGFs	O	O
,	O	O
without	O	O
bacteria	O	O
,	O	O
was	O	O
recorded	O	O
.	O	O

An	O	O
increase	O	O
of	O	O
bacterial	O	O
aggregation	O	O
on	O	O
HGFs	O	O
was	O	O
also	O	O
detected	O	O
with	O	O
HEMA	O	O
.	O	O

Data	O	O
obtained	O	O
in	O	O
this	O	O
study	O	O
suggest	O	O
that	O	O
HEMA	O	O
exhibits	O	O
a	O	O
toxic	O	O
effect	O	O
mainly	O	O
on	O	O
eukaryotic	O	O
cells	O	O
and	O	O
this	O	O
effect	O	O
can	O	O
be	O	O
modulated	O	O
by	O	O
co-cultivation	O	O
with	O	O
the	O	O
S.	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
cells	O	O
which	O	O
,	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
the	O	O
monomer	O	O
,	O	O
enhance	O	O
their	O	O
aggregation	O	O
rate	O	O
on	O	O
HGFs	O	O
.	O	O

A	O	O
well-known	O	O
indication	O	O
for	O	O
the	O	O
cytologic	O	O
examination	O	O
of	O	O
bronchoalveolar	O	O
lavage	O	O
(	O	O
BAL	O	O
)	O	O
fluid	O	O
is	O	O
the	O	O
identification	O	O
of	O	O
infectious	O	O
organisms	O	O
.	O	O

However	O	O
,	O	O
an	O	O
important	O	O
distinction	O	O
must	O	O
be	O	O
made	O	O
as	O	O
to	O	O
whether	O	O
the	O	O
organisms	O	O
seen	O	O
represent	O	O
a	O	O
true	O	O
opportunistic	O	O
lower	O	O
respiratory	O	O
tract	O	O
infection	O	O
or	O	O
a	O	O
non-pathologic	O	O
contamination	O	O
.	O	O

We	O	O
describe	O	O
herein	O	O
the	O	O
case	O	O
of	O	O
a	O	O
13-month-old	O	O
male	O	O
infant	O	O
who	O	O
presented	O	O
with	O	O
persistent	O	O
chest	O	O
congestion	O	O
and	O	O
tracheobronchitis	O	O
and	O	O
who	O	O
underwent	O	O
BAL	O	O
as	O	O
part	O	O
of	O	O
his	O	O
clinical	O	O
work-up	O	O
.	O	O

On	O	O
cytological	O	O
examination	O	O
of	O	O
the	O	O
BAL	O	O
fluid	O	O
,	O	O
the	O	O
Romanowsky-stained	O	O
cytospin	O	O
slides	O	O
contained	O	O
numerous	O	O
squamous	O	O
epithelial	O	O
cells	O	O
with	O	O
some	O	O
showing	O	O
rare	O	O
striated	O	O
rod-like	O	O
structures	O	O
on	O	O
their	O	O
surfaces	O	O
.	O	O

The	O	O
peculiar	O	O
structures	O	O
also	O	O
had	O	O
rounded	O	O
ends	O	O
and	O	O
were	O	O
very	O	O
large	O	O
when	O	O
compared	O	O
to	O	O
adjacent	O	O
known	O	O
bacterial	O	O
cocci	O	O
.	O	O

We	O	O
have	O	O
determined	O	O
that	O	O
the	O	O
striated	O	O
rod-like	O	O
structures	O	O
in	O	O
the	O	O
infant	O	O
's	O	O
BAL	O	O
fluid	O	O
were	O	O
indeed	O	O
bacteria	O	O
,	O	O
Simonsiella	B-bacteria	B-bacteria
sp	E-bacteria	I-bacteria
.	O	O

Simonsiella	B-bacteria	B-bacteria
has	O	O
reportedly	O	O
been	O	O
found	O	O
in	O	O
up	O	O
to	O	O
32	O	O
%	O	O
of	O	O
oral	O	O
swabs	O	O
in	O	O
normal	O	O
humans	O	O
and	O	O
it	O	O
is	O	O
considered	O	O
a	O	O
commensal	O	O
and	O	O
non-pathogenic	O	O
organism	O	O
.	O	O

The	O	O
characteristically	O	O
large	O	O
size	O	O
,	O	O
the	O	O
association	O	O
with	O	O
normal	O	O
oral-derived	O	O
squamous	O	O
cells	O	O
and	O	O
the	O	O
striated	O	O
appearance	O	O
is	O	O
diagnostic	O	O
and	O	O
will	O	O
hopefully	O	O
eliminate	O	O
any	O	O
possibility	O	O
of	O	O
confusion	O	O
with	O	O
a	O	O
truly	O	O
pathogenic	O	O
organism	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
gingival	O	O
fluid	O	O
(	O	O
GCF	O	O
)	O	O
cytokine	O	O
messenger	O	O
RNA	O	O
(	O	O
mRNA	O	O
)	O	O
levels	O	O
,	O	O
subgingival	O	O
bacteria	O	O
,	O	O
and	O	O
clinical	O	O
periodontal	O	O
conditions	O	O
during	O	O
a	O	O
normal	O	O
pregnancy	O	O
to	O	O
postpartum	O	O
.	O	O

Subgingival	O	O
bacterial	O	O
samples	O	O
were	O	O
analyzed	O	O
with	O	O
the	O	O
checkerboard	O	O
DNA-DNA	O	O
hybridization	O	O
method	O	O
.	O	O

GCF	O	O
samples	O	O
were	O	O
assessed	O	O
with	O	O
real-time	O	O
PCR	O	O
including	O	O
five	O	O
proinflammatory	O	O
cytokines	O	O
and	O	O
secretory	O	O
leukocyte	O	O
protease	O	O
inhibitor	O	O
.	O	O

Nineteen	O	O
pregnant	O	O
women	O	O
with	O	O
a	O	O
mean	O	O
age	O	O
of	O	O
32	O	O
years	O	O
(	O	O
S.D	O	O
.	O	O

+/-	O	O
4	O	O
years	O	O
,	O	O
range	O	O
26-42	O	O
)	O	O
participated	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Full-mouth	O	O
bleeding	O	O
scores	O	O
(	O	O
BOP	O	O
)	O	O
decreased	O	O
from	O	O
an	O	O
average	O	O
of	O	O
41.2	O	O
%	O	O
(	O	O
S.D	O	O
.	O	O

+/-	O	O
18.6	O	O
%	O	O
)	O	O
at	O	O
the	O	O
12th	O	O
week	O	O
of	O	O
pregnancy	O	O
to	O	O
26.6	O	O
%	O	O
(	O	O
S.D	O	O
.	O	O

+/-	O	O
14.4	O	O
%	O	O
)	O	O
at	O	O
the	O	O
4-6	O	O
weeks	O	O
postpartum	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Between	O	O
week	O	O
12	O	O
and	O	O
4-6	O	O
weeks	O	O
postpartum	O	O
,	O	O
the	O	O
mean	O	O
probing	O	O
pocket	O	O
depth	O	O
changed	O	O
from	O	O
2.4	O	O
mm	O	O
(	O	O
S.D	O	O
.	O	O

+/-	O	O
0.4	O	O
)	O	O
to	O	O
2.3	O	O
mm	O	O
(	O	O
S.D	O	O
.	O	O

+/-	O	O
0.3	O	O
)	O	O
(	O	O
p	O	O
=	O	O
0.34	O	O
)	O	O
.	O	O

Higher	O	O
counts	O	O
of	O	O
Eubacterium	B-bacteria	B-bacteria
saburreum	E-bacteria	I-bacteria
,	O	O
Parvimonas	B-bacteria	B-bacteria
micra	E-bacteria	I-bacteria
,	O	O
Selenomonas	B-bacteria	B-bacteria
noxia	E-bacteria	I-bacteria
,	O	O
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
were	O	O
found	O	O
at	O	O
week	O	O
12	O	O
of	O	O
pregnancy	O	O
than	O	O
at	O	O
the	O	O
4-6	O	O
weeks	O	O
postpartum	O	O
examinations	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

During	O	O
and	O	O
after	O	O
pregnancy	O	O
,	O	O
statistically	O	O
significant	O	O
correlations	O	O
between	O	O
BOP	O	O
scores	O	O
and	O	O
bacterial	O	O
counts	O	O
were	O	O
observed	O	O
.	O	O

BOP	O	O
scores	O	O
and	O	O
GCF	O	O
levels	O	O
of	O	O
selected	O	O
cytokines	O	O
were	O	O
not	O	O
related	O	O
to	O	O
each	O	O
other	O	O
and	O	O
no	O	O
differences	O	O
in	O	O
GCF	O	O
levels	O	O
of	O	O
the	O	O
cytokines	O	O
were	O	O
observed	O	O
between	O	O
samples	O	O
from	O	O
the	O	O
12th	O	O
week	O	O
of	O	O
pregnancy	O	O
to	O	O
4-6	O	O
weeks	O	O
postpartum	O	O
.	O	O

Decreasing	O	O
postpartum	O	O
counts	O	O
of	O	O
Porphyromonas	B-bacteria	B-bacteria
endodontalis	E-bacteria	I-bacteria
and	O	O
Pseudomonas	B-bacteria	B-bacteria
aeruginosa	E-bacteria	I-bacteria
were	O	O
associated	O	O
with	O	O
decreasing	O	O
levels	O	O
of	O	O
Il-8	O	O
and	O	O
Il-1beta	O	O
.	O	O

BOP	O	O
decreased	O	O
after	O	O
pregnancy	O	O
without	O	O
any	O	O
active	O	O
periodontal	O	O
therapy	O	O
.	O	O

Associations	O	O
between	O	O
bacterial	O	O
counts	O	O
and	O	O
cytokine	O	O
levels	O	O
varied	O	O
greatly	O	O
in	O	O
pregnant	O	O
women	O	O
with	O	O
gingivitis	O	O
and	O	O
a	O	O
normal	O	O
pregnancy	O	O
outcome	O	O
.	O	O

Postpartum	O	O
associations	O	O
between	O	O
GCF	O	O
cytokines	O	O
and	O	O
bacterial	O	O
counts	O	O
were	O	O
more	O	O
consistent	O	O
.	O	O

Combined	O	O
assessments	O	O
of	O	O
gingival	O	O
fluid	O	O
cytokines	O	O
and	O	O
subgingival	O	O
bacteria	O	O
may	O	O
provide	O	O
important	O	O
information	O	O
on	O	O
host	O	O
response	O	O
.	O	O

Oral	O	O
bacterial	O	O
biofilms	O	O
trigger	O	O
chronic	O	O
inflammatory	O	O
responses	O	O
in	O	O
the	O	O
host	O	O
that	O	O
can	O	O
result	O	O
in	O	O
the	O	O
tissue	O	O
destructive	O	O
events	O	O
of	O	O
periodontitis	O	O
.	O	O

However	O	O
,	O	O
the	O	O
characteristics	O	O
of	O	O
the	O	O
capacity	O	O
of	O	O
specific	O	O
host	O	O
cell	O	O
types	O	O
to	O	O
respond	O	O
to	O	O
these	O	O
biofilms	O	O
remain	O	O
ill-defined	O	O
.	O	O

This	O	O
report	O	O
describes	O	O
the	O	O
use	O	O
of	O	O
a	O	O
novel	O	O
model	O	O
of	O	O
bacterial	O	O
biofilms	O	O
to	O	O
stimulate	O	O
oral	O	O
epithelial	O	O
cells	O	O
and	O	O
profile	O	O
select	O	O
cytokines	O	O
and	O	O
chemokines	O	O
that	O	O
contribute	O	O
to	O	O
the	O	O
local	O	O
inflammatory	O	O
environment	O	O
in	O	O
the	O	O
periodontium	O	O
.	O	O

Monoinfection	O	O
biofilms	O	O
were	O	O
developed	O	O
with	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
on	O	O
rigid	O	O
gas-permeable	O	O
contact	O	O
lenses	O	O
.	O	O

Biofilms	O	O
,	O	O
as	O	O
well	O	O
as	O	O
planktonic	O	O
cultures	O	O
of	O	O
these	O	O
same	O	O
bacterial	O	O
species	O	O
,	O	O
were	O	O
incubated	O	O
under	O	O
anaerobic	O	O
conditions	O	O
with	O	O
a	O	O
human	O	O
oral	O	O
epithelial	O	O
cell	O	O
line	O	O
,	O	O
OKF4	O	O
,	O	O
for	O	O
up	O	O
to	O	O
24h	O	O
.	O	O

Gro-1alpha	O	O
,	O	O
IL1alpha	O	O
,	O	O
IL-6	O	O
,	O	O
IL-8	O	O
,	O	O
TGFalpha	O	O
,	O	O
Fractalkine	O	O
,	O	O
MIP-1alpha	O	O
,	O	O
and	O	O
IP-10	O	O
were	O	O
shown	O	O
to	O	O
be	O	O
produced	O	O
in	O	O
response	O	O
to	O	O
a	O	O
range	O	O
of	O	O
the	O	O
planktonic	O	O
or	O	O
biofilm	O	O
forms	O	O
of	O	O
these	O	O
species	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
biofilms	O	O
significantly	O	O
inhibited	O	O
the	O	O
production	O	O
of	O	O
all	O	O
of	O	O
these	O	O
cytokines	O	O
and	O	O
chemokines	O	O
,	O	O
except	O	O
MIP-1alpha	O	O
.	O	O

Generally	O	O
,	O	O
the	O	O
biofilms	O	O
of	O	O
all	O	O
species	O	O
inhibited	O	O
Gro-1alpha	O	O
,	O	O
TGFalpha	O	O
,	O	O
and	O	O
Fractalkine	O	O
production	O	O
,	O	O
while	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
biofilms	O	O
stimulated	O	O
significant	O	O
increases	O	O
in	O	O
IL-1alpha	O	O
,	O	O
IL-6	O	O
,	O	O
IL-8	O	O
,	O	O
and	O	O
IP-10	O	O
.	O	O

A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
biofilms	O	O
induced	O	O
elevated	O	O
levels	O	O
of	O	O
IL-6	O	O
,	O	O
IL-8	O	O
and	O	O
IP-10	O	O
.	O	O

The	O	O
oral	O	O
streptococcal	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
in	O	O
biofilms	O	O
or	O	O
planktonic	O	O
forms	O	O
were	O	O
poor	O	O
stimulants	O	O
for	O	O
any	O	O
of	O	O
these	O	O
mediators	O	O
from	O	O
the	O	O
epithelial	O	O
cells	O	O
.	O	O

The	O	O
results	O	O
of	O	O
these	O	O
studies	O	O
demonstrate	O	O
that	O	O
oral	O	O
bacteria	O	O
in	O	O
biofilms	O	O
elicit	O	O
a	O	O
substantially	O	O
different	O	O
profile	O	O
of	O	O
responses	O	O
compared	O	O
to	O	O
planktonic	O	O
bacteria	O	O
of	O	O
the	O	O
same	O	O
species	O	O
.	O	O

Moreover	O	O
,	O	O
certain	O	O
oral	O	O
species	O	O
are	O	O
highly	O	O
stimulatory	O	O
when	O	O
in	O	O
biofilms	O	O
and	O	O
interact	O	O
with	O	O
host	O	O
cell	O	O
receptors	O	O
to	O	O
trigger	O	O
pathways	O	O
of	O	O
responses	O	O
that	O	O
appear	O	O
quite	O	O
divergent	O	O
from	O	O
individual	O	O
bacteria	O	O
.	O	O

Oral	O	O
candidiasis	O	O
is	O	O
often	O	O
accompanied	O	O
by	O	O
severe	O	O
inflammation	O	O
,	O	O
resulting	O	O
in	O	O
a	O	O
decline	O	O
in	O	O
the	O	O
quality	O	O
of	O	O
life	O	O
of	O	O
immunosuppressed	O	O
individuals	O	O
and	O	O
elderly	O	O
people	O	O
.	O	O

To	O	O
develop	O	O
a	O	O
new	O	O
oral	O	O
therapeutic	O	O
option	O	O
for	O	O
candidiasis	O	O
,	O	O
a	O	O
nonpathogenic	O	O
commensal	O	O
oral	O	O
probiotic	O	O
microorganism	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
,	O	O
was	O	O
evaluated	O	O
for	O	O
its	O	O
ability	O	O
to	O	O
modulate	O	O
Candida	O	O
albicans	O	O
growth	O	O
in	O	O
vitro	O	O
,	O	O
and	O	O
its	O	O
therapeutic	O	O
activity	O	O
in	O	O
an	O	O
experimental	O	O
oral	O	O
candidiasis	O	O
model	O	O
was	O	O
tested	O	O
.	O	O

In	O	O
vitro	O	O
inhibition	O	O
of	O	O
mycelial	O	O
growth	O	O
of	O	O
C.	O	O
albicans	O	O
was	O	O
determined	O	O
by	O	O
plate	O	O
assay	O	O
and	O	O
fluorescence	O	O
microscopy	O	O
.	O	O

Addition	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
to	O	O
modified	O	O
RPMI	O	O
1640	O	O
culture	O	O
medium	O	O
inhibited	O	O
the	O	O
adherence	O	O
of	O	O
C.	O	O
albicans	O	O
to	O	O
the	O	O
plastic	O	O
petri	O	O
dish	O	O
in	O	O
a	O	O
dose-dependent	O	O
manner	O	O
.	O	O

Preculture	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
potentiated	O	O
its	O	O
inhibitory	O	O
activity	O	O
for	O	O
adherence	O	O
of	O	O
C.	O	O
albicans	O	O
.	O	O

Interestingly	O	O
,	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
was	O	O
not	O	O
directly	O	O
fungicidal	O	O
but	O	O
appeared	O	O
to	O	O
inhibit	O	O
Candida	O	O
adhesion	O	O
to	O	O
the	O	O
substratum	O	O
by	O	O
preferentially	O	O
binding	O	O
to	O	O
hyphae	O	O
rather	O	O
than	O	O
yeast	O	O
.	O	O

To	O	O
determine	O	O
the	O	O
potentially	O	O
anti-infective	O	O
attributes	O	O
of	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
in	O	O
oral	O	O
candidiasis	O	O
,	O	O
the	O	O
probiotic	O	O
was	O	O
administered	O	O
to	O	O
mice	O	O
with	O	O
orally	O	O
induced	O	O
candidiasis	O	O
.	O	O

Oral	O	O
treatment	O	O
with	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
significantly	O	O
protected	O	O
the	O	O
mice	O	O
from	O	O
severe	O	O
candidiasis	O	O
.	O	O

These	O	O
findings	O	O
suggest	O	O
that	O	O
S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
may	O	O
inhibit	O	O
the	O	O
process	O	O
of	O	O
invasion	O	O
of	O	O
C.	O	O
albicans	O	O
into	O	O
mucous	O	O
surfaces	O	O
or	O	O
its	O	O
adhesion	O	O
to	O	O
denture	O	O
acrylic	O	O
resins	O	O
by	O	O
mechanisms	O	O
not	O	O
associated	O	O
with	O	O
the	O	O
antimicrobial	O	O
activity	O	O
of	O	O
the	O	O
bacteriocin	O	O
.	O	O

S.	B-bacteria	B-bacteria
salivarius	I-bacteria	I-bacteria
K12	E-bacteria	I-bacteria
may	O	O
be	O	O
useful	O	O
as	O	O
a	O	O
probiotic	O	O
as	O	O
a	O	O
protective	O	O
tool	O	O
for	O	O
oral	O	O
care	O	O
,	O	O
especially	O	O
with	O	O
regard	O	O
to	O	O
candidiasis	O	O
.	O	O

A	O	O
total	O	O
of	O	O
three	O	O
intensive	O	O
care	O	O
units	O	O
(	O	O
ICU	O	O
)	O	O
at	O	O
a	O	O
German	O	O
university	O	O
hospital	O	O
were	O	O
involved	O	O
in	O	O
an	O	O
outbreak	O	O
of	O	O
Burkholderia	B-bacteria	B-bacteria
cepacia	I-bacteria	I-bacteria
complex	E-bacteria	I-bacteria
(	O	O
Bcc	B-bacteria	B-bacteria
)	O	O
.	O	O

Patients	O	O
with	O	O
microbiological	O	O
detection	O	O
of	O	O
Bcc	B-bacteria	B-bacteria
were	O	O
evaluated	O	O
.	O	O

Products	O	O
used	O	O
for	O	O
mouth	O	O
hygiene	O	O
were	O	O
microbiologically	O	O
tested	O	O
.	O	O

The	O	O
clonal	O	O
identity	O	O
of	O	O
Bcc	B-bacteria	B-bacteria
was	O	O
proven	O	O
by	O	O
pulse-field	O	O
gel	O	O
electrophoresis	O	O
(	O	O
PFGE	O	O
)	O	O
.	O	O

On	O	O
3	O	O
ICUs	O	O
12	O	O
cases	O	O
were	O	O
identified	O	O
whereby	O	O
the	O	O
first	O	O
detection	O	O
of	O	O
Bcc	B-bacteria	B-bacteria
was	O	O
in	O	O
respiratory	O	O
specimens	O	O
of	O	O
11	O	O
patients	O	O
and	O	O
1	O	O
in	O	O
a	O	O
wound	O	O
swab	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Of	O	O
these	O	O
patients	O	O
six	O	O
developed	O	O
ventilator-associated	O	O
pneumonia	O	O
(	O	O
VAP	O	O
)	O	O
.	O	O

Investigations	O	O
revealed	O	O
that	O	O
five	O	O
different	O	O
batches	O	O
of	O	O
an	O	O
alcohol-free	O	O
mouthwash	O	O
containing	O	O
hexetidine	O	O
were	O	O
highly	O	O
contaminated	O	O
.	O	O

Isolates	O	O
of	O	O
Bcc	B-bacteria	B-bacteria
from	O	O
patients	O	O
and	O	O
mouthwashes	O	O
were	O	O
genetically	O	O
indistinguishable	O	O
.	O	O

A	O	O
recall	O	O
of	O	O
the	O	O
product	O	O
was	O	O
initiated	O	O
.	O	O

After	O	O
elimination	O	O
of	O	O
the	O	O
product	O	O
from	O	O
the	O	O
ICUs	O	O
no	O	O
more	O	O
cases	O	O
were	O	O
identified	O	O
.	O	O

The	O	O
source	O	O
of	O	O
the	O	O
outbreak	O	O
was	O	O
an	O	O
intrinsically	O	O
contaminated	O	O
alcohol-free	O	O
mouthwash	O	O
.	O	O

Detection	O	O
of	O	O
Bcc	B-bacteria	B-bacteria
in	O	O
specimens	O	O
from	O	O
ICU	O	O
patients	O	O
should	O	O
lead	O	O
to	O	O
further	O	O
investigations	O	O
.	O	O

Antiseptic	O	O
oral	O	O
care	O	O
products	O	O
are	O	O
recommended	O	O
for	O	O
reducing	O	O
the	O	O
risk	O	O
of	O	O
VAP	O	O
but	O	O
they	O	O
may	O	O
be	O	O
microbiologically	O	O
contaminated	O	O
and	O	O
,	O	O
in	O	O
consequence	O	O
,	O	O
increase	O	O
the	O	O
risk	O	O
.	O	O

The	O	O
safety	O	O
of	O	O
patient	O	O
care	O	O
products	O	O
should	O	O
be	O	O
increased	O	O
by	O	O
stricter	O	O
regulations	O	O
.	O	O

Dental	O	O
caries	O	O
and	O	O
pulpal	O	O
diseases	O	O
are	O	O
common	O	O
oral	O	O
bacterial	O	O
infectious	O	O
diseases	O	O
.	O	O

Controlling	O	O
and	O	O
reducing	O	O
the	O	O
causative	O	O
pathogens	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
is	O	O
a	O	O
key	O	O
step	O	O
toward	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
the	O	O
two	O	O
diseases	O	O
.	O	O

Chrysophsin-1	O	O
is	O	O
a	O	O
cationic	O	O
antimicrobial	O	O
peptide	O	O
having	O	O
broad-spectrum	O	O
bactericidal	O	O
activity	O	O
against	O	O
both	O	O
Gram-positive	O	O
and	O	O
Gram-negative	O	O
bacteria	O	O
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
investigated	O	O
the	O	O
antibacterial	O	O
activity	O	O
of	O	O
chrysophsin-1	O	O
against	O	O
several	O	O
oral	O	O
pathogens	O	O
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
and	O	O
performed	O	O
a	O	O
preliminary	O	O
study	O	O
of	O	O
the	O	O
antimicrobial	O	O
mechanism	O	O
.	O	O

Cytotoxic	O	O
activity	O	O
of	O	O
chrysophsin-1	O	O
against	O	O
human	O	O
gingival	O	O
fibroblasts	O	O
(	O	O
HGFs	O	O
)	O	O
was	O	O
investigated	O	O
.	O	O

Minimal	O	O
inhibitory	O	O
concentration	O	O
(	O	O
MIC	O	O
)	O	O
,	O	O
minimal	O	O
bactericidal	O	O
concentration	O	O
(	O	O
MBC	O	O
)	O	O
and	O	O
time-kill	O	O
assay	O	O
were	O	O
used	O	O
to	O	O
evaluate	O	O
the	O	O
killing	O	O
effect	O	O
of	O	O
chrysophsin-1	O	O
.	O	O

Scanning	O	O
electron	O	O
microscopy	O	O
(	O	O
SEM	O	O
)	O	O
was	O	O
used	O	O
to	O	O
analyze	O	O
morphological	O	O
and	O	O
membrane	O	O
change	O	O
in	O	O
oral	O	O
pathogens	O	O
.	O	O

Live/Dead	O	O
staining	O	O
,	O	O
in	O	O
conjunction	O	O
with	O	O
confocal	O	O
scanning	O	O
laser	O	O
microscopy	O	O
(	O	O
CSLM	O	O
)	O	O
,	O	O
was	O	O
used	O	O
to	O	O
observe	O	O
and	O	O
analyze	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

MIC	O	O
and	O	O
MBC	O	O
results	O	O
demonstrated	O	O
that	O	O
chrysophsin-1	O	O
had	O	O
different	O	O
antimicrobial	O	O
activities	O	O
against	O	O
the	O	O
tested	O	O
oral	O	O
microbes	O	O
.	O	O

Lysis	O	O
and	O	O
pore	O	O
formation	O	O
of	O	O
the	O	O
cytomembrane	O	O
were	O	O
observed	O	O
following	O	O
treatment	O	O
of	O	O
the	O	O
bacteria	O	O
with	O	O
chrysophsin-1	O	O
for	O	O
4h	O	O
or	O	O
24h	O	O
by	O	O
SEM	O	O
.	O	O

Furthermore	O	O
,	O	O
CLSM	O	O
images	O	O
showed	O	O
that	O	O
chrysophsin-1	O	O
remarkably	O	O
reduced	O	O
the	O	O
viability	O	O
of	O	O
cells	O	O
within	O	O
biofilms	O	O
and	O	O
had	O	O
a	O	O
significantly	O	O
lethal	O	O
effect	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilms	O	O
.	O	O

Toxicity	O	O
studies	O	O
showed	O	O
that	O	O
chrysophsin-1	O	O
at	O	O
concentration	O	O
between	O	O
8	O	O
mug/ml	O	O
and	O	O
32	O	O
mug/ml	O	O
had	O	O
little	O	O
effect	O	O
on	O	O
viability	O	O
of	O	O
HGFs	O	O
in	O	O
5	O	O
min	O	O
.	O	O

Our	O	O
findings	O	O
suggest	O	O
that	O	O
chrysophsin-1	O	O
may	O	O
have	O	O
potential	O	O
clinical	O	O
applications	O	O
in	O	O
the	O	O
prevention	O	O
and	O	O
treatment	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
pulpal	O	O
diseases	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
a	O	O
Gram-negative	O	O
anaerobe	O	O
that	O	O
resides	O	O
exclusively	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
.	O	O

Long-term	O	O
colonization	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
requires	O	O
the	O	O
bacteria	O	O
to	O	O
evade	O	O
host	O	O
immune	O	O
responses	O	O
while	O	O
adapting	O	O
to	O	O
the	O	O
changing	O	O
host	O	O
physiology	O	O
and	O	O
alterations	O	O
in	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
.	O	O

The	O	O
genetic	O	O
diversity	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
appears	O	O
to	O	O
reflect	O	O
the	O	O
variability	O	O
of	O	O
its	O	O
habitat	O	O
;	O	O
however	O	O
,	O	O
little	O	O
is	O	O
known	O	O
about	O	O
the	O	O
molecular	O	O
mechanisms	O	O
generating	O	O
this	O	O
diversity	O	O
.	O	O

Previously	O	O
,	O	O
our	O	O
research	O	O
group	O	O
established	O	O
that	O	O
chromosomal	O	O
DNA	O	O
transfer	O	O
occurs	O	O
between	O	O
P.	B-bacteria	B-bacteria
gingivalis	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

In	O	O
this	O	O
study	O	O
,	O	O
we	O	O
examine	O	O
the	O	O
role	O	O
of	O	O
putative	O	O
DNA	O	O
transfer	O	O
genes	O	O
in	O	O
conjugation	O	O
and	O	O
transformation	O	O
and	O	O
demonstrate	O	O
that	O	O
natural	O	O
competence	O	O
mediated	O	O
by	O	O
comF	O	O
is	O	O
the	O	O
dominant	O	O
form	O	O
of	O	O
chromosomal	O	O
DNA	O	O
transfer	O	O
,	O	O
with	O	O
transfer	O	O
by	O	O
a	O	O
conjugation-like	O	O
mechanism	O	O
playing	O	O
a	O	O
minor	O	O
role	O	O
.	O	O

Our	O	O
results	O	O
reveal	O	O
that	O	O
natural	O	O
competence	O	O
mechanisms	O	O
are	O	O
present	O	O
in	O	O
multiple	O	O
strains	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
and	O	O
DNA	O	O
uptake	O	O
is	O	O
not	O	O
sensitive	O	O
to	O	O
DNA	O	O
source	O	O
or	O	O
modification	O	O
status	O	O
.	O	O

Furthermore	O	O
,	O	O
extracellular	O	O
DNA	O	O
was	O	O
observed	O	O
for	O	O
the	O	O
first	O	O
time	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
biofilms	O	O
and	O	O
is	O	O
predicted	O	O
to	O	O
be	O	O
the	O	O
major	O	O
DNA	O	O
source	O	O
for	O	O
horizontal	O	O
transfer	O	O
and	O	O
allelic	O	O
exchange	O	O
between	O	O
strains	O	O
.	O	O

We	O	O
propose	O	O
that	O	O
exchange	O	O
of	O	O
DNA	O	O
in	O	O
plaque	O	O
biofilms	O	O
by	O	O
a	O	O
transformation-like	O	O
process	O	O
is	O	O
of	O	O
major	O	O
ecological	O	O
importance	O	O
in	O	O
the	O	O
survival	O	O
and	O	O
persistence	O	O
of	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
in	O	O
the	O	O
challenging	O	O
oral	O	O
environment	O	O
.	O	O


:	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
colonizes	O	O
the	O	O
oral	O	O
cavities	O	O
of	O	O
humans	O	O
worldwide	O	O
.	O	O

The	O	O
long-term	O	O
persistence	O	O
of	O	O
these	O	O
bacteria	O	O
can	O	O
lead	O	O
to	O	O
the	O	O
development	O	O
of	O	O
chronic	O	O
periodontitis	O	O
and	O	O
host	O	O
morbidity	O	O
associated	O	O
with	O	O
tooth	O	O
loss	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
is	O	O
a	O	O
genetically	O	O
diverse	O	O
species	O	O
,	O	O
and	O	O
this	O	O
variability	O	O
is	O	O
believed	O	O
to	O	O
contribute	O	O
to	O	O
its	O	O
successful	O	O
colonization	O	O
and	O	O
survival	O	O
in	O	O
diverse	O	O
human	O	O
hosts	O	O
,	O	O
as	O	O
well	O	O
as	O	O
evasion	O	O
of	O	O
host	O	O
immune	O	O
defenses	O	O
and	O	O
immunization	O	O
strategies	O	O
.	O	O

We	O	O
establish	O	O
here	O	O
that	O	O
natural	O	O
competence	O	O
is	O	O
the	O	O
major	O	O
driving	O	O
force	O	O
behind	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
DNA	O	O
exchange	O	O
and	O	O
that	O	O
conjugative	O	O
DNA	O	O
transfer	O	O
plays	O	O
a	O	O
minor	O	O
role	O	O
.	O	O

Furthermore	O	O
,	O	O
we	O	O
reveal	O	O
for	O	O
the	O	O
first	O	O
time	O	O
the	O	O
presence	O	O
of	O	O
extracellular	O	O
DNA	O	O
in	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
biofilms	O	O
,	O	O
which	O	O
is	O	O
most	O	O
likely	O	O
the	O	O
source	O	O
of	O	O
DNA	O	O
exchanged	O	O
between	O	O
strains	O	O
within	O	O
dental	O	O
plaque	O	O
.	O	O

These	O	O
studies	O	O
expand	O	O
our	O	O
understanding	O	O
of	O	O
the	O	O
mechanisms	O	O
used	O	O
by	O	O
this	O	O
important	O	O
member	O	O
of	O	O
the	O	O
human	O	O
oral	O	O
flora	O	O
to	O	O
transition	O	O
its	O	O
relationship	O	O
with	O	O
the	O	O
host	O	O
from	O	O
a	O	O
commensal	O	O
to	O	O
a	O	O
pathogenic	O	O
relationship	O	O
.	O	O

The	O	O
ability	O	O
to	O	O
track	O	O
microbes	O	O
in	O	O
real	O	O
time	O	O
in	O	O
vivo	O	O
is	O	O
of	O	O
enormous	O	O
value	O	O
for	O	O
preclinical	O	O
investigations	O	O
in	O	O
infectious	O	O
disease	O	O
or	O	O
gene	O	O
therapy	O	O
research	O	O
.	O	O

Bacteria	O	O
present	O	O
an	O	O
attractive	O	O
class	O	O
of	O	O
vector	O	O
for	O	O
cancer	O	O
therapy	O	O
,	O	O
possessing	O	O
a	O	O
natural	O	O
ability	O	O
to	O	O
grow	O	O
preferentially	O	O
within	O	O
tumours	O	O
following	O	O
systemic	O	O
administration	O	O
.	O	O

Bioluminescent	O	O
Imaging	O	O
(	O	O
BLI	O	O
)	O	O
represents	O	O
a	O	O
powerful	O	O
tool	O	O
for	O	O
use	O	O
with	O	O
bacteria	O	O
engineered	O	O
to	O	O
express	O	O
reporter	O	O
genes	O	O
such	O	O
as	O	O
lux	O	O
.	O	O

BLI	O	O
is	O	O
traditionally	O	O
used	O	O
as	O	O
a	O	O
2D	O	O
modality	O	O
resulting	O	O
in	O	O
images	O	O
that	O	O
are	O	O
limited	O	O
in	O	O
their	O	O
ability	O	O
to	O	O
anatomically	O	O
locate	O	O
cell	O	O
populations	O	O
.	O	O

Use	O	O
of	O	O
3D	O	O
diffuse	O	O
optical	O	O
tomography	O	O
can	O	O
localize	O	O
the	O	O
signals	O	O
but	O	O
still	O	O
need	O	O
to	O	O
be	O	O
combined	O	O
with	O	O
an	O	O
anatomical	O	O
imaging	O	O
modality	O	O
like	O	O
micro-Computed	O	O
Tomography	O	O
(	O	O
muCT	O	O
)	O	O
for	O	O
interpretation.In	O	O
this	O	O
study	O	O
,	O	O
the	O	O
non-pathogenic	O	O
commensal	O	O
bacteria	O	O
E.	B-bacteria	B-bacteria
coli	I-bacteria	I-bacteria
K-12	I-bacteria	I-bacteria
MG1655	E-bacteria	I-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
breve	I-bacteria	I-bacteria
UCC2003	E-bacteria	I-bacteria
,	O	O
or	O	O
Salmonella	B-bacteria	B-bacteria
Typhimurium	I-bacteria	I-bacteria
SL7207	E-bacteria	I-bacteria
each	O	O
expressing	O	O
the	O	O
luxABCDE	O	O
operon	O	O
were	O	O
intravenously	O	O
(	O	O
i.v	O	O
.	O	O
)	O	O
administered	O	O
to	O	O
mice	O	O
bearing	O	O
subcutaneous	O	O
(	O	O
s.c	O	O
)	O	O
FLuc-expressing	O	O
xenograft	O	O
tumours	O	O
.	O	O

Bacterial	O	O
lux	O	O
signal	O	O
was	O	O
detected	O	O
specifically	O	O
in	O	O
tumours	O	O
of	O	O
mice	O	O
post	O	O
i.v.-administration	O	O
and	O	O
bioluminescence	O	O
correlated	O	O
with	O	O
the	O	O
numbers	O	O
of	O	O
bacteria	O	O
recovered	O	O
from	O	O
tissue	O	O
.	O	O

Through	O	O
whole	O	O
body	O	O
imaging	O	O
for	O	O
both	O	O
lux	O	O
and	O	O
FLuc	O	O
,	O	O
bacteria	O	O
and	O	O
tumour	O	O
cells	O	O
were	O	O
co-localised	O	O
.	O	O

3D	O	O
BLI	O	O
and	O	O
muCT	O	O
image	O	O
analysis	O	O
revealed	O	O
a	O	O
pattern	O	O
of	O	O
multiple	O	O
clusters	O	O
of	O	O
bacteria	O	O
within	O	O
tumours	O	O
.	O	O

Investigation	O	O
of	O	O
spatial	O	O
resolution	O	O
of	O	O
3D	O	O
optical	O	O
imaging	O	O
was	O	O
supported	O	O
by	O	O
ex	O	O
vivo	O	O
histological	O	O
analyses	O	O
.	O	O

In	O	O
vivo	O	O
imaging	O	O
of	O	O
orally-administered	O	O
commensal	O	O
bacteria	O	O
in	O	O
the	O	O
gastrointestinal	O	O
tract	O	O
(	O	O
GIT	O	O
)	O	O
was	O	O
also	O	O
achieved	O	O
using	O	O
3D	O	O
BLI	O	O
.	O	O

This	O	O
study	O	O
demonstrates	O	O
for	O	O
the	O	O
first	O	O
time	O	O
the	O	O
potential	O	O
to	O	O
simultaneously	O	O
image	O	O
multiple	O	O
BLI	O	O
reporter	O	O
genes	O	O
three	O	O
dimensionally	O	O
in	O	O
vivo	O	O
using	O	O
approaches	O	O
that	O	O
provide	O	O
unique	O	O
information	O	O
on	O	O
spatial	O	O
locations	O	O
.	O	O

Contaminated	O	O
hands	O	O
play	O	O
a	O	O
major	O	O
role	O	O
in	O	O
fecal-oral	O	O
transmission	O	O
of	O	O
diseases	O	O
.	O	O

In	O	O
1847	O	O
,	O	O
Dr	O	O
Semmelweis	O	O
Ignac	O	O
pointed	O	O
to	O	O
the	O	O
link	O	O
between	O	O
infection	O	O
and	O	O
unclean	O	O
hands	O	O
,	O	O
and	O	O
demonstrated	O	O
that	O	O
washing	O	O
hands	O	O
could	O	O
reduce	O	O
transmission	O	O
of	O	O
puerperal	O	O
fever	O	O
(	O	O
child	O	O
birth	O	O
fever	O	O
)	O	O
,	O	O
a	O	O
dreaded	O	O
disease	O	O
with	O	O
high	O	O
mortality	O	O
in	O	O
those	O	O
days	O	O
.	O	O

A	O	O
cross-sectional	O	O
study	O	O
was	O	O
conducted	O	O
to	O	O
find	O	O
out	O	O
the	O	O
extent	O	O
of	O	O
germs	O	O
present	O	O
in	O	O
hand	O	O
,	O	O
and	O	O
also	O	O
the	O	O
students	O	O
'	O	O
perception	O	O
on	O	O
hand	O	O
washing	O	O
.	O	O

This	O	O
was	O	O
assessed	O	O
by	O	O
questionnaire	O	O
as	O	O
well	O	O
as	O	O
by	O	O
collection	O	O
of	O	O
swab	O	O
from	O	O
hand	O	O
and	O	O
performing	O	O
bacteriological	O	O
culture	O	O
in	O	O
the	O	O
laboratory	O	O
.	O	O

In	O	O
regard	O	O
to	O	O
students	O	O
'	O	O
perception	O	O
about	O	O
the	O	O
dirty	O	O
areas	O	O
of	O	O
the	O	O
hands	O	O
,	O	O
it	O	O
was	O	O
observed	O	O
that	O	O
majority	O	O
(	O	O
78	O	O
%	O	O
)	O	O
felt	O	O
palm	O	O
was	O	O
likely	O	O
to	O	O
be	O	O
more	O	O
dirty	O	O
while	O	O
less	O	O
than	O	O
70	O	O
%	O	O
felt	O	O
that	O	O
web	O	O
spaces	O	O
could	O	O
harbor	O	O
dirt	O	O
.	O	O

Almost	O	O
86	O	O
%	O	O
reported	O	O
that	O	O
they	O	O
washed	O	O
hands	O	O
before	O	O
eating	O	O
lunch	O	O
,	O	O
but	O	O
only	O	O
21.3	O	O
%	O	O
said	O	O
they	O	O
always	O	O
used	O	O
soap	O	O
while	O	O
47.3	O	O
%	O	O
never	O	O
used	O	O
it	O	O
.	O	O

Availability	O	O
of	O	O
soap	O	O
all	O	O
the	O	O
time	O	O
in	O	O
the	O	O
school	O	O
was	O	O
reported	O	O
by	O	O
only	O	O
18.4	O	O
%	O	O
students	O	O
.	O	O

The	O	O
swabs	O	O
of	O	O
61	O	O
%	O	O
children	O	O
showed	O	O
potential	O	O
pathogens	O	O
.	O	O

The	O	O
commonest	O	O
of	O	O
these	O	O
was	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
which	O	O
was	O	O
seen	O	O
in	O	O
44	O	O
%	O	O
samples	O	O
.	O	O

The	O	O
students	O	O
'	O	O
hands	O	O
were	O	O
contaminated	O	O
before	O	O
taking	O	O
food	O	O
.	O	O

Although	O	O
they	O	O
washed	O	O
hands	O	O
before	O	O
meals	O	O
,	O	O
they	O	O
hardly	O	O
used	O	O
soap	O	O
due	O	O
to	O	O
non-availability	O	O
of	O	O
soap	O	O
.	O	O

The	O	O
school	O	O
authority	O	O
should	O	O
be	O	O
asked	O	O
to	O	O
keep	O	O
soaps	O	O
in	O	O
the	O	O
toilets	O	O
for	O	O
hand	O	O
washing	O	O
.	O	O

Previous	O	O
studies	O	O
demonstrated	O	O
that	O	O
a	O	O
cranberry	O	O
high-molecular-mass	O	O
,	O	O
nondialyzable	O	O
material	O	O
(	O	O
NDM	O	O
)	O	O
can	O	O
inhibit	O	O
adhesion	O	O
of	O	O
numerous	O	O
species	O	O
of	O	O
bacteria	O	O
and	O	O
prevents	O	O
bacterial	O	O
coaggregation	O	O
of	O	O
bacterial	O	O
pairs	O	O
.	O	O

Bacterial	O	O
coaggregation	O	O
leads	O	O
to	O	O
plaque	O	O
formation	O	O
leading	O	O
to	O	O
biofilm	O	O
development	O	O
on	O	O
surfaces	O	O
of	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
the	O	O
present	O	O
study	O	O
,	O	O
we	O	O
evaluated	O	O
the	O	O
effect	O	O
of	O	O
low	O	O
concentrations	O	O
of	O	O
NDM	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
metabolic	O	O
activity	O	O
and	O	O
biofilm	O	O
formation	O	O
on	O	O
restorative	O	O
dental	O	O
surfaces	O	O
.	O	O

We	O	O
found	O	O
that	O	O
the	O	O
NDM	O	O
selectively	O	O
inhibited	O	O
metabolic	O	O
activity	O	O
of	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
without	O	O
affecting	O	O
bacterial	O	O
viability	O	O
.	O	O

Inhibiting	O	O
the	O	O
metabolic	O	O
activity	O	O
of	O	O
bacteria	O	O
in	O	O
biofilm	O	O
may	O	O
benefit	O	O
the	O	O
health	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

To	O	O
investigate	O	O
whether	O	O
a	O	O
standard	O	O
dental	O	O
prophylaxis	O	O
followed	O	O
by	O	O
tooth	O	O
brushing	O	O
with	O	O
an	O	O
antibacterial	O	O
dentifrice	O	O
will	O	O
affect	O	O
the	O	O
oral	O	O
bacterial	O	O
community	O	O
,	O	O
as	O	O
determined	O	O
by	O	O
denaturing	O	O
gradient	O	O
gel	O	O
electrophoresis	O	O
(	O	O
DGGE	O	O
)	O	O
combined	O	O
with	O	O
16S	O	O
rRNA	O	O
gene	O	O
sequence	O	O
analysis	O	O
.	O	O

Twenty-four	O	O
healthy	O	O
adults	O	O
were	O	O
instructed	O	O
to	O	O
brush	O	O
their	O	O
teeth	O	O
using	O	O
commercial	O	O
dentifrice	O	O
for	O	O
1	O	O
week	O	O
during	O	O
a	O	O
washout	O	O
period	O	O
.	O	O

An	O	O
initial	O	O
set	O	O
of	O	O
pooled	O	O
supragingival	O	O
plaque	O	O
samples	O	O
was	O	O
collected	O	O
from	O	O
each	O	O
participant	O	O
at	O	O
baseline	O	O
(	O	O
0	O	O
h	O	O
)	O	O
before	O	O
prophylaxis	O	O
treatment	O	O
.	O	O

The	O	O
subjects	O	O
were	O	O
given	O	O
a	O	O
clinical	O	O
examination	O	O
and	O	O
dental	O	O
prophylaxis	O	O
and	O	O
asked	O	O
to	O	O
brush	O	O
for	O	O
1	O	O
min	O	O
with	O	O
a	O	O
dentifrice	O	O
containing	O	O
0.3	O	O
%	O	O
triclosan	O	O
,	O	O
2.0	O	O
%	O	O
PVM/MA	O	O
copolymer	O	O
and	O	O
0.243	O	O
%	O	O
sodium	O	O
fluoride	O	O
(	O	O
Colgate	O	O
Total	O	O
)	O	O
.	O	O

On	O	O
the	O	O
following	O	O
day	O	O
,	O	O
a	O	O
second	O	O
set	O	O
of	O	O
pooled	O	O
supragingival	O	O
plaque	O	O
samples	O	O
(	O	O
24	O	O
h	O	O
)	O	O
was	O	O
collected	O	O
.	O	O

Total	O	O
bacterial	O	O
genomic	O	O
DNA	O	O
was	O	O
isolated	O	O
from	O	O
the	O	O
samples	O	O
.	O	O

Differences	O	O
in	O	O
the	O	O
microbial	O	O
composition	O	O
before	O	O
and	O	O
after	O	O
the	O	O
prophylactic	O	O
procedure	O	O
and	O	O
tooth	O	O
brushing	O	O
were	O	O
assessed	O	O
by	O	O
comparing	O	O
the	O	O
DGGE	O	O
profiles	O	O
and	O	O
16S	O	O
rRNA	O	O
gene	O	O
segments	O	O
sequence	O	O
analysis	O	O
.	O	O

Two	O	O
distinct	O	O
clusters	O	O
of	O	O
DGGE	O	O
profiles	O	O
were	O	O
found	O	O
,	O	O
suggesting	O	O
that	O	O
a	O	O
shift	O	O
in	O	O
the	O	O
microbial	O	O
composition	O	O
had	O	O
occurred	O	O
24	O	O
h	O	O
after	O	O
the	O	O
prophylaxis	O	O
and	O	O
brushing	O	O
.	O	O

A	O	O
detailed	O	O
sequencing	O	O
analysis	O	O
of	O	O
16S	O	O
rRNA	O	O
gene	O	O
segments	O	O
further	O	O
identified	O	O
6	O	O
phyla	O	O
and	O	O
29	O	O
genera	O	O
,	O	O
including	O	O
known	O	O
and	O	O
unknown	O	O
bacterial	O	O
species	O	O
.	O	O

Importantly	O	O
,	O	O
an	O	O
increase	O	O
in	O	O
bacterial	O	O
diversity	O	O
was	O	O
observed	O	O
after	O	O
24	O	O
h	O	O
,	O	O
including	O	O
members	O	O
of	O	O
the	O	O
Streptococcaceae	B-bacteria	B-bacteria
family	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Corynebacterium	B-bacteria	B-bacteria
,	O	O
TM7	B-bacteria	B-bacteria
and	O	O
other	O	O
commensal	O	O
bacteria	O	O
.	O	O

The	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
use	O	O
of	O	O
a	O	O
standard	O	O
prophylaxis	O	O
followed	O	O
by	O	O
the	O	O
use	O	O
of	O	O
the	O	O
dentifrice	O	O
containing	O	O
0.3	O	O
%	O	O
triclosan	O	O
,	O	O
2.0	O	O
%	O	O
PVM/MA	O	O
copolymer	O	O
and	O	O
0.243	O	O
%	O	O
sodium	O	O
fluoride	O	O
may	O	O
promote	O	O
a	O	O
healthier	O	O
composition	O	O
within	O	O
the	O	O
oral	O	O
bacterial	O	O
community	O	O
.	O	O

To	O	O
investigate	O	O
the	O	O
effects	O	O
of	O	O
chlorhexidine	O	O
(	O	O
CHX	O	O
)	O	O
,	O	O
Listerine	O	O
and	O	O
Fluoride	O	O
Listerine	O	O
on	O	O
putative	O	O
root-caries	O	O
pathogens	O	O
in	O	O
the	O	O
biofilm	O	O
in	O	O
the	O	O
artificial	O	O
mouth	O	O
model	O	O
.	O	O

A	O	O
total	O	O
of	O	O
24	O	O
human	O	O
dentine	O	O
discs	O	O
were	O	O
prepared	O	O
.	O	O

A	O	O
biofilm	O	O
composed	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
and	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
was	O	O
cultured	O	O
on	O	O
the	O	O
surfaces	O	O
of	O	O
human	O	O
dentine	O	O
discs	O	O
in	O	O
an	O	O
artificial-mouth	O	O
model	O	O
.	O	O

Sucrose	O	O
was	O	O
supplied	O	O
by	O	O
computer-controlled	O	O
release	O	O
on	O	O
a	O	O
daily	O	O
basis	O	O
to	O	O
simulate	O	O
the	O	O
real-life	O	O
situation	O	O
.	O	O

Three	O	O
treatment	O	O
reagents	O	O
,	O	O
CHX	O	O
,	O	O
Listerine	O	O
and	O	O
Fluoride	O	O
Listerine	O	O
,	O	O
were	O	O
supplied	O	O
at	O	O
a	O	O
flow	O	O
rate	O	O
of	O	O
15	O	O
ml/h	O	O
for	O	O
6	O	O
min	O	O
twice	O	O
a	O	O
day	O	O
.	O	O

The	O	O
dentine	O	O
discs	O	O
with	O	O
biofilm	O	O
were	O	O
removed	O	O
from	O	O
the	O	O
artificial	O	O
mouth	O	O
after	O	O
being	O	O
cultured	O	O
for	O	O
1	O	O
,	O	O
2	O	O
,	O	O
3	O	O
,	O	O
4	O	O
,	O	O
5	O	O
and	O	O
6	O	O
days	O	O
.	O	O

The	O	O
bacteria	O	O
in	O	O
the	O	O
biofilm	O	O
were	O	O
analysed	O	O
by	O	O
plating	O	O
on	O	O
BHIS	O	O
agar	O	O
and	O	O
the	O	O
colony-forming	O	O
units	O	O
of	O	O
each	O	O
species	O	O
were	O	O
counted	O	O
.	O	O

The	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
CHX	O	O
group	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
in	O	O
the	O	O
other	O	O
three	O	O
groups	O	O
(	O	O
including	O	O
control	O	O
)	O	O
.	O	O

There	O	O
was	O	O
no	O	O
decline	O	O
in	O	O
the	O	O
number	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
Listerine	O	O
group	O	O
.	O	O

S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
was	O	O
reduced	O	O
significantly	O	O
in	O	O
the	O	O
CHX	O	O
group	O	O
compared	O	O
with	O	O
the	O	O
control	O	O
group	O	O
.	O	O

The	O	O
number	O	O
and	O	O
proportion	O	O
of	O	O
A.	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
in	O	O
the	O	O
CHX	O	O
group	O	O
were	O	O
significantly	O	O
lower	O	O
than	O	O
in	O	O
the	O	O
other	O	O
three	O	O
groups	O	O
.	O	O

The	O	O
proportion	O	O
of	O	O
L.	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
in	O	O
the	O	O
CHX	O	O
group	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
in	O	O
the	O	O
other	O	O
three	O	O
groups	O	O
.	O	O

CHX	O	O
has	O	O
the	O	O
most	O	O
significant	O	O
effect	O	O
on	O	O
inhibition	O	O
of	O	O
the	O	O
putative	O	O
root-caries	O	O
bacteria	O	O
,	O	O
with	O	O
the	O	O
exception	O	O
of	O	O
L.	B-bacteria	B-bacteria
rhamnosus	E-bacteria	I-bacteria
.	O	O

Both	O	O
Listerine	O	O
and	O	O
a	O	O
combination	O	O
of	O	O
fluoride	O	O
and	O	O
Listerine	O	O
could	O	O
not	O	O
effectively	O	O
reduce	O	O
the	O	O
numbers	O	O
of	O	O
bacteria	O	O
in	O	O
the	O	O
biofilm	O	O
.	O	O

The	O	O
effects	O	O
of	O	O
CHX	O	O
,	O	O
Listerine	O	O
and	O	O
Fluoride	O	O
Listerine	O	O
on	O	O
root	O	O
caries	O	O
prevention	O	O
need	O	O
further	O	O
investigation	O	O
.	O	O

A	O	O
randomized	O	O
clinical	O	O
trial	O	O
studied	O	O
the	O	O
effects	O	O
of	O	O
early	O	O
administration	O	O
of	O	O
Bifidobacterium	B-bacteria	B-bacteria
animalis	I-bacteria	I-bacteria
subsp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
lactis	I-bacteria	I-bacteria
BB-12	E-bacteria	I-bacteria
(	O	OO	O
BB-12	B-bacteria	B-bacteria
)	O	O
on	O	O
oral	O	O
colonization	O	O
of	O	O
(	O	O
1	O	O
)	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
,	O	O
and	O	O
(	O	O
2	O	O
)	O	O
BB-12	B-bacteria	B-bacteria
.	O	O

In	O	O
this	O	O
double-blind	O	O
,	O	O
placebo-controlled	O	O
study	O	O
,	O	O
infants	O	O
(	O	O
n	O	O
=	O	O
106	O	O
)	O	O
received	O	O
probiotic	O	O
bacteria	O	O
(	O	O
BB-12	B-bacteria	B-bacteria
group	O	O
)	O	O
,	O	O
xylitol	O	O
(	O	O
X	O	O
group	O	O
)	O	O
,	O	O
or	O	O
sorbitol	O	O
(	O	O
S	O	O
group	O	O
)	O	O
.	O	O

Test	O	O
tablets	O	O
were	O	O
administered	O	O
twice	O	O
a	O	O
day	O	O
(	O	O
from	O	O
the	O	O
age	O	O
of	O	O
1-2	O	O
months	O	O
)	O	O
with	O	O
a	O	O
novel	O	O
slow-release	O	O
pacifier	O	O
or	O	O
a	O	O
spoon	O	O
(	O	O
daily	O	O
dose	O	O
of	O	O
BB-12	B-bacteria	B-bacteria
10	O	O
(	O	O
10	O	O
)	O	O
CFU	O	O
,	O	O
polyol	O	O
200-600	O	O
mg	O	O
)	O	O
.	O	O

Samples	O	O
were	O	O
collected	O	O
from	O	O
mucosa/teeth	O	O
at	O	O
the	O	O
age	O	O
of	O	O
8	O	O
months	O	O
and	O	O
2	O	O
years	O	O
for	O	O
BB-	O	O
12	O	O
determination	O	O
(	O	O
qPCR	O	O
)	O	O
and	O	O
plate	O	O
culturing	O	O
of	O	O
MS	B-bacteria	B-bacteria
(	O	O
MSB	O	O
,	O	O
TYCSB	O	O
)	O	O
,	O	O
lactobacilli	B-bacteria	B-bacteria
(	O	O
Rogosa	O	O
)	O	O
and	O	O
yeasts	O	O
(	O	O
Sabouraud	O	O
)	O	O
.	O	O

The	O	O
MS	B-bacteria	B-bacteria
levels	O	O
of	O	O
the	O	O
mothers	O	O
were	O	O
determined	O	O
(	O	O
Dentocult	O	O
SM	O	O
Strip	O	O
Mutans	O	O
)	O	O
.	O	O

The	O	O
baseline	O	O
characteristics	O	O
of	O	O
the	O	O
three	O	O
groups	O	O
were	O	O
similar	O	O
.	O	O

Mean	O	O
duration	O	O
of	O	O
tablet	O	O
delivery	O	O
was	O	O
14.9	O	O
+/-	O	O
6.7	O	O
months	O	O
.	O	O

In	O	O
all	O	O
groups	O	O
,	O	O
>	O	O
90	O	O
%	O	O
of	O	O
the	O	O
mothers	O	O
showed	O	O
high	O	O
MS	B-bacteria	B-bacteria
counts	O	O
(	O	O
log	O	O
CFU	O	O
>	O	O
/=5	O	O
)	O	O
.	O	O

MS	B-bacteria	B-bacteria
colonization	O	O
percentages	O	O
of	O	O
the	O	O
children	O	O
at	O	O
the	O	O
age	O	O
of	O	O
2	O	O
years	O	O
were	O	O
rather	O	O
low	O	O
(	O	O
BB-12	B-bacteria	B-bacteria
group	O	O
:	O	O
6	O	O
%	O	O
;	O	O
X	O	O
group	O	O
:	O	O
31	O	O
%	O	O
;	O	O
S	O	O
group	O	O
:	O	O
10	O	O
%	O	O
;	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
levels	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
and	O	O
yeasts	O	O
did	O	O
not	O	O
differ	O	O
between	O	O
the	O	O
groups	O	O
.	O	O

BB-12	B-bacteria	B-bacteria
cell	O	O
counts	O	O
barely	O	O
exceeding	O	O
the	O	O
detection	O	O
limit	O	O
were	O	O
found	O	O
in	O	O
three	O	O
of	O	O
the	O	O
oral	O	O
samples	O	O
of	O	O
the	O	O
8-month-old	O	O
children	O	O
;	O	O
however	O	O
,	O	O
the	O	O
2-year	O	O
samples	O	O
did	O	O
not	O	O
contain	O	O
BB-12	O	O
.	O	O

The	O	O
early	O	O
administration	O	O
of	O	O
BB-12	B-bacteria	B-bacteria
did	O	O
not	O	O
result	O	O
in	O	O
permanent	O	O
oral	O	O
colonization	O	O
of	O	O
this	O	O
probiotic	O	O
or	O	O
significantly	O	O
affect	O	O
MS	B-bacteria	B-bacteria
colonization	O	O
in	O	O
the	O	O
children	O	O
.	O	O

In	O	O
this	O	O
protocol	O	O
,	O	O
we	O	O
describe	O	O
the	O	O
application	O	O
of	O	O
commercially	O	O
available	O	O
three-dimensional	O	O
organotypic	O	O
tissues	O	O
of	O	O
human	O	O
oral	O	O
mucosa	O	O
to	O	O
study	O	O
the	O	O
interaction	O	O
between	O	O
Candida	O	O
albicans	O	O
and	O	O
epithelial	O	O
cells	O	O
.	O	O

Infection	O	O
experiments	O	O
show	O	O
high	O	O
reproducibility	O	O
and	O	O
can	O	O
be	O	O
used	O	O
to	O	O
analyse	O	O
directly	O	O
pathogen/epithelial	O	O
cell	O	O
interactions	O	O
.	O	O

However	O	O
,	O	O
the	O	O
system	O	O
is	O	O
also	O	O
very	O	O
flexible	O	O
.	O	O

Using	O	O
histological	O	O
,	O	O
biochemical	O	O
,	O	O
immunological	O	O
,	O	O
and	O	O
molecular	O	O
methods	O	O
,	O	O
it	O	O
is	O	O
possible	O	O
to	O	O
analyse	O	O
several	O	O
stages	O	O
of	O	O
infection	O	O
by	O	O
C.	O	O
albicans	O	O
wild	O	O
type	O	O
or	O	O
mutant	O	O
strains	O	O
and	O	O
demonstrate	O	O
the	O	O
consequence	O	O
of	O	O
disrupting	O	O
genes	O	O
encoding	O	O
putative	O	O
virulence	O	O
factors	O	O
required	O	O
for	O	O
host	O	O
cell	O	O
invasion	O	O
and	O	O
immune	O	O
defence	O	O
induction	O	O
.	O	O

This	O	O
model	O	O
provides	O	O
information	O	O
about	O	O
host	O	O
and	O	O
pathogen	O	O
protein	O	O
and	O	O
gene	O	O
expression	O	O
during	O	O
direct	O	O
interactions	O	O
with	O	O
each	O	O
other	O	O
.	O	O

It	O	O
can	O	O
additionally	O	O
be	O	O
supplemented	O	O
with	O	O
other	O	O
host	O	O
factors	O	O
,	O	O
such	O	O
as	O	O
immune	O	O
cells	O	O
,	O	O
saliva	O	O
,	O	O
and	O	O
probiotic	O	O
bacteria	O	O
,	O	O
which	O	O
are	O	O
relevant	O	O
for	O	O
host	O	O
immune	O	O
defence	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Granulicatella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
facultative	O	O
anaerobic	O	O
,	O	O
catalase-negative	O	O
Gram-positive	O	O
cocci	O	O
,	O	O
oral	O	O
microbiome	O	O
researches	O	O
find	O	O
out	O	O
Granulicatella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
are	O	O
dominant	O	O
bacteria	O	O
in	O	O
oral	O	O
cavity	O	O
which	O	O
may	O	O
cause	O	O
opportunistic	O	O
infection	O	O
like	O	O
periodontal	O	O
disease	O	O
,	O	O
endodontic	O	O
infection	O	O
.	O	O

This	O	O
review	O	O
summarized	O	O
research	O	O
progress	O	O
of	O	O
Granulicatella	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
.	O	O

The	O	O
development	O	O
of	O	O
multispecies	O	O
biofilm	O	O
models	O	O
are	O	O
needed	O	O
to	O	O
explain	O	O
the	O	O
interactions	O	O
that	O	O
take	O	O
place	O	O
in	O	O
root	O	O
canal	O	O
biofilms	O	O
during	O	O
apical	O	O
periodontitis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
ability	O	O
of	O	O
4	O	O
root	O	O
canal	O	O
bacteria	O	O
to	O	O
establish	O	O
a	O	O
multispecies	O	O
biofilm	O	O
community	O	O
and	O	O
to	O	O
characterize	O	O
the	O	O
main	O	O
structural	O	O
,	O	O
compositional	O	O
,	O	O
and	O	O
physiological	O	O
features	O	O
of	O	O
this	O	O
community	O	O
.	O	O

Four	O	O
clinical	O	O
isolates	O	O
isolated	O	O
from	O	O
infected	O	O
root	O	O
canals	O	O
,	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
,	O	O
Lactobacillus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
,	O	O
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
were	O	O
grown	O	O
together	O	O
in	O	O
a	O	O
miniflow	O	O
cell	O	O
system	O	O
.	O	O

Simultaneous	O	O
detection	O	O
of	O	O
the	O	O
4	O	O
species	O	O
in	O	O
the	O	O
biofilm	O	O
communities	O	O
was	O	O
achieved	O	O
by	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
in	O	O
combination	O	O
with	O	O
confocal	O	O
microscopy	O	O
at	O	O
different	O	O
time	O	O
points	O	O
.	O	O

The	O	O
LIVE/DEAD	O	O
BacLight	O	O
technique	O	O
(	O	O
Molecular	O	O
Probes	O	O
,	O	O
Carlsbad	O	O
,	O	O
CA	O	O
)	O	O
was	O	O
used	O	O
to	O	O
assess	O	O
cell	O	O
viability	O	O
and	O	O
to	O	O
calculate	O	O
3-dimensional	O	O
architectural	O	O
parameters	O	O
such	O	O
as	O	O
biovolume	O	O
(	O	O
mum	O	O
(	O	O
3	O	O
)	O	O
)	O	O
.	O	O

Redox	O	O
fluorescence	O	O
dye	O	O
5-cyano-2,3-ditolyl	O	O
tetrazolium	O	O
chloride	O	O
was	O	O
used	O	O
to	O	O
assess	O	O
the	O	O
metabolic	O	O
activity	O	O
of	O	O
biofilm	O	O
bacteria	O	O
.	O	O

The	O	O
4	O	O
species	O	O
tested	O	O
were	O	O
able	O	O
to	O	O
form	O	O
stable	O	O
and	O	O
reproducible	O	O
biofilm	O	O
communities	O	O
.	O	O

The	O	O
biofilms	O	O
formed	O	O
in	O	O
rich	O	O
medium	O	O
generally	O	O
showed	O	O
continuous	O	O
growth	O	O
over	O	O
time	O	O
,	O	O
however	O	O
,	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
glucose	O	O
biofilms	O	O
showed	O	O
significantly	O	O
smaller	O	O
biovolumes	O	O
.	O	O

A	O	O
high	O	O
proportion	O	O
of	O	O
viable	O	O
cells	O	O
(	O	O
>	O	O
90	O	O
%	O	O
)	O	O
were	O	O
generally	O	O
observed	O	O
,	O	O
and	O	O
biofilm	O	O
growth	O	O
was	O	O
correlated	O	O
with	O	O
high	O	O
metabolic	O	O
activity	O	O
of	O	O
cells	O	O
.	O	O

The	O	O
community	O	O
structure	O	O
of	O	O
biofilms	O	O
formed	O	O
in	O	O
rich	O	O
medium	O	O
did	O	O
not	O	O
change	O	O
considerably	O	O
over	O	O
the	O	O
120-hour	O	O
period	O	O
,	O	O
during	O	O
which	O	O
E.	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
and	O	O
S.	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
were	O	O
most	O	O
abundant	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
4	O	O
root	O	O
canal	O	O
bacteria	O	O
to	O	O
form	O	O
multispecies	O	O
biofilm	O	O
communities	O	O
shown	O	O
in	O	O
this	O	O
study	O	O
give	O	O
insights	O	O
into	O	O
assessing	O	O
the	O	O
community	O	O
lifestyle	O	O
of	O	O
these	O	O
microorganisms	O	O
in	O	O
vivo	O	O
.	O	O

This	O	O
multispecies	O	O
model	O	O
could	O	O
be	O	O
useful	O	O
for	O	O
further	O	O
research	O	O
simulating	O	O
stresses	O	O
representative	O	O
of	O	O
in	O	O
vivo	O	O
conditions	O	O
.	O	O

Both	O	O
hydrogen	O	O
sulfide	O	O
(	O	O
H2S	O	O
)	O	O
and	O	O
methyl	O	O
mercaptan	O	O
(	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
)	O	O
are	O	O
frequently	O	O
detected	O	O
in	O	O
large	O	O
amounts	O	O
in	O	O
malodorous	O	O
mouth	O	O
air	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
bacterial	O	O
composition	O	O
of	O	O
saliva	O	O
of	O	O
30	O	O
subjects	O	O
with	O	O
severe	O	O
oral	O	O
malodor	O	O
exhibiting	O	O
extreme	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH/H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
ratios	O	O
(	O	O
high	O	O
H	O	O
(	O	O
2	O	O
)	O	O
S	O	O
but	O	O
low	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
concentrations	O	O
,	O	O
n	O	O
5	O	O
14	O	O
;	O	O
high	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
but	O	O
low	O	O
H2S	O	O
concentrations	O	O
,	O	O
n	O	O
5	O	O
16	O	O
)	O	O
and	O	O
13	O	O
subjects	O	O
without	O	O
malodor	O	O
,	O	O
using	O	O
barcoded	O	O
pyrosequencing	O	O
analysis	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
.	O	O

Phylogenetic	O	O
community	O	O
analysis	O	O
with	O	O
the	O	O
UniFrac	O	O
distance	O	O
metric	O	O
revealed	O	O
a	O	O
distinct	O	O
bacterial	O	O
community	O	O
structure	O	O
in	O	O
each	O	O
malodor	O	O
group	O	O
.	O	O

The	O	O
H2S	O	O
group	O	O
showed	O	O
higher	O	O
proportions	O	O
of	O	O
the	O	O
genera	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Fusobacterium	B-bacteria	B-bacteria
,	O	O
Porphyromonas	B-bacteria	B-bacteria
and	O	O
SR1	B-bacteria	B-bacteria
than	O	O
the	O	O
other	O	O
two	O	O
groups	O	O
,	O	O
whereas	O	O
the	O	O
CH	O	O
(	O	O
3	O	O
)	O	O
SH	O	O
group	O	O
had	O	O
higher	O	O
proportions	O	O
of	O	O
the	O	O
genera	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Atopobium	B-bacteria	B-bacteria
,	O	O
Megasphaera	B-bacteria	B-bacteria
,	O	O
and	O	O
Selenomonas	B-bacteria	B-bacteria
.	O	O

Our	O	O
results	O	O
suggested	O	O
that	O	O
distinct	O	O
bacterial	O	O
populations	O	O
in	O	O
the	O	O
oral	O	O
microbiota	O	O
are	O	O
involved	O	O
in	O	O
production	O	O
of	O	O
high	O	O
levels	O	O
of	O	O
H2S	O	O
and	O	O
CH3SH	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

In	O	O
1986	O	O
,	O	O
oral	O	O
microbiology	O	O
,	O	O
and	O	O
especially	O	O
the	O	O
microbiology	O	O
of	O	O
periodontal	O	O
infections	O	O
,	O	O
was	O	O
of	O	O
central	O	O
importance	O	O
.	O	O

Interest	O	O
in	O	O
periodontology	O	O
was	O	O
growing	O	O
rapidly	O	O
and	O	O
with	O	O
it	O	O
,	O	O
interest	O	O
in	O	O
developments	O	O
in	O	O
microbiology	O	O
and	O	O
the	O	O
immunology	O	O
of	O	O
infectious	O	O
diseases	O	O
of	O	O
the	O	O
periodontium	O	O
.	O	O

At	O	O
national	O	O
and	O	O
international	O	O
meetings	O	O
discussions	O	O
took	O	O
place	O	O
concerning	O	O
the	O	O
role	O	O
of	O	O
the	O	O
newly	O	O
discovered	O	O
bacterial	O	O
species	O	O
Actinobacillus	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
and	O	O
the	O	O
role	O	O
of	O	O
antibiotics	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
severe	O	O
periodontitis	O	O
.	O	O

Since	O	O
the	O	O
1980s	O	O
,	O	O
much	O	O
has	O	O
changed	O	O
in	O	O
periodontology	O	O
,	O	O
not	O	O
least	O	O
of	O	O
all	O	O
as	O	O
a	O	O
result	O	O
of	O	O
a	O	O
new	O	O
specialism	O	O
:	O	O
oral	O	O
implantology	O	O
.	O	O

With	O	O
it	O	O
,	O	O
a	O	O
new	O	O
disease	O	O
also	O	O
came	O	O
into	O	O
existence	O	O
:	O	O
peri-implantitis	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
dependence	O	O
of	O	O
the	O	O
condition	O	O
of	O	O
the	O	O
microflora	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
on	O	O
the	O	O
etiology	O	O
of	O	O
xerostomia	O	O
,	O	O
patients'	O	O
sex	O	O
,	O	O
age	O	O
,	O	O
degree	O	O
of	O	O
hyposalivation	O	O
,	O	O
and	O	O
duration	O	O
of	O	O
the	O	O
sense	O	O
of	O	O
dryness	O	O
.	O	O

A	O	O
total	O	O
of	O	O
64	O	O
patients	O	O
with	O	O
complaints	O	O
of	O	O
oral	O	O
dryness	O	O
referred	O	O
to	O	O
the	O	O
Clinic	O	O
of	O	O
Oral	O	O
and	O	O
Dental	O	O
Diseases	O	O
,	O	O
Hospital	O	O
of	O	O
Lithuanian	O	O
University	O	O
of	O	O
Health	O	O
Sciences	O	O
,	O	O
for	O	O
consultation	O	O
during	O	O
the	O	O
period	O	O
from	O	O
2003	O	O
to	O	O
2005	O	O
were	O	O
selected	O	O
for	O	O
the	O	O
study	O	O
.	O	O

The	O	O
etiological	O	O
factors	O	O
of	O	O
xerostomia	O	O
were	O	O
as	O	O
follows	O	O
:	O	O
radiotherapy	O	O
(	O	O
PRT	O	O
)	O	O
to	O	O
the	O	O
maxillofacial	O	O
area	O	O
,	O	O
Sjogren	O	O
's	O	O
syndrome	O	O
(	O	O
SS	O	O
)	O	O
,	O	O
and	O	O
xerogenic	O	O
medications	O	O
,	O	O
tricyclic	O	O
antidepressants	O	O
(	O	O
TCAs	O	O
)	O	O
.	O	O

There	O	O
were	O	O
50	O	O
women	O	O
and	O	O
14	O	O
men	O	O
.	O	O

Their	O	O
mean	O	O
age	O	O
was	O	O
60.5	O	O
+/-	O	O
1.6	O	O
years	O	O
.	O	O

All	O	O
the	O	O
patients	O	O
in	O	O
the	O	O
PRT	O	O
group	O	O
had	O	O
high	O	O
counts	O	O
of	O	O
Candida	O	O
spp	O	O
.	O	O
as	O	O
compared	O	O
with	O	O
percentages	O	O
of	O	O
patients	O	O
in	O	O
the	O	O
TCA	O	O
and	O	O
SS	O	O
groups	O	O
(	O	O
100	O	O
%	O	O
vs.	O	O
66.7	O	O
%	O	O
and	O	O
56.2	O	O
%	O	O
,	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Patients'	O	O
age	O	O
and	O	O
sex	O	O
in	O	O
different	O	O
etiology	O	O
groups	O	O
had	O	O
no	O	O
significant	O	O
impact	O	O
on	O	O
the	O	O
condition	O	O
of	O	O
their	O	O
oral	O	O
microflora	O	O
.	O	O

There	O	O
were	O	O
equal	O	O
percentages	O	O
of	O	O
patients	O	O
with	O	O
deficient	O	O
and	O	O
normal	O	O
salivation	O	O
in	O	O
the	O	O
TCA	O	O
group	O	O
(	O	O
44	O	O
%	O	O
in	O	O
both	O	O
the	O	O
groups	O	O
;	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

All	O	O
the	O	O
patients	O	O
in	O	O
the	O	O
PRT	O	O
group	O	O
had	O	O
pronounced	O	O
hyposalivation	O	O
(	O	O
P	O	O
<	O	O
0.002	O	O
)	O	O
.	O	O

A	O	O
significantly	O	O
greater	O	O
percentage	O	O
of	O	O
patients	O	O
with	O	O
severely	O	O
reduced	O	O
salivation	O	O
had	O	O
high	O	O
counts	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
.	O	O

Significantly	O	O
greater	O	O
percentages	O	O
of	O	O
patients	O	O
with	O	O
the	O	O
clinical	O	O
duration	O	O
of	O	O
xerostomia	O	O
of	O	O
up	O	O
to	O	O
6	O	O
months	O	O
had	O	O
high	O	O
counts	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
and	O	O
Candida	O	O
spp	O	O
.	O	O
colonies	O	O
.	O	O

In	O	O
patients	O	O
with	O	O
xerostomia	O	O
,	O	O
the	O	O
condition	O	O
of	O	O
the	O	O
microflora	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
and	O	O
impairment	O	O
of	O	O
major	O	O
salivary	O	O
gland	O	O
function	O	O
varied	O	O
according	O	O
to	O	O
the	O	O
etiology	O	O
of	O	O
the	O	O
disease	O	O
.	O	O

The	O	O
level	O	O
of	O	O
hyposalivation	O	O
and	O	O
the	O	O
duration	O	O
of	O	O
xerostomia	O	O
were	O	O
found	O	O
to	O	O
have	O	O
a	O	O
significant	O	O
impact	O	O
on	O	O
the	O	O
microflora	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Oral	O	O
dryness	O	O
can	O	O
contribute	O	O
to	O	O
several	O	O
diseases	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
the	O	O
subjective	O	O
oral	O	O
dryness	O	O
,	O	O
salivary	O	O
flow	O	O
rates	O	O
,	O	O
the	O	O
number	O	O
of	O	O
oral	O	O
microbiota	O	O
,	O	O
and	O	O
the	O	O
dental	O	O
status	O	O
between	O	O
medicated	O	O
hypertensive	O	O
patients	O	O
and	O	O
control	O	O
subjects	O	O
.	O	O

Four	O	O
hundred	O	O
subjects	O	O
including	O	O
200	O	O
ambulatory	O	O
hypertensive	O	O
patients	O	O
who	O	O
were	O	O
taking	O	O
antihypertensive	O	O
medications	O	O
and	O	O
200	O	O
control	O	O
subjects	O	O
were	O	O
included	O	O
.	O	O

Each	O	O
subject	O	O
's	O	O
medical	O	O
history	O	O
was	O	O
reviewed	O	O
.	O	O

The	O	O
subject	O	O
's	O	O
oral	O	O
health	O	O
status	O	O
,	O	O
salivary	O	O
flow	O	O
rate	O	O
,	O	O
and	O	O
the	O	O
number	O	O
of	O	O
oral	O	O
microbiota	O	O
were	O	O
also	O	O
evaluated	O	O
.	O	O

The	O	O
prevalence	O	O
rate	O	O
of	O	O
xerostomia	O	O
in	O	O
the	O	O
medicated	O	O
hypertensive	O	O
group	O	O
was	O	O
50	O	O
%	O	O
whereas	O	O
only	O	O
25.5	O	O
%	O	O
of	O	O
the	O	O
control	O	O
group	O	O
had	O	O
xerostomia	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Using	O	O
modified	O	O
Schirmer	O	O
test	O	O
(	O	O
MST	O	O
)	O	O
,	O	O
the	O	O
mean	O	O
unstimulated	O	O
salivary	O	O
flow	O	O
rate	O	O
of	O	O
the	O	O
medicated	O	O
hypertensive	O	O
group	O	O
(	O	O
23.11	O	O
+/-	O	O
6.08	O	O
mm/3	O	O
min	O	O
)	O	O
was	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
the	O	O
control	O	O
group	O	O
(	O	O
31.30	O	O
+/-	O	O
3.36	O	O
mm/3	O	O
min	O	O
)	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
mean	O	O
stimulated	O	O
salivary	O	O
flow	O	O
rate	O	O
of	O	O
the	O	O
medicated	O	O
hypertensive	O	O
group	O	O
(	O	O
0.73	O	O
+/-	O	O
0.30	O	O
ml/min	O	O
)	O	O
was	O	O
also	O	O
significantly	O	O
lower	O	O
than	O	O
that	O	O
of	O	O
the	O	O
control	O	O
group	O	O
(	O	O
1.31	O	O
+/-	O	O
0.34	O	O
mi/min	O	O
)	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

The	O	O
strongest	O	O
associated	O	O
factor	O	O
for	O	O
dry	O	O
mouth	O	O
was	O	O
the	O	O
use	O	O
of	O	O
antihypertensive	O	O
medications	O	O
(	O	O
OR	O	O
=	O	O
6.28	O	O
)	O	O
.	O	O

The	O	O
mean	O	O
levels	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
,	O	O
Lactobacilli	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
and	O	O
Candida	O	O
spp	O	O
.	O	O
in	O	O
the	O	O
medicated	O	O
hypertensive	O	O
group	O	O
were	O	O
significantly	O	O
higher	O	O
than	O	O
in	O	O
the	O	O
control	O	O
group	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Furthermore	O	O
,	O	O
medicated	O	O
hypertensive	O	O
patients	O	O
were	O	O
more	O	O
likely	O	O
to	O	O
have	O	O
missing	O	O
teeth	O	O
compared	O	O
to	O	O
control	O	O
subjects	O	O
.	O	O

Xerostomia	O	O
,	O	O
hyposalivation	O	O
,	O	O
and	O	O
increasing	O	O
number	O	O
of	O	O
oral	O	O
microbiota	O	O
were	O	O
more	O	O
prevalent	O	O
in	O	O
hypertensive	O	O
patients	O	O
taking	O	O
antihypertensive	O	O
medications	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
if	O	O
three	O	O
probiotic	O	O
bacteria	O	O
present	O	O
in	O	O
the	O	O
milk	O	O
product	O	O
Cultura	O	O
Dofilus	O	O
(	O	O
R	O	O
)	O	O
naturell	O	O
could	O	O
be	O	O
detected	O	O
in	O	O
saliva	O	O
and	O	O
on	O	O
oral	O	O
mucosal	O	O
surfaces	O	O
,	O	O
and	O	O
if	O	O
they	O	O
colonized	O	O
dental	O	O
surfaces	O	O
in	O	O
situ	O	O
in	O	O
8	O	O
caries-inactive	O	O
individuals	O	O
after	O	O
8	O	O
daily	O	O
exposures	O	O
to	O	O
the	O	O
milk	O	O
product	O	O
for	O	O
up	O	O
to	O	O
3	O	O
days	O	O
.	O	O

Bacteria	O	O
were	O	O
identified	O	O
by	O	O
fluorescence	O	O
in	O	O
situ	O	O
hybridization	O	O
and	O	O
confocal	O	O
laser	O	O
scanning	O	O
microscopy	O	O
.	O	O

While	O	O
probiotic	O	O
bacteria	O	O
were	O	O
present	O	O
sporadically	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
on	O	O
mucosal	O	O
surfaces	O	O
and	O	O
in	O	O
saliva	O	O
after	O	O
3	O	O
days	O	O
of	O	O
frequent	O	O
use	O	O
of	O	O
the	O	O
probiotic	O	O
milk	O	O
,	O	O
they	O	O
were	O	O
not	O	O
detected	O	O
on	O	O
dental	O	O
surfaces	O	O
.	O	O

Probiotic	O	O
bacteria	O	O
may	O	O
thus	O	O
contribute	O	O
to	O	O
general	O	O
oral	O	O
health	O	O
,	O	O
but	O	O
their	O	O
potential	O	O
role	O	O
in	O	O
biofilm-induced	O	O
dental	O	O
diseases	O	O
remains	O	O
unclear	O	O
.	O	O

Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
is	O	O
a	O	O
gram-negative	O	O
periodontopathogen	O	O
found	O	O
within	O	O
the	O	O
subgingival	O	O
plaque	O	O
on	O	O
the	O	O
tooth	O	O
surface	O	O
.	O	O

It	O	O
is	O	O
associated	O	O
with	O	O
localized	O	O
aggressive	O	O
periodontitis	O	O
,	O	O
a	O	O
severe	O	O
form	O	O
of	O	O
periodontitis	O	O
in	O	O
adolescents	O	O
,	O	O
and	O	O
is	O	O
the	O	O
cause	O	O
various	O	O
extra-oral	O	O
infections	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
this	O	O
organism	O	O
to	O	O
tenaciously	O	O
adhere	O	O
to	O	O
abiotic	O	O
surfaces	O	O
has	O	O
been	O	O
attributed	O	O
to	O	O
bundle-forming	O	O
type	O	O
IVb-like	O	O
fimbriae	O	O
whose	O	O
major	O	O
component	O	O
is	O	O
the	O	O
fimbrial	O	O
lower	O	O
molecular	O	O
weight	O	O
protein	O	O
(	O	O
Flp	O	O
)	O	O
.	O	O

In	O	O
this	O	O
study	O	O
the	O	O
adhesion	O	O
of	O	O
purified	O	O
Flp	O	O
fimbriae	O	O
isolated	O	O
from	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
to	O	O
materials	O	O
with	O	O
different	O	O
surface	O	O
chemistries	O	O
was	O	O
measured	O	O
using	O	O
atomic	O	O
force	O	O
microscopy	O	O
(	O	O
AFM	O	O
)	O	O
.	O	O

The	O	O
adhesion	O	O
of	O	O
Flp	O	O
fimbriae	O	O
to	O	O
uncoated	O	O
and	O	O
saliva-coated	O	O
tooth	O	O
,	O	O
hydroxylapatite	O	O
,	O	O
and	O	O
glass	O	O
surfaces	O	O
was	O	O
compared	O	O
.	O	O

Force	O	O
data	O	O
were	O	O
used	O	O
to	O	O
quantify	O	O
the	O	O
magnitude	O	O
of	O	O
adhesion	O	O
of	O	O
the	O	O
fimbriae	O	O
and	O	O
force-distance	O	O
profiles	O	O
were	O	O
used	O	O
to	O	O
predict	O	O
the	O	O
mechanisms	O	O
of	O	O
adhesion	O	O
.	O	O

The	O	O
results	O	O
of	O	O
this	O	O
study	O	O
confirm	O	O
that	O	O
non-specific	O	O
interactions	O	O
likely	O	O
dominate	O	O
the	O	O
adhesion	O	O
of	O	O
these	O	O
fimbriae	O	O
to	O	O
the	O	O
surfaces	O	O
used	O	O
in	O	O
this	O	O
study	O	O
.	O	O

However	O	O
,	O	O
force	O	O
data	O	O
indicate	O	O
that	O	O
non-specific	O	O
electrostatic	O	O
interactions	O	O
may	O	O
be	O	O
more	O	O
significant	O	O
under	O	O
the	O	O
conditions	O	O
used	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Salivary	O	O
coatings	O	O
did	O	O
affect	O	O
both	O	O
the	O	O
hydrophobicity	O	O
and	O	O
adhesion	O	O
of	O	O
these	O	O
fimbriae	O	O
to	O	O
the	O	O
surfaces	O	O
used	O	O
in	O	O
this	O	O
study	O	O
.	O	O

Additionally	O	O
,	O	O
these	O	O
data	O	O
demonstrate	O	O
the	O	O
affect	O	O
of	O	O
salivary	O	O
proteins	O	O
on	O	O
bacterial	O	O
adhesion	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

Many	O	O
human	O	O
microbial	O	O
infectious	O	O
diseases	O	O
including	O	O
dental	O	O
caries	O	O
are	O	O
polymicrobial	O	O
in	O	O
nature	O	O
.	O	O

How	O	O
these	O	O
complex	O	O
multi-species	O	O
communities	O	O
evolve	O	O
from	O	O
a	O	O
healthy	O	O
to	O	O
a	O	O
diseased	O	O
state	O	O
is	O	O
not	O	O
well	O	O
understood	O	O
.	O	O

Although	O	O
many	O	O
health-	O	O
or	O	O
disease-associated	O	O
oral	O	O
bacteria	O	O
have	O	O
been	O	O
characterized	O	O
in	O	O
vitro	O	O
,	O	O
their	O	O
physiology	O	O
within	O	O
the	O	O
complex	O	O
oral	O	O
microbiome	O	O
is	O	O
difficult	O	O
to	O	O
determine	O	O
with	O	O
current	O	O
approaches	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
about	O	O
half	O	O
of	O	O
these	O	O
species	O	O
remain	O	O
uncultivated	O	O
to	O	O
date	O	O
with	O	O
little	O	O
known	O	O
besides	O	O
their	O	O
16S	O	O
rRNA	O	O
sequence	O	O
.	O	O

Lacking	O	O
culture-based	O	O
physiological	O	O
analyses	O	O
,	O	O
the	O	O
functional	O	O
roles	O	O
of	O	O
uncultivated	O	O
species	O	O
will	O	O
remain	O	O
enigmatic	O	O
despite	O	O
their	O	O
apparent	O	O
disease	O	O
correlation	O	O
.	O	O

To	O	O
start	O	O
addressing	O	O
these	O	O
knowledge	O	O
gaps	O	O
,	O	O
we	O	O
applied	O	O
a	O	O
combination	O	O
of	O	O
Magnetic	O	O
Resonance	O	O
Spectroscopy	O	O
(	O	O
MRS	O	O
)	O	O
with	O	O
RNA	O	O
and	O	O
DNA	O	O
based	O	O
Stable	O	O
Isotope	O	O
Probing	O	O
(	O	O
SIP	O	O
)	O	O
to	O	O
oral	O	O
plaque	O	O
communities	O	O
from	O	O
healthy	O	O
children	O	O
for	O	O
in	O	O
vitro	O	O
temporal	O	O
monitoring	O	O
of	O	O
metabolites	O	O
and	O	O
identification	O	O
of	O	O
metabolically	O	O
active	O	O
and	O	O
inactive	O	O
bacterial	O	O
species	O	O
.	O	O

Supragingival	O	O
plaque	O	O
samples	O	O
from	O	O
caries-free	O	O
children	O	O
incubated	O	O
with	O	O
(	O	O
13	O	O
)	O	O
C-substrates	O	O
under	O	O
imposed	O	O
healthy	O	O
(	O	O
buffered	O	O
,	O	O
pH	O	O
7	O	O
)	O	O
and	O	O
diseased	O	O
states	O	O
(	O	O
pH	O	O
5.5	O	O
and	O	O
pH	O	O
4.5	O	O
)	O	O
produced	O	O
lactate	O	O
as	O	O
the	O	O
dominant	O	O
organic	O	O
acid	O	O
from	O	O
glucose	O	O
metabolism	O	O
.	O	O

Rapid	O	O
lactate	O	O
utilization	O	O
upon	O	O
glucose	O	O
depletion	O	O
was	O	O
observed	O	O
under	O	O
pH	O	O
7	O	O
conditions	O	O
.	O	O

SIP	O	O
analyses	O	O
revealed	O	O
a	O	O
number	O	O
of	O	O
genera	O	O
containing	O	O
cultured	O	O
and	O	O
uncultivated	O	O
taxa	O	O
with	O	O
metabolic	O	O
capabilities	O	O
at	O	O
pH	O	O
5.5	O	O
.	O	O

The	O	O
diversity	O	O
of	O	O
active	O	O
species	O	O
decreased	O	O
significantly	O	O
at	O	O
pH	O	O
4.5	O	O
and	O	O
was	O	O
dominated	O	O
by	O	O
Lactobacillus	B-bacteria	B-bacteria
and	O	O
Propionibacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
,	O	O
both	O	O
of	O	O
which	O	O
have	O	O
been	O	O
previously	O	O
found	O	O
within	O	O
carious	O	O
lesions	O	O
from	O	O
children	O	O
.	O	O

Our	O	O
approach	O	O
allowed	O	O
for	O	O
identification	O	O
of	O	O
species	O	O
that	O	O
metabolize	O	O
carbohydrates	O	O
under	O	O
different	O	O
pH	O	O
conditions	O	O
and	O	O
supports	O	O
the	O	O
importance	O	O
of	O	O
Lactobacilli	B-bacteria	B-bacteria
and	O	O
Propionibacterium	B-bacteria	B-bacteria
in	O	O
the	O	O
development	O	O
of	O	O
childhood	O	O
caries	O	O
.	O	O

Identification	O	O
of	O	O
species	O	O
within	O	O
healthy	O	O
subjects	O	O
that	O	O
are	O	O
active	O	O
at	O	O
low	O	O
pH	O	O
can	O	O
lead	O	O
to	O	O
a	O	O
better	O	O
understanding	O	O
of	O	O
oral	O	O
caries	O	O
onset	O	O
and	O	O
generate	O	O
appropriate	O	O
targets	O	O
for	O	O
preventative	O	O
measures	O	O
in	O	O
the	O	O
early	O	O
stages	O	O
.	O	O

This	O	O
randomized	O	O
double-blind	O	O
clinical	O	O
study	O	O
evaluated	O	O
the	O	O
antimicrobial	O	O
efficacy	O	O
of	O	O
two	O	O
mouthwashes	O	O
containing	O	O
(	O	O
1	O	O
)	O	O
0.075	O	O
%	O	O
cetylpyridinium	O	O
chloride	O	O
(	O	O
CPC	O	O
)	O	O
+	O	O
0.05	O	O
%	O	O
sodium	O	O
fluoride	O	O
(	O	O
NaF	O	O
)	O	O
in	O	O
an	O	O
alcohol-free	O	O
base	O	O
and	O	O
(	O	O
2	O	O
)	O	O
0.075	O	O
%	O	O
CPC	O	O
+	O	O
0.05	O	O
%	O	O
NaF	O	O
in	O	O
a	O	O
6	O	O
%	O	O
alcohol	O	O
base	O	O
,	O	O
versus	O	O
a	O	O
negative	O	O
control	O	O
mouthwash	O	O
containing	O	O
0.05	O	O
%	O	O
NaF	O	O
in	O	O
an	O	O
alcohol-free	O	O
base	O	O
on	O	O
numbers	O	O
of	O	O
bacteria	O	O
in	O	O
supragingival	O	O
plaque	O	O
12	O	O
hours	O	O
after	O	O
a	O	O
single	O	O
use	O	O
and	O	O
12	O	O
hours	O	O
after	O	O
14	O	O
days	O	O
'	O	O
use	O	O
.	O	O

Enrolled	O	O
subjects	O	O
completed	O	O
a	O	O
one-week	O	O
washout	O	O
phase	O	O
prior	O	O
to	O	O
providing	O	O
baseline	O	O
samples	O	O
of	O	O
supragingival	O	O
plaque	O	O
that	O	O
were	O	O
analyzed	O	O
for	O	O
numbers	O	O
of	O	O
anaerobic	O	O
microorganisms	O	O
.	O	O

Subjects	O	O
were	O	O
randomized	O	O
to	O	O
a	O	O
treatment	O	O
group	O	O
and	O	O
instructed	O	O
to	O	O
rinse	O	O
with	O	O
20	O	O
mL	O	O
of	O	O
the	O	O
assigned	O	O
mouthwash	O	O
for	O	O
30	O	O
seconds	O	O
.	O	O

Post-treatment	O	O
microbiological	O	O
analyses	O	O
were	O	O
conducted	O	O
on	O	O
plaque	O	O
samples	O	O
collected	O	O
12	O	O
hours	O	O
after	O	O
the	O	O
first	O	O
use	O	O
of	O	O
each	O	O
assigned	O	O
mouthwash	O	O
and	O	O
after	O	O
completing	O	O
14	O	O
days	O	O
of	O	O
twice-daily	O	O
use	O	O
of	O	O
each	O	O
assigned	O	O
mouthwash	O	O
.	O	O

Oral	O	O
examinations	O	O
were	O	O
completed	O	O
by	O	O
a	O	O
dentist	O	O
at	O	O
each	O	O
sample	O	O
collection	O	O
to	O	O
assess	O	O
soft	O	O
and	O	O
hard	O	O
tissue	O	O
oral	O	O
health	O	O
over	O	O
the	O	O
course	O	O
of	O	O
the	O	O
study	O	O
.	O	O

The	O	O
study	O	O
enrolled	O	O
188	O	O
adults	O	O
(	O	O
mean	O	O
age	O	O
45.78	O	O
years	O	O
;	O	O
age	O	O
range	O	O
23-69	O	O
)	O	O
.	O	O

Subjects	O	O
rinsing	O	O
with	O	O
the	O	O
CPC-containing	O	O
mouthwash	O	O
realized	O	O
a	O	O
statistically	O	O
significant	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
reduction	O	O
in	O	O
numbers	O	O
of	O	O
supragingival	O	O
anaerobic	O	O
bacteria	O	O
at	O	O
the	O	O
12-hour	O	O
evaluation	O	O
after	O	O
a	O	O
single	O	O
use	O	O
.	O	O

In	O	O
comparison	O	O
to	O	O
the	O	O
control	O	O
mouthwash	O	O
,	O	O
use	O	O
of	O	O
the	O	O
CPC	O	O
mouthwash	O	O
in	O	O
an	O	O
alcohol	O	O
base	O	O
resulted	O	O
in	O	O
a	O	O
35.3	O	O
%	O	O
reduction	O	O
in	O	O
numbers	O	O
of	O	O
anaerobic	O	O
plaque	O	O
bacteria	O	O
,	O	O
while	O	O
the	O	O
CPC	O	O
mouthwash	O	O
in	O	O
an	O	O
alcohol-free	O	O
base	O	O
demonstrated	O	O
a	O	O
34.5	O	O
%	O	O
reduction	O	O
.	O	O

Further	O	O
,	O	O
the	O	O
analysis	O	O
after	O	O
twice-daily	O	O
use	O	O
for	O	O
14	O	O
days	O	O
indicated	O	O
that	O	O
the	O	O
CPC	O	O
mouthwash	O	O
in	O	O
an	O	O
alcohol	O	O
base	O	O
demonstrated	O	O
a	O	O
73.8	O	O
%	O	O
reduction	O	O
in	O	O
anaerobic	O	O
plaque	O	O
bacteria	O	O
,	O	O
while	O	O
the	O	O
CPC	O	O
mouthwash	O	O
in	O	O
an	O	O
alcohol-free	O	O
base	O	O
demonstrated	O	O
a	O	O
70.9	O	O
%	O	O
reduction	O	O
in	O	O
anaerobic	O	O
plaque	O	O
bacteria	O	O
versus	O	O
the	O	O
control	O	O
mouthwash	O	O
.	O	O

The	O	O
CPC	O	O
mouthwash	O	O
in	O	O
an	O	O
alcohol-free	O	O
base	O	O
reduced	O	O
supragingival	O	O
plaque	O	O
bacteria	O	O
by	O	O
34.5	O	O
%	O	O
and	O	O
70.9	O	O
%	O	O
compared	O	O
to	O	O
the	O	O
control	O	O
mouthwash	O	O
12	O	O
hours	O	O
after	O	O
a	O	O
single	O	O
use	O	O
and	O	O
after	O	O
14	O	O
days	O	O
of	O	O
use	O	O
,	O	O
respectively	O	O
.	O	O

In	O	O
addition	O	O
,	O	O
the	O	O
CPC	O	O
mouthwash	O	O
in	O	O
an	O	O
alcohol	O	O
base	O	O
reduced	O	O
supragingival	O	O
bacteria	O	O
by	O	O
35.3	O	O
%	O	O
and	O	O
73.8	O	O
%	O	O
compared	O	O
to	O	O
the	O	O
control	O	O
mouthwash	O	O
12	O	O
hours	O	O
after	O	O
a	O	O
single	O	O
use	O	O
and	O	O
after	O	O
14	O	O
days	O	O
of	O	O
use	O	O
,	O	O
respectively	O	O
.	O	O

There	O	O
were	O	O
no	O	O
statistically	O	O
significant	O	O
differences	O	O
between	O	O
the	O	O
CPC-containing	O	O
mouthwashes	O	O
at	O	O
either	O	O
of	O	O
the	O	O
post-treatment	O	O
time	O	O
points	O	O
.	O	O

This	O	O
study	O	O
is	O	O
a	O	O
proof	O	O
of	O	O
concept	O	O
to	O	O
determine	O	O
the	O	O
efficacy	O	O
of	O	O
a	O	O
custom-fabricated	O	O
tray	O	O
in	O	O
placing	O	O
antimicrobial	O	O
and	O	O
debriding	O	O
agents	O	O
in	O	O
the	O	O
periodontal	O	O
pockets	O	O
of	O	O
persons	O	O
with	O	O
active	O	O
gingival	O	O
infections	O	O
.	O	O

Localized	O	O
subgingival	O	O
delivery	O	O
of	O	O
antimicrobial	O	O
and	O	O
antibiotic	O	O
agents	O	O
is	O	O
routinely	O	O
employed	O	O
as	O	O
adjunctive	O	O
therapy	O	O
for	O	O
the	O	O
treatment	O	O
and	O	O
management	O	O
of	O	O
periopathogens	O	O
associated	O	O
with	O	O
periodontal	O	O
disease	O	O
.	O	O

Because	O	O
these	O	O
delivery	O	O
techniques	O	O
often	O	O
face	O	O
time	O	O
constraints	O	O
and	O	O
impose	O	O
temporary	O	O
restrictions	O	O
on	O	O
patient	O	O
brushing	O	O
and	O	O
flossing	O	O
,	O	O
a	O	O
custom-formed	O	O
prescription	O	O
dental	O	O
tray	O	O
can	O	O
be	O	O
used	O	O
to	O	O
deliver	O	O
and	O	O
maintain	O	O
medications	O	O
in	O	O
periodontal	O	O
pockets	O	O
between	O	O
office	O	O
visits	O	O
and	O	O
without	O	O
brushing	O	O
or	O	O
flossing	O	O
restrictions	O	O
.	O	O

The	O	O
ability	O	O
of	O	O
this	O	O
tray	O	O
to	O	O
maintain	O	O
sufficient	O	O
concentrations	O	O
of	O	O
medication	O	O
in	O	O
the	O	O
periodontal	O	O
pockets	O	O
to	O	O
have	O	O
a	O	O
therapeutic	O	O
effect	O	O
is	O	O
evaluated	O	O
here	O	O
with	O	O
theoretical	O	O
modeling	O	O
and	O	O
practical	O	O
application	O	O
.	O	O

Hydrogen	O	O
peroxide	O	O
is	O	O
an	O	O
oral	O	O
debriding	O	O
agent	O	O
and	O	O
oral	O	O
wound	O	O
cleanser	O	O
with	O	O
antimicrobial	O	O
properties	O	O
.	O	O

The	O	O
debriding	O	O
effect	O	O
of	O	O
1.7	O	O
%	O	O
hydrogen	O	O
peroxide	O	O
gel	O	O
was	O	O
tested	O	O
in	O	O
vitro	O	O
on	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
biofilm	O	O
using	O	O
glass	O	O
carriers	O	O
for	O	O
collection	O	O
.	O	O

Diffusion	O	O
modeling	O	O
tested	O	O
the	O	O
potential	O	O
of	O	O
the	O	O
customized	O	O
tray	O	O
to	O	O
place	O	O
hydrogen	O	O
peroxide	O	O
gel	O	O
into	O	O
the	O	O
sulcus	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
crevicular	O	O
fluid	O	O
flow	O	O
.	O	O

Changes	O	O
in	O	O
periodontal	O	O
microflora	O	O
with	O	O
scanning	O	O
electron	O	O
microscopy	O	O
analysis	O	O
of	O	O
in	O	O
vivo	O	O
paper	O	O
point	O	O
site	O	O
sampling	O	O
were	O	O
analyzed	O	O
before	O	O
and	O	O
after	O	O
a	O	O
thin	O	O
ribbon	O	O
of	O	O
1.7	O	O
%	O	O
hydrogen	O	O
peroxide	O	O
gel	O	O
(	O	O
approximately	O	O
0.7	O	O
gm	O	O
)	O	O
and	O	O
a	O	O
subtherapeutic	O	O
dose	O	O
(	O	O
three	O	O
drops	O	O
)	O	O
of	O	O
Vibramycin	O	O
(	O	O
50	O	O
mg/5	O	O
ml	O	O
)	O	O
were	O	O
placed	O	O
via	O	O
Perio	O	O
Trays	O	O
into	O	O
periodontal	O	O
pockets	O	O
,	O	O
ranging	O	O
from	O	O
4-8	O	O
mm	O	O
at	O	O
daily	O	O
prescribed	O	O
intervals	O	O
for	O	O
two	O	O
to	O	O
five	O	O
weeks	O	O
.	O	O

In	O	O
vitro	O	O
results	O	O
indicate	O	O
that	O	O
1.7	O	O
%	O	O
hydrogen	O	O
peroxide	O	O
gel	O	O
breaks	O	O
down	O	O
the	O	O
exopolysaccharide	O	O
slime	O	O
and	O	O
cell	O	O
walls	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
and	O	O
begins	O	O
to	O	O
debride	O	O
the	O	O
cells	O	O
from	O	O
glass	O	O
carriers	O	O
within	O	O
10	O	O
minutes	O	O
.	O	O

Diffusion	O	O
modeling	O	O
indicates	O	O
that	O	O
hydrogen	O	O
peroxide	O	O
can	O	O
penetrate	O	O
into	O	O
the	O	O
deeper	O	O
pockets	O	O
(	O	O
9	O	O
mm	O	O
)	O	O
,	O	O
but	O	O
also	O	O
its	O	O
concentration	O	O
in	O	O
these	O	O
deep	O	O
pockets	O	O
will	O	O
increase	O	O
over	O	O
wearing	O	O
time	O	O
in	O	O
the	O	O
absence	O	O
of	O	O
degradation	O	O
by	O	O
peroxidases	O	O
and	O	O
catalase	O	O
.	O	O

Site	O	O
sampling	O	O
data	O	O
confirm	O	O
diffusion	O	O
modeling	O	O
results	O	O
,	O	O
with	O	O
evidence	O	O
that	O	O
medication	O	O
delivered	O	O
with	O	O
the	O	O
prescription	O	O
tray	O	O
reduced	O	O
subgingival	O	O
bacterial	O	O
loads	O	O
and	O	O
enhanced	O	O
healing	O	O
of	O	O
corresponding	O	O
oral	O	O
tissues	O	O
.	O	O

The	O	O
prescription	O	O
Perio	O	O
Tray	O	O
effectively	O	O
placed	O	O
medication	O	O
in	O	O
the	O	O
gingival	O	O
sulcus	O	O
.	O	O

Mathematical	O	O
modeling	O	O
indicated	O	O
Perio	O	O
Tray	O	O
placement	O	O
of	O	O
hydrogen	O	O
peroxide	O	O
gel	O	O
in	O	O
periodontal	O	O
pockets	O	O
with	O	O
depths	O	O
up	O	O
to	O	O
9	O	O
mm	O	O
over	O	O
15	O	O
minutes	O	O
treatment	O	O
time	O	O
was	O	O
theoretically	O	O
possible	O	O
.	O	O

Pathology	O	O
reports	O	O
reveal	O	O
reductions	O	O
in	O	O
subgingival	O	O
bacterial	O	O
loads	O	O
and	O	O
improvements	O	O
in	O	O
pretreatment	O	O
pocket	O	O
depths	O	O
of	O	O
up	O	O
to	O	O
8	O	O
mm	O	O
after	O	O
1.7	O	O
%	O	O
hydrogen	O	O
peroxide	O	O
and	O	O
Vibramycin	O	O
Syrup	O	O
were	O	O
prescribed	O	O
for	O	O
use	O	O
with	O	O
the	O	O
Perio	O	O
Tray	O	O
.	O	O

The	O	O
in	O	O
vitro	O	O
analysis	O	O
indicating	O	O
that	O	O
hydrogen	O	O
peroxide	O	O
is	O	O
the	O	O
active	O	O
and	O	O
effective	O	O
oral	O	O
debriding	O	O
agent	O	O
needs	O	O
to	O	O
be	O	O
confirmed	O	O
with	O	O
additional	O	O
studies	O	O
.	O	O

Noma	O	O
is	O	O
a	O	O
gangrenous	O	O
disease	O	O
that	O	O
leads	O	O
to	O	O
severe	O	O
disfigurement	O	O
of	O	O
the	O	O
face	O	O
with	O	O
high	O	O
morbidity	O	O
and	O	O
mortality	O	O
,	O	O
but	O	O
its	O	O
etiology	O	O
remains	O	O
unknown	O	O
.	O	O

Young	O	O
children	O	O
in	O	O
developing	O	O
countries	O	O
are	O	O
almost	O	O
exclusively	O	O
affected	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
record	O	O
and	O	O
compare	O	O
bacterial	O	O
diversity	O	O
in	O	O
oral	O	O
samples	O	O
from	O	O
children	O	O
with	O	O
or	O	O
without	O	O
acute	O	O
noma	O	O
or	O	O
acute	O	O
necrotizing	O	O
gingivitis	O	O
from	O	O
a	O	O
defined	O	O
geographical	O	O
region	O	O
in	O	O
Niger	O	O
by	O	O
culture-independent	O	O
molecular	O	O
methods	O	O
.	O	O

Gingival	O	O
samples	O	O
from	O	O
23	O	O
healthy	O	O
children	O	O
,	O	O
nine	O	O
children	O	O
with	O	O
acute	O	O
necrotizing	O	O
gingivitis	O	O
,	O	O
and	O	O
23	O	O
children	O	O
with	O	O
acute	O	O
noma	O	O
(	O	O
both	O	O
healthy	O	O
and	O	O
diseased	O	O
oral	O	O
sites	O	O
)	O	O
were	O	O
amplified	O	O
using	O	O
``	O	O
universal	O	O
''	O	O
PCR	O	O
primers	O	O
for	O	O
the	O	O
16	O	O
S	O	O
rRNA	O	O
gene	O	O
and	O	O
pooled	O	O
according	O	O
to	O	O
category	O	O
(	O	O
noma	O	O
,	O	O
healthy	O	O
,	O	O
or	O	O
acute	O	O
necrotizing	O	O
gingivitis	O	O
)	O	O
,	O	O
gender	O	O
,	O	O
and	O	O
site	O	O
status	O	O
(	O	O
diseased	O	O
or	O	O
control	O	O
site	O	O
)	O	O
.	O	O

Seven	O	O
libraries	O	O
were	O	O
generated	O	O
.	O	O

A	O	O
total	O	O
of	O	O
1237	O	O
partial	O	O
16	O	O
S	O	O
rRNA	O	O
sequences	O	O
representing	O	O
339	O	O
bacterial	O	O
species	O	O
or	O	O
phylotypes	O	O
at	O	O
a	O	O
98-99	O	O
%	O	O
identity	O	O
level	O	O
were	O	O
obtained	O	O
.	O	O

Analysis	O	O
of	O	O
bacterial	O	O
composition	O	O
and	O	O
frequency	O	O
showed	O	O
that	O	O
diseased	O	O
(	O	O
noma	O	O
or	O	O
acute	O	O
necrotizing	O	O
gingivitis	O	O
)	O	O
and	O	O
healthy	O	O
site	O	O
bacterial	O	O
communities	O	O
are	O	O
composed	O	O
of	O	O
similar	O	O
bacteria	O	O
,	O	O
but	O	O
differ	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
a	O	O
limited	O	O
group	O	O
of	O	O
phylotypes	O	O
.	O	O

Large	O	O
increases	O	O
in	O	O
counts	O	O
of	O	O
Prevotella	O	O
intermedia	O	O
and	O	O
members	O	O
of	O	O
the	O	O
Peptostreptococcus	B-bacteria	B-bacteria
genus	E-bacteria	I-bacteria
are	O	O
associated	O	O
with	O	O
disease	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
no	O	O
clear-cut	O	O
differences	O	O
were	O	O
found	O	O
between	O	O
noma	O	O
and	O	O
non-noma	O	O
libraries	O	O
.	O	O

Similarities	O	O
between	O	O
acute	O	O
necrotizing	O	O
gingivitis	O	O
and	O	O
noma	O	O
samples	O	O
support	O	O
the	O	O
hypothesis	O	O
that	O	O
the	O	O
disease	O	O
could	O	O
evolve	O	O
from	O	O
acute	O	O
necrotizing	O	O
gingivitis	O	O
in	O	O
certain	O	O
children	O	O
for	O	O
reasons	O	O
still	O	O
to	O	O
be	O	O
elucidated	O	O
.	O	O

This	O	O
study	O	O
revealed	O	O
oral	O	O
microbiological	O	O
patterns	O	O
associated	O	O
with	O	O
noma	O	O
and	O	O
acute	O	O
necrotizing	O	O
gingivitis	O	O
,	O	O
but	O	O
no	O	O
evidence	O	O
was	O	O
found	O	O
for	O	O
a	O	O
specific	O	O
infection-triggering	O	O
agent	O	O
.	O	O

Although	O	O
oral	O	O
bacteria-associated	O	O
systemic	O	O
diseases	O	O
have	O	O
been	O	O
reported	O	O
,	O	O
association	O	O
between	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
pathogen	O	O
of	O	O
dental	O	O
caries	O	O
,	O	O
and	O	O
ulcerative	O	O
colitis	O	O
(	O	O
UC	O	O
)	O	O
has	O	O
not	O	O
been	O	O
reported	O	O
.	O	O

We	O	O
investigated	O	O
the	O	O
effect	O	O
of	O	O
various	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
on	O	O
dextran	O	O
sodium	O	O
sulfate	O	O
(	O	O
DSS	O	O
)	O	O
-induced	O	O
mouse	O	O
colitis	O	O
.	O	O

Administration	O	O
of	O	O
TW295	O	O
,	O	O
the	O	O
specific	O	O
strain	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
caused	O	O
aggravation	O	O
of	O	O
colitis	O	O
;	O	O
the	O	O
standard	O	O
strain	O	O
,	O	O
MT8148	O	O
did	O	O
not	O	O
.	O	O

Localization	O	O
of	O	O
TW295	O	O
in	O	O
hepatocytes	O	O
in	O	O
liver	O	O
was	O	O
observed	O	O
.	O	O

Increased	O	O
expression	O	O
of	O	O
interferon-gamma	O	O
in	O	O
liver	O	O
was	O	O
also	O	O
noted	O	O
,	O	O
indicating	O	O
that	O	O
the	O	O
liver	O	O
is	O	O
target	O	O
organ	O	O
for	O	O
the	O	O
specific	O	O
strain	O	O
of	O	O
S.	O	O
mutans-mediated	O	O
aggravation	O	O
of	O	O
colitis	O	O
.	O	O

The	O	O
detection	O	O
frequency	O	O
of	O	O
the	O	O
specific	O	O
strains	O	O
in	O	O
UC	O	O
patients	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
in	O	O
healthy	O	O
subjects	O	O
.	O	O

Administration	O	O
of	O	O
the	O	O
specific	O	O
strains	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
isolated	O	O
from	O	O
patients	O	O
caused	O	O
aggravation	O	O
of	O	O
colitis	O	O
.	O	O

Infection	O	O
with	O	O
highly-virulent	O	O
specific	O	O
types	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
might	O	O
be	O	O
a	O	O
potential	O	O
risk	O	O
factor	O	O
in	O	O
the	O	O
aggravation	O	O
of	O	O
UC	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
investigate	O	O
the	O	O
effectiveness	O	O
of	O	O
tablets	O	O
containing	O	O
two	O	O
probiotic	O	O
Lactobacillus	B-bacteria	B-bacteria
reuteri	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
in	O	O
inhibiting	O	O
regrowth	O	O
of	O	O
salivary	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
after	O	O
full-mouth	O	O
disinfection	O	O
(	O	O
FMD	O	O
)	O	O
with	O	O
chlorhexidine	O	O
.	O	O

The	O	O
null	O	O
hypothesis	O	O
was	O	O
that	O	O
the	O	O
levels	O	O
of	O	O
MS	B-bacteria	B-bacteria
would	O	O
not	O	O
differ	O	O
in	O	O
comparison	O	O
with	O	O
a	O	O
placebo	O	O
protocol	O	O
.	O	O

The	O	O
study	O	O
population	O	O
was	O	O
comprised	O	O
of	O	O
62	O	O
young	O	O
adults	O	O
(	O	O
mean	O	O
age	O	O
23	O	O
years	O	O
)	O	O
with	O	O
moderate	O	O
or	O	O
high	O	O
counts	O	O
of	O	O
salivary	O	O
MS	B-bacteria	B-bacteria
who	O	O
volunteered	O	O
after	O	O
informed	O	O
consent	O	O
.	O	O

The	O	O
study	O	O
was	O	O
a	O	O
double-blinded	O	O
randomized	O	O
controlled	O	O
trial	O	O
with	O	O
two	O	O
parallel	O	O
groups	O	O
.	O	O

After	O	O
a	O	O
3-day	O	O
chlorhexidine	O	O
regimen	O	O
,	O	O
the	O	O
subjects	O	O
were	O	O
randomly	O	O
assigned	O	O
to	O	O
a	O	O
test	O	O
group	O	O
(	O	O
n	O	O
=	O	O
32	O	O
)	O	O
with	O	O
probiotic	O	O
lozenges	O	O
(	O	O
2/day	O	O
)	O	O
or	O	O
a	O	O
placebo	O	O
group	O	O
(	O	O
n	O	O
=	O	O
30	O	O
)	O	O
.	O	O

The	O	O
intervention	O	O
period	O	O
was	O	O
6	O	O
weeks	O	O
,	O	O
and	O	O
stimulated	O	O
whole	O	O
saliva	O	O
was	O	O
collected	O	O
at	O	O
baseline	O	O
and	O	O
after	O	O
1	O	O
,	O	O
6	O	O
,	O	O
and	O	O
12	O	O
weeks	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
processed	O	O
for	O	O
MS	B-bacteria	B-bacteria
by	O	O
a	O	O
chair-side	O	O
test	O	O
and	O	O
DNA-DNA	O	O
hybridization	O	O
as	O	O
an	O	O
estimate	O	O
of	O	O
19	O	O
bacterial	O	O
strains	O	O
associated	O	O
with	O	O
oral	O	O
health	O	O
and	O	O
disease	O	O
.	O	O

There	O	O
was	O	O
no	O	O
significant	O	O
difference	O	O
between	O	O
the	O	O
groups	O	O
at	O	O
inclusion	O	O
,	O	O
and	O	O
FMD	O	O
reduced	O	O
the	O	O
salivary	O	O
MS	B-bacteria	B-bacteria
levels	O	O
significantly	O	O
in	O	O
both	O	O
groups	O	O
.	O	O

The	O	O
MS	B-bacteria	B-bacteria
suppression	O	O
lasted	O	O
less	O	O
than	O	O
6	O	O
weeks	O	O
and	O	O
there	O	O
were	O	O
no	O	O
statistical	O	O
differences	O	O
in	O	O
salivary	O	O
MS	B-bacteria	B-bacteria
regrowth	O	O
between	O	O
the	O	O
test	O	O
and	O	O
control	O	O
groups	O	O
at	O	O
any	O	O
of	O	O
the	O	O
follow-ups	O	O
.	O	O

Likewise	O	O
,	O	O
there	O	O
were	O	O
no	O	O
major	O	O
differences	O	O
in	O	O
the	O	O
regrowth	O	O
patterns	O	O
of	O	O
the	O	O
checkerboard	O	O
panel	O	O
between	O	O
the	O	O
two	O	O
groups	O	O
.	O	O

We	O	O
conclude	O	O
that	O	O
daily	O	O
oral	O	O
administration	O	O
of	O	O
L.	B-bacteria	B-bacteria
reuteri	E-bacteria	I-bacteria
did	O	O
not	O	O
seem	O	O
to	O	O
affect	O	O
or	O	O
delay	O	O
the	O	O
regrowth	O	O
of	O	O
salivary	O	O
MS	B-bacteria	B-bacteria
after	O	O
FMD	O	O
with	O	O
chlorhexidine	O	O
.	O	O

Wingless	O	O
proteins	O	O
,	O	O
termed	O	O
Wnt	O	O
,	O	O
are	O	O
involved	O	O
in	O	O
embryonic	O	O
development	O	O
,	O	O
blood	O	O
cell	O	O
differentiation	O	O
,	O	O
and	O	O
tumorigenesis	O	O
.	O	O

In	O	O
mammalian	O	O
hematopoiesis	O	O
,	O	O
Wnt	O	O
signaling	O	O
is	O	O
essential	O	O
for	O	O
stem-cell	O	O
homeostasis	O	O
and	O	O
lymphocyte	O	O
differentiation	O	O
.	O	O

Recent	O	O
studies	O	O
have	O	O
suggested	O	O
that	O	O
these	O	O
molecules	O	O
are	O	O
associated	O	O
with	O	O
cardiovascular	O	O
diseases	O	O
,	O	O
rheumatoid	O	O
arthritis	O	O
,	O	O
and	O	O
osteoarthritis	O	O
.	O	O

Furthermore	O	O
,	O	O
Wnt5a	O	O
signaling	O	O
is	O	O
essential	O	O
for	O	O
the	O	O
general	O	O
inflammatory	O	O
response	O	O
of	O	O
human	O	O
macrophages	O	O
.	O	O

Periodontitis	O	O
is	O	O
a	O	O
chronic	O	O
inflammatory	O	O
disease	O	O
caused	O	O
by	O	O
gram-negative	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
the	O	O
resultant	O	O
host	O	O
immune	O	O
response	O	O
.	O	O

Periodontitis	O	O
is	O	O
characterized	O	O
by	O	O
loss	O	O
of	O	O
tooth-supporting	O	O
structures	O	O
and	O	O
alveolar	O	O
bone	O	O
resorption	O	O
.	O	O

There	O	O
have	O	O
been	O	O
no	O	O
previous	O	O
reports	O	O
on	O	O
Wnt5a	O	O
expression	O	O
in	O	O
periodontitis	O	O
tissue	O	O
,	O	O
and	O	O
only	O	O
few	O	O
study	O	O
reported	O	O
the	O	O
molecular	O	O
mechanisms	O	O
of	O	O
Wnt5a	O	O
expression	O	O
in	O	O
LPS-stimulated	O	O
monocytic	O	O
cells	O	O
.	O	O

Using	O	O
RT-PCR	O	O
,	O	O
we	O	O
demonstrated	O	O
that	O	O
Wnt5a	O	O
mRNA	O	O
expression	O	O
was	O	O
up-regulated	O	O
in	O	O
chronic	O	O
periodontitis	O	O
tissue	O	O
as	O	O
compared	O	O
to	O	O
healthy	O	O
control	O	O
tissue	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS	O	O
induced	O	O
Wnt5a	O	O
mRNA	O	O
in	O	O
the	O	O
human	O	O
monocytic	O	O
cell	O	O
line	O	O
THP-1	O	O
with	O	O
a	O	O
peak	O	O
at	O	O
4	O	O
hrs	O	O
after	O	O
stimulation	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS	O	O
induced	O	O
higher	O	O
up-regulation	O	O
of	O	O
Wnt5a	O	O
mRNA	O	O
than	O	O
E.	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
LPS	O	O
.	O	O

The	O	O
LPS	O	O
receptors	O	O
TLR2	O	O
and	O	O
TLR4	O	O
were	O	O
equally	O	O
expressed	O	O
on	O	O
the	O	O
surface	O	O
of	O	O
THP-1	O	O
cells	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS	O	O
induced	O	O
IkappaBalpha	O	O
degradation	O	O
and	O	O
was	O	O
able	O	O
to	O	O
increase	O	O
the	O	O
NF-kappaB	O	O
binding	O	O
activity	O	O
to	O	O
DNA	O	O
.	O	O

P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS-induced	O	O
Wnt5a	O	O
expression	O	O
was	O	O
inhibited	O	O
by	O	O
NF-kappaB	O	O
inhibitors	O	O
,	O	O
suggesting	O	O
NF-kappaB	O	O
involvement	O	O
.	O	O

Furthermore	O	O
,	O	O
IFN-gamma	O	O
synergistically	O	O
enhanced	O	O
the	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS-induced	O	O
production	O	O
of	O	O
Wnt5a	O	O
.	O	O

Pharmacological	O	O
investigation	O	O
and	O	O
siRNA	O	O
experiments	O	O
showed	O	O
that	O	O
STAT1	O	O
was	O	O
important	O	O
for	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS-induced	O	O
Wnt5a	O	O
expression	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
the	O	O
modulation	O	O
of	O	O
Wnt5a	O	O
expression	O	O
by	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
may	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
the	O	O
periodontal	O	O
inflammatory	O	O
process	O	O
and	O	O
serve	O	O
a	O	O
target	O	O
for	O	O
the	O	O
development	O	O
of	O	O
new	O	O
therapies	O	O
.	O	O

Virulent	O	O
biofilms	O	O
are	O	O
responsible	O	O
for	O	O
a	O	O
range	O	O
of	O	O
infections	O	O
,	O	O
including	O	O
oral	O	O
diseases	O	O
.	O	O

All	O	O
biofilms	O	O
harbor	O	O
a	O	O
microbial-derived	O	O
extracellular-matrix	O	O
.	O	O

The	O	O
exopolysaccharides	O	O
(	O	O
EPS	O	O
)	O	O
formed	O	O
on	O	O
tooth-pellicle	O	O
and	O	O
bacterial	O	O
surfaces	O	O
provide	O	O
binding	O	O
sites	O	O
for	O	O
microorganisms	O	O
;	O	O
eventually	O	O
the	O	O
accumulated	O	O
EPS	O	O
enmeshes	O	O
microbial	O	O
cells	O	O
.	O	O

The	O	O
metabolic	O	O
activity	O	O
of	O	O
the	O	O
bacteria	O	O
within	O	O
this	O	O
matrix	O	O
leads	O	O
to	O	O
acidification	O	O
of	O	O
the	O	O
milieu	O	O
.	O	O

We	O	O
explored	O	O
the	O	O
mechanisms	O	O
through	O	O
which	O	O
the	O	O
Streptococcus	B-bacteria	B-bacteria
mutans-produced	O	O
EPS-matrix	O	O
modulates	O	O
the	O	O
three-dimensional	O	O
(	O	O
3D	O	O
)	O	O
architecture	O	O
and	O	O
the	O	O
population	O	O
shifts	O	O
during	O	O
morphogenesis	O	O
of	O	O
biofilms	O	O
on	O	O
a	O	O
saliva-coated-apatitic	O	O
surface	O	O
using	O	O
a	O	O
mixed-bacterial	O	O
species	O	O
system	O	O
.	O	O

Concomitantly	O	O
,	O	O
we	O	O
examined	O	O
whether	O	O
the	O	O
matrix	O	O
influences	O	O
the	O	O
development	O	O
of	O	O
pH-microenvironments	O	O
within	O	O
intact-biofilms	O	O
using	O	O
a	O	O
novel	O	O
3D	O	O
in	O	O
situ	O	O
pH-mapping	O	O
technique	O	O
.	O	O

Data	O	O
reveal	O	O
that	O	O
the	O	O
production	O	O
of	O	O
the	O	O
EPS-matrix	O	O
helps	O	O
to	O	O
create	O	O
spatial	O	O
heterogeneities	O	O
by	O	O
forming	O	O
an	O	O
intricate	O	O
network	O	O
of	O	O
exopolysaccharide-enmeshed	O	O
bacterial-islets	O	O
(	O	O
microcolonies	O	O
)	O	O
through	O	O
localized	O	O
cell-to-matrix	O	O
interactions	O	O
.	O	O

This	O	O
complex	O	O
3D	O	O
architecture	O	O
creates	O	O
compartmentalized	O	O
acidic	O	O
and	O	O
EPS-rich	O	O
microenvironments	O	O
throughout	O	O
the	O	O
biofilm	O	O
,	O	O
which	O	O
triggers	O	O
the	O	O
dominance	O	O
of	O	O
pathogenic	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
within	O	O
a	O	O
mixed-species	O	O
system	O	O
.	O	O

The	O	O
establishment	O	O
of	O	O
a	O	O
3D-matrix	O	O
and	O	O
EPS-enmeshed	O	O
microcolonies	O	O
were	O	O
largely	O	O
mediated	O	O
by	O	O
the	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
gtfB/gtfC	O	O
genes	O	O
,	O	O
expression	O	O
of	O	O
which	O	O
was	O	O
enhanced	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
Actinomyces	B-bacteria	B-bacteria
naeslundii	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
.	O	O

Acidic	O	O
pockets	O	O
were	O	O
found	O	O
only	O	O
in	O	O
the	O	O
interiors	O	O
of	O	O
bacterial-islets	O	O
that	O	O
are	O	O
protected	O	O
by	O	O
EPS	O	O
,	O	O
which	O	O
impedes	O	O
rapid	O	O
neutralization	O	O
by	O	O
buffer	O	O
(	O	O
pH	O	O
7.0	O	O
)	O	O
.	O	O

As	O	O
a	O	O
result	O	O
,	O	O
regions	O	O
of	O	O
low	O	O
pH	O	O
(	O	O
<	O	O
5.5	O	O
)	O	O
were	O	O
detected	O	O
at	O	O
specific	O	O
locations	O	O
along	O	O
the	O	O
surface	O	O
of	O	O
attachment	O	O
.	O	O

Resistance	O	O
to	O	O
chlorhexidine	O	O
was	O	O
enhanced	O	O
in	O	O
cells	O	O
within	O	O
EPS-microcolony	O	O
complexes	O	O
compared	O	O
to	O	O
those	O	O
outside	O	O
such	O	O
structures	O	O
within	O	O
the	O	O
biofilm	O	O
.	O	O

Our	O	O
results	O	O
illustrate	O	O
the	O	O
critical	O	O
interaction	O	O
between	O	O
matrix	O	O
architecture	O	O
and	O	O
pH	O	O
heterogeneity	O	O
in	O	O
the	O	O
3D	O	O
environment	O	O
.	O	O

The	O	O
formation	O	O
of	O	O
structured	O	O
acidic-microenvironments	O	O
in	O	O
close	O	O
proximity	O	O
to	O	O
the	O	O
apatite-surface	O	O
is	O	O
an	O	O
essential	O	O
factor	O	O
associated	O	O
with	O	O
virulence	O	O
in	O	O
cariogenic-biofilms	O	O
.	O	O

These	O	O
observations	O	O
may	O	O
have	O	O
relevance	O	O
beyond	O	O
the	O	O
mouth	O	O
,	O	O
as	O	O
matrix	O	O
is	O	O
inherent	O	O
to	O	O
all	O	O
biofilms	O	O
.	O	O

Determining	O	O
the	O	O
bacterial	O	O
composition	O	O
of	O	O
the	O	O
canine	O	O
oral	O	O
microbiome	O	O
is	O	O
of	O	O
interest	O	O
for	O	O
two	O	O
primary	O	O
reasons	O	O
.	O	O

First	O	O
,	O	O
while	O	O
the	O	O
human	O	O
oral	O	O
microbiome	O	O
has	O	O
been	O	O
well	O	O
studied	O	O
using	O	O
molecular	O	O
techniques	O	O
,	O	O
the	O	O
oral	O	O
microbiomes	O	O
of	O	O
other	O	O
mammals	O	O
have	O	O
not	O	O
been	O	O
studied	O	O
in	O	O
equal	O	O
depth	O	O
using	O	O
culture	O	O
independent	O	O
methods	O	O
.	O	O

This	O	O
study	O	O
allows	O	O
a	O	O
comparison	O	O
of	O	O
the	O	O
number	O	O
of	O	O
bacterial	O	O
taxa	O	O
,	O	O
based	O	O
on	O	O
16S	O	O
rRNA-gene	O	O
sequence	O	O
comparison	O	O
,	O	O
shared	O	O
between	O	O
humans	O	O
and	O	O
dogs	O	O
,	O	O
two	O	O
divergent	O	O
mammalian	O	O
species	O	O
.	O	O

Second	O	O
,	O	O
canine	O	O
oral	O	O
bacteria	O	O
are	O	O
of	O	O
interest	O	O
to	O	O
veterinary	O	O
and	O	O
human	O	O
medical	O	O
communities	O	O
for	O	O
understanding	O	O
their	O	O
roles	O	O
in	O	O
health	O	O
and	O	O
infectious	O	O
diseases	O	O
.	O	O

The	O	O
bacteria	O	O
involved	O	O
are	O	O
mostly	O	O
unnamed	O	O
and	O	O
not	O	O
linked	O	O
by	O	O
16S	O	O
rRNA-gene	O	O
sequence	O	O
identity	O	O
to	O	O
a	O	O
taxonomic	O	O
scheme	O	O
.	O	O

This	O	O
manuscript	O	O
describes	O	O
the	O	O
analysis	O	O
of	O	O
5,958	O	O
16S	O	O
rRNA-gene	O	O
sequences	O	O
from	O	O
65	O	O
clone	O	O
libraries	O	O
.	O	O

Full	O	O
length	O	O
16S	O	O
rRNA	O	O
reference	O	O
sequences	O	O
have	O	O
been	O	O
obtained	O	O
for	O	O
353	O	O
canine	O	O
bacterial	O	O
taxa	O	O
,	O	O
which	O	O
were	O	O
placed	O	O
in	O	O
14	O	O
bacterial	O	O
phyla	O	O
,	O	O
23	O	O
classes	O	O
,	O	O
37	O	O
orders	O	O
,	O	O
66	O	O
families	O	O
,	O	O
and	O	O
148	O	O
genera	O	O
.	O	O

Eighty	O	O
percent	O	O
of	O	O
the	O	O
taxa	O	O
are	O	O
currently	O	O
unnamed	O	O
.	O	O

The	O	O
bacterial	O	O
taxa	O	O
identified	O	O
in	O	O
dogs	O	O
are	O	O
markedly	O	O
different	O	O
from	O	O
those	O	O
of	O	O
humans	O	O
with	O	O
only	O	O
16.4	O	O
%	O	O
of	O	O
oral	O	O
taxa	O	O
are	O	O
shared	O	O
between	O	O
dogs	O	O
and	O	O
humans	O	O
based	O	O
on	O	O
a	O	O
98.5	O	O
%	O	O
16S	O	O
rRNA	O	O
sequence	O	O
similarity	O	O
cutoff	O	O
.	O	O

This	O	O
indicates	O	O
that	O	O
there	O	O
is	O	O
a	O	O
large	O	O
divergence	O	O
in	O	O
the	O	O
bacteria	O	O
comprising	O	O
the	O	O
oral	O	O
microbiomes	O	O
of	O	O
divergent	O	O
mammalian	O	O
species	O	O
.	O	O

The	O	O
historic	O	O
practice	O	O
of	O	O
identifying	O	O
animal	O	O
associated	O	O
bacteria	O	O
based	O	O
on	O	O
phenotypic	O	O
similarities	O	O
to	O	O
human	O	O
bacteria	O	O
is	O	O
generally	O	O
invalid	O	O
.	O	O

This	O	O
report	O	O
describes	O	O
the	O	O
diversity	O	O
of	O	O
the	O	O
canine	O	O
oral	O	O
microbiome	O	O
and	O	O
provides	O	O
a	O	O
provisional	O	O
16S	O	O
rRNA	O	O
based	O	O
taxonomic	O	O
scheme	O	O
for	O	O
naming	O	O
and	O	O
identifying	O	O
unnamed	O	O
canine	O	O
bacterial	O	O
taxa	O	O
.	O	O

Objective	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
evaluate	O	O
the	O	O
changes	O	O
of	O	O
the	O	O
oral	O	O
microbial	O	O
flora	O	O
,	O	O
concentrating	O	O
on	O	O
the	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
after	O	O
the	O	O
first	O	O
3	O	O
and	O	O
6	O	O
months	O	O
of	O	O
orthodontic	O	O
treatment	O	O
.	O	O

40	O	O
patients	O	O
,	O	O
aged	O	O
7-17	O	O
,	O	O
that	O	O
presented	O	O
for	O	O
orthodontic	O	O
treatment	O	O
between	O	O
April	O	O
and	O	O
September	O	O
2010	O	O
in	O	O
the	O	O
Department	O	O
of	O	O
Orthodontics	O	O
and	O	O
Dento-Facial	O	O
Orthopedics	O	O
of	O	O
``	O	O
Carol	O	O
Davila	O	O
''	O	O
University	O	O
of	O	O
Medicine	O	O
and	O	O
Pharmacy	O	O
,	O	O
Bucharest	O	O
have	O	O
been	O	O
selected	O	O
.	O	O

According	O	O
to	O	O
the	O	O
protocol	O	O
,	O	O
coronary	O	O
and	O	O
subgingival	O	O
plaque	O	O
was	O	O
collected	O	O
from	O	O
the	O	O
dental	O	O
surface	O	O
before	O	O
starting	O	O
any	O	O
orthodontic	O	O
treatment	O	O
(	O	O
T0	O	O
)	O	O
,	O	O
3	O	O
months	O	O
after	O	O
wearing	O	O
orthodontic	O	O
appliances	O	O
(	O	O
T1	O	O
)	O	O
and	O	O
6	O	O
months	O	O
after	O	O
wearing	O	O
orthodontic	O	O
appliances	O	O
(	O	O
T2	O	O
)	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
studied	O	O
in	O	O
Cantacuzino	O	O
National	O	O
Institute	O	O
of	O	O
Research-Development	O	O
for	O	O
Microbiology	O	O
and	O	O
Immunology	O	O
[	O	O
isolation	O	O
on	O	O
Columbia	O	O
agar	O	O
with	O	O
5	O	O
%	O	O
sheep	O	O
blood	O	O
,	O	O
identification	O	O
on	O	O
morphotinctorial	O	O
,	O	O
growth	O	O
and	O	O
biochemical	O	O
characteristics	O	O
using	O	O
API	O	O
20	O	O
STREP	O	O
(	O	O
BioMerieux	O	O
)	O	O
]	O	O
.	O	O

Bacterial	O	O
concentration	O	O
(	O	O
colony-forming	O	O
units/sample	O	O
=	O	O
CFU/sample	O	O
)	O	O
for	O	O
the	O	O
aerobic	O	O
and	O	O
anaerobic	O	O
flora	O	O
was	O	O
calculated	O	O
by	O	O
the	O	O
serial	O	O
dilution	O	O
method	O	O
of	O	O
counting	O	O
bacteria	O	O
.	O	O

106	O	O
strains	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
dental	O	O
plaque	O	O
,	O	O
belonging	O	O
to	O	O
6	O	O
species	O	O
(	O	O
Streptococcus	B-bacteria	B-bacteria
mitis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
acidominimus	E-bacteria	I-bacteria
)	O	O
,	O	O
37	O	O
strains	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
in	O	O
patients	O	O
from	O	O
group	O	O
I	O	O
(	O	O
T0	O	O
)	O	O
,	O	O
40	O	O
strains	O	O
from	O	O
group	O	O
II	O	O
(	O	O
T1	O	O
)	O	O
and	O	O
29	O	O
strains	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
from	O	O
group	O	O
III	O	O
(	O	O
T2	O	O
)	O	O
.	O	O

After	O	O
3	O	O
months	O	O
(	O	O
T1	O	O
)	O	O
the	O	O
aerobic	O	O
bacteria	O	O
percentage	O	O
,	O	O
detected	O	O
at	O	O
a	O	O
concentration	O	O
between	O	O
10	O	O
(	O	O
5	O	O
)	O	O
and	O	O
10	O	O
(	O	O
6	O	O
)	O	O
,	O	O
increased	O	O
from	O	O
30	O	O
to	O	O
38.2	O	O
%	O	O
.	O	O

The	O	O
percentage	O	O
of	O	O
patients	O	O
with	O	O
a	O	O
bacterial	O	O
concentration	O	O
higher	O	O
than	O	O
10	O	O
(	O	O
6	O	O
)	O	O
CFU/sample	O	O
increased	O	O
from	O	O
5	O	O
%	O	O
to	O	O
8.8	O	O
%	O	O
.	O	O

The	O	O
samples	O	O
colected	O	O
at	O	O
T2	O	O
(	O	O
patients	O	O
examined	O	O
after	O	O
6	O	O
months	O	O
of	O	O
orthodonic	O	O
treatment	O	O
)	O	O
presented	O	O
a	O	O
lower	O	O
bacterial	O	O
concentration	O	O
,	O	O
as	O	O
compared	O	O
to	O	O
group	O	O
II	O	O
(	O	O
T1	O	O
)	O	O
.	O	O

The	O	O
most	O	O
common	O	O
isolated	O	O
species	O	O
of	O	O
streptococci	B-bacteria	B-bacteria
were	O	O
S.	B-bacteria	B-bacteria
salivarius	E-bacteria	I-bacteria
,	O	O
S.	B-bacteria	B-bacteria
oralis	E-bacteria	I-bacteria
and	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
37.5	O	O
%	O	O
,	O	O
22.5	O	O
%	O	O
and	O	O
10	O	O
%	O	O
)	O	O
,	O	O
whose	O	O
frequency	O	O
increased	O	O
after	O	O
3	O	O
months	O	O
of	O	O
treatment	O	O
to	O	O
41.14	O	O
%	O	O
,	O	O
32.3	O	O
%	O	O
and	O	O
respectively	O	O
14.4	O	O
%	O	O
,	O	O
returning	O	O
after	O	O
6	O	O
months	O	O
of	O	O
treatment	O	O
at	O	O
values	O	O
similar	O	O
to	O	O
those	O	O
recorded	O	O
before	O	O
beginning	O	O
the	O	O
orthodontic	O	O
treatment	O	O
.	O	O

Presence	O	O
of	O	O
orthodontic	O	O
appliances	O	O
may	O	O
produce	O	O
a	O	O
transitory	O	O
increase	O	O
of	O	O
bacterial	O	O
concentration	O	O
(	O	O
CFU/sample	O	O
)	O	O
and	O	O
isolation	O	O
rate	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
returning	O	O
to	O	O
the	O	O
level	O	O
prior	O	O
to	O	O
the	O	O
application	O	O
of	O	O
these	O	O
devices	O	O
after	O	O
a	O	O
time	O	O
interval	O	O
of	O	O
several	O	O
months	O	O
.	O	O

In	O	O
this	O	O
study	O	O
hypothesing	O	O
the	O	O
translocation	O	O
of	O	O
oral	O	O
bacteria	O	O
from	O	O
oropharynx	O	O
into	O	O
the	O	O
middle	O	O
ear	O	O
cavity	O	O
may	O	O
be	O	O
involved	O	O
in	O	O
the	O	O
pathogenesis	O	O
of	O	O
otitis	O	O
media	O	O
with	O	O
effusion	O	O
(	O	O
OME	O	O
)	O	O
,	O	O
we	O	O
aimed	O	O
to	O	O
investigate	O	O
the	O	O
presence	O	O
and	O	O
similarity	O	O
of	O	O
Fusobacterium	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
Treponema	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
in	O	O
saliva	O	O
,	O	O
nasopharyngeal	O	O
secretion	O	O
and	O	O
the	O	O
middle	O	O
ear	O	O
effusion	O	O
samples	O	O
from	O	O
the	O	O
children	O	O
with	O	O
OME	O	O
.	O	O

Totally	O	O
20	O	O
children	O	O
with	O	O
OME	O	O
undergoing	O	O
myringotomy	O	O
and	O	O
ventilation	O	O
tube	O	O
placement	O	O
were	O	O
attended	O	O
.	O	O

Stimulated	O	O
saliva	O	O
samples	O	O
were	O	O
collected	O	O
after	O	O
otorhinolaryngological	O	O
and	O	O
oral	O	O
examinations	O	O
were	O	O
done	O	O
.	O	O

The	O	O
middle	O	O
ear	O	O
effusion	O	O
and	O	O
nasopharyngeal	O	O
secretions	O	O
were	O	O
collected	O	O
during	O	O
the	O	O
operations	O	O
.	O	O

The	O	O
presence	O	O
of	O	O
F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
and	O	O
T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
were	O	O
detected	O	O
using	O	O
16SrRNA-based	O	O
PCR	O	O
.	O	O

The	O	O
clonal	O	O
similarities	O	O
of	O	O
the	O	O
bacteria	O	O
were	O	O
detected	O	O
in	O	O
the	O	O
samples	O	O
which	O	O
the	O	O
same	O	O
bacteria	O	O
had	O	O
been	O	O
detected	O	O
in	O	O
each	O	O
samples	O	O
of	O	O
the	O	O
same	O	O
child	O	O
.	O	O

After	O	O
DNA	O	O
sequencing	O	O
,	O	O
clonal	O	O
similarity	O	O
was	O	O
determined	O	O
by	O	O
16SrRNA	O	O
gene	O	O
clone	O	O
library	O	O
analysis	O	O
.	O	O

The	O	O
sequences	O	O
from	O	O
each	O	O
clone	O	O
were	O	O
compared	O	O
with	O	O
similar	O	O
sequences	O	O
of	O	O
reference	O	O
organisms	O	O
by	O	O
FASTA	O	O
search	O	O
.	O	O

T.	B-bacteria	B-bacteria
denticola	E-bacteria	I-bacteria
was	O	O
detected	O	O
only	O	O
in	O	O
four	O	O
(	O	O
20	O	O
%	O	O
)	O	O
saliva	O	O
and	O	O
in	O	O
one	O	O
(	O	O
5	O	O
%	O	O
)	O	O
nasopharyngeal	O	O
sample	O	O
.	O	O

F.	B-bacteria	B-bacteria
nucleatum	E-bacteria	I-bacteria
was	O	O
detected	O	O
in	O	O
11	O	O
(	O	O
55	O	O
%	O	O
)	O	O
saliva	O	O
,	O	O
eight	O	O
(	O	O
40	O	O
%	O	O
)	O	O
nasopharyngeal	O	O
and	O	O
six	O	O
(	O	O
30	O	O
%	O	O
)	O	O
middle	O	O
ear	O	O
effusion	O	O
samples	O	O
.	O	O

Sequences	O	O
from	O	O
F.nucleatum	B-bacteria	B-bacteria
clones	O	O
derived	O	O
from	O	O
three	O	O
different	O	O
anatomic	O	O
sites	O	O
within	O	O
patients	O	O
were	O	O
similar	O	O
in	O	O
33	O	O
%	O	O
of	O	O
OME	O	O
patients	O	O
,	O	O
indicating	O	O
their	O	O
genetic	O	O
relatedness	O	O
.	O	O

Bacteria	O	O
involved	O	O
in	O	O
this	O	O
process	O	O
most	O	O
likely	O	O
originate	O	O
from	O	O
the	O	O
oropharynx	O	O
since	O	O
they	O	O
show	O	O
a	O	O
close	O	O
genetic	O	O
relatedness	O	O
with	O	O
their	O	O
oropharyngeal	O	O
counterparts	O	O
.	O	O

Candida	O	O
albicans	O	O
frequently	O	O
causes	O	O
superficial	O	O
infections	O	O
by	O	O
invading	O	O
and	O	O
damaging	O	O
epithelial	O	O
cells	O	O
,	O	O
but	O	O
may	O	O
also	O	O
cause	O	O
systemic	O	O
infections	O	O
by	O	O
penetrating	O	O
through	O	O
epithelial	O	O
barriers	O	O
.	O	O

C.	O	O
albicans	O	O
is	O	O
a	O	O
remarkable	O	O
pathogen	O	O
because	O	O
it	O	O
can	O	O
invade	O	O
epithelial	O	O
cells	O	O
via	O	O
two	O	O
distinct	O	O
mechanisms	O	O
:	O	O
induced	O	O
endocytosis	O	O
,	O	O
analogous	O	O
to	O	O
facultative	O	O
intracellular	O	O
enteropathogenic	O	O
bacteria	O	O
,	O	O
and	O	O
active	O	O
penetration	O	O
,	O	O
similar	O	O
to	O	O
plant	O	O
pathogenic	O	O
fungi	O	O
.	O	O

Here	O	O
we	O	O
investigated	O	O
the	O	O
contributions	O	O
of	O	O
the	O	O
two	O	O
invasion	O	O
routes	O	O
of	O	O
C.	O	O
albicans	O	O
to	O	O
epithelial	O	O
invasion	O	O
.	O	O

Using	O	O
selective	O	O
cellular	O	O
inhibition	O	O
approaches	O	O
and	O	O
differential	O	O
fluorescence	O	O
microscopy	O	O
,	O	O
we	O	O
demonstrate	O	O
that	O	O
induced	O	O
endocytosis	O	O
contributes	O	O
considerably	O	O
to	O	O
the	O	O
early	O	O
time	O	O
points	O	O
of	O	O
invasion	O	O
,	O	O
while	O	O
active	O	O
penetration	O	O
represents	O	O
the	O	O
dominant	O	O
epithelial	O	O
invasion	O	O
route	O	O
.	O	O

Although	O	O
induced	O	O
endocytosis	O	O
depends	O	O
mainly	O	O
on	O	O
Als3-E-cadherin	O	O
interactions	O	O
,	O	O
we	O	O
observed	O	O
E-cadherin	O	O
independent	O	O
induced	O	O
endocytosis	O	O
.	O	O

Finally	O	O
,	O	O
we	O	O
provide	O	O
evidence	O	O
of	O	O
a	O	O
protective	O	O
role	O	O
for	O	O
serum	O	O
factors	O	O
in	O	O
oral	O	O
infection	O	O
:	O	O
human	O	O
serum	O	O
strongly	O	O
inhibited	O	O
C.	O	O
albicans	O	O
adhesion	O	O
to	O	O
,	O	O
invasion	O	O
and	O	O
damage	O	O
of	O	O
oral	O	O
epithelial	O	O
cells	O	O
.	O	O

Probiotics	O	O
are	O	O
living	O	O
microorganisms	O	O
(	O	O
e.g.	O	O
,	O	O
bacteria	O	O
)	O	O
that	O	O
are	O	O
either	O	O
the	O	O
same	O	O
as	O	O
or	O	O
similar	O	O
to	O	O
organisms	O	O
found	O	O
naturally	O	O
in	O	O
the	O	O
human	O	O
body	O	O
and	O	O
may	O	O
be	O	O
beneficial	O	O
to	O	O
health	O	O
.	O	O

Current	O	O
researches	O	O
have	O	O
shown	O	O
that	O	O
the	O	O
balance	O	O
between	O	O
beneficial	O	O
and	O	O
pathogenic	O	O
bacteria	O	O
is	O	O
essential	O	O
in	O	O
order	O	O
to	O	O
maintain	O	O
the	O	O
oral	O	O
health	O	O
.	O	O

Therefore	O	O
,	O	O
oral	O	O
cavity	O	O
has	O	O
recently	O	O
been	O	O
suggested	O	O
as	O	O
a	O	O
relevant	O	O
target	O	O
for	O	O
probiotic	O	O
applications	O	O
.	O	O

Dental	O	O
caries	O	O
can	O	O
be	O	O
seen	O	O
as	O	O
a	O	O
microbial	O	O
imbalance	O	O
where	O	O
the	O	O
oral	O	O
microbiota	O	O
shift	O	O
towards	O	O
community	O	O
dominance	O	O
which	O	O
produces	O	O
acidogenic	O	O
and	O	O
acid-tolerant	O	O
gram	O	O
positive	O	O
bacteria	O	O
.	O	O

Similarly	O	O
,	O	O
the	O	O
accumulation	O	O
of	O	O
bacteria	O	O
within	O	O
the	O	O
biofilm	O	O
,	O	O
facilitated	O	O
by	O	O
poor	O	O
oral	O	O
hygiene	O	O
,	O	O
predisposes	O	O
to	O	O
allogenic	O	O
shifts	O	O
in	O	O
the	O	O
microbial	O	O
community	O	O
,	O	O
leading	O	O
to	O	O
the	O	O
onset	O	O
of	O	O
periodontal	O	O
inflammation	O	O
.	O	O

probiotic	O	O
bacteria	O	O
belonging	O	O
to	O	O
the	O	O
genus	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
,	O	O
Bifidobacterium	B-bacteria	B-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
have	O	O
been	O	O
proven	O	O
effective	O	O
for	O	O
preventing	O	O
caries	O	O
by	O	O
reducing	O	O
the	O	O
number	O	O
of	O	O
cariogenic	O	O
bacteria	O	O
in	O	O
saliva	O	O
after	O	O
a	O	O
short	O	O
period	O	O
of	O	O
consuming	O	O
the	O	O
probiotic	O	O
.	O	O

In	O	O
contrast	O	O
,	O	O
the	O	O
effect	O	O
of	O	O
probiotics	O	O
on	O	O
improving	O	O
gingivitis	O	O
and	O	O
periodontitis	O	O
has	O	O
been	O	O
less	O	O
investigated	O	O
.	O	O

The	O	O
currently	O	O
available	O	O
studies	O	O
on	O	O
the	O	O
effect	O	O
of	O	O
probiotics	O	O
on	O	O
periodontal	O	O
pathogens	O	O
and	O	O
clinical	O	O
periodontal	O	O
parameters	O	O
showed	O	O
differing	O	O
results	O	O
depending	O	O
on	O	O
the	O	O
strains	O	O
used	O	O
and	O	O
the	O	O
endpoints	O	O
analyzed	O	O
.	O	O

Many	O	O
of	O	O
the	O	O
clinical	O	O
studies	O	O
are	O	O
pilot	O	O
in	O	O
nature	O	O
and	O	O
with	O	O
low	O	O
quality	O	O
,	O	O
therefore	O	O
,	O	O
properly	O	O
conducted	O	O
clinical	O	O
trials	O	O
,	O	O
using	O	O
probiotic	O	O
strains	O	O
with	O	O
in	O	O
vitro	O	O
proven	O	O
periodontal	O	O
probiotic	O	O
effects	O	O
,	O	O
are	O	O
needed	O	O
.	O	O

The	O	O
putative	O	O
beneficial	O	O
effects	O	O
of	O	O
probiotics	O	O
on	O	O
oral	O	O
malodour	O	O
have	O	O
also	O	O
been	O	O
evaluated	O	O
,	O	O
but	O	O
further	O	O
evidence	O	O
is	O	O
needed	O	O
to	O	O
fully	O	O
explore	O	O
the	O	O
potential	O	O
of	O	O
probiotics	O	O
for	O	O
preventing	O	O
malodour	O	O
.	O	O

Campylobacter	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
,	O	O
a	O	O
bacterium	O	O
colonizing	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
,	O	O
has	O	O
been	O	O
shown	O	O
to	O	O
be	O	O
associated	O	O
with	O	O
inflammatory	O	O
bowel	O	O
disease	O	O
(	O	O
IBD	O	O
)	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
if	O	O
patients	O	O
with	O	O
IBD	O	O
are	O	O
colonized	O	O
with	O	O
specific	O	O
oral	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
that	O	O
have	O	O
potential	O	O
to	O	O
cause	O	O
enteric	O	O
diseases	O	O
.	O	O


:	O	O
Seventy	O	O
oral	O	O
and	O	O
enteric	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
isolates	O	O
obtained	O	O
from	O	O
eight	O	O
patients	O	O
with	O	O
IBD	O	O
and	O	O
six	O	O
controls	O	O
were	O	O
examined	O	O
for	O	O
housekeeping	O	O
genes	O	O
by	O	O
multilocus	O	O
sequence	O	O
typing	O	O
(	O	O
MLST	O	O
)	O	O
,	O	O
Caco2	O	O
cell	O	O
invasion	O	O
by	O	O
gentamicin-protection-assay	O	O
,	O	O
protein	O	O
analysis	O	O
by	O	O
mass	O	O
spectrometry	O	O
and	O	O
SDS-PAGE	O	O
,	O	O
and	O	O
morphology	O	O
by	O	O
scanning	O	O
electron	O	O
microscopy	O	O
.	O	O

The	O	O
whole	O	O
genome	O	O
sequenced	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strain	I-bacteria	I-bacteria
13826	E-bacteria	I-bacteria
which	O	O
was	O	O
isolated	O	O
from	O	O
an	O	O
individual	O	O
with	O	O
bloody	O	O
diarrhea	O	O
was	O	O
included	O	O
in	O	O
MLST	O	O
analysis	O	O
.	O	O


:	O	O
MLST	O	O
analysis	O	O
showed	O	O
that	O	O
87.5	O	O
%	O	O
of	O	O
individuals	O	O
whose	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
belonged	O	O
to	O	O
Cluster	O	O
I	O	O
had	O	O
inflammatory	O	O
enteric	O	O
diseases	O	O
(	O	O
six	O	O
IBD	O	O
and	O	O
one	O	O
with	O	O
bloody	O	O
diarrhea	O	O
)	O	O
,	O	O
which	O	O
was	O	O
significantly	O	O
higher	O	O
than	O	O
that	O	O
in	O	O
the	O	O
remaining	O	O
individuals	O	O
(	O	O
28.6	O	O
%	O	O
)	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Enteric	B-bacteria	B-bacteria
invasive	I-bacteria	I-bacteria
C.	I-bacteria	I-bacteria
concisus	E-bacteria	I-bacteria
(	O	O
EICC	B-bacteria	B-bacteria
)	O	O
oral	O	O
strain	O	O
was	O	O
detected	O	O
in	O	O
50	O	O
%	O	O
of	O	O
patients	O	O
with	O	O
IBD	O	O
and	O	O
none	O	O
of	O	O
the	O	O
controls	O	O
.	O	O

All	O	O
EICC	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
were	O	O
in	O	O
Cluster	O	O
1	O	O
.	O	O

The	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
colonizing	O	O
intestinal	O	O
tissues	O	O
of	O	O
patient	O	O
No	O	O
.	O	O

1	O	O
was	O	O
closely	O	O
related	O	O
to	O	O
the	O	O
oral	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strain	E-bacteria	I-bacteria
from	O	O
patient	O	O
No	O	O
.	O	O

6	O	O
and	O	O
had	O	O
gene	O	O
recombination	O	O
with	O	O
the	O	O
patient	O	O
's	O	O
own	O	O
oral	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
.	O	O

The	O	O
oral	O	O
and	O	O
intestinal	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
of	O	O
patient	O	O
No	O	O
.	O	O
3	O	O
were	O	O
the	O	O
same	O	O
strain	O	O
.	O	O

Some	O	O
individuals	O	O
were	O	O
colonized	O	O
with	O	O
multiple	O	O
oral	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
strains	O	O
that	O	O
have	O	O
undergone	O	O
natural	O	O
recombination	O	O
.	O	O

This	O	O
study	O	O
provides	O	O
the	O	O
first	O	O
evidence	O	O
that	O	O
patients	O	O
with	O	O
IBD	O	O
are	O	O
colonized	O	O
with	O	O
specific	O	O
oral	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
,	O	O
with	O	O
some	O	O
being	O	O
EICC	B-bacteria	B-bacteria
strains	E-bacteria	I-bacteria
.	O	O

C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
colonizing	O	O
intestinal	O	O
tissues	O	O
of	O	O
patients	O	O
with	O	O
IBD	O	O
at	O	O
least	O	O
in	O	O
some	O	O
instances	O	O
results	O	O
from	O	O
an	O	O
endogenous	O	O
colonization	O	O
of	O	O
the	O	O
patient	O	O
's	O	O
oral	O	O
C.	B-bacteria	B-bacteria
concisus	E-bacteria	I-bacteria
and	O	O
that	O	O
C.	B-bacteria	B-bacteria
concisus	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
undergo	O	O
natural	O	O
recombination	O	O
.	O	O

Highantagonistic	O	O
strains	O	O
of	O	O
lactobacillus	B-bacteria	B-bacteria
isolated	O	O
from	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
healthy	O	O
people	O	O
,	O	O
genetically	O	O
identified	O	O
as	O	O
L.	B-bacteria	B-bacteria
fermentum	I-bacteria	I-bacteria
39	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
50	E-bacteria	I-bacteria
,	O	O
L.	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
24	E-bacteria	I-bacteria
,	O	O
showed	O	O
high	O	O
degree	O	O
of	O	O
autoaggregation	O	O
,	O	O
surface	O	O
hydrophobicity	O	O
,	O	O
coaggregation	O	O
,	O	O
adhesion	O	O
,	O	O
and	O	O
the	O	O
ability	O	O
to	O	O
form	O	O
biofilms	O	O
.	O	O

These	O	O
strains	O	O
can	O	O
be	O	O
used	O	O
to	O	O
create	O	O
new	O	O
probiotic	O	O
drugs	O	O
for	O	O
the	O	O
prevention	O	O
and	O	O
correction	O	O
the	O	O
dysbiosis	O	O
of	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
phylogenetic	O	O
significance	O	O
of	O	O
the	O	O
diversity	O	O
of	O	O
key	O	O
enzymes	O	O
of	O	O
methylotrophic	O	O
and	O	O
autotrophic	O	O
metabolism	O	O
is	O	O
discussed	O	O
.	O	O

Primers	O	O
for	O	O
these	O	O
key	O	O
enzymes	O	O
were	O	O
designed	O	O
using	O	O
gene	O	O
sequences	O	O
encoding	O	O
methanol	O	O
dehydrogenase	O	O
(	O	O
mxaF	O	O
;	O	O
using	O	O
subsets	O	O
from	O	O
database	O	O
sequences	O	O
for	O	O
22	O	O
Bacteria	O	O
)	O	O
,	O	O
hydroxypyruvate	O	O
reductase	O	O
(	O	O
hpr	O	O
;	O	O
36	O	O
sequences	O	O
)	O	O
,	O	O
methylamine	O	O
dehydrogenase	O	O
(	O	O
mauA	O	O
;	O	O
12	O	O
sequences	O	O
)	O	O
,	O	O
methanesulfonate	O	O
monooxygenase	O	O
(	O	O
msmA	O	O
;	O	O
four	O	O
sequences	O	O
)	O	O
,	O	O
and	O	O
the	O	O
ccbL	O	O
and	O	O
cbbM	O	O
genes	O	O
of	O	O
ribulose	O	O
bisphosphate	O	O
carboxylase	O	O
(	O	O
26	O	O
and	O	O
23	O	O
sequences	O	O
)	O	O
.	O	O

These	O	O
were	O	O
effective	O	O
in	O	O
amplifying	O	O
the	O	O
correct	O	O
gene	O	O
products	O	O
for	O	O
the	O	O
target	O	O
genes	O	O
in	O	O
reference	O	O
organisms	O	O
and	O	O
in	O	O
test	O	O
organisms	O	O
not	O	O
previously	O	O
shown	O	O
to	O	O
contain	O	O
the	O	O
genes	O	O
,	O	O
as	O	O
well	O	O
as	O	O
in	O	O
some	O	O
methylotrophic	B-bacteria	B-bacteria
Proteobacteria	E-bacteria	I-bacteria
isolated	O	O
from	O	O
the	O	O
human	O	O
mouth	O	O
.	O	O

The	O	O
availability	O	O
of	O	O
the	O	O
new	O	O
primers	O	O
increases	O	O
the	O	O
probability	O	O
of	O	O
detecting	O	O
diverse	O	O
examples	O	O
of	O	O
the	O	O
genes	O	O
encoding	O	O
these	O	O
key	O	O
enzymes	O	O
both	O	O
in	O	O
natural	O	O
populations	O	O
and	O	O
in	O	O
isolated	O	O
bacterial	O	O
strains	O	O
.	O	O

The	O	O
objectives	O	O
of	O	O
this	O	O
study	O	O
were	O	O
to	O	O
identify	O	O
the	O	O
bacteria	O	O
involved	O	O
in	O	O
delayed-onset	O	O
infections	O	O
after	O	O
lower	O	O
third	O	O
molar	O	O
removal	O	O
and	O	O
to	O	O
determine	O	O
the	O	O
most	O	O
suitable	O	O
antibiotic	O	O
for	O	O
such	O	O
complication	O	O
.	O	O

Bacterial	O	O
samples	O	O
were	O	O
collected	O	O
from	O	O
13	O	O
patients	O	O
who	O	O
developed	O	O
delayed-onset	O	O
infections	O	O
after	O	O
lower	O	O
third	O	O
molar	O	O
extraction	O	O
.	O	O

After	O	O
the	O	O
identification	O	O
of	O	O
the	O	O
bacterial	O	O
isolates	O	O
,	O	O
the	O	O
in	O	O
vitro	O	O
antimicrobial	O	O
susceptibility	O	O
of	O	O
the	O	O
isolated	O	O
strains	O	O
was	O	O
determined	O	O
.	O	O

A	O	O
total	O	O
of	O	O
11	O	O
patients	O	O
(	O	O
12	O	O
samples	O	O
)	O	O
were	O	O
finally	O	O
included	O	O
in	O	O
the	O	O
study	O	O
.	O	O

Up	O	O
to	O	O
7	O	O
bacteria	O	O
genera	O	O
were	O	O
identified	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
was	O	O
present	O	O
in	O	O
11	O	O
patients	O	O
,	O	O
Prevotella	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
in	O	O
8	O	O
cases	O	O
,	O	O
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
in	O	O
7	O	O
.	O	O

Some	O	O
strains	O	O
of	O	O
these	O	O
bacteria	O	O
were	O	O
not	O	O
susceptible	O	O
to	O	O
amoxicillin	O	O
,	O	O
amoxicillin/clavulanate	O	O
,	O	O
and	O	O
metronidazol	O	O
,	O	O
whereas	O	O
no	O	O
resistances	O	O
were	O	O
found	O	O
to	O	O
clindamycin	O	O
.	O	O

Fusobacterium	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
sp.	E-bacteria	I-bacteria
,	O	O
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
are	O	O
frequently	O	O
present	O	O
in	O	O
delayed-onset	O	O
infections	O	O
after	O	O
lower	O	O
third	O	O
molar	O	O
removal	O	O
.	O	O

Based	O	O
on	O	O
the	O	O
results	O	O
of	O	O
the	O	O
microbial	O	O
susceptibility	O	O
tests	O	O
,	O	O
clindamycin	O	O
seems	O	O
to	O	O
be	O	O
the	O	O
most	O	O
adequate	O	O
antibiotic	O	O
for	O	O
the	O	O
treatment	O	O
of	O	O
this	O	O
complication	O	O
.	O	O

Bacteria	O	O
communicate	O	O
by	O	O
producing	O	O
quorum	O	O
sensing	O	O
molecules	O	O
called	O	O
autoinducers	O	O
,	O	O
which	O	O
include	O	O
autoinducer-1	O	O
,	O	O
an	O	O
N-hexanoyl	O	O
homoserine	O	O
lactone	O	O
(	O	O
AHL	O	O
)	O	O
,	O	O
and	O	O
autoinducer-2	O	O
.	O	O

Bacteria	O	O
present	O	O
in	O	O
the	O	O
human	O	O
oral	O	O
cavity	O	O
have	O	O
been	O	O
shown	O	O
to	O	O
produce	O	O
autoinducer-2	O	O
,	O	O
but	O	O
not	O	O
AHL	O	O
.	O	O

Here	O	O
,	O	O
we	O	O
report	O	O
the	O	O
isolation	O	O
of	O	O
two	O	O
AHL-producing	B-bacteria	B-bacteria
Klebsiella	I-bacteria	I-bacteria
pneumoniae	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
from	O	O
the	O	O
posterior	O	O
dorsal	O	O
surface	O	O
of	O	O
the	O	O
tongue	O	O
of	O	O
a	O	O
healthy	O	O
individual	O	O
.	O	O

Spent	O	O
culture	O	O
supernatant	O	O
extracts	O	O
from	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
activated	O	O
the	O	O
biosensors	O	O
Agrobacterium	B-bacteria	B-bacteria
tumefaciens	I-bacteria	I-bacteria
NTL4	E-bacteria	I-bacteria
(	O	O
pZLR4	B-bacteria	B-bacteria
)	O	O
and	O	O
Escherichia	B-bacteria	B-bacteria
coli	E-bacteria	I-bacteria
[O	O
pSB401	B-bacteria	B-bacteria
]O	O
,	O	O
suggesting	O	O
the	O	O
presence	O	O
of	O	O
both	O	O
long	O	O
and	O	O
short	O	O
chain	O	O
AHLs	O	O
.	O	O

High	O	O
resolution	O	O
mass	O	O
spectrometry	O	O
analyses	O	O
of	O	O
these	O	O
extracts	O	O
confirmed	O	O
that	O	O
both	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
isolates	O	O
produced	O	O
N-octanoylhomoserine	O	O
lactone	O	O
and	O	O
N-3-dodecanoyl-L-homoserine	O	O
lactone	O	O
.	O	O

To	O	O
the	O	O
best	O	O
of	O	O
our	O	O
knowledge	O	O
,	O	O
this	O	O
is	O	O
the	O	O
first	O	O
report	O	O
of	O	O
the	O	O
isolation	O	O
of	O	O
K.	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
from	O	O
the	O	O
posterior	O	O
dorsal	O	O
surface	O	O
of	O	O
the	O	O
human	O	O
tongue	O	O
and	O	O
the	O	O
production	O	O
of	O	O
these	O	O
AHLs	O	O
by	O	O
this	O	O
bacterium	O	O
.	O	O

To	O	O
determine	O	O
whether	O	O
variation	O	O
in	O	O
glucan	O	O
synthesis	O	O
by	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
isolates	E-bacteria	I-bacteria
is	O	O
associated	O	O
with	O	O
caries	O	O
development	O	O
in	O	O
children	O	O
receiving	O	O
a	O	O
fluoride	O	O
mouth	O	O
rinse	O	O
(	O	O
FMR	O	O
)	O	O
.	O	O

Of	O	O
122	O	O
children	O	O
(	O	O
aged	O	O
9	O	O
to	O	O
10	O	O
years	O	O
)	O	O
,	O	O
64	O	O
had	O	O
received	O	O
FMR	O	O
(	O	O
FMR	O	O
(	O	O
+	O	O
)	O	O
group	O	O
)	O	O
and	O	O
the	O	O
remaining	O	O
58	O	O
children	O	O
had	O	O
not	O	O
(	O	O
FMR	O	O
(	O	O
-	O	O
)	O	O
group	O	O
)	O	O
.	O	O

The	O	O
number	O	O
of	O	O
decayed	O	O
and	O	O
filled	O	O
teeth	O	O
(	O	O
DFT	O	O
)	O	O
and	O	O
increases	O	O
in	O	O
the	O	O
number	O	O
of	O	O
DFT	O	O
in	O	O
1	O	O
year	O	O
(	O	O
dDFT	O	O
)	O	O
were	O	O
recorded	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
to	O	O
isolate	O	O
the	O	O
clinical	O	O
S.	B-bacteria	B-bacteria
mutans	I-bacteria	I-bacteria
strains	E-bacteria	I-bacteria
.	O	O

The	O	O
isolates	O	O
were	O	O
incubated	O	O
in	O	O
heart	O	O
infusion	O	O
broth	O	O
supplemented	O	O
with	O	O
1	O	O
%	O	O
sucrose	O	O
,	O	O
then	O	O
the	O	O
amount	O	O
of	O	O
water-insoluble	O	O
glucan	O	O
(	O	O
WIG	O	O
)	O	O
formed	O	O
on	O	O
a	O	O
glass	O	O
tube	O	O
surface	O	O
was	O	O
evaluated	O	O
.	O	O

In	O	O
the	O	O
FMR	O	O
(	O	O
-	O	O
)	O	O
group	O	O
,	O	O
children	O	O
carrying	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
had	O	O
a	O	O
higher	O	O
DFT	O	O
(	O	O
P	O	O
=	O	O
0.039	O	O
)	O	O
and	O	O
tended	O	O
to	O	O
have	O	O
a	O	O
higher	O	O
dDFT	O	O
(	O	O
P	O	O
=	O	O
0.080	O	O
)	O	O
than	O	O
the	O	O
others	O	O
.	O	O

In	O	O
the	O	O
FMR	O	O
(	O	O
+	O	O
)	O	O
group	O	O
,	O	O
although	O	O
the	O	O
differences	O	O
between	O	O
children	O	O
with	O	O
and	O	O
without	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
were	O	O
not	O	O
significant	O	O
,	O	O
children	O	O
carrying	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
that	O	O
produced	O	O
a	O	O
high	O	O
amount	O	O
of	O	O
WIG	O	O
had	O	O
higher	O	O
dDFT	O	O
than	O	O
the	O	O
other	O	O
S.	O	O
mutans-positive	O	O
children	O	O
(	O	O
P	O	O
=	O	O
0.034	O	O
)	O	O
.	O	O

This	O	O
study	O	O
revealed	O	O
that	O	O
the	O	O
variation	O	O
in	O	O
glucan	O	O
synthesis	O	O
by	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
associated	O	O
with	O	O
caries	O	O
development	O	O
in	O	O
children	O	O
receiving	O	O
a	O	O
FMR	O	O
.	O	O

Nickel	O	O
chromium	O	O
brackets	O	O
are	O	O
the	O	O
most	O	O
common	O	O
type	O	O
of	O	O
fixed	O	O
orthodontic	O	O
appliance	O	O
used	O	O
in	O	O
our	O	O
environment	O	O
and	O	O
may	O	O
alter	O	O
the	O	O
oral	O	O
microflora	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
determine	O	O
the	O	O
effect	O	O
of	O	O
nickel	O	O
chromium	O	O
brackets	O	O
in	O	O
orthodontic	O	O
treatment	O	O
on	O	O
the	O	O
oral	O	O
microflora	O	O
and	O	O
to	O	O
compare	O	O
with	O	O
a	O	O
control	O	O
group	O	O
of	O	O
dental	O	O
students	O	O
.	O	O

Thirty-eight	O	O
randomly	O	O
selected	O	O
participants	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
groups	O	O
.	O	O

Group	O	O
1	O	O
was	O	O
19	O	O
orthodontic	O	O
patients	O	O
(	O	O
OS	O	O
)	O	O
with	O	O
anterior	O	O
segment	O	O
crowding	O	O
.	O	O

Group	O	O
2	O	O
were	O	O
19	O	O
normal	O	O
dental	O	O
students	O	O
(	O	O
DS	O	O
)	O	O
who	O	O
served	O	O
as	O	O
a	O	O
control	O	O
group	O	O
.	O	O

Two	O	O
samples	O	O
of	O	O
stimulated	O	O
saliva	O	O
were	O	O
collected	O	O
.	O	O

The	O	O
initial	O	O
sample	O	O
was	O	O
collected	O	O
before	O	O
the	O	O
placement	O	O
of	O	O
nickel	O	O
chromium	O	O
brackets	O	O
(	O	O
OS1	O	O
)	O	O
and	O	O
the	O	O
other	O	O
6	O	O
months	O	O
after	O	O
wearing	O	O
the	O	O
appliance	O	O
in	O	O
both	O	O
arches	O	O
(	O	O
OS2	O	O
)	O	O
for	O	O
group	O	O
1	O	O
.	O	O

Group	O	O
2	O	O
also	O	O
had	O	O
the	O	O
initial	O	O
(	O	O
DS1	O	O
)	O	O
and	O	O
second	O	O
samples	O	O
(	O	O
DS2	O	O
)	O	O
collected	O	O
after	O	O
a	O	O
6	O	O
month	O	O
interval	O	O
.	O	O

The	O	O
saliva	O	O
was	O	O
analysed	O	O
after	O	O
being	O	O
inoculated	O	O
onto	O	O
blood	O	O
,	O	O
chocolate	O	O
and	O	O
MacConkey	O	O
agar	O	O
plates	O	O
which	O	O
were	O	O
incubated	O	O
for	O	O
24	O	O
hours	O	O
at	O	O
37	O	O
degrees	O	O
C	O	O
aerobically	O	O
except	O	O
chocolate	O	O
agar	O	O
,	O	O
which	O	O
was	O	O
incubated	O	O
in	O	O
a	O	O
candle	O	O
extinction	O	O
jar	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
that	O	O
Streptococcus	B-bacteria	B-bacteria
viridans	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
prevalent	O	O
microorganism	O	O
and	O	O
was	O	O
isolated	O	O
in	O	O
15	O	O
(	O	O
79	O	O
%	O	O
)	O	O
,	O	O
and	O	O
11	O	O
(	O	O
57.9	O	O
%	O	O
)	O	O
,	O	O
of	O	O
groups	O	O
OS1	O	O
and	O	O
DS1	O	O
respectively	O	O
.	O	O

There	O	O
was	O	O
no	O	O
statistical	O	O
difference	O	O
between	O	O
both	O	O
control	O	O
groups	O	O
OS1	O	O
and	O	O
DS1	O	O
(	O	O
p	O	O
>	O	O
0.05	O	O
)	O	O
,	O	O
and	O	O
treatment	O	O
groups	O	O
OS2	O	O
and	O	O
DS2	O	O
for	O	O
Streptococcus	B-bacteria	B-bacteria
viridans	E-bacteria	I-bacteria
.	O	O

There	O	O
was	O	O
a	O	O
significant	O	O
difference	O	O
between	O	O
DS1	O	O
with	O	O
7	O	O
(	O	O
36.8	O	O
%	O	O
)	O	O
and	O	O
OS1	O	O
with	O	O
2	O	O
(	O	O
10.5	O	O
%	O	O
)	O	O
for	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
was	O	O
cultured	O	O
in	O	O
all	O	O
groups	O	O
except	O	O
OS2	O	O
.	O	O

There	O	O
was	O	O
also	O	O
no	O	O
statistically	O	O
significant	O	O
difference	O	O
between	O	O
groups	O	O
OS1	O	O
and	O	O
OS2	O	O
and	O	O
the	O	O
control	O	O
groups	O	O
DS1	O	O
and	O	O
DS2	O	O
for	O	O
all	O	O
the	O	O
organisms	O	O
cultured	O	O
.	O	O

There	O	O
was	O	O
no	O	O
change	O	O
in	O	O
composition	O	O
of	O	O
bacteria	O	O
between	O	O
groups	O	O
OS1	O	O
,	O	O
OS2	O	O
and	O	O
DS1	O	O
.	O	O

There	O	O
is	O	O
no	O	O
difference	O	O
in	O	O
the	O	O
oral	O	O
microflora	O	O
between	O	O
orthodontic	O	O
patients	O	O
and	O	O
normal	O	O
subjects	O	O
and	O	O
wearing	O	O
nickel	O	O
chromium	O	O
brackets	O	O
does	O	O
not	O	O
significantly	O	O
alter	O	O
the	O	O
composition	O	O
of	O	O
the	O	O
oral	O	O
microflora	O	O
.	O	O

A	O	O
comparative	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
between	O	O
cinnamon	O	O
oil	O	O
and	O	O
clove	O	O
oil	O	O
on	O	O
the	O	O
oral	O	O
micro-biota	O	O
causing	O	O
dental	O	O
caries	O	O
.	O	O

Cinnamon	O	O
oil	O	O
was	O	O
found	O	O
to	O	O
be	O	O
more	O	O
effective	O	O
than	O	O
clove	O	O
oil	O	O
exhibiting	O	O
broad	O	O
spectrum	O	O
of	O	O
antibacterial	O	O
activity	O	O
inhibiting	O	O
all	O	O
the	O	O
ten	O	O
test	O	O
bacterial	O	O
species	O	O
involved	O	O
in	O	O
dental	O	O
caries	O	O
.	O	O

Cinnamon	O	O
oil	O	O
produced	O	O
maximum	O	O
inhibition	O	O
zone	O	O
of	O	O
diameter	O	O
(	O	O
IZD	O	O
)	O	O
of	O	O
24.0	O	O
mm	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
major	O	O
causative	O	O
bacteria	O	O
of	O	O
dental	O	O
plaque	O	O
)	O	O
as	O	O
compared	O	O
to	O	O
clove	O	O
oil	O	O
(	O	O
IZD	O	O
=	O	O
13.0mm	O	O
)	O	O
.	O	O

This	O	O
is	O	O
contrary	O	O
to	O	O
the	O	O
popular	O	O
belief	O	O
that	O	O
clove	O	O
oil	O	O
is	O	O
effective	O	O
in	O	O
tooth	O	O
decay	O	O
and	O	O
dental	O	O
plaque	O	O
.	O	O

This	O	O
study	O	O
shows	O	O
the	O	O
potential	O	O
of	O	O
cinnamon	O	O
oil	O	O
over	O	O
clove	O	O
oil	O	O
in	O	O
the	O	O
treatment	O	O
of	O	O
dental	O	O
caries	O	O
.	O	O

Empirically	O	O
prescribed	O	O
antibiotics	O	O
are	O	O
widely	O	O
employed	O	O
in	O	O
the	O	O
management	O	O
of	O	O
odontogenic	O	O
infections	O	O
.	O	O

To	O	O
characterise	O	O
the	O	O
infections	O	O
associated	O	O
with	O	O
extracted	O	O
teeth	O	O
and	O	O
assess	O	O
effectiveness	O	O
of	O	O
the	O	O
antibiotics	O	O
prescribed	O	O
empirically	O	O
following	O	O
tooth	O	O
extraction	O	O
.	O	O

The	O	O
study	O	O
was	O	O
cross-sectional	O	O
and	O	O
consisted	O	O
of	O	O
41	O	O
consecutively	O	O
recruited	O	O
subjects	O	O
who	O	O
required	O	O
extraction	O	O
for	O	O
infections	O	O
associated	O	O
with	O	O
the	O	O
tooth	O	O
.	O	O

Appropriate	O	O
clinical	O	O
specimens	O	O
were	O	O
collected	O	O
aseptically	O	O
from	O	O
each	O	O
patient	O	O
and	O	O
transported	O	O
in	O	O
Stuart	O	O
's	O	O
transport	O	O
medium	O	O
for	O	O
processing	O	O
in	O	O
the	O	O
laboratory	O	O
.	O	O

Isolation	O	O
,	O	O
identification	O	O
,	O	O
and	O	O
susceptibility	O	O
pattern	O	O
of	O	O
anaerobic	O	O
and	O	O
facultative	O	O
organisms	O	O
were	O	O
done	O	O
employing	O	O
standard	O	O
bacteriologic	O	O
techniques	O	O
.	O	O

Antimicrobial	O	O
susceptibility	O	O
testing	O	O
was	O	O
performed	O	O
by	O	O
the	O	O
disc	O	O
diffusion	O	O
technique	O	O
.	O	O

There	O	O
were	O	O
positive	O	O
cultures	O	O
for	O	O
37	O	O
patients	O	O
.	O	O

Twenty-eight	O	O
aerobic	O	O
(	O	O
45.9	O	O
%	O	O
)	O	O
bacteria	O	O
and	O	O
32	O	O
anaerobic	O	O
(	O	O
54.1	O	O
%	O	O
)	O	O
bacteria	O	O
were	O	O
isolated	O	O
,	O	O
an	O	O
approximation	O	O
of	O	O
two	O	O
microorganisms	O	O
per	O	O
patient	O	O
.	O	O

Staphylococcus	B-bacteria	B-bacteria
was	O	O
the	O	O
most	O	O
predominant	O	O
aerobe	O	O
(	O	O
25.0	O	O
%	O	O
)	O	O
whereas	O	O
Bacteroides	B-bacteria	B-bacteria
fragilis	E-bacteria	I-bacteria
was	O	O
the	O	O
most	O	O
predominant	O	O
anaerobe	O	O
(	O	O
34.2	O	O
%	O	O
)	O	O
.	O	O

All	O	O
the	O	O
bacteria	O	O
isolated	O	O
showed	O	O
in	O	O
vitro	O	O
resistance	O	O
to	O	O
cephalexin	O	O
,	O	O
cloxacillin	O	O
and	O	O
metronidazole	O	O
.	O	O

Eighteen	O	O
(	O	O
64.3	O	O
%	O	O
)	O	O
different	O	O
aerobic	O	O
bacteria	O	O
and	O	O
13	O	O
(	O	O
40.6	O	O
%	O	O
)	O	O
different	O	O
anaerobic	O	O
bacteria	O	O
were	O	O
sensitive	O	O
to	O	O
ciprofloxacillin	O	O
and	O	O
these	O	O
included	O	O
staphylococcus	B-bacteria	B-bacteria
and	O	O
Bacteroides	B-bacteria	B-bacteria
fragilis	E-bacteria	I-bacteria
.	O	O

Sensitivity	O	O
pattern	O	O
for	O	O
amoxycillin	O	O
was	O	O
very	O	O
poor	O	O
with	O	O
3.6	O	O
%	O	O
and	O	O
6.3	O	O
%	O	O
for	O	O
aerobes	O	O
and	O	O
anaerobes	O	O
respectively	O	O
.	O	O

Odontogenic	O	O
infections	O	O
from	O	O
our	O	O
centre	O	O
are	O	O
polymicrobial	O	O
in	O	O
nature	O	O
with	O	O
anaerobes	O	O
predominating	O	O
.	O	O

High	O	O
resistance	O	O
to	O	O
most	O	O
of	O	O
the	O	O
antibiotics	O	O
routinely	O	O
prescribed	O	O
in	O	O
our	O	O
centre	O	O
is	O	O
common	O	O
.	O	O

Ciprofloxacillin	O	O
demonstrated	O	O
the	O	O
highest	O	O
sensitivity	O	O
pattern	O	O
.	O	O

The	O	O
efficacy	O	O
of	O	O
early	O	O
maternal	O	O
caries	O	O
prevention	O	O
was	O	O
evaluated	O	O
.	O	O

Furthermore	O	O
,	O	O
the	O	O
difference	O	O
between	O	O
children	O	O
colonised	O	O
with	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
MS	B-bacteria	B-bacteria
)	O	O
at	O	O
an	O	O
early	O	O
or	O	O
late	O	O
stage	O	O
with	O	O
regard	O	O
to	O	O
the	O	O
prevalence	O	O
of	O	O
carious	O	O
lesions	O	O
was	O	O
determined	O	O
.	O	O

The	O	O
children	O	O
of	O	O
first-time	O	O
mothers	O	O
selected	O	O
on	O	O
the	O	O
basis	O	O
of	O	O
high	O	O
salivary	O	O
levels	O	O
of	O	O
MS	B-bacteria	B-bacteria
for	O	O
participation	O	O
in	O	O
a	O	O
caries	O	O
prevention	O	O
programme	O	O
were	O	O
recalled	O	O
at	O	O
the	O	O
age	O	O
of	O	O
19	O	O
years	O	O
.	O	O

They	O	O
were	O	O
examined	O	O
for	O	O
salivary	O	O
MS	B-bacteria	B-bacteria
,	O	O
lesion	O	O
prevalence	O	O
(	O	O
decayed	O	O
and	O	O
filled	O	O
surfaces	O	O
,	O	O
DFS	O	O
)	O	O
and	O	O
MS	B-bacteria	B-bacteria
in	O	O
plaque	O	O
from	O	O
12	O	O
selected	O	O
proximal	O	O
surfaces	O	O
.	O	O

The	O	O
recall	O	O
rate	O	O
was	O	O
70	O	O
%	O	O
for	O	O
the	O	O
children	O	O
of	O	O
both	O	O
the	O	O
high-control	O	O
and	O	O
interventional	O	O
groups	O	O
.	O	O

All	O	O
high-control	O	O
children	O	O
and	O	O
67	O	O
%	O	O
of	O	O
the	O	O
interventional	O	O
children	O	O
were	O	O
colonised	O	O
by	O	O
MS	B-bacteria	B-bacteria
.	O	O

All	O	O
the	O	O
children	O	O
with	O	O
non-detectable	O	O
MS	B-bacteria	B-bacteria
in	O	O
saliva	O	O
were	O	O
also	O	O
negative	O	O
in	O	O
all	O	O
plaque	O	O
samples	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
difference	O	O
was	O	O
found	O	O
between	O	O
the	O	O
groups	O	O
in	O	O
terms	O	O
of	O	O
DFS	O	O
,	O	O
although	O	O
more	O	O
interventional	O	O
children	O	O
were	O	O
caries	O	O
free	O	O
than	O	O
in	O	O
the	O	O
control	O	O
group	O	O
.	O	O

Early-colonised	O	O
children	O	O
,	O	O
irrespective	O	O
of	O	O
group	O	O
identity	O	O
,	O	O
had	O	O
higher	O	O
salivary	O	O
MS	B-bacteria	B-bacteria
levels	O	O
and	O	O
DFS	O	O
than	O	O
later	O	O
MS-colonised	O	O
children	O	O
.	O	O

The	O	O
results	O	O
indicate	O	O
that	O	O
it	O	O
is	O	O
possible	O	O
to	O	O
remain	O	O
negative	O	O
for	O	O
MS	B-bacteria	B-bacteria
into	O	O
adulthood	O	O
if	O	O
non-colonised	O	O
at	O	O
an	O	O
early	O	O
age	O	O
and	O	O
this	O	O
affects	O	O
the	O	O
development	O	O
of	O	O
carious	O	O
lesions	O	O
.	O	O

Strategies	O	O
for	O	O
the	O	O
prevention	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
early	O	O
childhood	O	O
should	O	O
,	O	O
therefore	O	O
,	O	O
include	O	O
measures	O	O
to	O	O
prevent	O	O
or	O	O
delay	O	O
early	O	O
colonisation	O	O
by	O	O
cariogenic	O	O
bacteria	O	O
.	O	O

Oral	O	O
streptococci	B-bacteria	B-bacteria
are	O	O
able	O	O
to	O	O
produce	O	O
growth-inhibiting	O	O
amounts	O	O
of	O	O
hydrogen	O	O
peroxide	O	O
(	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
)	O	O
as	O	O
byproduct	O	O
of	O	O
aerobic	O	O
metabolism	O	O
.	O	O

Several	O	O
recent	O	O
studies	O	O
showed	O	O
that	O	O
the	O	O
produced	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
is	O	O
not	O	O
a	O	O
simple	O	O
byproduct	O	O
of	O	O
metabolism	O	O
but	O	O
functions	O	O
in	O	O
several	O	O
aspects	O	O
of	O	O
oral	O	O
bacterial	O	O
biofilm	O	O
ecology	O	O
.	O	O

First	O	O
,	O	O
the	O	O
release	O	O
of	O	O
DNA	O	O
from	O	O
cells	O	O
is	O	O
closely	O	O
associated	O	O
to	O	O
the	O	O
production	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
in	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
.	O	O

Extracellular	O	O
DNA	O	O
is	O	O
crucial	O	O
for	O	O
biofilm	O	O
development	O	O
and	O	O
stabilization	O	O
and	O	O
can	O	O
also	O	O
serve	O	O
as	O	O
source	O	O
for	O	O
horizontal	O	O
gene	O	O
transfer	O	O
between	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

Second	O	O
,	O	O
due	O	O
to	O	O
the	O	O
growth	O	O
inhibiting	O	O
nature	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
,	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
compatible	O	O
species	O	O
associate	O	O
with	O	O
the	O	O
producers	O	O
.	O	O

H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
production	O	O
therefore	O	O
might	O	O
help	O	O
in	O	O
structuring	O	O
the	O	O
initial	O	O
biofilm	O	O
development	O	O
.	O	O

On	O	O
the	O	O
other	O	O
hand	O	O
,	O	O
the	O	O
oral	O	O
environment	O	O
harbors	O	O
salivary	O	O
peroxidases	O	O
that	O	O
are	O	O
potent	O	O
in	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
scavenging	O	O
.	O	O

Therefore	O	O
,	O	O
the	O	O
effects	O	O
of	O	O
biofilm	O	O
intrinsic	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
production	O	O
might	O	O
be	O	O
locally	O	O
confined	O	O
.	O	O

However	O	O
,	O	O
taking	O	O
into	O	O
account	O	O
that	O	O
80	O	O
%	O	O
of	O	O
initial	O	O
oral	O	O
biofilm	O	O
constituents	O	O
are	O	O
streptococci	B-bacteria	B-bacteria
,	O	O
the	O	O
influence	O	O
of	O	O
H	O	O
(	O	O
2	O	O
)	O	O
O	O	O
(	O	O
2	O	O
)	O	O
on	O	O
biofilm	O	O
development	O	O
and	O	O
environmental	O	O
adaptation	O	O
might	O	O
be	O	O
under	O	O
appreciated	O	O
in	O	O
current	O	O
research	O	O
.	O	O

Currently	O	O
there	O	O
are	O	O
no	O	O
evidence-based	O	O
ecological	O	O
measures	O	O
for	O	O
prevention	O	O
of	O	O
overgrowth	O	O
and	O	O
subsequent	O	O
infection	O	O
by	O	O
fungi	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
increase	O	O
our	O	O
knowledge	O	O
on	O	O
fungal-bacterial	O	O
ecological	O	O
interactions	O	O
.	O	O

Salivary	O	O
Candida	O	O
abundance	O	O
of	O	O
82	O	O
Dutch	O	O
adults	O	O
aged	O	O
58-80	O	O
years	O	O
was	O	O
established	O	O
relative	O	O
to	O	O
the	O	O
bacterial	O	O
load	O	O
by	O	O
quantitative	O	O
PCR	O	O
analysis	O	O
of	O	O
the	O	O
Internal	O	O
Transcribed	O	O
(	O	O
ITS	O	O
)	O	O
region	O	O
(	O	O
Candida	O	O
)	O	O
and	O	O
16S	O	O
rDNA	O	O
gene	O	O
(	O	O
bacteria	O	O
)	O	O
.	O	O

The	O	O
salivary	O	O
microbiome	O	O
was	O	O
assessed	O	O
using	O	O
barcoded	O	O
pyrosequencing	O	O
of	O	O
the	O	O
bacterial	O	O
hypervariable	O	O
regions	O	O
V5-V7	O	O
of	O	O
16S	O	O
rDNA	O	O
.	O	O

Sequencing	O	O
data	O	O
was	O	O
preprocessed	O	O
by	O	O
denoising	O	O
and	O	O
chimera	O	O
removal	O	O
,	O	O
clustered	O	O
in	O	O
Operational	O	O
Taxonomic	O	O
Units	O	O
(	O	O
OTUs	O	O
)	O	O
and	O	O
assigned	O	O
to	O	O
taxonomy	O	O
.	O	O

Both	O	O
OTU-based	O	O
(	O	O
PCA	O	O
,	O	O
diversity	O	O
statistics	O	O
)	O	O
and	O	O
phylogeny-based	O	O
analyses	O	O
(	O	O
UniFrac	O	O
,	O	O
PCoA	O	O
)	O	O
were	O	O
performed	O	O
.	O	O

Saliva	O	O
of	O	O
Dutch	O	O
older	O	O
adults	O	O
contained	O	O
0-4	O	O
x	O	O
10	O	O
(	O	O
8	O	O
)	O	O
CFU/mL	O	O
Candida	O	O
with	O	O
a	O	O
median	O	O
Candida	O	O
load	O	O
of	O	O
0.06	O	O
%	O	O
.	O	O

With	O	O
increased	O	O
Candida	O	O
load	O	O
the	O	O
diversity	O	O
of	O	O
the	O	O
salivary	O	O
microbiome	O	O
decreased	O	O
significantly	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

Increase	O	O
in	O	O
the	O	O
Candida	O	O
load	O	O
correlated	O	O
positively	O	O
with	O	O
class	O	O
Bacilli	O	O
,	O	O
and	O	O
negatively	O	O
with	O	O
class	O	O
Fusobacteria	B-bacteria	B-bacteria
,	O	O
Flavobacteria	B-bacteria	B-bacteria
,	O	O
and	O	O
Bacteroidia	B-bacteria	B-bacteria
.	O	O

Microbiomes	O	O
with	O	O
high	O	O
Candida	O	O
load	O	O
were	O	O
less	O	O
diverse	O	O
and	O	O
had	O	O
a	O	O
distinct	O	O
microbial	O	O
composition	O	O
towards	O	O
dominance	O	O
by	O	O
saccharolytic	O	O
and	O	O
acidogenic	O	O
bacteria	O	O
--	O	O
streptococci	B-bacteria	B-bacteria
.	O	O

The	O	O
control	O	O
of	O	O
the	O	O
acidification	O	O
of	O	O
the	O	O
oral	O	O
environment	O	O
may	O	O
be	O	O
a	O	O
potential	O	O
preventive	O	O
measure	O	O
for	O	O
Candida	O	O
outgrowth	O	O
that	O	O
should	O	O
be	O	O
evaluated	O	O
in	O	O
longitudinal	O	O
clinical	O	O
intervention	O	O
trials	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
relationship	O	O
between	O	O
infection	O	O
with	O	O
cariogenic	O	O
bacteria	O	O
or	O	O
periodontal	O	O
pathogens	O	O
and	O	O
the	O	O
oral	O	O
condition	O	O
of	O	O
children	O	O
in	O	O
the	O	O
primary	O	O
and	O	O
mixed	O	O
dentition	O	O
stages	O	O
.	O	O

Children	O	O
aged	O	O
3	O	O
to	O	O
11	O	O
years	O	O
were	O	O
selected	O	O
Detection	O	O
of	O	O
cariogenic	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
and	O	O
single	O	O
nucleotide	O	O
polymorphism	O	O
(	O	O
SNP	O	O
)	O	O
analyses	O	O
were	O	O
performed	O	O
,	O	O
and	O	O
the	O	O
prevalence	O	O
of	O	O
infection	O	O
with	O	O
cariogenic	O	O
bacteria	O	O
or	O	O
periodontal	O	O
pathogens	O	O
based	O	O
on	O	O
caries	O	O
experience	O	O
and	O	O
dental	O	O
stage	O	O
was	O	O
compared	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
in	O	O
both	O	O
stages	O	O
was	O	O
significantly	O	O
higher	O	O
in	O	O
the	O	O
caries	O	O
group	O	O
than	O	O
in	O	O
the	O	O
caries-free	O	O
group	O	O
.	O	O

The	O	O
prevalence	O	O
of	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
was	O	O
significantly	O	O
higher	O	O
in	O	O
the	O	O
caries	O	O
group	O	O
only	O	O
in	O	O
the	O	O
mixed	O	O
dentition	O	O
stage	O	O
.	O	O

The	O	O
prevalence	O	O
ofperiodontal	O	O
pathogens	O	O
was	O	O
significantly	O	O
higher	O	O
in	O	O
the	O	O
mixed	O	O
dentition	O	O
stage	O	O
than	O	O
in	O	O
the	O	O
primary	O	O
dentition	O	O
stage	O	O
,	O	O
regardless	O	O
of	O	O
caries	O	O
experience	O	O
.	O	O

However	O	O
,	O	O
there	O	O
were	O	O
no	O	O
significant	O	O
differences	O	O
in	O	O
the	O	O
prevalence	O	O
of	O	O
the	O	O
periodontal	O	O
pathogens	O	O
between	O	O
the	O	O
primary	O	O
dentition	O	O
and	O	O
mixed	O	O
dentition	O	O
stages	O	O
,	O	O
based	O	O
on	O	O
caries	O	O
experience	O	O
.	O	O

Our	O	O
data	O	O
suggested	O	O
that	O	O
cariogenic	O	O
and	O	O
periodontopathic	O	O
bacteria	O	O
have	O	O
different	O	O
infection	O	O
patterns	O	O
,	O	O
and	O	O
that	O	O
the	O	O
period	O	O
of	O	O
infection	O	O
with	O	O
these	O	O
bacteria	O	O
also	O	O
differs	O	O
.	O	O

Congenital	O	O
heart	O	O
disease	O	O
(	O	O
CHD	O	O
)	O	O
,	O	O
abnormalities	O	O
in	O	O
the	O	O
structural	O	O
development	O	O
of	O	O
the	O	O
heart	O	O
,	O	O
occurs	O	O
in	O	O
approximately	O	O
8:1000	O	O
live	O	O
births	O	O
.	O	O

The	O	O
causative	O	O
microorganism	O	O
for	O	O
infective	O	O
endocarditis	O	O
in	O	O
more	O	O
than	O	O
60	O	O
%	O	O
of	O	O
the	O	O
patients	O	O
with	O	O
positive	O	O
hemoculture	O	O
of	O	O
viridans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
s.mutans	B-bacteria	B-bacteria
,	O	O
s.mitior	B-bacteria	B-bacteria
)	O	O
thus	O	O
making	O	O
it	O	O
mandatory	O	O
for	O	O
these	O	O
children	O	O
to	O	O
maintain	O	O
their	O	O
oral	O	O
health	O	O
.	O	O

The	O	O
present	O	O
study	O	O
assessed	O	O
the	O	O
oral	O	O
health	O	O
of	O	O
children	O	O
with	O	O
congenital	O	O
heart	O	O
disease	O	O
following	O	O
preventive	O	O
treatment	O	O
.	O	O

A	O	O
total	O	O
of	O	O
74	O	O
children	O	O
with	O	O
congenital	O	O
heart	O	O
disease	O	O
were	O	O
selected	O	O
for	O	O
the	O	O
study	O	O
with	O	O
30	O	O
healthy	O	O
controls	O	O
between	O	O
the	O	O
ages	O	O
5-16	O	O
.	O	O

The	O	O
oral	O	O
health	O	O
was	O	O
assessed	O	O
by	O	O
measuring	O	O
the	O	O
microbial	O	O
counts	O	O
,	O	O
the	O	O
OHI-S	O	O
and	O	O
the	O	O
gingival	O	O
indices	O	O
.	O	O

The	O	O
data	O	O
thus	O	O
obtained	O	O
were	O	O
subjected	O	O
to	O	O
paired	O	O
and	O	O
unpaired	O	O
t-test	O	O
.	O	O

Poor	O	O
oral	O	O
health	O	O
was	O	O
prevalent	O	O
among	O	O
these	O	O
children	O	O
of	O	O
the	O	O
study	O	O
group	O	O
as	O	O
compared	O	O
to	O	O
the	O	O
controls	O	O
indicating	O	O
a	O	O
lack	O	O
of	O	O
sound	O	O
knowledge	O	O
of	O	O
the	O	O
maintenance	O	O
of	O	O
oral	O	O
hygiene	O	O
.	O	O

Following	O	O
preventive	O	O
treatment	O	O
the	O	O
oral	O	O
health	O	O
improved	O	O
considerably	O	O
.	O	O

Interaction	O	O
of	O	O
oral	O	O
streptococci	B-bacteria	B-bacteria
biofilm	O	O
is	O	O
the	O	O
main	O	O
etiological	O	O
factor	O	O
for	O	O
dental	O	O
caries	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
compare	O	O
oral	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
OS	B-bacteria	B-bacteria
)	O	O
distribution	O	O
in	O	O
the	O	O
biofilm	O	O
of	O	O
primary	O	O
dentition	O	O
from	O	O
caries-free	O	O
and	O	O
caries-affected	O	O
preschool	O	O
Mexican	O	O
children	O	O
.	O	O

This	O	O
cross-sectional	O	O
study	O	O
involved	O	O
40	O	O
caries-free	O	O
and	O	O
40	O	O
caries-affected	O	O
children	O	O
with	O	O
primary	O	O
dentition	O	O
.	O	O

Each	O	O
child	O	O
was	O	O
examined	O	O
using	O	O
the	O	O
dmfs	O	O
index	O	O
,	O	O
DNA	O	O
was	O	O
extracted	O	O
from	O	O
saliva	O	O
and	O	O
presence	O	O
of	O	O
OS	O	O
was	O	O
determined	O	O
by	O	O
PCR	O	O
.	O	O

Data	O	O
obtained	O	O
showed	O	O
no	O	O
statistical	O	O
difference	O	O
regarding	O	O
age	O	O
and	O	O
gender	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
Smut	B-bacteria	B-bacteria
)	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
sobrinus	E-bacteria	I-bacteria
(	O	O
Ssob	B-bacteria	B-bacteria
)	O	O
and	O	O
their	O	O
combination	O	O
showed	O	O
significant	O	O
statistical	O	O
differences	O	O
between	O	O
groups	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

Smut	B-bacteria	B-bacteria
,	O	O
Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
had	O	O
an	O	O
inverse	O	O
relation	O	O
with	O	O
dmfs	O	O
index	O	O
and	O	O
Ssob	B-bacteria	B-bacteria
had	O	O
a	O	O
direct	O	O
relation	O	O
similar	O	O
to	O	O
combined	O	O
with	O	O
Smut	B-bacteria	B-bacteria
.	O	O

Smut-Ssob	B-bacteria	B-bacteria
combined	O	O
with	O	O
other	O	O
OS	B-bacteria	B-bacteria
showed	O	O
statistical	O	O
differences	O	O
(	O	O
P	O	O
<	O	O
0.05	O	O
)	O	O
.	O	O

In	O	O
free-caries	O	O
group	O	O
Streptococcus	B-bacteria	B-bacteria
gordonii	E-bacteria	I-bacteria
was	O	O
more	O	O
frequently	O	O
identified	O	O
than	O	O
Smut	B-bacteria	B-bacteria
.	O	O

The	O	O
ratio	O	O
Smut/Streptococcus	B-bacteria	B-bacteria
sanguinis	E-bacteria	I-bacteria
could	O	O
represent	O	O
a	O	O
high	O	O
risk	O	O
of	O	O
dental	O	O
caries	O	O
development	O	O
;	O	O
this	O	O
ratio	O	O
was	O	O
higher	O	O
in	O	O
the	O	O
caries-affected	O	O
(	O	O
1.18	O	O
)	O	O
than	O	O
in	O	O
the	O	O
caries-free	O	O
group	O	O
(	O	O
0.32	O	O
)	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
OS	B-bacteria	B-bacteria
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
dental	O	O
caries	O	O
predisposition	O	O
and	O	O
severity	O	O
,	O	O
not	O	O
only	O	O
the	O	O
presence	O	O
of	O	O
Smut	B-bacteria	B-bacteria
and	O	O
Srob	B-bacteria	B-bacteria
,	O	O
but	O	O
also	O	O
the	O	O
complexity	O	O
and	O	O
distribution	O	O
of	O	O
OS	B-bacteria	B-bacteria
in	O	O
the	O	O
biofilm	O	O
.	O	O

Mouthwashes	O	O
decrease	O	O
the	O	O
risk	O	O
of	O	O
VAP	O	O
by	O	O
reducing	O	O
the	O	O
number	O	O
of	O	O
microorganisms	O	O
and	O	O
their	O	O
transmission	O	O
and	O	O
colonization	O	O
in	O	O
the	O	O
lung	O	O
.	O	O

Among	O	O
the	O	O
oral	O	O
rinses	O	O
,	O	O
chlorhexidine	O	O
is	O	O
considered	O	O
as	O	O
the	O	O
gold	O	O
standard	O	O
but	O	O
it	O	O
has	O	O
a	O	O
variety	O	O
of	O	O
complications	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
determine	O	O
and	O	O
compare	O	O
anti-bacterial	O	O
effects	O	O
of	O	O
the	O	O
chlorhexidine	O	O
gluconate	O	O
and	O	O
herbal	O	O
mouthwashes	O	O
in	O	O
intensive	O	O
care	O	O
unit	O	O
patients	O	O
.	O	O

In	O	O
this	O	O
double	O	O
blind	O	O
randomized	O	O
clinical	O	O
trial	O	O
,	O	O
60	O	O
patients	O	O
who	O	O
were	O	O
admitted	O	O
in	O	O
ICU	O	O
were	O	O
divided	O	O
into	O	O
two	O	O
equal	O	O
30	O	O
persons	O	O
groups	O	O
.	O	O

In	O	O
the	O	O
first	O	O
group	O	O
Chlorhexidine	O	O
gluconate	O	O
2	O	O
%	O	O
mouthwash	O	O
and	O	O
in	O	O
the	O	O
second	O	O
group	O	O
herbal	O	O
mouth	O	O
wash	O	O
was	O	O
used	O	O
.	O	O

Just	O	O
before	O	O
and	O	O
again	O	O
after	O	O
6	O	O
min	O	O
of	O	O
oral	O	O
rinsing	O	O
,	O	O
salivary	O	O
samples	O	O
were	O	O
obtained	O	O
without	O	O
any	O	O
stimulation	O	O
in	O	O
order	O	O
to	O	O
culture	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
.	O	O

The	O	O
data	O	O
were	O	O
processed	O	O
in	O	O
SPSS16	O	O
software	O	O
and	O	O
were	O	O
analyzed	O	O
by	O	O
appropriate	O	O
statistical	O	O
tests	O	O
.	O	O

Matrica	O	O
(	O	O
R	O	O
)	O	O
and	O	O
chlorhexidine	O	O
mouthwashes	O	O
have	O	O
significant	O	O
antibacterial	O	O
effects	O	O
against	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
and	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

Decreasing	O	O
of	O	O
the	O	O
number	O	O
of	O	O
bacteria	O	O
in	O	O
samples	O	O
after	O	O
oral	O	O
rinsing	O	O
was	O	O
significant	O	O
in	O	O
both	O	O
groups	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
but	O	O
chlorhexidine	O	O
was	O	O
significantly	O	O
more	O	O
effective	O	O
than	O	O
herbal	O	O
mouth	O	O
wash	O	O
in	O	O
reducing	O	O
the	O	O
number	O	O
of	O	O
colonies	O	O
(	O	O
p	O	O
<	O	O
0.001	O	O
)	O	O
.	O	O

The	O	O
herbal	O	O
mouth	O	O
wash	O	O
has	O	O
significant	O	O
antibacterial	O	O
effects	O	O
against	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
and	O	O
Streptococcus	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
,	O	O
but	O	O
its	O	O
efficacy	O	O
is	O	O
less	O	O
than	O	O
chlorhexidine	O	O
,	O	O
so	O	O
after	O	O
further	O	O
investigation	O	O
,	O	O
it	O	O
would	O	O
be	O	O
considered	O	O
as	O	O
an	O	O
alternative	O	O
to	O	O
chlorhexidine	O	O
in	O	O
ICUs	O	O
(	O	O
Tab	O	O
.	O	O
3	O	O
,	O	O
Ref	O	O
.	O	O
33	O	O
)	O	O
.	O	O

Outbreaks	O	O
of	O	O
antibiotic-resistant	O	O
bacterial	O	O
infections	O	O
emphasize	O	O
the	O	O
importance	O	O
of	O	O
surveillance	O	O
of	O	O
potentially	O	O
pathogenic	O	O
bacteria	O	O
.	O	O

Genomic	O	O
sequencing	O	O
of	O	O
clinical	O	O
microbiological	O	O
specimens	O	O
expands	O	O
our	O	O
capacity	O	O
to	O	O
cultivable	O	O
,	O	O
fastidious	O	O
and	O	O
uncultivable	O	O
members	O	O
of	O	O
the	O	O
bacterial	O	O
community	O	O
.	O	O

Herein	O	O
,	O	O
we	O	O
compared	O	O
the	O	O
primary	O	O
data	O	O
collected	O	O
by	O	O
the	O	O
NIH	O	O
's	O	O
Human	O	O
Microbiome	O	O
Project	O	O
(	O	O
HMP	O	O
)	O	O
with	O	O
published	O	O
epidemiological	O	O
surveillance	O	O
data	O	O
of	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
.	O	O

The	O	O
HMP	O	O
's	O	O
initial	O	O
dataset	O	O
contained	O	O
microbial	O	O
survey	O	O
data	O	O
from	O	O
five	O	O
body	O	O
regions	O	O
(	O	O
skin	O	O
,	O	O
nares	O	O
,	O	O
oral	O	O
cavity	O	O
,	O	O
gut	O	O
and	O	O
vagina	O	O
)	O	O
of	O	O
242	O	O
healthy	O	O
volunteers	O	O
.	O	O

A	O	O
significant	O	O
component	O	O
of	O	O
the	O	O
HMP	O	O
dataset	O	O
was	O	O
deep	O	O
sequencing	O	O
of	O	O
the	O	O
16S	O	O
ribosomal	O	O
RNA	O	O
gene	O	O
,	O	O
which	O	O
contains	O	O
variable	O	O
regions	O	O
enabling	O	O
taxonomic	O	O
classification	O	O
.	O	O

Since	O	O
species-level	O	O
identification	O	O
is	O	O
essential	O	O
in	O	O
clinical	O	O
microbiology	O	O
,	O	O
we	O	O
built	O	O
a	O	O
reference	O	O
database	O	O
and	O	O
used	O	O
phylogenetic	O	O
placement	O	O
followed	O	O
by	O	O
most	O	O
recent	O	O
common	O	O
ancestor	O	O
classification	O	O
to	O	O
look	O	O
at	O	O
the	O	O
species	O	O
distribution	O	O
for	O	O
Staphylococcus	B-bacteria	B-bacteria
,	O	O
Klebsiella	B-bacteria	B-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
.	O	O

We	O	O
show	O	O
that	O	O
selecting	O	O
the	O	O
accurate	O	O
region	O	O
of	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
to	O	O
sequence	O	O
is	O	O
analogous	O	O
to	O	O
carefully	O	O
selecting	O	O
culture	O	O
conditions	O	O
to	O	O
distinguish	O	O
closely	O	O
related	O	O
bacterial	O	O
species	O	O
.	O	O

Analysis	O	O
of	O	O
the	O	O
HMP	O	O
data	O	O
showed	O	O
that	O	O
Staphylococcus	B-bacteria	B-bacteria
aureus	E-bacteria	I-bacteria
was	O	O
present	O	O
in	O	O
the	O	O
nares	O	O
of	O	O
36	O	O
%	O	O
of	O	O
healthy	O	O
volunteers	O	O
,	O	O
consistent	O	O
with	O	O
culture-based	O	O
epidemiological	O	O
data	O	O
.	O	O

Klebsiella	B-bacteria	B-bacteria
pneumoniae	E-bacteria	I-bacteria
and	O	O
Enterococcus	B-bacteria	B-bacteria
faecalis	E-bacteria	I-bacteria
were	O	O
found	O	O
less	O	O
frequently	O	O
,	O	O
but	O	O
across	O	O
many	O	O
habitats	O	O
.	O	O

This	O	O
work	O	O
demonstrates	O	O
that	O	O
large	O	O
16S	O	O
rRNA	O	O
survey	O	O
studies	O	O
can	O	O
be	O	O
used	O	O
to	O	O
support	O	O
epidemiological	O	O
goals	O	O
in	O	O
the	O	O
context	O	O
of	O	O
an	O	O
increasing	O	O
awareness	O	O
that	O	O
microbes	O	O
flourish	O	O
and	O	O
compete	O	O
within	O	O
a	O	O
larger	O	O
bacterial	O	O
community	O	O
.	O	O

This	O	O
demonstrates	O	O
how	O	O
genomic	O	O
techniques	O	O
and	O	O
information	O	O
could	O	O
be	O	O
critically	O	O
important	O	O
to	O	O
trace	O	O
microbial	O	O
evolution	O	O
and	O	O
implement	O	O
hospital	O	O
infection	O	O
control	O	O
.	O	O

The	O	O
mouth	O	O
is	O	O
a	O	O
complex	O	O
biological	O	O
structure	O	O
inhabited	O	O
by	O	O
diverse	O	O
bacterial	O	O
communities	O	O
.	O	O

The	O	O
purpose	O	O
of	O	O
this	O	O
study	O	O
is	O	O
to	O	O
describe	O	O
the	O	O
effects	O	O
of	O	O
allogeneic	O	O
stem	O	O
cell	O	O
transplantation	O	O
on	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
to	O	O
examine	O	O
differences	O	O
among	O	O
those	O	O
patients	O	O
who	O	O
acquired	O	O
respiratory	O	O
complications	O	O
after	O	O
transplantation	O	O
.	O	O

All	O	O
patients	O	O
were	O	O
consented	O	O
at	O	O
the	O	O
National	O	O
Institutes	O	O
of	O	O
Health	O	O
,	O	O
Clinical	O	O
Center	O	O
.	O	O

Bacterial	O	O
DNA	O	O
was	O	O
analyzed	O	O
from	O	O
patients	O	O
'	O	O
oral	O	O
specimens	O	O
using	O	O
the	O	O
Human	O	O
Oral	O	O
Microbe	O	O
Identification	O	O
Microarray	O	O
.	O	O

The	O	O
specimens	O	O
were	O	O
collected	O	O
from	O	O
four	O	O
oral	O	O
sites	O	O
in	O	O
45	O	O
allogeneic	O	O
transplantation	O	O
patients	O	O
.	O	O

Specimens	O	O
were	O	O
collected	O	O
at	O	O
baseline	O	O
prior	O	O
to	O	O
transplantation	O	O
,	O	O
after	O	O
transplantation	O	O
at	O	O
the	O	O
nadir	O	O
of	O	O
the	O	O
neutrophil	O	O
count	O	O
and	O	O
after	O	O
myeloid	O	O
engraftment	O	O
.	O	O

If	O	O
respiratory	O	O
signs	O	O
and	O	O
symptoms	O	O
developed	O	O
,	O	O
additional	O	O
specimens	O	O
were	O	O
obtained	O	O
.	O	O

Patients	O	O
were	O	O
followed	O	O
for	O	O
100	O	O
days	O	O
post	O	O
transplantation	O	O
.	O	O

Eleven	O	O
patients	O	O
'	O	O
specimens	O	O
were	O	O
subjected	O	O
to	O	O
further	O	O
statistical	O	O
analysis	O	O
.	O	O

Many	O	O
common	O	O
bacterial	O	O
genera	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
and	O	O
Camplyobacter	B-bacteria	B-bacteria
were	O	O
identified	O	O
as	O	O
being	O	O
present	O	O
before	O	O
and	O	O
after	O	O
transplantation	O	O
.	O	O

Five	O	O
of	O	O
11	O	O
patients	O	O
developed	O	O
respiratory	O	O
complications	O	O
following	O	O
transplantation	O	O
and	O	O
there	O	O
was	O	O
preliminary	O	O
evidence	O	O
that	O	O
the	O	O
oral	O	O
microbiome	O	O
changed	O	O
in	O	O
their	O	O
oral	O	O
specimens	O	O
.	O	O

Cluster	O	O
analysis	O	O
and	O	O
principal	O	O
component	O	O
analysis	O	O
revealed	O	O
this	O	O
change	O	O
in	O	O
the	O	O
oral	O	O
microbiota	O	O
.	O	O

After	O	O
allogeneic	O	O
transplantation	O	O
,	O	O
the	O	O
oral	O	O
bacterial	O	O
community	O	O
's	O	O
response	O	O
to	O	O
a	O	O
new	O	O
immune	O	O
system	O	O
was	O	O
not	O	O
apparent	O	O
and	O	O
many	O	O
of	O	O
the	O	O
most	O	O
common	O	O
core	O	O
oral	O	O
taxa	O	O
remained	O	O
unaffected	O	O
.	O	O

However	O	O
,	O	O
the	O	O
oral	O	O
microbiome	O	O
was	O	O
affected	O	O
in	O	O
patients	O	O
who	O	O
developed	O	O
respiratory	O	O
signs	O	O
and	O	O
symptoms	O	O
after	O	O
transplantation	O	O
.	O	O

The	O	O
association	O	O
related	O	O
to	O	O
the	O	O
change	O	O
in	O	O
the	O	O
oral	O	O
microbiota	O	O
and	O	O
respiratory	O	O
complications	O	O
after	O	O
transplantation	O	O
will	O	O
be	O	O
validated	O	O
by	O	O
future	O	O
studies	O	O
using	O	O
high	O	O
throughput	O	O
molecular	O	O
methods	O	O
.	O	O

Antimicrobial	O	O
resistance	O	O
is	O	O
on	O	O
the	O	O
increase	O	O
in	O	O
'medical	O	O
and	O	O
dental	O	O
fields	O	O
.	O	O

Beta-lactam	O	O
antibiotics	O	O
are	O	O
the	O	O
most	O	O
widely	O	O
used	O	O
antimicrobials	O	O
in	O	O
dental	O	O
patients	O	O
.	O	O

This	O	O
study	O	O
investigated	O	O
the	O	O
prevalence	O	O
of	O	O
beta-lactamase-producing	O	O
anaerobic	O	O
oral	O	O
bacteria	O	O
in	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
.	O	O

Pooled	O	O
subgingival	O	O
samples	O	O
from	O	O
two	O	O
sites	O	O
in	O	O
42	O	O
patients	O	O
with	O	O
chronic	O	O
periodontitis	O	O
were	O	O
cultured	O	O
anaerobically	O	O
on	O	O
blood	O	O
agar	O	O
plates	O	O
containing	O	O
amoxycillin	O	O
or/and	O	O
Augmentin	O	O
.	O	O

Colonies	O	O
that	O	O
grew	O	O
on	O	O
amoxycillin	O	O
but	O	O
not	O	O
Augmentin	O	O
were	O	O
identified	O	O
and	O	O
tested	O	O
for	O	O
beta-lactamase	O	O
production	O	O
.	O	O

Sixty-nine	O	O
percent	O	O
of	O	O
patients	O	O
carried	O	O
beta-lactamase-producing	O	O
anaerobes	O	O
,	O	O
with	O	O
a	O	O
mean	O	O
of	O	O
one	O	O
to	O	O
two	O	O
strains	O	O
per	O	O
patient	O	O
.	O	O

Seventy	O	O
isolates	O	O
of	O	O
the	O	O
beta-lactamase-	O	O
producing	O	O
strains	O	O
formed	O	O
4	O	O
%	O	O
of	O	O
the	O	O
total	O	O
cultivable	O	O
anaerobic	O	O
flora	O	O
.	O	O

Prevotella	B-bacteria	B-bacteria
was	O	O
the	O	O
most	O	O
prevalent	O	O
beta-lactamase-producing	O	O
species	O	O
,	O	O
followed	O	O
by	O	O
Capnocytophaga	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Bacteroides	B-bacteria	B-bacteria
.	O	O

A	O	O
high	O	O
prevalence	O	O
of	O	O
beta-lactamase-producing	O	O
oral	O	O
anaerobes	O	O
was	O	O
detected	O	O
in	O	O
this	O	O
preliminary	O	O
study	O	O
.	O	O

However	O	O
,	O	O
the	O	O
percentage	O	O
of	O	O
beta-lactamase	O	O
producers	O	O
in	O	O
the	O	O
total	O	O
number	O	O
of	O	O
bacteria	O	O
per	O	O
patient	O	O
was	O	O
low	O	O
.	O	O

Therefore	O	O
,	O	O
beta-lactam	O	O
antibiotics	O	O
still	O	O
remain	O	O
the	O	O
drug	O	O
of	O	O
choice	O	O
in	O	O
infections	O	O
with	O	O
odontogenic	O	O
origin	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
the	O	O
present	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
bacterial	O	O
diversity	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
patients	O	O
with	O	O
different	O	O
oral	O	O
hygiene	O	O
indexes	O	O
using	O	O
of	O	O
two	O	O
16S	O	O
rRNA	O	O
gene	O	O
libraries	O	O
.	O	O

Each	O	O
library	O	O
was	O	O
composed	O	O
of	O	O
samples	O	O
from	O	O
patients	O	O
with	O	O
different	O	O
averages	O	O
of	O	O
the	O	O
differentiated	O	O
Silness-Loe	O	O
biofilm	O	O
index	O	O
:	O	O
the	O	O
first	O	O
library	O	O
(	O	O
A	O	O
)	O	O
with	O	O
an	O	O
index	O	O
between	O	O
1.0	O	O
and	O	O
3.0	O	O
(	O	O
considered	O	O
a	O	O
high	O	O
index	O	O
)	O	O
and	O	O
the	O	O
second	O	O
library	O	O
(	O	O
B	O	O
)	O	O
between	O	O
0	O	O
and	O	O
0.5	O	O
(	O	O
considered	O	O
a	O	O
low	O	O
index	O	O
)	O	O
.	O	O

Saliva	O	O
DNA	O	O
was	O	O
extracted	O	O
and	O	O
the	O	O
16S	O	O
rRNA	O	O
gene	O	O
was	O	O
amplified	O	O
and	O	O
cloned	O	O
.	O	O

The	O	O
obtained	O	O
sequences	O	O
were	O	O
compared	O	O
with	O	O
those	O	O
stored	O	O
at	O	O
NCBI	O	O
and	O	O
RDP	O	O
GenBank	O	O
.	O	O

The	O	O
saliva	O	O
of	O	O
patients	O	O
with	O	O
high	O	O
index	O	O
presented	O	O
five	O	O
known	O	O
genera	O	O
-	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
and	O	O
Peptostreptococcus	B-bacteria	B-bacteria
-	O	O
and	O	O
33.3	O	O
%	O	O
of	O	O
nonculturable	O	O
bacteria	O	O
grouped	O	O
into	O	O
23	O	O
operational	O	O
taxonomic	O	O
units	O	O
(	O	O
OTUs	O	O
)	O	O
.	O	O

The	O	O
saliva	O	O
of	O	O
patients	O	O
with	O	O
low	O	O
index	O	O
differed	O	O
significantly	O	O
from	O	O
the	O	O
first	O	O
library	O	O
(	O	O
p=0.000	O	O
)	O	O
and	O	O
was	O	O
composed	O	O
of	O	O
42	O	O
OTUs	O	O
distributed	O	O
into	O	O
11	O	O
known	O	O
genera	O	O
-	O	O
Streptococcus	B-bacteria	B-bacteria
,	O	O
Granulicatella	B-bacteria	B-bacteria
,	O	O
Gemella	B-bacteria	B-bacteria
,	O	O
Veillonella	B-bacteria	B-bacteria
,	O	O
Oribacterium	B-bacteria	B-bacteria
,	O	O
Haemophilus	B-bacteria	B-bacteria
,	O	O
Escherichia	B-bacteria	B-bacteria
,	O	O
Neisseria	B-bacteria	B-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
,	O	O
Capnocytophaga	B-bacteria	B-bacteria
,	O	O
Actinomyces	B-bacteria	B-bacteria
-	O	O
including	O	O
24.87	O	O
%	O	O
of	O	O
nonculturable	O	O
bacteria	O	O
.	O	O

It	O	O
was	O	O
possible	O	O
to	O	O
conclude	O	O
that	O	O
there	O	O
is	O	O
greater	O	O
bacterial	O	O
diversity	O	O
in	O	O
the	O	O
saliva	O	O
of	O	O
patients	O	O
with	O	O
low	O	O
dental	O	O
plaque	O	O
in	O	O
relation	O	O
to	O	O
patients	O	O
with	O	O
high	O	O
dental	O	O
plaque	O	O
.	O	O

The	O	O
objective	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
assess	O	O
the	O	O
possible	O	O
modifications	O	O
due	O	O
to	O	O
amoxicillin-clavulanic	O	O
acid	O	O
(	O	O
AMC	O	O
)	O	O
treatment	O	O
on	O	O
total	O	O
bacteria	O	O
and	O	O
on	O	O
Bifidobacterium	B-bacteria	B-bacteria
species	E-bacteria	I-bacteria
balance	O	O
in	O	O
human	O	O
colonic	O	O
microbiota	O	O
.	O	O

Eighteen	O	O
healthy	O	O
volunteers	O	O
(	O	O
19	O	O
to	O	O
36	O	O
years	O	O
old	O	O
)	O	O
were	O	O
given	O	O
a	O	O
875/125	O	O
mg	O	O
dose	O	O
of	O	O
AMC	O	O
twice	O	O
a	O	O
day	O	O
for	O	O
5	O	O
days	O	O
.	O	O

Fecal	O	O
samples	O	O
were	O	O
obtained	O	O
before	O	O
and	O	O
after	O	O
antibiotic	O	O
exposure	O	O
.	O	O

After	O	O
total	O	O
DNA	O	O
extraction	O	O
,	O	O
total	O	O
bacteria	O	O
and	O	O
bifidobacteria	B-bacteria	B-bacteria
were	O	O
specifically	O	O
quantified	O	O
using	O	O
real-time	O	O
PCR	O	O
.	O	O

Dominant	O	O
species	O	O
were	O	O
monitored	O	O
over	O	O
time	O	O
using	O	O
bacterial	O	O
and	O	O
bifidobacterial	O	O
Temporal	O	O
Temperature	O	O
Gradient	O	O
gel	O	O
Electrophoresis	O	O
(	O	O
TTGE	O	O
)	O	O
.	O	O

At	O	O
the	O	O
end	O	O
of	O	O
AMC	O	O
exposure	O	O
,	O	O
total	O	O
bacterial	O	O
concentrations	O	O
as	O	O
well	O	O
as	O	O
bifidobacteria	B-bacteria	B-bacteria
concentrations	O	O
were	O	O
significantly	O	O
reduced	O	O
compared	O	O
to	O	O
before	O	O
AMC	O	O
exposure:10.7+/-0.1	O	O
log	O	O
(	O	O
10	O	O
)	O	O
16S	O	O
rRNA	O	O
gene	O	O
copies/g	O	O
vs	O	O
11.1+/-0.1	O	O
log	O	O
(	O	O
10	O	O
)	O	O
(	O	O
p	O	O
=	O	O
0.003	O	O
)	O	O
and	O	O
8.1+/-0.5	O	O
log	O	O
(	O	O
10	O	O
)	O	O
16S	O	O
rRNA	O	O
gene	O	O
copies/g	O	O
vs	O	O
9.4+/-0.3	O	O
log	O	O
(	O	O
10	O	O
)	O	O
(	O	O
p	O	O
=	O	O
0.003	O	O
)	O	O
,	O	O
respectively	O	O
.	O	O

At	O	O
the	O	O
same	O	O
time	O	O
,	O	O
the	O	O
mean	O	O
similarity	O	O
percentages	O	O
of	O	O
TTGE	O	O
bacteria	O	O
and	O	O
TTGE	O	O
bifidobacteria	B-bacteria	B-bacteria
profiles	O	O
were	O	O
significantly	O	O
reduced	O	O
compared	O	O
to	O	O
before	O	O
AMC	O	O
exposure	O	O
:	O	O
51.6	O	O
%	O	O
+/-3.5	O	O
%	O	O
vs	O	O
81.4	O	O
%	O	O
+/-2.1	O	O
%	O	O
and	O	O
55.8	O	O
%	O	O
+/-7.6	O	O
%	O	O
vs	O	O
84.5	O	O
%	O	O
+/-4.1	O	O
%	O	O
,	O	O
respectively	O	O
.	O	O

Occurrence	O	O
of	O	O
B.	B-bacteria	B-bacteria
adolescentis	E-bacteria	I-bacteria
,	O	O
B.	B-bacteria	B-bacteria
bifidum	E-bacteria	I-bacteria
and	O	O
B.	B-bacteria	B-bacteria
pseudocatenulatum/B	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
catenulatum	E-bacteria	I-bacteria
species	O	O
significantly	O	O
decreased	O	O
.	O	O

Occurrence	O	O
of	O	O
B.	B-bacteria	B-bacteria
longum	E-bacteria	I-bacteria
remained	O	O
stable	O	O
.	O	O

Moreover	O	O
,	O	O
the	O	O
number	O	O
of	O	O
distinct	O	O
Bifidobacterium	B-bacteria	B-bacteria
species	O	O
per	O	O
sample	O	O
significantly	O	O
decreased	O	O
(	O	O
1.5+/-0.3	O	O
vs	O	O
2.3+/-0.3	O	O
;	O	O
p	O	O
=	O	O
0.01	O	O
)	O	O
.	O	O

Two	O	O
months	O	O
after	O	O
AMC	O	O
exposure	O	O
,	O	O
the	O	O
mean	O	O
similarity	O	O
percentage	O	O
of	O	O
TTGE	O	O
profiles	O	O
was	O	O
55.6	O	O
%	O	O
for	O	O
bacteria	O	O
and	O	O
62.3	O	O
%	O	O
for	O	O
bifidobacteria	B-bacteria	B-bacteria
.	O	O

These	O	O
results	O	O
clearly	O	O
demonstrated	O	O
that	O	O
a	O	O
common	O	O
antibiotic	O	O
treatment	O	O
may	O	O
qualitatively	O	O
alter	O	O
the	O	O
colonic	O	O
microbiota	O	O
.	O	O

Such	O	O
modifications	O	O
may	O	O
have	O	O
potential	O	O
long-term	O	O
physiological	O	O
consequences	O	O
.	O	O

Periodontal	O	O
(	O	O
gum	O	O
)	O	O
disease	O	O
is	O	O
one	O	O
of	O	O
the	O	O
main	O	O
global	O	O
oral	O	O
health	O	O
burdens	O	O
and	O	O
severe	O	O
periodontal	O	O
disease	O	O
(	O	O
periodontitis	O	O
)	O	O
is	O	O
a	O	O
leading	O	O
cause	O	O
of	O	O
tooth	O	O
loss	O	O
in	O	O
adults	O	O
globally	O	O
.	O	O

It	O	O
also	O	O
increases	O	O
the	O	O
risk	O	O
of	O	O
cardiovascular	O	O
disease	O	O
and	O	O
diabetes	O	O
mellitus	O	O
.	O	O

Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
lipopolysaccharide	O	O
(	O	O
LPS	O	O
)	O	O
is	O	O
a	O	O
key	O	O
virulent	O	O
attribute	O	O
that	O	O
significantly	O	O
contributes	O	O
to	O	O
periodontal	O	O
pathogenesis	O	O
.	O	O

Baicalin	O	O
is	O	O
a	O	O
flavonoid	O	O
from	O	O
Scutellaria	O	O
radix	O	O
,	O	O
an	O	O
herb	O	O
commonly	O	O
used	O	O
in	O	O
traditional	O	O
Chinese	O	O
medicine	O	O
for	O	O
treating	O	O
inflammatory	O	O
diseases	O	O
.	O	O

The	O	O
present	O	O
study	O	O
examined	O	O
the	O	O
modulatory	O	O
effect	O	O
of	O	O
baicalin	O	O
on	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS-induced	O	O
expression	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
in	O	O
human	O	O
oral	O	O
keratinocytes	O	O
(	O	O
HOKs	O	O
)	O	O
.	O	O

Cells	O	O
were	O	O
pre-treated	O	O
with	O	O
baicalin	O	O
(	O	O
0-80	O	O
microM	O	O
)	O	O
for	O	O
24	O	O
h	O	O
,	O	O
and	O	O
subsequently	O	O
treated	O	O
with	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS	O	O
at	O	O
10	O	O
microg/ml	O	O
with	O	O
or	O	O
without	O	O
baicalin	O	O
for	O	O
3	O	O
h.	O	O
IL-6	O	O
and	O	O
IL-8	O	O
transcripts	O	O
and	O	O
proteins	O	O
were	O	O
detected	O	O
by	O	O
real-time	O	O
polymerase	O	O
chain	O	O
reaction	O	O
and	O	O
enzyme-linked	O	O
immunosorbent	O	O
assay	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
expression	O	O
of	O	O
nuclear	O	O
factor-kappaB	O	O
(	O	O
NF-kappaB	O	O
)	O	O
,	O	O
p38	O	O
mitogen-activated	O	O
protein	O	O
kinase	O	O
(	O	O
MAPK	O	O
)	O	O
and	O	O
c-Jun	O	O
N-terminal	O	O
kinase	O	O
(	O	O
JNK	O	O
)	O	O
proteins	O	O
was	O	O
analyzed	O	O
by	O	O
western	O	O
blot	O	O
.	O	O

A	O	O
panel	O	O
of	O	O
genes	O	O
related	O	O
to	O	O
toll-like	O	O
receptor	O	O
(	O	O
TLR	O	O
)	O	O
signaling	O	O
was	O	O
examined	O	O
by	O	O
PCR	O	O
array	O	O
.	O	O

We	O	O
found	O	O
that	O	O
baicalin	O	O
significantly	O	O
downregulated	O	O
P.	O	O
gingivalis	O	O
LPS-stimulated	O	O
expression	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
,	O	O
and	O	O
inhibited	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS-activated	O	O
NF-kappaB	O	O
,	O	O
p38	O	O
MAPK	O	O
and	O	O
JNK	O	O
.	O	O

Furthermore	O	O
,	O	O
baicalin	O	O
markedly	O	O
downregulated	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS-induced	O	O
expression	O	O
of	O	O
genes	O	O
associated	O	O
with	O	O
TLR	O	O
signaling	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
the	O	O
present	O	O
study	O	O
shows	O	O
that	O	O
baicalin	O	O
may	O	O
significantly	O	O
downregulate	O	O
P.	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
LPS-upregulated	O	O
expression	O	O
of	O	O
IL-6	O	O
and	O	O
IL-8	O	O
in	O	O
HOKs	O	O
via	O	O
negative	O	O
regulation	O	O
of	O	O
TLR	O	O
signaling	O	O
.	O	O

In	O	O
the	O	O
aging	O	O
population	O	O
,	O	O
the	O	O
prevalence	O	O
of	O	O
root	O	O
caries	O	O
has	O	O
been	O	O
observed	O	O
,	O	O
which	O	O
is	O	O
a	O	O
characteristic	O	O
feature	O	O
of	O	O
the	O	O
elderly	O	O
people	O	O
.	O	O

The	O	O
most	O	O
important	O	O
element	O	O
used	O	O
in	O	O
caries	O	O
prevention	O	O
is	O	O
fluoride	O	O
,	O	O
which	O	O
is	O	O
derived	O	O
from	O	O
the	O	O
air	O	O
,	O	O
diet	O	O
or	O	O
fluoride-containing	O	O
preparations	O	O
and	O	O
materials	O	O
,	O	O
e.g	O	O
.	O	O

glass-ionomer	O	O
restorations	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
the	O	O
study	O	O
was	O	O
to	O	O
evaluate	O	O
the	O	O
effect	O	O
of	O	O
Ketac	O	O
Molar	O	O
Aplicap	O	O
glass-ionomer	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	I-bacteria	I-bacteria
bacteria	E-bacteria	I-bacteria
,	O	O
one	O	O
of	O	O
the	O	O
species	O	O
most	O	O
frequently	O	O
found	O	O
in	O	O
the	O	O
carietic	O	O
focus	O	O
of	O	O
the	O	O
tooth	O	O
root	O	O
.	O	O

The	O	O
study	O	O
was	O	O
carried	O	O
out	O	O
in	O	O
15	O	O
patients	O	O
with	O	O
good	O	O
oral	O	O
hygiene	O	O
,	O	O
in	O	O
whom	O	O
35	O	O
fillings	O	O
from	O	O
Ketac	O	O
Molar	O	O
Aplicap	O	O
conventional	O	O
glass-ionomer	O	O
material	O	O
were	O	O
performed	O	O
.	O	O

After	O	O
6	O	O
months	O	O
,	O	O
three-day	O	O
dental	O	O
plaque	O	O
from	O	O
these	O	O
fillings	O	O
and	O	O
from	O	O
the	O	O
tooth	O	O
enamel	O	O
of	O	O
the	O	O
control	O	O
group	O	O
was	O	O
examined	O	O
.	O	O

No	O	O
statistically	O	O
significant	O	O
differences	O	O
(	O	O
p	O	O
=	O	O
0.554	O	O
)	O	O
in	O	O
the	O	O
amounts	O	O
of	O	O
Lactobacillus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
between	O	O
the	O	O
study	O	O
and	O	O
control	O	O
group	O	O
were	O	O
revealed	O	O
.	O	O

Lack	O	O
of	O	O
inhibiting	O	O
effect	O	O
of	O	O
glass-ionomer	O	O
material	O	O
on	O	O
the	O	O
growth	O	O
of	O	O
the	O	O
dental	O	O
plaque	O	O
with	O	O
Lactobacillus	B-bacteria	B-bacteria
sp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
after	O	O
the	O	O
time	O	O
of	O	O
observation	O	O
is	O	O
implied	O	O
.	O	O

Imbalance	O	O
in	O	O
the	O	O
resident	O	O
microbiota	O	O
may	O	O
promote	O	O
the	O	O
growth	O	O
of	O	O
opportunistic	O	O
microorganisms	O	O
,	O	O
such	O	O
as	O	O
yeasts	O	O
of	O	O
Candida	O	O
genus	O	O
and	O	O
the	O	O
development	O	O
of	O	O
diseases	O	O
,	O	O
especially	O	O
in	O	O
aged	O	O
people	O	O
.	O	O

This	O	O
study	O	O
evaluated	O	O
whether	O	O
the	O	O
consumption	O	O
of	O	O
the	O	O
probiotic	O	O
Yakult	B-bacteria	B-bacteria
LBz	E-bacteria	I-bacteria
(	O	O
(	O	O
R	O	O
)	O	O
)	O	O
(	O	O
Lactobacillus	B-bacteria	B-bacteria
casei	E-bacteria	I-bacteria
and	O	O
Bifidobacterium	B-bacteria	B-bacteria
breve	E-bacteria	I-bacteria
)	O	O
was	O	O
able	O	O
to	O	O
influence	O	O
on	O	O
the	O	O
specific	O	O
immunological	O	O
response	O	O
against	O	O
Candida	O	O
and	O	O
on	O	O
the	O	O
presence	O	O
of	O	O
these	O	O
yeasts	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
42	O	O
healthy	O	O
aged	O	O
individuals	O	O
.	O	O

Saliva	O	O
samples	O	O
were	O	O
collected	O	O
before	O	O
and	O	O
after	O	O
the	O	O
probiotic	O	O
use	O	O
for	O	O
30	O	O
days	O	O
,	O	O
3	O	O
times	O	O
a	O	O
week	O	O
.	O	O

The	O	O
samples	O	O
were	O	O
plated	O	O
in	O	O
Dextrose	O	O
Saboraud	O	O
Agar	O	O
with	O	O
chloramphenicol	O	O
,	O	O
the	O	O
colony-forming	O	O
units	O	O
(	O	O
CFU/mL	O	O
)	O	O
were	O	O
counted	O	O
and	O	O
the	O	O
Candida	O	O
species	O	O
were	O	O
identified	O	O
.	O	O

Anti-Candida	O	O
IgA	O	O
analysis	O	O
was	O	O
conducted	O	O
using	O	O
the	O	O
ELISA	O	O
technique	O	O
.	O	O

ANOVA	O	O
and	O	O
Student	O	O
's	O	O
t-test	O	O
were	O	O
used	O	O
for	O	O
normally	O	O
distributed	O	O
data	O	O
and	O	O
the	O	O
Wilcoxon	O	O
test	O	O
was	O	O
used	O	O
for	O	O
data	O	O
with	O	O
non-normal	O	O
distribution	O	O
(	O	O
alpha=0.05	O	O
)	O	O
.	O	O

The	O	O
results	O	O
showed	O	O
a	O	O
statistically	O	O
significant	O	O
reduction	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
Candida	O	O
prevalence	O	O
(	O	O
from	O	O
92.9	O	O
%	O	O
to	O	O
85.7	O	O
%	O	O
)	O	O
,	O	O
in	O	O
CFU/mL	O	O
counts	O	O
of	O	O
Candida	O	O
and	O	O
in	O	O
the	O	O
number	O	O
of	O	O
non-albicans	O	O
species	O	O
after	O	O
consumption	O	O
of	O	O
the	O	O
probiotic	O	O
.	O	O

Immunological	O	O
analysis	O	O
demonstrated	O	O
a	O	O
significant	O	O
increase	O	O
(	O	O
p	O	O
<	O	O
0.05	O	O
)	O	O
in	O	O
anti-Candida	O	O
IgA	O	O
levels	O	O
.	O	O

In	O	O
conclusion	O	O
,	O	O
probiotic	O	O
bacteria	O	O
reduced	O	O
Candida	O	O
numbers	O	O
in	O	O
the	O	O
oral	O	O
cavity	O	O
of	O	O
the	O	O
elderly	O	O
and	O	O
increased	O	O
specific	O	O
secretory	O	O
immune	O	O
response	O	O
against	O	O
these	O	O
yeasts	O	O
,	O	O
suggesting	O	O
its	O	O
possible	O	O
use	O	O
in	O	O
controlling	O	O
oral	O	O
candidosis	O	O
.	O	O

Recent	O	O
insights	O	O
in	O	O
medical	O	O
science	O	O
indicate	O	O
that	O	O
human	O	O
biofilms	O	O
play	O	O
an	O	O
important	O	O
role	O	O
in	O	O
health	O	O
and	O	O
well-being	O	O
,	O	O
and	O	O
have	O	O
put	O	O
microbiota	O	O
modulation	O	O
through	O	O
bacteriotherapy	O	O
into	O	O
focus	O	O
.	O	O

In	O	O
dentistry	O	O
,	O	O
bacterial	O	O
interference	O	O
with	O	O
probiotic	B-bacteria	B-bacteria
bacteria	E-bacteria	I-bacteria
to	O	O
support	O	O
the	O	O
stability	O	O
and	O	O
diversity	O	O
of	O	O
oral	O	O
biofilms	O	O
has	O	O
gained	O	O
similar	O	O
interest	O	O
.	O	O

Investigations	O	O
in	O	O
vitro	O	O
into	O	O
metabolic	O	O
activity	O	O
,	O	O
co-aggregation	O	O
,	O	O
growth	O	O
inhibition	O	O
,	O	O
bacteriocin	O	O
production	O	O
,	O	O
and	O	O
adhesion	O	O
have	O	O
collectively	O	O
suggested	O	O
a	O	O
potential	O	O
role	O	O
for	O	O
probiotic	O	O
lactobacilli	B-bacteria	B-bacteria
and	O	O
bifidobacteria	B-bacteria	B-bacteria
to	O	O
modulate	O	O
the	O	O
oral	O	O
microbial	O	O
ecology	O	O
.	O	O

Likewise	O	O
,	O	O
short-term	O	O
clinical	O	O
studies	O	O
with	O	O
intermediate	O	O
microbial	O	O
endpoints	O	O
indicate	O	O
that	O	O
interference	O	O
with	O	O
caries-associated	O	O
bacteria	O	O
seems	O	O
possible	O	O
through	O	O
probiotic	O	O
dairy	O	O
products	O	O
,	O	O
tablets	O	O
,	O	O
lozenges	O	O
and	O	O
chewing	O	O
gum	O	O
in	O	O
various	O	O
dose	O	O
regimens	O	O
.	O	O

Few	O	O
randomized	O	O
controlled	O	O
clinical	O	O
trials	O	O
with	O	O
caries	O	O
outcomes	O	O
are	O	O
available	O	O
,	O	O
but	O	O
three	O	O
studies	O	O
with	O	O
preschool	O	O
children	O	O
and	O	O
the	O	O
elderly	O	O
have	O	O
demonstrated	O	O
preventive	O	O
fractions	O	O
between	O	O
21	O	O
%	O	O
and	O	O
75	O	O
%	O	O
,	O	O
following	O	O
regular	O	O
intake	O	O
of	O	O
milk	O	O
supplemented	O	O
with	O	O
probiotic	O	O
lactobacilli	B-bacteria	B-bacteria
.	O	O

However	O	O
,	O	O
further	O	O
large-scale	O	O
trials	O	O
with	O	O
orally	O	O
derived	O	O
anti-caries	O	O
candidates	O	O
are	O	O
needed	O	O
before	O	O
we	O	O
can	O	O
say	O	O
that	O	O
we	O	O
are	O	O
ready	O	O
for	O	O
bacteriotherapy	O	O
as	O	O
an	O	O
adjunct	O	O
to	O	O
complement	O	O
the	O	O
existing	O	O
evidence-based	O	O
methods	O	O
for	O	O
preventing	O	O
and	O	O
controlling	O	O
caries	O	O
in	O	O
daily	O	O
practice	O	O
.	O	O

Dental	O	O
caries	O	O
is	O	O
the	O	O
destruction	O	O
of	O	O
enamel	O	O
,	O	O
dentin	O	O
,	O	O
or	O	O
cementum	O	O
of	O	O
teeth	O	O
due	O	O
to	O	O
bacterial	O	O
activities	O	O
,	O	O
which	O	O
if	O	O
left	O	O
untreated	O	O
can	O	O
cause	O	O
considerable	O	O
pain	O	O
,	O	O
discomfort	O	O
,	O	O

treatment	O	O
costs	O	O
are	O	O
very	O	O
high	O	O
.	O	O

Of	O	O
the	O	O
oral	O	O
bacteria	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
is	O	O
considered	O	O
to	O	O
be	O	O
causative	O	O
agent	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
humans	O	O
.	O	O

This	O	O

aims	O	O
at	O	O
screening	O	O
the	O	O
antibacterial	O	O
potential	O	O
of	O	O
available	O	O
oral	O	O
hygiene	O	O
products	O	O
against	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
the	O	O
primary	O	O
etiological	O	O
agent	O	O
.	O	O

selective	O	O
number	O	O
of	O	O
toothpaste	O	O
mouth	O	O
rinse	O	O
available	O	O
in	O	O
the	O	O
nearby	O	O
local	O	O
market	O	O
was	O	O
subjected	O	O
to	O	O
the	O	O
.	O	O

The	O	O
experiments	O	O
were	O	O
designed	O	O
in	O	O
a	O	O
way	O	O
to	O	O
determine	O	O
which	O	O
one	O	O
of	O	O
these	O	O
products	O	O
had	O	O
the	O	O
greatest	O	O
anti-S.mutans	O	O
activity	O	O
.	O	O

Antibiotic	O	O
sensitivity	O	O
tests	O	O
against	O	O
the	O	O
pathogenic	O	O
strains	O	O
were	O	O
also	O	O
conducted	O	O
.	O	O


Pathogenic	O	O
strains	O	O
of	O	O
S.mutans	B-bacteria	B-bacteria
were	O	O
isolated	O	O
from	O	O
clinical	O	O
dental	O	O
specimen	O	O

identified	O	O
using	O	O
MTCC	O	O
standard	O	O
strain	O	O
No	B-bacteria	B-bacteria
.	I-bacteria	I-bacteria
890	E-bacteria	I-bacteria
.	O	O

Of	O	O
the	O	O
86.66	O	O
%	O	O
samples	O	O
which	O	O
showed	O	O
positive	O	O
for	O	O
S.mutans	B-bacteria	B-bacteria
growth	O	O
,	O	O
almost	O	O
96	O	O
%	O	O
conferred	O	O
sensitivity	O	O
to	O	O
0.08	O	O
mg/ml	O	O
of	O	O
penicillin	O	O
.	O	O

Among	O	O
the	O	O
toothpastes	O	O
used	O	O
,	O	O
A	O	O
showed	O	O
the	O	O
maximum	O	O
inhibitory	O	O
activity	O	O
against	O	O
S.mutans	B-bacteria	B-bacteria
inhibiting	O	O
its	O	O
growth	O	O
even	O	O
at	O	O
a	O	O
very	O	O
low	O	O
concentration	O	O
of	O	O
0.0156	O	O
g/ml	O	O
.	O	O

Similar	O	O
results	O	O
were	O	O
seen	O	O
in	O	O
the	O	O
case	O	O
of	O	O
the	O	O
mouth	O	O
rinses	O	O
used	O	O
for	O	O
the	O	O

,	O	O
which	O	O
showed	O	O
that	O	O
N	O	O
had	O	O
the	O	O
most	O	O
effective	O	O
activity	O	O
against	O	O
S.mutans	B-bacteria	B-bacteria
even	O	O
at	O	O
1:8	O	O
dilution	O	O
.	O	O

The	O	O
oral	O	O
hygiene	O	O
products	O	O
containing	O	O
triclosan	O	O
proved	O	O
to	O	O
be	O	O
the	O	O
most	O	O
effective	O	O
followed	O	O
by	O	O
those	O	O
containing	O	O
fluoride	O	O
.	O	O

Herbal	O	O
products	O	O
showed	O	O
comparatively	O	O
lesser	O	O
activity	O	O
in	O	O
inhibiting	O	O
the	O	O
growth	O	O
of	O	O
S.	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
.	O	O

Even	O	O
though	O	O
there	O	O
are	O	O
so	O	O
many	O	O
products	O	O
available	O	O
to	O	O
curb	O	O
the	O	O
progression	O	O
of	O	O
dental	O	O
caries	O	O
in	O	O
the	O	O
population	O	O
targeted	O	O
,	O	O
there	O	O
is	O	O
still	O	O
an	O	O
undoubted	O	O
prevalence	O	O

incidence	O	O
of	O	O
caries	O	O
among	O	O
the	O	O
general	O	O
public	O	O
.	O	O

The	O	O
need	O	O
for	O	O
a	O	O
better	O	O
alternative	O	O
to	O	O
help	O	O
control	O	O
dental	O	O
caries	O	O
is	O	O
on	O	O
the	O	O
rise	O	O
even	O	O
today	O	O
.	O	O

We	O	O
have	O	O
isolated	O	O
4	O	O
antibacterial	O	O
substances	O	O
that	O	O
were	O	O
active	O	O
against	O	O
the	O	O
oral	O	O
bacteria	O	O
that	O	O
cause	O	O
dental	O	O
caries	O	O
and	O	O
periodontitis	O	O
,	O	O
such	O	O
as	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
and	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
from	O	O
lemon	O	O
peel	O	O
,	O	O
a	O	O
waste	O	O
product	O	O
in	O	O
the	O	O
citrus	O	O
industry	O	O
.	O	O

The	O	O
isolated	O	O
substances	O	O
were	O	O
identified	O	O
as	O	O
8-geranyloxypsolaren	O	O
,	O	O
5-geranyloxypsolaren	O	O
,	O	O
5-geranyloxy-7-methoxycoumarin	O	O
,	O	O
and	O	O
phloroglucinol	O	O
1-beta-D-glucopyranoside	O	O
(	O	O
phlorin	O	O
)	O	O
upon	O	O
structural	O	O
analyses	O	O
.	O	O

Among	O	O
these	O	O
,	O	O
8-Geranyloxypsolaren	O	O
,	O	O
5-geranyloxypsolaren	O	O
,	O	O
and	O	O
5-geranyloxy-7-methoxycoumarin	O	O
exhibited	O	O
high	O	O
antibacterial	O	O
activity	O	O
.	O	O

These	O	O
3	O	O
compounds	O	O
were	O	O
effectively	O	O
extracted	O	O
using	O	O
ethanol	O	O
and	O	O
n-hexane	O	O
,	O	O
whereas	O	O
phlorin	O	O
was	O	O
extracted	O	O
with	O	O
water	O	O
.	O	O

Further	O	O
,	O	O
the	O	O
above	O	O
3	O	O
compounds	O	O
were	O	O
present	O	O
in	O	O
lemon	O	O
essential	O	O
oil	O	O
and	O	O
abundantly	O	O
present	O	O
in	O	O
the	O	O
residue	O	O
produced	O	O
upon	O	O
the	O	O
cooling	O	O
treatment	O	O
of	O	O
concentrated	O	O
lemon	O	O
essential	O	O
oil	O	O
.	O	O

The	O	O
aim	O	O
of	O	O
this	O	O
study	O	O
was	O	O
to	O	O
find	O	O
the	O	O
oral	O	O
isolate	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
,	O	O
which	O	O
has	O	O
the	O	O
potential	O	O
to	O	O
inhibit	O	O
either	O	O
periodontal	O	O
,	O	O
cariogenic	O	O
,	O	O
or	O	O
fungal	O	O
pathogens	O	O
in	O	O
vitro	O	O
,	O	O
and	O	O
to	O	O
examine	O	O
the	O	O
effects	O	O
of	O	O
bovine	O	O
milk	O	O
fermented	O	O
with	O	O
the	O	O
isolate	O	O
on	O	O
the	O	O
oral	O	O
carriage	O	O
of	O	O
cariogenic	O	O
and	O	O
periodontal	O	O
pathogens	O	O
.	O	O

The	O	O
inhibitory	O	O
effects	O	O
of	O	O
the	O	O
supernatant	O	O
of	O	O
Man-Rogosa-Sharpe	O	O
broth	O	O
,	O	O
in	O	O
which	O	O
each	O	O
of	O	O
42	O	O
oral	O	O
isolates	O	O
of	O	O
lactobacilli	B-bacteria	B-bacteria
grown	O	O
,	O	O
was	O	O
examined	O	O
.	O	O

One	O	O
isolate	O	O
,	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
L8020	E-bacteria	I-bacteria
,	O	O
that	O	O
showed	O	O
the	O	O
potential	O	O
to	O	O
inhibit	O	O
either	O	O
periodontal	O	O
,	O	O
cariogenic	O	O
,	O	O
or	O	O
fungal	O	O
pathogens	O	O
in	O	O
vitro	O	O
,	O	O
was	O	O
used	O	O
to	O	O
examine	O	O
the	O	O
effects	O	O
of	O	O
fermented	O	O
milk	O	O
on	O	O
the	O	O
oral	O	O
carriage	O	O
of	O	O
cariogenic	O	O
and	O	O
periodontal	O	O
pathogens	O	O
,	O	O
which	O	O
was	O	O
examined	O	O
by	O	O
a	O	O
placebo-controlled	O	O
and	O	O
cohort	O	O
trial	O	O
using	O	O
50	O	O
participants	O	O
.	O	O

Edible	O	O
yogurt	O	O
containing	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
L8020	E-bacteria	I-bacteria
significantly	O	O
reduced	O	O
the	O	O
oral	O	O
carriage	O	O
of	O	O
mutans	B-bacteria	B-bacteria
streptococci	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
and	O	O
four	O	O
periodontal	O	O
pathogens	O	O
examined	O	O
:	O	O
Porphyromonas	B-bacteria	B-bacteria
gingivalis	E-bacteria	I-bacteria
,	O	O
Prevotella	B-bacteria	B-bacteria
intermedia	E-bacteria	I-bacteria
,	O	O
Tannerella	B-bacteria	B-bacteria
forsythia	O	O
,	O	O
and	O	O
Fusobacterium	B-bacteria	B-bacteria
spp	I-bacteria	I-bacteria
.	E-bacteria	I-bacteria
(	O	O
P	O	O
<	O	O
0.01	O	O
)	O	O
,	O	O
but	O	O
the	O	O
phenomenon	O	O
were	O	O
not	O	O
observed	O	O
with	O	O
the	O	O
placebo	O	O
yogurt	O	O
(	O	O
P	O	O
>	O	O
0.05	O	O
)	O	O
.	O	O

These	O	O
results	O	O
suggest	O	O
that	O	O
yogurt	O	O
with	O	O
Lactobacillus	B-bacteria	B-bacteria
rhamnosus	I-bacteria	I-bacteria
L8020	E-bacteria	I-bacteria
could	O	O
reduce	O	O
the	O	O
risk	O	O
of	O	O
dental	O	O
caries	O	O
and	O	O
periodontal	O	O
disease	O	O
.	O	O

The	O	O
polysaccharide	O	O
gel	O	O
(	O	O
PG	O	O
)	O	O
extract	O	O
from	O	O
durian	O	O
fruit	O	O
rinds	O	O
(	O	O
Durio	O	O
zibethinus	O	O
Murr	O	O
.	O	O
``	O	O
Monthong	O	O
''	O	O
)	O	O
is	O	O
a	O	O
pectic	O	O
polysaccharide	O	O
with	O	O
antibacterial	O	O
activity	O	O
.	O	O

This	O	O
study	O	O
aimed	O	O
to	O	O
investigate	O	O
the	O	O
in	O	O
vitro	O	O
antibacterial	O	O
activity	O	O
of	O	O
PG	O	O
against	O	O
oral	O	O
pathogens	O	O
,	O	O
Streptococcus	B-bacteria	B-bacteria
mutans	E-bacteria	I-bacteria
(	O	O
S.mutans	B-bacteria	B-bacteria
)	O	O
and	O	O
Aggregatibacter	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
A.actinomycetemcomitans	B-bacteria	B-bacteria
)	O	O
.	O	O

The	O	O
inhibitory	O	O
activity	O	O
of	O	O
PG	O	O
at	O	O
50	O	O
,	O	O
100	O	O
,	O	O
and	O	O
150	O	O
mg/mL	O	O
against	O	O
S.mutans	B-bacteria	B-bacteria
(	O	O
American	O	O
Tissue	O	O
Culture	O	O
Collection	O	O
25175	O	O
)	O	O
and	O	O
A.	B-bacteria	B-bacteria
actinomycetemcomitans	E-bacteria	I-bacteria
(	O	O
American	O	O
Tissue	O	O
Culture	O	O
Collection	O	O
43718	O	O
)	O	O
was	O	O
determined	O	O
after	O	O
1-	O	O
and	O	O
5-min	O	O
exposure	O	O
by	O	O
broth	O	O
macrodilution	O	O
susceptibility	O	O
test	O	O
and	O	O
scanning	O	O
electron	O	O
microscopy	O	O
.	O	O

Normal	O	O
saline	O	O
or	O	O
culture	O	O
broth	O	O
medium	O	O
and	O	O
0.1	O	O
%	O	O
chlorhexidine	O	O
were	O	O
used	O	O
as	O	O
negative	O	O
and	O	O
positive	O	O
controls	O	O
,	O	O
respectively	O	O
.	O	O

For	O	O
1-min	O	O
exposure	O	O
,	O	O
150	O	O
mg/mL	O	O
PG	O	O
or	O	O
0.1	O	O
%	O	O
chlorhexidine	O	O
significantly	O	O
possessed	O	O
bactericidal	O	O
activity	O	O
against	O	O
both	O	O
tested	O	O
bacteria	O	O
(	O	O
P=0.037	O	O
)	O	O
,	O	O
while	O	O
PG	O	O
at	O	O
100	O	O
mg/mL	O	O
possessed	O	O
significant	O	O
bactericidal	O	O
activity	O	O
against	O	O
S.mutans	B-bacteria	B-bacteria
(	O	O
P=0.037	O	O
)	O	O
and	O	O
inhibitory	O	O
activity	O	O
against	O	O
A.actinomycetemcomitans	B-bacteria	B-bacteria
(	O	O
P=0.05	O	O
)	O	O
.	O	O

Blebs	O	O
,	O	O
irregular-shaped	O	O
cells	O	O
,	O	O
and	O	O
disrupted	O	O
cells	O	O
were	O	O
found	O	O
in	O	O
bacteria	O	O
treated	O	O
with	O	O
either	O	O
0.1	O	O
%	O	O
chlorhexidine	O	O
or	O	O
50-150mg/mL	O	O
PG	O	O
under	O	O
scanning	O	O
electron	O	O
microscopy	O	O
.	O	O

The	O	O
bactericidal	O	O
activity	O	O
of	O	O
PG	O	O
at	O	O
150	O	O
mg/mL	O	O
against	O	O
oral	O	O
bacteria	O	O
at	O	O
1-min	O	O
exposure	O	O
suggests	O	O
its	O	O
possibility	O	O
to	O	O
be	O	O
used	O	O
as	O	O
a	O	O
natural	O	O
antibacterial	O	O
ingredient	O	O
in	O	O
oral	O	O
hygiene	O	O
products	O	O
.	O	O

